date,datetime,title,summary,url,source,search_query,raw_content,finbert_sentiment,finbert_label,finbert_confidence,distilbert_sentiment,distilbert_label,distilbert_confidence,vader_compound,vader_positive,vader_negative,vader_neutral,textblob_polarity,textblob_subjectivity,ensemble_sentiment,confidence,fda_milestone_type,milestone_confidence,milestone_keywords_found,drug_specific,company_specific,importance_score,semantic_score
2015-04-02,2015-04-02 07:00:00,Biocon's Syngene to build a plant in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5"" target=""_blank"">Biocon's Syngene to build a plant in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5,Google News,Biocon profit,"Biocon's Syngene to build a plant in India - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5"" target=""_blank"">Biocon's Syngene to build a plant in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.7352352738380432,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7352352738380432,other,0.0,[],False,True,6,0.0
2016-02-11,2016-02-11 08:00:00,India’s First Lady Of Biotech - Asian Scientist Magazine,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPSDlHMVFzWFRwN1FETUFkaThiR0ZvWnJFbkZGb2k0aFRXZm5ESmFaQkRadllnQ1FBMHU2c1ZUSHk1dTdkS3F4UDBiMFRaY3hJUG9US0wyekJlcnVsb2hVTEpuTXNzVThEeG9aa0t6OU1xcVhRczgxaVByUlhLckVOS0cycHg3aXNCQm9pTGZQbUFEV2ZJVnlZNGhjbi0?oc=5"" target=""_blank"">India’s First Lady Of Biotech</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Asian Scientist Magazine</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxPSDlHMVFzWFRwN1FETUFkaThiR0ZvWnJFbkZGb2k0aFRXZm5ESmFaQkRadllnQ1FBMHU2c1ZUSHk1dTdkS3F4UDBiMFRaY3hJUG9US0wyekJlcnVsb2hVTEpuTXNzVThEeG9aa0t6OU1xcVhRczgxaVByUlhLckVOS0cycHg3aXNCQm9pTGZQbUFEV2ZJVnlZNGhjbi0?oc=5,Google News,Biocon guidance,"India’s First Lady Of Biotech - Asian Scientist Magazine <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPSDlHMVFzWFRwN1FETUFkaThiR0ZvWnJFbkZGb2k0aFRXZm5ESmFaQkRadllnQ1FBMHU2c1ZUSHk1dTdkS3F4UDBiMFRaY3hJUG9US0wyekJlcnVsb2hVTEpuTXNzVThEeG9aa0t6OU1xcVhRczgxaVByUlhLckVOS0cycHg3aXNCQm9pTGZQbUFEV2ZJVnlZNGhjbi0?oc=5"" target=""_blank"">India’s First Lady Of Biotech</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Asian Scientist Magazine</font>",0.0,neutral,0.9062685370445251,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.125,0.16666666666666666,0.0,0.5156342685222626,other,0.0,[],False,False,1,0.0
2016-10-21,2016-10-21 07:00:00,Biocon's Malaysia insulin plant will be ready for commercial production in H2 - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxNLUFfeE9nVVRoc01XRW10U041OUVBaUJGam1iSW9yZ1JTT19LdE43NFNsZ2lJUWNUeVFOOVFXcVRLSmtNanM2dVF4ZTJnOE83VTZHMWVJbmxsVGUzbWloSTYtR3FzRGhrVlNEM0g5c1pxOEs2alQ4cmdnZkcwc05vQlhfZExPMlFpQjMzLWR3QzY3cEJ4cG9kaDBHTHZnbzBjOWxZN2tOeFhkZEJCQldISy1XQ25aTl9Z?oc=5"" target=""_blank"">Biocon's Malaysia insulin plant will be ready for commercial production in H2</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxNLUFfeE9nVVRoc01XRW10U041OUVBaUJGam1iSW9yZ1JTT19LdE43NFNsZ2lJUWNUeVFOOVFXcVRLSmtNanM2dVF4ZTJnOE83VTZHMWVJbmxsVGUzbWloSTYtR3FzRGhrVlNEM0g5c1pxOEs2alQ4cmdnZkcwc05vQlhfZExPMlFpQjMzLWR3QzY3cEJ4cG9kaDBHTHZnbzBjOWxZN2tOeFhkZEJCQldISy1XQ25aTl9Z?oc=5,Google News,Biocon investor call,"Biocon's Malaysia insulin plant will be ready for commercial production in H2 - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxNLUFfeE9nVVRoc01XRW10U041OUVBaUJGam1iSW9yZ1JTT19LdE43NFNsZ2lJUWNUeVFOOVFXcVRLSmtNanM2dVF4ZTJnOE83VTZHMWVJbmxsVGUzbWloSTYtR3FzRGhrVlNEM0g5c1pxOEs2alQ4cmdnZkcwc05vQlhfZExPMlFpQjMzLWR3QzY3cEJ4cG9kaDBHTHZnbzBjOWxZN2tOeFhkZEJCQldISy1XQ25aTl9Z?oc=5"" target=""_blank"">Biocon's Malaysia insulin plant will be ready for commercial production in H2</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.5138480067253113,0.0,neutral,0.0,0.6124,0.152,0.0,0.848,0.08,0.2,0.0,0.40208266890843714,other,0.0,[],False,True,6,0.0
2015-12-02,2015-12-02 08:00:00,The Drug Rep Will See You Now - Type Investigations,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxQT0JLMC15OWFFN2VORk50NHAzbWJNdEFBci1wYkU0RHVJSjl0aENlYXRlRmdoc0RaYVNuejJJMHJaZ2NVU1A4ZWNFLUkwTEtGNmxIdnZLMWlHY043V3hmZlpRM01PNlRkNVlZNkFQdUc3UVZWWDMyeHhmMzFLeTFpQm9pZkQxbWM3cWc?oc=5"" target=""_blank"">The Drug Rep Will See You Now</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Type Investigations</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxQT0JLMC15OWFFN2VORk50NHAzbWJNdEFBci1wYkU0RHVJSjl0aENlYXRlRmdoc0RaYVNuejJJMHJaZ2NVU1A4ZWNFLUkwTEtGNmxIdnZLMWlHY043V3hmZlpRM01PNlRkNVlZNkFQdUc3UVZWWDMyeHhmMzFLeTFpQm9pZkQxbWM3cWc?oc=5,Google News,Biocon investor call,"The Drug Rep Will See You Now - Type Investigations <a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxQT0JLMC15OWFFN2VORk50NHAzbWJNdEFBci1wYkU0RHVJSjl0aENlYXRlRmdoc0RaYVNuejJJMHJaZ2NVU1A4ZWNFLUkwTEtGNmxIdnZLMWlHY043V3hmZlpRM01PNlRkNVlZNkFQdUc3UVZWWDMyeHhmMzFLeTFpQm9pZkQxbWM3cWc?oc=5"" target=""_blank"">The Drug Rep Will See You Now</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Type Investigations</font>",0.0,neutral,0.9398220181465149,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9398220181465149,other,0.0,[],False,False,1,0.0
2015-07-23,2015-07-23 07:00:00,UBL Q1 profits down by 4.7% to Rs 123 cr - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">UBL Q1 profits down by 4.7% to Rs 123 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"UBL Q1 profits down by 4.7% to Rs 123 cr - Business Standard <a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxNdE1kTHZsZUJneVprVm1vQkVCTlNiQXMyajdfU0RyWFpLSmV0RGh3bnFuRExGS1lTdW4yZ2x2czkyMVBNdEYzdVFHSnBISGxDRVNTbS1RTWotLTVUV2RET0xiWW80T2hMdEhmVVZ3aHpNRTdTaTdJN0s0LU9feU5uYV9HZjVvNFZKb3puWm9fUjRmdVgzbnJwRHFTU0Y0SHc1Mno5TUNUQTBxQlU5djA3YtIBtgFBVV95cUxQNWtSSTdGQUlPMTdXcDU4ZnFsV0xJcjBGQUt5UHVvajVTUGpXMXRpQWNzemUwT20wb1FOeVNENE5YZHBHRldJRnltSU02blpka3Bmdi11TlNocV9CY3ZXbDNvRE9WTzV3ekNWdTZnd1gzMFZqdW1pSzNPcndLWVl3MENHV1RlZHpvUDZxSmJWYk8tZWFYVWxDUkd0Qy1mVlRjWGxnVzRzcjF5QjZMSU1xUzJvemVKUQ?oc=5"" target=""_blank"">UBL Q1 profits down by 4.7% to Rs 123 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9749910831451416,negative,0.9749910831451416,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,-0.07777777777777778,0.14444444444444446,-0.5571377617972237,0.5843562869743064,other,0.0,[],False,False,1,0.0
2016-07-22,2016-07-22 07:00:00,"Axis Bank Q1 profit dips 21% at Rs 1,556 crore - Business Standard","<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxPZXppMjUtbVZKdzZrTGNmd3NfY1lxNmx3eUdSaVlPYWZLd1c3SVVkQ1V2NnVBRjlEZjFpX2lhYXNPZ09tdzZwb195ckd6QmJyMlNIUzV6Y2Q2UjNxVVVZa2ZMYU10TjhGYklCZ3EwZnkteGdybUhjWnEyVXgwMnM5MHNkNURQV01BMWV5UjItamlXMXZFdnE3MW9lTVBpVEtpVEEtZ2lPbVdBOG9hM21SRE5LcnI1bXJI0gG-AUFVX3lxTE5Ud1FPa0JGc1BGVXRZTGMzY0xYM21hbERHTV9UWjA4bVViYnZOU3N0eWVSZjFVLTJrWWk2R2lWMFlrU19CTnpHWngwdXNMalVnc3Z2dEdxc2xZcEtHSGRGLVBPWmE4aUt0dXpFRkVOTU5kUDhHelhzU1RkZU5RekpzN1UxY04xamhsUjNRUGRrSTNzb1dkYlVhSmRVYVB4QUhvWlk0MDVPUTZQZFNOaExGT1R5aTRxZUtST2ZCQWc?oc=5"" target=""_blank"">Axis Bank Q1 profit dips 21% at Rs 1,556 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxPZXppMjUtbVZKdzZrTGNmd3NfY1lxNmx3eUdSaVlPYWZLd1c3SVVkQ1V2NnVBRjlEZjFpX2lhYXNPZ09tdzZwb195ckd6QmJyMlNIUzV6Y2Q2UjNxVVVZa2ZMYU10TjhGYklCZ3EwZnkteGdybUhjWnEyVXgwMnM5MHNkNURQV01BMWV5UjItamlXMXZFdnE3MW9lTVBpVEtpVEEtZ2lPbVdBOG9hM21SRE5LcnI1bXJI0gG-AUFVX3lxTE5Ud1FPa0JGc1BGVXRZTGMzY0xYM21hbERHTV9UWjA4bVViYnZOU3N0eWVSZjFVLTJrWWk2R2lWMFlrU19CTnpHWngwdXNMalVnc3Z2dEdxc2xZcEtHSGRGLVBPWmE4aUt0dXpFRkVOTU5kUDhHelhzU1RkZU5RekpzN1UxY04xamhsUjNRUGRrSTNzb1dkYlVhSmRVYVB4QUhvWlk0MDVPUTZQZFNOaExGT1R5aTRxZUtST2ZCQWc?oc=5,Google News,Biocon Q1 earnings,"Axis Bank Q1 profit dips 21% at Rs 1,556 crore - Business Standard <a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxPZXppMjUtbVZKdzZrTGNmd3NfY1lxNmx3eUdSaVlPYWZLd1c3SVVkQ1V2NnVBRjlEZjFpX2lhYXNPZ09tdzZwb195ckd6QmJyMlNIUzV6Y2Q2UjNxVVVZa2ZMYU10TjhGYklCZ3EwZnkteGdybUhjWnEyVXgwMnM5MHNkNURQV01BMWV5UjItamlXMXZFdnE3MW9lTVBpVEtpVEEtZ2lPbVdBOG9hM21SRE5LcnI1bXJI0gG-AUFVX3lxTE5Ud1FPa0JGc1BGVXRZTGMzY0xYM21hbERHTV9UWjA4bVViYnZOU3N0eWVSZjFVLTJrWWk2R2lWMFlrU19CTnpHWngwdXNMalVnc3Z2dEdxc2xZcEtHSGRGLVBPWmE4aUt0dXpFRkVOTU5kUDhHelhzU1RkZU5RekpzN1UxY04xamhsUjNRUGRrSTNzb1dkYlVhSmRVYVB4QUhvWlk0MDVPUTZQZFNOaExGT1R5aTRxZUtST2ZCQWc?oc=5"" target=""_blank"">Axis Bank Q1 profit dips 21% at Rs 1,556 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9659640789031982,negative,0.9659640789031982,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,0.0,0.0,-0.5519794736589704,0.8331320394515991,other,0.0,[],False,False,1,0.0
2016-07-15,2016-07-15 07:00:00,Gujarat bourses have most vanishing firms - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Gujarat bourses have most vanishing firms</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"Gujarat bourses have most vanishing firms - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Gujarat bourses have most vanishing firms</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.791222095489502,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.25,0.25,0.0,0.520611047744751,other,0.0,[],False,False,1,0.0
2016-04-29,2016-04-29 07:00:00,Dabur profit jumps 17% - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNREtIbkk1UHQyS1RDdy1CMFJPc1NsaDZxd2VRTmR5Nm5hQU1wSXNsU012clR2Z2d3dWxrallzUFBLbWtJZWs1XzlIcTRYZklmd0NYYzB6dDB5UjI1cldRUXRncmtBbGUxaXRBUE1ab1ZMQ2xLNTRNRFdaRUVpbGVFRi1Nd2F3UHpkNGhFUlhBWEdGTFR1Sjd2QtIBngFBVV95cUxQTzd0MGZaS1dyWGh5ZVY3bnJtNkhsVU5IdHA4UndwcXF0M3dIQS1ialBiZ3hiS0otMkhQWW54bERPVU9Jam9jRU1lcmpiUmFCRUpvSzJhT2ZHUmxYTURBcVEyMk5fb1pWa1JnQl8tTjhka05kaVZJUTBCS09GNXY5UzVMQkQ0MXQ3bFBIb0lLbFliU3h0VWxJUEpkTTFNZw?oc=5"" target=""_blank"">Dabur profit jumps 17%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxNREtIbkk1UHQyS1RDdy1CMFJPc1NsaDZxd2VRTmR5Nm5hQU1wSXNsU012clR2Z2d3dWxrallzUFBLbWtJZWs1XzlIcTRYZklmd0NYYzB6dDB5UjI1cldRUXRncmtBbGUxaXRBUE1ab1ZMQ2xLNTRNRFdaRUVpbGVFRi1Nd2F3UHpkNGhFUlhBWEdGTFR1Sjd2QtIBngFBVV95cUxQTzd0MGZaS1dyWGh5ZVY3bnJtNkhsVU5IdHA4UndwcXF0M3dIQS1ialBiZ3hiS0otMkhQWW54bERPVU9Jam9jRU1lcmpiUmFCRUpvSzJhT2ZHUmxYTURBcVEyMk5fb1pWa1JnQl8tTjhka05kaVZJUTBCS09GNXY5UzVMQkQ0MXQ3bFBIb0lLbFliU3h0VWxJUEpkTTFNZw?oc=5,Google News,Biocon Q4 earnings,"Dabur profit jumps 17% - Business Standard <a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNREtIbkk1UHQyS1RDdy1CMFJPc1NsaDZxd2VRTmR5Nm5hQU1wSXNsU012clR2Z2d3dWxrallzUFBLbWtJZWs1XzlIcTRYZklmd0NYYzB6dDB5UjI1cldRUXRncmtBbGUxaXRBUE1ab1ZMQ2xLNTRNRFdaRUVpbGVFRi1Nd2F3UHpkNGhFUlhBWEdGTFR1Sjd2QtIBngFBVV95cUxQTzd0MGZaS1dyWGh5ZVY3bnJtNkhsVU5IdHA4UndwcXF0M3dIQS1ialBiZ3hiS0otMkhQWW54bERPVU9Jam9jRU1lcmpiUmFCRUpvSzJhT2ZHUmxYTURBcVEyMk5fb1pWa1JnQl8tTjhka05kaVZJUTBCS09GNXY5UzVMQkQ0MXQ3bFBIb0lLbFliU3h0VWxJUEpkTTFNZw?oc=5"" target=""_blank"">Dabur profit jumps 17%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8377547860145569,positive,0.8377547860145569,0.0,neutral,0.0,0.7003,0.326,0.0,0.674,0.0,0.0,0.47871702057974674,0.7690273930072784,other,0.0,[],False,False,1,0.0
2016-05-17,2016-05-17 07:00:00,Bristol-Myers Squibb pulls out of Biocon oral insulin pact - Fierce Biotech,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxOaldFczVRTnFEQ1pvb18teE8zX3Fib3NmS1g2U0p2eHg5c0JRNjR5Mm00ZHpOVnlNTDRTUVVqRXBkQUF1UE1zSUJzSGo4Q2xJZ1F2R0JLelZNSW92b2h0MlFfZklLYnRveVBvQXozWXg5aHBSaWFsUDV4dl9ZRXczSnlOUlhZSjZUUXJQMGVoOTgxU3pOUEs2TQ?oc=5"" target=""_blank"">Bristol-Myers Squibb pulls out of Biocon oral insulin pact</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Biotech</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxOaldFczVRTnFEQ1pvb18teE8zX3Fib3NmS1g2U0p2eHg5c0JRNjR5Mm00ZHpOVnlNTDRTUVVqRXBkQUF1UE1zSUJzSGo4Q2xJZ1F2R0JLelZNSW92b2h0MlFfZklLYnRveVBvQXozWXg5aHBSaWFsUDV4dl9ZRXczSnlOUlhZSjZUUXJQMGVoOTgxU3pOUEs2TQ?oc=5,Google News,Biocon partnership,"Bristol-Myers Squibb pulls out of Biocon oral insulin pact - Fierce Biotech <a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxOaldFczVRTnFEQ1pvb18teE8zX3Fib3NmS1g2U0p2eHg5c0JRNjR5Mm00ZHpOVnlNTDRTUVVqRXBkQUF1UE1zSUJzSGo4Q2xJZ1F2R0JLelZNSW92b2h0MlFfZklLYnRveVBvQXozWXg5aHBSaWFsUDV4dl9ZRXczSnlOUlhZSjZUUXJQMGVoOTgxU3pOUEs2TQ?oc=5"" target=""_blank"">Bristol-Myers Squibb pulls out of Biocon oral insulin pact</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Biotech</font>",0.0,neutral,0.5981063842773438,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.5981063842773438,other,0.0,[],False,True,6,0.0
2015-12-09,2015-12-09 08:00:00,NeoBiocon Partners With Novartis to Offer Vildagliptin for Diabetics in UAE - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxNa1FBaV9uRlBlZkpIUnpPTm1mUzUySHNTYk44MjZZUUpzU0RnZE5rUXd0NTNabXJKbGhtRU9ZQy1XWTRidVFKVVhGeS1EU09ueFJaakd0X25WRlJpZDlfNjAwSXM4ZURaTi0zX0dkUW91Sno4djJPMU5nY19UaXdMQWEtdzJpR0lSQVJTZklHbzRWVEU1MldqM05adHFQcFlWSFd0bm5HZG9hNTBqMC1CRWdXVFlTMHd2UWpjT0tEVlJJS2s0emNJV0ZRRHBWdEk?oc=5"" target=""_blank"">NeoBiocon Partners With Novartis to Offer Vildagliptin for Diabetics in UAE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxNa1FBaV9uRlBlZkpIUnpPTm1mUzUySHNTYk44MjZZUUpzU0RnZE5rUXd0NTNabXJKbGhtRU9ZQy1XWTRidVFKVVhGeS1EU09ueFJaakd0X25WRlJpZDlfNjAwSXM4ZURaTi0zX0dkUW91Sno4djJPMU5nY19UaXdMQWEtdzJpR0lSQVJTZklHbzRWVEU1MldqM05adHFQcFlWSFd0bm5HZG9hNTBqMC1CRWdXVFlTMHd2UWpjT0tEVlJJS2s0emNJV0ZRRHBWdEk?oc=5,Google News,Biocon partnership,"NeoBiocon Partners With Novartis to Offer Vildagliptin for Diabetics in UAE - PR Newswire <a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxNa1FBaV9uRlBlZkpIUnpPTm1mUzUySHNTYk44MjZZUUpzU0RnZE5rUXd0NTNabXJKbGhtRU9ZQy1XWTRidVFKVVhGeS1EU09ueFJaakd0X25WRlJpZDlfNjAwSXM4ZURaTi0zX0dkUW91Sno4djJPMU5nY19UaXdMQWEtdzJpR0lSQVJTZklHbzRWVEU1MldqM05adHFQcFlWSFd0bm5HZG9hNTBqMC1CRWdXVFlTMHd2UWpjT0tEVlJJS2s0emNJV0ZRRHBWdEk?oc=5"" target=""_blank"">NeoBiocon Partners With Novartis to Offer Vildagliptin for Diabetics in UAE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.8328171968460083,positive,0.8328171968460083,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.47589554105486187,0.8328171968460083,other,0.0,[],False,True,6,0.0
2016-09-06,2016-09-06 07:00:00,Indian CRO Syngene sets up Amgen R&D center in Bangalore - Fierce Biotech,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxPdGNVem1ZRkZWd3ozWWNncVZBbUhxaHhsc0puTWdHQ01XS3RxYjMxU0h2NFliMk9KMGlnOUtOUC1UamowZVVWeE1yTnBWb21XMktic2VHWl96bHNqRWJrWTNJcnpoQUplcldWUFdaWVZrNlY0blMwNi12ZWZWY200b0k1ZVV3RzlOdkEyYTg4SmQ?oc=5"" target=""_blank"">Indian CRO Syngene sets up Amgen R&amp;D center in Bangalore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Biotech</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxPdGNVem1ZRkZWd3ozWWNncVZBbUhxaHhsc0puTWdHQ01XS3RxYjMxU0h2NFliMk9KMGlnOUtOUC1UamowZVVWeE1yTnBWb21XMktic2VHWl96bHNqRWJrWTNJcnpoQUplcldWUFdaWVZrNlY0blMwNi12ZWZWY200b0k1ZVV3RzlOdkEyYTg4SmQ?oc=5,Google News,Biocon collaboration,"Indian CRO Syngene sets up Amgen R&D center in Bangalore - Fierce Biotech <a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxPdGNVem1ZRkZWd3ozWWNncVZBbUhxaHhsc0puTWdHQ01XS3RxYjMxU0h2NFliMk9KMGlnOUtOUC1UamowZVVWeE1yTnBWb21XMktic2VHWl96bHNqRWJrWTNJcnpoQUplcldWUFdaWVZrNlY0blMwNi12ZWZWY200b0k1ZVV3RzlOdkEyYTg4SmQ?oc=5"" target=""_blank"">Indian CRO Syngene sets up Amgen R&amp;D center in Bangalore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Biotech</font>",0.0,neutral,0.8901259899139404,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.06666666666666667,0.06666666666666667,0.0,0.47839632829030354,other,0.0,[],False,False,1,0.0
2015-12-09,2015-12-09 08:00:00,NeoBiocon partners Novartis to launch diabetes drugs in UAE - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">NeoBiocon partners Novartis to launch diabetes drugs in UAE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News,Biocon collaboration,"NeoBiocon partners Novartis to launch diabetes drugs in UAE - ET HealthWorld <a href=""https://news.google.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?oc=5"" target=""_blank"">NeoBiocon partners Novartis to launch diabetes drugs in UAE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.5260046124458313,positive,0.5260046124458313,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.30057406425476074,0.5260046124458313,other,0.0,[],False,True,6,0.0
2015-12-28,2015-12-28 08:00:00,Biocon launches hepatitis-C drug in India | Company Business News - Mint,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQZUJtU09ubUk0WXdfY1dybWs1aWd4Z0pyTkFFejZjRkJ2ckl5N3NBc01KTTJTNjJSTUI3QjNMNV9DaXRRMHF0WE9QSk5rSlo5Z0VmbFVvTzRfbjI4d2wyZ1FSZDRKZ0hOZzloYnM5MVdNU25WbEJEc3hpQngwWHV0YW5VdFFGUnRtVkxuTURPZkJiM3R0eEZxekttWjZwRlg2Xzg5djVB0gGzAUFVX3lxTE14bXdndTVvVmJRMVhaTWVkRGt3OEQyR2RYel9OdDcta2Voa0tteGEwenhscEdHdDBvMjgxSEIyS2R3ckd0ZnNHemtNazktZHhUZ0cwMlE1T0diWVlkUkF6REU5WE90TDZqT1JuR3J6SWdSMVhRR2U0alpuNlAzTVRaM0Z3RDl2d3I5VnZJaDVVUjhqc3UxVnFZMjVTRGhnamgzZG43SExUUXFBMHNDNkNZa2hF?oc=5"" target=""_blank"">Biocon launches hepatitis-C drug in India | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQZUJtU09ubUk0WXdfY1dybWs1aWd4Z0pyTkFFejZjRkJ2ckl5N3NBc01KTTJTNjJSTUI3QjNMNV9DaXRRMHF0WE9QSk5rSlo5Z0VmbFVvTzRfbjI4d2wyZ1FSZDRKZ0hOZzloYnM5MVdNU25WbEJEc3hpQngwWHV0YW5VdFFGUnRtVkxuTURPZkJiM3R0eEZxekttWjZwRlg2Xzg5djVB0gGzAUFVX3lxTE14bXdndTVvVmJRMVhaTWVkRGt3OEQyR2RYel9OdDcta2Voa0tteGEwenhscEdHdDBvMjgxSEIyS2R3ckd0ZnNHemtNazktZHhUZ0cwMlE1T0diWVlkUkF6REU5WE90TDZqT1JuR3J6SWdSMVhRR2U0alpuNlAzTVRaM0Z3RDl2d3I5VnZJaDVVUjhqc3UxVnFZMjVTRGhnamgzZG43SExUUXFBMHNDNkNZa2hF?oc=5,Google News,Biocon licensing deal,"Biocon launches hepatitis-C drug in India | Company Business News - Mint <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQZUJtU09ubUk0WXdfY1dybWs1aWd4Z0pyTkFFejZjRkJ2ckl5N3NBc01KTTJTNjJSTUI3QjNMNV9DaXRRMHF0WE9QSk5rSlo5Z0VmbFVvTzRfbjI4d2wyZ1FSZDRKZ0hOZzloYnM5MVdNU25WbEJEc3hpQngwWHV0YW5VdFFGUnRtVkxuTURPZkJiM3R0eEZxekttWjZwRlg2Xzg5djVB0gGzAUFVX3lxTE14bXdndTVvVmJRMVhaTWVkRGt3OEQyR2RYel9OdDcta2Voa0tteGEwenhscEdHdDBvMjgxSEIyS2R3ckd0ZnNHemtNazktZHhUZ0cwMlE1T0diWVlkUkF6REU5WE90TDZqT1JuR3J6SWdSMVhRR2U0alpuNlAzTVRaM0Z3RDl2d3I5VnZJaDVVUjhqc3UxVnFZMjVTRGhnamgzZG43SExUUXFBMHNDNkNZa2hF?oc=5"" target=""_blank"">Biocon launches hepatitis-C drug in India | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.9112608432769775,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9112608432769775,other,0.0,[],False,True,6,0.0
2015-12-25,2015-12-25 08:00:00,Biocon launches Hepatitis C drug under license from Gilead - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon launches Hepatitis C drug under license from Gilead</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon licensing deal,"Biocon launches Hepatitis C drug under license from Gilead - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon launches Hepatitis C drug under license from Gilead</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.8871683478355408,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8871683478355408,other,0.0,[],False,True,6,0.0
2015-07-24,2015-07-24 07:00:00,Biocon eyes US market for psoriasis drug post US-Cuba thaw - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon eyes US market for psoriasis drug post US-Cuba thaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon joint venture,"Biocon eyes US market for psoriasis drug post US-Cuba thaw - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon eyes US market for psoriasis drug post US-Cuba thaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.8267363905906677,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8267363905906677,other,0.0,[],False,True,6,0.0
2016-12-23,2016-12-23 08:00:00,How Biocon's Brewmaster Kiran Mazumdar-Shaw Made It A Global Force - Forbes India,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxQTTFtVHBOWHprS29Mc29VTlFEZHNwcmFiUFlzY0pSbGJTS3JxU2FOYTE4MDB0WlJHVGM5UXluWWFWNTk5RS1UTlBoeW5lTGRBR1RKSUtDU0dMTnk3M2dsbEFyTDRFbjlINDZic2k4VTRyN1lmRzhrR0xfUUVmdjNqYkdacjNmNXI1X3ZKR2ZTRldRWEQ2cW9iQUQ4ZG1seDNaVk9qRFNvRTNSSUg5WVlwdVFIMUY2MXd2amprTE1sSDZRMHlJWkNpVg?oc=5"" target=""_blank"">How Biocon's Brewmaster Kiran Mazumdar-Shaw Made It A Global Force</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Forbes India</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxQTTFtVHBOWHprS29Mc29VTlFEZHNwcmFiUFlzY0pSbGJTS3JxU2FOYTE4MDB0WlJHVGM5UXluWWFWNTk5RS1UTlBoeW5lTGRBR1RKSUtDU0dMTnk3M2dsbEFyTDRFbjlINDZic2k4VTRyN1lmRzhrR0xfUUVmdjNqYkdacjNmNXI1X3ZKR2ZTRldRWEQ2cW9iQUQ4ZG1seDNaVk9qRFNvRTNSSUg5WVlwdVFIMUY2MXd2amprTE1sSDZRMHlJWkNpVg?oc=5,Google News,Biocon joint venture,"How Biocon's Brewmaster Kiran Mazumdar-Shaw Made It A Global Force - Forbes India <a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxQTTFtVHBOWHprS29Mc29VTlFEZHNwcmFiUFlzY0pSbGJTS3JxU2FOYTE4MDB0WlJHVGM5UXluWWFWNTk5RS1UTlBoeW5lTGRBR1RKSUtDU0dMTnk3M2dsbEFyTDRFbjlINDZic2k4VTRyN1lmRzhrR0xfUUVmdjNqYkdacjNmNXI1X3ZKR2ZTRldRWEQ2cW9iQUQ4ZG1seDNaVk9qRFNvRTNSSUg5WVlwdVFIMUY2MXd2amprTE1sSDZRMHlJWkNpVg?oc=5"" target=""_blank"">How Biocon's Brewmaster Kiran Mazumdar-Shaw Made It A Global Force</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Forbes India</font>",0.0,neutral,0.567668616771698,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.567668616771698,other,0.0,[],False,True,6,0.0
2020-06-11,2020-06-11 07:00:00,Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5,Google News,Biocon Semglee FDA approval,"Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.0,neutral,0.595608115196228,0.0,neutral,0.0,0.7351,0.181,0.0,0.819,0.0,0.0,0.0,0.6653540575981141,approval_process,0.8257113993167877,['FDA approval'],True,True,26,0.6514227986335754
2021-07-29,2021-07-29 07:00:00,New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar - BioSpace,"<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxPWFE5cDVJQmQ3a2p4MTdMc0ZyVWtkb0FYbnVtNmUwME1iQlVkS3EwSnJXaFZPbWc2X2xqVlY2NmZITnh4Ui1qcUE3eU9vcVBKT0tDU0VnZXpvUG9DMnB6WEMwUFFIMU9aVDFGV25SWW9LMlBEdXpEdTBkUDNWanJWa2JVaHVTOTlITzh2aXdvMVN3TjFYdnM1UmN1SQ?oc=5"" target=""_blank"">New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpace</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxPWFE5cDVJQmQ3a2p4MTdMc0ZyVWtkb0FYbnVtNmUwME1iQlVkS3EwSnJXaFZPbWc2X2xqVlY2NmZITnh4Ui1qcUE3eU9vcVBKT0tDU0VnZXpvUG9DMnB6WEMwUFFIMU9aVDFGV25SWW9LMlBEdXpEdTBkUDNWanJWa2JVaHVTOTlITzh2aXdvMVN3TjFYdnM1UmN1SQ?oc=5,Google News,Biocon Semglee FDA approval,"New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar - BioSpace <a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxPWFE5cDVJQmQ3a2p4MTdMc0ZyVWtkb0FYbnVtNmUwME1iQlVkS3EwSnJXaFZPbWc2X2xqVlY2NmZITnh4Ui1qcUE3eU9vcVBKT0tDU0VnZXpvUG9DMnB6WEMwUFFIMU9aVDFGV25SWW9LMlBEdXpEdTBkUDNWanJWa2JVaHVTOTlITzh2aXdvMVN3TjFYdnM1UmN1SQ?oc=5"" target=""_blank"">New Day For Diabetes Patients As FDA Approves First-Ever Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpace</font>",0.5201907753944397,positive,0.5201907753944397,0.0,neutral,0.0,0.6597,0.184,0.0,0.816,0.06818181818181818,0.22727272727272727,0.29725187165396555,0.4160241978587526,approval_process,0.7528555393218994,['FDA approval'],False,False,11,0.5057110786437988
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News,Biocon Semglee FDA approval,"FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.7366463541984558,positive,0.7366463541984558,0.0,neutral,0.0,0.6597,0.184,0.0,0.816,0.1,0.19166666666666665,0.420940773827689,0.49878211806615197,approval_process,0.7800931334495544,['FDA approval'],True,False,21,0.5601862668991089
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News,Biocon Semglee FDA approval,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business <a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",0.5844137072563171,positive,0.5844137072563171,0.0,neutral,0.0,0.6597,0.172,0.0,0.828,0.0,0.0,0.3339506898607526,0.6220568536281585,approval_process,0.8245938718318939,['FDA approval'],False,True,16,0.6491877436637878
2021-11-16,2021-11-16 08:00:00,Biocon Launches Biosimilar Semglee - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxQbFpVT2xaTlU3bGFlR0hBQTFueTlTSmpmLUpINnlYVkVxdVppTGFOZWlhaVRTZlM0RHhIc2VWU2ZVVXF1VDRCT0JSV2xTdXF6dVZBUjN1YmhnSUlwRzdMXy1yMlo2TjE2SXV2bG5mRVJZYjdmdE55YWh0MzJlY0pNYW9HRVg0NUJQMlE?oc=5"" target=""_blank"">Biocon Launches Biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxQbFpVT2xaTlU3bGFlR0hBQTFueTlTSmpmLUpINnlYVkVxdVppTGFOZWlhaVRTZlM0RHhIc2VWU2ZVVXF1VDRCT0JSV2xTdXF6dVZBUjN1YmhnSUlwRzdMXy1yMlo2TjE2SXV2bG5mRVJZYjdmdE55YWh0MzJlY0pNYW9HRVg0NUJQMlE?oc=5,Google News,Biocon Semglee FDA approval,"Biocon Launches Biosimilar Semglee - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxQbFpVT2xaTlU3bGFlR0hBQTFueTlTSmpmLUpINnlYVkVxdVppTGFOZWlhaVRTZlM0RHhIc2VWU2ZVVXF1VDRCT0JSV2xTdXF6dVZBUjN1YmhnSUlwRzdMXy1yMlo2TjE2SXV2bG5mRVJZYjdmdE55YWh0MzJlY0pNYW9HRVg0NUJQMlE?oc=5"" target=""_blank"">Biocon Launches Biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.0,neutral,0.8726527094841003,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8726527094841003,other,0.0,[],True,True,16,0.0
2022-01-03,2022-01-03 08:00:00,New FDA Approved Insulin Marks Another Win for Insulin Affordability - diaTribe,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUkc2TjFlczdDaDhVR3BoTzFUVnk1d19INXNxVFVJaFMyUllpaHR4Tng1b3ZIU0NQek9URUNkalhyQVA2LVM5OHZWcUVybFJhSFNKYnFOcnBBOTNDazgwOWlrVi1xaVEyZ2pTR0VtcWVuYWxoZ01OWTNCWnhGZjFkSVE4WmpGeGVSZ0hGR3gtaF9SMzJXUGN0RkN5U0JmRmxWc1JVWlczZnQzZw?oc=5"" target=""_blank"">New FDA Approved Insulin Marks Another Win for Insulin Affordability</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUkc2TjFlczdDaDhVR3BoTzFUVnk1d19INXNxVFVJaFMyUllpaHR4Tng1b3ZIU0NQek9URUNkalhyQVA2LVM5OHZWcUVybFJhSFNKYnFOcnBBOTNDazgwOWlrVi1xaVEyZ2pTR0VtcWVuYWxoZ01OWTNCWnhGZjFkSVE4WmpGeGVSZ0hGR3gtaF9SMzJXUGN0RkN5U0JmRmxWc1JVWlczZnQzZw?oc=5,Google News,Biocon Semglee FDA approval,"New FDA Approved Insulin Marks Another Win for Insulin Affordability - diaTribe <a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUkc2TjFlczdDaDhVR3BoTzFUVnk1d19INXNxVFVJaFMyUllpaHR4Tng1b3ZIU0NQek9URUNkalhyQVA2LVM5OHZWcUVybFJhSFNKYnFOcnBBOTNDazgwOWlrVi1xaVEyZ2pTR0VtcWVuYWxoZ01OWTNCWnhGZjFkSVE4WmpGeGVSZ0hGR3gtaF9SMzJXUGN0RkN5U0JmRmxWc1JVWlczZnQzZw?oc=5"" target=""_blank"">New FDA Approved Insulin Marks Another Win for Insulin Affordability</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",0.9000426530838013,positive,0.9000426530838013,0.0,neutral,0.0,0.9217,0.398,0.0,0.602,0.4340909090909091,0.3136363636363636,0.5143100874764578,0.7519445207249035,approval_process,0.7626034021377563,['FDA approval'],False,False,11,0.5252068042755127
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon Semglee FDA approval,"Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.7746681571006775,0.0,neutral,0.0,0.4767,0.11,0.0,0.89,0.13333333333333333,0.13333333333333333,0.0,0.46156716347800364,approval_process,0.7767300009727478,['FDA approval'],True,True,26,0.5534600019454956
2021-07-30,2021-07-30 07:00:00,"Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval - ThePrint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News,Biocon Semglee FDA approval,"Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval - ThePrint <a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",0.7105980515480042,positive,0.7105980515480042,0.0,neutral,0.0,0.4767,0.11,0.0,0.89,0.0,0.0,0.40605602945600233,0.5936490257740021,other,0.0,[],True,True,16,0.0
2021-07-29,2021-07-29 07:00:00,Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar... - Moneycontrol,"<a href=""https://news.google.com/rss/articles/CBMihAJBVV95cUxPVEg5Q0xwWFZjY1FiSy1hWTdQZ1c2aGxySnlzV1NxYTRPRTR6aDNaRkpOby1KUWs1QTBhNEs1aVk0T2ZHbGdTc3Q1RDhhNlB4R25JSTlqdUtSck54Z19OckhNM0pnWVNxSWkyR3ZHdU0tZ0hWMTFBREZOQzZWRURTOG9xUmo2dzdFZzVMbGxWS0otMzBjc1Bqbm04NXBKU2tqUDdwcDBXWGJ2XzJzd3ZaWFdNekNQQ2ZpRFI4VVRreEtFLUNqc1dqaElXc1ZaN2RnVDBIUVZ3SU5KUEQyZVRHTVhCM21GckxFMWRMcHozVzJxRVhZNUk0eHhEdncyWmx5aHJZR9IBigJBVV95cUxNRVFyRWZxMnlNNWt1Zldpak43RFpGZXhtZjFUTTEzbGdSR0IwWnpoSVRKMXB0S2FOWkVCRWZLYlR5UTNZWDdEMGJPaktqdzNLTUFtV2trOTVLWVptbElueU1oZmdEdGJEdElUNl9WemVLY21LWjhVNFZrTl9tWWVydEwxNzBSODhUZmJrTERJczAtcFNTM19xaHFFeUhkb2gtYmxBSkJuNVhFY0MxZk9wbGdtcHYycFZac0Q2bXVUb1FCUXlSaWlRM1l3V2d0VmZJV2Z0Ul9MU0dkS2hRd253ZndwSU5QSFBXdndfbXNLckFIZ2oxOF85dTdocTJpVGdEdTktcmFPTC00dw?oc=5"" target=""_blank"">Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon Semglee FDA approval,"Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar... - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.7698100805282593,positive,0.7698100805282593,0.0,neutral,0.0,0.6597,0.172,0.0,0.828,0.16666666666666666,0.2222222222222222,0.4398914745875767,0.532058915731642,approval_process,0.7473947405815125,['FDA approval'],True,True,26,0.4947894811630249
2020-06-12,2020-06-12 07:00:00,"Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection - Express Pharma","<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxOTk1oVUE4dUU3MWZESDFmbmg0d0I3bG5nc1BkenBxVDRYSWgwbGZEb1NyZDdxNUotUUNieEZ4MTJGSlNfbGpJV2VsT0k5QUh3V3VWNHpWZzZyUE9aRXRoRmRySGxMcVc4TmZoY1dYdUpuQ3B4SS1LODVnRTB1R0phUUZMQ19XSGdOQjVtbGhFUnM5VGtPMTlfZXplX255YWRwZUJxWF83TG1YdE9SWEszTXdB0gG3AUFVX3lxTE1ZOElQQ1pUOVZ6OHdObXk4T0dzRmhWaDlrUmxaSVpsWExQbm95dXQzdmwzQTRhNXp0MzNnRzFhWG5zaDFMcFJQVFh4MlA0bEFCeDVaSlljUkdGemRJcEZRQU5YbTRHOUhnTko4bWJuTV9UNHgzRVRIMzNRSk52MWJQaXpFUmVtcVA0aV92Ulp1amhnb3IyOTFfVWtzOFpHaW1LSTQ1NEh0V0VDME85eTcyelI5S0VwOA?oc=5"" target=""_blank"">Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News,Biocon Semglee FDA approval,"Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection - Express Pharma <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.70448237657547,positive,0.70448237657547,0.0,neutral,0.0,0.7351,0.171,0.0,0.829,0.0,0.0,0.40256135804312565,0.719791188287735,approval_process,0.8278532922267914,['FDA approval'],True,True,26,0.6557065844535828
2020-09-01,2020-09-01 07:00:00,"Mylan, Biocon undercut insulin competitors on price with launch of Lantus copycat - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxPZ202Y2oxc25XczV1cGdDZ19UczNRTFlZTXM4T1JwQ0oxRmN2ZmxQSXhwUlZ6LVdvMUFZS3A5UmxfQWpVbG1sNXRROU9zdnZ0bUpxSlRsOW1POWZrSHpEOGVDUlJjeXNnQ1g5VGZidE10dEJqYlhXUXZIb05IZ1FzN0N5MEJqZUxfRV9UcTdIbS02T3hUUHN3VUxQT2l0VlRHNnlNNHpBdkI?oc=5"" target=""_blank"">Mylan, Biocon undercut insulin competitors on price with launch of Lantus copycat</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxPZ202Y2oxc25XczV1cGdDZ19UczNRTFlZTXM4T1JwQ0oxRmN2ZmxQSXhwUlZ6LVdvMUFZS3A5UmxfQWpVbG1sNXRROU9zdnZ0bUpxSlRsOW1POWZrSHpEOGVDUlJjeXNnQ1g5VGZidE10dEJqYlhXUXZIb05IZ1FzN0N5MEJqZUxfRV9UcTdIbS02T3hUUHN3VUxQT2l0VlRHNnlNNHpBdkI?oc=5,Google News,Biocon Semglee FDA approval,"Mylan, Biocon undercut insulin competitors on price with launch of Lantus copycat - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxPZ202Y2oxc25XczV1cGdDZ19UczNRTFlZTXM4T1JwQ0oxRmN2ZmxQSXhwUlZ6LVdvMUFZS3A5UmxfQWpVbG1sNXRROU9zdnZ0bUpxSlRsOW1POWZrSHpEOGVDUlJjeXNnQ1g5VGZidE10dEJqYlhXUXZIb05IZ1FzN0N5MEJqZUxfRV9UcTdIbS02T3hUUHN3VUxQT2l0VlRHNnlNNHpBdkI?oc=5"" target=""_blank"">Mylan, Biocon undercut insulin competitors on price with launch of Lantus copycat</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.5002273321151733,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.5002273321151733,other,0.0,[],False,True,6,0.0
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News,Biocon Semglee FDA approval,"Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.8506457209587097,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.0,0.4503228604793549,other,0.0,[],True,True,16,0.0
2021-09-29,2021-09-29 07:00:00,More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5"" target=""_blank"">More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5,Google News,Biocon Semglee FDA approval,"More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5"" target=""_blank"">More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.8951104283332825,negative,0.8951104283332825,0.0,neutral,0.0,-0.7172,0.0,0.158,0.842,0.024999999999999994,0.22499999999999998,-0.5114916733333043,0.5457701427777608,other,0.0,[],False,True,6,0.0
2021-08-02,2021-08-02 07:00:00,Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5"" target=""_blank"">Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5,Google News,Biocon Semglee FDA approval,"Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5"" target=""_blank"">Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",-0.9178489446640015,negative,0.9178489446640015,0.0,neutral,0.0,0.8885,0.266,0.0,0.734,-0.05,0.1,-0.5244851112365723,0.6187829815546672,approval_process,0.7204506099224091,['FDA approval'],False,False,11,0.4409012198448181
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News,Biocon Semglee FDA approval,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.8734995126724243,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.0,0.4617497563362122,regulatory_issues,0.5561130583286286,['manufacturing issue'],False,True,14,0.3122261166572571
2020-04-01,2020-04-01 07:00:00,FDA Clears Biocon's Insulin Factory in Malaysia - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxOckdFcFlnNU81Y0FqRkJGTXRnZVd3MHhwRW85eFQ5STFJUHVDTEhsN21VbXRVV0E3MjFfN3Jzc3l4dklwV21hc0ZIV3BsM2R1aHcyTW1FWk9zemYyUGJmd3k0d3RfdW1QN3h0NGN0cjZRQVNJWGZKMVdFZV9fTXdVTUJMczNzcFpRQjRXdXh4SQ?oc=5"" target=""_blank"">FDA Clears Biocon's Insulin Factory in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMijwFBVV95cUxOckdFcFlnNU81Y0FqRkJGTXRnZVd3MHhwRW85eFQ5STFJUHVDTEhsN21VbXRVV0E3MjFfN3Jzc3l4dklwV21hc0ZIV3BsM2R1aHcyTW1FWk9zemYyUGJmd3k0d3RfdW1QN3h0NGN0cjZRQVNJWGZKMVdFZV9fTXdVTUJMczNzcFpRQjRXdXh4SQ?oc=5,Google News,Biocon Semglee FDA approval,"FDA Clears Biocon's Insulin Factory in Malaysia - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxOckdFcFlnNU81Y0FqRkJGTXRnZVd3MHhwRW85eFQ5STFJUHVDTEhsN21VbXRVV0E3MjFfN3Jzc3l4dklwV21hc0ZIV3BsM2R1aHcyTW1FWk9zemYyUGJmd3k0d3RfdW1QN3h0NGN0cjZRQVNJWGZKMVdFZV9fTXdVTUJMczNzcFpRQjRXdXh4SQ?oc=5"" target=""_blank"">FDA Clears Biocon's Insulin Factory in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.40460479259490967,0.0,neutral,0.0,0.1531,0.115,0.0,0.885,-0.05,0.05,0.0,0.20256826419830323,other,0.0,[],False,True,6,0.0
2020-08-31,2020-08-31 07:00:00,Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMiowJBVV95cUxOWmhETXVZRS1NUWFGS25nY1BpbmNDeUJFcXNjWXUzcUhxRFMtZTB1OU9oQ1JtUXRDVW16MmVUR2hVVjVHYU4wRmtOa0NyNkNGS1pGRE1Xa1NuMjE5NTdHbXVZbmFTWlV6Y0dtOHUtVjhvUF9FSWJuTG4waEVVd1dWMUk1QTUydW9DQ09zWWh3NHlxQzVRZWl1WEgwNm8zYkdLQWJnTjMtZkpPeVhhSFRrNE1VNDc0bDZ0Vk5rOGNNQkE4MWx0aE0zQkZPZWpMZDFUMHlJTHh3RXFFa1AyVFJsRXpmaTNCbXZzODV1YWYtUnd4S3VzcDRaRjdjUEt2U1pKeGsxZWIyVmZkTVEtbVVQXzdiY1o1Q2R2SGZWeEFDcUk5azQ?oc=5"" target=""_blank"">Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMiowJBVV95cUxOWmhETXVZRS1NUWFGS25nY1BpbmNDeUJFcXNjWXUzcUhxRFMtZTB1OU9oQ1JtUXRDVW16MmVUR2hVVjVHYU4wRmtOa0NyNkNGS1pGRE1Xa1NuMjE5NTdHbXVZbmFTWlV6Y0dtOHUtVjhvUF9FSWJuTG4waEVVd1dWMUk1QTUydW9DQ09zWWh3NHlxQzVRZWl1WEgwNm8zYkdLQWJnTjMtZkpPeVhhSFRrNE1VNDc0bDZ0Vk5rOGNNQkE4MWx0aE0zQkZPZWpMZDFUMHlJTHh3RXFFa1AyVFJsRXpmaTNCbXZzODV1YWYtUnd4S3VzcDRaRjdjUEt2U1pKeGsxZWIyVmZkTVEtbVVQXzdiY1o1Q2R2SGZWeEFDcUk5azQ?oc=5,Google News,Biocon Semglee clinical trial,"Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes - PR Newswire <a href=""https://news.google.com/rss/articles/CBMiowJBVV95cUxOWmhETXVZRS1NUWFGS25nY1BpbmNDeUJFcXNjWXUzcUhxRFMtZTB1OU9oQ1JtUXRDVW16MmVUR2hVVjVHYU4wRmtOa0NyNkNGS1pGRE1Xa1NuMjE5NTdHbXVZbmFTWlV6Y0dtOHUtVjhvUF9FSWJuTG4waEVVd1dWMUk1QTUydW9DQ09zWWh3NHlxQzVRZWl1WEgwNm8zYkdLQWJnTjMtZkpPeVhhSFRrNE1VNDc0bDZ0Vk5rOGNNQkE4MWx0aE0zQkZPZWpMZDFUMHlJTHh3RXFFa1AyVFJsRXpmaTNCbXZzODV1YWYtUnd4S3VzcDRaRjdjUEt2U1pKeGsxZWIyVmZkTVEtbVVQXzdiY1o1Q2R2SGZWeEFDcUk5azQ?oc=5"" target=""_blank"">Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.7185096144676208,positive,0.7185096144676208,0.0,neutral,0.0,0.5574,0.087,0.0,0.913,0.0,0.0,0.4105769225529262,0.6379548072338104,other,0.0,[],True,True,16,0.0
2020-08-31,2020-08-31 07:00:00,Semglee Now Available for Patients With Diabetes - Medical Professionals Reference,"<a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxOSFdxWFR6R1NwdTNVdnZnWlVmaHd1eWxoamNJQ1p6V2NmRzljU1NNM0xwZ3V4RFlZcjlfVm1ET0hJT29EVDBEZFNodGVQT0FFTFNQTDlwby03dk1xM0JlTC1jSmNvU3JZZlVnMXVhdmhsbVFubTJSLWp6eU1MYm03N0gxRVZlajY5XzdxNA?oc=5"" target=""_blank"">Semglee Now Available for Patients With Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",https://news.google.com/rss/articles/CBMijAFBVV95cUxOSFdxWFR6R1NwdTNVdnZnWlVmaHd1eWxoamNJQ1p6V2NmRzljU1NNM0xwZ3V4RFlZcjlfVm1ET0hJT29EVDBEZFNodGVQT0FFTFNQTDlwby03dk1xM0JlTC1jSmNvU3JZZlVnMXVhdmhsbVFubTJSLWp6eU1MYm03N0gxRVZlajY5XzdxNA?oc=5,Google News,Biocon Semglee clinical trial,"Semglee Now Available for Patients With Diabetes - Medical Professionals Reference <a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxOSFdxWFR6R1NwdTNVdnZnWlVmaHd1eWxoamNJQ1p6V2NmRzljU1NNM0xwZ3V4RFlZcjlfVm1ET0hJT29EVDBEZFNodGVQT0FFTFNQTDlwby03dk1xM0JlTC1jSmNvU3JZZlVnMXVhdmhsbVFubTJSLWp6eU1MYm03N0gxRVZlajY5XzdxNA?oc=5"" target=""_blank"">Semglee Now Available for Patients With Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",0.0,neutral,0.8698808550834656,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.2,0.2,0.0,0.5349404275417328,other,0.0,[],True,False,11,0.0
2020-09-01,2020-09-01 07:00:00,Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US - Diabetes In Control,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOSml6X0d0cjlzclN4UWFKRU9kZlc3c3lSMXBUNG9SR19BVDNmdW41TWxpcHk5RjJad3VpVGlFSnU1YXpXd2Z3VlUtVzZNNGtGbGVLeXE2a09WZjVlZEgyMC1JalJxcFVJQURjQlZxVnh6SEpyWko3aXVlOWtNN2xOeG1TUnlqSjJGTG5OV3dYcnlGUDZwWnlZaURTdUhwdWhXRUlGbA?oc=5"" target=""_blank"">Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOSml6X0d0cjlzclN4UWFKRU9kZlc3c3lSMXBUNG9SR19BVDNmdW41TWxpcHk5RjJad3VpVGlFSnU1YXpXd2Z3VlUtVzZNNGtGbGVLeXE2a09WZjVlZEgyMC1JalJxcFVJQURjQlZxVnh6SEpyWko3aXVlOWtNN2xOeG1TUnlqSjJGTG5OV3dYcnlGUDZwWnlZaURTdUhwdWhXRUlGbA?oc=5,Google News,Biocon Semglee clinical trial,"Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US - Diabetes In Control <a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOSml6X0d0cjlzclN4UWFKRU9kZlc3c3lSMXBUNG9SR19BVDNmdW41TWxpcHk5RjJad3VpVGlFSnU1YXpXd2Z3VlUtVzZNNGtGbGVLeXE2a09WZjVlZEgyMC1JalJxcFVJQURjQlZxVnh6SEpyWko3aXVlOWtNN2xOeG1TUnlqSjJGTG5OV3dYcnlGUDZwWnlZaURTdUhwdWhXRUlGbA?oc=5"" target=""_blank"">Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",0.0,neutral,0.8588917851448059,0.0,neutral,0.0,0.6808,0.177,0.0,0.823,0.0,0.0,0.0,0.769845892572403,approval_process,0.779649943113327,['biosimilar approval'],True,False,21,0.559299886226654
2018-12-31,2018-12-31 01:41:28,Table 3 . Biosimilar Insulins in Clinical Trials. - researchgate.net,"<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxPMXhmOV9lakV1c2hyYl9oTjB6cXRlaG1pQ1pMSGh0X0J1Zkh5VFFQeVZXX0ZQTDF6bWFpdnpYVE5SWTR4VDZNVzloMm9qMElrQzBXYkhKWWxsVzdUN2hPWFU5V2gzOXdLYTVla2NSQTlYY1J3cUNyLW1fbW5wZC1qUjJRM2pqX1V0VmdhMWZhcnBUM0E?oc=5"" target=""_blank"">Table 3 . Biosimilar Insulins in Clinical Trials.</a>&nbsp;&nbsp;<font color=""#6f6f6f"">researchgate.net</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxPMXhmOV9lakV1c2hyYl9oTjB6cXRlaG1pQ1pMSGh0X0J1Zkh5VFFQeVZXX0ZQTDF6bWFpdnpYVE5SWTR4VDZNVzloMm9qMElrQzBXYkhKWWxsVzdUN2hPWFU5V2gzOXdLYTVla2NSQTlYY1J3cUNyLW1fbW5wZC1qUjJRM2pqX1V0VmdhMWZhcnBUM0E?oc=5,Google News,Biocon Semglee clinical trial,"Table 3 . Biosimilar Insulins in Clinical Trials. - researchgate.net <a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxPMXhmOV9lakV1c2hyYl9oTjB6cXRlaG1pQ1pMSGh0X0J1Zkh5VFFQeVZXX0ZQTDF6bWFpdnpYVE5SWTR4VDZNVzloMm9qMElrQzBXYkhKWWxsVzdUN2hPWFU5V2gzOXdLYTVla2NSQTlYY1J3cUNyLW1fbW5wZC1qUjJRM2pqX1V0VmdhMWZhcnBUM0E?oc=5"" target=""_blank"">Table 3 . Biosimilar Insulins in Clinical Trials.</a>&nbsp;&nbsp;<font color=""#6f6f6f"">researchgate.net</font>",0.0,neutral,0.9394456744194031,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9394456744194031,clinical_trials,0.9136222124099731,"['clinical trial', 'clinical data']",True,False,18,0.4272444248199463
2020-09-03,2020-09-03 07:00:00,Semglee now available for better blood sugar control in diabetes - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee now available for better blood sugar control in diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News,Biocon Semglee clinical trial,"Semglee now available for better blood sugar control in diabetes - Medical Dialogues <a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee now available for better blood sugar control in diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.0,neutral,0.5631252527236938,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,0.3,0.3,0.0,0.5211417509078979,other,0.0,[],True,False,11,0.0
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News,Biocon Semglee clinical trial,"Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.8496006727218628,0.0,neutral,0.0,0.5859,0.146,0.0,0.854,-0.05,0.05,0.0,0.49516689090728766,other,0.0,[],True,False,11,0.0
2021-11-16,2021-11-16 08:00:00,Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMitwJBVV95cUxPeFdZZElGeWNuVDhIc19nNG1ld1FRei1mSm5wYVozSmJhNE5CbWNBcE56czVrMk5oTEdmV205TDBMS3ZLbFQxaWVXcVlYd0VZWkZaeUtsSktQcjF0UkRXVFdsb3RKUlZ5ZzFPNG9aaTJrRkd3LWctbmx2Sld0VlpWQjlLQk02NU5IV1JLZUEyODFTbkQ3ZHY5cGVQLTI1WFplaUlISjk2Y182NUtUSVY5SGo3YWpiTmhrVkUyZTN3d3BRa2pfUENIcWVGTVBEYzVjOXctbTdQMHFmaGlYRnlxYWNXV2szY29BUFF5NjZjYjc2V2JmVl9mWWxkR28zd0o1amJBUVA4MDRYLVFKNk9qQjZaZTNCNTM3TXdGZERZbDBBNFVPNHlaMUQtbFFubWhORTZ1UVVhQQ?oc=5"" target=""_blank"">Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMitwJBVV95cUxPeFdZZElGeWNuVDhIc19nNG1ld1FRei1mSm5wYVozSmJhNE5CbWNBcE56czVrMk5oTEdmV205TDBMS3ZLbFQxaWVXcVlYd0VZWkZaeUtsSktQcjF0UkRXVFdsb3RKUlZ5ZzFPNG9aaTJrRkd3LWctbmx2Sld0VlpWQjlLQk02NU5IV1JLZUEyODFTbkQ3ZHY5cGVQLTI1WFplaUlISjk2Y182NUtUSVY5SGo3YWpiTmhrVkUyZTN3d3BRa2pfUENIcWVGTVBEYzVjOXctbTdQMHFmaGlYRnlxYWNXV2szY29BUFF5NjZjYjc2V2JmVl9mWWxkR28zd0o1amJBUVA4MDRYLVFKNk9qQjZaZTNCNTM3TXdGZERZbDBBNFVPNHlaMUQtbFFubWhORTZ1UVVhQQ?oc=5,Google News,Biocon Semglee clinical trial,"Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection - PR Newswire <a href=""https://news.google.com/rss/articles/CBMitwJBVV95cUxPeFdZZElGeWNuVDhIc19nNG1ld1FRei1mSm5wYVozSmJhNE5CbWNBcE56czVrMk5oTEdmV205TDBMS3ZLbFQxaWVXcVlYd0VZWkZaeUtsSktQcjF0UkRXVFdsb3RKUlZ5ZzFPNG9aaTJrRkd3LWctbmx2Sld0VlpWQjlLQk02NU5IV1JLZUEyODFTbkQ3ZHY5cGVQLTI1WFplaUlISjk2Y182NUtUSVY5SGo3YWpiTmhrVkUyZTN3d3BRa2pfUENIcWVGTVBEYzVjOXctbTdQMHFmaGlYRnlxYWNXV2szY29BUFF5NjZjYjc2V2JmVl9mWWxkR28zd0o1amJBUVA4MDRYLVFKNk9qQjZaZTNCNTM3TXdGZERZbDBBNFVPNHlaMUQtbFFubWhORTZ1UVVhQQ?oc=5"" target=""_blank"">Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.0,neutral,0.6810470819473267,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.6810470819473267,other,0.0,[],True,True,16,0.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News,Biocon insulin glargine-yfgn FDA,"Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon <a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.0,neutral,0.9149214029312134,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9149214029312134,other,0.0,[],False,True,6,0.0
2019-12-03,2019-12-03 08:00:00,Biocon gets FDA approval to produce pegfilgrastim in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5"" target=""_blank"">Biocon gets FDA approval to produce pegfilgrastim in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon gets FDA approval to produce pegfilgrastim in India - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5"" target=""_blank"">Biocon gets FDA approval to produce pegfilgrastim in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.8464288711547852,positive,0.8464288711547852,0.0,neutral,0.0,0.7351,0.22,0.0,0.78,0.0,0.0,0.48367364065987717,0.7907644355773926,approval_process,0.8222135603427887,['FDA approval'],False,True,16,0.6444271206855774
2018-06-02,2018-06-02 07:00:00,Mylan-Biocon’s insulin biosimilar faces FDA hurdle - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Mylan-Biocon’s insulin biosimilar faces FDA hurdle</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi3wFBVV95cUxQbG5HVktoenZ6cEVpYmp1ajBUUVRaRVBxZHc1SjJIa211aUZyZmpieWI1cG82bzEtRzdab05sQVN0WWhPSnM5WUY5YndCTUtnTVJKYU9DWUxiaFE3eWp6WjVoSkJfeGN0M1YyMWZtNWJzSzVobXh6UjhSS1pMWlBDM1hvRTdoT3BXNUJWT2N2ZElSRktwUmRkcFpKcEVJZHBTdlZMMkEyTkRQcUNDR0tybWJxa3BpVnhwYk9Tb1BJWk9RSGsyZ1ptY2dUTmZ0UTcyeFNoc2pLZFk5cWVfSjhF0gHkAUFVX3lxTE41WU1ZTlRhUUNTOENUdFBJelY2ZWVhQUJseWVRTmdwVllzbWFqX3U3LW9qLXR4RWxOZlQxdjBjQTFFZU4ydmlHblA1OXVaRk9zM3dvbVljWWl2bWlhT3I0aTBLMU1qUU92cTZ6NlJVRzEyMlVNQm5HT0pkV2FPV08wc05Pam16X2lNZ2lsVFgyWk1YRktLSVloUGpWRC1zWjk1aXJ6TUVRSFA4Z2RYRkdrQ1BHOE9NZ0JodWU1WXhtSUhYSV82OGdKNWFKQndUZjY4WHZrX2xFVmY5WGQ1YVJXUm5RQQ?oc=5,Google News,Biocon insulin biosimilar FDA,"Mylan-Biocon’s insulin biosimilar faces FDA hurdle - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Mylan-Biocon’s insulin biosimilar faces FDA hurdle</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.8330286145210266,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.0,0.48318097392717996,other,0.0,[],False,True,6,0.0
2020-01-28,2020-01-28 08:00:00,Biocon receives FDA Form 483 at Bangalore plant - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxNSGtGWlpLUmZXWDVSN0paWXdyX3g4TEJvR3F4YmdWQXNWMEhqNzQ2SlhZNkgtZHFuT2IyRVQ2MkNMQm9YU1lqdE00ZDN0ZHI1QTlTb09uQnkyOFBNVUhCUE9vRnJwRHI4a09TVkllMFFNZGM3Z0FXVi1CU0xQWGFxTWhoMDFqeXpzdjVBY3BhOXptRzFY?oc=5"" target=""_blank"">Biocon receives FDA Form 483 at Bangalore plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxNSGtGWlpLUmZXWDVSN0paWXdyX3g4TEJvR3F4YmdWQXNWMEhqNzQ2SlhZNkgtZHFuT2IyRVQ2MkNMQm9YU1lqdE00ZDN0ZHI1QTlTb09uQnkyOFBNVUhCUE9vRnJwRHI4a09TVkllMFFNZGM3Z0FXVi1CU0xQWGFxTWhoMDFqeXpzdjVBY3BhOXptRzFY?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon receives FDA Form 483 at Bangalore plant - BioProcess International <a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxNSGtGWlpLUmZXWDVSN0paWXdyX3g4TEJvR3F4YmdWQXNWMEhqNzQ2SlhZNkgtZHFuT2IyRVQ2MkNMQm9YU1lqdE00ZDN0ZHI1QTlTb09uQnkyOFBNVUhCUE9vRnJwRHI4a09TVkllMFFNZGM3Z0FXVi1CU0xQWGFxTWhoMDFqeXpzdjVBY3BhOXptRzFY?oc=5"" target=""_blank"">Biocon receives FDA Form 483 at Bangalore plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",0.0,neutral,0.8384245038032532,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8384245038032532,other,0.0,[],False,True,6,0.0
2017-05-10,2017-05-10 07:00:00,Biocon downplays FDA Form 483 for Bangalore plant - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxOVzhoNE9pZmpHQjZCRERrRUc3dGNTZjRsYkV3Ykw2OVhNeTVlWFhISHJ0R01ZbzlJV1BuQ3czRW85LXBuTXdDdEdQUlBSQUJrTjBPbjJITk0tcjBjcm1SNmlUSS16czlkUjBHVnM5QUlxeW4zN1NRdHgxdHpQMVJPVWpSelhlS01CSDBYS3dOeVBJTnVhUkM0?oc=5"" target=""_blank"">Biocon downplays FDA Form 483 for Bangalore plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxOVzhoNE9pZmpHQjZCRERrRUc3dGNTZjRsYkV3Ykw2OVhNeTVlWFhISHJ0R01ZbzlJV1BuQ3czRW85LXBuTXdDdEdQUlBSQUJrTjBPbjJITk0tcjBjcm1SNmlUSS16czlkUjBHVnM5QUlxeW4zN1NRdHgxdHpQMVJPVWpSelhlS01CSDBYS3dOeVBJTnVhUkM0?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon downplays FDA Form 483 for Bangalore plant - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxOVzhoNE9pZmpHQjZCRERrRUc3dGNTZjRsYkV3Ykw2OVhNeTVlWFhISHJ0R01ZbzlJV1BuQ3czRW85LXBuTXdDdEdQUlBSQUJrTjBPbjJITk0tcjBjcm1SNmlUSS16czlkUjBHVnM5QUlxeW4zN1NRdHgxdHpQMVJPVWpSelhlS01CSDBYS3dOeVBJTnVhUkM0?oc=5"" target=""_blank"">Biocon downplays FDA Form 483 for Bangalore plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.894479513168335,negative,0.894479513168335,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.5111311503819057,0.894479513168335,other,0.0,[],False,True,6,0.0
2018-10-12,2018-10-12 07:00:00,"Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product? - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxOT2g4a2Q1RXFrLTFyOE11c0JNWW81VWtzOUN5aGxBT3A4NFhfUU5FTDVHcUg5azdmNHNLS1hkNEF3dTRpSkhHX3haa2lwLUUyWnptNGZxbmJ0bENHb01vSWtxREdnRkY0OXJVeDdVLTBsVXkxWUg3c1ZMZTlLLU9XN25UUnZNQVZQZjQ4a090OFN6ZkpMdGlSMVBPMm1BeUVkUU9fclEyQ0NlZXZvX0FEREFmc3lNS05NNllRZA?oc=5"" target=""_blank"">Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxOT2g4a2Q1RXFrLTFyOE11c0JNWW81VWtzOUN5aGxBT3A4NFhfUU5FTDVHcUg5azdmNHNLS1hkNEF3dTRpSkhHX3haa2lwLUUyWnptNGZxbmJ0bENHb01vSWtxREdnRkY0OXJVeDdVLTBsVXkxWUg3c1ZMZTlLLU9XN25UUnZNQVZQZjQ4a090OFN6ZkpMdGlSMVBPMm1BeUVkUU9fclEyQ0NlZXZvX0FEREFmc3lNS05NNllRZA?oc=5,Google News,Biocon insulin biosimilar FDA,"Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product? - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxOT2g4a2Q1RXFrLTFyOE11c0JNWW81VWtzOUN5aGxBT3A4NFhfUU5FTDVHcUg5azdmNHNLS1hkNEF3dTRpSkhHX3haa2lwLUUyWnptNGZxbmJ0bENHb01vSWtxREdnRkY0OXJVeDdVLTBsVXkxWUg3c1ZMZTlLLU9XN25UUnZNQVZQZjQ4a090OFN6ZkpMdGlSMVBPMm1BeUVkUU9fclEyQ0NlZXZvX0FEREFmc3lNS05NNllRZA?oc=5"" target=""_blank"">Merck ditches biosimilar Lantus, but will that ease the path for Mylan’s rival insulin product?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.7234305143356323,positive,0.7234305143356323,0.0,neutral,0.0,0.7929,0.172,0.0,0.828,0.0,0.0,0.413388865334647,0.7581652571678161,other,0.0,[],False,False,1,0.0
2017-09-11,2017-09-11 07:00:00,Biocon insulin plant in Malaysia wins EU manufacturing approval - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxONzk5OUh6M19yUmNVOWdDY2JfN3BCbVBqZXdxMVZjN3pmNWpJeWUzejZfU1JkaG5PWEc0M3ZBeF8yb0pZZ2NhME82QWowcThmLWgwZVc5dllDRG1EYnB3TDdjaFZRRTFSSWh6X2dWVjc5aVY5eGQtQXNIMzFuSDRlSi1leFVWTFAwalppWWtlNV9hazNQUmdCSXM5VmU5d3ZIZG5jNVp3?oc=5"" target=""_blank"">Biocon insulin plant in Malaysia wins EU manufacturing approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxONzk5OUh6M19yUmNVOWdDY2JfN3BCbVBqZXdxMVZjN3pmNWpJeWUzejZfU1JkaG5PWEc0M3ZBeF8yb0pZZ2NhME82QWowcThmLWgwZVc5dllDRG1EYnB3TDdjaFZRRTFSSWh6X2dWVjc5aVY5eGQtQXNIMzFuSDRlSi1leFVWTFAwalppWWtlNV9hazNQUmdCSXM5VmU5d3ZIZG5jNVp3?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon insulin plant in Malaysia wins EU manufacturing approval - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxONzk5OUh6M19yUmNVOWdDY2JfN3BCbVBqZXdxMVZjN3pmNWpJeWUzejZfU1JkaG5PWEc0M3ZBeF8yb0pZZ2NhME82QWowcThmLWgwZVc5dllDRG1EYnB3TDdjaFZRRTFSSWh6X2dWVjc5aVY5eGQtQXNIMzFuSDRlSi1leFVWTFAwalppWWtlNV9hazNQUmdCSXM5VmU5d3ZIZG5jNVp3?oc=5"" target=""_blank"">Biocon insulin plant in Malaysia wins EU manufacturing approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.9015867114067078,positive,0.9015867114067078,0.0,neutral,0.0,0.8885,0.333,0.0,0.667,0.19999999999999998,0.13333333333333333,0.5151924065181187,0.6633622371355693,approval_process,0.7873438596725464,['drug approval'],False,True,16,0.5746877193450928
2022-01-10,2022-01-10 08:00:00,US FDA asking for more data on insulin Aspart; no commercial impact of application rejection as of now: Biocon - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMi5gFBVV95cUxPUFh1QjF0bzF2WVV5MUNnN01mLWxLUldKeElZUzFWNUJEai12RGtTVFU1TGQxWVFUclZvdHlNdk1LRnp4ZFZvTUhMWUpRN0lxVnhUZ1hBM2V4QkZUbENoLU5uTmFKZE94YmFvVkhKWVZjS09TTXFyUnZCX3VMbFl0REZPUjhZUG5NU1dGeE5SVG1uTi11NXc1NENlUDVZQzFCYXNHU3pGZHQyTHRZcE02QzI4UTlPYVd6NnVKMHVnckVoTmRoTGQ2ME5TUWlpb1FSVldBRjJON0NjbGdIalVxeVZCXzVEUdIB6wFBVV95cUxNS3h0QlB1cUFwRkRxYUFtNWgxeGYyVW1PVzd3Z0ZwT3g1T28wU0Z3aDctcXhGaDdCLTdXVjQxZ3VfZXJfdGVTTjNmNnJIQjZ0azY2cXdteDRWaWRMd2lFNHRmMUZtcW9WZnBrTnhiSXVTZWVKbUJSbzEyamcxYkxwanFwYWZIMVFndEdIS1lRbnJ3MEdqVDFtdUxoYWowTDkxWUFCX3dHWmpjR2V1Yjl0bzAtTUhtM2h6S3kwak5YZEg0dXQ1ZnQ1MFA1c0s3T0RDeDQ3OGZqZ2xPM1kyWWlxSU41ejRZcDBfRHhN?oc=5"" target=""_blank"">US FDA asking for more data on insulin Aspart; no commercial impact of application rejection as of now: Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon insulin biosimilar FDA,"US FDA asking for more data on insulin Aspart; no commercial impact of application rejection as of now: Biocon - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">US FDA asking for more data on insulin Aspart; no commercial impact of application rejection as of now: Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.9285985231399536,0.0,neutral,0.0,-0.886,0.0,0.222,0.778,0.2,0.2,0.0,0.6715328410466513,other,0.0,[],False,True,6,0.0
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News,Semglee FDA approval 2021,"FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS <a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",0.5834283232688904,positive,0.5834283232688904,0.0,neutral,0.0,0.6597,0.172,0.0,0.828,0.16666666666666666,0.2222222222222222,0.3333876132965088,0.4699316633118524,approval_process,0.7574118375778198,['FDA approval'],True,False,21,0.5148236751556396
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News,Semglee FDA approval 2021,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive <a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",0.6338136792182922,positive,0.6338136792182922,0.0,neutral,0.0,0.6597,0.213,0.0,0.787,0.16666666666666666,0.2222222222222222,0.3621792452675956,0.486726781961653,approval_process,0.7657920122146606,['FDA approval'],True,False,21,0.5315840244293213
2021-07-29,2021-07-29 07:00:00,Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5,Google News,Semglee FDA approval 2021,"Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1 <a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",0.8389886021614075,positive,0.8389886021614075,0.0,neutral,0.0,0.7351,0.212,0.0,0.788,0.16666666666666666,0.2222222222222222,0.4794220583779471,0.5802517562760248,approval_process,0.7598708868026733,['FDA approval'],True,False,21,0.5197417736053467
2021-07-29,2021-07-29 07:00:00,An FDA First: Semglee Is Approved As An Interchangeable Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5"" target=""_blank"">An FDA First: Semglee Is Approved As An Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5,Google News,Semglee FDA approval 2021,"An FDA First: Semglee Is Approved As An Interchangeable Biosimilar - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5"" target=""_blank"">An FDA First: Semglee Is Approved As An Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.6004779934883118,positive,0.6004779934883118,0.0,neutral,0.0,0.6808,0.177,0.0,0.823,0.16666666666666666,0.2222222222222222,0.34313028199332096,0.4826482200516595,other,0.0,[],True,False,11,0.0
2021-07-28,2021-07-28 07:00:00,FDA Approves First Interchangeable Biosimilar Insulin - Medscape,"<a href=""https://news.google.com/rss/articles/CBMiVkFVX3lxTE5YZUwzUFNjZ2c3X0dJXzh6RDNib2gzOHZKa0poeXIzcjd2Y2Raemd3dWltdUh6dkhlcTNTLWR4ZS1yMG1TbjRUSlU3dlpJUXBtWldReWh3?oc=5"" target=""_blank"">FDA Approves First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medscape</font>",https://news.google.com/rss/articles/CBMiVkFVX3lxTE5YZUwzUFNjZ2c3X0dJXzh6RDNib2gzOHZKa0poeXIzcjd2Y2Raemd3dWltdUh6dkhlcTNTLWR4ZS1yMG1TbjRUSlU3dlpJUXBtWldReWh3?oc=5,Google News,Semglee FDA approval 2021,"FDA Approves First Interchangeable Biosimilar Insulin - Medscape <a href=""https://news.google.com/rss/articles/CBMiVkFVX3lxTE5YZUwzUFNjZ2c3X0dJXzh6RDNib2gzOHZKa0poeXIzcjd2Y2Raemd3dWltdUh6dkhlcTNTLWR4ZS1yMG1TbjRUSlU3dlpJUXBtWldReWh3?oc=5"" target=""_blank"">FDA Approves First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medscape</font>",0.5064266920089722,positive,0.5064266920089722,0.0,neutral,0.0,0.6597,0.278,0.0,0.722,0.16666666666666666,0.2222222222222222,0.28938668114798405,0.4442644528918796,approval_process,0.7955113649368286,['FDA approval'],True,False,21,0.5910227298736572
2021-07-29,2021-07-29 07:00:00,The FDA just broke the logjam on interchangeable biologics. Here’s what that decision means - STAT,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPU0dtMGcxRy15OUdIUGhDZmlMSzVpMGplWkpHWDc4dDhqbkV2RlhuZFA1czd1MlVYNGpxLTlTZFhneDFkYVRsUTcyZXlibUxaTWg1TVFMbF9rUWNwellRaVdUSWR0cWkxeGdFWlRGVkNRR2RuSkxvMExLbXdCY0FscDRTVG1qbE1zVFQwMUNfZ29LcWpPd20yT1ZoNTQ?oc=5"" target=""_blank"">The FDA just broke the logjam on interchangeable biologics. Here’s what that decision means</a>&nbsp;&nbsp;<font color=""#6f6f6f"">STAT</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxPU0dtMGcxRy15OUdIUGhDZmlMSzVpMGplWkpHWDc4dDhqbkV2RlhuZFA1czd1MlVYNGpxLTlTZFhneDFkYVRsUTcyZXlibUxaTWg1TVFMbF9rUWNwellRaVdUSWR0cWkxeGdFWlRGVkNRR2RuSkxvMExLbXdCY0FscDRTVG1qbE1zVFQwMUNfZ29LcWpPd20yT1ZoNTQ?oc=5,Google News,Semglee FDA approval 2021,"The FDA just broke the logjam on interchangeable biologics. Here’s what that decision means - STAT <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPU0dtMGcxRy15OUdIUGhDZmlMSzVpMGplWkpHWDc4dDhqbkV2RlhuZFA1czd1MlVYNGpxLTlTZFhneDFkYVRsUTcyZXlibUxaTWg1TVFMbF9rUWNwellRaVdUSWR0cWkxeGdFWlRGVkNRR2RuSkxvMExLbXdCY0FscDRTVG1qbE1zVFQwMUNfZ29LcWpPd20yT1ZoNTQ?oc=5"" target=""_blank"">The FDA just broke the logjam on interchangeable biologics. Here’s what that decision means</a>&nbsp;&nbsp;<font color=""#6f6f6f"">STAT</font>",0.0,neutral,0.8949164152145386,0.0,neutral,0.0,-0.6808,0.0,0.157,0.843,0.0,0.0,0.0,0.7878582076072693,other,0.0,[],False,False,1,0.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News,Semglee FDA approval 2021,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control <a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",0.6942455172538757,positive,0.6942455172538757,0.0,neutral,0.0,0.4767,0.119,0.0,0.881,0.0,0.0,0.3967117241450718,0.5854727586269379,approval_process,0.8041950464248657,['FDA approval'],True,False,21,0.6083900928497314
2021-07-29,2021-07-29 07:00:00,FDA OKs First Interchangeable Insulin Biosimilar - MedPage Today,"<a href=""https://news.google.com/rss/articles/CBMiZkFVX3lxTE9tRWtfUjlNb0lkSUxrZHlZZjZQRV9QMWlxUnhlcmlUSXFheE9YVGdTZFd5cERReExSbXVabnhxQlZQUmtPNUxJTDd0WmY4RFNOMlV6a0U2a2pOTndSQXUwYTNodjktZw?oc=5"" target=""_blank"">FDA OKs First Interchangeable Insulin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MedPage Today</font>",https://news.google.com/rss/articles/CBMiZkFVX3lxTE9tRWtfUjlNb0lkSUxrZHlZZjZQRV9QMWlxUnhlcmlUSXFheE9YVGdTZFd5cERReExSbXVabnhxQlZQUmtPNUxJTDd0WmY4RFNOMlV6a0U2a2pOTndSQXUwYTNodjktZw?oc=5,Google News,Semglee FDA approval 2021,"FDA OKs First Interchangeable Insulin Biosimilar - MedPage Today <a href=""https://news.google.com/rss/articles/CBMiZkFVX3lxTE9tRWtfUjlNb0lkSUxrZHlZZjZQRV9QMWlxUnhlcmlUSXFheE9YVGdTZFd5cERReExSbXVabnhxQlZQUmtPNUxJTDd0WmY4RFNOMlV6a0U2a2pOTndSQXUwYTNodjktZw?oc=5"" target=""_blank"">FDA OKs First Interchangeable Insulin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MedPage Today</font>",0.0,neutral,0.8784279823303223,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.16666666666666666,0.2222222222222222,0.0,0.5225473244984945,other,0.0,[],False,False,1,0.0
2021-11-23,2021-11-23 08:00:00,OptumRx Excludes the Diabetes Biosimilar Semglee from Formulary - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxPdktpX0xDWUJQTU9HWHZXa2hXbmp1Q3ZDVDZzdnZPM1owTUh4MGRqSWFMS3A2TjRxb2VkZUF4UmRMbExxNXUtd3J3RTVCUDhDQmEtejFlX3NaRlJWR1d0NU1LS1d0WGJaTHF2c0ZDZVZjc25Fc1p0NEF3c1Y0X3l1Zmw3Y3puU3ZTREhtb0ZVWFgzcDZUNzdURExOb3c0X1JiSVNnTzREdmIya1hCTkdnaQ?oc=5"" target=""_blank"">OptumRx Excludes the Diabetes Biosimilar Semglee from Formulary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxPdktpX0xDWUJQTU9HWHZXa2hXbmp1Q3ZDVDZzdnZPM1owTUh4MGRqSWFMS3A2TjRxb2VkZUF4UmRMbExxNXUtd3J3RTVCUDhDQmEtejFlX3NaRlJWR1d0NU1LS1d0WGJaTHF2c0ZDZVZjc25Fc1p0NEF3c1Y0X3l1Zmw3Y3puU3ZTREhtb0ZVWFgzcDZUNzdURExOb3c0X1JiSVNnTzREdmIya1hCTkdnaQ?oc=5,Google News,Semglee FDA approval 2021,"OptumRx Excludes the Diabetes Biosimilar Semglee from Formulary - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxPdktpX0xDWUJQTU9HWHZXa2hXbmp1Q3ZDVDZzdnZPM1owTUh4MGRqSWFMS3A2TjRxb2VkZUF4UmRMbExxNXUtd3J3RTVCUDhDQmEtejFlX3NaRlJWR1d0NU1LS1d0WGJaTHF2c0ZDZVZjc25Fc1p0NEF3c1Y0X3l1Zmw3Y3puU3ZTREhtb0ZVWFgzcDZUNzdURExOb3c0X1JiSVNnTzREdmIya1hCTkdnaQ?oc=5"" target=""_blank"">OptumRx Excludes the Diabetes Biosimilar Semglee from Formulary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.0,neutral,0.8423548936843872,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8423548936843872,other,0.0,[],True,False,11,0.0
2021-08-04,2021-08-04 07:00:00,"FDA Approvals Roundup: Semglee, Saphnelo, Uptravi - Regulatory Affairs Professionals Society | RAPS","<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQb3JBVkpMS3Q4TlIydHdYNGpPa29CelpOejFSVXFwQ0hobzdNOGdYTlc4c2ZPbXpFTDZxYU1lbGl6SzBvOTZZUFRTMnRzbHJxbDB4S0xVYWdrOGhSdE9oTGFpYUlOSFo4bkdrUjdSem0wVVBkUVNadUNLX3dGTU53bi1QQWtvS1M2LU5GU2tHbE9odG1XZ3cxNWU5cW55cUtVVnpNTUZJOEJzZw?oc=5"" target=""_blank"">FDA Approvals Roundup: Semglee, Saphnelo, Uptravi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxQb3JBVkpMS3Q4TlIydHdYNGpPa29CelpOejFSVXFwQ0hobzdNOGdYTlc4c2ZPbXpFTDZxYU1lbGl6SzBvOTZZUFRTMnRzbHJxbDB4S0xVYWdrOGhSdE9oTGFpYUlOSFo4bkdrUjdSem0wVVBkUVNadUNLX3dGTU53bi1QQWtvS1M2LU5GU2tHbE9odG1XZ3cxNWU5cW55cUtVVnpNTUZJOEJzZw?oc=5,Google News,Semglee FDA approval 2021,"FDA Approvals Roundup: Semglee, Saphnelo, Uptravi - Regulatory Affairs Professionals Society | RAPS <a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQb3JBVkpMS3Q4TlIydHdYNGpPa29CelpOejFSVXFwQ0hobzdNOGdYTlc4c2ZPbXpFTDZxYU1lbGl6SzBvOTZZUFRTMnRzbHJxbDB4S0xVYWdrOGhSdE9oTGFpYUlOSFo4bkdrUjdSem0wVVBkUVNadUNLX3dGTU53bi1QQWtvS1M2LU5GU2tHbE9odG1XZ3cxNWU5cW55cUtVVnpNTUZJOEJzZw?oc=5"" target=""_blank"">FDA Approvals Roundup: Semglee, Saphnelo, Uptravi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",0.0,neutral,0.9213662147521973,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9213662147521973,approval_process,1.0,"['FDA approval', 'drug approval', 'biosimilar approval', 'interchangeable designation', 'marketing authorization', 'regulatory approval', 'FDA clearance']",True,False,26,0.7140103578567505
2021-07-29,2021-07-29 07:00:00,FDA approves first interchangeable biosimilar insulin product - European Pharmaceutical Review,"<a href=""https://news.google.com/rss/articles/CBMiuwFBVV95cUxQZkd1U3ZvajNsUEs2Rkd2UzQ1QWMyci0wc1pBQnk4a3gtaXEwN0hqRlpDbHM5c0dYNGtJZU1YRFp2T0hKaElKUDByWnF2dkVuc0g2cklBaWp1enpfSUE1UFF4ZW1rdWRiRjk4Sks3ZkpwLVRnYnlqblJocEFvUzNaLTUyRGZYR2RUeGw4Q3YxT2FOWnFkM0QydjZzZjduTFBRMnVwV3psaVh4M25aUFFSeWxPbmxaeXQ4RlFZ?oc=5"" target=""_blank"">FDA approves first interchangeable biosimilar insulin product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">European Pharmaceutical Review</font>",https://news.google.com/rss/articles/CBMiuwFBVV95cUxQZkd1U3ZvajNsUEs2Rkd2UzQ1QWMyci0wc1pBQnk4a3gtaXEwN0hqRlpDbHM5c0dYNGtJZU1YRFp2T0hKaElKUDByWnF2dkVuc0g2cklBaWp1enpfSUE1UFF4ZW1rdWRiRjk4Sks3ZkpwLVRnYnlqblJocEFvUzNaLTUyRGZYR2RUeGw4Q3YxT2FOWnFkM0QydjZzZjduTFBRMnVwV3psaVh4M25aUFFSeWxPbmxaeXQ4RlFZ?oc=5,Google News,Semglee FDA approval 2021,"FDA approves first interchangeable biosimilar insulin product - European Pharmaceutical Review <a href=""https://news.google.com/rss/articles/CBMiuwFBVV95cUxQZkd1U3ZvajNsUEs2Rkd2UzQ1QWMyci0wc1pBQnk4a3gtaXEwN0hqRlpDbHM5c0dYNGtJZU1YRFp2T0hKaElKUDByWnF2dkVuc0g2cklBaWp1enpfSUE1UFF4ZW1rdWRiRjk4Sks3ZkpwLVRnYnlqblJocEFvUzNaLTUyRGZYR2RUeGw4Q3YxT2FOWnFkM0QydjZzZjduTFBRMnVwV3psaVh4M25aUFFSeWxPbmxaeXQ4RlFZ?oc=5"" target=""_blank"">FDA approves first interchangeable biosimilar insulin product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">European Pharmaceutical Review</font>",0.6842642426490784,positive,0.6842642426490784,0.0,neutral,0.0,0.6597,0.213,0.0,0.787,0.125,0.16666666666666666,0.3910081386566162,0.4896547475496928,approval_process,0.8047485947608948,['FDA approval'],True,False,21,0.6094971895217896
2021-08-01,2021-08-01 07:00:00,FDA allows pharmacists to automatically swap ‘generic’ insulin for brand-name - NEWS10 ABC,"<a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxPTm9YY1RNTEV0MUJMbzZ1MmFMSUxHVkpXSV9oM0FiY3p0bEZqWkFucF9zSmlpWlQybEFMeWRGUFNNTHQwYm43YXFqc0dpX2FVektHcElfNnZDNjN1TU15eWRIZjVMY0JIOGN6TWxLRlhBakpydDdYWHpRdTQ2RHBBMS1ZemlyeUxQSnYtalF0Z2pLTmJnZ0EwQlVGeTF6a2FSR1kteWlac9IBrAFBVV95cUxQTzhPbEhVOFlQMk9lLUtoODV0SXVyamJ6Ry10NTZTV3NERms2S1EyRjkwaXFlaHlkVG94cTVPV1dPVlcyZTl0SkM2N3JBX3Itc2ZfLUc4aXE4OEx6TEZxeW1NTEJWa0t4NW1oV19mOUw4ZHZhZGlxOExNM1ppT2lfQkJYVU5qbnpPTnRfYlF6SWFubWJDNXFLc19OSG5YM0QxeDJ2THd0UWFwdVhG?oc=5"" target=""_blank"">FDA allows pharmacists to automatically swap ‘generic’ insulin for brand-name</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NEWS10 ABC</font>",https://news.google.com/rss/articles/CBMipwFBVV95cUxPTm9YY1RNTEV0MUJMbzZ1MmFMSUxHVkpXSV9oM0FiY3p0bEZqWkFucF9zSmlpWlQybEFMeWRGUFNNTHQwYm43YXFqc0dpX2FVektHcElfNnZDNjN1TU15eWRIZjVMY0JIOGN6TWxLRlhBakpydDdYWHpRdTQ2RHBBMS1ZemlyeUxQSnYtalF0Z2pLTmJnZ0EwQlVGeTF6a2FSR1kteWlac9IBrAFBVV95cUxQTzhPbEhVOFlQMk9lLUtoODV0SXVyamJ6Ry10NTZTV3NERms2S1EyRjkwaXFlaHlkVG94cTVPV1dPVlcyZTl0SkM2N3JBX3Itc2ZfLUc4aXE4OEx6TEZxeW1NTEJWa0t4NW1oV19mOUw4ZHZhZGlxOExNM1ppT2lfQkJYVU5qbnpPTnRfYlF6SWFubWJDNXFLc19OSG5YM0QxeDJ2THd0UWFwdVhG?oc=5,Google News,Semglee FDA approval 2021,"FDA allows pharmacists to automatically swap ‘generic’ insulin for brand-name - NEWS10 ABC <a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxPTm9YY1RNTEV0MUJMbzZ1MmFMSUxHVkpXSV9oM0FiY3p0bEZqWkFucF9zSmlpWlQybEFMeWRGUFNNTHQwYm43YXFqc0dpX2FVektHcElfNnZDNjN1TU15eWRIZjVMY0JIOGN6TWxLRlhBakpydDdYWHpRdTQ2RHBBMS1ZemlyeUxQSnYtalF0Z2pLTmJnZ0EwQlVGeTF6a2FSR1kteWlac9IBrAFBVV95cUxQTzhPbEhVOFlQMk9lLUtoODV0SXVyamJ6Ry10NTZTV3NERms2S1EyRjkwaXFlaHlkVG94cTVPV1dPVlcyZTl0SkM2N3JBX3Itc2ZfLUc4aXE4OEx6TEZxeW1NTEJWa0t4NW1oV19mOUw4ZHZhZGlxOExNM1ppT2lfQkJYVU5qbnpPTnRfYlF6SWFubWJDNXFLc19OSG5YM0QxeDJ2THd0UWFwdVhG?oc=5"" target=""_blank"">FDA allows pharmacists to automatically swap ‘generic’ insulin for brand-name</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NEWS10 ABC</font>",0.0,neutral,0.9334796071052551,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9334796071052551,other,0.0,[],False,False,1,0.0
2021-07-22,2021-07-22 07:00:00,First interchangeable awaiting FDA decision - BioWorld MedTech,"<a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxNV1Z1M1hSSWdCQU5tS3pQZVAzYm56ZG5hY1hrVDhjTFRfdFU5ZUtZQWFfZ0lfQzNsNm4xUkNCQ3NPdWo4RTZ0Z3o0NHRaRzNVVF9iX0dxWWo2eTFlWC1rb1QtaGx3THdLT3UwVUJfX3JaeVV1Q0JYdWZYXzQ3ZTVlcjFrQm1RLXFLRXhKdw?oc=5"" target=""_blank"">First interchangeable awaiting FDA decision</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioWorld MedTech</font>",https://news.google.com/rss/articles/CBMijAFBVV95cUxNV1Z1M1hSSWdCQU5tS3pQZVAzYm56ZG5hY1hrVDhjTFRfdFU5ZUtZQWFfZ0lfQzNsNm4xUkNCQ3NPdWo4RTZ0Z3o0NHRaRzNVVF9iX0dxWWo2eTFlWC1rb1QtaGx3THdLT3UwVUJfX3JaeVV1Q0JYdWZYXzQ3ZTVlcjFrQm1RLXFLRXhKdw?oc=5,Google News,Semglee FDA approval 2021,"First interchangeable awaiting FDA decision - BioWorld MedTech <a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxNV1Z1M1hSSWdCQU5tS3pQZVAzYm56ZG5hY1hrVDhjTFRfdFU5ZUtZQWFfZ0lfQzNsNm4xUkNCQ3NPdWo4RTZ0Z3o0NHRaRzNVVF9iX0dxWWo2eTFlWC1rb1QtaGx3THdLT3UwVUJfX3JaeVV1Q0JYdWZYXzQ3ZTVlcjFrQm1RLXFLRXhKdw?oc=5"" target=""_blank"">First interchangeable awaiting FDA decision</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioWorld MedTech</font>",0.0,neutral,0.8516944646835327,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.125,0.16666666666666666,0.0,0.48834723234176636,other,0.0,[],False,False,1,0.0
2021-07-23,2021-07-23 07:00:00,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr; - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr;</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5,Google News,Biocon BLA submission,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr; - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr;</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.9522649049758911,positive,0.9522649049758911,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5441513742719378,0.9522649049758911,other,0.0,[],False,True,6,0.0
2020-01-29,2020-01-29 08:00:00,FDA faults Biocon small molecule API facility during preapproval review - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPd01oaUlvY0xUN25md0JTUVlJb3dBeWdJTzl0MmItaFFjTFJpTnJYN0JUclFvSVVCaTBrb2VnREFDSnluUjkyU1Z5TjVXZ0loQmxDQ0N2SDFhME5UTWF5YjlKbXkxajJfa0o5elh0OFNEOWZnbGVZRkQzaW0ydVFVYm1WUnlQbE9ZclJ4TkhsVnFKdFJYT0E5U2JyNzhfX2hUdTQ3Q2ZOUThyT0YxRDJ0VWswODk?oc=5"" target=""_blank"">FDA faults Biocon small molecule API facility during preapproval review</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxPd01oaUlvY0xUN25md0JTUVlJb3dBeWdJTzl0MmItaFFjTFJpTnJYN0JUclFvSVVCaTBrb2VnREFDSnluUjkyU1Z5TjVXZ0loQmxDQ0N2SDFhME5UTWF5YjlKbXkxajJfa0o5elh0OFNEOWZnbGVZRkQzaW0ydVFVYm1WUnlQbE9ZclJ4TkhsVnFKdFJYT0E5U2JyNzhfX2hUdTQ3Q2ZOUThyT0YxRDJ0VWswODk?oc=5,Google News,Biocon FDA inspection,"FDA faults Biocon small molecule API facility during preapproval review - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPd01oaUlvY0xUN25md0JTUVlJb3dBeWdJTzl0MmItaFFjTFJpTnJYN0JUclFvSVVCaTBrb2VnREFDSnluUjkyU1Z5TjVXZ0loQmxDQ0N2SDFhME5UTWF5YjlKbXkxajJfa0o5elh0OFNEOWZnbGVZRkQzaW0ydVFVYm1WUnlQbE9ZclJ4TkhsVnFKdFJYT0E5U2JyNzhfX2hUdTQ3Q2ZOUThyT0YxRDJ0VWswODk?oc=5"" target=""_blank"">FDA faults Biocon small molecule API facility during preapproval review</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.9596816301345825,negative,0.9596816301345825,0.0,neutral,0.0,-0.7351,0.0,0.205,0.795,-0.16666666666666666,0.26666666666666666,-0.5483895029340471,0.6204827656004165,other,0.0,[],False,True,6,0.0
2019-03-12,2019-03-12 07:00:00,Biocon biosimilar plant criticized again by the FDA - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPa3I5RS1UMDh2TldyQk5zQ2dycXF4Tl8zVXZabEVpNFAwd19hQThONUFRNHZFenF1VGJIcHZjMU9kdU4tR2NvRnBkZFc3bldKOWpxWldJN3F3WjVQVUROMDVzZjh5SmdiRDkybEpDaDBOdDBMYnBleVBBUld3LURlRUEzbmtXSE1LdTFfMmRrSnhXU3Vv?oc=5"" target=""_blank"">Biocon biosimilar plant criticized again by the FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPa3I5RS1UMDh2TldyQk5zQ2dycXF4Tl8zVXZabEVpNFAwd19hQThONUFRNHZFenF1VGJIcHZjMU9kdU4tR2NvRnBkZFc3bldKOWpxWldJN3F3WjVQVUROMDVzZjh5SmdiRDkybEpDaDBOdDBMYnBleVBBUld3LURlRUEzbmtXSE1LdTFfMmRrSnhXU3Vv?oc=5,Google News,Biocon FDA inspection,"Biocon biosimilar plant criticized again by the FDA - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPa3I5RS1UMDh2TldyQk5zQ2dycXF4Tl8zVXZabEVpNFAwd19hQThONUFRNHZFenF1VGJIcHZjMU9kdU4tR2NvRnBkZFc3bldKOWpxWldJN3F3WjVQVUROMDVzZjh5SmdiRDkybEpDaDBOdDBMYnBleVBBUld3LURlRUEzbmtXSE1LdTFfMmRrSnhXU3Vv?oc=5"" target=""_blank"">Biocon biosimilar plant criticized again by the FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.9366018772125244,negative,0.9366018772125244,0.0,neutral,0.0,-0.6124,0.0,0.2,0.8,0.0,0.0,-0.5352010726928711,0.7745009386062622,other,0.0,[],False,True,6,0.0
2018-06-26,2018-06-26 07:00:00,FDA gives Biocon biosimilars plant clean bill of health - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQamJFdml3NUpCMXZDVTIta2ItSGlkQklqYlZYMXNSMFdjclIzd1Y0ZFRfcWowaHZQQkpOLXF6T2piN1hkTWVEMjM5NjJnV0FXTjJ1UHFDRnlvTzlKS0ZHZmF2R3ExNEcyNVZ6Mmh2WjJyRkFibjVZUzhhOThXeWtjR3o0eW5lWnZQaVpWdi1RNHdINWtKVUlTOFp0UQ?oc=5"" target=""_blank"">FDA gives Biocon biosimilars plant clean bill of health</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxQamJFdml3NUpCMXZDVTIta2ItSGlkQklqYlZYMXNSMFdjclIzd1Y0ZFRfcWowaHZQQkpOLXF6T2piN1hkTWVEMjM5NjJnV0FXTjJ1UHFDRnlvTzlKS0ZHZmF2R3ExNEcyNVZ6Mmh2WjJyRkFibjVZUzhhOThXeWtjR3o0eW5lWnZQaVpWdi1RNHdINWtKVUlTOFp0UQ?oc=5,Google News,Biocon FDA inspection,"FDA gives Biocon biosimilars plant clean bill of health - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQamJFdml3NUpCMXZDVTIta2ItSGlkQklqYlZYMXNSMFdjclIzd1Y0ZFRfcWowaHZQQkpOLXF6T2piN1hkTWVEMjM5NjJnV0FXTjJ1UHFDRnlvTzlKS0ZHZmF2R3ExNEcyNVZ6Mmh2WjJyRkFibjVZUzhhOThXeWtjR3o0eW5lWnZQaVpWdi1RNHdINWtKVUlTOFp0UQ?oc=5"" target=""_blank"">FDA gives Biocon biosimilars plant clean bill of health</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.8842906355857849,0.0,neutral,0.0,0.6597,0.197,0.0,0.803,0.24444444444444446,0.46666666666666673,0.0,0.5961450266767431,other,0.0,[],False,True,6,0.0
2017-11-20,2017-11-20 08:00:00,Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxOT01qREZtMVUzTnVhSks1WnZnRzE0WmZtaVlBNFBnS1JLQVJCTHZ2MWZoU2RXaGpTNHQ5NmdCR1dyMXg2Nl9Lc1RNRUdNbzF5LWZWMjY3eXo0bThiTzBJb0djNW4wUHFEa0w3eWNKbUJUcjU3OC1jUjZPV1RGXzdSSTVuQjVHVTNiQl9QYmhJOGY1Y2pSWDZuMUdTMnR1VkpUc2hzSU1KS184N2tRZG9QQVJLT1pEaGtpR2phRjdObmZSYmE1dXZv?oc=5"" target=""_blank"">Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxOT01qREZtMVUzTnVhSks1WnZnRzE0WmZtaVlBNFBnS1JLQVJCTHZ2MWZoU2RXaGpTNHQ5NmdCR1dyMXg2Nl9Lc1RNRUdNbzF5LWZWMjY3eXo0bThiTzBJb0djNW4wUHFEa0w3eWNKbUJUcjU3OC1jUjZPV1RGXzdSSTVuQjVHVTNiQl9QYmhJOGY1Y2pSWDZuMUdTMnR1VkpUc2hzSU1KS184N2tRZG9QQVJLT1pEaGtpR2phRjdObmZSYmE1dXZv?oc=5,Google News,Biocon FDA inspection,"Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxOT01qREZtMVUzTnVhSks1WnZnRzE0WmZtaVlBNFBnS1JLQVJCTHZ2MWZoU2RXaGpTNHQ5NmdCR1dyMXg2Nl9Lc1RNRUdNbzF5LWZWMjY3eXo0bThiTzBJb0djNW4wUHFEa0w3eWNKbUJUcjU3OC1jUjZPV1RGXzdSSTVuQjVHVTNiQl9QYmhJOGY1Y2pSWDZuMUdTMnR1VkpUc2hzSU1KS184N2tRZG9QQVJLT1pEaGtpR2phRjdObmZSYmE1dXZv?oc=5"" target=""_blank"">Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.7295303344726562,positive,0.7295303344726562,0.0,neutral,0.0,0.7003,0.127,0.0,0.873,0.4666666666666666,0.4000000000000001,0.41687447684151785,0.632165667046441,other,0.0,[],False,True,6,0.0
2020-03-20,2020-03-20 07:00:00,Biocon receives EIR from USFDA for good manufacturing practice inspection - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives EIR from USFDA for good manufacturing practice inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon receives EIR from USFDA for good manufacturing practice inspection - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives EIR from USFDA for good manufacturing practice inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.7384241223335266,positive,0.7384241223335266,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,0.35,0.30000000000000004,0.4219566413334438,0.5962413741111755,other,0.0,[],False,True,6,0.0
2018-05-02,2018-05-02 07:00:00,Biocon gets 7 USFDA observations for Bengaluru drug facility - Mint,"<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxQY2dVQXVjY0w5S3RXV2x2Uy1qUlZKdTZUdUZCOUFCZG5VdUlmak1zWjBDenFVQzU5dHlpWkdfem1jN05oRzlOWGlGTkdnLTZNYVA4Z2ZlY194YktHMkxHbm16ZmJza25Vd0E2VmFtSG9tTjBJUFFMS1ZvdmN6R1lWNEN4OS1na2YwQi1CYmJGZzJLTkJOZVJiUzk1Nk5Ia24wRG9ocjlCRzBncEg2SFNjMHAxZ3dwamxMYlZIUllpOV8?oc=5"" target=""_blank"">Biocon gets 7 USFDA observations for Bengaluru drug facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMiwAFBVV95cUxQY2dVQXVjY0w5S3RXV2x2Uy1qUlZKdTZUdUZCOUFCZG5VdUlmak1zWjBDenFVQzU5dHlpWkdfem1jN05oRzlOWGlGTkdnLTZNYVA4Z2ZlY194YktHMkxHbm16ZmJza25Vd0E2VmFtSG9tTjBJUFFMS1ZvdmN6R1lWNEN4OS1na2YwQi1CYmJGZzJLTkJOZVJiUzk1Nk5Ia24wRG9ocjlCRzBncEg2SFNjMHAxZ3dwamxMYlZIUllpOV8?oc=5,Google News,Biocon FDA inspection,"Biocon gets 7 USFDA observations for Bengaluru drug facility - Mint <a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxQY2dVQXVjY0w5S3RXV2x2Uy1qUlZKdTZUdUZCOUFCZG5VdUlmak1zWjBDenFVQzU5dHlpWkdfem1jN05oRzlOWGlGTkdnLTZNYVA4Z2ZlY194YktHMkxHbm16ZmJza25Vd0E2VmFtSG9tTjBJUFFMS1ZvdmN6R1lWNEN4OS1na2YwQi1CYmJGZzJLTkJOZVJiUzk1Nk5Ia24wRG9ocjlCRzBncEg2SFNjMHAxZ3dwamxMYlZIUllpOV8?oc=5"" target=""_blank"">Biocon gets 7 USFDA observations for Bengaluru drug facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.6764957308769226,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.6764957308769226,other,0.0,[],False,True,6,0.0
2017-09-18,2017-09-18 07:00:00,"Biocon's Vizag API plant clears US FDA inspection, shares up - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Vizag API plant clears US FDA inspection, shares up</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon's Vizag API plant clears US FDA inspection, shares up - Moneycontrol <a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxONXFwdTZ3c1VBVm5JTXRrc2Q2SWVnOVdhbmhBRHRBMUVFVzJEeFNCd2JEOU9wSl9KNkIzN0pyWkFsNVNRR3ZmTEd4WFJrU1lhQWhNLTZxdk9RZERZemtyV210VzROaUFkR0NLTW0tc3FfaWY0dHh6SmxUWUdUS01IeFNDdERFUFQ3cjk1Vm5Kd2Y4NXBPSUtqLVlCSlVqMnVvVHd3YVRnYzZybTlUZkFBMWduQjFOdlZfdnVQQmNDMVdDUdIBxwFBVV95cUxNTklEMkVNNnVZUjhya1NqRFBWMUh2eWxVVmZWTkZQdG9EUENGYWxRdDh2dFNSSkh0d3RiRnpUTlVpVTl2a3ZpNGk1NXdwZDZ4NjJwejJiMWEwMXpFeUZCRFRtMzZmMWRqaEktanRGekc0Rkh4VUQtZjdZMUhhaWhVVEp2Tjc3UlJveEJOLXJJVlJOSHlaTDQxd2lCdW5VajItYkFDZ05fR1ktR3ZObU5ZSmV5aW93VkxLQW5UVHdzNlYwTm0zOFI0?oc=5"" target=""_blank"">Biocon's Vizag API plant clears US FDA inspection, shares up</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.773132860660553,positive,0.773132860660553,0.0,neutral,0.0,0.6124,0.259,0.0,0.741,0.0,0.0,0.4417902060917446,0.6927664303302765,regulatory_review,0.7162017345428466,['FDA inspection'],False,True,15,0.5324034690856934
2018-06-23,2018-06-23 07:00:00,Biocon receives EIR from USFDA for its Bengaluru facility producing sterile | Company Business News - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives EIR from USFDA for its Bengaluru facility producing sterile | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon receives EIR from USFDA for its Bengaluru facility producing sterile | Company Business News - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives EIR from USFDA for its Bengaluru facility producing sterile | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.7444472908973694,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7444472908973694,other,0.0,[],False,True,6,0.0
2020-04-16,2020-04-16 07:00:00,Biocon Biologics gets EIR from US FDA for two manufacturing facilities - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxPR1g0aXdVeWMySG5EQXpza3g0MXFlY2NEM1dMNVFjSWlrclJGdEtJOFY4and1b1FBdUt6Y2hLYVFnOU5CNjBJSHl3RHhXRkRscTJhOW53ZUZuV2h3QUlqN2Y2QXBpUDFib05ZS1JpSDgza3c4amRMckFOUFZzT2I0WGJxOUstSzFBd1M3dVIzdVcxWnVWZjNlVHJYSmttaTE0alHSAacBQVVfeXFMT0xlMkI0RXJRZFBER2RpWElhVDFGTkZBWXIwTlNiSkVyR0RERXR4c25SV2RjeENYdTNyeG00WE9fZTQweU5xWHVXZi0wU2NHVXRhUTBjRWZJQUtsa1BQZjIxeVBNMHNJT2ZZQXU5Mmh1cjNSOG1uMm5Ia1ZpZnFvRWVhMWVvM1RxM1c3ejk3djVxMkp2cWRodTZBRUtDVVA0Mnh6NjhqMHM?oc=5"" target=""_blank"">Biocon Biologics gets EIR from US FDA for two manufacturing facilities</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxPR1g0aXdVeWMySG5EQXpza3g0MXFlY2NEM1dMNVFjSWlrclJGdEtJOFY4and1b1FBdUt6Y2hLYVFnOU5CNjBJSHl3RHhXRkRscTJhOW53ZUZuV2h3QUlqN2Y2QXBpUDFib05ZS1JpSDgza3c4amRMckFOUFZzT2I0WGJxOUstSzFBd1M3dVIzdVcxWnVWZjNlVHJYSmttaTE0alHSAacBQVVfeXFMT0xlMkI0RXJRZFBER2RpWElhVDFGTkZBWXIwTlNiSkVyR0RERXR4c25SV2RjeENYdTNyeG00WE9fZTQweU5xWHVXZi0wU2NHVXRhUTBjRWZJQUtsa1BQZjIxeVBNMHNJT2ZZQXU5Mmh1cjNSOG1uMm5Ia1ZpZnFvRWVhMWVvM1RxM1c3ejk3djVxMkp2cWRodTZBRUtDVVA0Mnh6NjhqMHM?oc=5,Google News,Biocon FDA inspection,"Biocon Biologics gets EIR from US FDA for two manufacturing facilities - Express Pharma <a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxPR1g0aXdVeWMySG5EQXpza3g0MXFlY2NEM1dMNVFjSWlrclJGdEtJOFY4and1b1FBdUt6Y2hLYVFnOU5CNjBJSHl3RHhXRkRscTJhOW53ZUZuV2h3QUlqN2Y2QXBpUDFib05ZS1JpSDgza3c4amRMckFOUFZzT2I0WGJxOUstSzFBd1M3dVIzdVcxWnVWZjNlVHJYSmttaTE0alHSAacBQVVfeXFMT0xlMkI0RXJRZFBER2RpWElhVDFGTkZBWXIwTlNiSkVyR0RERXR4c25SV2RjeENYdTNyeG00WE9fZTQweU5xWHVXZi0wU2NHVXRhUTBjRWZJQUtsa1BQZjIxeVBNMHNJT2ZZQXU5Mmh1cjNSOG1uMm5Ia1ZpZnFvRWVhMWVvM1RxM1c3ejk3djVxMkp2cWRodTZBRUtDVVA0Mnh6NjhqMHM?oc=5"" target=""_blank"">Biocon Biologics gets EIR from US FDA for two manufacturing facilities</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.7464746236801147,positive,0.7464746236801147,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.42655692781720844,0.7464746236801147,other,0.0,[],False,True,6,0.0
2021-09-25,2021-09-25 07:00:00,USFDA issues 6 observations after inspection of Biocon's Malaysian arm mfng facility - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA issues 6 observations after inspection of Biocon's Malaysian arm mfng facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"USFDA issues 6 observations after inspection of Biocon's Malaysian arm mfng facility - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMiygFBVV95cUxOczU2MVY2STk4dlFnVlBGNEdqVkgxUmM3NVhJMGRaMmNyQnBCQU5ZVE1iemJGRVFfMlBIeGQzR0t5S2pDSG8tTVdrb1lTLVU0T2VXLTd3M0lYRDZkNGVyRGZfOTMxYWQxQ0pGLUE4Q1BzM3pBdmEwa1BDczJ4TTRzb3JnakJkcFl3MXFJQ3VFNnlKTXpUODIyRHlUSmFWR1RreGVfMzNubTB1Z2RVWVBNUnJmVU5NeWMwZjJLaDgzMHZZSXg0Sm41cThB0gHPAUFVX3lxTE82MUlCSGl6b2hIOHNrS1dRMHE4Mlhzbk9xZXgwdEo5M2ZLWDlNY1BLWTR6LXJUaU03bDdHT1ZBV0FRdnV3djRwT0tpd1FFRXRnMkpYNE9hamxCV08xcW1CUnAtSnltejRqQzc4ZkN0N0p2azNaQm9JWjhJNkJvVTRiSlYtWlk3MG94X2x4UmEwdERnWGUwbGlFZW1wNEF6WTdpQVEtSWdqLVpYbjhBdmg2ODdlMjJZUnJKck1HYjhZQ3RUUzVqRldVbmpKUWVENA?oc=5"" target=""_blank"">USFDA issues 6 observations after inspection of Biocon's Malaysian arm mfng facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.8385418057441711,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8385418057441711,other,0.0,[],False,True,6,0.0
2019-11-05,2019-11-05 08:00:00,Biocon's Biologics drug products facility gets nod from US FDA - ANI News,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxNUV9NN1NuaHpkTjkwN1hJWUdsLVlldmo5cU5ldTVTdjBVOUc0QmlPQ0hwVFB2WnpWOEdsa2tZOUNuYURJN2lxYnBuY1pVbnhmYVdSNE1hRml4ZFItbVFnN0RrbkpZMGtGd2g0QnlDdl9qWGdqUldTTVJTWlA3U3pjazYzdEJDakZ2Q190SG05cnRiTlhXQk9UVmdtWFlYMGxvMUgwRjR3QnBWclRncV9OekFR?oc=5"" target=""_blank"">Biocon's Biologics drug products facility gets nod from US FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ANI News</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxNUV9NN1NuaHpkTjkwN1hJWUdsLVlldmo5cU5ldTVTdjBVOUc0QmlPQ0hwVFB2WnpWOEdsa2tZOUNuYURJN2lxYnBuY1pVbnhmYVdSNE1hRml4ZFItbVFnN0RrbkpZMGtGd2g0QnlDdl9qWGdqUldTTVJTWlA3U3pjazYzdEJDakZ2Q190SG05cnRiTlhXQk9UVmdtWFlYMGxvMUgwRjR3QnBWclRncV9OekFR?oc=5,Google News,Biocon FDA inspection,"Biocon's Biologics drug products facility gets nod from US FDA - ANI News <a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxNUV9NN1NuaHpkTjkwN1hJWUdsLVlldmo5cU5ldTVTdjBVOUc0QmlPQ0hwVFB2WnpWOEdsa2tZOUNuYURJN2lxYnBuY1pVbnhmYVdSNE1hRml4ZFItbVFnN0RrbkpZMGtGd2g0QnlDdl9qWGdqUldTTVJTWlA3U3pjazYzdEJDakZ2Q190SG05cnRiTlhXQk9UVmdtWFlYMGxvMUgwRjR3QnBWclRncV9OekFR?oc=5"" target=""_blank"">Biocon's Biologics drug products facility gets nod from US FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ANI News</font>",0.5715226531028748,positive,0.5715226531028748,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3265843732016427,0.5715226531028748,other,0.0,[],False,True,6,0.0
2020-02-22,2020-02-22 08:00:00,Biocon receives 3 USFDA observations for insulin facility in Malaysia - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives 3 USFDA observations for insulin facility in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon receives 3 USFDA observations for insulin facility in Malaysia - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives 3 USFDA observations for insulin facility in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.5603474974632263,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.5603474974632263,other,0.0,[],False,True,6,0.0
2017-11-21,2017-11-21 08:00:00,Biocon receives EIR from US FDA - Express Pharma,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives EIR from US FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon receives EIR from US FDA - Express Pharma <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives EIR from US FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.0,neutral,0.7128692865371704,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7128692865371704,other,0.0,[],False,True,6,0.0
2021-08-26,2021-08-26 07:00:00,First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News,Semglee interchangeable designation,"First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData - ET HealthWorld <a href=""https://news.google.com/rss/articles/CBMihwJBVV95cUxOeC1qbkFSLURXZVlJV2JzSHRLbDNJLXVxVmMtVWQtZ3VoSEJPZkxKQk5uZ3B5cjNCaUlSb0N4TXQ1U3paaGVqc1RNekt4VndTNzkzS1REN254a3pWbVBKdWJPTW5IZjZibHBPVHIxZHJlV2RWeHhQaXdEdHBlNE1vOHZpcmNLZnZGcWxrdWNLQm1IZktnb1hhdER6aVZlejcxZndkMFlFa0xHb1BDdFpwRzZ0d0dpUC10dl9yT0c4Z2NQYzRTNFFxOTZGVUtTek9xNjRkaXRqYksyZ3J5U1RSNjR6RDNocG9rczZiTE0xS3FWaHpTR0lOc1N4UU1fcEpxbGdFVUlDd9IBjAJBVV95cUxOVTZqU1M4Qlg0MjNFRXVNTzk2RExPM2xDWmFFbzdPZTJrN0pkSTBNdm8xUzhDWU1RVXNvV0t4Y1JCUzNac215WVJfZERBU3NEX0Flalc1OG81SlN0LWc2SWxkOXJMeEo5eDJGQWdJVkxGX2duWGttWFdZNlk1QldvOFJZZUtoWlVLQm50Y09GckhzSDVXcGZqODdkM3ZXZFo2RmNMWHF6azJ2UllyRHlFejYza2ZNMFBPd1MwZXdhN1dlRlhjcC02cS1kOEdzRXVqNS1iQXJWLV9kdzNiZGVCVmhxbmpZYlFjRFQ5U080eTg5eHk0UlV5V0NpWTU4aEF5VVJ5R0VqU0xhNnBI?oc=5"" target=""_blank"">First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.8445139527320862,positive,0.8445139527320862,0.0,neutral,0.0,0.8689,0.293,0.0,0.707,0.125,0.16666666666666666,0.48257940156119206,0.6128046509106954,other,0.0,[],True,False,11,0.0
2021-02-12,2021-02-12 08:00:00,Biocon Gains EU Authorization for Insulin Aspart Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzZyVVhHdGh1QWt5RE94SEFyN19tV1JuWXcyRzdIWjNSTUFCR2d2SWRVa0tfZ055dXpQc1lfblhWbXgwWmNNTU8tNWc5R0R1YUlwcTdQUGVOcm9GcFpxQmNZRktqckxEaHp2YlpBRjBNdkRpcVE4TFp0MjJjWDJhaE9uMzdzejBLNzRmQTFjS1pEQ2F2ZDRZQ2dGUm9IVDQ1UGtR?oc=5"" target=""_blank"">Biocon Gains EU Authorization for Insulin Aspart Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzZyVVhHdGh1QWt5RE94SEFyN19tV1JuWXcyRzdIWjNSTUFCR2d2SWRVa0tfZ055dXpQc1lfblhWbXgwWmNNTU8tNWc5R0R1YUlwcTdQUGVOcm9GcFpxQmNZRktqckxEaHp2YlpBRjBNdkRpcVE4TFp0MjJjWDJhaE9uMzdzejBLNzRmQTFjS1pEQ2F2ZDRZQ2dGUm9IVDQ1UGtR?oc=5,Google News,Biocon regulatory approval,"Biocon Gains EU Authorization for Insulin Aspart Biosimilar - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzZyVVhHdGh1QWt5RE94SEFyN19tV1JuWXcyRzdIWjNSTUFCR2d2SWRVa0tfZ055dXpQc1lfblhWbXgwWmNNTU8tNWc5R0R1YUlwcTdQUGVOcm9GcFpxQmNZRktqckxEaHp2YlpBRjBNdkRpcVE4TFp0MjJjWDJhaE9uMzdzejBLNzRmQTFjS1pEQ2F2ZDRZQ2dGUm9IVDQ1UGtR?oc=5"" target=""_blank"">Biocon Gains EU Authorization for Insulin Aspart Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.9120084643363953,positive,0.9120084643363953,0.0,neutral,0.0,0.5859,0.179,0.0,0.821,-0.05,0.05,0.5211476939065115,0.5159694881121318,other,0.0,[],False,True,6,0.0
2020-01-06,2020-01-06 08:00:00,True North $100-Million Investment in Biocon Biologics Kicks Off New Fundraising Round - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxQUWpKbDZNMkVodEVidDZUYVVfTUwyMFlfV2YySzBsak9xZmpOX25SV3JwWVU4UHFPS2VKX1M3X2l3UlJoT1FESFNldHEzWV9OeFZxT1Y2VEhhaVNYVmdQM05uZWtobkJOTHdGR0tWS2ZGRWo4UlNtYlloMUpETUVEM0VfaWl0R2tjOUZpV0VQU0pVNktta25zYTVUUGNUNTEtTU1mT2o2TUxBbTdibW5SLXRkZVE3MjVoeHF5b0x3MXN2YjBD?oc=5"" target=""_blank"">True North $100-Million Investment in Biocon Biologics Kicks Off New Fundraising Round</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxQUWpKbDZNMkVodEVidDZUYVVfTUwyMFlfV2YySzBsak9xZmpOX25SV3JwWVU4UHFPS2VKX1M3X2l3UlJoT1FESFNldHEzWV9OeFZxT1Y2VEhhaVNYVmdQM05uZWtobkJOTHdGR0tWS2ZGRWo4UlNtYlloMUpETUVEM0VfaWl0R2tjOUZpV0VQU0pVNktta25zYTVUUGNUNTEtTU1mT2o2TUxBbTdibW5SLXRkZVE3MjVoeHF5b0x3MXN2YjBD?oc=5,Google News,Biocon regulatory approval,"True North $100-Million Investment in Biocon Biologics Kicks Off New Fundraising Round - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxQUWpKbDZNMkVodEVidDZUYVVfTUwyMFlfV2YySzBsak9xZmpOX25SV3JwWVU4UHFPS2VKX1M3X2l3UlJoT1FESFNldHEzWV9OeFZxT1Y2VEhhaVNYVmdQM05uZWtobkJOTHdGR0tWS2ZGRWo4UlNtYlloMUpETUVEM0VfaWl0R2tjOUZpV0VQU0pVNktta25zYTVUUGNUNTEtTU1mT2o2TUxBbTdibW5SLXRkZVE3MjVoeHF5b0x3MXN2YjBD?oc=5"" target=""_blank"">True North $100-Million Investment in Biocon Biologics Kicks Off New Fundraising Round</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.8169723153114319,positive,0.8169723153114319,0.0,neutral,0.0,0.4215,0.083,0.0,0.917,0.05378787878787877,0.3431818181818182,0.4668413230351039,0.43075339803310353,other,0.0,[],False,True,6,0.0
2021-12-23,2021-12-23 08:00:00,Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval - NDTV,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval - NDTV <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV</font>",0.0,neutral,0.8966063857078552,0.0,neutral,0.0,0.4767,0.103,0.0,0.897,0.0,0.0,0.0,0.6866531928539277,approval_process,0.7706487774848938,['regulatory approval'],False,True,16,0.5412975549697876
2019-08-23,2019-08-23 07:00:00,Biocon Malaysia unit receives EU GMP certification - BioSpectrum Asia,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOdFpTeWFhSktHWGd1QjM5N0hkSVRqa29fZWxfZ3RVQTRQVi1YcUF2VVJJd19FWC13QnpPUVpGTW5zaF9JcUtjWmpZWVdta2tCZ1UzMGRsSllRRTFNY21NZU1pTWZ2Mlc0TUItVzlZNHllN3Zmc0JQbHdFZnhVSGMtZTd4anBLLTZkYXVwVXVlMnpGNERVTHYxX2dmU3kzdkRyS2RJ?oc=5"" target=""_blank"">Biocon Malaysia unit receives EU GMP certification</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum Asia</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxOdFpTeWFhSktHWGd1QjM5N0hkSVRqa29fZWxfZ3RVQTRQVi1YcUF2VVJJd19FWC13QnpPUVpGTW5zaF9JcUtjWmpZWVdta2tCZ1UzMGRsSllRRTFNY21NZU1pTWZ2Mlc0TUItVzlZNHllN3Zmc0JQbHdFZnhVSGMtZTd4anBLLTZkYXVwVXVlMnpGNERVTHYxX2dmU3kzdkRyS2RJ?oc=5,Google News,Biocon regulatory approval,"Biocon Malaysia unit receives EU GMP certification - BioSpectrum Asia <a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOdFpTeWFhSktHWGd1QjM5N0hkSVRqa29fZWxfZ3RVQTRQVi1YcUF2VVJJd19FWC13QnpPUVpGTW5zaF9JcUtjWmpZWVdta2tCZ1UzMGRsSllRRTFNY21NZU1pTWZ2Mlc0TUItVzlZNHllN3Zmc0JQbHdFZnhVSGMtZTd4anBLLTZkYXVwVXVlMnpGNERVTHYxX2dmU3kzdkRyS2RJ?oc=5"" target=""_blank"">Biocon Malaysia unit receives EU GMP certification</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum Asia</font>",0.669766366481781,positive,0.669766366481781,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3827236379895891,0.669766366481781,other,0.0,[],False,True,6,0.0
2019-08-22,2019-08-22 07:00:00,Biocon’s Malaysia Insulin glargine facility receives Certificate of GMP - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNcDlJb3NGUlBpTmpDQ3A5cVc1UXg0OVgzTjBDZHluME1GMmNxYlk5Q2RYeGxwQ1JUWnd0bWJhamlFa3JMOGtlbDUyVTJ4ZnRLSU9PT01wMktXUmh2NEZkeHlwQ1pjLUFaNnVBQldMaW5qN2o3dHBRZU1mblo1VVhGcjA1VkM0TDhHM2NQcnBEeTFvQzY0VnRvRkxLRC1jTEVlQWfSAacBQVVfeXFMTWJpVXp3V1piSi1YQmRucWd1aHNEQkN1UU8yRGNRYll1RWJydldVcmo3SkpCalNRT2YzMDViekhLTzRCWEdTM1hGWmJia3BnMzMzaGxtTW9VQ084QTNFVkdDX0g5UWVFbGUxVl9fVnhhcVFmZGl1YlYzOExZRXJnN21iOXJ1SjFWOTNudThldm03Z3BWd1dzaXVLOWNiNHpXaFhPNXh2aFU?oc=5"" target=""_blank"">Biocon’s Malaysia Insulin glargine facility receives Certificate of GMP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxNcDlJb3NGUlBpTmpDQ3A5cVc1UXg0OVgzTjBDZHluME1GMmNxYlk5Q2RYeGxwQ1JUWnd0bWJhamlFa3JMOGtlbDUyVTJ4ZnRLSU9PT01wMktXUmh2NEZkeHlwQ1pjLUFaNnVBQldMaW5qN2o3dHBRZU1mblo1VVhGcjA1VkM0TDhHM2NQcnBEeTFvQzY0VnRvRkxLRC1jTEVlQWfSAacBQVVfeXFMTWJpVXp3V1piSi1YQmRucWd1aHNEQkN1UU8yRGNRYll1RWJydldVcmo3SkpCalNRT2YzMDViekhLTzRCWEdTM1hGWmJia3BnMzMzaGxtTW9VQ084QTNFVkdDX0g5UWVFbGUxVl9fVnhhcVFmZGl1YlYzOExZRXJnN21iOXJ1SjFWOTNudThldm03Z3BWd1dzaXVLOWNiNHpXaFhPNXh2aFU?oc=5,Google News,Biocon regulatory approval,"Biocon’s Malaysia Insulin glargine facility receives Certificate of GMP - Express Pharma <a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNcDlJb3NGUlBpTmpDQ3A5cVc1UXg0OVgzTjBDZHluME1GMmNxYlk5Q2RYeGxwQ1JUWnd0bWJhamlFa3JMOGtlbDUyVTJ4ZnRLSU9PT01wMktXUmh2NEZkeHlwQ1pjLUFaNnVBQldMaW5qN2o3dHBRZU1mblo1VVhGcjA1VkM0TDhHM2NQcnBEeTFvQzY0VnRvRkxLRC1jTEVlQWfSAacBQVVfeXFMTWJpVXp3V1piSi1YQmRucWd1aHNEQkN1UU8yRGNRYll1RWJydldVcmo3SkpCalNRT2YzMDViekhLTzRCWEdTM1hGWmJia3BnMzMzaGxtTW9VQ084QTNFVkdDX0g5UWVFbGUxVl9fVnhhcVFmZGl1YlYzOExZRXJnN21iOXJ1SjFWOTNudThldm03Z3BWd1dzaXVLOWNiNHpXaFhPNXh2aFU?oc=5"" target=""_blank"">Biocon’s Malaysia Insulin glargine facility receives Certificate of GMP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.6796903610229492,positive,0.6796903610229492,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.38839449201311377,0.6796903610229492,other,0.0,[],False,True,6,0.0
2019-10-03,2019-10-03 07:00:00,Biocon and Mylan Launch Insulin Glargine Biosimilar in Australia - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTTdua0Zyb2FtQ19WbFBtNjgwV0F6ejlDRnBGMS1iUXRrVE0yb01EMGtsUTd6dGNoa2N2eXlGWWktM1RhWGFjYTBwRzAzU1dYdkFLTGNtVnV6cXUtTGxHaWNjTzEzOGVTNml2Nzg4WUZfalFKam9UaUQ3eUl4bkNNa2FLSHVja1ptZzFMSUJkM19nbmdXUGZFQTZidlhzYWd3LW94czdpWldkdw?oc=5"" target=""_blank"">Biocon and Mylan Launch Insulin Glargine Biosimilar in Australia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTTdua0Zyb2FtQ19WbFBtNjgwV0F6ejlDRnBGMS1iUXRrVE0yb01EMGtsUTd6dGNoa2N2eXlGWWktM1RhWGFjYTBwRzAzU1dYdkFLTGNtVnV6cXUtTGxHaWNjTzEzOGVTNml2Nzg4WUZfalFKam9UaUQ3eUl4bkNNa2FLSHVja1ptZzFMSUJkM19nbmdXUGZFQTZidlhzYWd3LW94czdpWldkdw?oc=5,Google News,Biocon insulin biosimilar,"Biocon and Mylan Launch Insulin Glargine Biosimilar in Australia - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTTdua0Zyb2FtQ19WbFBtNjgwV0F6ejlDRnBGMS1iUXRrVE0yb01EMGtsUTd6dGNoa2N2eXlGWWktM1RhWGFjYTBwRzAzU1dYdkFLTGNtVnV6cXUtTGxHaWNjTzEzOGVTNml2Nzg4WUZfalFKam9UaUQ3eUl4bkNNa2FLSHVja1ptZzFMSUJkM19nbmdXUGZFQTZidlhzYWd3LW94czdpWldkdw?oc=5"" target=""_blank"">Biocon and Mylan Launch Insulin Glargine Biosimilar in Australia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.889988899230957,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.0,0.46999444961547854,other,0.0,[],False,True,6,0.0
2021-11-16,2021-11-16 08:00:00,Interchangeable Biosimilars to Lantus Now Available - Medical Professionals Reference,"<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxNOWJaTXBIVTk2Sy1iNkQwZ2JvbXhJSXVvWi1SMm9XV0tJMTdvT0hBcVREV3VzMC0tOGNJQnR4a3Z4UWR5ZXNpZ00zaUtwakluRldZRnpyZHBFem53WGZwLVZEVGJsWG45c2RvTWp3cmJpYlhNMmtQX2lpZGZoUjBhc0puMFN0MjA3bkRXNVlBZVJaQllnZ2dpYWkxeWp4Zw?oc=5"" target=""_blank"">Interchangeable Biosimilars to Lantus Now Available</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxNOWJaTXBIVTk2Sy1iNkQwZ2JvbXhJSXVvWi1SMm9XV0tJMTdvT0hBcVREV3VzMC0tOGNJQnR4a3Z4UWR5ZXNpZ00zaUtwakluRldZRnpyZHBFem53WGZwLVZEVGJsWG45c2RvTWp3cmJpYlhNMmtQX2lpZGZoUjBhc0puMFN0MjA3bkRXNVlBZVJaQllnZ2dpYWkxeWp4Zw?oc=5,Google News,Biocon insulin biosimilar,"Interchangeable Biosimilars to Lantus Now Available - Medical Professionals Reference <a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxNOWJaTXBIVTk2Sy1iNkQwZ2JvbXhJSXVvWi1SMm9XV0tJMTdvT0hBcVREV3VzMC0tOGNJQnR4a3Z4UWR5ZXNpZ00zaUtwakluRldZRnpyZHBFem53WGZwLVZEVGJsWG45c2RvTWp3cmJpYlhNMmtQX2lpZGZoUjBhc0puMFN0MjA3bkRXNVlBZVJaQllnZ2dpYWkxeWp4Zw?oc=5"" target=""_blank"">Interchangeable Biosimilars to Lantus Now Available</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",0.0,neutral,0.8954537510871887,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.0,0.514393542210261,other,0.0,[],False,False,1,0.0
2018-11-15,2018-11-15 08:00:00,Mylan and Biocon launch new insulin glargine biosimilar in the UK - News-Medical,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPNTMyT0ktUnNRbkttbVE3bmJqdHhrUGdDcHgzdjdReExTdFJCcVhlbWVQQ0cxcXlxTWo1WXo1YlB5eEdBWHdfSzBLSXhIemFNUm1fenJ3TVpEaFBQY3hDYVJudXpCM204VEJ3MVQ5UnByYzdHQk0tOEFqc1RMS1lKa1JXVDQ1eDFWM05OVndTQzlHdm5KSkM2emUyRTFpZXFsU2pnYXFZWEdLMWdNNTRiT1NDWQ?oc=5"" target=""_blank"">Mylan and Biocon launch new insulin glargine biosimilar in the UK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">News-Medical</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPNTMyT0ktUnNRbkttbVE3bmJqdHhrUGdDcHgzdjdReExTdFJCcVhlbWVQQ0cxcXlxTWo1WXo1YlB5eEdBWHdfSzBLSXhIemFNUm1fenJ3TVpEaFBQY3hDYVJudXpCM204VEJ3MVQ5UnByYzdHQk0tOEFqc1RMS1lKa1JXVDQ1eDFWM05OVndTQzlHdm5KSkM2emUyRTFpZXFsU2pnYXFZWEdLMWdNNTRiT1NDWQ?oc=5,Google News,Biocon insulin biosimilar,"Mylan and Biocon launch new insulin glargine biosimilar in the UK - News-Medical <a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPNTMyT0ktUnNRbkttbVE3bmJqdHhrUGdDcHgzdjdReExTdFJCcVhlbWVQQ0cxcXlxTWo1WXo1YlB5eEdBWHdfSzBLSXhIemFNUm1fenJ3TVpEaFBQY3hDYVJudXpCM204VEJ3MVQ5UnByYzdHQk0tOEFqc1RMS1lKa1JXVDQ1eDFWM05OVndTQzlHdm5KSkM2emUyRTFpZXFsU2pnYXFZWEdLMWdNNTRiT1NDWQ?oc=5"" target=""_blank"">Mylan and Biocon launch new insulin glargine biosimilar in the UK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">News-Medical</font>",0.0,neutral,0.8785520195960999,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0909090909090909,0.30303030303030304,0.0,0.4847305552525954,other,0.0,[],False,True,6,0.0
2021-11-10,2021-11-10 17:10:54,A Century of Insulins - Biocon - Global Biopharmaceutical company - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5EV1kyWFloV3JhSGtrSU1BR1JMMnAzVnNZUnFNYjJMUmZmNnFsdUVFVXNoX0lCalY0ZjhUMlZTRnRpcjc5aHVVRFNyeG96RXFrN2pPb2xjUHk?oc=5"" target=""_blank"">A Century of Insulins - Biocon - Global Biopharmaceutical company</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5EV1kyWFloV3JhSGtrSU1BR1JMMnAzVnNZUnFNYjJMUmZmNnFsdUVFVXNoX0lCalY0ZjhUMlZTRnRpcjc5aHVVRFNyeG96RXFrN2pPb2xjUHk?oc=5,Google News,Biocon insulin biosimilar,"A Century of Insulins - Biocon - Global Biopharmaceutical company - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5EV1kyWFloV3JhSGtrSU1BR1JMMnAzVnNZUnFNYjJMUmZmNnFsdUVFVXNoX0lCalY0ZjhUMlZTRnRpcjc5aHVVRFNyeG96RXFrN2pPb2xjUHk?oc=5"" target=""_blank"">A Century of Insulins - Biocon - Global Biopharmaceutical company</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.0,neutral,0.9196791648864746,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9196791648864746,other,0.0,[],False,True,6,0.0
2020-09-05,2020-09-05 18:48:36,Biocon Malaysia - Asia’s largest insulin manufacturing and R&D facility - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiV0FVX3lxTE1LZlJJMjFMeEZNbHZ0T09HTE5RM2x0WXAyajAtcnRHX2lES3pVS2dwMlRVMDJSMzYwMUg4SHZkRjFISGt4bm5OYzl2VDQ5WkxfS2lLeERzbw?oc=5"" target=""_blank"">Biocon Malaysia - Asia’s largest insulin manufacturing and R&amp;D facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiV0FVX3lxTE1LZlJJMjFMeEZNbHZ0T09HTE5RM2x0WXAyajAtcnRHX2lES3pVS2dwMlRVMDJSMzYwMUg4SHZkRjFISGt4bm5OYzl2VDQ5WkxfS2lLeERzbw?oc=5,Google News,Biocon insulin biosimilar,"Biocon Malaysia - Asia’s largest insulin manufacturing and R&D facility - Biocon <a href=""https://news.google.com/rss/articles/CBMiV0FVX3lxTE1LZlJJMjFMeEZNbHZ0T09HTE5RM2x0WXAyajAtcnRHX2lES3pVS2dwMlRVMDJSMzYwMUg4SHZkRjFISGt4bm5OYzl2VDQ5WkxfS2lLeERzbw?oc=5"" target=""_blank"">Biocon Malaysia - Asia’s largest insulin manufacturing and R&amp;D facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.0,neutral,0.9056176543235779,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9056176543235779,other,0.0,[],False,True,6,0.0
2020-12-14,2020-12-14 08:00:00,Biocon Biologics and Mylan Receive CHMP Recommendation for Approval of Biosimilar Insulin Aspart - Biocon,"<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQN0czcVl2cDZKamNrOU1JYkZjUjROMGloeUNzclNuVWwxTWpQS01sME51cUtya0c0cThNUXhWNERiNm96OUd1Vk9pZXE1bE00YnhWbzN5RzQyaWdlNHJQXzFDSXBCbW9ybXRpZG1JajVBU0ZvRkNjN2Z0LWhPWGtvbVk5TFlfcERrdDhmWVJnZEhBTmVhYVFhU0o4SVhpeDhfb2lNa3JQRDVxckxQQmdENUk1bUVvdUhYSWRTTA?oc=5"" target=""_blank"">Biocon Biologics and Mylan Receive CHMP Recommendation for Approval of Biosimilar Insulin Aspart</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxQN0czcVl2cDZKamNrOU1JYkZjUjROMGloeUNzclNuVWwxTWpQS01sME51cUtya0c0cThNUXhWNERiNm96OUd1Vk9pZXE1bE00YnhWbzN5RzQyaWdlNHJQXzFDSXBCbW9ybXRpZG1JajVBU0ZvRkNjN2Z0LWhPWGtvbVk5TFlfcERrdDhmWVJnZEhBTmVhYVFhU0o4SVhpeDhfb2lNa3JQRDVxckxQQmdENUk1bUVvdUhYSWRTTA?oc=5,Google News,Biocon insulin biosimilar,"Biocon Biologics and Mylan Receive CHMP Recommendation for Approval of Biosimilar Insulin Aspart - Biocon <a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQN0czcVl2cDZKamNrOU1JYkZjUjROMGloeUNzclNuVWwxTWpQS01sME51cUtya0c0cThNUXhWNERiNm96OUd1Vk9pZXE1bE00YnhWbzN5RzQyaWdlNHJQXzFDSXBCbW9ybXRpZG1JajVBU0ZvRkNjN2Z0LWhPWGtvbVk5TFlfcERrdDhmWVJnZEhBTmVhYVFhU0o4SVhpeDhfb2lNa3JQRDVxckxQQmdENUk1bUVvdUhYSWRTTA?oc=5"" target=""_blank"">Biocon Biologics and Mylan Receive CHMP Recommendation for Approval of Biosimilar Insulin Aspart</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.8103600144386292,positive,0.8103600144386292,0.0,neutral,0.0,0.7351,0.181,0.0,0.819,0.0,0.0,0.46306286539350233,0.7727300072193146,approval_process,0.8078452348709106,['FDA approval'],True,True,26,0.6156904697418213
2021-10-21,2021-10-21 07:00:00,Biocon's interchangeable biosimilar Insulin glargine added on Express Scripts’ largest formulary in US - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's interchangeable biosimilar Insulin glargine added on Express Scripts’ largest formulary in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon insulin biosimilar,"Biocon's interchangeable biosimilar Insulin glargine added on Express Scripts’ largest formulary in US - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's interchangeable biosimilar Insulin glargine added on Express Scripts’ largest formulary in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.6982810497283936,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.0,0.41580719153086343,other,0.0,[],True,True,16,0.0
2018-11-14,2018-11-14 08:00:00,"UK launch for Mylan, Biocon insulin glargine biosimilar Semglee - PharmaTimes","<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNX1FYVk1KY01pNkhabnF6UzZ5MGd6Uy1meWo3MERsXzBIb3ZuRXhya2ItdWNrVWVLNndGOUQ3bEFxVDFhLTFfeVJFQ0xWRnc0VDFSQzNHdTltZjRja21tb0FpMVkzZ1Q2WVpYaXpwdlFpSGZ6aU1YQ1dCc2RIaWFHOHJTeFB4bDVKdjVnV0ktZ0U1eF9kUnpJenZBaExUZDRkTEE?oc=5"" target=""_blank"">UK launch for Mylan, Biocon insulin glargine biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PharmaTimes</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxNX1FYVk1KY01pNkhabnF6UzZ5MGd6Uy1meWo3MERsXzBIb3ZuRXhya2ItdWNrVWVLNndGOUQ3bEFxVDFhLTFfeVJFQ0xWRnc0VDFSQzNHdTltZjRja21tb0FpMVkzZ1Q2WVpYaXpwdlFpSGZ6aU1YQ1dCc2RIaWFHOHJTeFB4bDVKdjVnV0ktZ0U1eF9kUnpJenZBaExUZDRkTEE?oc=5,Google News,Biocon insulin biosimilar,"UK launch for Mylan, Biocon insulin glargine biosimilar Semglee - PharmaTimes <a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNX1FYVk1KY01pNkhabnF6UzZ5MGd6Uy1meWo3MERsXzBIb3ZuRXhya2ItdWNrVWVLNndGOUQ3bEFxVDFhLTFfeVJFQ0xWRnc0VDFSQzNHdTltZjRja21tb0FpMVkzZ1Q2WVpYaXpwdlFpSGZ6aU1YQ1dCc2RIaWFHOHJTeFB4bDVKdjVnV0ktZ0U1eF9kUnpJenZBaExUZDRkTEE?oc=5"" target=""_blank"">UK launch for Mylan, Biocon insulin glargine biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PharmaTimes</font>",0.0,neutral,0.8729130625724792,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8729130625724792,other,0.0,[],True,True,16,0.0
2021-07-30,2021-07-30 07:00:00,USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi4AFBVV95cUxOeVZGdTFBRTQ3eXA5RURReld4TW8ta1hGMXdXbmhPWWxaaURuQktHTzZqeWV1OXlobG5jWkJvNVhEbzJ5Nkw4U0RYTVdyaDBVbVRXcFNBTXBhZENxVXFuQXpIenBId2syS09aMmVLZkE3Nk0tdlhWOXUwOW5ocVNnVEw2VjJ2aDA4YjFXNVdHekFtUG1CNWJORGM3T0pLN1ctYnJnYnBxZDN5LU5ldjE0ZVRSMkN0STJzbi1HbExfakhZTV9kNUNwYi10b1hRWnVxR2IwempfWnprM0Y5X01EONIB5gFBVV95cUxNYy1GTHN4OHdoSzFTMkpEcFNtYmxLZWYxOTlqa1VkWHRkX3E2a3Etd2ZObjRMWlVJSTkzNzRKT2xGWk43eWJ0SlNaMGFNNHZUeU43UE9RdXV0RkY4RkhTTXRrdnIzVHN5MVYtcDNfc0hjazBmQVRTNktFYWtaUEd1NzRLMG5nOTluazhpc0hwU3F1RjU1bGc4MjN2SS1XOWtBUGVNVzhQd0RiQWVoYjNWZWljSncwRDZyb0JaLWFYaTZXOWZYTUZMQXpNR0c3TERGMmN6N3JNcTdRalJMTG1QLW1uU2JWQQ?oc=5"" target=""_blank"">USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon insulin biosimilar,"USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.6738199591636658,positive,0.6738199591636658,0.0,neutral,0.0,0.7351,0.205,0.0,0.795,0.125,0.16666666666666666,0.3850399766649518,0.5113066530545552,other,0.0,[],True,True,16,0.0
2021-11-16,2021-11-16 08:00:00,"Biocon Biologics, Viatris launch biosimilar insulin glargine in US - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics, Viatris launch biosimilar insulin glargine in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon insulin biosimilar,"Biocon Biologics, Viatris launch biosimilar insulin glargine in US - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics, Viatris launch biosimilar insulin glargine in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.8811124563217163,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8811124563217163,other,0.0,[],True,True,16,0.0
2021-11-16,2021-11-16 08:00:00,Biocon Biologics launches interchangeable biosimilars SEMGLEE and Insulin Glargine injection in US - BioSpectrum India,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxOaVBUS1VZaXVJc1BJb21DTWstRS1WT0V6UWszcnN2OXFZeEpjdnBZbjNQY1VyTGxYSC1YSkFlQlptTFIyYldOQlZYYzhtT0VtYzc0WW5jS3VTcGVXUGx0YVRSYnFkZ2lDck03SFNCVFJJZ3puZkJlQUQ2QXF4RWE1UlhZYkg3Z1B0YjZpem5LMmVDNTV5VWNlUHVUZGlrNEx6cXRYNjBGdFZhYTNjcTUtYkVlRlA4bURodXFOdURqVHZ3Zm1jRFFaaDlNUjhDeG41M1Q1UmRDV3JhNmxCWXhFVWNsSDQ?oc=5"" target=""_blank"">Biocon Biologics launches interchangeable biosimilars SEMGLEE and Insulin Glargine injection in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxOaVBUS1VZaXVJc1BJb21DTWstRS1WT0V6UWszcnN2OXFZeEpjdnBZbjNQY1VyTGxYSC1YSkFlQlptTFIyYldOQlZYYzhtT0VtYzc0WW5jS3VTcGVXUGx0YVRSYnFkZ2lDck03SFNCVFJJZ3puZkJlQUQ2QXF4RWE1UlhZYkg3Z1B0YjZpem5LMmVDNTV5VWNlUHVUZGlrNEx6cXRYNjBGdFZhYTNjcTUtYkVlRlA4bURodXFOdURqVHZ3Zm1jRFFaaDlNUjhDeG41M1Q1UmRDV3JhNmxCWXhFVWNsSDQ?oc=5,Google News,Biocon insulin biosimilar,"Biocon Biologics launches interchangeable biosimilars SEMGLEE and Insulin Glargine injection in US - BioSpectrum India <a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxOaVBUS1VZaXVJc1BJb21DTWstRS1WT0V6UWszcnN2OXFZeEpjdnBZbjNQY1VyTGxYSC1YSkFlQlptTFIyYldOQlZYYzhtT0VtYzc0WW5jS3VTcGVXUGx0YVRSYnFkZ2lDck03SFNCVFJJZ3puZkJlQUQ2QXF4RWE1UlhZYkg3Z1B0YjZpem5LMmVDNTV5VWNlUHVUZGlrNEx6cXRYNjBGdFZhYTNjcTUtYkVlRlA4bURodXFOdURqVHZ3Zm1jRFFaaDlNUjhDeG41M1Q1UmRDV3JhNmxCWXhFVWNsSDQ?oc=5"" target=""_blank"">Biocon Biologics launches interchangeable biosimilars SEMGLEE and Insulin Glargine injection in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",0.0,neutral,0.5950382947921753,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.5950382947921753,other,0.0,[],True,True,16,0.0
2020-06-16,2020-06-16 07:00:00,Entering the world of Biosimilars - Finshots,"<a href=""https://news.google.com/rss/articles/CBMickFVX3lxTE5neUdpNUVEWnRoVXBHVWlDcjRWT1dUaV9pZ3o2WnBKSlY2MkNpZHRqZGtBWWFKRUJ1SnZleUk4cUoteUszZzVVS1Radmp4SURtTlFqNmxYWlNzT2JSTEFYR19rRnRKOFdFM3FZRm9EOFBXUQ?oc=5"" target=""_blank"">Entering the world of Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Finshots</font>",https://news.google.com/rss/articles/CBMickFVX3lxTE5neUdpNUVEWnRoVXBHVWlDcjRWT1dUaV9pZ3o2WnBKSlY2MkNpZHRqZGtBWWFKRUJ1SnZleUk4cUoteUszZzVVS1Radmp4SURtTlFqNmxYWlNzT2JSTEFYR19rRnRKOFdFM3FZRm9EOFBXUQ?oc=5,Google News,Biocon insulin biosimilar,"Entering the world of Biosimilars - Finshots <a href=""https://news.google.com/rss/articles/CBMickFVX3lxTE5neUdpNUVEWnRoVXBHVWlDcjRWT1dUaV9pZ3o2WnBKSlY2MkNpZHRqZGtBWWFKRUJ1SnZleUk4cUoteUszZzVVS1Radmp4SURtTlFqNmxYWlNzT2JSTEFYR19rRnRKOFdFM3FZRm9EOFBXUQ?oc=5"" target=""_blank"">Entering the world of Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Finshots</font>",0.0,neutral,0.9293200969696045,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9293200969696045,other,0.0,[],False,False,1,0.0
2018-11-08,2018-11-08 08:00:00,GC launches Biocon’s antidiabetic biosimilar - koreabiomed.com,"<a href=""https://news.google.com/rss/articles/CBMibEFVX3lxTFBLWWdCWmlwNjRDQ2JiQ2VUMHhUeVJsRUx5WmFOeloyMWQtUDU4M1YxSHF2RVF5UTExTjhTNzAzYXNsd3VPVXM5d1l1VDF0Wm1TZjNmaGxtMlNRSE1qZTE2RWNEWDdLN2V4Z1lMRdIBcEFVX3lxTE5wRW1helNFdnRPeTloOS1USUhTZ3BNSkRKLV9PVlJPb21UcGt0ZnBwODd1OS0yME9yYWhCQ0hUdHJubEhXRy1aNjlnZzJkeWxSandyb29wYkxxUnNERTVyMmdYSGZ1QXBhc0Z0MEt6R0o?oc=5"" target=""_blank"">GC launches Biocon’s antidiabetic biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">koreabiomed.com</font>",https://news.google.com/rss/articles/CBMibEFVX3lxTFBLWWdCWmlwNjRDQ2JiQ2VUMHhUeVJsRUx5WmFOeloyMWQtUDU4M1YxSHF2RVF5UTExTjhTNzAzYXNsd3VPVXM5d1l1VDF0Wm1TZjNmaGxtMlNRSE1qZTE2RWNEWDdLN2V4Z1lMRdIBcEFVX3lxTE5wRW1helNFdnRPeTloOS1USUhTZ3BNSkRKLV9PVlJPb21UcGt0ZnBwODd1OS0yME9yYWhCQ0hUdHJubEhXRy1aNjlnZzJkeWxSandyb29wYkxxUnNERTVyMmdYSGZ1QXBhc0Z0MEt6R0o?oc=5,Google News,Biocon insulin biosimilar,"GC launches Biocon’s antidiabetic biosimilar - koreabiomed.com <a href=""https://news.google.com/rss/articles/CBMibEFVX3lxTFBLWWdCWmlwNjRDQ2JiQ2VUMHhUeVJsRUx5WmFOeloyMWQtUDU4M1YxSHF2RVF5UTExTjhTNzAzYXNsd3VPVXM5d1l1VDF0Wm1TZjNmaGxtMlNRSE1qZTE2RWNEWDdLN2V4Z1lMRdIBcEFVX3lxTE5wRW1helNFdnRPeTloOS1USUhTZ3BNSkRKLV9PVlJPb21UcGt0ZnBwODd1OS0yME9yYWhCQ0hUdHJubEhXRy1aNjlnZzJkeWxSandyb29wYkxxUnNERTVyMmdYSGZ1QXBhc0Z0MEt6R0o?oc=5"" target=""_blank"">GC launches Biocon’s antidiabetic biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">koreabiomed.com</font>",0.0,neutral,0.6316232085227966,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.6316232085227966,other,0.0,[],False,True,6,0.0
2021-11-25,2021-11-25 08:00:00,The Medicine Box: Kiran Mazumdar-Shaw on biosimilar interchangeable status for Biocon's diabetes drug - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">The Medicine Box: Kiran Mazumdar-Shaw on biosimilar interchangeable status for Biocon's diabetes drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon insulin biosimilar,"The Medicine Box: Kiran Mazumdar-Shaw on biosimilar interchangeable status for Biocon's diabetes drug - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">The Medicine Box: Kiran Mazumdar-Shaw on biosimilar interchangeable status for Biocon's diabetes drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.8470458984375,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8470458984375,other,0.0,[],False,True,6,0.0
2020-07-30,2020-07-30 07:00:00,Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital therapeutics: GlobalData - Express Pharma,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital therapeutics: GlobalData</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News,Biocon insulin biosimilar,"Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital therapeutics: GlobalData - Express Pharma <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital therapeutics: GlobalData</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.0,neutral,0.7300124168395996,0.0,neutral,0.0,0.7506,0.167,0.0,0.833,0.0,0.0,0.0,0.7403062084197998,other,0.0,[],False,True,6,0.0
2021-11-17,2021-11-17 08:00:00,Biocon Biologics and Viatris announce launch of interchangeable SEMGLEE (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection - Healthcare Radius,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxNcVo4UXpmWDVBNkZ3Rk9zQkhMNG9IN1MwaG5TQm9RTjVKLWJkcU9Gd0p1STRNNkozYlBDb09UZWFXYkZjUWdVVkpOaWdiaFM3akJTOWM1UktZMEM4bkw2YURvY0dhSjhrV3NUeGc2TXZRbEFRbDJ2QU91dDFqSU9BcEcyVjlhQWxHdnhMb2Jxb2NERW9GOEZzNkZKWVBrRTFhSjJEWUdCNk5zWlVtY3Zza0xURzlWWEZJMlQ5WVBZek5QdHRPQVNQVVgzNzdKTnhTOFEyMzVzSEx6OTViSEJXbUVfTnI?oc=5"" target=""_blank"">Biocon Biologics and Viatris announce launch of interchangeable SEMGLEE (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Healthcare Radius</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxNcVo4UXpmWDVBNkZ3Rk9zQkhMNG9IN1MwaG5TQm9RTjVKLWJkcU9Gd0p1STRNNkozYlBDb09UZWFXYkZjUWdVVkpOaWdiaFM3akJTOWM1UktZMEM4bkw2YURvY0dhSjhrV3NUeGc2TXZRbEFRbDJ2QU91dDFqSU9BcEcyVjlhQWxHdnhMb2Jxb2NERW9GOEZzNkZKWVBrRTFhSjJEWUdCNk5zWlVtY3Zza0xURzlWWEZJMlQ5WVBZek5QdHRPQVNQVVgzNzdKTnhTOFEyMzVzSEx6OTViSEJXbUVfTnI?oc=5,Google News,Biocon insulin biosimilar,"Biocon Biologics and Viatris announce launch of interchangeable SEMGLEE (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection - Healthcare Radius <a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxNcVo4UXpmWDVBNkZ3Rk9zQkhMNG9IN1MwaG5TQm9RTjVKLWJkcU9Gd0p1STRNNkozYlBDb09UZWFXYkZjUWdVVkpOaWdiaFM3akJTOWM1UktZMEM4bkw2YURvY0dhSjhrV3NUeGc2TXZRbEFRbDJ2QU91dDFqSU9BcEcyVjlhQWxHdnhMb2Jxb2NERW9GOEZzNkZKWVBrRTFhSjJEWUdCNk5zWlVtY3Zza0xURzlWWEZJMlQ5WVBZek5QdHRPQVNQVVgzNzdKTnhTOFEyMzVzSEx6OTViSEJXbUVfTnI?oc=5"" target=""_blank"">Biocon Biologics and Viatris announce launch of interchangeable SEMGLEE (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Healthcare Radius</font>",0.0,neutral,0.7053428888320923,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7053428888320923,other,0.0,[],True,True,16,0.0
2021-09-16,2021-09-16 07:00:00,Biocon in Malaysia : Largest Integrated Insulin Manufacturing Facility in Asia - MIDA | Malaysian Investment Development Authority,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxNUnlVLVJ3cWFlOFZ0X0NNeXllTWtTUkNsbVpuMm1Md0NDdUo4VFQta2xFUlJ5anZobi01OUg0Q3U1RDZzQUVWQUxCdlRGdERBRFBZWl81T2h0VndCZFN4a0N3czdOQ1MtN0J0amJUMTdOaUJ6ZHg5TWpQQkhkSXpseVBiMm5HMlg4dU9DaTRRRXZ2eTFjbE1HSjVjaWR0Ry1pWkNj?oc=5"" target=""_blank"">Biocon in Malaysia : Largest Integrated Insulin Manufacturing Facility in Asia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MIDA | Malaysian Investment Development Authority</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxNUnlVLVJ3cWFlOFZ0X0NNeXllTWtTUkNsbVpuMm1Md0NDdUo4VFQta2xFUlJ5anZobi01OUg0Q3U1RDZzQUVWQUxCdlRGdERBRFBZWl81T2h0VndCZFN4a0N3czdOQ1MtN0J0amJUMTdOaUJ6ZHg5TWpQQkhkSXpseVBiMm5HMlg4dU9DaTRRRXZ2eTFjbE1HSjVjaWR0Ry1pWkNj?oc=5,Google News,Biocon insulin biosimilar,"Biocon in Malaysia : Largest Integrated Insulin Manufacturing Facility in Asia - MIDA | Malaysian Investment Development Authority <a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxNUnlVLVJ3cWFlOFZ0X0NNeXllTWtTUkNsbVpuMm1Md0NDdUo4VFQta2xFUlJ5anZobi01OUg0Q3U1RDZzQUVWQUxCdlRGdERBRFBZWl81T2h0VndCZFN4a0N3czdOQ1MtN0J0amJUMTdOaUJ6ZHg5TWpQQkhkSXpseVBiMm5HMlg4dU9DaTRRRXZ2eTFjbE1HSjVjaWR0Ry1pWkNj?oc=5"" target=""_blank"">Biocon in Malaysia : Largest Integrated Insulin Manufacturing Facility in Asia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MIDA | Malaysian Investment Development Authority</font>",0.0,neutral,0.5648410320281982,0.0,neutral,0.0,0.0772,0.04,0.0,0.96,0.0,0.0,0.0,0.32102051601409914,other,0.0,[],False,True,6,0.0
2019-07-22,2019-07-22 07:00:00,The Indian pharmaceutical industry is in denial over drug-quality charges - STAT,"<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxOVnZuWEw5am00ZkZLTUFBbFdBN2pvdnhfbEpPaks0MnAzMHJ0N3YtX1hLZlBPSERmWFFEZ3VLWkp1X3JnRHhReXZyYzdKS1k3SURENGlsR1lUeUF1WU9KYlRqYU4wNHctVGdKLXZfMTZGZFhyeVhrWVgtMWRwaE5TbzNMejUwcVVYWE9IcFZNUXV6dw?oc=5"" target=""_blank"">The Indian pharmaceutical industry is in denial over drug-quality charges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">STAT</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxOVnZuWEw5am00ZkZLTUFBbFdBN2pvdnhfbEpPaks0MnAzMHJ0N3YtX1hLZlBPSERmWFFEZ3VLWkp1X3JnRHhReXZyYzdKS1k3SURENGlsR1lUeUF1WU9KYlRqYU4wNHctVGdKLXZfMTZGZFhyeVhrWVgtMWRwaE5TbzNMejUwcVVYWE9IcFZNUXV6dw?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"The Indian pharmaceutical industry is in denial over drug-quality charges - STAT <a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxOVnZuWEw5am00ZkZLTUFBbFdBN2pvdnhfbEpPaks0MnAzMHJ0N3YtX1hLZlBPSERmWFFEZ3VLWkp1X3JnRHhReXZyYzdKS1k3SURENGlsR1lUeUF1WU9KYlRqYU4wNHctVGdKLXZfMTZGZFhyeVhrWVgtMWRwaE5TbzNMejUwcVVYWE9IcFZNUXV6dw?oc=5"" target=""_blank"">The Indian pharmaceutical industry is in denial over drug-quality charges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">STAT</font>",-0.9110448956489563,negative,0.9110448956489563,0.0,neutral,0.0,-0.2732,0.0,0.084,0.916,0.0,0.0,-0.520597083227975,0.5921224478244782,other,0.0,[],False,False,1,0.0
2017-12-04,2017-12-04 08:00:00,US FDA approves Mylan and Biocon’s Ogivri - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMiekFVX3lxTE12Mk5vQm9zOU9WVGpla2tIbjNQSDljNGtESExOdmtfYnQ0S0VSeGNIWGpRZ1JIV3Rya0IyYkNfN1ZRQ3Y2Y1BXWGI5TDBwWk0yNGZDcy0yU2VwLXNVZlJ2QlNybmhiZk9SWFVacmU5aDZncURSS1hpYUpR0gF_QVVfeXFMTk1hY2ZhQmp3Q0psc1NWbEhBMEd6X1ViQzhveEhSd0JhcXNmeHNzTjZEaTl1NkJScVVqdmJjUVFxdTRJSlM0b0Jqd2xwanhCVzR5WGJFMDNkb2s4N01PVzVDRmRHbHV6VzBvRlI5RjN2cU9idTY2WHYwYmNheG55TQ?oc=5"" target=""_blank"">US FDA approves Mylan and Biocon’s Ogivri</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiekFVX3lxTE12Mk5vQm9zOU9WVGpla2tIbjNQSDljNGtESExOdmtfYnQ0S0VSeGNIWGpRZ1JIV3Rya0IyYkNfN1ZRQ3Y2Y1BXWGI5TDBwWk0yNGZDcy0yU2VwLXNVZlJ2QlNybmhiZk9SWFVacmU5aDZncURSS1hpYUpR0gF_QVVfeXFMTk1hY2ZhQmp3Q0psc1NWbEhBMEd6X1ViQzhveEhSd0JhcXNmeHNzTjZEaTl1NkJScVVqdmJjUVFxdTRJSlM0b0Jqd2xwanhCVzR5WGJFMDNkb2s4N01PVzVDRmRHbHV6VzBvRlI5RjN2cU9idTY2WHYwYmNheG55TQ?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"US FDA approves Mylan and Biocon’s Ogivri - Express Pharma <a href=""https://news.google.com/rss/articles/CBMiekFVX3lxTE12Mk5vQm9zOU9WVGpla2tIbjNQSDljNGtESExOdmtfYnQ0S0VSeGNIWGpRZ1JIV3Rya0IyYkNfN1ZRQ3Y2Y1BXWGI5TDBwWk0yNGZDcy0yU2VwLXNVZlJ2QlNybmhiZk9SWFVacmU5aDZncURSS1hpYUpR0gF_QVVfeXFMTk1hY2ZhQmp3Q0psc1NWbEhBMEd6X1ViQzhveEhSd0JhcXNmeHNzTjZEaTl1NkJScVVqdmJjUVFxdTRJSlM0b0Jqd2xwanhCVzR5WGJFMDNkb2s4N01PVzVDRmRHbHV6VzBvRlI5RjN2cU9idTY2WHYwYmNheG55TQ?oc=5"" target=""_blank"">US FDA approves Mylan and Biocon’s Ogivri</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.6854794025421143,positive,0.6854794025421143,0.0,neutral,0.0,0.6597,0.231,0.0,0.769,0.0,0.0,0.391702515738351,0.6725897012710571,approval_process,0.8323659300804138,['FDA approval'],False,True,16,0.6647318601608276
2018-07-17,2018-07-17 07:00:00,Glenmark receives ANDA approval for Colesevelam Hydrochloride - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxPaTYzSHpuQ1lINGZ3UDZHZ3FuVzFDQThURkpyZGZKSExaSllONElZR0o4RDFZX3dVUjZhcHlxMnVZWGJmRVd2NlZKb05WWHdiVnNGTUt4YWEzenhtTFVKemgtbjB6SVp5N0JabGQ4YkNZMHYzVDJHUlJUa2J2NFRzMW0wUzN5MFgtUV84SG9oMGtFdC0yZ3fSAZsBQVVfeXFMUHVSdk5pOGEyUUwxbmlnY01fZFdCQVl0ZDBLWmJ2TU44Sl9ydjIwRG5icGMwRDFUUXJueEZhOEl3OGFwQVJvWm4ycnk5dzR3dVloc254c25YQkk3M2tnNUxVQ2t1clhENUFacTJIUmRUYXJ6UmdNYXVULXJIVExyYk9scjZYNGl3Q3lvaGNDb1B0bkE2MDdGMzhKYVU?oc=5"" target=""_blank"">Glenmark receives ANDA approval for Colesevelam Hydrochloride</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMilgFBVV95cUxPaTYzSHpuQ1lINGZ3UDZHZ3FuVzFDQThURkpyZGZKSExaSllONElZR0o4RDFZX3dVUjZhcHlxMnVZWGJmRVd2NlZKb05WWHdiVnNGTUt4YWEzenhtTFVKemgtbjB6SVp5N0JabGQ4YkNZMHYzVDJHUlJUa2J2NFRzMW0wUzN5MFgtUV84SG9oMGtFdC0yZ3fSAZsBQVVfeXFMUHVSdk5pOGEyUUwxbmlnY01fZFdCQVl0ZDBLWmJ2TU44Sl9ydjIwRG5icGMwRDFUUXJueEZhOEl3OGFwQVJvWm4ycnk5dzR3dVloc254c25YQkk3M2tnNUxVQ2t1clhENUFacTJIUmRUYXJ6UmdNYXVULXJIVExyYk9scjZYNGl3Q3lvaGNDb1B0bkE2MDdGMzhKYVU?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Glenmark receives ANDA approval for Colesevelam Hydrochloride - Express Pharma <a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxPaTYzSHpuQ1lINGZ3UDZHZ3FuVzFDQThURkpyZGZKSExaSllONElZR0o4RDFZX3dVUjZhcHlxMnVZWGJmRVd2NlZKb05WWHdiVnNGTUt4YWEzenhtTFVKemgtbjB6SVp5N0JabGQ4YkNZMHYzVDJHUlJUa2J2NFRzMW0wUzN5MFgtUV84SG9oMGtFdC0yZ3fSAZsBQVVfeXFMUHVSdk5pOGEyUUwxbmlnY01fZFdCQVl0ZDBLWmJ2TU44Sl9ydjIwRG5icGMwRDFUUXJueEZhOEl3OGFwQVJvWm4ycnk5dzR3dVloc254c25YQkk3M2tnNUxVQ2t1clhENUFacTJIUmRUYXJ6UmdNYXVULXJIVExyYk9scjZYNGl3Q3lvaGNDb1B0bkE2MDdGMzhKYVU?oc=5"" target=""_blank"">Glenmark receives ANDA approval for Colesevelam Hydrochloride</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.8320503234863281,positive,0.8320503234863281,0.0,neutral,0.0,0.7351,0.256,0.0,0.744,0.0,0.0,0.4754573277064732,0.7835751617431641,other,0.0,[],False,False,1,0.0
2017-08-04,2017-08-04 07:00:00,Biocon shares plunge after company gets Form 483 observations from US drug regulator - IBTimes India,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxNYkVGbHF5MTUwWDFYSTFNX0dORVJVTGlHTEVuVzh1emJpV19OaEo5LUd2bnVCcVprT0l0V3NjbWZ0elU5M3BndndMc1M4QVRDcDVPWVZQZGVRQ3oyWlhjai00VjJGb0d3d202RjE2b0drYUNVRlV1dnlBQWZsMDhqbC1oU1J1UWNnOWl1YWNJb08tOHB4VXNpOTR0ZkhJRnV2XzlIa0tqVWs0d0RxQmp3S0RR?oc=5"" target=""_blank"">Biocon shares plunge after company gets Form 483 observations from US drug regulator</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IBTimes India</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxNYkVGbHF5MTUwWDFYSTFNX0dORVJVTGlHTEVuVzh1emJpV19OaEo5LUd2bnVCcVprT0l0V3NjbWZ0elU5M3BndndMc1M4QVRDcDVPWVZQZGVRQ3oyWlhjai00VjJGb0d3d202RjE2b0drYUNVRlV1dnlBQWZsMDhqbC1oU1J1UWNnOWl1YWNJb08tOHB4VXNpOTR0ZkhJRnV2XzlIa0tqVWs0d0RxQmp3S0RR?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Biocon shares plunge after company gets Form 483 observations from US drug regulator - IBTimes India <a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxNYkVGbHF5MTUwWDFYSTFNX0dORVJVTGlHTEVuVzh1emJpV19OaEo5LUd2bnVCcVprT0l0V3NjbWZ0elU5M3BndndMc1M4QVRDcDVPWVZQZGVRQ3oyWlhjai00VjJGb0d3d202RjE2b0drYUNVRlV1dnlBQWZsMDhqbC1oU1J1UWNnOWl1YWNJb08tOHB4VXNpOTR0ZkhJRnV2XzlIa0tqVWs0d0RxQmp3S0RR?oc=5"" target=""_blank"">Biocon shares plunge after company gets Form 483 observations from US drug regulator</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IBTimes India</font>",-0.9624296426773071,negative,0.9624296426773071,0.0,neutral,0.0,0.5267,0.128,0.0,0.872,0.0,0.0,-0.5499597958156041,0.7445648213386535,other,0.0,[],False,True,6,0.0
2019-12-02,2019-12-02 08:00:00,"Mylan and Biocon Launch Biosimilar Trastuzumab, Ogivri, in the United States - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxOMXVpVlNGSEcxRm0tUjNyU092VWoxVmx3cTNOYVZCV1c2eGN6ME1MWVVfSUxZNk1DNjl0SmFwMC1xaW9fZHIwdmR1ekxDOVJ3ZURaaGNZOEdMcWhNTXBvV1BMVUV1c1hCR1RjY3BrSnU0MnJZZTFIbEg3cnpTdEg3ODRvbzFjV01Ec0otd3VwMlZ4TWVKbFNHX0dyVHc0YXNhNnNVcEJVYXBJd2o5d1g4bTM5M2FKWDg?oc=5"" target=""_blank"">Mylan and Biocon Launch Biosimilar Trastuzumab, Ogivri, in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxOMXVpVlNGSEcxRm0tUjNyU092VWoxVmx3cTNOYVZCV1c2eGN6ME1MWVVfSUxZNk1DNjl0SmFwMC1xaW9fZHIwdmR1ekxDOVJ3ZURaaGNZOEdMcWhNTXBvV1BMVUV1c1hCR1RjY3BrSnU0MnJZZTFIbEg3cnpTdEg3ODRvbzFjV01Ec0otd3VwMlZ4TWVKbFNHX0dyVHc0YXNhNnNVcEJVYXBJd2o5d1g4bTM5M2FKWDg?oc=5,Google News,Biocon biosimilarity study,"Mylan and Biocon Launch Biosimilar Trastuzumab, Ogivri, in the United States - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxOMXVpVlNGSEcxRm0tUjNyU092VWoxVmx3cTNOYVZCV1c2eGN6ME1MWVVfSUxZNk1DNjl0SmFwMC1xaW9fZHIwdmR1ekxDOVJ3ZURaaGNZOEdMcWhNTXBvV1BMVUV1c1hCR1RjY3BrSnU0MnJZZTFIbEg3cnpTdEg3ODRvbzFjV01Ec0otd3VwMlZ4TWVKbFNHX0dyVHc0YXNhNnNVcEJVYXBJd2o5d1g4bTM5M2FKWDg?oc=5"" target=""_blank"">Mylan and Biocon Launch Biosimilar Trastuzumab, Ogivri, in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.8856120109558105,0.0,neutral,0.0,0.6808,0.167,0.0,0.833,-0.05,0.05,0.0,0.5388040036519369,other,0.0,[],False,True,6,0.0
2019-07-01,2019-07-01 07:00:00,The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars - Nature,"<a href=""https://news.google.com/rss/articles/CBMiXkFVX3lxTFBVUVFfbnFJRzZyWkhETUlVei1ZOXNZcDI2Z1A5ZGlnbnBldi1HZWEwcjE0MGVVZ1YzbDJfSmpFbnVwOFJySzQ4N3puT0p5NmRSR1QyZmZFdW1UMHdFc3c?oc=5"" target=""_blank"">The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Nature</font>",https://news.google.com/rss/articles/CBMiXkFVX3lxTFBVUVFfbnFJRzZyWkhETUlVei1ZOXNZcDI2Z1A5ZGlnbnBldi1HZWEwcjE0MGVVZ1YzbDJfSmpFbnVwOFJySzQ4N3puT0p5NmRSR1QyZmZFdW1UMHdFc3c?oc=5,Google News,Biocon biosimilarity study,"The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars - Nature <a href=""https://news.google.com/rss/articles/CBMiXkFVX3lxTFBVUVFfbnFJRzZyWkhETUlVei1ZOXNZcDI2Z1A5ZGlnbnBldi1HZWEwcjE0MGVVZ1YzbDJfSmpFbnVwOFJySzQ4N3puT0p5NmRSR1QyZmZFdW1UMHdFc3c?oc=5"" target=""_blank"">The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Nature</font>",0.0,neutral,0.7911017537117004,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7911017537117004,other,0.0,[],False,False,1,0.0
2017-03-06,2017-03-06 08:00:00,New Delhi High Court Allows Marketing of Biocon-Mylan Biosimilar of Trastuzumab - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNUllPX0NfUnlKVU1LcXRRNjRmRGg0R1E5cFhvekxrVXBOTFcySjU4Mlg5MzRKa1ZoNHhKbVNQMU1GTTdMX2ZEQzlHb0I0cDFEbHhGa1FLano1Umd3N21jS3FOWDJpU0p2Vmc4NXVkNkx5N1NBVXc4Xy12Y2I2UkREMlVoY195SENKNE1GYzBfNFdlSVdQQTVacUZDZEE0ckpha2Jad0ZwMVhGZ1Q3cXZVYllmNWtyUTE2LUs1MFNB?oc=5"" target=""_blank"">New Delhi High Court Allows Marketing of Biocon-Mylan Biosimilar of Trastuzumab</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNUllPX0NfUnlKVU1LcXRRNjRmRGg0R1E5cFhvekxrVXBOTFcySjU4Mlg5MzRKa1ZoNHhKbVNQMU1GTTdMX2ZEQzlHb0I0cDFEbHhGa1FLano1Umd3N21jS3FOWDJpU0p2Vmc4NXVkNkx5N1NBVXc4Xy12Y2I2UkREMlVoY195SENKNE1GYzBfNFdlSVdQQTVacUZDZEE0ckpha2Jad0ZwMVhGZ1Q3cXZVYllmNWtyUTE2LUs1MFNB?oc=5,Google News,Biocon biosimilarity study,"New Delhi High Court Allows Marketing of Biocon-Mylan Biosimilar of Trastuzumab - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNUllPX0NfUnlKVU1LcXRRNjRmRGg0R1E5cFhvekxrVXBOTFcySjU4Mlg5MzRKa1ZoNHhKbVNQMU1GTTdMX2ZEQzlHb0I0cDFEbHhGa1FLano1Umd3N21jS3FOWDJpU0p2Vmc4NXVkNkx5N1NBVXc4Xy12Y2I2UkREMlVoY195SENKNE1GYzBfNFdlSVdQQTVacUZDZEE0ckpha2Jad0ZwMVhGZ1Q3cXZVYllmNWtyUTE2LUs1MFNB?oc=5"" target=""_blank"">New Delhi High Court Allows Marketing of Biocon-Mylan Biosimilar of Trastuzumab</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.9134127497673035,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.07127272727272728,0.3269090909090909,0.0,0.49234273852001537,other,0.0,[],False,True,6,0.0
2019-12-03,2019-12-03 08:00:00,"Biocon, Mylan launch Ogivri in the US - BioSpectrum India","<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxPeXIzdTBKS1Jtd1RxU0hXb0RvdzBGVE1BZUVfLUJVWjU1dzIySzNzbU1PQkVxRjA4Nk5CSUNjRzNUdWtZSTVsS3pzUEZZbXh0cWFiOW5GRGpEUW1mZlVQd3o4Q3Bac05Tc3hiZF9EZ24zel9wOFBUWXAwVHVFSnRrcEM1T1JlUjBjdW56RXNyRmNrdw?oc=5"" target=""_blank"">Biocon, Mylan launch Ogivri in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxPeXIzdTBKS1Jtd1RxU0hXb0RvdzBGVE1BZUVfLUJVWjU1dzIySzNzbU1PQkVxRjA4Nk5CSUNjRzNUdWtZSTVsS3pzUEZZbXh0cWFiOW5GRGpEUW1mZlVQd3o4Q3Bac05Tc3hiZF9EZ24zel9wOFBUWXAwVHVFSnRrcEM1T1JlUjBjdW56RXNyRmNrdw?oc=5,Google News,Biocon biosimilarity study,"Biocon, Mylan launch Ogivri in the US - BioSpectrum India <a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxPeXIzdTBKS1Jtd1RxU0hXb0RvdzBGVE1BZUVfLUJVWjU1dzIySzNzbU1PQkVxRjA4Nk5CSUNjRzNUdWtZSTVsS3pzUEZZbXh0cWFiOW5GRGpEUW1mZlVQd3o4Q3Bac05Tc3hiZF9EZ24zel9wOFBUWXAwVHVFSnRrcEM1T1JlUjBjdW56RXNyRmNrdw?oc=5"" target=""_blank"">Biocon, Mylan launch Ogivri in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",0.0,neutral,0.9193960428237915,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9193960428237915,other,0.0,[],False,True,6,0.0
2021-09-17,2021-09-17 07:00:00,Biocon Biologics to offer 15 pc stake to Serum Institute Life Sciences at valuation of $4.9B - YourStory.com,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxQZlR1aW1OUFNwYkNWeVV1b2hFdEdhSzV0MTVFeTlVTHBUX2s0LWdrNGtaNkRXM3YyTzZYbm8zSGZIM2xxaG8wb2dSV0p5RWZ2MHRQaW1wSUtkcGhSTU1tcTNpdFZVckRnSEVKYWt5a1N4aVpTZnVySDFNU2p2c0dITGFBaFNQeWg3VmVCVDNHR2E5VXZSdHp5U1N3?oc=5"" target=""_blank"">Biocon Biologics to offer 15 pc stake to Serum Institute Life Sciences at valuation of $4.9B</a>&nbsp;&nbsp;<font color=""#6f6f6f"">YourStory.com</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxQZlR1aW1OUFNwYkNWeVV1b2hFdEdhSzV0MTVFeTlVTHBUX2s0LWdrNGtaNkRXM3YyTzZYbm8zSGZIM2xxaG8wb2dSV0p5RWZ2MHRQaW1wSUtkcGhSTU1tcTNpdFZVckRnSEVKYWt5a1N4aVpTZnVySDFNU2p2c0dITGFBaFNQeWg3VmVCVDNHR2E5VXZSdHp5U1N3?oc=5,Google News,Biocon regulatory filing,"Biocon Biologics to offer 15 pc stake to Serum Institute Life Sciences at valuation of $4.9B - YourStory.com <a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxQZlR1aW1OUFNwYkNWeVV1b2hFdEdhSzV0MTVFeTlVTHBUX2s0LWdrNGtaNkRXM3YyTzZYbm8zSGZIM2xxaG8wb2dSV0p5RWZ2MHRQaW1wSUtkcGhSTU1tcTNpdFZVckRnSEVKYWt5a1N4aVpTZnVySDFNU2p2c0dITGFBaFNQeWg3VmVCVDNHR2E5VXZSdHp5U1N3?oc=5"" target=""_blank"">Biocon Biologics to offer 15 pc stake to Serum Institute Life Sciences at valuation of $4.9B</a>&nbsp;&nbsp;<font color=""#6f6f6f"">YourStory.com</font>",0.0,neutral,0.6164674758911133,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.6164674758911133,other,0.0,[],False,True,6,0.0
2021-09-08,2021-09-08 07:00:00,Biocon inks patent litigation settlement pact with Celgene over bone marrow cancer medicine - The New Indian Express,"<a href=""https://news.google.com/rss/articles/CBMi7wFBVV95cUxOQ2ZSNjgxQkhWNV9jR0N3bGFnZDJSbnl5bDRsSnRmbWFYMnZ1WjRRblo0YmtiSGZCSE1hRF8yb3ZYRklsUl9ERExlYzMxcTFzWW9ZODBWN0dsTE43d2VOdXJsR2E0R3RNUkE5NEJBWW9jMlFHNDJvam0tZDdxQTNiY3ltcmNxOFBwQm1Vb2lINVVEMjRLam8wNGpBMVMzeVpOM3U3NnJUbkxka0l4WWhVS3lPMmI4X3R6T21TR2g1QlB2WHJLLWNRUmZIbjVqR2xZaGJxMlhUdWI4QWoweHZyamtPdHliY2V3ZnJPb3hQWdIB_AFBVV95cUxOSlFqM1ZCcnhOX2tRTGNad3hiSFlOblJicVl3WGdxMldtWFkyYlRkSjlOY2phNmljSWdWM3RMTHpObWpBT0tYQWR0b24xVU9hOHBST2M5bDZPZUV1U0dNT3gwUlVOb2E2QWhncDhmWE1KaFNRZk1pa1BaQjhWNVJtZjFsOHlkQzNGLWd4WW1RcmtuU2VoNHlRZ2swdEhQaXRXT3NSMnpRQ3VTY0hET0h3ZHA2LXcxSjNoTFc1TXdMWHNHVm41T2s5TFEyMFF4elNmMXRZaXBxSHlxd1VYUnJjMnpPMEQzdUNiUUhtNkx6NkVpRVpKdHZfV1RNb1c?oc=5"" target=""_blank"">Biocon inks patent litigation settlement pact with Celgene over bone marrow cancer medicine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.com/rss/articles/CBMi7wFBVV95cUxOQ2ZSNjgxQkhWNV9jR0N3bGFnZDJSbnl5bDRsSnRmbWFYMnZ1WjRRblo0YmtiSGZCSE1hRF8yb3ZYRklsUl9ERExlYzMxcTFzWW9ZODBWN0dsTE43d2VOdXJsR2E0R3RNUkE5NEJBWW9jMlFHNDJvam0tZDdxQTNiY3ltcmNxOFBwQm1Vb2lINVVEMjRLam8wNGpBMVMzeVpOM3U3NnJUbkxka0l4WWhVS3lPMmI4X3R6T21TR2g1QlB2WHJLLWNRUmZIbjVqR2xZaGJxMlhUdWI4QWoweHZyamtPdHliY2V3ZnJPb3hQWdIB_AFBVV95cUxOSlFqM1ZCcnhOX2tRTGNad3hiSFlOblJicVl3WGdxMldtWFkyYlRkSjlOY2phNmljSWdWM3RMTHpObWpBT0tYQWR0b24xVU9hOHBST2M5bDZPZUV1U0dNT3gwUlVOb2E2QWhncDhmWE1KaFNRZk1pa1BaQjhWNVJtZjFsOHlkQzNGLWd4WW1RcmtuU2VoNHlRZ2swdEhQaXRXT3NSMnpRQ3VTY0hET0h3ZHA2LXcxSjNoTFc1TXdMWHNHVm41T2s5TFEyMFF4elNmMXRZaXBxSHlxd1VYUnJjMnpPMEQzdUNiUUhtNkx6NkVpRVpKdHZfV1RNb1c?oc=5,Google News,Biocon regulatory filing,"Biocon inks patent litigation settlement pact with Celgene over bone marrow cancer medicine - The New Indian Express <a href=""https://news.google.com/rss/articles/CBMi7wFBVV95cUxOQ2ZSNjgxQkhWNV9jR0N3bGFnZDJSbnl5bDRsSnRmbWFYMnZ1WjRRblo0YmtiSGZCSE1hRF8yb3ZYRklsUl9ERExlYzMxcTFzWW9ZODBWN0dsTE43d2VOdXJsR2E0R3RNUkE5NEJBWW9jMlFHNDJvam0tZDdxQTNiY3ltcmNxOFBwQm1Vb2lINVVEMjRLam8wNGpBMVMzeVpOM3U3NnJUbkxka0l4WWhVS3lPMmI4X3R6T21TR2g1QlB2WHJLLWNRUmZIbjVqR2xZaGJxMlhUdWI4QWoweHZyamtPdHliY2V3ZnJPb3hQWdIB_AFBVV95cUxOSlFqM1ZCcnhOX2tRTGNad3hiSFlOblJicVl3WGdxMldtWFkyYlRkSjlOY2phNmljSWdWM3RMTHpObWpBT0tYQWR0b24xVU9hOHBST2M5bDZPZUV1U0dNT3gwUlVOb2E2QWhncDhmWE1KaFNRZk1pa1BaQjhWNVJtZjFsOHlkQzNGLWd4WW1RcmtuU2VoNHlRZ2swdEhQaXRXT3NSMnpRQ3VTY0hET0h3ZHA2LXcxSjNoTFc1TXdMWHNHVm41T2s5TFEyMFF4elNmMXRZaXBxSHlxd1VYUnJjMnpPMEQzdUNiUUhtNkx6NkVpRVpKdHZfV1RNb1c?oc=5"" target=""_blank"">Biocon inks patent litigation settlement pact with Celgene over bone marrow cancer medicine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",0.0,neutral,0.5210973620414734,0.0,neutral,0.0,-0.9081,0.0,0.279,0.721,0.0909090909090909,0.30303030303030304,0.0,0.5067021509835214,other,0.0,[],False,True,6,0.0
2021-04-26,2021-04-26 07:00:00,"Biocon Biologics, Viatris gets European Commission Approval for co-developed Cancer drug - The Hans India","<a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxOUklCR1hsQUpTOVhrQm9QeDV6dkhrQm56M1lUUTJwZ3h1bU1rUjNuZFlMMTExWjh4YVR3TTRiZWJlWUtDcmgycHhDejZaaUdhY2FYZzZkeGhRRGpNdXE4bmVJaTBDWlZEM3dDVk9vbnVQVDBGV3JBUzljU2pIdjFLY0txOFRaZVNPZThZTktxbDZaZGxPdjVNZW1xZEgtend2c3d2NHpZTnhWVTZHWTNrSXJuWk1OUjBxU2VCMFFJZVJpY0NOR1g3c08zY24?oc=5"" target=""_blank"">Biocon Biologics, Viatris gets European Commission Approval for co-developed Cancer drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hans India</font>",https://news.google.com/rss/articles/CBMizAFBVV95cUxOUklCR1hsQUpTOVhrQm9QeDV6dkhrQm56M1lUUTJwZ3h1bU1rUjNuZFlMMTExWjh4YVR3TTRiZWJlWUtDcmgycHhDejZaaUdhY2FYZzZkeGhRRGpNdXE4bmVJaTBDWlZEM3dDVk9vbnVQVDBGV3JBUzljU2pIdjFLY0txOFRaZVNPZThZTktxbDZaZGxPdjVNZW1xZEgtend2c3d2NHpZTnhWVTZHWTNrSXJuWk1OUjBxU2VCMFFJZVJpY0NOR1g3c08zY24?oc=5,Google News,Biocon regulatory filing,"Biocon Biologics, Viatris gets European Commission Approval for co-developed Cancer drug - The Hans India <a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxOUklCR1hsQUpTOVhrQm9QeDV6dkhrQm56M1lUUTJwZ3h1bU1rUjNuZFlMMTExWjh4YVR3TTRiZWJlWUtDcmgycHhDejZaaUdhY2FYZzZkeGhRRGpNdXE4bmVJaTBDWlZEM3dDVk9vbnVQVDBGV3JBUzljU2pIdjFLY0txOFRaZVNPZThZTktxbDZaZGxPdjVNZW1xZEgtend2c3d2NHpZTnhWVTZHWTNrSXJuWk1OUjBxU2VCMFFJZVJpY0NOR1g3c08zY24?oc=5"" target=""_blank"">Biocon Biologics, Viatris gets European Commission Approval for co-developed Cancer drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hans India</font>",0.8379985690116882,positive,0.8379985690116882,0.0,neutral,0.0,-0.5574,0.151,0.215,0.634,0.0,0.0,0.4788563251495361,0.6976992845058441,other,0.0,[],False,True,6,0.0
2022-01-21,2022-01-21 08:00:00,Biocon Q3: Net profit jumps 18% to Rs 220 cr - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3: Net profit jumps 18% to Rs 220 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon Q3: Net profit jumps 18% to Rs 220 cr - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3: Net profit jumps 18% to Rs 220 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.9279548525810242,positive,0.9279548525810242,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,0.0,0.0,0.5302599157605853,0.814127426290512,other,0.0,[],False,True,6,0.0
2020-11-07,2020-11-07 08:00:00,Biocon Biologics to raise $150 million from Goldman Sachs at $3.94 billion valuation - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to raise $150 million from Goldman Sachs at $3.94 billion valuation</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon Biologics to raise $150 million from Goldman Sachs at $3.94 billion valuation - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to raise $150 million from Goldman Sachs at $3.94 billion valuation</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.658638060092926,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.658638060092926,other,0.0,[],False,True,6,0.0
2017-12-08,2017-12-08 08:00:00,Biocon gets shareholders' nod for transfer of biosimilars business - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets shareholders' nod for transfer of biosimilars business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi0wFBVV95cUxNckJjYXZyREZFdU9WXzhSa3EwLVdTWFFQckdEWERjUnNoRTRJX2NtWTdmZERHS3ZmVkpkVTNUOVBIZEhtQi1fdExDWVpHOG9EaU5SeDBHQkxaSU51aTVGcXYwVnNrM3FleFFIR3NGRjRCWW5UX29Tb213dERhVWtoejJaaDU0Q2k5RmYyX2NOS2ExYjdJa2RXRTc5SFJyR0V5ajFVd1Q4bHFqVk1Fc0lYRVNIMkdES05zV29QTGdXRGh4eXBKLVVPVmozV29wWmIwUjF30gHYAUFVX3lxTFBlaHZZaXpVZFVxRGptdnVZaTZaeUw5T0hkYU1DWVBhMUFTeWNwRWs1dGlUSW1sN3l5UGxCUTNQd0IxaEhKU0xwUnpNNlMyZFl3cVpnVTZLRmYtckVuUnpGNnlzZERnTWU5cXA4cEdHWXByM0pkUVFKWGNNeVBQLVFOdXEyYU03X2lzSVZ1T1dTemMzWXR1dG0zMkMwZXA1Q0U5M0FDdWNmczYyRzFhYXFlSTlkek0xdWZ4WnZ3cllodGVpYUkzLV9kdEVIMm9remQ2N1RuV3ZKVw?oc=5,Google News,Biocon regulatory filing,"Biocon gets shareholders' nod for transfer of biosimilars business - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets shareholders' nod for transfer of biosimilars business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.603866696357727,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.603866696357727,other,0.0,[],False,True,6,0.0
2021-01-08,2021-01-08 08:00:00,Biocon Biologics receives Rs 555 crore Capital Injection from ADQ - The Hans India,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNYmdWUXVBUXFURHctN2RYNzlQb09aTENyb1hfd2poelVpUWV1UmRmeU9VcTJkYTh3ekNkVWhuckdNQkVodnc2VjFJZU04SWQweTBrU0NPWnMyeE5vZURTczBVWUlydjQ2RmpleFo4X3NtalFrVXl5THF1Nl9MWS1BQzdzaUpiNmQ4MldOVzU3TDQta3VtbUtEOTNfNkNpQnJ2SjVmT3RRNjc1dFNYSVdV?oc=5"" target=""_blank"">Biocon Biologics receives Rs 555 crore Capital Injection from ADQ</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hans India</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNYmdWUXVBUXFURHctN2RYNzlQb09aTENyb1hfd2poelVpUWV1UmRmeU9VcTJkYTh3ekNkVWhuckdNQkVodnc2VjFJZU04SWQweTBrU0NPWnMyeE5vZURTczBVWUlydjQ2RmpleFo4X3NtalFrVXl5THF1Nl9MWS1BQzdzaUpiNmQ4MldOVzU3TDQta3VtbUtEOTNfNkNpQnJ2SjVmT3RRNjc1dFNYSVdV?oc=5,Google News,Biocon regulatory filing,"Biocon Biologics receives Rs 555 crore Capital Injection from ADQ - The Hans India <a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNYmdWUXVBUXFURHctN2RYNzlQb09aTENyb1hfd2poelVpUWV1UmRmeU9VcTJkYTh3ekNkVWhuckdNQkVodnc2VjFJZU04SWQweTBrU0NPWnMyeE5vZURTczBVWUlydjQ2RmpleFo4X3NtalFrVXl5THF1Nl9MWS1BQzdzaUpiNmQ4MldOVzU3TDQta3VtbUtEOTNfNkNpQnJ2SjVmT3RRNjc1dFNYSVdV?oc=5"" target=""_blank"">Biocon Biologics receives Rs 555 crore Capital Injection from ADQ</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hans India</font>",0.5462997555732727,positive,0.5462997555732727,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.31217128889901297,0.5462997555732727,other,0.0,[],False,True,6,0.0
2021-04-30,2021-04-30 07:00:00,Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9341988563537598,positive,0.9341988563537598,0.0,neutral,0.0,0.7003,0.172,0.0,0.828,0.020833333333333332,0.16666666666666666,0.5338279179164341,0.5517773965623644,other,0.0,[],False,True,6,0.0
2018-05-18,2018-05-18 07:00:00,Biocon sells 1.88% stake in Syngene for Rs230 crore | Company Business News - Mint,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxOSHpON0JJcHFlTDZQQ3g3eGFfd2hXaHFPRXJva25Xc19ULWhtSHFDZUFFTG02N0pydlM3Y1Nqc3prVG5VcEh2MGVUSXJudEM4a0J2RlAyVWZOTkRHYWl4cFNoaUZUa0tkN3lHd28xdFg5N2JPbW9JU1ptWHBFQkRaSWpCQ0pOZHZyYWZ3ZjdGbi1BbThoU29aOFRSdEVTWDNYSXpjaWJ5Slg1VGpFVkpaQnlR0gG_AUFVX3lxTE1IS0xwUkNGUGVjOGhET1lQV05jVVNWcmp1T1FBQ2JOTGJjd3JoN243R1ZyTzJoUTB2OWxLTHJMLTVHMnQzTjNxZk5lZmlYMDN3cmZNWHRBVDFLWENMcDdRMWVla2Zmd240T3dUcXhvM3V0MWpaV2wtS0kyTGNlRlR2RVEyQjRMdVBiank2V3k2OVh1QWFfdlhjTGxtZUtCTHZhekFMY2pNanhFVTB0VGcyTGRsb1pLNDlvQl94Ym80?oc=5"" target=""_blank"">Biocon sells 1.88% stake in Syngene for Rs230 crore | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxOSHpON0JJcHFlTDZQQ3g3eGFfd2hXaHFPRXJva25Xc19ULWhtSHFDZUFFTG02N0pydlM3Y1Nqc3prVG5VcEh2MGVUSXJudEM4a0J2RlAyVWZOTkRHYWl4cFNoaUZUa0tkN3lHd28xdFg5N2JPbW9JU1ptWHBFQkRaSWpCQ0pOZHZyYWZ3ZjdGbi1BbThoU29aOFRSdEVTWDNYSXpjaWJ5Slg1VGpFVkpaQnlR0gG_AUFVX3lxTE1IS0xwUkNGUGVjOGhET1lQV05jVVNWcmp1T1FBQ2JOTGJjd3JoN243R1ZyTzJoUTB2OWxLTHJMLTVHMnQzTjNxZk5lZmlYMDN3cmZNWHRBVDFLWENMcDdRMWVla2Zmd240T3dUcXhvM3V0MWpaV2wtS0kyTGNlRlR2RVEyQjRMdVBiank2V3k2OVh1QWFfdlhjTGxtZUtCTHZhekFMY2pNanhFVTB0VGcyTGRsb1pLNDlvQl94Ym80?oc=5,Google News,Biocon regulatory filing,"Biocon sells 1.88% stake in Syngene for Rs230 crore | Company Business News - Mint <a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxOSHpON0JJcHFlTDZQQ3g3eGFfd2hXaHFPRXJva25Xc19ULWhtSHFDZUFFTG02N0pydlM3Y1Nqc3prVG5VcEh2MGVUSXJudEM4a0J2RlAyVWZOTkRHYWl4cFNoaUZUa0tkN3lHd28xdFg5N2JPbW9JU1ptWHBFQkRaSWpCQ0pOZHZyYWZ3ZjdGbi1BbThoU29aOFRSdEVTWDNYSXpjaWJ5Slg1VGpFVkpaQnlR0gG_AUFVX3lxTE1IS0xwUkNGUGVjOGhET1lQV05jVVNWcmp1T1FBQ2JOTGJjd3JoN243R1ZyTzJoUTB2OWxLTHJMLTVHMnQzTjNxZk5lZmlYMDN3cmZNWHRBVDFLWENMcDdRMWVla2Zmd240T3dUcXhvM3V0MWpaV2wtS0kyTGNlRlR2RVEyQjRMdVBiank2V3k2OVh1QWFfdlhjTGxtZUtCTHZhekFMY2pNanhFVTB0VGcyTGRsb1pLNDlvQl94Ym80?oc=5"" target=""_blank"">Biocon sells 1.88% stake in Syngene for Rs230 crore | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.9366198182106018,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9366198182106018,other,0.0,[],False,True,6,0.0
2020-05-16,2020-05-16 07:00:00,Biopharma Co. Biocon Posts a Q4FY20 Profit fall of 42% at ₹123 Cr - The Indian Wire,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biopharma Co. Biocon Posts a Q4FY20 Profit fall of 42% at ₹123 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Wire</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNY1FVbGJRX0pGemdxLVc2SHF6dGdfcnFPc3JvRVNCRVFPYldudnludHU0cXRqWnNLU19Wd1VEeW5jbTJYM28yRUZWUHMzR19oa2tvUV9va0FwOTR5SGxoMmdhWEZ4UVp3R1BHcWhzaGFMNEZDMDIyaGxTVnd1RTZMZlRZX0ZxY3pGWWVmUmpRQTFaQkpkQzdRTGxKTDhNUnZMYzlXM2xVN3FPMXA1RWJha0dvLUVpMGw5X0HSAboBQVVfeXFMTWNRVWxiUV9KRnpncS1XNkhxenRnX3JxT3Nyb0VTQkVRT2JXbnZ5bnR1NHF0alpzS1NfVndVRHluY20yWDNvMkVGVlBzM0dfaGtrb1Ffb2tBcDk0eUhsaDJnYVhGeFFad0dQR3Foc2hhTDRGQzAyMmhsU1Z3dUU2TGZUWV9GcWN6RlllZlJqUUExWkJKZEM3UUxsSkw4TVJ2TGM5VzNsVTdxTzFwNUViYWtHby1FaTBsOV9B?oc=5,Google News,Biocon regulatory filing,"Biopharma Co. Biocon Posts a Q4FY20 Profit fall of 42% at ₹123 Cr - The Indian Wire <a href=""https://news.google.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?oc=5"" target=""_blank"">Biopharma Co. Biocon Posts a Q4FY20 Profit fall of 42% at ₹123 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Wire</font>",-0.9717919230461121,negative,0.9717919230461121,0.0,neutral,0.0,0.7003,0.162,0.0,0.838,0.0,0.0,-0.555309670312064,0.836045961523056,other,0.0,[],False,True,6,0.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News,Biocon financial results,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.9249867796897888,positive,0.9249867796897888,0.0,neutral,0.0,0.7003,0.073,0.0,0.927,-0.06222222222222222,0.11555555555555556,0.5285638741084507,0.5625030006373369,other,0.0,[],False,True,6,0.0
2022-01-08,2022-01-08 00:39:13,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - ICICI Direct,"<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5,Google News,Biocon financial results,"Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - ICICI Direct <a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",0.0,neutral,0.9198204278945923,0.0,neutral,0.0,0.5267,0.167,0.0,0.833,0.09318181818181817,0.35,0.0,0.5132340820254702,other,0.0,[],False,True,6,0.0
2020-07-24,2020-07-24 07:00:00,"Biocon releases Q1FY21 results; Revenue up by 14 per cent at Rs 1,690 Cr - Express Pharma","<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNNlR6ekpqcGU5Skt1WV9WdUZxXzF1R1k1dWVmdzYxY1FOUjB3VkRJN0NreXM5Uks5QWppa3VNMFpMMTVVUWptZUdyNmMwd2JYb2hxZVoyc01uLVFjZlNfQUVFNlJvRHhLdjlLUGhFTy1xVlVmeEhoUDNJTmJudlUtRDgwM0RKNXlfVElpMjVlU0RFOUNBaXJVbDF0aGJhVnRYWWfSAacBQVVfeXFMUEx6R3p5UXZnelpQaE1yTmlGNl8xSUx5NVZQTWQ5LUVYMWRtVVFLTGZXblZDbWMzc0lEWmdqODBMaFEyTzRTZ0tpRGIxMWtOckxvMGVnMGUwZUh3SUhQQ09ReUxsYW55dldPVDh5VXp6NjdndUF6dUszeDlnSzRrcHZiaWtBRmhncDFyYnh3RlpZRjRkcXIwTlJfdkNENFdOT3ZKZF9haFE?oc=5"" target=""_blank"">Biocon releases Q1FY21 results; Revenue up by 14 per cent at Rs 1,690 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxNNlR6ekpqcGU5Skt1WV9WdUZxXzF1R1k1dWVmdzYxY1FOUjB3VkRJN0NreXM5Uks5QWppa3VNMFpMMTVVUWptZUdyNmMwd2JYb2hxZVoyc01uLVFjZlNfQUVFNlJvRHhLdjlLUGhFTy1xVlVmeEhoUDNJTmJudlUtRDgwM0RKNXlfVElpMjVlU0RFOUNBaXJVbDF0aGJhVnRYWWfSAacBQVVfeXFMUEx6R3p5UXZnelpQaE1yTmlGNl8xSUx5NVZQTWQ5LUVYMWRtVVFLTGZXblZDbWMzc0lEWmdqODBMaFEyTzRTZ0tpRGIxMWtOckxvMGVnMGUwZUh3SUhQQ09ReUxsYW55dldPVDh5VXp6NjdndUF6dUszeDlnSzRrcHZiaWtBRmhncDFyYnh3RlpZRjRkcXIwTlJfdkNENFdOT3ZKZF9haFE?oc=5,Google News,Biocon financial results,"Biocon releases Q1FY21 results; Revenue up by 14 per cent at Rs 1,690 Cr - Express Pharma <a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNNlR6ekpqcGU5Skt1WV9WdUZxXzF1R1k1dWVmdzYxY1FOUjB3VkRJN0NreXM5Uks5QWppa3VNMFpMMTVVUWptZUdyNmMwd2JYb2hxZVoyc01uLVFjZlNfQUVFNlJvRHhLdjlLUGhFTy1xVlVmeEhoUDNJTmJudlUtRDgwM0RKNXlfVElpMjVlU0RFOUNBaXJVbDF0aGJhVnRYWWfSAacBQVVfeXFMUEx6R3p5UXZnelpQaE1yTmlGNl8xSUx5NVZQTWQ5LUVYMWRtVVFLTGZXblZDbWMzc0lEWmdqODBMaFEyTzRTZ0tpRGIxMWtOckxvMGVnMGUwZUh3SUhQQ09ReUxsYW55dldPVDh5VXp6NjdndUF6dUszeDlnSzRrcHZiaWtBRmhncDFyYnh3RlpZRjRkcXIwTlJfdkNENFdOT3ZKZF9haFE?oc=5"" target=""_blank"">Biocon releases Q1FY21 results; Revenue up by 14 per cent at Rs 1,690 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.9507468938827515,positive,0.9507468938827515,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5432839393615723,0.9507468938827515,other,0.0,[],False,True,6,0.0
2020-01-24,2020-01-24 08:00:00,US to lead Biocon Biologics' drive towards $1 billion revenue - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">US to lead Biocon Biologics' drive towards $1 billion revenue</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"US to lead Biocon Biologics' drive towards $1 billion revenue - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">US to lead Biocon Biologics' drive towards $1 billion revenue</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.763129711151123,positive,0.763129711151123,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.4360741206577846,0.763129711151123,other,0.0,[],False,True,6,0.0
2020-01-27,2020-01-27 08:00:00,Biocon’s biosimilar thrust yields growth but no gains in earnings yet - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon’s biosimilar thrust yields growth but no gains in earnings yet</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"Biocon’s biosimilar thrust yields growth but no gains in earnings yet - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon’s biosimilar thrust yields growth but no gains in earnings yet</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.7859727144241333,positive,0.7859727144241333,0.0,neutral,0.0,0.7003,0.308,0.151,0.541,0.0,0.0,0.449127265385219,0.7431363572120666,other,0.0,[],False,True,6,0.0
2019-01-28,2019-01-28 08:00:00,Biosimilars make Biocon stand apart - Mint,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxNUk1qa1EyeWNiQkpYcnkwSzlXR19zSWdkb3Nnc1UteTIwMTk4QmFWdDZtVXpXNG9weHE0RnVvTHRfVkJIY1I1ZlhhbXNqX0hmTUp3N1FnSkhTMGl3dW1mTU81R3JtT1Qyc2RYV0RXSkhMVlItRlpnNW05dmM2R2QtaUdCZ2lTVDBOMnZ6NTJkRVBlSnhQcklFcHFsaV94Z25WRndN0gGoAUFVX3lxTE5IOWFzdEVKbDh1cEkzclZrSjAwZ1JTRnBIU0NhRjhTMV9JM01uV3pIU0NkWDBDcUxXTXhUSUdOaGpQSnZnTXA0YXB1TGFxOHp6UzZ2bW53YjkzSFhuWXZDcnQwQVpVZWRJQ2dIb09TNVJ5ekxRWXNDQkc0V2MtUHRrcFhORE1TazNWMzFJOHhLOFNyRkkyZFMtcTFRT1VGMEFITHhVX1VadA?oc=5"" target=""_blank"">Biosimilars make Biocon stand apart</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxNUk1qa1EyeWNiQkpYcnkwSzlXR19zSWdkb3Nnc1UteTIwMTk4QmFWdDZtVXpXNG9weHE0RnVvTHRfVkJIY1I1ZlhhbXNqX0hmTUp3N1FnSkhTMGl3dW1mTU81R3JtT1Qyc2RYV0RXSkhMVlItRlpnNW05dmM2R2QtaUdCZ2lTVDBOMnZ6NTJkRVBlSnhQcklFcHFsaV94Z25WRndN0gGoAUFVX3lxTE5IOWFzdEVKbDh1cEkzclZrSjAwZ1JTRnBIU0NhRjhTMV9JM01uV3pIU0NkWDBDcUxXTXhUSUdOaGpQSnZnTXA0YXB1TGFxOHp6UzZ2bW53YjkzSFhuWXZDcnQwQVpVZWRJQ2dIb09TNVJ5ekxRWXNDQkc0V2MtUHRrcFhORE1TazNWMzFJOHhLOFNyRkkyZFMtcTFRT1VGMEFITHhVX1VadA?oc=5,Google News,Biocon revenue growth,"Biosimilars make Biocon stand apart - Mint <a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxNUk1qa1EyeWNiQkpYcnkwSzlXR19zSWdkb3Nnc1UteTIwMTk4QmFWdDZtVXpXNG9weHE0RnVvTHRfVkJIY1I1ZlhhbXNqX0hmTUp3N1FnSkhTMGl3dW1mTU81R3JtT1Qyc2RYV0RXSkhMVlItRlpnNW05dmM2R2QtaUdCZ2lTVDBOMnZ6NTJkRVBlSnhQcklFcHFsaV94Z25WRndN0gGoAUFVX3lxTE5IOWFzdEVKbDh1cEkzclZrSjAwZ1JTRnBIU0NhRjhTMV9JM01uV3pIU0NkWDBDcUxXTXhUSUdOaGpQSnZnTXA0YXB1TGFxOHp6UzZ2bW53YjkzSFhuWXZDcnQwQVpVZWRJQ2dIb09TNVJ5ekxRWXNDQkc0V2MtUHRrcFhORE1TazNWMzFJOHhLOFNyRkkyZFMtcTFRT1VGMEFITHhVX1VadA?oc=5"" target=""_blank"">Biosimilars make Biocon stand apart</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.9070755243301392,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9070755243301392,other,0.0,[],False,True,6,0.0
2018-10-25,2018-10-25 07:00:00,"Biocon Q2 FY19 numbers reflect green shoots of biosimilar value-unlocking, says Kiran Mazumdar-Shaw - Business Today","<a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon Q2 FY19 numbers reflect green shoots of biosimilar value-unlocking, says Kiran Mazumdar-Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi-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?oc=5,Google News,Biocon revenue growth,"Biocon Q2 FY19 numbers reflect green shoots of biosimilar value-unlocking, says Kiran Mazumdar-Shaw - Business Today <a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxNcUp1QXVYdElQRldhcDQxcXoxcVFYM3ZoRXR1YmxWeXF6QkpxdzNsbFVQYXk4eER4S3hweFpyN3dDMzdLaFJBWWNERlRJcXdVS3FfS0NuRHNwYTF3eWluekFiTEhNNVRSYWJudEpuX0FXR09kYzZjOXhvZVRzd0xSanpWUmF4QW5iQW1Fd3JVUm5MT0RKRG9HcF9OXy12ZHpXcS0xLTNSX01qMFV3TDc5Y3RFcW9BR2cwNHpFVlRESmk3Tm9OSk1oTkJYdlE4RFRwVUJxQms0ZUpFZzYwRHFjUGhhQm9DejRKN1hlejlnZFBFX0Y5NUFreGRNa9IBgAJBVV95cUxQZnM3TXlUMjFyY2hNMmIteUZ6N0ZGbHlfeDRBamNwMG9ndHdiNEM3NFZ6akhINFVuQkRpR0pUZXNjZHdDYVZLMGNzUUxHdnl2MWMzNk1SYVFMLVZVZjJVQUtleXhYa3Z6dnFzUFd2MW5fek41cktyb1NGbWxfeDNiYXpMalk4ZWpDWGRmejYzVlNZdTVva0xhci1YOWduWXljVzVvUjJoTEU1eFJkdFhQM1RNOS1OVi05TXVOcnF5dkZiRTJxMDZvSzlfdlhRbk1lUWpaeEVfemtObmRCZ3VvN2hJTk51QTdYemlUVWtCQ0dMQnFaUGVHVmNIRlpDY0RR?oc=5"" target=""_blank"">Biocon Q2 FY19 numbers reflect green shoots of biosimilar value-unlocking, says Kiran Mazumdar-Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.7631794810295105,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.13333333333333333,0.19999999999999998,0.0,0.4482564071814219,other,0.0,[],False,True,6,0.0
2020-07-24,2020-07-24 07:00:00,"Biocon Q1 net profit declines 26 pc, revenue up 14 pc - The Statesman","<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQME9KSGNveUcwYzFDVTdtTUpJaFRiTE1sVUdFOGtoejNxNGFqX2dSUnFBZkhLb3hkNUVDS2swR21ESmZmUHQ3N09ta0hDb2JDdzZfYmhJcGdOclo4VndxNW9EUHBjVXNrUGZuR0tVeF94V3BrRkxPNEVyVkwxMnh2M1F6SW1zSVpXLXVWandfMjNWQ0ZOTmlDZUxTWEZDNDFRTjFKLXFn0gGrAUFVX3lxTE1RY21jbzkxcGt6Tm9uWTZ4TE0tVFVIS0t2NWV6QlphY0JiRElsd3dDakdtTUJCcnV4a0wzOUZDcHlNblpuRXpiVUxGQkQ3ZUltOFBzQ0otbXZUYXZVX21jWlpnc0hZN2I4SVRWc1BONU9kRXdzdm9jWWlOenIzeG83UFppbjk2LURMWHVWbVVhTjMxQ1V3UUJZMEpYQUJVQ0JZLVZLbFdHQ3RjVQ?oc=5"" target=""_blank"">Biocon Q1 net profit declines 26 pc, revenue up 14 pc</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQME9KSGNveUcwYzFDVTdtTUpJaFRiTE1sVUdFOGtoejNxNGFqX2dSUnFBZkhLb3hkNUVDS2swR21ESmZmUHQ3N09ta0hDb2JDdzZfYmhJcGdOclo4VndxNW9EUHBjVXNrUGZuR0tVeF94V3BrRkxPNEVyVkwxMnh2M1F6SW1zSVpXLXVWandfMjNWQ0ZOTmlDZUxTWEZDNDFRTjFKLXFn0gGrAUFVX3lxTE1RY21jbzkxcGt6Tm9uWTZ4TE0tVFVIS0t2NWV6QlphY0JiRElsd3dDakdtTUJCcnV4a0wzOUZDcHlNblpuRXpiVUxGQkQ3ZUltOFBzQ0otbXZUYXZVX21jWlpnc0hZN2I4SVRWc1BONU9kRXdzdm9jWWlOenIzeG83UFppbjk2LURMWHVWbVVhTjMxQ1V3UUJZMEpYQUJVQ0JZLVZLbFdHQ3RjVQ?oc=5,Google News,Biocon revenue growth,"Biocon Q1 net profit declines 26 pc, revenue up 14 pc - The Statesman <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQME9KSGNveUcwYzFDVTdtTUpJaFRiTE1sVUdFOGtoejNxNGFqX2dSUnFBZkhLb3hkNUVDS2swR21ESmZmUHQ3N09ta0hDb2JDdzZfYmhJcGdOclo4VndxNW9EUHBjVXNrUGZuR0tVeF94V3BrRkxPNEVyVkwxMnh2M1F6SW1zSVpXLXVWandfMjNWQ0ZOTmlDZUxTWEZDNDFRTjFKLXFn0gGrAUFVX3lxTE1RY21jbzkxcGt6Tm9uWTZ4TE0tVFVIS0t2NWV6QlphY0JiRElsd3dDakdtTUJCcnV4a0wzOUZDcHlNblpuRXpiVUxGQkQ3ZUltOFBzQ0otbXZUYXZVX21jWlpnc0hZN2I4SVRWc1BONU9kRXdzdm9jWWlOenIzeG83UFppbjk2LURMWHVWbVVhTjMxQ1V3UUJZMEpYQUJVQ0JZLVZLbFdHQ3RjVQ?oc=5"" target=""_blank"">Biocon Q1 net profit declines 26 pc, revenue up 14 pc</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",-0.9568995237350464,negative,0.9568995237350464,0.0,neutral,0.0,0.7003,0.182,0.0,0.818,0.0,0.0,-0.5467997278485979,0.8285997618675232,other,0.0,[],False,True,6,0.0
2021-06-10,2021-06-10 23:01:52,Biocon Q2 net profit increases to Rs 306 crore - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxPUW96UkJxQktNeUNJS0NpZGY4OUhHd0FKUGhNQkE4WklzV0tHeFJoNElEeDhpMmtwM2F3U3VnSkd1RGRsNlNGM0VkOWlPS1pfeGJpckp5VFhNRUJzdDFDcWtBaVdpa1dxQ1BwWWRkbmI4M1Y3cmx3MENCRXlzajB2SU5R?oc=5"" target=""_blank"">Biocon Q2 net profit increases to Rs 306 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiggFBVV95cUxPUW96UkJxQktNeUNJS0NpZGY4OUhHd0FKUGhNQkE4WklzV0tHeFJoNElEeDhpMmtwM2F3U3VnSkd1RGRsNlNGM0VkOWlPS1pfeGJpckp5VFhNRUJzdDFDcWtBaVdpa1dxQ1BwWWRkbmI4M1Y3cmx3MENCRXlzajB2SU5R?oc=5,Google News,Biocon revenue growth,"Biocon Q2 net profit increases to Rs 306 crore - Equitypandit <a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxPUW96UkJxQktNeUNJS0NpZGY4OUhHd0FKUGhNQkE4WklzV0tHeFJoNElEeDhpMmtwM2F3U3VnSkd1RGRsNlNGM0VkOWlPS1pfeGJpckp5VFhNRUJzdDFDcWtBaVdpa1dxQ1BwWWRkbmI4M1Y3cmx3MENCRXlzajB2SU5R?oc=5"" target=""_blank"">Biocon Q2 net profit increases to Rs 306 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.9410327672958374,positive,0.9410327672958374,0.0,neutral,0.0,0.7003,0.225,0.0,0.775,0.0,0.0,0.5377330098833356,0.8206663836479187,other,0.0,[],False,True,6,0.0
2018-10-25,2018-10-25 07:00:00,"Biocon Q2 net profit jumps 167% to Rs 184 crore, beats analyst estimates - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 net profit jumps 167% to Rs 184 crore, beats analyst estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"Biocon Q2 net profit jumps 167% to Rs 184 crore, beats analyst estimates - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 net profit jumps 167% to Rs 184 crore, beats analyst estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.903657078742981,positive,0.903657078742981,0.0,neutral,0.0,0.7003,0.172,0.0,0.828,0.0,0.0,0.5163754735674176,0.8019785393714904,other,0.0,[],False,True,6,0.0
2018-04-27,2018-04-27 07:00:00,"Biocon Q4FY18 Revenue Rs 1,237 Cr, Up 27 per cent - BioSpectrum India","<a href=""https://news.google.com/rss/articles/CBMioAFBVV95cUxNNDRVbGJ1YnZEMHVMMFZVNnFJZWVORU1wY0RwRUFlSXRJeXJQMXpOdG9RN1hFcmxMS1VYUFYwejM3RFNCQjI3cmNkQkFZdGhybWhQV1FKeS1YN2VkM1NnMVlEbnBuSlc4SzY4X0I4b3FrdzNVSXdHdHFDaUNPZHBSdWJtbnBNSEJvaW9vNk55VDFMVGdvUUNNMUFkVWpLdlJU?oc=5"" target=""_blank"">Biocon Q4FY18 Revenue Rs 1,237 Cr, Up 27 per cent</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMioAFBVV95cUxNNDRVbGJ1YnZEMHVMMFZVNnFJZWVORU1wY0RwRUFlSXRJeXJQMXpOdG9RN1hFcmxMS1VYUFYwejM3RFNCQjI3cmNkQkFZdGhybWhQV1FKeS1YN2VkM1NnMVlEbnBuSlc4SzY4X0I4b3FrdzNVSXdHdHFDaUNPZHBSdWJtbnBNSEJvaW9vNk55VDFMVGdvUUNNMUFkVWpLdlJU?oc=5,Google News,Biocon revenue growth,"Biocon Q4FY18 Revenue Rs 1,237 Cr, Up 27 per cent - BioSpectrum India <a href=""https://news.google.com/rss/articles/CBMioAFBVV95cUxNNDRVbGJ1YnZEMHVMMFZVNnFJZWVORU1wY0RwRUFlSXRJeXJQMXpOdG9RN1hFcmxMS1VYUFYwejM3RFNCQjI3cmNkQkFZdGhybWhQV1FKeS1YN2VkM1NnMVlEbnBuSlc4SzY4X0I4b3FrdzNVSXdHdHFDaUNPZHBSdWJtbnBNSEJvaW9vNk55VDFMVGdvUUNNMUFkVWpLdlJU?oc=5"" target=""_blank"">Biocon Q4FY18 Revenue Rs 1,237 Cr, Up 27 per cent</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",0.9434539079666138,positive,0.9434539079666138,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.539116518838065,0.9434539079666138,other,0.0,[],False,True,6,0.0
2020-05-15,2020-05-15 07:00:00,Biocon profit slumps 42% in Q4 as covid-19 disrupts biologics business - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon profit slumps 42% in Q4 as covid-19 disrupts biologics business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Biocon profit slumps 42% in Q4 as covid-19 disrupts biologics business - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon profit slumps 42% in Q4 as covid-19 disrupts biologics business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",-0.9712345600128174,negative,0.9712345600128174,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,0.0,0.0,-0.5549911771501814,0.8357672800064087,other,0.0,[],False,True,6,0.0
2021-01-22,2021-01-22 08:00:00,"Biocon reports 17% drop in net profit, Christiane Hamacher steps down as MD of Biocon Biologics - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon reports 17% drop in net profit, Christiane Hamacher steps down as MD of Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Biocon reports 17% drop in net profit, Christiane Hamacher steps down as MD of Biocon Biologics - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon reports 17% drop in net profit, Christiane Hamacher steps down as MD of Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",-0.9447938203811646,negative,0.9447938203811646,0.0,neutral,0.0,0.3818,0.126,0.091,0.783,0.0126984126984127,0.13968253968253969,-0.5398821830749512,0.446430744359859,other,0.0,[],False,True,6,0.0
2018-10-26,2018-10-26 07:00:00,Biocon Sep-quarter net profit sees five-fold surge on exceptional income - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Sep-quarter net profit sees five-fold surge on exceptional income</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Biocon Sep-quarter net profit sees five-fold surge on exceptional income - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Sep-quarter net profit sees five-fold surge on exceptional income</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9387204647064209,positive,0.9387204647064209,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,0.2222222222222222,0.3333333333333333,0.5364116941179548,0.6204142289762143,other,0.0,[],False,True,6,0.0
2019-10-23,2019-10-23 07:00:00,Biocon posts 39% fall in net profit Q2 even as biologics business booms - Mint,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxQSGZUVW5wODdIM3lReXNCbnN2R2VHM1NEcHo2RDdKR3hvVW1xa1k4UllDR3pnMWdFRUYtWUZ5Qi1uU2ZLUk1TRDdYa0l4OWZCU2JOS01uTDZBcFJvallZYjdZM3BFY3I3Y2UtWTRNV0R5UTRzWW9HUDM2VWdNeDF4UjlHMDBHZENTb0RJQ1ZqYk1UNXpYNVd0N2VKSUU0blk0YTZYaEwxV1ppeFdGY082N3JKVUNoel9odklKcktsc1FNaU91WHhSRjVjN0hwc2pObDlrcW1LTV_SAd4BQVVfeXFMTUFwQ2dtdlotdkhxNVRuc0gwSnI4a19KQlE5bHRTLUdSMGIwNTRCV2RFY1ljNEx0OUx0R3dzR3AwUFBQR0hyRGtRTGpMUWprOS1KZWh2RllMU21acUlSTG82d2stU2dYLW1Bc3RTbV93WEk3UFo4YnBuSVBYbWt2MmM3M1pHblJHaElyODZSdG5kazZMajN0bGFVSTR2WmZZdi1venNnaUZ6akxuQ29NOGZiRXRkM3VoREVvSnhiU1ZLQnhVUGVwREdJVGVtYTRlSEd4MlBhVVFCMFlqZkJn?oc=5"" target=""_blank"">Biocon posts 39% fall in net profit Q2 even as biologics business booms</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxQSGZUVW5wODdIM3lReXNCbnN2R2VHM1NEcHo2RDdKR3hvVW1xa1k4UllDR3pnMWdFRUYtWUZ5Qi1uU2ZLUk1TRDdYa0l4OWZCU2JOS01uTDZBcFJvallZYjdZM3BFY3I3Y2UtWTRNV0R5UTRzWW9HUDM2VWdNeDF4UjlHMDBHZENTb0RJQ1ZqYk1UNXpYNVd0N2VKSUU0blk0YTZYaEwxV1ppeFdGY082N3JKVUNoel9odklKcktsc1FNaU91WHhSRjVjN0hwc2pObDlrcW1LTV_SAd4BQVVfeXFMTUFwQ2dtdlotdkhxNVRuc0gwSnI4a19KQlE5bHRTLUdSMGIwNTRCV2RFY1ljNEx0OUx0R3dzR3AwUFBQR0hyRGtRTGpMUWprOS1KZWh2RllMU21acUlSTG82d2stU2dYLW1Bc3RTbV93WEk3UFo4YnBuSVBYbWt2MmM3M1pHblJHaElyODZSdG5kazZMajN0bGFVSTR2WmZZdi1venNnaUZ6akxuQ29NOGZiRXRkM3VoREVvSnhiU1ZLQnhVUGVwREdJVGVtYTRlSEd4MlBhVVFCMFlqZkJn?oc=5,Google News,Biocon profit,"Biocon posts 39% fall in net profit Q2 even as biologics business booms - Mint <a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxQSGZUVW5wODdIM3lReXNCbnN2R2VHM1NEcHo2RDdKR3hvVW1xa1k4UllDR3pnMWdFRUYtWUZ5Qi1uU2ZLUk1TRDdYa0l4OWZCU2JOS01uTDZBcFJvallZYjdZM3BFY3I3Y2UtWTRNV0R5UTRzWW9HUDM2VWdNeDF4UjlHMDBHZENTb0RJQ1ZqYk1UNXpYNVd0N2VKSUU0blk0YTZYaEwxV1ppeFdGY082N3JKVUNoel9odklKcktsc1FNaU91WHhSRjVjN0hwc2pObDlrcW1LTV_SAd4BQVVfeXFMTUFwQ2dtdlotdkhxNVRuc0gwSnI4a19KQlE5bHRTLUdSMGIwNTRCV2RFY1ljNEx0OUx0R3dzR3AwUFBQR0hyRGtRTGpMUWprOS1KZWh2RllMU21acUlSTG82d2stU2dYLW1Bc3RTbV93WEk3UFo4YnBuSVBYbWt2MmM3M1pHblJHaElyODZSdG5kazZMajN0bGFVSTR2WmZZdi1venNnaUZ6akxuQ29NOGZiRXRkM3VoREVvSnhiU1ZLQnhVUGVwREdJVGVtYTRlSEd4MlBhVVFCMFlqZkJn?oc=5"" target=""_blank"">Biocon posts 39% fall in net profit Q2 even as biologics business booms</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",-0.9741950035095215,negative,0.9741950035095215,0.0,neutral,0.0,0.7003,0.172,0.0,0.828,0.0,0.0,-0.556682859148298,0.8372475017547607,other,0.0,[],False,True,6,0.0
2020-10-24,2020-10-24 07:00:00,"Biocon posts 22% fall in Q2 net profit on high R&D expenses, staff costs - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon posts 22% fall in Q2 net profit on high R&amp;D expenses, staff costs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Biocon posts 22% fall in Q2 net profit on high R&D expenses, staff costs - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon posts 22% fall in Q2 net profit on high R&amp;D expenses, staff costs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9737831354141235,negative,0.9737831354141235,0.0,neutral,0.0,0.7003,0.153,0.0,0.847,0.05333333333333334,0.18000000000000002,-0.5564475059509277,0.5758054895824856,other,0.0,[],False,True,6,0.0
2021-07-23,2021-07-23 07:00:00,Biocon net profit falls 35% to Rs 108 crore in Apr-Jun - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon net profit falls 35% to Rs 108 crore in Apr-Jun</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Biocon net profit falls 35% to Rs 108 crore in Apr-Jun - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon net profit falls 35% to Rs 108 crore in Apr-Jun</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",-0.970291793346405,negative,0.970291793346405,0.0,neutral,0.0,0.7003,0.182,0.0,0.818,0.0,0.0,-0.5544524533408028,0.8352958966732025,other,0.0,[],False,True,6,0.0
2021-01-22,2021-01-22 08:00:00,Biocon’s net profit falls 19% in December quarter - The Statesman,"<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxON2dYbnhoTDhDX1kwSXJjMFBQLV9IRm5WSXhKMU5RZGpWNVFDdVVrT2xNdlNQX0x6dlBUemdhLXdKYjF3M2UyeEp2UzcxQ3BzQnh6bXBDZFFKUGliaU5ONDdhU0M3NmdNYVVCcWFlQ3JzdjFpMmh1aWZhbzhqb1NoTlBlZURqOHRicGVZQ0dPNl81dFdzRFJXcG81ajJTazjSAaQBQVVfeXFMTUpEVHFWU20zTXpXVEk3UG5JY0NtYnotbm1IaVg5RW80MnctYmw5UVk1YUh4WkhNMjVqeTUzWTVPZkVHZWFUU2xFQmoyMndzdmdVOTFlcmJBeDVlbFlnVHdkUzltRXNXLTdKTldJejBXa1RjSFI5MnFuOFpHTjJyN0tZS1BWUlBrdmlFZ1VCdm1kNkxmNEV0X25KMFVIYll3Ti1MM00?oc=5"" target=""_blank"">Biocon’s net profit falls 19% in December quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxON2dYbnhoTDhDX1kwSXJjMFBQLV9IRm5WSXhKMU5RZGpWNVFDdVVrT2xNdlNQX0x6dlBUemdhLXdKYjF3M2UyeEp2UzcxQ3BzQnh6bXBDZFFKUGliaU5ONDdhU0M3NmdNYVVCcWFlQ3JzdjFpMmh1aWZhbzhqb1NoTlBlZURqOHRicGVZQ0dPNl81dFdzRFJXcG81ajJTazjSAaQBQVVfeXFMTUpEVHFWU20zTXpXVEk3UG5JY0NtYnotbm1IaVg5RW80MnctYmw5UVk1YUh4WkhNMjVqeTUzWTVPZkVHZWFUU2xFQmoyMndzdmdVOTFlcmJBeDVlbFlnVHdkUzltRXNXLTdKTldJejBXa1RjSFI5MnFuOFpHTjJyN0tZS1BWUlBrdmlFZ1VCdm1kNkxmNEV0X25KMFVIYll3Ti1MM00?oc=5,Google News,Biocon profit,"Biocon’s net profit falls 19% in December quarter - The Statesman <a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxON2dYbnhoTDhDX1kwSXJjMFBQLV9IRm5WSXhKMU5RZGpWNVFDdVVrT2xNdlNQX0x6dlBUemdhLXdKYjF3M2UyeEp2UzcxQ3BzQnh6bXBDZFFKUGliaU5ONDdhU0M3NmdNYVVCcWFlQ3JzdjFpMmh1aWZhbzhqb1NoTlBlZURqOHRicGVZQ0dPNl81dFdzRFJXcG81ajJTazjSAaQBQVVfeXFMTUpEVHFWU20zTXpXVEk3UG5JY0NtYnotbm1IaVg5RW80MnctYmw5UVk1YUh4WkhNMjVqeTUzWTVPZkVHZWFUU2xFQmoyMndzdmdVOTFlcmJBeDVlbFlnVHdkUzltRXNXLTdKTldJejBXa1RjSFI5MnFuOFpHTjJyN0tZS1BWUlBrdmlFZ1VCdm1kNkxmNEV0X25KMFVIYll3Ti1MM00?oc=5"" target=""_blank"">Biocon’s net profit falls 19% in December quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",-0.9707717895507812,negative,0.9707717895507812,0.0,neutral,0.0,0.7003,0.225,0.0,0.775,0.0,0.0,-0.5547267368861607,0.8355358947753906,other,0.0,[],False,True,6,0.0
2020-05-15,2020-05-15 07:00:00,Biocon shares slump over 4% as profit declines 42% in March quarter - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares slump over 4% as profit declines 42% in March quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Biocon shares slump over 4% as profit declines 42% in March quarter - Business Standard <a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxOaHV1Vktpd2daV3k0Wnp4VTlzemlXYzZldUsyQXlza3JVT2toSWFKV0hPbjBEZ2drS3pPNURTTFdldjlCVXRaYzVtQlJiMTRnWGVTSWNFUjhZWVJfU3A3R1VlMGFQdng0Zy1McGtvTC00RmJEQjVjWFlTZWhfQjV3aFR1bHNNUmtDMzdoZm16VkFicDl4dkliUERFR0hPWGtoaGxwRWVTNXpYamxldjl4VmFxdm9ETXVpUjZUVzJQWnl6eVprRC1MRDc3YS1IVmhi0gHWAUFVX3lxTFBZZUN2LVF0U3NuUEpIQ1Zhb1FaS1VTVk85a2RpRzdVNUdSX3A3Sk1qMVg2SVZxTS1Ybi1MZVB0b3c5SXBXNzRPWEJPZmM2bV92ZUh6dXVDdkg1SXNQSzhPbG9pSFlua2Q1eHE5UHZQQndLVi1qNFZrZWhhaVAwRE9ybzNSYXk0YlBpTkFlT2ZjdmY5WUxoRWxKdzBxSGFTMDNnQlJvTnc5TVloUzNNMGdxYkwwcWxhTEFDWHRXSlh2SmYzQVI4RFpjSms2cEstQm1yYWlIb1E?oc=5"" target=""_blank"">Biocon shares slump over 4% as profit declines 42% in March quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9703594446182251,negative,0.9703594446182251,0.0,neutral,0.0,0.8481,0.282,0.0,0.718,0.0,0.0,-0.5544911112104143,0.9092297223091126,other,0.0,[],False,True,6,0.0
2021-04-29,2021-04-29 07:00:00,Biocon Q4 results: Net profit surges 86 pc to Rs 296.4 cr - The Statesman,"<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxPelB6bmVJUmdReTEzcTh0X19UQUUzX0ctZVBHYUlGQ2dBYXdrRm1HNDlsUVFsTWV0VE9Tbk82R0VEUzlfZmpkcXA0cTlRdGt0aWx2VU5od1JYRE5TWGRCSUJPLVZDaHRWN1NhX01DcnZaOVAzazhSN2U0WThTWVRUd3paRjFvSjlEeXMzd1EtUFVuTGhMUm1TTU1IZnZ6cW41RzIyVVY4WVg0eDjSAbABQVVfeXFMTTN3Zmh5WlVZWE5WUEFhRDVPa013WWlOZ2pVb3VIandHamxVUnlhakxHcGFGMlMtZE9IMjR4UFNhYlR3Wl9iZVFlV0gzVEZIV2xaRHA0em5DZ3EzZXc3SjJVUjd4OExyUHR6WkxXT3YwblR3OUNQNTk5SGRYNjJpODBad2xVLTJOUVg3V29PXzE3VXNETE5RLXhKNkxyMzBFQWdaNnBaSUlSeFY4d1RDeFI?oc=5"" target=""_blank"">Biocon Q4 results: Net profit surges 86 pc to Rs 296.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxPelB6bmVJUmdReTEzcTh0X19UQUUzX0ctZVBHYUlGQ2dBYXdrRm1HNDlsUVFsTWV0VE9Tbk82R0VEUzlfZmpkcXA0cTlRdGt0aWx2VU5od1JYRE5TWGRCSUJPLVZDaHRWN1NhX01DcnZaOVAzazhSN2U0WThTWVRUd3paRjFvSjlEeXMzd1EtUFVuTGhMUm1TTU1IZnZ6cW41RzIyVVY4WVg0eDjSAbABQVVfeXFMTTN3Zmh5WlVZWE5WUEFhRDVPa013WWlOZ2pVb3VIandHamxVUnlhakxHcGFGMlMtZE9IMjR4UFNhYlR3Wl9iZVFlV0gzVEZIV2xaRHA0em5DZ3EzZXc3SjJVUjd4OExyUHR6WkxXT3YwblR3OUNQNTk5SGRYNjJpODBad2xVLTJOUVg3V29PXzE3VXNETE5RLXhKNkxyMzBFQWdaNnBaSUlSeFY4d1RDeFI?oc=5,Google News,Biocon profit,"Biocon Q4 results: Net profit surges 86 pc to Rs 296.4 cr - The Statesman <a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxPelB6bmVJUmdReTEzcTh0X19UQUUzX0ctZVBHYUlGQ2dBYXdrRm1HNDlsUVFsTWV0VE9Tbk82R0VEUzlfZmpkcXA0cTlRdGt0aWx2VU5od1JYRE5TWGRCSUJPLVZDaHRWN1NhX01DcnZaOVAzazhSN2U0WThTWVRUd3paRjFvSjlEeXMzd1EtUFVuTGhMUm1TTU1IZnZ6cW41RzIyVVY4WVg0eDjSAbABQVVfeXFMTTN3Zmh5WlVZWE5WUEFhRDVPa013WWlOZ2pVb3VIandHamxVUnlhakxHcGFGMlMtZE9IMjR4UFNhYlR3Wl9iZVFlV0gzVEZIV2xaRHA0em5DZ3EzZXc3SjJVUjd4OExyUHR6WkxXT3YwblR3OUNQNTk5SGRYNjJpODBad2xVLTJOUVg3V29PXzE3VXNETE5RLXhKNkxyMzBFQWdaNnBaSUlSeFY4d1RDeFI?oc=5"" target=""_blank"">Biocon Q4 results: Net profit surges 86 pc to Rs 296.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",0.9229081273078918,positive,0.9229081273078918,0.0,neutral,0.0,0.1531,0.157,0.141,0.703,0.0,0.0,0.5273760727473668,0.5380040636539459,other,0.0,[],False,True,6,0.0
2019-10-23,2019-10-23 07:00:00,Biocon Q2 net profit at Rs 216 crore - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxNa2gxZEh0QmI4cnlmNjR0UEp4WEVHWjVnakY5NktwV1JUSUxMaXVienYwUTZ6WUtvR09oYXowMFBwYXZnN3VCWGRpcGdkZFZhcjVQNjRHU0NGNmNCYTZvVV9Nck1BQU44TmhFSXk5M3FhWDNnQ21GX3NpaXBDT2VIcG1oMDRVNHJ5alHSAY8BQVVfeXFMTk9qM1JOWXc0d3o2alpKT1JjaWxCNTFKV1o2T1JyVkMzdkJtUWRsYkdFRXFDQlFCTXpvbjBMcFRacWJQT1VNQnRlRE5QOTd6MUlNODV2bzFpczF4cEF3ZGZESTNKek1qaHhpTGdWTzlUdFNrbFJFbUpzendQdU9zSDVqdEFSUXN1N0xRbkF5cUk?oc=5"" target=""_blank"">Biocon Q2 net profit at Rs 216 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxNa2gxZEh0QmI4cnlmNjR0UEp4WEVHWjVnakY5NktwV1JUSUxMaXVienYwUTZ6WUtvR09oYXowMFBwYXZnN3VCWGRpcGdkZFZhcjVQNjRHU0NGNmNCYTZvVV9Nck1BQU44TmhFSXk5M3FhWDNnQ21GX3NpaXBDT2VIcG1oMDRVNHJ5alHSAY8BQVVfeXFMTk9qM1JOWXc0d3o2alpKT1JjaWxCNTFKV1o2T1JyVkMzdkJtUWRsYkdFRXFDQlFCTXpvbjBMcFRacWJQT1VNQnRlRE5QOTd6MUlNODV2bzFpczF4cEF3ZGZESTNKek1qaHhpTGdWTzlUdFNrbFJFbUpzendQdU9zSDVqdEFSUXN1N0xRbkF5cUk?oc=5,Google News,Biocon profit,"Biocon Q2 net profit at Rs 216 crore - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxNa2gxZEh0QmI4cnlmNjR0UEp4WEVHWjVnakY5NktwV1JUSUxMaXVienYwUTZ6WUtvR09oYXowMFBwYXZnN3VCWGRpcGdkZFZhcjVQNjRHU0NGNmNCYTZvVV9Nck1BQU44TmhFSXk5M3FhWDNnQ21GX3NpaXBDT2VIcG1oMDRVNHJ5alHSAY8BQVVfeXFMTk9qM1JOWXc0d3o2alpKT1JjaWxCNTFKV1o2T1JyVkMzdkJtUWRsYkdFRXFDQlFCTXpvbjBMcFRacWJQT1VNQnRlRE5QOTd6MUlNODV2bzFpczF4cEF3ZGZESTNKek1qaHhpTGdWTzlUdFNrbFJFbUpzendQdU9zSDVqdEFSUXN1N0xRbkF5cUk?oc=5"" target=""_blank"">Biocon Q2 net profit at Rs 216 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.9152131676673889,0.0,neutral,0.0,0.7003,0.225,0.0,0.775,0.0,0.0,0.0,0.8077565838336944,other,0.0,[],False,True,6,0.0
2021-07-23,2021-07-23 07:00:00,Biocon Q1 net profit declines 35 pc to Rs 108.4 cr - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxPc3hTd0pmVWVxQjFacWp6bUlUaHJkR2EzX1FyN1R2aEpqbEtrRHR1cnRwcTU0QlZfU2VUeE56eTBDV2c5TUNSUmxXa1o1YlYzUE5vc2xhWmxnc0xXZ1ExdTZkVlRVT2pDUEFXZjE5MUtaNFp1SGFMM2w5YTU2WVVuOFY0aHJZcGhJNUJCOHN4LV9hcWhOSEdqc2lFME0wcVd3V1ItdDRPZVJSQzJGTkZ3?oc=5"" target=""_blank"">Biocon Q1 net profit declines 35 pc to Rs 108.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxPc3hTd0pmVWVxQjFacWp6bUlUaHJkR2EzX1FyN1R2aEpqbEtrRHR1cnRwcTU0QlZfU2VUeE56eTBDV2c5TUNSUmxXa1o1YlYzUE5vc2xhWmxnc0xXZ1ExdTZkVlRVT2pDUEFXZjE5MUtaNFp1SGFMM2w5YTU2WVVuOFY0aHJZcGhJNUJCOHN4LV9hcWhOSEdqc2lFME0wcVd3V1ItdDRPZVJSQzJGTkZ3?oc=5,Google News,Biocon profit,"Biocon Q1 net profit declines 35 pc to Rs 108.4 cr - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxPc3hTd0pmVWVxQjFacWp6bUlUaHJkR2EzX1FyN1R2aEpqbEtrRHR1cnRwcTU0QlZfU2VUeE56eTBDV2c5TUNSUmxXa1o1YlYzUE5vc2xhWmxnc0xXZ1ExdTZkVlRVT2pDUEFXZjE5MUtaNFp1SGFMM2w5YTU2WVVuOFY0aHJZcGhJNUJCOHN4LV9hcWhOSEdqc2lFME0wcVd3V1ItdDRPZVJSQzJGTkZ3?oc=5"" target=""_blank"">Biocon Q1 net profit declines 35 pc to Rs 108.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",-0.971390426158905,negative,0.971390426158905,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,0.0,0.0,-0.5550802435193744,0.8358452130794525,other,0.0,[],False,True,6,0.0
2020-09-05,2020-09-05 18:49:33,BOARD OF DIRECTORS - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiakFVX3lxTE5jNmRpOU5sZXBpOVRrcnd2V2dORUZYNWd4SzRTLWtlTktEQU5SaktFdnJfSlFfeDdSYUE3cDVzcE9MeThPeHZFVWtLejNGZElpNm85Rks5bjBXZFhkV2VGcTQyaXEtbU9IWlE?oc=5"" target=""_blank"">BOARD OF DIRECTORS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiakFVX3lxTE5jNmRpOU5sZXBpOVRrcnd2V2dORUZYNWd4SzRTLWtlTktEQU5SaktFdnJfSlFfeDdSYUE3cDVzcE9MeThPeHZFVWtLejNGZElpNm85Rks5bjBXZFhkV2VGcTQyaXEtbU9IWlE?oc=5,Google News,Biocon guidance,"BOARD OF DIRECTORS - Biocon <a href=""https://news.google.com/rss/articles/CBMiakFVX3lxTE5jNmRpOU5sZXBpOVRrcnd2V2dORUZYNWd4SzRTLWtlTktEQU5SaktFdnJfSlFfeDdSYUE3cDVzcE9MeThPeHZFVWtLejNGZElpNm85Rks5bjBXZFhkV2VGcTQyaXEtbU9IWlE?oc=5"" target=""_blank"">BOARD OF DIRECTORS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.0,neutral,0.9211488962173462,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9211488962173462,other,0.0,[],False,True,6,0.0
2021-08-10,2021-08-10 07:00:00,"Viatris shows no signs of growing pains in its 'trough year,' but one analyst has longer-term worries - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxPMVlkUEM2dUFkOHFydHhFdU1rMjF2UFJxaW9HLXJHYjZBV0RQQUh6azhnSWMxMWlBc0JxOVRtemZCOGhGQlNEZnRkMXV1MXRJSndCcUV0dlhaN2RYYmg5djZCTTA0Zlc1MWhaR0NQQ2JxOVBxa1NmSllza1BxMklEUFdJN0JXaEdHT2dNTEE1eHJVdlRtWmJpMVdnV2l6T2NYZTBZek5KVlJNckJFc1VmMGpB?oc=5"" target=""_blank"">Viatris shows no signs of growing pains in its 'trough year,' but one analyst has longer-term worries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxPMVlkUEM2dUFkOHFydHhFdU1rMjF2UFJxaW9HLXJHYjZBV0RQQUh6azhnSWMxMWlBc0JxOVRtemZCOGhGQlNEZnRkMXV1MXRJSndCcUV0dlhaN2RYYmg5djZCTTA0Zlc1MWhaR0NQQ2JxOVBxa1NmSllza1BxMklEUFdJN0JXaEdHT2dNTEE1eHJVdlRtWmJpMVdnV2l6T2NYZTBZek5KVlJNckJFc1VmMGpB?oc=5,Google News,Biocon guidance,"Viatris shows no signs of growing pains in its 'trough year,' but one analyst has longer-term worries - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxPMVlkUEM2dUFkOHFydHhFdU1rMjF2UFJxaW9HLXJHYjZBV0RQQUh6azhnSWMxMWlBc0JxOVRtemZCOGhGQlNEZnRkMXV1MXRJSndCcUV0dlhaN2RYYmg5djZCTTA0Zlc1MWhaR0NQQ2JxOVBxa1NmSllza1BxMklEUFdJN0JXaEdHT2dNTEE1eHJVdlRtWmJpMVdnV2l6T2NYZTBZek5KVlJNckJFc1VmMGpB?oc=5"" target=""_blank"">Viatris shows no signs of growing pains in its 'trough year,' but one analyst has longer-term worries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.9439606070518494,negative,0.9439606070518494,0.0,neutral,0.0,-0.8834,0.068,0.273,0.659,0.0,0.0,-0.5394060611724854,0.9136803035259247,other,0.0,[],False,False,1,0.0
2020-07-14,2020-07-14 05:36:45,Enhancing road verges to aid pollinator conservation: A review - ScienceDirect.com,"<a href=""https://news.google.com/rss/articles/CBMidkFVX3lxTE5hODJMb0poZE5kaXFTWnpCZnItX1ByYm5lUHBqSkhGeTFrbnRlUElrSDVzbmNIcldLdlZoaFZtdXpIbDdCWElidnduWTR0NE5TWjlzeXNBSS0yMk5fNzNxdlI4dUNjUkU3ek00bWd0cE9obFJmaHc?oc=5"" target=""_blank"">Enhancing road verges to aid pollinator conservation: A review</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ScienceDirect.com</font>",https://news.google.com/rss/articles/CBMidkFVX3lxTE5hODJMb0poZE5kaXFTWnpCZnItX1ByYm5lUHBqSkhGeTFrbnRlUElrSDVzbmNIcldLdlZoaFZtdXpIbDdCWElidnduWTR0NE5TWjlzeXNBSS0yMk5fNzNxdlI4dUNjUkU3ek00bWd0cE9obFJmaHc?oc=5,Google News,Biocon guidance,"Enhancing road verges to aid pollinator conservation: A review - ScienceDirect.com <a href=""https://news.google.com/rss/articles/CBMidkFVX3lxTE5hODJMb0poZE5kaXFTWnpCZnItX1ByYm5lUHBqSkhGeTFrbnRlUElrSDVzbmNIcldLdlZoaFZtdXpIbDdCWElidnduWTR0NE5TWjlzeXNBSS0yMk5fNzNxdlI4dUNjUkU3ek00bWd0cE9obFJmaHc?oc=5"" target=""_blank"">Enhancing road verges to aid pollinator conservation: A review</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ScienceDirect.com</font>",0.0,neutral,0.8576905131340027,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8576905131340027,other,0.0,[],False,False,1,0.0
2017-12-04,2017-12-04 12:26:00,Conservation social science: Understanding and integrating human dimensions to improve conservation - ScienceDirect.com,"<a href=""https://news.google.com/rss/articles/CBMidkFVX3lxTE1NeHhCUUI0M3NWY1RBUDlhQVZ4eFl2NDA1c2toMUNZRjVvMWFJeTlOTFktV0s0ZnVrT1M1Z2d1d1RaaktIaDE1N1ZEZkdwWE15ZjF1RGNFREF3VldmcEZvUVhmSHFxaXhIUlZtd2UxUGVNZFRDYXc?oc=5"" target=""_blank"">Conservation social science: Understanding and integrating human dimensions to improve conservation</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ScienceDirect.com</font>",https://news.google.com/rss/articles/CBMidkFVX3lxTE1NeHhCUUI0M3NWY1RBUDlhQVZ4eFl2NDA1c2toMUNZRjVvMWFJeTlOTFktV0s0ZnVrT1M1Z2d1d1RaaktIaDE1N1ZEZkdwWE15ZjF1RGNFREF3VldmcEZvUVhmSHFxaXhIUlZtd2UxUGVNZFRDYXc?oc=5,Google News,Biocon guidance,"Conservation social science: Understanding and integrating human dimensions to improve conservation - ScienceDirect.com <a href=""https://news.google.com/rss/articles/CBMidkFVX3lxTE1NeHhCUUI0M3NWY1RBUDlhQVZ4eFl2NDA1c2toMUNZRjVvMWFJeTlOTFktV0s0ZnVrT1M1Z2d1d1RaaktIaDE1N1ZEZkdwWE15ZjF1RGNFREF3VldmcEZvUVhmSHFxaXhIUlZtd2UxUGVNZFRDYXc?oc=5"" target=""_blank"">Conservation social science: Understanding and integrating human dimensions to improve conservation</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ScienceDirect.com</font>",0.0,neutral,0.7284125089645386,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,0.013333333333333332,0.06666666666666668,0.0,0.480681947432624,other,0.0,[],False,False,1,0.0
2020-01-31,2020-01-31 08:00:00,FiercePharmaAsia—Coronavirus drugs?; Sanofi Korea vaccine bribery probe; Novartis' China plan - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxNMnlHU2dzcXJLZ2hxYlNqU2REeFRTRUtFSGtEYk9kaVVfeFA4VUtGVXFQTHk5ZVItVHZhRFBzT3FSVm9JUDBhdTZBR2M4N3VfODYtY2RGZ1hjLThrdE5MWkNQdEpYUl9QZkYydjJfYlNPSDFFUzkzdVBxYm5aN0pKLXJWUFBieEJfVkN1UmtMbWFEZzY4bWEyQ1lJU0IxWTRrYVJkX1o3UTgxMkVoUGFHS1ZrbmVRWDJhNWJ5OXBtWXlEVWs?oc=5"" target=""_blank"">FiercePharmaAsia—Coronavirus drugs?; Sanofi Korea vaccine bribery probe; Novartis' China plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxNMnlHU2dzcXJLZ2hxYlNqU2REeFRTRUtFSGtEYk9kaVVfeFA4VUtGVXFQTHk5ZVItVHZhRFBzT3FSVm9JUDBhdTZBR2M4N3VfODYtY2RGZ1hjLThrdE5MWkNQdEpYUl9QZkYydjJfYlNPSDFFUzkzdVBxYm5aN0pKLXJWUFBieEJfVkN1UmtMbWFEZzY4bWEyQ1lJU0IxWTRrYVJkX1o3UTgxMkVoUGFHS1ZrbmVRWDJhNWJ5OXBtWXlEVWs?oc=5,Google News,Biocon guidance,"FiercePharmaAsia—Coronavirus drugs?; Sanofi Korea vaccine bribery probe; Novartis' China plan - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxNMnlHU2dzcXJLZ2hxYlNqU2REeFRTRUtFSGtEYk9kaVVfeFA4VUtGVXFQTHk5ZVItVHZhRFBzT3FSVm9JUDBhdTZBR2M4N3VfODYtY2RGZ1hjLThrdE5MWkNQdEpYUl9QZkYydjJfYlNPSDFFUzkzdVBxYm5aN0pKLXJWUFBieEJfVkN1UmtMbWFEZzY4bWEyQ1lJU0IxWTRrYVJkX1o3UTgxMkVoUGFHS1ZrbmVRWDJhNWJ5OXBtWXlEVWs?oc=5"" target=""_blank"">FiercePharmaAsia—Coronavirus drugs?; Sanofi Korea vaccine bribery probe; Novartis' China plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.7450486421585083,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7450486421585083,other,0.0,[],False,False,1,0.0
2021-10-05,2021-10-05 07:00:00,Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw - Medical Dialogues <a href=""https://news.google.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?oc=5"" target=""_blank"">Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",-0.5542773008346558,negative,0.5542773008346558,0.0,neutral,0.0,0.765,0.191,0.0,0.809,-0.25,0.45,-0.3167298861912318,0.523092433611552,other,0.0,[],False,True,6,0.0
2018-12-04,2018-12-04 08:00:00,Biocon Foundation revives and inaugurates Hebbagodi Lake - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxNOVpwZjF0cUk2ZjJjLTdacVdOcTdFVS1VaFZtSWdfWG5LVG12eTY1TUxUOW5WbG1yOFF2aWZVSGc4YWpvcnlGRWxjTWJadEhmUkZCd1hwZW9vc3dLMnFUbGhjektvQXp6XzlTd2FJZ3pXdXRmcVNDM1FBMklGZ3hsRkpzSVZuNndZSm0zSlZLRdIBlAFBVV95cUxNb1o3dXQ1TGxRcHljZXZlcHdjZTBlZ2NZZXpMdXA2UWRjRmYxWUJOVEt6VWxNZ2lfd2RLTjQxa3pka1E2bDNfY196NkZ6bHBUM1M0T3BOZVN1eEYxUl83WTJEdzRJM0E4cW5WellRaEZwbW0zYmZmdEplT1c2dTdzc1NjZkc5RGxJZHJFYzIzclNhUG53?oc=5"" target=""_blank"">Biocon Foundation revives and inaugurates Hebbagodi Lake</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMijwFBVV95cUxNOVpwZjF0cUk2ZjJjLTdacVdOcTdFVS1VaFZtSWdfWG5LVG12eTY1TUxUOW5WbG1yOFF2aWZVSGc4YWpvcnlGRWxjTWJadEhmUkZCd1hwZW9vc3dLMnFUbGhjektvQXp6XzlTd2FJZ3pXdXRmcVNDM1FBMklGZ3hsRkpzSVZuNndZSm0zSlZLRdIBlAFBVV95cUxNb1o3dXQ1TGxRcHljZXZlcHdjZTBlZ2NZZXpMdXA2UWRjRmYxWUJOVEt6VWxNZ2lfd2RLTjQxa3pka1E2bDNfY196NkZ6bHBUM1M0T3BOZVN1eEYxUl83WTJEdzRJM0E4cW5WellRaEZwbW0zYmZmdEplT1c2dTdzc1NjZkc5RGxJZHJFYzIzclNhUG53?oc=5,Google News,Biocon guidance,"Biocon Foundation revives and inaugurates Hebbagodi Lake - Express Pharma <a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxNOVpwZjF0cUk2ZjJjLTdacVdOcTdFVS1VaFZtSWdfWG5LVG12eTY1TUxUOW5WbG1yOFF2aWZVSGc4YWpvcnlGRWxjTWJadEhmUkZCd1hwZW9vc3dLMnFUbGhjektvQXp6XzlTd2FJZ3pXdXRmcVNDM1FBMklGZ3hsRkpzSVZuNndZSm0zSlZLRdIBlAFBVV95cUxNb1o3dXQ1TGxRcHljZXZlcHdjZTBlZ2NZZXpMdXA2UWRjRmYxWUJOVEt6VWxNZ2lfd2RLTjQxa3pka1E2bDNfY196NkZ6bHBUM1M0T3BOZVN1eEYxUl83WTJEdzRJM0E4cW5WellRaEZwbW0zYmZmdEplT1c2dTdzc1NjZkc5RGxJZHJFYzIzclNhUG53?oc=5"" target=""_blank"">Biocon Foundation revives and inaugurates Hebbagodi Lake</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.0,neutral,0.6259524822235107,0.0,neutral,0.0,0.6369,0.224,0.0,0.776,0.0,0.0,0.0,0.6314262411117554,other,0.0,[],False,True,6,0.0
2020-09-05,2020-09-05 18:51:28,BOARD OF DIRECTORS - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPWlU0Q1dfUmhJM3VySG1mTW83MjVYaWtxLURURWhicTlpd1JrX3lnZ0xxQlo4cFdZdWRfTHZpbXRGdFFlU2hJMnpvTXJYLWhKMVBGYW55R1gzcVlKbXotV0d0aXdpbTVuZGNWU0cxRV85WFR5RHk5MThBRHRyTWRYR1ktSWdVaUt5Qnc?oc=5"" target=""_blank"">BOARD OF DIRECTORS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxPWlU0Q1dfUmhJM3VySG1mTW83MjVYaWtxLURURWhicTlpd1JrX3lnZ0xxQlo4cFdZdWRfTHZpbXRGdFFlU2hJMnpvTXJYLWhKMVBGYW55R1gzcVlKbXotV0d0aXdpbTVuZGNWU0cxRV85WFR5RHk5MThBRHRyTWRYR1ktSWdVaUt5Qnc?oc=5,Google News,Biocon investor call,"BOARD OF DIRECTORS - Biocon <a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPWlU0Q1dfUmhJM3VySG1mTW83MjVYaWtxLURURWhicTlpd1JrX3lnZ0xxQlo4cFdZdWRfTHZpbXRGdFFlU2hJMnpvTXJYLWhKMVBGYW55R1gzcVlKbXotV0d0aXdpbTVuZGNWU0cxRV85WFR5RHk5MThBRHRyTWRYR1ktSWdVaUt5Qnc?oc=5"" target=""_blank"">BOARD OF DIRECTORS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.0,neutral,0.9211488962173462,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9211488962173462,other,0.0,[],False,True,6,0.0
2017-07-25,2017-07-25 07:00:00,Is Biocon undervalued? - Fortune India,"<a href=""https://news.google.com/rss/articles/CBMidkFVX3lxTE5ic2Fra2pqZE9RUzlKWHJQY0ducHZPZXQydjBHa29GdFMwWUduaHRTRnhOd29QTnV3RXJkRU5BZGFRYkt4SjNKVWduSVFZay1lZ0FZN01GMl9yYW9nUXZxbmxlU2Z1ZUM0bmZ0TWxJaENDbzhCQmfSAYMBQVVfeXFMUDZubEZfbnVRSVhpNjBTOEJVV0lXa0tSMEdzSFFWb25aOF95bFZhekxtWlFBQThnYzZ2aWdOQTM1d1d6Nkw0cnYwM2E4QUVNMVNoV1BQT0JrU2FEU0NVVEE1bmxkelh1VGZwdFdxYTFDaG4zY3lMdUhsVlFVQnRiR0Fsdmc?oc=5"" target=""_blank"">Is Biocon undervalued?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",https://news.google.com/rss/articles/CBMidkFVX3lxTE5ic2Fra2pqZE9RUzlKWHJQY0ducHZPZXQydjBHa29GdFMwWUduaHRTRnhOd29QTnV3RXJkRU5BZGFRYkt4SjNKVWduSVFZay1lZ0FZN01GMl9yYW9nUXZxbmxlU2Z1ZUM0bmZ0TWxJaENDbzhCQmfSAYMBQVVfeXFMUDZubEZfbnVRSVhpNjBTOEJVV0lXa0tSMEdzSFFWb25aOF95bFZhekxtWlFBQThnYzZ2aWdOQTM1d1d6Nkw0cnYwM2E4QUVNMVNoV1BQT0JrU2FEU0NVVEE1bmxkelh1VGZwdFdxYTFDaG4zY3lMdUhsVlFVQnRiR0Fsdmc?oc=5,Google News,Biocon investor call,"Is Biocon undervalued? - Fortune India <a href=""https://news.google.com/rss/articles/CBMidkFVX3lxTE5ic2Fra2pqZE9RUzlKWHJQY0ducHZPZXQydjBHa29GdFMwWUduaHRTRnhOd29QTnV3RXJkRU5BZGFRYkt4SjNKVWduSVFZay1lZ0FZN01GMl9yYW9nUXZxbmxlU2Z1ZUM0bmZ0TWxJaENDbzhCQmfSAYMBQVVfeXFMUDZubEZfbnVRSVhpNjBTOEJVV0lXa0tSMEdzSFFWb25aOF95bFZhekxtWlFBQThnYzZ2aWdOQTM1d1d6Nkw0cnYwM2E4QUVNMVNoV1BQT0JrU2FEU0NVVEE1bmxkelh1VGZwdFdxYTFDaG4zY3lMdUhsVlFVQnRiR0Fsdmc?oc=5"" target=""_blank"">Is Biocon undervalued?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",0.0,neutral,0.8774858713150024,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8774858713150024,other,0.0,[],False,True,6,0.0
2020-09-05,2020-09-05 18:48:34,Who we are - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiVkFVX3lxTE05cTFHX1J1UzBZZDF0OHpjXzZiVUJORVBXR2ZuSkxhYmNFYnlNdEd5eGpfa21hWjlJVXdudTVzdHJ4MmVuYndEdDRuUVNoS2FDWGtzMWhR?oc=5"" target=""_blank"">Who we are</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiVkFVX3lxTE05cTFHX1J1UzBZZDF0OHpjXzZiVUJORVBXR2ZuSkxhYmNFYnlNdEd5eGpfa21hWjlJVXdudTVzdHJ4MmVuYndEdDRuUVNoS2FDWGtzMWhR?oc=5,Google News,Biocon annual results,"Who we are - Biocon <a href=""https://news.google.com/rss/articles/CBMiVkFVX3lxTE05cTFHX1J1UzBZZDF0OHpjXzZiVUJORVBXR2ZuSkxhYmNFYnlNdEd5eGpfa21hWjlJVXdudTVzdHJ4MmVuYndEdDRuUVNoS2FDWGtzMWhR?oc=5"" target=""_blank"">Who we are</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.0,neutral,0.9248720407485962,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9248720407485962,other,0.0,[],False,True,6,0.0
2021-01-07,2021-01-07 08:00:00,Biocon Biologics valued at over $4 bn with ADQ investment - VCCircle,"<a href=""https://news.google.com/rss/articles/CBMiiAFBVV95cUxNU0xIeE8xWFhUSm1XSUxPWE9TbmNtV0FiUWRVYUQ0dC1Qa0pDcmZoVkVENDNvRGRyRkxKQ0xfVWRjRzhXRFpIcUZ5cFllNlJ5NkZMRVM2QkhBS2lRcXZmcEVCS19lNnMzY0t3U1EyM2w0U0xITmswNkYwVkZsTGxYSHpBTWZTbVkx?oc=5"" target=""_blank"">Biocon Biologics valued at over $4 bn with ADQ investment</a>&nbsp;&nbsp;<font color=""#6f6f6f"">VCCircle</font>",https://news.google.com/rss/articles/CBMiiAFBVV95cUxNU0xIeE8xWFhUSm1XSUxPWE9TbmNtV0FiUWRVYUQ0dC1Qa0pDcmZoVkVENDNvRGRyRkxKQ0xfVWRjRzhXRFpIcUZ5cFllNlJ5NkZMRVM2QkhBS2lRcXZmcEVCS19lNnMzY0t3U1EyM2w0U0xITmswNkYwVkZsTGxYSHpBTWZTbVkx?oc=5,Google News,Biocon annual results,"Biocon Biologics valued at over $4 bn with ADQ investment - VCCircle <a href=""https://news.google.com/rss/articles/CBMiiAFBVV95cUxNU0xIeE8xWFhUSm1XSUxPWE9TbmNtV0FiUWRVYUQ0dC1Qa0pDcmZoVkVENDNvRGRyRkxKQ0xfVWRjRzhXRFpIcUZ5cFllNlJ5NkZMRVM2QkhBS2lRcXZmcEVCS19lNnMzY0t3U1EyM2w0U0xITmswNkYwVkZsTGxYSHpBTWZTbVkx?oc=5"" target=""_blank"">Biocon Biologics valued at over $4 bn with ADQ investment</a>&nbsp;&nbsp;<font color=""#6f6f6f"">VCCircle</font>",0.0,neutral,0.6026789546012878,0.0,neutral,0.0,0.7003,0.209,0.0,0.791,0.0,0.0,0.0,0.6514894773006439,other,0.0,[],False,True,6,0.0
2021-03-19,2021-03-19 18:39:45,Biocon Ltd Stock Price: Biocon Share Price Today - India Infoline,"<a href=""https://news.google.com/rss/articles/CBMibEFVX3lxTE9LVV9laDdhUl9NV2dwNnZkeVRNWEdRdkhsYTl0Nk5PM0xIUGV3ZEdpNzdwQkx5UVlLMWw2ZlJtSU4xYjFONDFtSnZRaEtLMG5kbC1vUFVkLTdEVHFvYXBwVm1MZHdzeWQwQWc5cw?oc=5"" target=""_blank"">Biocon Ltd Stock Price: Biocon Share Price Today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Infoline</font>",https://news.google.com/rss/articles/CBMibEFVX3lxTE9LVV9laDdhUl9NV2dwNnZkeVRNWEdRdkhsYTl0Nk5PM0xIUGV3ZEdpNzdwQkx5UVlLMWw2ZlJtSU4xYjFONDFtSnZRaEtLMG5kbC1vUFVkLTdEVHFvYXBwVm1MZHdzeWQwQWc5cw?oc=5,Google News,Biocon annual results,"Biocon Ltd Stock Price: Biocon Share Price Today - India Infoline <a href=""https://news.google.com/rss/articles/CBMibEFVX3lxTE9LVV9laDdhUl9NV2dwNnZkeVRNWEdRdkhsYTl0Nk5PM0xIUGV3ZEdpNzdwQkx5UVlLMWw2ZlJtSU4xYjFONDFtSnZRaEtLMG5kbC1vUFVkLTdEVHFvYXBwVm1MZHdzeWQwQWc5cw?oc=5"" target=""_blank"">Biocon Ltd Stock Price: Biocon Share Price Today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Infoline</font>",0.0,neutral,0.9266384840011597,0.0,neutral,0.0,0.5267,0.18,0.0,0.82,0.0,0.0,0.0,0.7266692420005798,other,0.0,[],False,True,6,0.0
2020-02-25,2020-02-25 08:00:00,Newsbreak: Sale of Malaysian Bio-XCell’s facility to Biocon hits a snag - The Edge Malaysia,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPVWJ1ZXdyekFvVl83TUtpNU5aZWZuTTM2eGhsa0JkQWl5bVp3aHoybm55T2U5SmZMb1UzamZfRDU4YklRY2ZMT0drU3FITE5sSU53a2FYX0dhaXY3UWM3Mk5JQWZwV1NQTXRldC16ZDZ4TG1USDE4S2EtTmNEYzRfM2ppSHNsb2l1aXYzYzZLalpPaFRvTWFhdElwTlM?oc=5"" target=""_blank"">Newsbreak: Sale of Malaysian Bio-XCell’s facility to Biocon hits a snag</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Edge Malaysia</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxPVWJ1ZXdyekFvVl83TUtpNU5aZWZuTTM2eGhsa0JkQWl5bVp3aHoybm55T2U5SmZMb1UzamZfRDU4YklRY2ZMT0drU3FITE5sSU53a2FYX0dhaXY3UWM3Mk5JQWZwV1NQTXRldC16ZDZ4TG1USDE4S2EtTmNEYzRfM2ppSHNsb2l1aXYzYzZLalpPaFRvTWFhdElwTlM?oc=5,Google News,Biocon annual results,"Newsbreak: Sale of Malaysian Bio-XCell’s facility to Biocon hits a snag - The Edge Malaysia <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPVWJ1ZXdyekFvVl83TUtpNU5aZWZuTTM2eGhsa0JkQWl5bVp3aHoybm55T2U5SmZMb1UzamZfRDU4YklRY2ZMT0drU3FITE5sSU53a2FYX0dhaXY3UWM3Mk5JQWZwV1NQTXRldC16ZDZ4TG1USDE4S2EtTmNEYzRfM2ppSHNsb2l1aXYzYzZLalpPaFRvTWFhdElwTlM?oc=5"" target=""_blank"">Newsbreak: Sale of Malaysian Bio-XCell’s facility to Biocon hits a snag</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Edge Malaysia</font>",0.0,neutral,0.8897694945335388,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8897694945335388,other,0.0,[],False,True,6,0.0
2021-07-23,2021-07-23 07:00:00,Jubilant Pharmova posts Q1 consolidated net profit of Rs 160 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Jubilant Pharmova posts Q1 consolidated net profit of Rs 160 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"Jubilant Pharmova posts Q1 consolidated net profit of Rs 160 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Jubilant Pharmova posts Q1 consolidated net profit of Rs 160 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.5008594393730164,positive,0.5008594393730164,0.0,neutral,0.0,0.8689,0.282,0.0,0.718,0.0,0.0,0.28620539392743793,0.6848797196865082,other,0.0,[],False,False,1,0.0
2020-07-24,2020-07-24 07:00:00,Welspun India Q1 net falls 65% to Rs 53.75 crore on lower income - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Welspun India Q1 net falls 65% to Rs 53.75 crore on lower income</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"Welspun India Q1 net falls 65% to Rs 53.75 crore on lower income - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Welspun India Q1 net falls 65% to Rs 53.75 crore on lower income</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9703735709190369,negative,0.9703735709190369,0.0,neutral,0.0,-0.5267,0.0,0.128,0.872,0.0,0.0,-0.5544991833823067,0.7485367854595184,other,0.0,[],False,False,1,0.0
2020-07-24,2020-07-24 07:00:00,Biocon share price fall 3 pc on Q1FY21 numbers - The Statesman,"<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQQ1k0R29oSG5RVldIY2MyS2lGTkRLUTFzQnUxQVJJc3hVbHhIRzNMR2ZnT2xYNGRZd201V1JUdGcxMXg2Sl8zN01WZ01pRV85SzlVWWxwdlVPZC1Yd2tNeTJJejZwNDNVYmJ4Q3hxelBBMHVOZUR6amhPSTlkOHhBOC1WVGl2ZUtuZ3NONUtsR0o4SzBmbGs0cFJYU04yUdIBowFBVV95cUxQdWpiSVlIUHd1OHBzdmRYYzJESURHNlJUYU00X3JQSHlGTXpKTVl5YmlZZ0NKSy1EaFFfMnJxakR4ZTBaaUpWTVNSS21FSzZQS19RQTR6M2ViMjZxX3RQMkJYU3RHSklmUnB5YmRrek1Sa2FnQXlGYjJCb0dKM0ZjakNPTjlnV0pERjk1OTVoZG0yZjgzWkVrdWJSZmZOZk9aLUFj?oc=5"" target=""_blank"">Biocon share price fall 3 pc on Q1FY21 numbers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQQ1k0R29oSG5RVldIY2MyS2lGTkRLUTFzQnUxQVJJc3hVbHhIRzNMR2ZnT2xYNGRZd201V1JUdGcxMXg2Sl8zN01WZ01pRV85SzlVWWxwdlVPZC1Yd2tNeTJJejZwNDNVYmJ4Q3hxelBBMHVOZUR6amhPSTlkOHhBOC1WVGl2ZUtuZ3NONUtsR0o4SzBmbGs0cFJYU04yUdIBowFBVV95cUxQdWpiSVlIUHd1OHBzdmRYYzJESURHNlJUYU00X3JQSHlGTXpKTVl5YmlZZ0NKSy1EaFFfMnJxakR4ZTBaaUpWTVNSS21FSzZQS19RQTR6M2ViMjZxX3RQMkJYU3RHSklmUnB5YmRrek1Sa2FnQXlGYjJCb0dKM0ZjakNPTjlnV0pERjk1OTVoZG0yZjgzWkVrdWJSZmZOZk9aLUFj?oc=5,Google News,Biocon Q1 earnings,"Biocon share price fall 3 pc on Q1FY21 numbers - The Statesman <a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQQ1k0R29oSG5RVldIY2MyS2lGTkRLUTFzQnUxQVJJc3hVbHhIRzNMR2ZnT2xYNGRZd201V1JUdGcxMXg2Sl8zN01WZ01pRV85SzlVWWxwdlVPZC1Yd2tNeTJJejZwNDNVYmJ4Q3hxelBBMHVOZUR6amhPSTlkOHhBOC1WVGl2ZUtuZ3NONUtsR0o4SzBmbGs0cFJYU04yUdIBowFBVV95cUxQdWpiSVlIUHd1OHBzdmRYYzJESURHNlJUYU00X3JQSHlGTXpKTVl5YmlZZ0NKSy1EaFFfMnJxakR4ZTBaaUpWTVNSS21FSzZQS19RQTR6M2ViMjZxX3RQMkJYU3RHSklmUnB5YmRrek1Sa2FnQXlGYjJCb0dKM0ZjakNPTjlnV0pERjk1OTVoZG0yZjgzWkVrdWJSZmZOZk9aLUFj?oc=5"" target=""_blank"">Biocon share price fall 3 pc on Q1FY21 numbers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",-0.9472426772117615,negative,0.9472426772117615,0.0,neutral,0.0,0.5267,0.18,0.0,0.82,0.0,0.0,-0.5412815298352922,0.7369713386058807,other,0.0,[],False,True,6,0.0
2021-07-23,2021-07-23 07:00:00,Liquor firm United Spirits Q1 posts consolidate net profit at Rs 50 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Liquor firm United Spirits Q1 posts consolidate net profit at Rs 50 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"Liquor firm United Spirits Q1 posts consolidate net profit at Rs 50 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Liquor firm United Spirits Q1 posts consolidate net profit at Rs 50 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.7190176248550415,positive,0.7190176248550415,0.0,neutral,0.0,0.886,0.289,0.0,0.711,-0.06666666666666667,0.13333333333333333,0.41086721420288086,0.5572280971739028,other,0.0,[],False,False,1,0.0
2019-07-26,2019-07-26 07:00:00,"Sensex Today: Sensex ends 51 points higher, Nifty at 11,284; Bajaj Auto rises over 5% post result - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Sensex Today: Sensex ends 51 points higher, Nifty at 11,284; Bajaj Auto rises over 5% post result</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"Sensex Today: Sensex ends 51 points higher, Nifty at 11,284; Bajaj Auto rises over 5% post result - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Sensex Today: Sensex ends 51 points higher, Nifty at 11,284; Bajaj Auto rises over 5% post result</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.9206473231315613,positive,0.9206473231315613,0.0,neutral,0.0,0.6597,0.124,0.0,0.876,0.16666666666666666,0.3333333333333333,0.5260841846466064,0.5823379965994093,other,0.0,[],False,False,1,0.0
2021-08-10,2021-08-10 07:00:00,Kalyan Jewellers Q1 consolidated loss narrows to Rs 51 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Kalyan Jewellers Q1 consolidated loss narrows to Rs 51 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"Kalyan Jewellers Q1 consolidated loss narrows to Rs 51 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Kalyan Jewellers Q1 consolidated loss narrows to Rs 51 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9501411318778992,negative,0.9501411318778992,0.0,neutral,0.0,-0.5574,0.0,0.161,0.839,0.0,0.0,-0.5429377896445138,0.7537705659389495,other,0.0,[],False,False,1,0.0
2022-01-21,2022-01-21 08:00:00,Biocon Ltd shares surge over 2% after firm reports rise in Q3 net - Free Press Journal,"<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxPUk9ZVC1ubGpZdWFGZlNKLVJqelhsSVJNMHBzT1FFbjNkWG8wT2R2VVpCNmVOWW5aYTZ2cTd0S1pwNTBFbzlhNmlDTi1ZckQwTFdPQVZaZTJhNko5Y0w4ZGI3YWxmWDBpVnNTOEYtQVpXZ2NIa1h5YXNJc3JYWnZ1ZUM1Z1JhUk1DUk15YXNPZWpLcmQxUU1wRG5ZV1I2bktXdlRmNGVEMWLSAa4BQVVfeXFMUDRSN2pKLTJRTjNIUEpxQnMyNzZpY0dvSTdEOWEyejZnVzgwV09SOFdCTkhhb0FGNGxNUFh3UHVLTExhOHpTQkNuMnNabGJjV25PaFRJenR3eDB6QjNiTHA0QzJ2ZE5wY1RRb25ZNjBscVJVU3k5eFA0TGlGRk1RQmFBLVBzNDV3MUZ4VzN3Zk9jWTBCSlQ4TkNaSlJQdHVhbGlwUmtWSTllZlRvQ3lR?oc=5"" target=""_blank"">Biocon Ltd shares surge over 2% after firm reports rise in Q3 net</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxPUk9ZVC1ubGpZdWFGZlNKLVJqelhsSVJNMHBzT1FFbjNkWG8wT2R2VVpCNmVOWW5aYTZ2cTd0S1pwNTBFbzlhNmlDTi1ZckQwTFdPQVZaZTJhNko5Y0w4ZGI3YWxmWDBpVnNTOEYtQVpXZ2NIa1h5YXNJc3JYWnZ1ZUM1Z1JhUk1DUk15YXNPZWpLcmQxUU1wRG5ZV1I2bktXdlRmNGVEMWLSAa4BQVVfeXFMUDRSN2pKLTJRTjNIUEpxQnMyNzZpY0dvSTdEOWEyejZnVzgwV09SOFdCTkhhb0FGNGxNUFh3UHVLTExhOHpTQkNuMnNabGJjV25PaFRJenR3eDB6QjNiTHA0QzJ2ZE5wY1RRb25ZNjBscVJVU3k5eFA0TGlGRk1RQmFBLVBzNDV3MUZ4VzN3Zk9jWTBCSlQ4TkNaSlJQdHVhbGlwUmtWSTllZlRvQ3lR?oc=5,Google News,Biocon Q3 earnings,"Biocon Ltd shares surge over 2% after firm reports rise in Q3 net - Free Press Journal <a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxPUk9ZVC1ubGpZdWFGZlNKLVJqelhsSVJNMHBzT1FFbjNkWG8wT2R2VVpCNmVOWW5aYTZ2cTd0S1pwNTBFbzlhNmlDTi1ZckQwTFdPQVZaZTJhNko5Y0w4ZGI3YWxmWDBpVnNTOEYtQVpXZ2NIa1h5YXNJc3JYWnZ1ZUM1Z1JhUk1DUk15YXNPZWpLcmQxUU1wRG5ZV1I2bktXdlRmNGVEMWLSAa4BQVVfeXFMUDRSN2pKLTJRTjNIUEpxQnMyNzZpY0dvSTdEOWEyejZnVzgwV09SOFdCTkhhb0FGNGxNUFh3UHVLTExhOHpTQkNuMnNabGJjV25PaFRJenR3eDB6QjNiTHA0QzJ2ZE5wY1RRb25ZNjBscVJVU3k5eFA0TGlGRk1RQmFBLVBzNDV3MUZ4VzN3Zk9jWTBCSlQ4TkNaSlJQdHVhbGlwUmtWSTllZlRvQ3lR?oc=5"" target=""_blank"">Biocon Ltd shares surge over 2% after firm reports rise in Q3 net</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",0.9110409617424011,positive,0.9110409617424011,0.0,neutral,0.0,0.7717,0.199,0.0,0.801,0.0,0.32,0.5205948352813721,0.8413704808712006,other,0.0,[],False,True,6,0.0
2025-04-10,2025-04-10 07:00:00,FDA Approves Biocon Biologics' Bevacizumab Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxOLXg5SmhvUG5XNFdIOUhnbUZIaEgzSnZjR01VRlhRTzVrQnBNX2NpakRSZ2lLejRPWm1WaUM0TEhTTFh0Z0xSVEUtVnMxOTJZVWNhTVM0cExOM0ltUktxTGtBam9VX3A1V1lLdzVXRDlHU3BGSjl6dlozTEplUjRFTkNyVGY5X3V5Y0laRHA5TXljbGlfSHRiWmdB?oc=5"" target=""_blank"">FDA Approves Biocon Biologics' Bevacizumab Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxOLXg5SmhvUG5XNFdIOUhnbUZIaEgzSnZjR01VRlhRTzVrQnBNX2NpakRSZ2lLejRPWm1WaUM0TEhTTFh0Z0xSVEUtVnMxOTJZVWNhTVM0cExOM0ltUktxTGtBam9VX3A1V1lLdzVXRDlHU3BGSjl6dlozTEplUjRFTkNyVGY5X3V5Y0laRHA5TXljbGlfSHRiWmdB?oc=5,Google News,Biocon Semglee FDA approval,"FDA Approves Biocon Biologics' Bevacizumab Biosimilar - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxOLXg5SmhvUG5XNFdIOUhnbUZIaEgzSnZjR01VRlhRTzVrQnBNX2NpakRSZ2lLejRPWm1WaUM0TEhTTFh0Z0xSVEUtVnMxOTJZVWNhTVM0cExOM0ltUktxTGtBam9VX3A1V1lLdzVXRDlHU3BGSjl6dlozTEplUjRFTkNyVGY5X3V5Y0laRHA5TXljbGlfSHRiWmdB?oc=5"" target=""_blank"">FDA Approves Biocon Biologics' Bevacizumab Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.5271222591400146,0.0,neutral,0.0,0.6597,0.231,0.0,0.769,-0.05,0.05,0.0,0.4122740863800049,approval_process,0.8330743610858917,['FDA approval'],False,True,16,0.6661487221717834
2025-03-11,2025-03-11 07:00:00,Exploring FDA-approved biosimilar insulin products - TechTarget,"<a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxPZTRaVW1FUFQ5cHYzLUlaMFNlWjVCQ0VnanZFVEJJMHU0c2JsZEltM3FjUDhzalNhelJtUHh4UWxGaTU3ZUNkNkhSTW9YakttS0F0eGZERXNZcDdOQl94d2RvS1lKQWJHeTloUHUyS01kU0FqVDg2TWZhWWFPdzFLblFiYWtuQTNBV05RSmxscnYwWkdqM28zTFRKTmxEcEMwZ0V2dzh4WQ?oc=5"" target=""_blank"">Exploring FDA-approved biosimilar insulin products</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TechTarget</font>",https://news.google.com/rss/articles/CBMipwFBVV95cUxPZTRaVW1FUFQ5cHYzLUlaMFNlWjVCQ0VnanZFVEJJMHU0c2JsZEltM3FjUDhzalNhelJtUHh4UWxGaTU3ZUNkNkhSTW9YakttS0F0eGZERXNZcDdOQl94d2RvS1lKQWJHeTloUHUyS01kU0FqVDg2TWZhWWFPdzFLblFiYWtuQTNBV05RSmxscnYwWkdqM28zTFRKTmxEcEMwZ0V2dzh4WQ?oc=5,Google News,Biocon Semglee FDA approval,"Exploring FDA-approved biosimilar insulin products - TechTarget <a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxPZTRaVW1FUFQ5cHYzLUlaMFNlWjVCQ0VnanZFVEJJMHU0c2JsZEltM3FjUDhzalNhelJtUHh4UWxGaTU3ZUNkNkhSTW9YakttS0F0eGZERXNZcDdOQl94d2RvS1lKQWJHeTloUHUyS01kU0FqVDg2TWZhWWFPdzFLblFiYWtuQTNBV05RSmxscnYwWkdqM28zTFRKTmxEcEMwZ0V2dzh4WQ?oc=5"" target=""_blank"">Exploring FDA-approved biosimilar insulin products</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TechTarget</font>",0.0,neutral,0.8894971013069153,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8894971013069153,other,0.0,[],True,False,11,0.0
2023-01-12,2023-01-12 08:00:00,"FDA rejects Biocon insulin biosimilar over data, manufacturing concerns - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxONmphTnpGZUFmQkphZmdhLTIzaTNlNTZVRUhndTlfbnM2OU9Ta3ZXMGFoMVY2UGRVV0VoODFvSHVhLXJOaDBGMUtpLTVsOUh6c1pOMlZwVW1XcUlxVUZKSC05c3BPQzV3a2F1cl94SVZUb0VTdUxFcjczV1ZGbld4am5TVkVvVEhaanktSU5TLUZzZ1F2NmsxQ19VRk1Ldw?oc=5"" target=""_blank"">FDA rejects Biocon insulin biosimilar over data, manufacturing concerns</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxONmphTnpGZUFmQkphZmdhLTIzaTNlNTZVRUhndTlfbnM2OU9Ta3ZXMGFoMVY2UGRVV0VoODFvSHVhLXJOaDBGMUtpLTVsOUh6c1pOMlZwVW1XcUlxVUZKSC05c3BPQzV3a2F1cl94SVZUb0VTdUxFcjczV1ZGbld4am5TVkVvVEhaanktSU5TLUZzZ1F2NmsxQ19VRk1Ldw?oc=5,Google News,Biocon Semglee FDA approval,"FDA rejects Biocon insulin biosimilar over data, manufacturing concerns - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxONmphTnpGZUFmQkphZmdhLTIzaTNlNTZVRUhndTlfbnM2OU9Ta3ZXMGFoMVY2UGRVV0VoODFvSHVhLXJOaDBGMUtpLTVsOUh6c1pOMlZwVW1XcUlxVUZKSC05c3BPQzV3a2F1cl94SVZUb0VTdUxFcjczV1ZGbld4am5TVkVvVEhaanktSU5TLUZzZ1F2NmsxQ19VRk1Ldw?oc=5"" target=""_blank"">FDA rejects Biocon insulin biosimilar over data, manufacturing concerns</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.5697662234306335,negative,0.5697662234306335,0.0,neutral,0.0,-0.7506,0.0,0.225,0.775,0.0,0.0,-0.3255806991032192,0.6601831117153167,other,0.0,[],False,True,6,0.0
2022-02-28,2022-02-28 08:00:00,Viatris unloads biosimilar business to partner Biocon for $3.3B - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5"" target=""_blank"">Viatris unloads biosimilar business to partner Biocon for $3.3B</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5,Google News,Biocon Semglee FDA approval,"Viatris unloads biosimilar business to partner Biocon for $3.3B - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5"" target=""_blank"">Viatris unloads biosimilar business to partner Biocon for $3.3B</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.7530370354652405,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7530370354652405,other,0.0,[],False,True,6,0.0
2023-08-17,2023-08-17 07:00:00,"FDA again slams Biocon's troubled plant in Malaysia, citing 8 manufacturing shortfalls - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxPYlVISGJQWWNUeXZnbXV0c21ZUTRoRGpFcVp4LWlia0ViWXZjSHh4UnlhbXhDUDlnaVRfV2F6QTh0czUtTFlhc3RaWUdWS1BSdzhzejVCd3g4c2ZsbDJzY2VEcWdYUDBlVW9Pa2cxRFlqWUUzUENaTWhYSFZMd2pXdml0Z0JaNlVzMndaNVJiX2xOR0JzelhHUWFXemp5VTFNeWtlUlh6Wld4QlBRaTVJbA?oc=5"" target=""_blank"">FDA again slams Biocon's troubled plant in Malaysia, citing 8 manufacturing shortfalls</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxPYlVISGJQWWNUeXZnbXV0c21ZUTRoRGpFcVp4LWlia0ViWXZjSHh4UnlhbXhDUDlnaVRfV2F6QTh0czUtTFlhc3RaWUdWS1BSdzhzejVCd3g4c2ZsbDJzY2VEcWdYUDBlVW9Pa2cxRFlqWUUzUENaTWhYSFZMd2pXdml0Z0JaNlVzMndaNVJiX2xOR0JzelhHUWFXemp5VTFNeWtlUlh6Wld4QlBRaTVJbA?oc=5,Google News,Biocon Semglee FDA submission,"FDA again slams Biocon's troubled plant in Malaysia, citing 8 manufacturing shortfalls - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxPYlVISGJQWWNUeXZnbXV0c21ZUTRoRGpFcVp4LWlia0ViWXZjSHh4UnlhbXhDUDlnaVRfV2F6QTh0czUtTFlhc3RaWUdWS1BSdzhzejVCd3g4c2ZsbDJzY2VEcWdYUDBlVW9Pa2cxRFlqWUUzUENaTWhYSFZMd2pXdml0Z0JaNlVzMndaNVJiX2xOR0JzelhHUWFXemp5VTFNeWtlUlh6Wld4QlBRaTVJbA?oc=5"" target=""_blank"">FDA again slams Biocon's troubled plant in Malaysia, citing 8 manufacturing shortfalls</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.9552541375160217,negative,0.9552541375160217,0.0,neutral,0.0,-0.7184,0.0,0.188,0.812,-0.3333333333333333,0.6666666666666666,-0.5458595071520124,0.6689958236164517,other,0.0,[],False,True,6,0.0
2024-04-04,2024-04-04 07:00:00,Eye on Pharma: Biosimilar Ozempic; Celltrion Omalizumab Biosimilar Submission - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxPeTNpMHRoenZwaGZ6bWZQTHEzZm1PbllFczRSQmFyQUVfZUJETnZtZWZ6RVp4b2FPMHpkc2gtTFJOVzJOTDN5Q2RhUE45di1tMEhNcml5TGhHS3YtODJLYWpFeUZGeG9qNDUxX2QzOTdxVEJkRHVyYmZnNXRJaWxxamZndVQ5cjBWU1NDbGtHakprSWFFVEhIa0EwNVRCZHVJY2w4blI2eTNQUTc0M1Jwa3pzNnU4ODdtVXdlQVZtMkJuRmJMTVNkVXd5YW1GOWh3dHQ0?oc=5"" target=""_blank"">Eye on Pharma: Biosimilar Ozempic; Celltrion Omalizumab Biosimilar Submission</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMi0wFBVV95cUxPeTNpMHRoenZwaGZ6bWZQTHEzZm1PbllFczRSQmFyQUVfZUJETnZtZWZ6RVp4b2FPMHpkc2gtTFJOVzJOTDN5Q2RhUE45di1tMEhNcml5TGhHS3YtODJLYWpFeUZGeG9qNDUxX2QzOTdxVEJkRHVyYmZnNXRJaWxxamZndVQ5cjBWU1NDbGtHakprSWFFVEhIa0EwNVRCZHVJY2w4blI2eTNQUTc0M1Jwa3pzNnU4ODdtVXdlQVZtMkJuRmJMTVNkVXd5YW1GOWh3dHQ0?oc=5,Google News,Biocon Semglee FDA submission,"Eye on Pharma: Biosimilar Ozempic; Celltrion Omalizumab Biosimilar Submission - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxPeTNpMHRoenZwaGZ6bWZQTHEzZm1PbllFczRSQmFyQUVfZUJETnZtZWZ6RVp4b2FPMHpkc2gtTFJOVzJOTDN5Q2RhUE45di1tMEhNcml5TGhHS3YtODJLYWpFeUZGeG9qNDUxX2QzOTdxVEJkRHVyYmZnNXRJaWxxamZndVQ5cjBWU1NDbGtHakprSWFFVEhIa0EwNVRCZHVJY2w4blI2eTNQUTc0M1Jwa3pzNnU4ODdtVXdlQVZtMkJuRmJMTVNkVXd5YW1GOWh3dHQ0?oc=5"" target=""_blank"">Eye on Pharma: Biosimilar Ozempic; Celltrion Omalizumab Biosimilar Submission</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.9325511455535889,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.0,0.49127557277679446,application_phase,1.0,"['FDA submission', 'BLA submission', 'NDA submission']",False,False,9,0.49551036953926086
2023-11-21,2023-11-21 08:00:00,"With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxPYlFzNmxBdGVpOEk3cUo0RUM1RmJxTy1lLVNBVTJ2NnNNR3RPbG5FTllNUExNZUtJSmpTTExZYmtVMjYyVlVwX0ktd0NtOE1Pa1F2S1d1ZEZyenZFZ3pOQl95WG8taHhhTVlTR1Z6YkVUM21IenZsQ09wb3RFcTdaZ25ybXNvRHllcjF1OWYwN3hXNHJMNEtjc0ljMHB4RTVSU05uaVM3dXB1ZEV0ZnRSaHBySGtmVXRU?oc=5"" target=""_blank"">With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxPYlFzNmxBdGVpOEk3cUo0RUM1RmJxTy1lLVNBVTJ2NnNNR3RPbG5FTllNUExNZUtJSmpTTExZYmtVMjYyVlVwX0ktd0NtOE1Pa1F2S1d1ZEZyenZFZ3pOQl95WG8taHhhTVlTR1Z6YkVUM21IenZsQ09wb3RFcTdaZ25ybXNvRHllcjF1OWYwN3hXNHJMNEtjc0ljMHB4RTVSU05uaVM3dXB1ZEV0ZnRSaHBySGtmVXRU?oc=5,Google News,Biocon Semglee FDA submission,"With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxPYlFzNmxBdGVpOEk3cUo0RUM1RmJxTy1lLVNBVTJ2NnNNR3RPbG5FTllNUExNZUtJSmpTTExZYmtVMjYyVlVwX0ktd0NtOE1Pa1F2S1d1ZEZyenZFZ3pOQl95WG8taHhhTVlTR1Z6YkVUM21IenZsQ09wb3RFcTdaZ25ybXNvRHllcjF1OWYwN3hXNHJMNEtjc0ljMHB4RTVSU05uaVM3dXB1ZEV0ZnRSaHBySGtmVXRU?oc=5"" target=""_blank"">With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.49434736371040344,0.0,neutral,0.0,-0.4215,0.0,0.095,0.905,0.0,0.0,0.0,0.4579236818552017,other,0.0,[],False,False,1,0.0
2023-09-19,2023-09-19 07:00:00,First Interchangeable Biosimilar to Insulin Found Noninferior Insulin Glargine for Diabetes - Pharmacy Times,"<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxQRms4Rm1SQ0hZRVRaRFdEVVdwdHIxT1hwRkJuYk9oRTlpbmVWcmVBd3NTRmxpeXdVTUV3elVudTl5R2lPMGgyTWpBcmNPNXRzLWVEM2lJOHBXbzYyNXF3UFgwSHpqQmNKaDdJSDdiZTA0R3UtcWhxa0xSYWtNVWpqa2NEQzE0OGRHZUY0a2VVczlINDhnRFhnN0hBQjdqd0Z0cVpZMkxWY05CNFlYUjFoYjVheGFxS3FNTGJ3ZVY3dVFMTUVT?oc=5"" target=""_blank"">First Interchangeable Biosimilar to Insulin Found Noninferior Insulin Glargine for Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmacy Times</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxQRms4Rm1SQ0hZRVRaRFdEVVdwdHIxT1hwRkJuYk9oRTlpbmVWcmVBd3NTRmxpeXdVTUV3elVudTl5R2lPMGgyTWpBcmNPNXRzLWVEM2lJOHBXbzYyNXF3UFgwSHpqQmNKaDdJSDdiZTA0R3UtcWhxa0xSYWtNVWpqa2NEQzE0OGRHZUY0a2VVczlINDhnRFhnN0hBQjdqd0Z0cVpZMkxWY05CNFlYUjFoYjVheGFxS3FNTGJ3ZVY3dVFMTUVT?oc=5,Google News,Biocon Semglee clinical trial,"First Interchangeable Biosimilar to Insulin Found Noninferior Insulin Glargine for Diabetes - Pharmacy Times <a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxQRms4Rm1SQ0hZRVRaRFdEVVdwdHIxT1hwRkJuYk9oRTlpbmVWcmVBd3NTRmxpeXdVTUV3elVudTl5R2lPMGgyTWpBcmNPNXRzLWVEM2lJOHBXbzYyNXF3UFgwSHpqQmNKaDdJSDdiZTA0R3UtcWhxa0xSYWtNVWpqa2NEQzE0OGRHZUY0a2VVczlINDhnRFhnN0hBQjdqd0Z0cVpZMkxWY05CNFlYUjFoYjVheGFxS3FNTGJ3ZVY3dVFMTUVT?oc=5"" target=""_blank"">First Interchangeable Biosimilar to Insulin Found Noninferior Insulin Glargine for Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmacy Times</font>",0.0,neutral,0.6052965521812439,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.125,0.16666666666666666,0.0,0.36514827609062195,other,0.0,[],False,False,1,0.0
2023-06-01,2023-06-01 07:00:00,Biosimilars Are Not Having a Big Impact on Insulin Prices - Drug Topics,"<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNakN1U0NiMERCdmctMzdSWC1jNEROZERiX19zYTh5eHBndVdzb3A5R1VVY1VnZ2NMT2Frb25SQ0pBb0tlVy1STTB2Nk9yN1pVeFZfWFREWWQ0RXQxQ0t5Y3U4SWNBVlg5VV9oMU1HaGpVUnVtRFBUeEpJaUl3dHpxTWcyVEE3WkNidlJUZ1pYbDMzb0k?oc=5"" target=""_blank"">Biosimilars Are Not Having a Big Impact on Insulin Prices</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Topics</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxNakN1U0NiMERCdmctMzdSWC1jNEROZERiX19zYTh5eHBndVdzb3A5R1VVY1VnZ2NMT2Frb25SQ0pBb0tlVy1STTB2Nk9yN1pVeFZfWFREWWQ0RXQxQ0t5Y3U4SWNBVlg5VV9oMU1HaGpVUnVtRFBUeEpJaUl3dHpxTWcyVEE3WkNidlJUZ1pYbDMzb0k?oc=5,Google News,Biocon Semglee clinical trial,"Biosimilars Are Not Having a Big Impact on Insulin Prices - Drug Topics <a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNakN1U0NiMERCdmctMzdSWC1jNEROZERiX19zYTh5eHBndVdzb3A5R1VVY1VnZ2NMT2Frb25SQ0pBb0tlVy1STTB2Nk9yN1pVeFZfWFREWWQ0RXQxQ0t5Y3U4SWNBVlg5VV9oMU1HaGpVUnVtRFBUeEpJaUl3dHpxTWcyVEE3WkNidlJUZ1pYbDMzb0k?oc=5"" target=""_blank"">Biosimilars Are Not Having a Big Impact on Insulin Prices</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Topics</font>",0.0,neutral,0.8329055905342102,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.06666666666666667,0.0,0.8329055905342102,other,0.0,[],False,False,1,0.0
2022-11-18,2022-11-18 08:00:00,FDA approves Rezvoglar as second ‘interchangeable’ insulin biosimilar - BioPharma Dive,"<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQdDlLRjh5NkZkdF9pZl9PODg2cDA1NXZoWGxRUjNlNEdkV0toQnFrS2h5MllSeWk0cjZHTjk1T2VFeU1JWTdNV3lhMzNpOXl6TXZ6dVRMcnRSRzVJSEdibjluTF9QamVlQlZBcDdzcVFBZTlpUVRQM3VIWG9WS19sdzNJOUNBLTFqYkxuYXZJMXMwQ1FSb0E2RjRrTQ?oc=5"" target=""_blank"">FDA approves Rezvoglar as second ‘interchangeable’ insulin biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioPharma Dive</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxQdDlLRjh5NkZkdF9pZl9PODg2cDA1NXZoWGxRUjNlNEdkV0toQnFrS2h5MllSeWk0cjZHTjk1T2VFeU1JWTdNV3lhMzNpOXl6TXZ6dVRMcnRSRzVJSEdibjluTF9QamVlQlZBcDdzcVFBZTlpUVRQM3VIWG9WS19sdzNJOUNBLTFqYkxuYXZJMXMwQ1FSb0E2RjRrTQ?oc=5,Google News,Biocon Semglee clinical trial,"FDA approves Rezvoglar as second ‘interchangeable’ insulin biosimilar - BioPharma Dive <a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQdDlLRjh5NkZkdF9pZl9PODg2cDA1NXZoWGxRUjNlNEdkV0toQnFrS2h5MllSeWk0cjZHTjk1T2VFeU1JWTdNV3lhMzNpOXl6TXZ6dVRMcnRSRzVJSEdibjluTF9QamVlQlZBcDdzcVFBZTlpUVRQM3VIWG9WS19sdzNJOUNBLTFqYkxuYXZJMXMwQ1FSb0E2RjRrTQ?oc=5"" target=""_blank"">FDA approves Rezvoglar as second ‘interchangeable’ insulin biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioPharma Dive</font>",0.643006443977356,positive,0.643006443977356,0.0,neutral,0.0,0.6597,0.213,0.0,0.787,0.0,0.0,0.36743225370134625,0.651353221988678,approval_process,0.7571117877960205,['FDA approval'],False,False,11,0.514223575592041
2024-02-08,2024-02-08 08:00:00,"Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5"" target=""_blank"">Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5,Google News,Biocon Semglee clinical trial,"Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5"" target=""_blank"">Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.952604353427887,positive,0.952604353427887,0.0,neutral,0.0,0.2023,0.07,0.06,0.87,0.0,0.0,0.5443453448159354,0.5774521767139434,other,0.0,[],False,True,6,0.0
2023-07-30,2023-07-30 07:00:00,Why Are Companies Launching Biosimilars With 2 Prices? Julie Reed Explains - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNQ255dk9GZmNIdGxGOXU5TkV4NjhjMTlMakFETVFfdlhjU2cxVHRHVEJVbXhXaUQ4d1FaNk5OUGdMMUYybW9GWHhmcXp3WHRVdVNmb1JLWkZxVTVkczdFQUZHcWE3a1pKeFlFUmh6NkZlV280c0ZET0c4YzFDZkVGbllZQ1oyZ3R1SVN1TzVQVUZaRWozdk9fVUt3dmc4RjNFdm1XVFptUmVMb1prcEw1UnlPeS1EUQ?oc=5"" target=""_blank"">Why Are Companies Launching Biosimilars With 2 Prices? Julie Reed Explains</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNQ255dk9GZmNIdGxGOXU5TkV4NjhjMTlMakFETVFfdlhjU2cxVHRHVEJVbXhXaUQ4d1FaNk5OUGdMMUYybW9GWHhmcXp3WHRVdVNmb1JLWkZxVTVkczdFQUZHcWE3a1pKeFlFUmh6NkZlV280c0ZET0c4YzFDZkVGbllZQ1oyZ3R1SVN1TzVQVUZaRWozdk9fVUt3dmc4RjNFdm1XVFptUmVMb1prcEw1UnlPeS1EUQ?oc=5,Google News,Biocon Semglee clinical trial,"Why Are Companies Launching Biosimilars With 2 Prices? Julie Reed Explains - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNQ255dk9GZmNIdGxGOXU5TkV4NjhjMTlMakFETVFfdlhjU2cxVHRHVEJVbXhXaUQ4d1FaNk5OUGdMMUYybW9GWHhmcXp3WHRVdVNmb1JLWkZxVTVkczdFQUZHcWE3a1pKeFlFUmh6NkZlV280c0ZET0c4YzFDZkVGbllZQ1oyZ3R1SVN1TzVQVUZaRWozdk9fVUt3dmc4RjNFdm1XVFptUmVMb1prcEw1UnlPeS1EUQ?oc=5"" target=""_blank"">Why Are Companies Launching Biosimilars With 2 Prices? Julie Reed Explains</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.9413663744926453,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.0,0.49568318724632265,other,0.0,[],False,False,1,0.0
2025-03-23,2025-03-23 10:45:06,FDA declines to approve Biocon's biosimilar insulin product - FirstWord Pharma,"<a href=""https://news.google.com/rss/articles/CBMiU0FVX3lxTE5ya1NrTmZCUHpQX2k3TU5JcHBTcHBNbFV5d1dIVGpsc0xGc2U5RXo0X1NCb2FBYzQ1T1FNa2pNZWVydkdHWjdYUzdZclVmbW4ySEdZ?oc=5"" target=""_blank"">FDA declines to approve Biocon's biosimilar insulin product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">FirstWord Pharma</font>",https://news.google.com/rss/articles/CBMiU0FVX3lxTE5ya1NrTmZCUHpQX2k3TU5JcHBTcHBNbFV5d1dIVGpsc0xGc2U5RXo0X1NCb2FBYzQ1T1FNa2pNZWVydkdHWjdYUzdZclVmbW4ySEdZ?oc=5,Google News,Biocon insulin glargine-yfgn FDA,"FDA declines to approve Biocon's biosimilar insulin product - FirstWord Pharma <a href=""https://news.google.com/rss/articles/CBMiU0FVX3lxTE5ya1NrTmZCUHpQX2k3TU5JcHBTcHBNbFV5d1dIVGpsc0xGc2U5RXo0X1NCb2FBYzQ1T1FNa2pNZWVydkdHWjdYUzdZclVmbW4ySEdZ?oc=5"" target=""_blank"">FDA declines to approve Biocon's biosimilar insulin product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">FirstWord Pharma</font>",-0.8526067137718201,negative,0.8526067137718201,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.48720383644104004,0.8526067137718201,other,0.0,[],True,True,16,0.0
2025-02-18,2025-02-18 08:00:00,"FDA signs off on Sanofi's insulin biosimilar, the first for Novo Nordisk's rapid-acting NovoLog - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNnJEU3B0VDBCSWY1SEtJWFVSNzM3QUlmd2RVRExYb0lfTXVmdURVaV9hb08zLWVTZ0VtTWh3ZV9TQzVmeDdaMVcyekFhcEFnVWk3QXdKeHJDa3FhejR6a3dTaWVwdG1tYXFfWlpmaGRBTllWWkhSd1c2eEhheGprUk1fVk9xcmVyWWIxYXJISUpZN2dpWWpKWmhNczNveGVHN0pOMUtmZEs?oc=5"" target=""_blank"">FDA signs off on Sanofi's insulin biosimilar, the first for Novo Nordisk's rapid-acting NovoLog</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNnJEU3B0VDBCSWY1SEtJWFVSNzM3QUlmd2RVRExYb0lfTXVmdURVaV9hb08zLWVTZ0VtTWh3ZV9TQzVmeDdaMVcyekFhcEFnVWk3QXdKeHJDa3FhejR6a3dTaWVwdG1tYXFfWlpmaGRBTllWWkhSd1c2eEhheGprUk1fVk9xcmVyWWIxYXJISUpZN2dpWWpKWmhNczNveGVHN0pOMUtmZEs?oc=5,Google News,Biocon insulin glargine-yfgn FDA,"FDA signs off on Sanofi's insulin biosimilar, the first for Novo Nordisk's rapid-acting NovoLog - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxPNnJEU3B0VDBCSWY1SEtJWFVSNzM3QUlmd2RVRExYb0lfTXVmdURVaV9hb08zLWVTZ0VtTWh3ZV9TQzVmeDdaMVcyekFhcEFnVWk3QXdKeHJDa3FhejR6a3dTaWVwdG1tYXFfWlpmaGRBTllWWkhSd1c2eEhheGprUk1fVk9xcmVyWWIxYXJISUpZN2dpWWpKWmhNczNveGVHN0pOMUtmZEs?oc=5"" target=""_blank"">FDA signs off on Sanofi's insulin biosimilar, the first for Novo Nordisk's rapid-acting NovoLog</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.7515958547592163,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.16666666666666666,0.2222222222222222,0.0,0.45913126071294147,other,0.0,[],False,False,1,0.0
2025-02-17,2025-02-17 08:00:00,Sanofi Leapfrogs Biocon To Land First US Rapid-Acting Insulin Biosimilar - insights.citeline.com,"<a href=""https://news.google.com/rss/articles/CBMi_gFBVV95cUxQVVRWUVRHVjVfYy1pRXNlQ3RrVjAyMWNFM3ZoWkFHYU5rekU2dU1KSmhhTXFkeDZVTlZZVWZhdnNPQ19hZWhfNTBES1pZaGt3cXZlMThJNWo2X2RhX0YxY3B4VVdjV256Y1NwaWRpcjROdkV5cERWTEpkUVMwQjlWYkw3Z2J4ZU5JMnV4SVd1Q2FyWVE4TG95bWxVamUwUlF4eFNsWU5lSDY5ZjBRS1pWS0F6ZHRlNVdzMldPOTNkN0ZZQmNvQ2x0dlRicXc3Mk1DS24zVVFfcW0wMFBUUU80YzFMYkdWN0ZaMDZReVdSZ2g2NWpZbzQxTk1xMkNnUQ?oc=5"" target=""_blank"">Sanofi Leapfrogs Biocon To Land First US Rapid-Acting Insulin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">insights.citeline.com</font>",https://news.google.com/rss/articles/CBMi_gFBVV95cUxQVVRWUVRHVjVfYy1pRXNlQ3RrVjAyMWNFM3ZoWkFHYU5rekU2dU1KSmhhTXFkeDZVTlZZVWZhdnNPQ19hZWhfNTBES1pZaGt3cXZlMThJNWo2X2RhX0YxY3B4VVdjV256Y1NwaWRpcjROdkV5cERWTEpkUVMwQjlWYkw3Z2J4ZU5JMnV4SVd1Q2FyWVE4TG95bWxVamUwUlF4eFNsWU5lSDY5ZjBRS1pWS0F6ZHRlNVdzMldPOTNkN0ZZQmNvQ2x0dlRicXc3Mk1DS24zVVFfcW0wMFBUUU80YzFMYkdWN0ZaMDZReVdSZ2g2NWpZbzQxTk1xMkNnUQ?oc=5,Google News,Biocon insulin biosimilar FDA,"Sanofi Leapfrogs Biocon To Land First US Rapid-Acting Insulin Biosimilar - insights.citeline.com <a href=""https://news.google.com/rss/articles/CBMi_gFBVV95cUxQVVRWUVRHVjVfYy1pRXNlQ3RrVjAyMWNFM3ZoWkFHYU5rekU2dU1KSmhhTXFkeDZVTlZZVWZhdnNPQ19hZWhfNTBES1pZaGt3cXZlMThJNWo2X2RhX0YxY3B4VVdjV256Y1NwaWRpcjROdkV5cERWTEpkUVMwQjlWYkw3Z2J4ZU5JMnV4SVd1Q2FyWVE4TG95bWxVamUwUlF4eFNsWU5lSDY5ZjBRS1pWS0F6ZHRlNVdzMldPOTNkN0ZZQmNvQ2x0dlRicXc3Mk1DS24zVVFfcW0wMFBUUU80YzFMYkdWN0ZaMDZReVdSZ2g2NWpZbzQxTk1xMkNnUQ?oc=5"" target=""_blank"">Sanofi Leapfrogs Biocon To Land First US Rapid-Acting Insulin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">insights.citeline.com</font>",0.0,neutral,0.5246836543083191,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.16666666666666666,0.2222222222222222,0.0,0.34567516048749286,other,0.0,[],False,True,6,0.0
2024-02-29,2024-02-29 12:35:59,FDA hits Biocon insulin biosimilar with another CRL - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxPQ3NaT2g3Y0RhVFl5TWRtNXJ5YW9PcmstUVpqcFpLNHVxZWlqZEZwZ25kd3RtMlpWV2JMUHBVUkZrOWVoS0tMU0lBSjBQZVZKcHozdXk1bFRFSWpwWHdRLXhRanl0RV9xYjJHZkktb1ltelI5dEY1Um9mSXVpM21YRmtHaEpTTUplbmtPQWRSU3pBZFNsUzhsMFJR?oc=5"" target=""_blank"">FDA hits Biocon insulin biosimilar with another CRL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxPQ3NaT2g3Y0RhVFl5TWRtNXJ5YW9PcmstUVpqcFpLNHVxZWlqZEZwZ25kd3RtMlpWV2JMUHBVUkZrOWVoS0tMU0lBSjBQZVZKcHozdXk1bFRFSWpwWHdRLXhRanl0RV9xYjJHZkktb1ltelI5dEY1Um9mSXVpM21YRmtHaEpTTUplbmtPQWRSU3pBZFNsUzhsMFJR?oc=5,Google News,Biocon insulin biosimilar FDA,"FDA hits Biocon insulin biosimilar with another CRL - BioProcess International <a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxPQ3NaT2g3Y0RhVFl5TWRtNXJ5YW9PcmstUVpqcFpLNHVxZWlqZEZwZ25kd3RtMlpWV2JMUHBVUkZrOWVoS0tMU0lBSjBQZVZKcHozdXk1bFRFSWpwWHdRLXhRanl0RV9xYjJHZkktb1ltelI5dEY1Um9mSXVpM21YRmtHaEpTTUplbmtPQWRSU3pBZFNsUzhsMFJR?oc=5"" target=""_blank"">FDA hits Biocon insulin biosimilar with another CRL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",0.0,neutral,0.5056241750717163,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.5056241750717163,other,0.0,[],False,True,6,0.0
2025-04-10,2025-04-10 07:00:00,"Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE - Express Pharma","<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxOczFIemVhMFg4bFNuUVZVb2pFb1FpZ1U2N0xzOE90bXhhOWdIYzFpZDNhUWVrZ2p2QU9WdUJ2czRxTjhpTFJDUGcxWmtRS3pTdVgzbzNWSzE0azc0OW9EejUwRWtFWURMTjU0elhKek1iX1hCX3ZzVHotd0pUV2FXckh4TGpTY2MwamxsMTRFYzdWaGwwMzc3WFdPXy1oVjJxSW9FNHAzSkvSAa4BQVVfeXFMUEhYYklLRFBhRW9sMmNrdDhQVnJkc0Jnc01SQ0VfRWMtR01aZENKOUJ0UkZyXzJOcEo4MkswVHZsdEQzMmljTlZJQkVSVFkwMWtvVm5vUmpTMUdrUFR3a21SVEZBZU9GdTVQcGZMZFJIU0NuSEREdVItc0NlM3lNU2NWY2s2MTdJYW9lUlB3LWJCY1ZRLVg0bk9feUdCMkhUdmcxVmQ0Q0licGM3UTJn?oc=5"" target=""_blank"">Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxOczFIemVhMFg4bFNuUVZVb2pFb1FpZ1U2N0xzOE90bXhhOWdIYzFpZDNhUWVrZ2p2QU9WdUJ2czRxTjhpTFJDUGcxWmtRS3pTdVgzbzNWSzE0azc0OW9EejUwRWtFWURMTjU0elhKek1iX1hCX3ZzVHotd0pUV2FXckh4TGpTY2MwamxsMTRFYzdWaGwwMzc3WFdPXy1oVjJxSW9FNHAzSkvSAa4BQVVfeXFMUEhYYklLRFBhRW9sMmNrdDhQVnJkc0Jnc01SQ0VfRWMtR01aZENKOUJ0UkZyXzJOcEo4MkswVHZsdEQzMmljTlZJQkVSVFkwMWtvVm5vUmpTMUdrUFR3a21SVEZBZU9GdTVQcGZMZFJIU0NuSEREdVItc0NlM3lNU2NWY2s2MTdJYW9lUlB3LWJCY1ZRLVg0bk9feUdCMkhUdmcxVmQ0Q0licGM3UTJn?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE - Express Pharma <a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxOczFIemVhMFg4bFNuUVZVb2pFb1FpZ1U2N0xzOE90bXhhOWdIYzFpZDNhUWVrZ2p2QU9WdUJ2czRxTjhpTFJDUGcxWmtRS3pTdVgzbzNWSzE0azc0OW9EejUwRWtFWURMTjU0elhKek1iX1hCX3ZzVHotd0pUV2FXckh4TGpTY2MwamxsMTRFYzdWaGwwMzc3WFdPXy1oVjJxSW9FNHAzSkvSAa4BQVVfeXFMUEhYYklLRFBhRW9sMmNrdDhQVnJkc0Jnc01SQ0VfRWMtR01aZENKOUJ0UkZyXzJOcEo4MkswVHZsdEQzMmljTlZJQkVSVFkwMWtvVm5vUmpTMUdrUFR3a21SVEZBZU9GdTVQcGZMZFJIU0NuSEREdVItc0NlM3lNU2NWY2s2MTdJYW9lUlB3LWJCY1ZRLVg0bk9feUdCMkhUdmcxVmQ0Q0licGM3UTJn?oc=5"" target=""_blank"">Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.5463883280754089,positive,0.5463883280754089,0.0,neutral,0.0,0.8689,0.329,0.0,0.671,0.0,0.0,0.3122219017573765,0.7076441640377045,approval_process,0.8261142373085022,['FDA approval'],False,True,16,0.6522284746170044
2025-04-10,2025-04-10 07:00:00,"Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQcG5TMThQVFo3VWx4b2R4aWtKYVFYLWV4REk5SFc1M01TdTJ1SzZiU1AyUlEzNVBNNzUxYVduVUFoeDFUMm5TRUoxWU1LXzl3bm90UkZuLUtuTm5IRXpranhkc0RDckRBbkIxREVRNmNlejRpdlVuaXFGeTAweTRzQktueE5SS3RVc3ItTG52UHhnVkZ3V1lpV2xIQ0otVEU5Vko4T1FSVlhTdElPRFdTdUttSGhxOXpIYUo4MEoxWWtaWXpvNDJ0clNhQnV6VC1sWjJPMHlIZVBrd1JjVGhOWDl0ZXBXYzNmSFJjdTdleWxHdVExUXVtX3Nn?oc=5"" target=""_blank"">Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxQcG5TMThQVFo3VWx4b2R4aWtKYVFYLWV4REk5SFc1M01TdTJ1SzZiU1AyUlEzNVBNNzUxYVduVUFoeDFUMm5TRUoxWU1LXzl3bm90UkZuLUtuTm5IRXpranhkc0RDckRBbkIxREVRNmNlejRpdlVuaXFGeTAweTRzQktueE5SS3RVc3ItTG52UHhnVkZ3V1lpV2xIQ0otVEU5Vko4T1FSVlhTdElPRFdTdUttSGhxOXpIYUo4MEoxWWtaWXpvNDJ0clNhQnV6VC1sWjJPMHlIZVBrd1JjVGhOWDl0ZXBXYzNmSFJjdTdleWxHdVExUXVtX3Nn?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQcG5TMThQVFo3VWx4b2R4aWtKYVFYLWV4REk5SFc1M01TdTJ1SzZiU1AyUlEzNVBNNzUxYVduVUFoeDFUMm5TRUoxWU1LXzl3bm90UkZuLUtuTm5IRXpranhkc0RDckRBbkIxREVRNmNlejRpdlVuaXFGeTAweTRzQktueE5SS3RVc3ItTG52UHhnVkZ3V1lpV2xIQ0otVEU5Vko4T1FSVlhTdElPRFdTdUttSGhxOXpIYUo4MEoxWWtaWXpvNDJ0clNhQnV6VC1sWjJPMHlIZVBrd1JjVGhOWDl0ZXBXYzNmSFJjdTdleWxHdVExUXVtX3Nn?oc=5"" target=""_blank"">Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.9183073043823242,positive,0.9183073043823242,0.0,neutral,0.0,0.7351,0.162,0.0,0.838,0.0,0.0,0.5247470310756138,0.8267036521911622,approval_process,0.8269002437591553,['FDA approval'],False,True,16,0.6538004875183105
2024-07-03,2024-07-03 07:00:00,Biocon expanded plant approved to make Avastin biosimilar - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMirAFBVV95cUxQVFZKNTFGZXZKVHl1cjZwQkJjeWtkS0pUcjFnU21Hd3A5ZGNZc05oWkxvRHkxNFRwT3ZzX1E2aGVvUFJob0tDRmcyNWNHY0RxbmVNREZHNUFOanpIbWo4WXA0SHFvaXJRZFdyek9kU0JabXJkRkpwbGJ2TnNHZk0xS3BlMG1Kb04yalpBeWZIXzFlRnMtQnpKbU1SM1R6R3NCR0FER1pVcFF5Z2t6?oc=5"" target=""_blank"">Biocon expanded plant approved to make Avastin biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMirAFBVV95cUxQVFZKNTFGZXZKVHl1cjZwQkJjeWtkS0pUcjFnU21Hd3A5ZGNZc05oWkxvRHkxNFRwT3ZzX1E2aGVvUFJob0tDRmcyNWNHY0RxbmVNREZHNUFOanpIbWo4WXA0SHFvaXJRZFdyek9kU0JabXJkRkpwbGJ2TnNHZk0xS3BlMG1Kb04yalpBeWZIXzFlRnMtQnpKbU1SM1R6R3NCR0FER1pVcFF5Z2t6?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon expanded plant approved to make Avastin biosimilar - BioProcess International <a href=""https://news.google.com/rss/articles/CBMirAFBVV95cUxQVFZKNTFGZXZKVHl1cjZwQkJjeWtkS0pUcjFnU21Hd3A5ZGNZc05oWkxvRHkxNFRwT3ZzX1E2aGVvUFJob0tDRmcyNWNHY0RxbmVNREZHNUFOanpIbWo4WXA0SHFvaXJRZFdyek9kU0JabXJkRkpwbGJ2TnNHZk0xS3BlMG1Kb04yalpBeWZIXzFlRnMtQnpKbU1SM1R6R3NCR0FER1pVcFF5Z2t6?oc=5"" target=""_blank"">Biocon expanded plant approved to make Avastin biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",0.6355764865875244,positive,0.6355764865875244,0.0,neutral,0.0,0.6808,0.219,0.0,0.781,0.0,0.0,0.3631865637642997,0.6581882432937622,other,0.0,[],False,True,6,0.0
2023-02-14,2023-02-14 08:00:00,"FDA Issues CRL for Biocon Biologics, Viatris Avastin Biosimilar - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxNZzBzUGxKcmloU1A4ai1QaGpYbkxMMGFwOXFKR096d2dtWlN1alhKaW5MZG5JZWQtb3R4SXlwb3ZLbDlhWDY1NHFWT3ZtVUZCY0xzRk5lb2ZHUUo0ekhoTXpYdW1BNF9KTnl2Wjl4aXRvQzZHTG9wUWx6ckJTbnhtMzhLbzVLVzhJUUFTZy0tVDdlckktYW95QUJuZ0JHZw?oc=5"" target=""_blank"">FDA Issues CRL for Biocon Biologics, Viatris Avastin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxNZzBzUGxKcmloU1A4ai1QaGpYbkxMMGFwOXFKR096d2dtWlN1alhKaW5MZG5JZWQtb3R4SXlwb3ZLbDlhWDY1NHFWT3ZtVUZCY0xzRk5lb2ZHUUo0ekhoTXpYdW1BNF9KTnl2Wjl4aXRvQzZHTG9wUWx6ckJTbnhtMzhLbzVLVzhJUUFTZy0tVDdlckktYW95QUJuZ0JHZw?oc=5,Google News,Biocon insulin biosimilar FDA,"FDA Issues CRL for Biocon Biologics, Viatris Avastin Biosimilar - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxNZzBzUGxKcmloU1A4ai1QaGpYbkxMMGFwOXFKR096d2dtWlN1alhKaW5MZG5JZWQtb3R4SXlwb3ZLbDlhWDY1NHFWT3ZtVUZCY0xzRk5lb2ZHUUo0ekhoTXpYdW1BNF9KTnl2Wjl4aXRvQzZHTG9wUWx6ckJTbnhtMzhLbzVLVzhJUUFTZy0tVDdlckktYW95QUJuZ0JHZw?oc=5"" target=""_blank"">FDA Issues CRL for Biocon Biologics, Viatris Avastin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.9099240303039551,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.0,0.47996201515197756,other,0.0,[],False,True,6,0.0
2023-10-09,2023-10-09 07:00:00,FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmZTQWVscmJKUVNMTmtvei0wVWs3UjBIODNmZGd3ZWhwazdBQ19zdHAwaVFoNzdvWGpaeDloc2tqSzZVVFdJRms2WDg5TW1DTTlDTGZWMWM5WWhkaGRHUjd5alhtOFZsb1FWN0tZdTdBU3RNOC1ESUtIWWFfWml6eTJDWGg3QkZmQjdvSk1OeThSVy05MW9YNGtyLTRyTmFJM0kyWGZKR2tSUGVycDB0SmdOZEVWSGs?oc=5"" target=""_blank"">FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmZTQWVscmJKUVNMTmtvei0wVWs3UjBIODNmZGd3ZWhwazdBQ19zdHAwaVFoNzdvWGpaeDloc2tqSzZVVFdJRms2WDg5TW1DTTlDTGZWMWM5WWhkaGRHUjd5alhtOFZsb1FWN0tZdTdBU3RNOC1ESUtIWWFfWml6eTJDWGg3QkZmQjdvSk1OeThSVy05MW9YNGtyLTRyTmFJM0kyWGZKR2tSUGVycDB0SmdOZEVWSGs?oc=5,Google News,Biocon insulin biosimilar FDA,"FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxPNmZTQWVscmJKUVNMTmtvei0wVWs3UjBIODNmZGd3ZWhwazdBQ19zdHAwaVFoNzdvWGpaeDloc2tqSzZVVFdJRms2WDg5TW1DTTlDTGZWMWM5WWhkaGRHUjd5alhtOFZsb1FWN0tZdTdBU3RNOC1ESUtIWWFfWml6eTJDWGg3QkZmQjdvSk1OeThSVy05MW9YNGtyLTRyTmFJM0kyWGZKR2tSUGVycDB0SmdOZEVWSGs?oc=5"" target=""_blank"">FDA hits Biocon's insulin copycat with a CRL as plant awaits pre-approval inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.7395175695419312,negative,0.7395175695419312,0.0,neutral,0.0,0.1531,0.085,0.0,0.915,0.0,0.0,-0.4225814683096749,0.4463087847709656,regulatory_review,1.0,"['FDA inspection', 'pre-approval inspection']",False,True,15,0.5846893787384033
2022-11-18,2022-11-18 08:00:00,"Lilly wades deeper into copycat insulin market, scoring interchangeability tag for Lantus biosim - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxNTjNrMUFUamhrWjB1d0pLc2pES3N1ajkwRkFCT215eDIzd2VOMXJzZFJVMkJSbnhvVlYwZ0VsNGZmRkIxUUJla3F2X2pNT3YyV2hUMGJCaGg5cXpYY2xiQ2QxbEtuY1BnckM0OTYwczE0cjlHOTBhTkVUanhtTk1jTjNFWEZMUzFuMzF6dDZyLWFYU2U5R2NmTm1nRWstYUlhRTZmX1k2Q3d6WVh6V042NlFuYUVFVVJPb0t2eklaRQ?oc=5"" target=""_blank"">Lilly wades deeper into copycat insulin market, scoring interchangeability tag for Lantus biosim</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMivwFBVV95cUxNTjNrMUFUamhrWjB1d0pLc2pES3N1ajkwRkFCT215eDIzd2VOMXJzZFJVMkJSbnhvVlYwZ0VsNGZmRkIxUUJla3F2X2pNT3YyV2hUMGJCaGg5cXpYY2xiQ2QxbEtuY1BnckM0OTYwczE0cjlHOTBhTkVUanhtTk1jTjNFWEZMUzFuMzF6dDZyLWFYU2U5R2NmTm1nRWstYUlhRTZmX1k2Q3d6WVh6V042NlFuYUVFVVJPb0t2eklaRQ?oc=5,Google News,Biocon insulin biosimilar FDA,"Lilly wades deeper into copycat insulin market, scoring interchangeability tag for Lantus biosim - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxNTjNrMUFUamhrWjB1d0pLc2pES3N1ajkwRkFCT215eDIzd2VOMXJzZFJVMkJSbnhvVlYwZ0VsNGZmRkIxUUJla3F2X2pNT3YyV2hUMGJCaGg5cXpYY2xiQ2QxbEtuY1BnckM0OTYwczE0cjlHOTBhTkVUanhtTk1jTjNFWEZMUzFuMzF6dDZyLWFYU2U5R2NmTm1nRWstYUlhRTZmX1k2Q3d6WVh6V042NlFuYUVFVVJPb0t2eklaRQ?oc=5"" target=""_blank"">Lilly wades deeper into copycat insulin market, scoring interchangeability tag for Lantus biosim</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.9257948994636536,positive,0.9257948994636536,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5290256568363735,0.9257948994636536,other,0.0,[],False,False,1,0.0
2023-02-13,2023-02-13 08:00:00,Biocon's proposed Avastin biosim hit with FDA rejection after failed plant inspection - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxNNlo5VXZOMTRueS0tQUdmR0prdWd6NDVHQzcyWWt1dGtJeVVCeERUX0l4TVJzRXl0YUt3Nl9wZVAtcFVnenZoQlJfY0hPaXZBVElQZzMzS1ZNV1oyRDJQSkl0QzNscGM4SExDZUhYaDAza1NCLXUyR0M5Uzg2UVZFTmR6aDBXRldqSWV4ZFFUQm5wRGRpVTZtbDRYSUl0Vi1VbklrY09VTjVpQTNQNWxSZFdGVS1zRUdPV3JwNg?oc=5"" target=""_blank"">Biocon's proposed Avastin biosim hit with FDA rejection after failed plant inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxNNlo5VXZOMTRueS0tQUdmR0prdWd6NDVHQzcyWWt1dGtJeVVCeERUX0l4TVJzRXl0YUt3Nl9wZVAtcFVnenZoQlJfY0hPaXZBVElQZzMzS1ZNV1oyRDJQSkl0QzNscGM4SExDZUhYaDAza1NCLXUyR0M5Uzg2UVZFTmR6aDBXRldqSWV4ZFFUQm5wRGRpVTZtbDRYSUl0Vi1VbklrY09VTjVpQTNQNWxSZFdGVS1zRUdPV3JwNg?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon's proposed Avastin biosim hit with FDA rejection after failed plant inspection - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxNNlo5VXZOMTRueS0tQUdmR0prdWd6NDVHQzcyWWt1dGtJeVVCeERUX0l4TVJzRXl0YUt3Nl9wZVAtcFVnenZoQlJfY0hPaXZBVElQZzMzS1ZNV1oyRDJQSkl0QzNscGM4SExDZUhYaDAza1NCLXUyR0M5Uzg2UVZFTmR6aDBXRldqSWV4ZFFUQm5wRGRpVTZtbDRYSUl0Vi1VbklrY09VTjVpQTNQNWxSZFdGVS1zRUdPV3JwNg?oc=5"" target=""_blank"">Biocon's proposed Avastin biosim hit with FDA rejection after failed plant inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.8460134863853455,negative,0.8460134863853455,0.0,neutral,0.0,-0.9274,0.0,0.343,0.657,-0.3333333333333333,0.19999999999999998,-0.4834362779344831,0.7022489399062263,regulatory_review,0.7313665568828582,['FDA inspection'],False,True,15,0.5627331137657166
2022-09-01,2022-09-01 07:00:00,"FDA slaps Biocon following inspections of biosimilar production sites in India, Malaysia - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxNdzVWY0FTVzAwR3dkNkg1eVhFajNMRmpNaUlnRjM1MWh6TkhsVkt4c0JHcnZ4T29yRF9wdGFGSDMxYlR3ci1VWExnOFBlYk50a241NnhTbGtvb2FoNkQxSjZmVk05N2RQMDFOUDVZbXlHQTFjV2ZWS05fZ25EU3drTDhfMk81eWhrZlpncFFpdnlJbmdya2NQZUlNaFBmU3k0ZnVWaW9meFh0MkpDc2c?oc=5"" target=""_blank"">FDA slaps Biocon following inspections of biosimilar production sites in India, Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxNdzVWY0FTVzAwR3dkNkg1eVhFajNMRmpNaUlnRjM1MWh6TkhsVkt4c0JHcnZ4T29yRF9wdGFGSDMxYlR3ci1VWExnOFBlYk50a241NnhTbGtvb2FoNkQxSjZmVk05N2RQMDFOUDVZbXlHQTFjV2ZWS05fZ25EU3drTDhfMk81eWhrZlpncFFpdnlJbmdya2NQZUlNaFBmU3k0ZnVWaW9meFh0MkpDc2c?oc=5,Google News,Biocon insulin biosimilar FDA,"FDA slaps Biocon following inspections of biosimilar production sites in India, Malaysia - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxNdzVWY0FTVzAwR3dkNkg1eVhFajNMRmpNaUlnRjM1MWh6TkhsVkt4c0JHcnZ4T29yRF9wdGFGSDMxYlR3ci1VWExnOFBlYk50a241NnhTbGtvb2FoNkQxSjZmVk05N2RQMDFOUDVZbXlHQTFjV2ZWS05fZ25EU3drTDhfMk81eWhrZlpncFFpdnlJbmdya2NQZUlNaFBmU3k0ZnVWaW9meFh0MkpDc2c?oc=5"" target=""_blank"">FDA slaps Biocon following inspections of biosimilar production sites in India, Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.9167571067810059,negative,0.9167571067810059,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.06666666666666667,-0.5238612038748605,0.9167571067810059,other,0.0,[],False,True,6,0.0
2023-10-13,2023-10-13 07:00:00,"Fierce Pharma Asia—GSK, Zhifei's vaccine pact; BioNTech's latest China deal; Biocon's biosimilar rejection - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxNMjRYMUEwbm93MlRtcWQzd0JoWHRrUEpaRlZyZC1nODB4QjBBS0gzSVV4OFoyM003UkJDZ3ZDVF80Q29mbU53OS1qY2VTWFhacmNRUEFEemItdEZTc0Zndk9QZzA5Sm05ZUJaZVZvR19jUV9sNGJ2VGtwMEJieFZGbEJ5WjlQek1EbXhNNU43c3JZQlMzWFV3dEI1VEl2V29PV3VJaU9lemJFN2R4YVh5cjdaSkJfX0E?oc=5"" target=""_blank"">Fierce Pharma Asia—GSK, Zhifei's vaccine pact; BioNTech's latest China deal; Biocon's biosimilar rejection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxNMjRYMUEwbm93MlRtcWQzd0JoWHRrUEpaRlZyZC1nODB4QjBBS0gzSVV4OFoyM003UkJDZ3ZDVF80Q29mbU53OS1qY2VTWFhacmNRUEFEemItdEZTc0Zndk9QZzA5Sm05ZUJaZVZvR19jUV9sNGJ2VGtwMEJieFZGbEJ5WjlQek1EbXhNNU43c3JZQlMzWFV3dEI1VEl2V29PV3VJaU9lemJFN2R4YVh5cjdaSkJfX0E?oc=5,Google News,Biocon insulin biosimilar FDA,"Fierce Pharma Asia—GSK, Zhifei's vaccine pact; BioNTech's latest China deal; Biocon's biosimilar rejection - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxNMjRYMUEwbm93MlRtcWQzd0JoWHRrUEpaRlZyZC1nODB4QjBBS0gzSVV4OFoyM003UkJDZ3ZDVF80Q29mbU53OS1qY2VTWFhacmNRUEFEemItdEZTc0Zndk9QZzA5Sm05ZUJaZVZvR19jUV9sNGJ2VGtwMEJieFZGbEJ5WjlQek1EbXhNNU43c3JZQlMzWFV3dEI1VEl2V29PV3VJaU9lemJFN2R4YVh5cjdaSkJfX0E?oc=5"" target=""_blank"">Fierce Pharma Asia—GSK, Zhifei's vaccine pact; BioNTech's latest China deal; Biocon's biosimilar rejection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.5407335162162781,0.0,neutral,0.0,-0.5423,0.0,0.101,0.899,0.3333333333333333,0.6,0.0,0.47212228318320376,other,0.0,[],False,True,6,0.0
2024-02-29,2024-02-29 17:55:18,Biocon hit by FDA 483 with 6 observations at Malaysian plant - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxOdXhGaFVRUkpIbDFYSHYybndOTkRwanNRRXh1LWI3STdHS2xHR21lUEIwSEJoa3hXQ2llaEQ5SzZXZmtjcjE2d0hyVzNSVnQ3OUgyY2pQcU9PeEVRNC1CU2NPSThoY1JRa3BzM1Nxamd0dnd0TFJrYllpTEdaazNuTnNFSmlmeHRxMGJmdkJ1T1NOaGdmQ0g4elNEVlRnMkNDa0NIekd3?oc=5"" target=""_blank"">Biocon hit by FDA 483 with 6 observations at Malaysian plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxOdXhGaFVRUkpIbDFYSHYybndOTkRwanNRRXh1LWI3STdHS2xHR21lUEIwSEJoa3hXQ2llaEQ5SzZXZmtjcjE2d0hyVzNSVnQ3OUgyY2pQcU9PeEVRNC1CU2NPSThoY1JRa3BzM1Nxamd0dnd0TFJrYllpTEdaazNuTnNFSmlmeHRxMGJmdkJ1T1NOaGdmQ0g4elNEVlRnMkNDa0NIekd3?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon hit by FDA 483 with 6 observations at Malaysian plant - BioProcess International <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxOdXhGaFVRUkpIbDFYSHYybndOTkRwanNRRXh1LWI3STdHS2xHR21lUEIwSEJoa3hXQ2llaEQ5SzZXZmtjcjE2d0hyVzNSVnQ3OUgyY2pQcU9PeEVRNC1CU2NPSThoY1JRa3BzM1Nxamd0dnd0TFJrYllpTEdaazNuTnNFSmlmeHRxMGJmdkJ1T1NOaGdmQ0g4elNEVlRnMkNDa0NIekd3?oc=5"" target=""_blank"">Biocon hit by FDA 483 with 6 observations at Malaysian plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",-0.9314208626747131,negative,0.9314208626747131,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.532240492956979,0.9314208626747131,other,0.0,[],False,True,6,0.0
2025-04-10,2025-04-10 07:00:00,Biocon Biologics obtains FDA nod for Avastin biosimilar - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMigwFBVV95cUxPQkF3Z0xBMFJ2NjdSVF9aMzV2YlhORFdfZV9DUWdYc0ZPa3FkOFlNYi1rV3lhYmYtRFpTUktFNHdhUm4wM1VFd3dnUFg0MndGZmlRVG1iSkpzclJZNl9TMDh3S1ZnNVJGU1E1Z2tUQUt5blVITy1sSzg1VXZnQUhpOHJvcw?oc=5"" target=""_blank"">Biocon Biologics obtains FDA nod for Avastin biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMigwFBVV95cUxPQkF3Z0xBMFJ2NjdSVF9aMzV2YlhORFdfZV9DUWdYc0ZPa3FkOFlNYi1rV3lhYmYtRFpTUktFNHdhUm4wM1VFd3dnUFg0MndGZmlRVG1iSkpzclJZNl9TMDh3S1ZnNVJGU1E1Z2tUQUt5blVITy1sSzg1VXZnQUhpOHJvcw?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon Biologics obtains FDA nod for Avastin biosimilar - Drug Store News <a href=""https://news.google.com/rss/articles/CBMigwFBVV95cUxPQkF3Z0xBMFJ2NjdSVF9aMzV2YlhORFdfZV9DUWdYc0ZPa3FkOFlNYi1rV3lhYmYtRFpTUktFNHdhUm4wM1VFd3dnUFg0MndGZmlRVG1iSkpzclJZNl9TMDh3S1ZnNVJGU1E1Z2tUQUt5blVITy1sSzg1VXZnQUhpOHJvcw?oc=5"" target=""_blank"">Biocon Biologics obtains FDA nod for Avastin biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",0.0,neutral,0.7763556241989136,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7763556241989136,other,0.0,[],False,True,6,0.0
2025-01-13,2025-01-13 08:00:00,Biocon share price jumps over 4% after US FDA clears Malaysian insulin facility - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price jumps over 4% after US FDA clears Malaysian insulin facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon share price jumps over 4% after US FDA clears Malaysian insulin facility - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price jumps over 4% after US FDA clears Malaysian insulin facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.46100711822509766,positive,0.46100711822509766,0.0,neutral,0.0,0.6124,0.212,0.0,0.788,0.0,0.0,0.2634326389857701,0.5367035591125489,other,0.0,[],False,True,6,0.0
2023-09-21,2023-09-21 07:00:00,Meitheal partners with Chinese company for US licencing of insulin biosimilars - Pharmaceutical Technology,"<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxQaE9RYWg2eGo5NURycXNqT2dzX1JjR1JxRngzbnNoTGpIZjN2a3lLVWhRVFBaM1RCQ1VXS2FFRkd5dkZ6S1M2SFh6aElZNEQ3OHdSeVJ4bEpQM2E1RWNBSmRiXzFRYXgyZ0RUbkFJd3dWckdLQTdUM0VUNnpEV2JIR0g0RUlpdEwxRHZjVHZDVTg2LTZ4Ykx4bzV5TWliUllnRVBkUjM1RWs5WXJFQUJGWXZiMHJIaVF4S3ZhMUpmaC1qS05s?oc=5"" target=""_blank"">Meitheal partners with Chinese company for US licencing of insulin biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxQaE9RYWg2eGo5NURycXNqT2dzX1JjR1JxRngzbnNoTGpIZjN2a3lLVWhRVFBaM1RCQ1VXS2FFRkd5dkZ6S1M2SFh6aElZNEQ3OHdSeVJ4bEpQM2E1RWNBSmRiXzFRYXgyZ0RUbkFJd3dWckdLQTdUM0VUNnpEV2JIR0g0RUlpdEwxRHZjVHZDVTg2LTZ4Ykx4bzV5TWliUllnRVBkUjM1RWs5WXJFQUJGWXZiMHJIaVF4S3ZhMUpmaC1qS05s?oc=5,Google News,Biocon insulin biosimilar FDA,"Meitheal partners with Chinese company for US licencing of insulin biosimilars - Pharmaceutical Technology <a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxQaE9RYWg2eGo5NURycXNqT2dzX1JjR1JxRngzbnNoTGpIZjN2a3lLVWhRVFBaM1RCQ1VXS2FFRkd5dkZ6S1M2SFh6aElZNEQ3OHdSeVJ4bEpQM2E1RWNBSmRiXzFRYXgyZ0RUbkFJd3dWckdLQTdUM0VUNnpEV2JIR0g0RUlpdEwxRHZjVHZDVTg2LTZ4Ykx4bzV5TWliUllnRVBkUjM1RWs5WXJFQUJGWXZiMHJIaVF4S3ZhMUpmaC1qS05s?oc=5"" target=""_blank"">Meitheal partners with Chinese company for US licencing of insulin biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",0.7089191675186157,positive,0.7089191675186157,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.4050966671534947,0.7089191675186157,other,0.0,[],False,False,1,0.0
2022-07-06,2022-07-06 07:00:00,Viatris starts yet another insulin biosimilar recall over potential missing labels - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxOM3gxV3NwMUNuWFhnSmZlUXFvZHdib1d0MklwczV1UWdCSkdrRXZYOVpMdi1NblhuVVNoMFNOSzdrS1l6alFzc1JxN3J4d0FXN3BrNlJsaFJ5dE82aldzMURNWk54emhOaUFjODUyVkVhcGxEWHlQTEJHWWdUMnYySlVXc1NxaElOZ0YtMXlJZ0doVlhWOVhyMWlwbHBucklwTGIzdmtzYm5RbTE4UWVmQndZdWVmMndsalE?oc=5"" target=""_blank"">Viatris starts yet another insulin biosimilar recall over potential missing labels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxOM3gxV3NwMUNuWFhnSmZlUXFvZHdib1d0MklwczV1UWdCSkdrRXZYOVpMdi1NblhuVVNoMFNOSzdrS1l6alFzc1JxN3J4d0FXN3BrNlJsaFJ5dE82aldzMURNWk54emhOaUFjODUyVkVhcGxEWHlQTEJHWWdUMnYySlVXc1NxaElOZ0YtMXlJZ0doVlhWOVhyMWlwbHBucklwTGIzdmtzYm5RbTE4UWVmQndZdWVmMndsalE?oc=5,Google News,Biocon insulin biosimilar FDA,"Viatris starts yet another insulin biosimilar recall over potential missing labels - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxOM3gxV3NwMUNuWFhnSmZlUXFvZHdib1d0MklwczV1UWdCSkdrRXZYOVpMdi1NblhuVVNoMFNOSzdrS1l6alFzc1JxN3J4d0FXN3BrNlJsaFJ5dE82aldzMURNWk54emhOaUFjODUyVkVhcGxEWHlQTEJHWWdUMnYySlVXc1NxaElOZ0YtMXlJZ0doVlhWOVhyMWlwbHBucklwTGIzdmtzYm5RbTE4UWVmQndZdWVmMndsalE?oc=5"" target=""_blank"">Viatris starts yet another insulin biosimilar recall over potential missing labels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.7730820775032043,negative,0.7730820775032043,0.0,neutral,0.0,-0.5267,0.0,0.145,0.855,-0.08,0.41999999999999993,-0.44176118714468815,0.4599273591677348,regulatory_issues,0.6038116008043289,['recall'],False,False,9,0.40762320160865784
2023-09-06,2023-09-06 07:00:00,"Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5"" target=""_blank"">Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5"" target=""_blank"">Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.6408355832099915,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.6408355832099915,other,0.0,[],False,True,6,0.0
2024-06-24,2024-06-24 07:00:00,Biocon Biologics receives EMA approval for cancer drug - Fortune India,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxORF8ybDV4Slo5eVdEMVlIZUZQenhpd2RObV8yUWRBV3ItRFdVLVl5WEliVDdhSTJGeTNBN0ZfdkxRRU5RaHMzVmhLdGNkM2FnR004ZlpKaWJwWGprMlJCbWtoSUFxR04tVm5sYnoxVmFsdUZZS0dlSEhRZ0NIYkNsRGNqdjhSQW8wSElNamFtc0tTT2g4eFNrZ2pHaE7SAaoBQVVfeXFMTm1uRVVJWjVUWWRzakdoWjEyd1J6eHZhc1FfZ00tZGZRYWp6d2RmWGktY0U3d3JhdU40Y3lDTmFJOURHcm9ab0dNNFVMekNjcVZnQ3l1dVBja1J0dm9jTzI1ZDVybGhTS2huRTdJNnpuZm1QVnlZNjdhVDVvLWo0X0c4cl9KM0JTbFlvNkZ4SGJsVlFWc3U2Z1F6T1lwM3hHeWpIUnh6RDZSOUE?oc=5"" target=""_blank"">Biocon Biologics receives EMA approval for cancer drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxORF8ybDV4Slo5eVdEMVlIZUZQenhpd2RObV8yUWRBV3ItRFdVLVl5WEliVDdhSTJGeTNBN0ZfdkxRRU5RaHMzVmhLdGNkM2FnR004ZlpKaWJwWGprMlJCbWtoSUFxR04tVm5sYnoxVmFsdUZZS0dlSEhRZ0NIYkNsRGNqdjhSQW8wSElNamFtc0tTT2g4eFNrZ2pHaE7SAaoBQVVfeXFMTm1uRVVJWjVUWWRzakdoWjEyd1J6eHZhc1FfZ00tZGZRYWp6d2RmWGktY0U3d3JhdU40Y3lDTmFJOURHcm9ab0dNNFVMekNjcVZnQ3l1dVBja1J0dm9jTzI1ZDVybGhTS2huRTdJNnpuZm1QVnlZNjdhVDVvLWo0X0c4cl9KM0JTbFlvNkZ4SGJsVlFWc3U2Z1F6T1lwM3hHeWpIUnh6RDZSOUE?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon Biologics receives EMA approval for cancer drug - Fortune India <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxORF8ybDV4Slo5eVdEMVlIZUZQenhpd2RObV8yUWRBV3ItRFdVLVl5WEliVDdhSTJGeTNBN0ZfdkxRRU5RaHMzVmhLdGNkM2FnR004ZlpKaWJwWGprMlJCbWtoSUFxR04tVm5sYnoxVmFsdUZZS0dlSEhRZ0NIYkNsRGNqdjhSQW8wSElNamFtc0tTT2g4eFNrZ2pHaE7SAaoBQVVfeXFMTm1uRVVJWjVUWWRzakdoWjEyd1J6eHZhc1FfZ00tZGZRYWp6d2RmWGktY0U3d3JhdU40Y3lDTmFJOURHcm9ab0dNNFVMekNjcVZnQ3l1dVBja1J0dm9jTzI1ZDVybGhTS2huRTdJNnpuZm1QVnlZNjdhVDVvLWo0X0c4cl9KM0JTbFlvNkZ4SGJsVlFWc3U2Z1F6T1lwM3hHeWpIUnh6RDZSOUE?oc=5"" target=""_blank"">Biocon Biologics receives EMA approval for cancer drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",0.7786021828651428,positive,0.7786021828651428,0.0,neutral,0.0,-0.5574,0.188,0.267,0.545,0.0,0.0,0.4449155330657959,0.6680010914325714,other,0.0,[],False,True,6,0.0
2022-04-26,2022-04-26 07:00:00,Biocon Biologics' arm gets USD 90 million contract from Malaysia for supply of insulins - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics' arm gets USD 90 million contract from Malaysia for supply of insulins</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.com/rss/articles/CBMi6AFBVV95cUxNTV9Ub1R2eGJPVWJLLXV0WElBazFKMzdhdENsQnlhZXk5UVJnRTFRdjdabTR5b01NM0VkMEhtWl9jQ2hMdmRLN1g3LTFDbE9rQXZUaXR2LXJhQVpvWjBDczlSemgzVnJSdjNxWWZ2M01XYjFCc0xOTkpVZDdRTmoxZXZaZ3hEM2N0cHNXSDI0SnFia1hFdnRuTjNTUElqY2lnZV9KN0VvWmpIOVVrVGhZdkNLOEROR202ZHFkdmF5WXVNaU04T0hydllYOW9LVERpSDN4MjFIcGVybW1VdUhHYmNiaGI4M2810gH2AUFVX3lxTE9sLWlTeE9zdG1XeEU2bmRTVXVNUlFuOW11TjBSNDZ2NmVJcW9IV2VYdzl5dGhoems1WFhVdTVJNmw1aWtWQ1RkZGFZeVZGY3Q3ZXBickx6REI1ejRscnhaa3QyRjVsd1NSNVB1ZmZ3VGhreUZrOEc5UmZ5dU5MUWRWQUcxdjB3T01JMjZtbERyYkM2RUt2RFU1eVh1R1c2ZVdrOG5pQkFLelJEbTZSejV0aF82VWJqaUliOWdEdk53NE1zS3JyeEtJekxmcVM5VmJVUHp0clZTWXpJalhaOGViNXh0YjFteTlYNUVBQ0V0TG9zMUJTQQ?oc=5,Google News,Biocon insulin biosimilar FDA,"Biocon Biologics' arm gets USD 90 million contract from Malaysia for supply of insulins - The New Indian Express <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics' arm gets USD 90 million contract from Malaysia for supply of insulins</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",0.8434069156646729,positive,0.8434069156646729,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0909090909090909,0.30303030303030304,0.4819468089512416,0.4671580032868819,other,0.0,[],False,True,6,0.0
2023-10-07,2023-10-07 07:00:00,USFDA rejects proposed Biocon's Insulin Aspart application in CRL - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA rejects proposed Biocon's Insulin Aspart application in CRL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon insulin biosimilar FDA,"USFDA rejects proposed Biocon's Insulin Aspart application in CRL - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA rejects proposed Biocon's Insulin Aspart application in CRL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.5522840619087219,negative,0.5522840619087219,0.0,neutral,0.0,-0.7506,0.0,0.225,0.775,0.0,0.0,-0.31559089251926964,0.6514420309543609,application_phase,0.6456154823303223,['drug application'],False,True,14,0.49123096466064453
2022-11-17,2022-11-17 08:00:00,FDA approves second interchangeable insulin glargine biosimilar for patients with diabetes - Healio,"<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxOTEc1aEdUZmZ0Z2VDUDc1c1R1bGROYXhyZE9YQmcyRjJ2bTdSYlExVUx3cFBUcEpKZTkxYzZtYkJtUGdyTFlDTHAzSFBONHZaOWh3YkJDb0tsU09fYnNzTXUyc3JmS2g2V2dHdnh6ZFNlcmF6RUYzU1VKQ0I4Ri1yNGdOekxLMnFSckpXYXprWHpFUVl5ejQyeC1WWWJTZXRBc0FFdUVDN1VJT2RrLTZPeHZEWlloVzBKbWNDTEpjenNFNGc?oc=5"" target=""_blank"">FDA approves second interchangeable insulin glargine biosimilar for patients with diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Healio</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxOTEc1aEdUZmZ0Z2VDUDc1c1R1bGROYXhyZE9YQmcyRjJ2bTdSYlExVUx3cFBUcEpKZTkxYzZtYkJtUGdyTFlDTHAzSFBONHZaOWh3YkJDb0tsU09fYnNzTXUyc3JmS2g2V2dHdnh6ZFNlcmF6RUYzU1VKQ0I4Ri1yNGdOekxLMnFSckpXYXprWHpFUVl5ejQyeC1WWWJTZXRBc0FFdUVDN1VJT2RrLTZPeHZEWlloVzBKbWNDTEpjenNFNGc?oc=5,Google News,Semglee FDA approval 2021,"FDA approves second interchangeable insulin glargine biosimilar for patients with diabetes - Healio <a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxOTEc1aEdUZmZ0Z2VDUDc1c1R1bGROYXhyZE9YQmcyRjJ2bTdSYlExVUx3cFBUcEpKZTkxYzZtYkJtUGdyTFlDTHAzSFBONHZaOWh3YkJDb0tsU09fYnNzTXUyc3JmS2g2V2dHdnh6ZFNlcmF6RUYzU1VKQ0I4Ri1yNGdOekxLMnFSckpXYXprWHpFUVl5ejQyeC1WWWJTZXRBc0FFdUVDN1VJT2RrLTZPeHZEWlloVzBKbWNDTEpjenNFNGc?oc=5"" target=""_blank"">FDA approves second interchangeable insulin glargine biosimilar for patients with diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Healio</font>",0.7059784531593323,positive,0.7059784531593323,0.0,neutral,0.0,0.6597,0.184,0.0,0.816,0.0,0.0,0.40341625894818983,0.6828392265796661,approval_process,0.7826697826385498,['FDA approval'],False,False,11,0.5653395652770996
2023-07-20,2023-07-20 07:00:00,Payer Controls Limiting Semglee Uptake Despite Patient Demand - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQR3E3OG9USk1vYUpjdGxlaWtNc243WHJ6UmMzSkxDSHNXSHhLSVJKaWotX19TRzJlb3czRFg2cy1Tck1KS3I1N0EweHBydV84VFdsRzF6MGNBNXpIMmY5eUxQQUhINlFEMGlPbjNjXzQyWEdlcFhveHZhX0lsQkxvRjlpYWFQTklETWM2UnM2V1N6MEY2b0tvbUtFTjVMOGw5RllqYUxB?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQR3E3OG9USk1vYUpjdGxlaWtNc243WHJ6UmMzSkxDSHNXSHhLSVJKaWotX19TRzJlb3czRFg2cy1Tck1KS3I1N0EweHBydV84VFdsRzF6MGNBNXpIMmY5eUxQQUhINlFEMGlPbjNjXzQyWEdlcFhveHZhX0lsQkxvRjlpYWFQTklETWM2UnM2V1N6MEY2b0tvbUtFTjVMOGw5RllqYUxB?oc=5,Google News,Semglee FDA approval 2021,"Payer Controls Limiting Semglee Uptake Despite Patient Demand - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQR3E3OG9USk1vYUpjdGxlaWtNc243WHJ6UmMzSkxDSHNXSHhLSVJKaWotX19TRzJlb3czRFg2cy1Tck1KS3I1N0EweHBydV84VFdsRzF6MGNBNXpIMmY5eUxQQUhINlFEMGlPbjNjXzQyWEdlcFhveHZhX0lsQkxvRjlpYWFQTklETWM2UnM2V1N6MEY2b0tvbUtFTjVMOGw5RllqYUxB?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.8966668248176575,0.0,neutral,0.0,0.0951,0.056,0.0,0.944,-0.05,0.05,0.0,0.3472556082725525,other,0.0,[],True,False,11,0.0
2022-11-18,2022-11-18 08:00:00,FDA Approves Second Interchangeable Lantus Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxQc2Q0OWlxR2hTVVNzcUNWNGx1S01OWThjNzRmUnQybDdaeldnTXp3QzhtaFYyWi1FQkNmRmd6ejRLOTFuaWdVdUN0WjJJQWpuUTJNd1YzdjJVRVpRcGdkX3RNU1FQc0UzU1VMRE12YXRTbFlxRDRNNnB6cjlnWHE1Y2VvT1k2MVBudWFKUHpFc1FYdU13TDEwS2Y1UXpMY1ZkTHpj?oc=5"" target=""_blank"">FDA Approves Second Interchangeable Lantus Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxQc2Q0OWlxR2hTVVNzcUNWNGx1S01OWThjNzRmUnQybDdaeldnTXp3QzhtaFYyWi1FQkNmRmd6ejRLOTFuaWdVdUN0WjJJQWpuUTJNd1YzdjJVRVpRcGdkX3RNU1FQc0UzU1VMRE12YXRTbFlxRDRNNnB6cjlnWHE1Y2VvT1k2MVBudWFKUHpFc1FYdU13TDEwS2Y1UXpMY1ZkTHpj?oc=5,Google News,Semglee FDA approval 2021,"FDA Approves Second Interchangeable Lantus Biosimilar - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxQc2Q0OWlxR2hTVVNzcUNWNGx1S01OWThjNzRmUnQybDdaeldnTXp3QzhtaFYyWi1FQkNmRmd6ejRLOTFuaWdVdUN0WjJJQWpuUTJNd1YzdjJVRVpRcGdkX3RNU1FQc0UzU1VMRE12YXRTbFlxRDRNNnB6cjlnWHE1Y2VvT1k2MVBudWFKUHpFc1FYdU13TDEwS2Y1UXpMY1ZkTHpj?oc=5"" target=""_blank"">FDA Approves Second Interchangeable Lantus Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.6096327900886536,positive,0.6096327900886536,0.0,neutral,0.0,0.6597,0.231,0.0,0.769,0.0,0.0,0.3483615943363735,0.6346663950443268,approval_process,0.8089102506637573,['FDA approval'],False,False,11,0.6178205013275146
2023-04-01,2023-04-01 07:00:00,Lilly Launches Rezvoglar in the US - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxNRE9mTUMyNjVsVm40YTN5V016VjVWaENpT29mSml3ZWtZUzFUY3p5ZEFKSkV0ZlFMTjY1ektwamYxWmpKYjRsaEt0d1l2c01Nb3U0a1lrN1lSWU9fSnNFT2R6eUFuYmhUQnlvVGUzTEVtUTVPRGdxNGhtX0ktbGszRFJ3?oc=5"" target=""_blank"">Lilly Launches Rezvoglar in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMiggFBVV95cUxNRE9mTUMyNjVsVm40YTN5V016VjVWaENpT29mSml3ZWtZUzFUY3p5ZEFKSkV0ZlFMTjY1ektwamYxWmpKYjRsaEt0d1l2c01Nb3U0a1lrN1lSWU9fSnNFT2R6eUFuYmhUQnlvVGUzTEVtUTVPRGdxNGhtX0ktbGszRFJ3?oc=5,Google News,Semglee FDA approval 2021,"Lilly Launches Rezvoglar in the US - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxNRE9mTUMyNjVsVm40YTN5V016VjVWaENpT29mSml3ZWtZUzFUY3p5ZEFKSkV0ZlFMTjY1ektwamYxWmpKYjRsaEt0d1l2c01Nb3U0a1lrN1lSWU9fSnNFT2R6eUFuYmhUQnlvVGUzTEVtUTVPRGdxNGhtX0ktbGszRFJ3?oc=5"" target=""_blank"">Lilly Launches Rezvoglar in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.7816988825798035,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.0,0.41584944128990176,other,0.0,[],False,False,1,0.0
2023-01-09,2023-01-09 08:00:00,Biocon Biologics gets complete response letter from USFDA for proposed biosimilar Insulin-R - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics gets complete response letter from USFDA for proposed biosimilar Insulin-R</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News,Biocon BLA submission,"Biocon Biologics gets complete response letter from USFDA for proposed biosimilar Insulin-R - Medical Dialogues <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics gets complete response letter from USFDA for proposed biosimilar Insulin-R</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.0,neutral,0.713128387928009,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.05,0.2,0.0,0.38156419396400454,other,0.0,[],True,True,16,0.0
2023-02-12,2023-02-12 08:00:00,Biocon says USFDA issued CRL for Bevacizumab license application - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon says USFDA issued CRL for Bevacizumab license application</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon BLA submission,"Biocon says USFDA issued CRL for Bevacizumab license application - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon says USFDA issued CRL for Bevacizumab license application</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.799424946308136,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.799424946308136,application_phase,0.5678276956081391,['IND application'],False,True,14,0.3356553912162781
2024-02-29,2024-02-29 08:00:00,Biocon Biologics signs agreement with Janssen Biotech for psoriasis drug - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics signs agreement with Janssen Biotech for psoriasis drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxQRTVuQzUwOWlkWHhzdTkyNHludnBHSmJHLTMwazdnaHhlcjBvbnh2VDYzSlZBRUlCblk2dnoxN2pXcjh4ZXl2M0pvNV9QN2hnUHZGb1E2eVFpS0ZXUFNKbE8wLUdRS29FdFEwREVVOUlpYms2VzhMMjRwcV90dnZnWHprLU80Sl9rRGhvNzJLN2xWdV9vb0RfSkp4MUtzT1dyVDlHNUxLdUhsZG9LamstR0dtOEJPemhHV0djb28tYWhwVTdrWDhfTVVfYm5jVXIwLVdkUzBramvSAd4BQVVfeXFMUGlGRWpMNXdfUVNmLWk3S2wtc29EVnhoTkxIeG1ZVy13QXlKSjZaR0p2NkI4TmI4MXo5amFEbnFvRXZfaHVZQzBLYXp1Y1J5a1F1U0RMWXlUSzlOWHZVWVRQeTByT3dsX2YwMlBSMlF6bjE3NUlRZlFBaHMxeklNTjBDZUF0TGVVWm9lZmtBOHJ0NHk2ZnRHaDdlbjUxWkFmQ0I2OU1fSThRcDI3R1paMlo4XzBHdm5zZ1FYeUNERnN5WGljeHotYjZuQS1vLXhIdUgya3NBMlNkWDRKSFZB?oc=5,Google News,Biocon BLA submission,"Biocon Biologics signs agreement with Janssen Biotech for psoriasis drug - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics signs agreement with Janssen Biotech for psoriasis drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8815470933914185,positive,0.8815470933914185,0.0,neutral,0.0,0.7506,0.211,0.0,0.789,0.0,0.0,0.5037411962236676,0.8160735466957092,other,0.0,[],False,True,6,0.0
2023-03-20,2023-03-20 07:00:00,Why Biocon Share Price is Falling - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxNckdGOGZic1dBTUpiNUxESzlLNU5nRm1Zd284YlBHZW9KbktBdHJYMWVwdDlBQTYzUEl6d3l5cG1RcnBNT3dseTJNTWlXSDF4Y3p3UGpCenVGV3JaekhmYUZlOHM2cy1WTGtHTFlhZzl6NU4xay1URXpHY0doUkk1a1dEYXV3X1hYZ1NvTWNQbVJOVnU3blRCbGl5c2t4UnV3MlVBSFV3?oc=5"" target=""_blank"">Why Biocon Share Price is Falling</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxNckdGOGZic1dBTUpiNUxESzlLNU5nRm1Zd284YlBHZW9KbktBdHJYMWVwdDlBQTYzUEl6d3l5cG1RcnBNT3dseTJNTWlXSDF4Y3p3UGpCenVGV3JaekhmYUZlOHM2cy1WTGtHTFlhZzl6NU4xay1URXpHY0doUkk1a1dEYXV3X1hYZ1NvTWNQbVJOVnU3blRCbGl5c2t4UnV3MlVBSFV3?oc=5,Google News,Biocon BLA submission,"Why Biocon Share Price is Falling - Equitymaster <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxNckdGOGZic1dBTUpiNUxESzlLNU5nRm1Zd284YlBHZW9KbktBdHJYMWVwdDlBQTYzUEl6d3l5cG1RcnBNT3dseTJNTWlXSDF4Y3p3UGpCenVGV3JaekhmYUZlOHM2cy1WTGtHTFlhZzl6NU4xay1URXpHY0doUkk1a1dEYXV3X1hYZ1NvTWNQbVJOVnU3blRCbGl5c2t4UnV3MlVBSFV3?oc=5"" target=""_blank"">Why Biocon Share Price is Falling</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",-0.9572405219078064,negative,0.9572405219078064,0.0,neutral,0.0,0.4215,0.232,0.084,0.684,0.0,0.0,-0.5469945839473179,0.6893702609539032,other,0.0,[],False,True,6,0.0
2024-09-28,2024-09-28 07:00:00,US FDA concludes inspection of Biocon Biologics’ Insulins Facility in Malaysia - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">US FDA concludes inspection of Biocon Biologics’ Insulins Facility in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"US FDA concludes inspection of Biocon Biologics’ Insulins Facility in Malaysia - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">US FDA concludes inspection of Biocon Biologics’ Insulins Facility in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.6682268977165222,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.6682268977165222,regulatory_review,0.7549721717834472,['FDA inspection'],False,True,15,0.6099443435668945
2024-09-19,2024-09-19 07:00:00,Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQa0M4b3g4LThibmRENjZLbDVNZXczX2JMc1FLYzIwOWV1dmZ5RE5JUURQdGwzS005c29Vak1qbUhRMXRsV0xkTDFSaENMZGdfaVZUNDNTQ3ZnMXNZQTEycDMzbGVHdVRnbzlQZ3NxT3dGSmNiSjFvaVAwcXpseXRjNlB6QnhGcVIxRkdPT2NYLVR4V1FQSmEtSEJkT2czVXBKZURrcktkWE1VYU5JS3lXaDBzQnJ4dHBXclRwRQ?oc=5"" target=""_blank"">Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxQa0M4b3g4LThibmRENjZLbDVNZXczX2JMc1FLYzIwOWV1dmZ5RE5JUURQdGwzS005c29Vak1qbUhRMXRsV0xkTDFSaENMZGdfaVZUNDNTQ3ZnMXNZQTEycDMzbGVHdVRnbzlQZ3NxT3dGSmNiSjFvaVAwcXpseXRjNlB6QnhGcVIxRkdPT2NYLVR4V1FQSmEtSEJkT2czVXBKZURrcktkWE1VYU5JS3lXaDBzQnJ4dHBXclRwRQ?oc=5,Google News,Biocon FDA inspection,"Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQa0M4b3g4LThibmRENjZLbDVNZXczX2JMc1FLYzIwOWV1dmZ5RE5JUURQdGwzS005c29Vak1qbUhRMXRsV0xkTDFSaENMZGdfaVZUNDNTQ3ZnMXNZQTEycDMzbGVHdVRnbzlQZ3NxT3dGSmNiSjFvaVAwcXpseXRjNlB6QnhGcVIxRkdPT2NYLVR4V1FQSmEtSEJkT2czVXBKZURrcktkWE1VYU5JS3lXaDBzQnJ4dHBXclRwRQ?oc=5"" target=""_blank"">Granules India scolded over truckloads of torn manufacturing documents after recent FDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.9660661220550537,negative,0.9660661220550537,0.0,neutral,0.0,-0.4588,0.0,0.118,0.882,0.0,0.16666666666666666,-0.5520377840314592,0.7124330610275269,regulatory_review,0.7077520310878753,['FDA inspection'],False,False,10,0.5155040621757507
2024-10-30,2024-10-30 07:00:00,Biocon Biologics' Bengaluru unit classified as voluntary action indicated by USFDA - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics' Bengaluru unit classified as voluntary action indicated by USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon Biologics' Bengaluru unit classified as voluntary action indicated by USFDA - The Economic Times <a href=""https://news.google.com/rss/articles/CBMi9gFBVV95cUxQUGZudlNOWXAxZXlkSzdDMG9reFpSME85SGQ2Tjl5SmVOYjJIbXI3UXVUODZrX0Jpc19WQmlQalVCMlRRTDdlSTZDNk5TVmxBU0JVM0hGTGk2cEFKOUQyS3lraGkyVlVrSFNsWUhPNEdMSEc1Xy1rSm1VWVNmRGMzYVNkcVpTMUZFdVlWSUgtazR2STJrcDFsZE9DNWM1QWxzY0Rlc1lEekRSVzFNTkNrTmpEb3NISk9Pc1VmeVhWUUk4dFJ0SFJJcDlNU01lMzFpbzJ1M0RlZDMtT1ROVUNPOTFrQU9NSHRWeHduWk9FcmVqZHh3c3fSAfsBQVVfeXFMTW95SFNWU3VrU2VTZUJoOW96a09CZWFFTlZrcEhqOG1QSzB6VTNHQ1R4Y2lxNzFSV1ZzWTJTV3VCNmVhUFJ5XzhUTXV0Nkc2V08zbUtCTVlVWUIwaEVqMDlOM3ZIYk1sVFpsX1RpZmhqZEduNUF0V09BZEkyU0tUYWpPUmRBXzJZbE5vWm9oQXIzWlhjSkdwX1poS3Q3UEJEU0pGR3JyVE0tbFBIdlpxN2J4SjNsWmQwcGhpQy1BcHNkc1pCMGFOaDA1ZjdFcDV2Y0llRjlYYm9BZWEwYWp5WkMzQ0dzMWRMX1pRVVpsc21sVUNBRm9NcnFtMkU?oc=5"" target=""_blank"">Biocon Biologics' Bengaluru unit classified as voluntary action indicated by USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.499813437461853,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.12000000000000002,0.12000000000000002,0.0,0.3099067187309265,other,0.0,[],False,True,6,0.0
2025-01-13,2025-01-13 08:00:00,"USFDA classifies Biocon Biologics Johor Bahru site, Malaysia as VAI - Indian Pharma Post","<a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA classifies Biocon Biologics Johor Bahru site, Malaysia as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"USFDA classifies Biocon Biologics Johor Bahru site, Malaysia as VAI - Indian Pharma Post <a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA classifies Biocon Biologics Johor Bahru site, Malaysia as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",0.0,neutral,0.9331548810005188,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9331548810005188,other,0.0,[],False,True,6,0.0
2025-01-13,2025-01-13 08:00:00,US FDA classifies Biocon Biologics site as VAI - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxPOXliSi1SaXVLQWNkZ00yRTlqLXlXUTlnRjY5V3I1XzQ1aDhDSzRJemQ4R3lZOFBjYXpOejdaS2l3aFFlSWU2WWNjeHZMRm1yckpmbEJqRkZ4MU5mSHZDVXpacDRzRmZfb1pZaUEtLVR6a3F6MzNvOUo1ckpUaFNTd3B30gGHAUFVX3lxTE1LWi1faURNMm5CTDg1dnk3UkNpeTFwQmtpU1N6dmRCRlhuZDkzRUdla3FJV0tsNHktQmE3Y2d5bUdKSDBkM2h2YkJaeC1JMEcwYkpxU2w4Mm5ObkxNVm9UQThWTk9UdWljSWZvQTQxYkFTSnRPMFlzTnkyNHd2UnhTTXNIdU12aw?oc=5"" target=""_blank"">US FDA classifies Biocon Biologics site as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiggFBVV95cUxPOXliSi1SaXVLQWNkZ00yRTlqLXlXUTlnRjY5V3I1XzQ1aDhDSzRJemQ4R3lZOFBjYXpOejdaS2l3aFFlSWU2WWNjeHZMRm1yckpmbEJqRkZ4MU5mSHZDVXpacDRzRmZfb1pZaUEtLVR6a3F6MzNvOUo1ckpUaFNTd3B30gGHAUFVX3lxTE1LWi1faURNMm5CTDg1dnk3UkNpeTFwQmtpU1N6dmRCRlhuZDkzRUdla3FJV0tsNHktQmE3Y2d5bUdKSDBkM2h2YkJaeC1JMEcwYkpxU2w4Mm5ObkxNVm9UQThWTk9UdWljSWZvQTQxYkFTSnRPMFlzTnkyNHd2UnhTTXNIdU12aw?oc=5,Google News,Biocon FDA inspection,"US FDA classifies Biocon Biologics site as VAI - Express Pharma <a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxPOXliSi1SaXVLQWNkZ00yRTlqLXlXUTlnRjY5V3I1XzQ1aDhDSzRJemQ4R3lZOFBjYXpOejdaS2l3aFFlSWU2WWNjeHZMRm1yckpmbEJqRkZ4MU5mSHZDVXpacDRzRmZfb1pZaUEtLVR6a3F6MzNvOUo1ckpUaFNTd3B30gGHAUFVX3lxTE1LWi1faURNMm5CTDg1dnk3UkNpeTFwQmtpU1N6dmRCRlhuZDkzRUdla3FJV0tsNHktQmE3Y2d5bUdKSDBkM2h2YkJaeC1JMEcwYkpxU2w4Mm5ObkxNVm9UQThWTk9UdWljSWZvQTQxYkFTSnRPMFlzTnkyNHd2UnhTTXNIdU12aw?oc=5"" target=""_blank"">US FDA classifies Biocon Biologics site as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.0,neutral,0.932612419128418,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.932612419128418,other,0.0,[],False,True,6,0.0
2024-11-11,2024-11-11 08:00:00,Biocon shares surge 5% after USFDA clears Bengaluru unit as VAI - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge 5% after USFDA clears Bengaluru unit as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon shares surge 5% after USFDA clears Bengaluru unit as VAI - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge 5% after USFDA clears Bengaluru unit as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.8938897252082825,positive,0.8938897252082825,0.0,neutral,0.0,0.6124,0.241,0.0,0.759,0.0,0.0,0.5107941286904472,0.7531448626041413,other,0.0,[],False,True,6,0.0
2024-09-28,2024-09-28 07:00:00,U.S. FDA issues 4 observations to Biocon API facility in Bengaluru - The Hindu,"<a href=""https://news.google.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?oc=5"" target=""_blank"">U.S. FDA issues 4 observations to Biocon API facility in Bengaluru</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"U.S. FDA issues 4 observations to Biocon API facility in Bengaluru - The Hindu <a href=""https://news.google.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?oc=5"" target=""_blank"">U.S. FDA issues 4 observations to Biocon API facility in Bengaluru</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",0.0,neutral,0.8307430148124695,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8307430148124695,other,0.0,[],False,True,6,0.0
2024-09-10,2024-09-10 07:00:00,"FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRFZDZXhpX2U1U2RjMHN1c1B2WGY1aVIyNExmOEo5TGE0VDlQTEJfcVVwejNza0JjdTN2Y1I3Qk1jQnZ4cW4zOTRRWjJDTWVjTTNXbl9JUXU3dW9wNGlYSklOR1BOcFlCT3JRLU5xWC1vTkFSSUw4cDJUbXdlUXVCTy05UG1mMzZEVll0LVQ4SnlSWjgwOHZNbV9KRDkyMjlRd1gtX09nRVhZZTA?oc=5"" target=""_blank"">FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRFZDZXhpX2U1U2RjMHN1c1B2WGY1aVIyNExmOEo5TGE0VDlQTEJfcVVwejNza0JjdTN2Y1I3Qk1jQnZ4cW4zOTRRWjJDTWVjTTNXbl9JUXU3dW9wNGlYSklOR1BOcFlCT3JRLU5xWC1vTkFSSUw4cDJUbXdlUXVCTy05UG1mMzZEVll0LVQ4SnlSWjgwOHZNbV9KRDkyMjlRd1gtX09nRVhZZTA?oc=5,Google News,Biocon FDA inspection,"FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRFZDZXhpX2U1U2RjMHN1c1B2WGY1aVIyNExmOEo5TGE0VDlQTEJfcVVwejNza0JjdTN2Y1I3Qk1jQnZ4cW4zOTRRWjJDTWVjTTNXbl9JUXU3dW9wNGlYSklOR1BOcFlCT3JRLU5xWC1vTkFSSUw4cDJUbXdlUXVCTy05UG1mMzZEVll0LVQ4SnlSWjgwOHZNbV9KRDkyMjlRd1gtX09nRVhZZTA?oc=5"" target=""_blank"">FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.9095746874809265,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9095746874809265,regulatory_review,0.7665302872657775,['FDA inspection'],False,False,10,0.6330605745315552
2023-08-18,2023-08-18 07:00:00,Another FDA inspection ends in 483 for Biocon in Malaysia - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNQkJLMk90M3R5dkYybGthQ0ZvcUNOMXRVdDNkYldCYTk4WUw1alpvYTVmRVlyYmRzei12cmx2cEVfTXlKY0ZPMlE5bkEwaFdsM0FacmRxaUFKc2lTRFVnamlWRVJvcnVTREFzTGhDaE8tdTB0UXFOeGxnejkxcF9rT25xZG1FWnhuMVJrN3lEdUhPY2RESTR5MnFiM0FiMjJ5RHc?oc=5"" target=""_blank"">Another FDA inspection ends in 483 for Biocon in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxNQkJLMk90M3R5dkYybGthQ0ZvcUNOMXRVdDNkYldCYTk4WUw1alpvYTVmRVlyYmRzei12cmx2cEVfTXlKY0ZPMlE5bkEwaFdsM0FacmRxaUFKc2lTRFVnamlWRVJvcnVTREFzTGhDaE8tdTB0UXFOeGxnejkxcF9rT25xZG1FWnhuMVJrN3lEdUhPY2RESTR5MnFiM0FiMjJ5RHc?oc=5,Google News,Biocon FDA inspection,"Another FDA inspection ends in 483 for Biocon in Malaysia - BioProcess International <a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNQkJLMk90M3R5dkYybGthQ0ZvcUNOMXRVdDNkYldCYTk4WUw1alpvYTVmRVlyYmRzei12cmx2cEVfTXlKY0ZPMlE5bkEwaFdsM0FacmRxaUFKc2lTRFVnamlWRVJvcnVTREFzTGhDaE8tdTB0UXFOeGxnejkxcF9rT25xZG1FWnhuMVJrN3lEdUhPY2RESTR5MnFiM0FiMjJ5RHc?oc=5"" target=""_blank"">Another FDA inspection ends in 483 for Biocon in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",0.0,neutral,0.8516349792480469,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8516349792480469,regulatory_review,0.7379916131496429,['FDA inspection'],False,True,15,0.5759832262992859
2024-12-09,2024-12-09 08:00:00,Biocon gets EIR with VAI status from USFDA for Bengaluru API facility - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets EIR with VAI status from USFDA for Bengaluru API facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon gets EIR with VAI status from USFDA for Bengaluru API facility - Medical Dialogues <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets EIR with VAI status from USFDA for Bengaluru API facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.6834158301353455,positive,0.6834158301353455,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3905233315059117,0.6834158301353455,other,0.0,[],False,True,6,0.0
2024-09-28,2024-09-28 07:00:00,US FDA issues four observations for Biocon's Bengaluru API facility - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">US FDA issues four observations for Biocon's Bengaluru API facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"US FDA issues four observations for Biocon's Bengaluru API facility - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">US FDA issues four observations for Biocon's Bengaluru API facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.8912187218666077,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8912187218666077,other,0.0,[],False,True,6,0.0
2024-09-30,2024-09-30 07:00:00,Biocon shares drop 2% after USFDA issues 4 observations for Bengaluru API facility - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares drop 2% after USFDA issues 4 observations for Bengaluru API facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi5gFBVV95cUxOSVlDNUt3ZHRUcFpscGxMQ1FrLVJ2ZmlOOFYyNG9LUVJSd2F1TkRMSXdUUnVGclFVdVNCb05xQjFyRWo2OGdrd2liU19LZ21WMHk4LWFSalYwM04tbkFfX1djdDd2eFJ6UkpqUFI4MG9aUmFjYkN0MWlZYmZELUtQdFFIVG41UHJNSDhvQ2w4WDJldmNyU2VvZFVScEZid0U4STAwSzN0TndLZWJpUVl3dk9iN2MzeEVtRzRmNUgzUjVocDUzQVlwV0w4aXVJVEpPNkxwMUphVVVZazg2SDdOeFBhZFJuZ9IB6wFBVV95cUxOeDY3dkw4NG9aZFRaSmFHUkJPNFVnMW9xNllKTjFpekloTnJFUUJLSHhKbHFqbTExQ25wWU5weXdWdEtYZjh2QTFzVVR4VHdrNm1td3FQWUE5Q3gtRXRHUk90NEMxZWtlNHo1d3ZIOHNTVVpjMU5ieEdreXc2WFc4VEg2dlR4OC1zN0FPSEl6NWd4Ukc5bUNiajF4anJKN2NLN0gtQ1JYQWhaZUR5TzVZUnJqYldTclk0MGx3OEktTXFBTUtjZmVEaElfZGFaUDBsRkJPYVlpejNVaWFLT1lvRXZmY3g0MnhFaXdR?oc=5,Google News,Biocon FDA inspection,"Biocon shares drop 2% after USFDA issues 4 observations for Bengaluru API facility - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares drop 2% after USFDA issues 4 observations for Bengaluru API facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",-0.9645284414291382,negative,0.9645284414291382,0.0,neutral,0.0,0.0516,0.12,0.115,0.765,0.13333333333333333,0.13333333333333333,-0.551159109388079,0.38315392492082384,other,0.0,[],False,True,6,0.0
2024-08-30,2024-08-30 07:00:00,"Biocon receives FDA report, can start supplies to US from Vizag facility - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives FDA report, can start supplies to US from Vizag facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon receives FDA report, can start supplies to US from Vizag facility - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives FDA report, can start supplies to US from Vizag facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.7687703967094421,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7687703967094421,other,0.0,[],False,True,6,0.0
2024-08-05,2024-08-05 07:00:00,Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.9117307662963867,0.0,neutral,0.0,-0.5267,0.0,0.121,0.879,-0.06000000000000001,0.24000000000000005,0.0,0.4994769220987956,regulatory_issues,0.6655054926872254,['regulatory action'],False,True,14,0.5310109853744507
2024-08-08,2024-08-08 07:00:00,CNBC-TV18 accesses USFDA observations for Biocon Biologics unit. Details here - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">CNBC-TV18 accesses USFDA observations for Biocon Biologics unit. Details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"CNBC-TV18 accesses USFDA observations for Biocon Biologics unit. Details here - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">CNBC-TV18 accesses USFDA observations for Biocon Biologics unit. Details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.9469960927963257,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9469960927963257,other,0.0,[],False,True,6,0.0
2024-07-29,2024-07-29 07:00:00,Biocon falls 1.5% after firm discloses 10 USFDA observations following inspection between July 15 and July 26 - Upstox,"<a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxOajQ2ZlhLLUtCNmtuaFg4eWRHd1dVNTJLNmxITUlfOHdzb1g2OEVXSXFkRjZHVzlZTTlPVS0wVGpHcDliMzlEOTJOS3FHVXZsNmRSZ2dvQlowb1d6THJNNDNiVE9kdHRORnhpZllQYkRXMHBxTDhHRTRXVDUyY1lmYmlESjE5Nzd5MHJGX0syUk4yaXFhNk1lc2RFaFR1UmRXVDdFdUlQLUdIVVlHWm1OVXEyd1pPYVpTQ2JXcDhwYUpGNTVuNVNuSTEtM205ZlN5NXh4MTNQR0dxVTRaQnFEWUVMWFhZWnpySEFSRHRBbk1XcXA0c2xIeTFOTQ?oc=5"" target=""_blank"">Biocon falls 1.5% after firm discloses 10 USFDA observations following inspection between July 15 and July 26</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi-wFBVV95cUxOajQ2ZlhLLUtCNmtuaFg4eWRHd1dVNTJLNmxITUlfOHdzb1g2OEVXSXFkRjZHVzlZTTlPVS0wVGpHcDliMzlEOTJOS3FHVXZsNmRSZ2dvQlowb1d6THJNNDNiVE9kdHRORnhpZllQYkRXMHBxTDhHRTRXVDUyY1lmYmlESjE5Nzd5MHJGX0syUk4yaXFhNk1lc2RFaFR1UmRXVDdFdUlQLUdIVVlHWm1OVXEyd1pPYVpTQ2JXcDhwYUpGNTVuNVNuSTEtM205ZlN5NXh4MTNQR0dxVTRaQnFEWUVMWFhZWnpySEFSRHRBbk1XcXA0c2xIeTFOTQ?oc=5,Google News,Biocon FDA inspection,"Biocon falls 1.5% after firm discloses 10 USFDA observations following inspection between July 15 and July 26 - Upstox <a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxOajQ2ZlhLLUtCNmtuaFg4eWRHd1dVNTJLNmxITUlfOHdzb1g2OEVXSXFkRjZHVzlZTTlPVS0wVGpHcDliMzlEOTJOS3FHVXZsNmRSZ2dvQlowb1d6THJNNDNiVE9kdHRORnhpZllQYkRXMHBxTDhHRTRXVDUyY1lmYmlESjE5Nzd5MHJGX0syUk4yaXFhNk1lc2RFaFR1UmRXVDdFdUlQLUdIVVlHWm1OVXEyd1pPYVpTQ2JXcDhwYUpGNTVuNVNuSTEtM205ZlN5NXh4MTNQR0dxVTRaQnFEWUVMWFhZWnpySEFSRHRBbk1XcXA0c2xIeTFOTQ?oc=5"" target=""_blank"">Biocon falls 1.5% after firm discloses 10 USFDA observations following inspection between July 15 and July 26</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",-0.9589223861694336,negative,0.9589223861694336,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.08,0.2,-0.5479556492396763,0.5194611930847168,other,0.0,[],False,True,6,0.0
2024-03-05,2024-03-05 00:14:53,FDA rejects Mylan and Biocon’s insulin glargine again - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxOSlg5Tk1ZS2lGZmFra3RMTlNPU0dXY0wxWTRIaFFBa3owVUZWMlppbFR5UlN6aVJpZW1qTzFGMlpJWXY2V0dud0RBMEVxeHR2VC03TjFVYXJoVktURm1tOUUtbHlBS19oV19oZmxVbGE0aEVKUUtSUlFyWGNpLWxmbDhlNHhYUnowSi1leEJqcjFudkx2UE9WeWJfZmY?oc=5"" target=""_blank"">FDA rejects Mylan and Biocon’s insulin glargine again</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxOSlg5Tk1ZS2lGZmFra3RMTlNPU0dXY0wxWTRIaFFBa3owVUZWMlppbFR5UlN6aVJpZW1qTzFGMlpJWXY2V0dud0RBMEVxeHR2VC03TjFVYXJoVktURm1tOUUtbHlBS19oV19oZmxVbGE0aEVKUUtSUlFyWGNpLWxmbDhlNHhYUnowSi1leEJqcjFudkx2UE9WeWJfZmY?oc=5,Google News,Biocon FDA inspection,"FDA rejects Mylan and Biocon’s insulin glargine again - BioProcess International <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxOSlg5Tk1ZS2lGZmFra3RMTlNPU0dXY0wxWTRIaFFBa3owVUZWMlppbFR5UlN6aVJpZW1qTzFGMlpJWXY2V0dud0RBMEVxeHR2VC03TjFVYXJoVktURm1tOUUtbHlBS19oV19oZmxVbGE0aEVKUUtSUlFyWGNpLWxmbDhlNHhYUnowSi1leEJqcjFudkx2UE9WeWJfZmY?oc=5"" target=""_blank"">FDA rejects Mylan and Biocon’s insulin glargine again</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",-0.8111332654953003,negative,0.8111332654953003,0.0,neutral,0.0,-0.7506,0.0,0.242,0.758,0.0,0.0,-0.46350472314017155,0.7808666327476501,other,0.0,[],False,True,6,0.0
2024-09-28,2024-09-28 07:00:00,Biocon gets 4 observations from USFDA for Bengaluru API facility - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets 4 observations from USFDA for Bengaluru API facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon gets 4 observations from USFDA for Bengaluru API facility - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets 4 observations from USFDA for Bengaluru API facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.5548532009124756,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.5548532009124756,other,0.0,[],False,True,6,0.0
2024-12-25,2024-12-25 08:00:00,USFDA issues EIR for Biocon Bengaluru facility - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOYS1MQnZveVREbDgxMmtXMk0zZGRkRnFNbHpKXzIxSlN0ZzFtNG1faFJ4dW5ZbzE4UUhmMkVNdF9QVTBwVlBIQ0hxcXg2ZXo1NXo3blVzOXBHZ0lEZmVkYnZsc2gtWEhTdXVaV1kzd0ZfUmJLQkxpYVdXZkwzMmN5UDMwR25RczFxLW10ckxIc1Z6X1ZNRFdvR3JZdU50cXR5ZmFfdNIBqgFBVV95cUxNM01pS2w0OUl0N2cyQ0wzQ3dlYXo1cDRWajYtVzFsemFjSFV3WEpOLVpjV21PdjNOYk1pN2U2SFdKT0tQQm04SWVDMWhxT3BXSDk3TG93cnB0eXhTZFB2N0s5Q0Q5Vmdqb0NXTjZMWmVBeFN0UzVGelhuaEhRQ1o0Zms2RmRCTnE0MXV5VjRWMF8ya3hTcG15cmR3WUV2NVJyMVFPSThnc2NQdw?oc=5"" target=""_blank"">USFDA issues EIR for Biocon Bengaluru facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOYS1MQnZveVREbDgxMmtXMk0zZGRkRnFNbHpKXzIxSlN0ZzFtNG1faFJ4dW5ZbzE4UUhmMkVNdF9QVTBwVlBIQ0hxcXg2ZXo1NXo3blVzOXBHZ0lEZmVkYnZsc2gtWEhTdXVaV1kzd0ZfUmJLQkxpYVdXZkwzMmN5UDMwR25RczFxLW10ckxIc1Z6X1ZNRFdvR3JZdU50cXR5ZmFfdNIBqgFBVV95cUxNM01pS2w0OUl0N2cyQ0wzQ3dlYXo1cDRWajYtVzFsemFjSFV3WEpOLVpjV21PdjNOYk1pN2U2SFdKT0tQQm04SWVDMWhxT3BXSDk3TG93cnB0eXhTZFB2N0s5Q0Q5Vmdqb0NXTjZMWmVBeFN0UzVGelhuaEhRQ1o0Zms2RmRCTnE0MXV5VjRWMF8ya3hTcG15cmR3WUV2NVJyMVFPSThnc2NQdw?oc=5,Google News,Biocon FDA inspection,"USFDA issues EIR for Biocon Bengaluru facility - Medical Dialogues <a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOYS1MQnZveVREbDgxMmtXMk0zZGRkRnFNbHpKXzIxSlN0ZzFtNG1faFJ4dW5ZbzE4UUhmMkVNdF9QVTBwVlBIQ0hxcXg2ZXo1NXo3blVzOXBHZ0lEZmVkYnZsc2gtWEhTdXVaV1kzd0ZfUmJLQkxpYVdXZkwzMmN5UDMwR25RczFxLW10ckxIc1Z6X1ZNRFdvR3JZdU50cXR5ZmFfdNIBqgFBVV95cUxNM01pS2w0OUl0N2cyQ0wzQ3dlYXo1cDRWajYtVzFsemFjSFV3WEpOLVpjV21PdjNOYk1pN2U2SFdKT0tQQm04SWVDMWhxT3BXSDk3TG93cnB0eXhTZFB2N0s5Q0Q5Vmdqb0NXTjZMWmVBeFN0UzVGelhuaEhRQ1o0Zms2RmRCTnE0MXV5VjRWMF8ya3hTcG15cmR3WUV2NVJyMVFPSThnc2NQdw?oc=5"" target=""_blank"">USFDA issues EIR for Biocon Bengaluru facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.0,neutral,0.8879385590553284,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8879385590553284,other,0.0,[],False,True,6,0.0
2024-02-29,2024-02-29 08:00:00,US FDA issues 4 observations for Biocon Biologics' insulin facility - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">US FDA issues 4 observations for Biocon Biologics' insulin facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"US FDA issues 4 observations for Biocon Biologics' insulin facility - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">US FDA issues 4 observations for Biocon Biologics' insulin facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.8431184887886047,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8431184887886047,other,0.0,[],False,True,6,0.0
2022-08-31,2022-08-31 07:00:00,US FDA issues 11 observations each for two sites in Bengaluru: Biocon - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">US FDA issues 11 observations each for two sites in Bengaluru: Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"US FDA issues 11 observations each for two sites in Bengaluru: Biocon - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">US FDA issues 11 observations each for two sites in Bengaluru: Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.8912433385848999,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8912433385848999,other,0.0,[],False,True,6,0.0
2024-03-01,2024-03-01 08:00:00,Biocon Biologics Biocon Campus (Site 1) facility gets 4 USFDA observations - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics Biocon Campus (Site 1) facility gets 4 USFDA observations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon Biologics Biocon Campus (Site 1) facility gets 4 USFDA observations - Medical Dialogues <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics Biocon Campus (Site 1) facility gets 4 USFDA observations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.6422196626663208,positive,0.6422196626663208,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3669826643807547,0.6422196626663208,other,0.0,[],False,True,6,0.0
2024-06-15,2024-06-15 07:00:00,Biocon API facility in Visakhapatnam receives 3 observations from USFDA inspection - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon API facility in Visakhapatnam receives 3 observations from USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon API facility in Visakhapatnam receives 3 observations from USFDA inspection - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon API facility in Visakhapatnam receives 3 observations from USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.6728252172470093,positive,0.6728252172470093,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3844715527125767,0.6728252172470093,regulatory_review,0.6502508789300918,['FDA inspection'],False,True,15,0.4005017578601837
2024-06-22,2024-06-22 07:00:00,Biocon gets 4 observations from USFDA for Andhra Pradesh facility - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets 4 observations from USFDA for Andhra Pradesh facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon gets 4 observations from USFDA for Andhra Pradesh facility - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets 4 observations from USFDA for Andhra Pradesh facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.49958598613739014,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.0,0.3164596597353617,other,0.0,[],False,True,6,0.0
2023-06-03,2023-06-03 07:00:00,USFDA issues zero observations to Biocon Pharma Bengaluru facility - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA issues zero observations to Biocon Pharma Bengaluru facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"USFDA issues zero observations to Biocon Pharma Bengaluru facility - Medical Dialogues <a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA issues zero observations to Biocon Pharma Bengaluru facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.0,neutral,0.9067877531051636,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9067877531051636,other,0.0,[],False,True,6,0.0
2023-10-18,2023-10-18 07:00:00,Biocon Biologics arm gets OAI status from USFDA for Malaysia insulin facility - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics arm gets OAI status from USFDA for Malaysia insulin facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon Biologics arm gets OAI status from USFDA for Malaysia insulin facility - Medical Dialogues <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics arm gets OAI status from USFDA for Malaysia insulin facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.679394006729126,positive,0.679394006729126,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.38822514670235764,0.679394006729126,other,0.0,[],False,True,6,0.0
2024-06-15,2024-06-15 07:00:00,Biocon receives 3 USFDA observations for Visakhapatnam API facility - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives 3 USFDA observations for Visakhapatnam API facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon receives 3 USFDA observations for Visakhapatnam API facility - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives 3 USFDA observations for Visakhapatnam API facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.7928865551948547,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7928865551948547,other,0.0,[],False,True,6,0.0
2023-10-18,2023-10-18 07:00:00,Official action indicated for Biocon arm's unit in Malaysia after FDA probe - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Official action indicated for Biocon arm's unit in Malaysia after FDA probe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Official action indicated for Biocon arm's unit in Malaysia after FDA probe - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Official action indicated for Biocon arm's unit in Malaysia after FDA probe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.5217875242233276,negative,0.5217875242233276,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.05,0.05,-0.29816429955618723,0.28589376211166384,other,0.0,[],False,True,6,0.0
2023-10-18,2023-10-18 07:00:00,Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon FDA inspection,"Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall most in three months as Malaysia unit may face approval delays post USFDA inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",-0.9671845436096191,negative,0.9671845436096191,0.0,neutral,0.0,0.8625,0.227,0.0,0.773,0.3333333333333333,0.3333333333333333,-0.5526768820626395,0.7210059589809842,regulatory_review,0.5959022462368011,['FDA inspection'],False,True,15,0.2918044924736023
2025-05-02,2025-05-02 07:00:00,Interchangeable Status Rapidly Boosted Scripts for Insulin Biosimilar - MedPage Today,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE16VFBnbWd1S0QzRXFKbWRrSjJaT2w3cGZ0RXN6RnJMTWFOTWZscjhrR0h3bG9uM1JJVXpnVE4wUlB5YU5IZ3ZRazFiU05tYjJtMDJwRTNORGxGRXZ2THJaeFJubWsxOWVhd0ZUazU4UkI?oc=5"" target=""_blank"">Interchangeable Status Rapidly Boosted Scripts for Insulin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MedPage Today</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE16VFBnbWd1S0QzRXFKbWRrSjJaT2w3cGZ0RXN6RnJMTWFOTWZscjhrR0h3bG9uM1JJVXpnVE4wUlB5YU5IZ3ZRazFiU05tYjJtMDJwRTNORGxGRXZ2THJaeFJubWsxOWVhd0ZUazU4UkI?oc=5,Google News,Semglee interchangeable designation,"Interchangeable Status Rapidly Boosted Scripts for Insulin Biosimilar - MedPage Today <a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE16VFBnbWd1S0QzRXFKbWRrSjJaT2w3cGZ0RXN6RnJMTWFOTWZscjhrR0h3bG9uM1JJVXpnVE4wUlB5YU5IZ3ZRazFiU05tYjJtMDJwRTNORGxGRXZ2THJaeFJubWsxOWVhd0ZUazU4UkI?oc=5"" target=""_blank"">Interchangeable Status Rapidly Boosted Scripts for Insulin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MedPage Today</font>",0.9407426714897156,positive,0.9407426714897156,0.0,neutral,0.0,0.6124,0.2,0.0,0.8,0.0,0.0,0.5375672408512661,0.7765713357448578,other,0.0,[],False,False,1,0.0
2022-11-03,2022-11-03 07:00:00,IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5"" target=""_blank"">IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5,Google News,Semglee interchangeable designation,"IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5"" target=""_blank"">IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.5918096303939819,positive,0.5918096303939819,0.0,neutral,0.0,0.6597,0.184,0.0,0.816,-0.05,0.05,0.33817693165370394,0.43383654346466066,other,0.0,[],True,False,11,0.0
2025-06-27,2025-06-27 04:58:53,Biocon Biologics: A Visionary Play on the $13B Eylea® Market with Yesafili™'s Canadian Approval and Global Ambitions - AInvest,"<a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxNSm1GRVRhRzFkMFhWLTJtNHNTY2pxWUM1dUprN1UyWG84X01kdjRJNHFpa0xRMy1YNVFiNW1SQmh3UnhSNjZMWHVnaFEyOE8tMXpvTUtLRnEyRXdyZUtMUTJuU2RJaXhjVkstWjN2Q2hyN3J6c0VwRVhiM081anJtdkoyVWJib1FMY3FDZW1oU3Fld2tPQkN4Q1BLSzV4LUExWjNHU0VNbEdxRExCcTVjNlQ1NjdKTzIzbUw0TzVsVi1SZlpXWlE?oc=5"" target=""_blank"">Biocon Biologics: A Visionary Play on the $13B Eylea® Market with Yesafili™'s Canadian Approval and Global Ambitions</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AInvest</font>",https://news.google.com/rss/articles/CBMixgFBVV95cUxNSm1GRVRhRzFkMFhWLTJtNHNTY2pxWUM1dUprN1UyWG84X01kdjRJNHFpa0xRMy1YNVFiNW1SQmh3UnhSNjZMWHVnaFEyOE8tMXpvTUtLRnEyRXdyZUtMUTJuU2RJaXhjVkstWjN2Q2hyN3J6c0VwRVhiM081anJtdkoyVWJib1FMY3FDZW1oU3Fld2tPQkN4Q1BLSzV4LUExWjNHU0VNbEdxRExCcTVjNlQ1NjdKTzIzbUw0TzVsVi1SZlpXWlE?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics: A Visionary Play on the $13B Eylea® Market with Yesafili™'s Canadian Approval and Global Ambitions - AInvest <a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxNSm1GRVRhRzFkMFhWLTJtNHNTY2pxWUM1dUprN1UyWG84X01kdjRJNHFpa0xRMy1YNVFiNW1SQmh3UnhSNjZMWHVnaFEyOE8tMXpvTUtLRnEyRXdyZUtMUTJuU2RJaXhjVkstWjN2Q2hyN3J6c0VwRVhiM081anJtdkoyVWJib1FMY3FDZW1oU3Fld2tPQkN4Q1BLSzV4LUExWjNHU0VNbEdxRExCcTVjNlQ1NjdKTzIzbUw0TzVsVi1SZlpXWlE?oc=5"" target=""_blank"">Biocon Biologics: A Visionary Play on the $13B Eylea® Market with Yesafili™'s Canadian Approval and Global Ambitions</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AInvest</font>",0.6630027294158936,positive,0.6630027294158936,0.0,neutral,0.0,0.9501,0.372,0.0,0.628,0.0,0.0,0.37885870252336773,0.8065513647079467,approval_process,0.8079403638839722,['FDA approval'],False,True,16,0.6158807277679443
2025-05-27,2025-05-27 07:00:00,Biocon Biologics receives MHRA approval for YESINTEK - European Pharmaceutical Manufacturer,"<a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon Biologics receives MHRA approval for YESINTEK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">European Pharmaceutical Manufacturer</font>",https://news.google.com/rss/articles/CBMi-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?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics receives MHRA approval for YESINTEK - European Pharmaceutical Manufacturer <a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxNLUhOQnF6VzVfN1Y1RTVzdFZEcnJBdVQxeElLN2lHNjdzenJuQlE1VE9pcGxQNWZheXEzazJHYlVoQWFQcWtySDNNaE1iR1AyZWxsdElhSm5PUFRQQ2QzVVpDbVgzdGkwVDZwVkotSU1tSy03STlHWEUzWjJzOUNPOE5rNHc1Tmh2MWxvSlpWeW1KQnJWUW9TOFNqMVpzWmRLU0VYUjBRdXVWT1JkR3IzbTlyUzFSamI0WVZNamo3dWMzdy1WNmh4T2FzU2FjZHBta3BmcGE1OGsyVDVjMVBzRmpfaW5HQlp1SGVHY1RBZkh2Uzc0V0VUbEJWUdIBhgJBVV95cUxOTDMxSTNzVWZNLU14UC1JdXRlT09FalJmWVI2aU8ySkRUSjdUWC1rZVQzbHBqTHpXam84UnhETzk2WHdXZ0FGbHNFUmdPeGJfeHgxcnR2Rm10S1NQZWpiLU1BZmJrUW1kZWx5THBuOWFhdFlmZVNtR1BYdGhvb0hlbHVjT0xJeEVZektxc3o3ZnE1UWgycW42VDBkalhhblNmdWM4bWV5SjB6OE5tbUEyanJQMmd4TmtWMDhkU3BodjZRQW11cnd4VzQ5Z0xkMHVMUS0xMHFWR1l5TFg0UkJVRWdXMHM2OGpnZ1dScEs4cnhsWm9MUHJjcF9GdWR6empVYTJ5NDhR?oc=5"" target=""_blank"">Biocon Biologics receives MHRA approval for YESINTEK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">European Pharmaceutical Manufacturer</font>",0.8589955568313599,positive,0.8589955568313599,0.0,neutral,0.0,0.7351,0.237,0.0,0.763,0.0,0.0,0.4908546039036342,0.79704777841568,approval_process,0.8183872997760773,['FDA approval'],False,True,16,0.6367745995521545
2025-06-02,2025-06-02 07:00:00,Biocon gets regulatory nod for GLP-1 diabetes drug Liraglutide in India - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets regulatory nod for GLP-1 diabetes drug Liraglutide in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon gets regulatory nod for GLP-1 diabetes drug Liraglutide in India - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets regulatory nod for GLP-1 diabetes drug Liraglutide in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.7653644680976868,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7653644680976868,other,0.0,[],False,True,6,0.0
2025-01-07,2025-01-07 08:00:00,"Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.8767358064651489,positive,0.8767358064651489,0.0,neutral,0.0,0.7351,0.171,0.0,0.829,0.0,0.0,0.5009918894086565,0.8059179032325745,approval_process,0.7158581614494324,['drug approval'],False,True,16,0.43171632289886475
2025-06-03,2025-06-03 07:00:00,Biocon shares in focus after CDSCO nod for diabetes drug Liraglutide - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after CDSCO nod for diabetes drug Liraglutide</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon shares in focus after CDSCO nod for diabetes drug Liraglutide - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after CDSCO nod for diabetes drug Liraglutide</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",-0.6122721433639526,negative,0.6122721433639526,0.0,neutral,0.0,0.5267,0.136,0.0,0.864,0.13333333333333333,0.13333333333333333,-0.3498697962079729,0.424101825565762,other,0.0,[],False,True,6,0.0
2025-04-28,2025-04-28 07:00:00,"Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNU1ZBMkczS3B4SWZ5WGVoVzBWcmNqUHdkTU53MXdTSFVBaWdMMFZyUW42NE5NRjc4Z0NudGItQnNqdFVEc3lkZmpQVF96RFlnY0dpdlkzRkphRkZTUkNKd2xOSEJvdXpMaW9Wc3VmOGJLeEdndmpmQjFhakpfbTlvRWJiRDBiMTNwSE9rcVVRa1ZJREdXYkVyb3MydkYyNkU2RzJyN2NEN0hBNHNMUVRvejctem5uVUt6SkE?oc=5"" target=""_blank"">Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNU1ZBMkczS3B4SWZ5WGVoVzBWcmNqUHdkTU53MXdTSFVBaWdMMFZyUW42NE5NRjc4Z0NudGItQnNqdFVEc3lkZmpQVF96RFlnY0dpdlkzRkphRkZTUkNKd2xOSEJvdXpMaW9Wc3VmOGJLeEdndmpmQjFhakpfbTlvRWJiRDBiMTNwSE9rcVVRa1ZJREdXYkVyb3MydkYyNkU2RzJyN2NEN0hBNHNMUVRvejctem5uVUt6SkE?oc=5,Google News,Biocon regulatory approval,"Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals - Equitypandit <a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNU1ZBMkczS3B4SWZ5WGVoVzBWcmNqUHdkTU53MXdTSFVBaWdMMFZyUW42NE5NRjc4Z0NudGItQnNqdFVEc3lkZmpQVF96RFlnY0dpdlkzRkphRkZTUkNKd2xOSEJvdXpMaW9Wc3VmOGJLeEdndmpmQjFhakpfbTlvRWJiRDBiMTNwSE9rcVVRa1ZJREdXYkVyb3MydkYyNkU2RzJyN2NEN0hBNHNMUVRvejctem5uVUt6SkE?oc=5"" target=""_blank"">Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.9370501637458801,positive,0.9370501637458801,0.0,neutral,0.0,0.7906,0.273,0.0,0.727,0.19999999999999998,0.3333333333333333,0.5354572364262172,0.64255005458196,approval_process,0.7697956264019012,['regulatory approval'],False,True,16,0.5395912528038025
2025-04-11,2025-04-11 07:00:00,"Biocon Shares in Focus, Strengthens US Oncology Footprint with Biosimilar Approval - Groww","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxOR195WnVUMnhKeVg3Sk16NmFQbkY3cDU1QlE1eEUzV1dmdmtmRkRuNFAwRWptdFJuNG4xdFJrYU5JWWZTSm9vTzZfZHhkdWhIcjhSU1FDOWVwa0JXWnBPMGNNenlkWEhYaW1zZ1d4c0VkUUJkaUwyc3FFZnBzVjZBMGtsLWRydGw5ZkhMbFdFTFJleHVKTnFCdlViZXcxdw?oc=5"" target=""_blank"">Biocon Shares in Focus, Strengthens US Oncology Footprint with Biosimilar Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Groww</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxOR195WnVUMnhKeVg3Sk16NmFQbkY3cDU1QlE1eEUzV1dmdmtmRkRuNFAwRWptdFJuNG4xdFJrYU5JWWZTSm9vTzZfZHhkdWhIcjhSU1FDOWVwa0JXWnBPMGNNenlkWEhYaW1zZ1d4c0VkUUJkaUwyc3FFZnBzVjZBMGtsLWRydGw5ZkhMbFdFTFJleHVKTnFCdlViZXcxdw?oc=5,Google News,Biocon regulatory approval,"Biocon Shares in Focus, Strengthens US Oncology Footprint with Biosimilar Approval - Groww <a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxOR195WnVUMnhKeVg3Sk16NmFQbkY3cDU1QlE1eEUzV1dmdmtmRkRuNFAwRWptdFJuNG4xdFJrYU5JWWZTSm9vTzZfZHhkdWhIcjhSU1FDOWVwa0JXWnBPMGNNenlkWEhYaW1zZ1d4c0VkUUJkaUwyc3FFZnBzVjZBMGtsLWRydGw5ZkhMbFdFTFJleHVKTnFCdlViZXcxdw?oc=5"" target=""_blank"">Biocon Shares in Focus, Strengthens US Oncology Footprint with Biosimilar Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Groww</font>",0.9288952946662903,positive,0.9288952946662903,0.0,neutral,0.0,0.91,0.391,0.0,0.609,0.0,0.0,0.5307973112378802,0.9194476473331452,approval_process,1.0,"['FDA approval', 'biosimilar approval']",False,True,16,0.6001510620117188
2025-01-13,2025-01-13 08:00:00,"Biocon stock soars 4% after USFDA clears Malaysia unit, ends regulatory hurdles - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock soars 4% after USFDA clears Malaysia unit, ends regulatory hurdles</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon stock soars 4% after USFDA clears Malaysia unit, ends regulatory hurdles - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock soars 4% after USFDA clears Malaysia unit, ends regulatory hurdles</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",-0.5704920291900635,negative,0.5704920291900635,0.0,neutral,0.0,0.1531,0.091,0.0,0.909,0.0,0.0,-0.32599544525146484,0.36179601459503175,other,0.0,[],False,True,6,0.0
2025-06-03,2025-06-03 07:00:00,Pharma stock jumps after receiving approval for its diabetes drug - Trade Brains,"<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNZGQydkNHYWVJRkhFZVl6bGtrQjBVTjJZTnVic3lKT0UwR2ZfRDBhVHBuR2tKTnpNRmRsRDdqWUdxc0twdFIxcWdTTkhUdGM3WUFNYzJJWWZBNEV4RlQ5eUZZZnJtaHBJQ2NVeXVyVEU1RXlCRU5GWnJOekZ2MzVqbk5WQ2JmY1g0Y0wtT1FqUThobHc?oc=5"" target=""_blank"">Pharma stock jumps after receiving approval for its diabetes drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxNZGQydkNHYWVJRkhFZVl6bGtrQjBVTjJZTnVic3lKT0UwR2ZfRDBhVHBuR2tKTnpNRmRsRDdqWUdxc0twdFIxcWdTTkhUdGM3WUFNYzJJWWZBNEV4RlQ5eUZZZnJtaHBJQ2NVeXVyVEU1RXlCRU5GWnJOekZ2MzVqbk5WQ2JmY1g0Y0wtT1FqUThobHc?oc=5,Google News,Biocon regulatory approval,"Pharma stock jumps after receiving approval for its diabetes drug - Trade Brains <a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNZGQydkNHYWVJRkhFZVl6bGtrQjBVTjJZTnVic3lKT0UwR2ZfRDBhVHBuR2tKTnpNRmRsRDdqWUdxc0twdFIxcWdTTkhUdGM3WUFNYzJJWWZBNEV4RlQ5eUZZZnJtaHBJQ2NVeXVyVEU1RXlCRU5GWnJOekZ2MzVqbk5WQ2JmY1g0Y0wtT1FqUThobHc?oc=5"" target=""_blank"">Pharma stock jumps after receiving approval for its diabetes drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",0.865413248538971,positive,0.865413248538971,0.0,neutral,0.0,0.7351,0.205,0.0,0.795,0.0,0.0,0.49452185630798334,0.8002566242694855,other,0.0,[],False,False,1,0.0
2025-04-11,2025-04-11 07:00:00,Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar - Samco,"<a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2tPSFdjb2k4bFdmQ1ozeG95NkpOcG5DcGFxZDRUazJEVExuaUluYTkwc1NyLUlySHVIR2tWWUJEaUZfZV9jbS05Vk9HTUhJM1BQVUpkTVF4b253SlY1NWwyYU5XSHhSSDloZTZUNGJLSEhrbXMtOEduX25kTUV6ZE9QdFNSM3J5YjdRWjJuSEhqWDdDZDZWUGd4WWIxU0pTVU5jMXJQMTRfNDVGd2xIamRLdVdIT3FOT2VYMVNheERwdw?oc=5"" target=""_blank"">Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2tPSFdjb2k4bFdmQ1ozeG95NkpOcG5DcGFxZDRUazJEVExuaUluYTkwc1NyLUlySHVIR2tWWUJEaUZfZV9jbS05Vk9HTUhJM1BQVUpkTVF4b253SlY1NWwyYU5XSHhSSDloZTZUNGJLSEhrbXMtOEduX25kTUV6ZE9QdFNSM3J5YjdRWjJuSEhqWDdDZDZWUGd4WWIxU0pTVU5jMXJQMTRfNDVGd2xIamRLdVdIT3FOT2VYMVNheERwdw?oc=5,Google News,Biocon regulatory approval,"Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar - Samco <a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2tPSFdjb2k4bFdmQ1ozeG95NkpOcG5DcGFxZDRUazJEVExuaUluYTkwc1NyLUlySHVIR2tWWUJEaUZfZV9jbS05Vk9HTUhJM1BQVUpkTVF4b253SlY1NWwyYU5XSHhSSDloZTZUNGJLSEhrbXMtOEduX25kTUV6ZE9QdFNSM3J5YjdRWjJuSEhqWDdDZDZWUGd4WWIxU0pTVU5jMXJQMTRfNDVGd2xIamRLdVdIT3FOT2VYMVNheERwdw?oc=5"" target=""_blank"">Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",0.936037003993988,positive,0.936037003993988,0.0,neutral,0.0,0.8625,0.325,0.0,0.675,0.0,0.0,0.5348782879965646,0.899268501996994,approval_process,0.7589389681816101,['FDA approval'],False,True,16,0.5178779363632202
2025-01-07,2025-01-07 08:00:00,Explained: Why Biocon share price jumped over 7% today - India Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon share price jumped over 7% today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Explained: Why Biocon share price jumped over 7% today - India Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon share price jumped over 7% today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",0.0,neutral,0.5457174181938171,0.0,neutral,0.0,0.5267,0.167,0.0,0.833,0.0,0.0,0.0,0.5362087090969085,other,0.0,[],False,True,6,0.0
2025-06-03,2025-06-03 07:00:00,Biocon share price pops 2% on CDSCO nod for diabetes drug; key details here - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price pops 2% on CDSCO nod for diabetes drug; key details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon share price pops 2% on CDSCO nod for diabetes drug; key details here - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price pops 2% on CDSCO nod for diabetes drug; key details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.8856284618377686,0.0,neutral,0.0,0.5267,0.121,0.0,0.879,0.0,0.5,0.0,0.7061642309188843,other,0.0,[],False,True,6,0.0
2025-04-24,2025-04-24 07:00:00,"Biocon to Raise ₹4,500 Crore; Approves Capital Expansion Plan - India Infoline","<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxNOUdhVjBNSmRzQ0tFLUVRWmZKTWRVVHJYU1BMX2dLTXVwc3I0Q00yeFUwRVR0WlBKbkpLSExzbk1UX3FjM2hfNjhEakpFWklZdmRPUDMyS3l3OXRha3NkYThtUFZkNWdpb2gwYjQ3RkQzaENhd1NZY3RZNUp0YjZydVU1TTM2d0R1ekJmZDdsblNyYmRHZlphUkNmVlVZcmVjMkJVZw?oc=5"" target=""_blank"">Biocon to Raise ₹4,500 Crore; Approves Capital Expansion Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Infoline</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxNOUdhVjBNSmRzQ0tFLUVRWmZKTWRVVHJYU1BMX2dLTXVwc3I0Q00yeFUwRVR0WlBKbkpLSExzbk1UX3FjM2hfNjhEakpFWklZdmRPUDMyS3l3OXRha3NkYThtUFZkNWdpb2gwYjQ3RkQzaENhd1NZY3RZNUp0YjZydVU1TTM2d0R1ekJmZDdsblNyYmRHZlphUkNmVlVZcmVjMkJVZw?oc=5,Google News,Biocon regulatory approval,"Biocon to Raise ₹4,500 Crore; Approves Capital Expansion Plan - India Infoline <a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxNOUdhVjBNSmRzQ0tFLUVRWmZKTWRVVHJYU1BMX2dLTXVwc3I0Q00yeFUwRVR0WlBKbkpLSExzbk1UX3FjM2hfNjhEakpFWklZdmRPUDMyS3l3OXRha3NkYThtUFZkNWdpb2gwYjQ3RkQzaENhd1NZY3RZNUp0YjZydVU1TTM2d0R1ekJmZDdsblNyYmRHZlphUkNmVlVZcmVjMkJVZw?oc=5"" target=""_blank"">Biocon to Raise ₹4,500 Crore; Approves Capital Expansion Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Infoline</font>",0.808385968208313,positive,0.808385968208313,0.0,neutral,0.0,0.6597,0.197,0.0,0.803,0.0,0.0,0.4619348389761788,0.7340429841041565,other,0.0,[],False,True,6,0.0
2025-06-03,2025-06-03 07:00:00,Biocon gets CDSCO nod for generic diabetes medication - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets CDSCO nod for generic diabetes medication</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon gets CDSCO nod for generic diabetes medication - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets CDSCO nod for generic diabetes medication</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.814926266670227,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.08,0.08,0.0,0.4474631333351135,other,0.0,[],False,True,6,0.0
2025-04-28,2025-04-28 07:00:00,"Zydus Lifesciences, Biocon and Aurobindo Pharma shares gain on approvals from US, EU regulators - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMi0gFBVV95cUxQM0VRaVNLcjdxRmFfWFVtRXZRSlhhdVhfSUlEQ2drb3FuOU8xOE1ZZ3pQM0d5Tl9fRVJYUDItcUdKSWlCQmZFUDNPTmUyWDlUUmdENk5YUG15ZXlSX3d3N0V5b3Q0SGxpc0VVMTVFZ2ZOYVd2U3hmSGhlTVItc21QTDQteWpZYnNwRVZiWVhwMnJETzloYnBzbkV5Uk5lTmNMTEw5bWZCd0UyQ25IN2R1X2NrbUpFbW9Qc1VsOHhhcms1dGVBZURubGwwR1V1UkRNM0E?oc=5"" target=""_blank"">Zydus Lifesciences, Biocon and Aurobindo Pharma shares gain on approvals from US, EU regulators</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi0gFBVV95cUxQM0VRaVNLcjdxRmFfWFVtRXZRSlhhdVhfSUlEQ2drb3FuOU8xOE1ZZ3pQM0d5Tl9fRVJYUDItcUdKSWlCQmZFUDNPTmUyWDlUUmdENk5YUG15ZXlSX3d3N0V5b3Q0SGxpc0VVMTVFZ2ZOYVd2U3hmSGhlTVItc21QTDQteWpZYnNwRVZiWVhwMnJETzloYnBzbkV5Uk5lTmNMTEw5bWZCd0UyQ25IN2R1X2NrbUpFbW9Qc1VsOHhhcms1dGVBZURubGwwR1V1UkRNM0E?oc=5,Google News,Biocon regulatory approval,"Zydus Lifesciences, Biocon and Aurobindo Pharma shares gain on approvals from US, EU regulators - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMi0gFBVV95cUxQM0VRaVNLcjdxRmFfWFVtRXZRSlhhdVhfSUlEQ2drb3FuOU8xOE1ZZ3pQM0d5Tl9fRVJYUDItcUdKSWlCQmZFUDNPTmUyWDlUUmdENk5YUG15ZXlSX3d3N0V5b3Q0SGxpc0VVMTVFZ2ZOYVd2U3hmSGhlTVItc21QTDQteWpZYnNwRVZiWVhwMnJETzloYnBzbkV5Uk5lTmNMTEw5bWZCd0UyQ25IN2R1X2NrbUpFbW9Qc1VsOHhhcms1dGVBZURubGwwR1V1UkRNM0E?oc=5"" target=""_blank"">Zydus Lifesciences, Biocon and Aurobindo Pharma shares gain on approvals from US, EU regulators</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.9348706007003784,positive,0.9348706007003784,0.0,neutral,0.0,0.8807,0.272,0.0,0.728,0.0,0.0,0.5342117718287877,0.9077853003501892,other,0.0,[],False,True,6,0.0
2025-06-03,2025-06-03 07:00:00,Biocon Gains 1% After India Nod for Diabetes Drug Liraglutide - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxNUl9rSDRTN1Vmd1YtZWpYaC1jTHdHSnZUWGR5emhKSVNNamJtVDc1amZoenlyaGNzRG91WUNMTkppRjliZEJCbkJfazY3R3h4SENtVUlhVlN1Smdqbl92S3lab2Q4WjBkLVFpTmg1RjJrekZHT0xxVXYweU9HX3AtMHJHdzYxNEM0XzYteWVUZ05uLXh2?oc=5"" target=""_blank"">Biocon Gains 1% After India Nod for Diabetes Drug Liraglutide</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxNUl9rSDRTN1Vmd1YtZWpYaC1jTHdHSnZUWGR5emhKSVNNamJtVDc1amZoenlyaGNzRG91WUNMTkppRjliZEJCbkJfazY3R3h4SENtVUlhVlN1Smdqbl92S3lab2Q4WjBkLVFpTmg1RjJrekZHT0xxVXYweU9HX3AtMHJHdzYxNEM0XzYteWVUZ05uLXh2?oc=5,Google News,Biocon regulatory approval,"Biocon Gains 1% After India Nod for Diabetes Drug Liraglutide - Equitypandit <a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxNUl9rSDRTN1Vmd1YtZWpYaC1jTHdHSnZUWGR5emhKSVNNamJtVDc1amZoenlyaGNzRG91WUNMTkppRjliZEJCbkJfazY3R3h4SENtVUlhVlN1Smdqbl92S3lab2Q4WjBkLVFpTmg1RjJrekZHT0xxVXYweU9HX3AtMHJHdzYxNEM0XzYteWVUZ05uLXh2?oc=5"" target=""_blank"">Biocon Gains 1% After India Nod for Diabetes Drug Liraglutide</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.9411212205886841,positive,0.9411212205886841,0.0,neutral,0.0,0.5859,0.179,0.0,0.821,0.0,0.0,0.5377835546221051,0.7635106102943421,other,0.0,[],False,True,6,0.0
2025-01-02,2025-01-02 08:00:00,Biocon arm Biocon Pharma receives approval for Tacrolimus capsules in China - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon arm Biocon Pharma receives approval for Tacrolimus capsules in China</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon arm Biocon Pharma receives approval for Tacrolimus capsules in China - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon arm Biocon Pharma receives approval for Tacrolimus capsules in China</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.6567342877388,positive,0.6567342877388,0.0,neutral,0.0,0.7351,0.193,0.0,0.807,0.0,0.0,0.37527673585074284,0.6959171438694001,other,0.0,[],False,True,6,0.0
2025-01-13,2025-01-13 08:00:00,Biocon Shares Gain 4% as Malaysia Unit Gets Clearance from USFDA - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNS21UTmM5dTJLZlFJZDJubDBXTWZzemZLdE83WkRVWDU4NFFQWjh4bFZPYnNRdWhVeHB0Y19XNWN0UnNWQzI4QXRRZWhqMjR4SUtaN1kxVVJoZDhJc0F4SVY2Vk1mYWNUS2pRTnpEUHdYa08zWDJCUzZjN0pzU0tmLVc4ZkdlRkctZG1oRmxmNzdaYXdMNWdUag?oc=5"" target=""_blank"">Biocon Shares Gain 4% as Malaysia Unit Gets Clearance from USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxNS21UTmM5dTJLZlFJZDJubDBXTWZzemZLdE83WkRVWDU4NFFQWjh4bFZPYnNRdWhVeHB0Y19XNWN0UnNWQzI4QXRRZWhqMjR4SUtaN1kxVVJoZDhJc0F4SVY2Vk1mYWNUS2pRTnpEUHdYa08zWDJCUzZjN0pzU0tmLVc4ZkdlRkctZG1oRmxmNzdaYXdMNWdUag?oc=5,Google News,Biocon regulatory approval,"Biocon Shares Gain 4% as Malaysia Unit Gets Clearance from USFDA - Equitypandit <a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNS21UTmM5dTJLZlFJZDJubDBXTWZzemZLdE83WkRVWDU4NFFQWjh4bFZPYnNRdWhVeHB0Y19XNWN0UnNWQzI4QXRRZWhqMjR4SUtaN1kxVVJoZDhJc0F4SVY2Vk1mYWNUS2pRTnpEUHdYa08zWDJCUzZjN0pzU0tmLVc4ZkdlRkctZG1oRmxmNzdaYXdMNWdUag?oc=5"" target=""_blank"">Biocon Shares Gain 4% as Malaysia Unit Gets Clearance from USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.9420116543769836,positive,0.9420116543769836,0.0,neutral,0.0,0.8807,0.337,0.0,0.663,0.0,0.0,0.5382923739297049,0.9113558271884918,other,0.0,[],False,True,6,0.0
2025-01-07,2025-01-07 08:00:00,"Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.8878949880599976,positive,0.8878949880599976,0.0,neutral,0.0,0.9468,0.42,0.0,0.58,0.0,0.0,0.5073685646057129,0.9173474940299988,approval_process,0.7213665246963501,['drug approval'],False,True,16,0.4427330493927002
2023-11-14,2023-11-14 08:00:00,Medicines and Healthcare products Regulatory Agency (MHRA) issues UK marketing approval for Biocon Biologics biosimilar aflibercept (YESAFILI) - Ophthalmology Times,"<a href=""https://news.google.com/rss/articles/CBMiiwJBVV95cUxOVzlPRXlnYkRPWnM2QURUcFQ5UjVqcEEyUXN5UnRTQXRDWldTeGxBTFdRN2puZ2ZhbUZYVnhrVHdqMGo4dUdfMnVMZ2tPQnlOZkpJMkhaODNyTDR6aE5qWkxkMHdiZmplVjFfendUdm54QW15N1hxV2xLd1p3cWFFY3BkcWRrd25IMFQ3SUZLT0Q2ZGpJakljVlZMblRSR0dDaFRYeGUzTFhuaE4zcWh0VDVROU1PY1dybUZvUDAtdUZuanZXUnAtWTlpTDhTdXZfdnR2SFhnNGt6RzdUVEVqaVhseTdKckZHa29BaklXVy1MYmpsSG1acDU4QmwwRnMtMEhWYVZZMGd6bEU?oc=5"" target=""_blank"">Medicines and Healthcare products Regulatory Agency (MHRA) issues UK marketing approval for Biocon Biologics biosimilar aflibercept (YESAFILI)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Ophthalmology Times</font>",https://news.google.com/rss/articles/CBMiiwJBVV95cUxOVzlPRXlnYkRPWnM2QURUcFQ5UjVqcEEyUXN5UnRTQXRDWldTeGxBTFdRN2puZ2ZhbUZYVnhrVHdqMGo4dUdfMnVMZ2tPQnlOZkpJMkhaODNyTDR6aE5qWkxkMHdiZmplVjFfendUdm54QW15N1hxV2xLd1p3cWFFY3BkcWRrd25IMFQ3SUZLT0Q2ZGpJakljVlZMblRSR0dDaFRYeGUzTFhuaE4zcWh0VDVROU1PY1dybUZvUDAtdUZuanZXUnAtWTlpTDhTdXZfdnR2SFhnNGt6RzdUVEVqaVhseTdKckZHa29BaklXVy1MYmpsSG1acDU4QmwwRnMtMEhWYVZZMGd6bEU?oc=5,Google News,Biocon regulatory approval,"Medicines and Healthcare products Regulatory Agency (MHRA) issues UK marketing approval for Biocon Biologics biosimilar aflibercept (YESAFILI) - Ophthalmology Times <a href=""https://news.google.com/rss/articles/CBMiiwJBVV95cUxOVzlPRXlnYkRPWnM2QURUcFQ5UjVqcEEyUXN5UnRTQXRDWldTeGxBTFdRN2puZ2ZhbUZYVnhrVHdqMGo4dUdfMnVMZ2tPQnlOZkpJMkhaODNyTDR6aE5qWkxkMHdiZmplVjFfendUdm54QW15N1hxV2xLd1p3cWFFY3BkcWRrd25IMFQ3SUZLT0Q2ZGpJakljVlZMblRSR0dDaFRYeGUzTFhuaE4zcWh0VDVROU1PY1dybUZvUDAtdUZuanZXUnAtWTlpTDhTdXZfdnR2SFhnNGt6RzdUVEVqaVhseTdKckZHa29BaklXVy1MYmpsSG1acDU4QmwwRnMtMEhWYVZZMGd6bEU?oc=5"" target=""_blank"">Medicines and Healthcare products Regulatory Agency (MHRA) issues UK marketing approval for Biocon Biologics biosimilar aflibercept (YESAFILI)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Ophthalmology Times</font>",0.6329691410064697,positive,0.6329691410064697,0.0,neutral,0.0,0.7351,0.14,0.0,0.86,0.0,0.0,0.36169665200369694,0.6840345705032349,other,0.0,[],False,True,6,0.0
2022-11-16,2022-11-16 08:00:00,Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMimAJBVV95cUxPbURCZFZkaDZYMG4yaWNOVEp5Y25pYUhXYS1EZTVjazZiekw3TnRCT291Yk5UZTVraWlraDJuNUZ1bGR2NUxpS0VpR21QQ0d4dzRMcWswVU1QWGNqSmNRVllFSGZuRVhnVHVOSE1CdWlXeXdZM25FNFp0ZGhEbHRSSkRxb3ROQ0JsVldxcTZwdGtRdF9FTld3VnRUekEtUHd1SjZON19LWlVBbzhJWjlkdzlUak9BcDZUSnUwYXR2djBST3ByNnFFOGlIU1NJRXlBN2ZZN21FOFVwSXVSLTRUZ1huWXJWc3lWX0x2NzRSUDNoelhreXFvTWJlSVdKejU1aVA4YnEyQnNWMTQwQ2J1MHNFVmd2R0FO0gGeAkFVX3lxTFBZVkViaGpRQ3E5SXg5bVlOZUQzdkRYYms0bzF5MkhxbmVBRVRzbG5GREtoSm4zNXV2ekJzU1pCQ0lTQXczLUxVbHdlTVIzNEYySzdYUllSbDRzYktGaVlkU2JEZndycWhtVC1zTnJ1WDFXcF9vRXJ6VFRvckl1MFV1QnI2OVZsenA0Zks4RjFpZWhOa0NVNE9JaFYtcktKN182TUFWcEdyU1RZSWYwZVRXbENkNkxPV0dwMXRpMjZWTGVxVWFyaWFOTXpjVDZjQ3hGWUFWNjdwS2s3amF5MTBGUjhaQ214QTRTeGpzNkx4NGd3OWlxUkRLSS1ULXBINllSb0ZQeU9OaEVxbEFiblVhRlpFMmxMQVoxQ2Q5TXc?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.7135533094406128,positive,0.7135533094406128,0.0,neutral,0.0,0.5574,0.141,0.0,0.859,0.13333333333333333,0.13333333333333333,0.4077447482517787,0.46809554759131533,approval_process,1.0,"['regulatory approval', 'FDA approval', 'drug approval', 'biosimilar approval', 'interchangeable designation', 'marketing authorization', 'FDA clearance']",False,True,21,0.730959415435791
2025-04-28,2025-04-28 07:00:00,Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA - Trade Brains,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPMjNlVFpucURuR0NYN1RwalhfbEd6T3Y3M0NvX2NfdExPUGJPRGJjV0RxWjBVUjg5ZzBDUVFZanJtUHlsZ1YzQ1RrcFF0T2NDeFFHcUR2cF9zaUlrMDkyZTZ2YmhuMmR1dUtEd0xXNHNoUmtVSDdHbnk4aW1UQ2Y5SDJtakc3RjE4VUx1Rnd4cnpxcng3Rjk5RElfVy1tbU9kYWNZSWhKTjN0Mmpodmc?oc=5"" target=""_blank"">Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPMjNlVFpucURuR0NYN1RwalhfbEd6T3Y3M0NvX2NfdExPUGJPRGJjV0RxWjBVUjg5ZzBDUVFZanJtUHlsZ1YzQ1RrcFF0T2NDeFFHcUR2cF9zaUlrMDkyZTZ2YmhuMmR1dUtEd0xXNHNoUmtVSDdHbnk4aW1UQ2Y5SDJtakc3RjE4VUx1Rnd4cnpxcng3Rjk5RElfVy1tbU9kYWNZSWhKTjN0Mmpodmc?oc=5,Google News,Biocon regulatory approval,"Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA - Trade Brains <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPMjNlVFpucURuR0NYN1RwalhfbEd6T3Y3M0NvX2NfdExPUGJPRGJjV0RxWjBVUjg5ZzBDUVFZanJtUHlsZ1YzQ1RrcFF0T2NDeFFHcUR2cF9zaUlrMDkyZTZ2YmhuMmR1dUtEd0xXNHNoUmtVSDdHbnk4aW1UQ2Y5SDJtakc3RjE4VUx1Rnd4cnpxcng3Rjk5RElfVy1tbU9kYWNZSWhKTjN0Mmpodmc?oc=5"" target=""_blank"">Pharma stocks jumps 3% after securing regulatory approvals from USFDA and EMA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",0.931842029094696,positive,0.931842029094696,0.0,neutral,0.0,0.5574,0.141,0.0,0.859,0.0,0.0,0.5324811594826834,0.744621014547348,approval_process,0.729274794459343,['regulatory approval'],False,False,11,0.4585495889186859
2025-05-27,2025-05-27 07:00:00,Biocon Biologics receives MHRA approval for Yesintek - The Pharma Letter,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxOTklGZGlyYnJKb1VEZXRfQ1dZaFhrcnBNX0ZkR2FUY1hEVzJnemdsRTJaZV9ZUzB6U3FqWEdHbzZDOU5KWnA3MERxUTZfSHkzc25WVVh3ams5YTByUDRRTlJlTHpKaDVndkhXQjdCVzVWRGx0azBLZWkyQVFseTNFZF82VjRpNjVaTWdSczNReWZTRkxHTk1oWElVMUs?oc=5"" target=""_blank"">Biocon Biologics receives MHRA approval for Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Pharma Letter</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxOTklGZGlyYnJKb1VEZXRfQ1dZaFhrcnBNX0ZkR2FUY1hEVzJnemdsRTJaZV9ZUzB6U3FqWEdHbzZDOU5KWnA3MERxUTZfSHkzc25WVVh3ams5YTByUDRRTlJlTHpKaDVndkhXQjdCVzVWRGx0azBLZWkyQVFseTNFZF82VjRpNjVaTWdSczNReWZTRkxHTk1oWElVMUs?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics receives MHRA approval for Yesintek - The Pharma Letter <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxOTklGZGlyYnJKb1VEZXRfQ1dZaFhrcnBNX0ZkR2FUY1hEVzJnemdsRTJaZV9ZUzB6U3FqWEdHbzZDOU5KWnA3MERxUTZfSHkzc25WVVh3ams5YTByUDRRTlJlTHpKaDVndkhXQjdCVzVWRGx0azBLZWkyQVFseTNFZF82VjRpNjVaTWdSczNReWZTRkxHTk1oWElVMUs?oc=5"" target=""_blank"">Biocon Biologics receives MHRA approval for Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Pharma Letter</font>",0.6265360713005066,positive,0.6265360713005066,0.0,neutral,0.0,0.7351,0.237,0.0,0.763,0.0,0.0,0.35802061217171804,0.6808180356502533,approval_process,0.8091680705547333,['FDA approval'],False,True,16,0.6183361411094666
2024-02-29,2024-02-29 08:00:00,"With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxQY2hCRXpYRld6OVhjbmZOU1ozRmY2WTU1R2NwbDNrSjdzbGRxbzhDNlVPZDBmUXpfcTRHeTZMelVIYzdMNWVrcnVLamNuallIeERwZ24zQVpiOWx5MmtTOUhfaW53ZTU3YVQ2UzV5TDdUMm1aX0poVnlDUzV4V2V6OTczZElkX3lTTmVfcUYtdFdCUi1LRmYySw?oc=5"" target=""_blank"">With J&amp;J settlement, Biocon Biologics gets a license to challenge Stelara in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxQY2hCRXpYRld6OVhjbmZOU1ozRmY2WTU1R2NwbDNrSjdzbGRxbzhDNlVPZDBmUXpfcTRHeTZMelVIYzdMNWVrcnVLamNuallIeERwZ24zQVpiOWx5MmtTOUhfaW53ZTU3YVQ2UzV5TDdUMm1aX0poVnlDUzV4V2V6OTczZElkX3lTTmVfcUYtdFdCUi1LRmYySw?oc=5,Google News,Biocon regulatory approval,"With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxQY2hCRXpYRld6OVhjbmZOU1ozRmY2WTU1R2NwbDNrSjdzbGRxbzhDNlVPZDBmUXpfcTRHeTZMelVIYzdMNWVrcnVLamNuallIeERwZ24zQVpiOWx5MmtTOUhfaW53ZTU3YVQ2UzV5TDdUMm1aX0poVnlDUzV4V2V6OTczZElkX3lTTmVfcUYtdFdCUi1LRmYySw?oc=5"" target=""_blank"">With J&amp;J settlement, Biocon Biologics gets a license to challenge Stelara in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.7858726978302002,positive,0.7858726978302002,0.0,neutral,0.0,0.1531,0.08,0.0,0.92,0.0,0.0,0.44907011304582867,0.4694863489151001,other,0.0,[],False,True,6,0.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5"" target=""_blank"">Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5,Google News,Biocon regulatory approval,"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5"" target=""_blank"">Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.0,neutral,0.9036998152732849,0.0,neutral,0.0,0.7003,0.116,0.0,0.884,0.26666666666666666,0.4,0.0,0.6235554939799838,other,0.0,[],False,True,6,0.0
2024-04-08,2024-04-08 07:00:00,Generic Weight Loss Drugs Boosted by UK Approval for Biocon - Bloomberg.com,"<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxOaWU2UkJfbnEwdTFfUXpzR1Z4WXlCcnZQQVV2dmptTUt4UDl1NGh6TEZLRERjZ2ZuWTBvMzBMUkhVY1lKaVF5dkFrODd4NHdBZzNvRzFwcDREV18tbUt6OE5paGlxWFNvOVBKOWxDb3Bwb2VJU1dzUGE3Rkd4R0VWT3gzUzNhdzN2cW1LdDFJQnF5Q1JJakxiZDUzWTBUazZVMlota19ENWtPdFNKRGJ4NVpCQWdWeGhhaThzVWdSWjI?oc=5"" target=""_blank"">Generic Weight Loss Drugs Boosted by UK Approval for Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Bloomberg.com</font>",https://news.google.com/rss/articles/CBMiwAFBVV95cUxOaWU2UkJfbnEwdTFfUXpzR1Z4WXlCcnZQQVV2dmptTUt4UDl1NGh6TEZLRERjZ2ZuWTBvMzBMUkhVY1lKaVF5dkFrODd4NHdBZzNvRzFwcDREV18tbUt6OE5paGlxWFNvOVBKOWxDb3Bwb2VJU1dzUGE3Rkd4R0VWT3gzUzNhdzN2cW1LdDFJQnF5Q1JJakxiZDUzWTBUazZVMlota19ENWtPdFNKRGJ4NVpCQWdWeGhhaThzVWdSWjI?oc=5,Google News,Biocon regulatory approval,"Generic Weight Loss Drugs Boosted by UK Approval for Biocon - Bloomberg.com <a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxOaWU2UkJfbnEwdTFfUXpzR1Z4WXlCcnZQQVV2dmptTUt4UDl1NGh6TEZLRERjZ2ZuWTBvMzBMUkhVY1lKaVF5dkFrODd4NHdBZzNvRzFwcDREV18tbUt6OE5paGlxWFNvOVBKOWxDb3Bwb2VJU1dzUGE3Rkd4R0VWT3gzUzNhdzN2cW1LdDFJQnF5Q1JJakxiZDUzWTBUazZVMlota19ENWtPdFNKRGJ4NVpCQWdWeGhhaThzVWdSWjI?oc=5"" target=""_blank"">Generic Weight Loss Drugs Boosted by UK Approval for Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Bloomberg.com</font>",0.9426953196525574,positive,0.9426953196525574,0.0,neutral,0.0,0.765,0.331,0.136,0.533,0.0,0.0,0.5386830398014614,0.8538476598262787,other,0.0,[],False,True,6,0.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5"" target=""_blank"">Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5,Google News,Biocon regulatory approval,"Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5"" target=""_blank"">Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.0,neutral,0.9082497954368591,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9082497954368591,other,0.0,[],False,True,6,0.0
2025-06-27,2025-06-27 07:08:30,Biocon Biologics gets Health Canada approval for its AMD biosimilar Yesafili - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics gets Health Canada approval for its AMD biosimilar Yesafili</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics gets Health Canada approval for its AMD biosimilar Yesafili - The New Indian Express <a href=""https://news.google.com/rss/articles/CBMiygFBVV95cUxQbk9VbWZWbGFxR1lnaGp2U0xKU0RYU3RPX29pOTZzUW1WM0tGeGctOXFqeEszQzc1YjVPUWhnWUVJRExvX0JUOHNLUXFscHFKSXVBcDhhMGFDdU1MUENqWVRabThVbFpZaUNFUU1xNlZqLXl5bm43dWhNejBOdVltajZFMi1nUmk0UXhCVUZ3TFRXQ0ZQMDI4RloyZlRmOGQ0SlZ5UDlSZ0lhVE90aVdwZ05TblktZ2hXTzd3eWRnZTNhZHpJM3Nfek5n0gHXAUFVX3lxTE5TWFR6NkxEOWdHLW43bFdEaXlQUlhGck9TVUg2YlNQbGRrajRiblI0RFVqdUVoMmkwUE1CZkxtU243TUVmRzYtdWJKclZuTXBoaklRTVZUOVZCaGZ4QnJwdmR3cUdwVHZVdHluZTJXSzB4MFA5UUx4QlJyMDVQdmtNU05ILTB6UHF2ZHFoVkJpQWx0YzFPNTZXVGl4QkZNSUIxM2RyMFAwR1ZZOGcySHhUSHlDWE81SEhQSGh4N2RmeUg5NWtoWUhiZHkxSS0tcGJ6QnRGQ2Rz?oc=5"" target=""_blank"">Biocon Biologics gets Health Canada approval for its AMD biosimilar Yesafili</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",0.8459761142730713,positive,0.8459761142730713,0.0,neutral,0.0,0.7351,0.171,0.0,0.829,0.0909090909090909,0.30303030303030304,0.48341492244175505,0.5573284017273874,other,0.0,[],False,True,6,0.0
2024-06-24,2024-06-24 07:00:00,Biocon mAns facility approved by EMA to manufacture cancer drug in India - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon mAns facility approved by EMA to manufacture cancer drug in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.com/rss/articles/CBMi7AFBVV95cUxNcnVTUEQxdUd5bklDdzZUWlhzaFd4T1dsbmdTb1BKbWFLeGdYM3BET2hZNk5ySW5YVFZHM1lUZ3FoeWNpbi16OEZNZEhtbVNjaERGS3gzQU9JMGdXbjlTeXRPZ0cyakF4dTg2ZDlSdUdkOHVOcnU1cml6cU1PeWxLeEZXWmppYkx4QUJZLW9RMDBON1NBTEpfcnoxWlN6dHkzRUlKS3FBUFJYcXJXS2h0NFJtSmxoM0hFREI5NktXckJnbXZJSlVWdzVZWWk0MWJCRVBHNm9FTnEyd1Z3akdBNmVRQ3VKdk5ybDFuZdIB8gFBVV95cUxQaEdmMlVfdkp3dUJFbVFDLXJ5aDY5V0pOdWpvX1BFZ2dNVzkyQTFobmZGV19HandzQlM4dWNUaW1ZTWM4eGhqeE82QVU1bk8xLXFyb284TjhHU0dua1k2dWUwYUxKNmZpazk1UmJXalpiSUZVWDVMR3lKTndGZE9LSkR1d284VmRyd0lOV3hza1VFOHhRa1NLSlJfWnNlalJHZXlfVE9OamNORFE4MTBKaHVRMGpiaEVkamhIRjNuSjJObGptSWZHS3VUaXoxZ1EySWNQcUxyZUx4MHJwVDZMdmlYeWUzUC1qZm96clJsSXJRdw?oc=5,Google News,Biocon regulatory approval,"Biocon mAns facility approved by EMA to manufacture cancer drug in India - ET HealthWorld <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon mAns facility approved by EMA to manufacture cancer drug in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.0,neutral,0.8818305730819702,0.0,neutral,0.0,-0.6369,0.139,0.218,0.644,0.0,0.0,0.0,0.7593652865409851,other,0.0,[],False,True,6,0.0
2024-08-29,2024-08-29 07:00:00,"Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan - Newswire Canada","<a href=""https://news.google.com/rss/articles/CBMi_gFBVV95cUxQTnV2VjJzMWxWcUZzckZYbWZEbkExNENNUE5mY3BwVk1VYllJZk8wVmZ2NWpsY1hkcVZKbF9ibnk0aldIeDFqa29BaEpTWXhCT0I0WGlKS3dmSTBLb0xndi1kV2Jma0dRbU90cG5XbzlMdGRWQ3VmRWZwY3BrbFcxVi1xd3dLcWxIUUo3VW5RVWxXd3U3WVlFbkhZVUZTVl9yZTJldHZjUUZwMlphNm9MQUNWbXl4TG5iaG5fM3hLR1c1QjRjbnRnOEhEeDJDeEd4eWNlOTVTZFpQRTRxSm5nMjN5NmI4ekNHS0w1a3ZYbWIwWkFSRi0tRTlLMDl4QQ?oc=5"" target=""_blank"">Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Newswire Canada</font>",https://news.google.com/rss/articles/CBMi_gFBVV95cUxQTnV2VjJzMWxWcUZzckZYbWZEbkExNENNUE5mY3BwVk1VYllJZk8wVmZ2NWpsY1hkcVZKbF9ibnk0aldIeDFqa29BaEpTWXhCT0I0WGlKS3dmSTBLb0xndi1kV2Jma0dRbU90cG5XbzlMdGRWQ3VmRWZwY3BrbFcxVi1xd3dLcWxIUUo3VW5RVWxXd3U3WVlFbkhZVUZTVl9yZTJldHZjUUZwMlphNm9MQUNWbXl4TG5iaG5fM3hLR1c1QjRjbnRnOEhEeDJDeEd4eWNlOTVTZFpQRTRxSm5nMjN5NmI4ekNHS0w1a3ZYbWIwWkFSRi0tRTlLMDl4QQ?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan - Newswire Canada <a href=""https://news.google.com/rss/articles/CBMi_gFBVV95cUxQTnV2VjJzMWxWcUZzckZYbWZEbkExNENNUE5mY3BwVk1VYllJZk8wVmZ2NWpsY1hkcVZKbF9ibnk0aldIeDFqa29BaEpTWXhCT0I0WGlKS3dmSTBLb0xndi1kV2Jma0dRbU90cG5XbzlMdGRWQ3VmRWZwY3BrbFcxVi1xd3dLcWxIUUo3VW5RVWxXd3U3WVlFbkhZVUZTVl9yZTJldHZjUUZwMlphNm9MQUNWbXl4TG5iaG5fM3hLR1c1QjRjbnRnOEhEeDJDeEd4eWNlOTVTZFpQRTRxSm5nMjN5NmI4ekNHS0w1a3ZYbWIwWkFSRi0tRTlLMDl4QQ?oc=5"" target=""_blank"">Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Newswire Canada</font>",0.7316128015518188,positive,0.7316128015518188,0.0,neutral,0.0,0.5574,0.103,0.0,0.897,0.0,0.0,0.4180644580296108,0.6445064007759094,other,0.0,[],False,True,6,0.0
2025-05-21,2025-05-21 07:00:00,Biocon Biologics and Yoshindo expand access to Ustekinumab Biosimilar in Japan - BioSpectrum Asia,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxQVENIcWJjOHRHUkdaNEl6RlFvOWM1Z1A1dklpckxNUzdvRG5OdnpNQnUtRk5sQllURnNJekdJNXRncEJqRHFZNE5EeTMwbXcwTVM0bjluNk5DakdVQTJlUU1HdDVJN0dhSi1XWTJ1c0xMZzlmcU1NTlF5N05GYWRLNTNsRW5jczQ3SkxNSThrNXNpZHk0SHNCQ1pXUTBjSEZsRFFOckxNNGRpcl9fVjYyMWdwWExmUFRtc21DOE9MNGhtY2tPRk5nNA?oc=5"" target=""_blank"">Biocon Biologics and Yoshindo expand access to Ustekinumab Biosimilar in Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum Asia</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxQVENIcWJjOHRHUkdaNEl6RlFvOWM1Z1A1dklpckxNUzdvRG5OdnpNQnUtRk5sQllURnNJekdJNXRncEJqRHFZNE5EeTMwbXcwTVM0bjluNk5DakdVQTJlUU1HdDVJN0dhSi1XWTJ1c0xMZzlmcU1NTlF5N05GYWRLNTNsRW5jczQ3SkxNSThrNXNpZHk0SHNCQ1pXUTBjSEZsRFFOckxNNGRpcl9fVjYyMWdwWExmUFRtc21DOE9MNGhtY2tPRk5nNA?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics and Yoshindo expand access to Ustekinumab Biosimilar in Japan - BioSpectrum Asia <a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxQVENIcWJjOHRHUkdaNEl6RlFvOWM1Z1A1dklpckxNUzdvRG5OdnpNQnUtRk5sQllURnNJekdJNXRncEJqRHFZNE5EeTMwbXcwTVM0bjluNk5DakdVQTJlUU1HdDVJN0dhSi1XWTJ1c0xMZzlmcU1NTlF5N05GYWRLNTNsRW5jczQ3SkxNSThrNXNpZHk0SHNCQ1pXUTBjSEZsRFFOckxNNGRpcl9fVjYyMWdwWExmUFRtc21DOE9MNGhtY2tPRk5nNA?oc=5"" target=""_blank"">Biocon Biologics and Yoshindo expand access to Ustekinumab Biosimilar in Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum Asia</font>",0.9413320422172546,positive,0.9413320422172546,0.0,neutral,0.0,0.5574,0.15,0.0,0.85,0.0,0.0,0.5379040241241455,0.7493660211086273,other,0.0,[],False,True,6,0.0
2022-06-21,2022-06-21 07:00:00,Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval - outlookbusiness.com,"<a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">outlookbusiness.com</font>",https://news.google.com/rss/articles/CBMi-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?oc=5,Google News,Biocon regulatory approval,"Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval - outlookbusiness.com <a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">outlookbusiness.com</font>",0.0,neutral,0.8866255283355713,0.0,neutral,0.0,-0.3612,0.087,0.157,0.756,0.0,0.0,0.0,0.6239127641677856,approval_process,0.8242462277412415,['drug approval'],False,True,16,0.6484924554824829
2024-05-13,2024-05-13 07:00:00,"Biocon inks distribution, supply deal for obesity treatment drug in Mexico - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon inks distribution, supply deal for obesity treatment drug in Mexico</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon inks distribution, supply deal for obesity treatment drug in Mexico - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon inks distribution, supply deal for obesity treatment drug in Mexico</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.8286079168319702,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8286079168319702,other,0.0,[],False,True,6,0.0
2024-04-08,2024-04-08 07:00:00,Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot - ET HealthWorld,"<a href=""https://news.google.com/rss/articles/CBMi7AFBVV95cUxPZDFFWWZ4VlFEVWN6SGhTV2FIMFR3STY0dHhtZTJ2bjVVNHl3UC1xNTNFYTFpNEhvVlkxb2hKb1Y1YzdaYzVqUXNwODVIU2t3YUIyaW1TZWNSNlhiSU5ySktLSEQxWHFXYXh0VUxGTjJUdnRfenVkVFJOeFNWRGlSX2g3U1R4bzZrSHBiX21rQkFLUjhFWWMyT0gxVFlGaGZOc202dzUwZEg1dkZpYWZvU2RfZ3FBQmJhZUZ4Xy1UMkJOQTYzUnI1VGZRbXQ0ZTd2TFVTcDVKTGpGOGFyLXJTbjU3cmtOcGNLalFUcg?oc=5"" target=""_blank"">Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.com/rss/articles/CBMi7AFBVV95cUxPZDFFWWZ4VlFEVWN6SGhTV2FIMFR3STY0dHhtZTJ2bjVVNHl3UC1xNTNFYTFpNEhvVlkxb2hKb1Y1YzdaYzVqUXNwODVIU2t3YUIyaW1TZWNSNlhiSU5ySktLSEQxWHFXYXh0VUxGTjJUdnRfenVkVFJOeFNWRGlSX2g3U1R4bzZrSHBiX21rQkFLUjhFWWMyT0gxVFlGaGZOc202dzUwZEg1dkZpYWZvU2RfZ3FBQmJhZUZ4Xy1UMkJOQTYzUnI1VGZRbXQ0ZTd2TFVTcDVKTGpGOGFyLXJTbjU3cmtOcGNLalFUcg?oc=5,Google News,Biocon regulatory approval,"Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot - ET HealthWorld <a href=""https://news.google.com/rss/articles/CBMi7AFBVV95cUxPZDFFWWZ4VlFEVWN6SGhTV2FIMFR3STY0dHhtZTJ2bjVVNHl3UC1xNTNFYTFpNEhvVlkxb2hKb1Y1YzdaYzVqUXNwODVIU2t3YUIyaW1TZWNSNlhiSU5ySktLSEQxWHFXYXh0VUxGTjJUdnRfenVkVFJOeFNWRGlSX2g3U1R4bzZrSHBiX21rQkFLUjhFWWMyT0gxVFlGaGZOc202dzUwZEg1dkZpYWZvU2RfZ3FBQmJhZUZ4Xy1UMkJOQTYzUnI1VGZRbXQ0ZTd2TFVTcDVKTGpGOGFyLXJTbjU3cmtOcGNLalFUcg?oc=5"" target=""_blank"">Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.0,neutral,0.7812833189964294,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7812833189964294,other,0.0,[],False,True,6,0.0
2023-10-06,2023-10-06 07:00:00,"Biocon, Juno Pharma ink pact for commercialisation of Liraglutide in Canada - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon, Juno Pharma ink pact for commercialisation of Liraglutide in Canada</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon, Juno Pharma ink pact for commercialisation of Liraglutide in Canada - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon, Juno Pharma ink pact for commercialisation of Liraglutide in Canada</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.8432513475418091,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8432513475418091,other,0.0,[],False,True,6,0.0
2025-01-07,2025-01-07 08:00:00,"Biocon shares zoom 8% after Jefferies upgrade to 'hold', price target lifted by 43% - Moneycontrol","<a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxOYWtLbG9WR0d0QjJ5Sjh3dUtHbDdyOXgzbWxOcWw1bnk3c0Zza28waTJaWXhRN3Z4YUE1dnQ1Smk5WGduaVJwaHNKbHUwbXpTbGRjYVVVZl9TOXRtX05MazZ4b2VkeTZMX2lXdVFWUXo2OTVNQXdpa09tSGV4bzRHWWRJSW5hb1JmV2tsNU9sOGxZTmdrYXVYNzg1bVdjYkkxNnNucHQtVHRnZElubDBmMnl6X0dTN0dFeHJGWDRBOTY4QdIBxwFBVV95cUxNOVZwa0IwR25FVjdiNW1wejVDMm83cEdFWmVxa1c0NFkxS0M4Skl1TzhCOURvNHo2QXJPS252bERKSUJoXzJMMGFJN01NYlFzYmlhZER5NzdSV1paTW5ONXJ5YmhYVDZUZlFpVU00Q2k4NHJlXzFOblY2SUljVDhiaE96a1E2c3Rnd2wtUGctQmlfNVZXbGlYNGdrcERCVTVQVGh5WjNPR2h5TVdoVjgyWXpqUnlqdm5tNlF3cW55X29QSVVxSk0w?oc=5"" target=""_blank"">Biocon shares zoom 8% after Jefferies upgrade to 'hold', price target lifted by 43%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon shares zoom 8% after Jefferies upgrade to 'hold', price target lifted by 43% - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares zoom 8% after Jefferies upgrade to 'hold', price target lifted by 43%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.9202525615692139,positive,0.9202525615692139,0.0,neutral,0.0,0.5267,0.128,0.0,0.872,0.0,0.0,0.5258586066109794,0.7234762807846069,other,0.0,[],False,True,6,0.0
2024-12-24,2024-12-24 08:00:00,"Biocon, Zentiva get EU approval for generic diabetes, weight management drug - The Hindu","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon, Zentiva get EU approval for generic diabetes, weight management drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon, Zentiva get EU approval for generic diabetes, weight management drug - The Hindu <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon, Zentiva get EU approval for generic diabetes, weight management drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",0.5134391188621521,positive,0.5134391188621521,0.0,neutral,0.0,0.7351,0.193,0.0,0.807,0.0,0.0,0.293393782206944,0.6242695594310761,other,0.0,[],False,True,6,0.0
2024-09-05,2024-09-05 07:00:00,Why Biocon Share Price is Rising - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOb1VTNGotRFpobWVFdTVJTndHNTExRGJ0V2NZbTE5NVN6cVZnUlV1RnVSWmMxWS14WjEtNEVxVlRaLUFjUVdwTFFhSjFkWjUxOElXN1FDc0ZGWkYtUWJCYjlzYUpQTTJOemNjSDI5b09faEdDWXFfOXFhYjFoNk1welN4bDJYdC1vVzk5YVYyZ1RFaGVURGZuSXNJcEdkSTJHY0dxMw?oc=5"" target=""_blank"">Why Biocon Share Price is Rising</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOb1VTNGotRFpobWVFdTVJTndHNTExRGJ0V2NZbTE5NVN6cVZnUlV1RnVSWmMxWS14WjEtNEVxVlRaLUFjUVdwTFFhSjFkWjUxOElXN1FDc0ZGWkYtUWJCYjlzYUpQTTJOemNjSDI5b09faEdDWXFfOXFhYjFoNk1welN4bDJYdC1vVzk5YVYyZ1RFaGVURGZuSXNJcEdkSTJHY0dxMw?oc=5,Google News,Biocon regulatory approval,"Why Biocon Share Price is Rising - Equitymaster <a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOb1VTNGotRFpobWVFdTVJTndHNTExRGJ0V2NZbTE5NVN6cVZnUlV1RnVSWmMxWS14WjEtNEVxVlRaLUFjUVdwTFFhSjFkWjUxOElXN1FDc0ZGWkYtUWJCYjlzYUpQTTJOemNjSDI5b09faEdDWXFfOXFhYjFoNk1welN4bDJYdC1vVzk5YVYyZ1RFaGVURGZuSXNJcEdkSTJHY0dxMw?oc=5"" target=""_blank"">Why Biocon Share Price is Rising</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",0.875948429107666,positive,0.875948429107666,0.0,neutral,0.0,0.5267,0.239,0.0,0.761,0.0,0.0,0.5005419594900948,0.701324214553833,other,0.0,[],False,True,6,0.0
2025-06-17,2025-06-17 04:16:08,Biocon shares in focus after CDSCO nod for diabetes drug Liraglutide - MSN,"<a href=""https://news.google.com/rss/articles/CBMizgJBVV95cUxOSkJxM0s0d0JWMWExd0tGckJ2ZTllbkN1X1JYNFZUWWFDYWdlM21GbF8yRkh1aXdoZV9ZU1JRVzg2dm5PQWVIQlQtREZvUlVjZW1OUUIzRlFycjZUblg3ZG9NS21nTVNWSVBMUHVxbFduODI1Nmg5UXBHc1QycFllVUVJQWJzd2U4cWdjOXFqdmdKRWFKcjhCYUlqaVBxMEpRZnhtOVgxRjA2WnlXS0I2ai1Rd19QbW9PLW5IY1d2SjVZVzJrVEtWSEhYREVXOENON3ZnVW1WemU3SzZYVTF4RXFreWpRSFBCUVM2aVVoMV9USERKb2lzTUtQMFdkc0VCU3dyVzAyMldMcEtBRzRuMVR2RVRvUFE4dGd0dXZBd0YtVlU1MDBGa09JMEktbkVjN1lsYUNtdjZwUnNxeTNMa3JmcXFMbmFwN3ZyU05n?oc=5"" target=""_blank"">Biocon shares in focus after CDSCO nod for diabetes drug Liraglutide</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.com/rss/articles/CBMizgJBVV95cUxOSkJxM0s0d0JWMWExd0tGckJ2ZTllbkN1X1JYNFZUWWFDYWdlM21GbF8yRkh1aXdoZV9ZU1JRVzg2dm5PQWVIQlQtREZvUlVjZW1OUUIzRlFycjZUblg3ZG9NS21nTVNWSVBMUHVxbFduODI1Nmg5UXBHc1QycFllVUVJQWJzd2U4cWdjOXFqdmdKRWFKcjhCYUlqaVBxMEpRZnhtOVgxRjA2WnlXS0I2ai1Rd19QbW9PLW5IY1d2SjVZVzJrVEtWSEhYREVXOENON3ZnVW1WemU3SzZYVTF4RXFreWpRSFBCUVM2aVVoMV9USERKb2lzTUtQMFdkc0VCU3dyVzAyMldMcEtBRzRuMVR2RVRvUFE4dGd0dXZBd0YtVlU1MDBGa09JMEktbkVjN1lsYUNtdjZwUnNxeTNMa3JmcXFMbmFwN3ZyU05n?oc=5,Google News,Biocon regulatory approval,"Biocon shares in focus after CDSCO nod for diabetes drug Liraglutide - MSN <a href=""https://news.google.com/rss/articles/CBMizgJBVV95cUxOSkJxM0s0d0JWMWExd0tGckJ2ZTllbkN1X1JYNFZUWWFDYWdlM21GbF8yRkh1aXdoZV9ZU1JRVzg2dm5PQWVIQlQtREZvUlVjZW1OUUIzRlFycjZUblg3ZG9NS21nTVNWSVBMUHVxbFduODI1Nmg5UXBHc1QycFllVUVJQWJzd2U4cWdjOXFqdmdKRWFKcjhCYUlqaVBxMEpRZnhtOVgxRjA2WnlXS0I2ai1Rd19QbW9PLW5IY1d2SjVZVzJrVEtWSEhYREVXOENON3ZnVW1WemU3SzZYVTF4RXFreWpRSFBCUVM2aVVoMV9USERKb2lzTUtQMFdkc0VCU3dyVzAyMldMcEtBRzRuMVR2RVRvUFE4dGd0dXZBd0YtVlU1MDBGa09JMEktbkVjN1lsYUNtdjZwUnNxeTNMa3JmcXFMbmFwN3ZyU05n?oc=5"" target=""_blank"">Biocon shares in focus after CDSCO nod for diabetes drug Liraglutide</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",-0.6476929783821106,negative,0.6476929783821106,0.0,neutral,0.0,0.5267,0.155,0.0,0.845,0.0,0.0,-0.370110273361206,0.5871964891910553,other,0.0,[],False,True,6,0.0
2025-04-23,2025-04-23 07:00:00,"Biocon board approves fundraise of up to ₹4,500 crore, plans share capital expansion - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon board approves fundraise of up to ₹4,500 crore, plans share capital expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"Biocon board approves fundraise of up to ₹4,500 crore, plans share capital expansion - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon board approves fundraise of up to ₹4,500 crore, plans share capital expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.5032855868339539,0.0,neutral,0.0,0.8316,0.259,0.0,0.741,0.0,0.0,0.0,0.6674427934169769,other,0.0,[],False,True,6,0.0
2022-08-25,2022-08-25 07:00:00,CBI files chargesheet in Biocon bribery case against five people - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxQMGFqTjRYeTQ3OG1HdjVpNFV1RmxLVDdUeUpVTHNOeU4xVGtpRDJSU3dwb05jbl9lUERXTUtxa25fa0JabVFMTXgzbDZoangwVEhzWkxhWVhJX2JEUEpyVk5sd3haN2t5aVdOLUNaeWFDRk5LWTNTRjV5NEdmQ3B1dGZVMndkRDFTRGZkcVl2TlgwN1A3TEE3TmIxZXpGaHQtQzFNQVRpaWRpQV9WZmloWlVvQ2ZUM3Y0bnVrNjlndGZpMkstMnNvaHdzOTJkQQ?oc=5"" target=""_blank"">CBI files chargesheet in Biocon bribery case against five people</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxQMGFqTjRYeTQ3OG1HdjVpNFV1RmxLVDdUeUpVTHNOeU4xVGtpRDJSU3dwb05jbl9lUERXTUtxa25fa0JabVFMTXgzbDZoangwVEhzWkxhWVhJX2JEUEpyVk5sd3haN2t5aVdOLUNaeWFDRk5LWTNTRjV5NEdmQ3B1dGZVMndkRDFTRGZkcVl2TlgwN1A3TEE3TmIxZXpGaHQtQzFNQVRpaWRpQV9WZmloWlVvQ2ZUM3Y0bnVrNjlndGZpMkstMnNvaHdzOTJkQQ?oc=5,Google News,Biocon regulatory approval,"CBI files chargesheet in Biocon bribery case against five people - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxQMGFqTjRYeTQ3OG1HdjVpNFV1RmxLVDdUeUpVTHNOeU4xVGtpRDJSU3dwb05jbl9lUERXTUtxa25fa0JabVFMTXgzbDZoangwVEhzWkxhWVhJX2JEUEpyVk5sd3haN2t5aVdOLUNaeWFDRk5LWTNTRjV5NEdmQ3B1dGZVMndkRDFTRGZkcVl2TlgwN1A3TEE3TmIxZXpGaHQtQzFNQVRpaWRpQV9WZmloWlVvQ2ZUM3Y0bnVrNjlndGZpMkstMnNvaHdzOTJkQQ?oc=5"" target=""_blank"">CBI files chargesheet in Biocon bribery case against five people</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.5034695863723755,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.5034695863723755,other,0.0,[],False,True,6,0.0
2022-06-23,2022-06-23 07:00:00,"CBI arrests Biocon executive, four others in bribery case - The New Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">CBI arrests Biocon executive, four others in bribery case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News,Biocon regulatory approval,"CBI arrests Biocon executive, four others in bribery case - The New Indian Express <a href=""https://news.google.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?oc=5"" target=""_blank"">CBI arrests Biocon executive, four others in bribery case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",-0.8362470865249634,negative,0.8362470865249634,0.0,neutral,0.0,-0.7003,0.0,0.182,0.818,0.0909090909090909,0.30303030303030304,-0.47785547801426476,0.5424853924780181,other,0.0,[],False,True,6,0.0
2022-06-22,2022-06-22 07:00:00,Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOXzB3RUJSTENoQkRnaHZTekxaUmtDNlpZOGxqRDg4clhBQ3BhZXVsbTg0N0dnVktLS2pVRWFuVUxPelZJZ2gyZHN0TUI0eXRORldNTXdaSjNEcFVXRGdEWEpxM2h3N3IteFFBbWo1bHZDV1JLQmIxZlJfelN1Rm4wUnBqQUFOMkhyWDZGbFR5U2RiS1pBenVyMjhDYi1fMXJ2UDhDOUpjZ1hKZXdURVJUWXdFMTg2aHc5RUotUlN1NDVKUElGMW9YRzlRNmtXWDBzZGFhNnFYN2_SAd4BQVVfeXFMTnZWLVBGZldIc0FHMEt3ZjlTajhaMllXOWpxOGJOZG9YdG5XY1QwcEhZb2RyckJfdW44SU9raHJPRDNid21jNTBYcDhsd2VQRk5xdnM5LW1uQXM2YVRkcVRjMkRFR21Ob2JlUGRCSklFWFh6Z2xhYVBRS2RMYVB2UXd2UWs4enZEMEpYODdRa2c3bDVKVDhYVnlXNmVNNkh0azFjV2J3dlZGMkctd1YxTDNnWDIxOUZZMkFneEppWE1oam04aEN4ZXdnTUx5a1BrdDVPM0t2NU5PZVNKTllR?oc=5"" target=""_blank"">Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOXzB3RUJSTENoQkRnaHZTekxaUmtDNlpZOGxqRDg4clhBQ3BhZXVsbTg0N0dnVktLS2pVRWFuVUxPelZJZ2gyZHN0TUI0eXRORldNTXdaSjNEcFVXRGdEWEpxM2h3N3IteFFBbWo1bHZDV1JLQmIxZlJfelN1Rm4wUnBqQUFOMkhyWDZGbFR5U2RiS1pBenVyMjhDYi1fMXJ2UDhDOUpjZ1hKZXdURVJUWXdFMTg2aHc5RUotUlN1NDVKUElGMW9YRzlRNmtXWDBzZGFhNnFYN2_SAd4BQVVfeXFMTnZWLVBGZldIc0FHMEt3ZjlTajhaMllXOWpxOGJOZG9YdG5XY1QwcEhZb2RyckJfdW44SU9raHJPRDNid21jNTBYcDhsd2VQRk5xdnM5LW1uQXM2YVRkcVRjMkRFR21Ob2JlUGRCSklFWFh6Z2xhYVBRS2RMYVB2UXd2UWs4enZEMEpYODdRa2c3bDVKVDhYVnlXNmVNNkh0azFjV2J3dlZGMkctd1YxTDNnWDIxOUZZMkFneEppWE1oam04aEN4ZXdnTUx5a1BrdDVPM0t2NU5PZVNKTllR?oc=5,Google News,Biocon regulatory approval,"Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case - Medical Dialogues <a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOXzB3RUJSTENoQkRnaHZTekxaUmtDNlpZOGxqRDg4clhBQ3BhZXVsbTg0N0dnVktLS2pVRWFuVUxPelZJZ2gyZHN0TUI0eXRORldNTXdaSjNEcFVXRGdEWEpxM2h3N3IteFFBbWo1bHZDV1JLQmIxZlJfelN1Rm4wUnBqQUFOMkhyWDZGbFR5U2RiS1pBenVyMjhDYi1fMXJ2UDhDOUpjZ1hKZXdURVJUWXdFMTg2aHc5RUotUlN1NDVKUElGMW9YRzlRNmtXWDBzZGFhNnFYN2_SAd4BQVVfeXFMTnZWLVBGZldIc0FHMEt3ZjlTajhaMllXOWpxOGJOZG9YdG5XY1QwcEhZb2RyckJfdW44SU9raHJPRDNid21jNTBYcDhsd2VQRk5xdnM5LW1uQXM2YVRkcVRjMkRFR21Ob2JlUGRCSklFWFh6Z2xhYVBRS2RMYVB2UXd2UWs4enZEMEpYODdRa2c3bDVKVDhYVnlXNmVNNkh0azFjV2J3dlZGMkctd1YxTDNnWDIxOUZZMkFneEppWE1oam04aEN4ZXdnTUx5a1BrdDVPM0t2NU5PZVNKTllR?oc=5"" target=""_blank"">Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",-0.829997181892395,negative,0.829997181892395,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.47428410393851145,0.829997181892395,approval_process,0.780775398015976,['drug approval'],False,True,16,0.5615507960319519
2023-10-02,2023-10-02 07:00:00,"Viatris to sell India API, women’s healthcare biz for $1.2 bn - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Viatris to sell India API, women’s healthcare biz for $1.2 bn</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMiuwFBVV95cUxPS1ZZNnhIRm1WRjBxcG0xTGEtSnRDVGI1STlhTTNIcGpsLVFWbkN6WVpRVUU5TnF5OFUtZjRTTllfb3pSMlNSN2NBTmFleDcyTGxUTXNFeDJ4RHMtTW5xNTM3ZkNSOUYxRFpKOEd5TllzSVpmR2hROVhrQ05rcENoR0xVTjhBSXV2Y2c3NDluZm1zamQ0bEtkT0gxSHRnb3NOdjFWUE10NUNrVi1JenJXbm9Ya2xqQkEzVjUw0gHAAUFVX3lxTE5ub1ZISVBZUTZna0xjdXFMck5oWGxwSjdxWl90RHV2bGpZd2NodWtpWG1vQnIzZ0pRNTRnX1R4TEZ3blNfSl9iclFXRG13QkxTWDZmSU9KU3lzdTdZaDcyZkpsV1llN0pmRDBRZDIzem9iSEJDUlc2bHVzc3QtOEpzYW5IRlc5dUpoZ1RSbGZOZmwxTnpOM0pMX1laZkwzRG5vYmlwZ01tRzZKUmo0VEdPOWs3bTJBTk90cHZjczBaSw?oc=5,Google News,Biocon regulatory approval,"Viatris to sell India API, women’s healthcare biz for $1.2 bn - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Viatris to sell India API, women’s healthcare biz for $1.2 bn</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.8988125920295715,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8988125920295715,other,0.0,[],False,False,1,0.0
2025-06-04,2025-06-04 06:18:40,Biocon Cleared to Launch Generic Diabetes Drug in India - IndiaMedToday,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxQRFMwR2tranlUMjJkQmpTNFAyQmdxdHNubVM5aGFNRkdlTWZvUEVYR0RuY0Z4Rnl2eEk1SG5BLUZ5YzBneFlqaWdlWUpfaVFWSjBtLWJZOUJ5S2VFM2d3Zkl5cW5yZFdjMjBvWks5MmNLMVQ4TXJka3ZUTVZNRjhEcUpvQVZyUl9rTXc?oc=5"" target=""_blank"">Biocon Cleared to Launch Generic Diabetes Drug in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IndiaMedToday</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxQRFMwR2tranlUMjJkQmpTNFAyQmdxdHNubVM5aGFNRkdlTWZvUEVYR0RuY0Z4Rnl2eEk1SG5BLUZ5YzBneFlqaWdlWUpfaVFWSjBtLWJZOUJ5S2VFM2d3Zkl5cW5yZFdjMjBvWks5MmNLMVQ4TXJka3ZUTVZNRjhEcUpvQVZyUl9rTXc?oc=5,Google News,Biocon regulatory approval,"Biocon Cleared to Launch Generic Diabetes Drug in India - IndiaMedToday <a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxQRFMwR2tranlUMjJkQmpTNFAyQmdxdHNubVM5aGFNRkdlTWZvUEVYR0RuY0Z4Rnl2eEk1SG5BLUZ5YzBneFlqaWdlWUpfaVFWSjBtLWJZOUJ5S2VFM2d3Zkl5cW5yZFdjMjBvWks5MmNLMVQ4TXJka3ZUTVZNRjhEcUpvQVZyUl9rTXc?oc=5"" target=""_blank"">Biocon Cleared to Launch Generic Diabetes Drug in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IndiaMedToday</font>",0.6858667135238647,positive,0.6858667135238647,0.0,neutral,0.0,0.2023,0.123,0.0,0.877,0.0,0.0,0.3919238362993513,0.4440833567619324,other,0.0,[],False,True,6,0.0
2025-01-07,2025-01-07 08:00:00,Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval - theafricalogistics.com,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5"" target=""_blank"">Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theafricalogistics.com</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5,Google News,Biocon regulatory approval,"Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval - theafricalogistics.com <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5"" target=""_blank"">Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theafricalogistics.com</font>",0.835119903087616,positive,0.835119903087616,0.0,neutral,0.0,0.7579,0.263,0.0,0.737,0.0,0.06666666666666667,0.47721137319292345,0.796509951543808,approval_process,0.7522668242454529,['regulatory approval'],False,True,16,0.5045336484909058
2023-07-05,2023-07-05 07:00:00,Boehringer Ingelheim launches first interchangeable biosimilar to AbbVie's Humira - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxOZUF4dzl5cWoybEotdk5Zb2c0cTR2NmlEZUtpRDNtVkZWRFVub1J3bGtkRGNLRHpfQnYtcHNVdjFfdUo4T3FPZjg4eUtWTHJDX29nS0E0WWh3bnlIR2tlbGwzX0dPZW1UaUZvMjhiS2lBcXZOM3lHUVB2b3QyX3p3eHBGUVp3eUFSTHd1R05TNi15VXRTQlF5QWV1cEMyRTZzbG4tTW9vdTJnVllTNjlTd0ZSOA?oc=5"" target=""_blank"">Boehringer Ingelheim launches first interchangeable biosimilar to AbbVie's Humira</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxOZUF4dzl5cWoybEotdk5Zb2c0cTR2NmlEZUtpRDNtVkZWRFVub1J3bGtkRGNLRHpfQnYtcHNVdjFfdUo4T3FPZjg4eUtWTHJDX29nS0E0WWh3bnlIR2tlbGwzX0dPZW1UaUZvMjhiS2lBcXZOM3lHUVB2b3QyX3p3eHBGUVp3eUFSTHd1R05TNi15VXRTQlF5QWV1cEMyRTZzbG4tTW9vdTJnVllTNjlTd0ZSOA?oc=5,Google News,Biocon Semglee trial,"Boehringer Ingelheim launches first interchangeable biosimilar to AbbVie's Humira - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxOZUF4dzl5cWoybEotdk5Zb2c0cTR2NmlEZUtpRDNtVkZWRFVub1J3bGtkRGNLRHpfQnYtcHNVdjFfdUo4T3FPZjg4eUtWTHJDX29nS0E0WWh3bnlIR2tlbGwzX0dPZW1UaUZvMjhiS2lBcXZOM3lHUVB2b3QyX3p3eHBGUVp3eUFSTHd1R05TNi15VXRTQlF5QWV1cEMyRTZzbG4tTW9vdTJnVllTNjlTd0ZSOA?oc=5"" target=""_blank"">Boehringer Ingelheim launches first interchangeable biosimilar to AbbVie's Humira</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.7675918340682983,positive,0.7675918340682983,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.16666666666666666,0.2222222222222222,0.43862390518188477,0.4671292503674825,other,0.0,[],False,False,1,0.0
2025-03-06,2025-03-06 08:00:00,"Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMi5wFBVV95cUxNeVFmRjZpczFvYk5IZEg2dUJnNjFDV2JlcXhQOTloM2ktQWtVdnZQeG91QWd4bTEtVFpjRlh2ZUwzWlVDaDdIYkh2WVh3ZE9xQU9TeDQ0ZkgxM1I3UGg0R3lJWmFNRktFVU9BeHlfczRSczFuYTZTMmU1blIwdFNhejB6R1VFWTFZUDJncFB3WTdiRHp6YU9CY1I1cHl0T1RFZEFsWWxqXy1aQlJ2Und2dWlLaXZnOGxaUE0yWjJkWWtZVjRtN0Y0OG9zMmdoM2o1aGJtbzlUZmc1SWdQX1NnaS1ORy1CeVU?oc=5"" target=""_blank"">Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi5wFBVV95cUxNeVFmRjZpczFvYk5IZEg2dUJnNjFDV2JlcXhQOTloM2ktQWtVdnZQeG91QWd4bTEtVFpjRlh2ZUwzWlVDaDdIYkh2WVh3ZE9xQU9TeDQ0ZkgxM1I3UGg0R3lJWmFNRktFVU9BeHlfczRSczFuYTZTMmU1blIwdFNhejB6R1VFWTFZUDJncFB3WTdiRHp6YU9CY1I1cHl0T1RFZEFsWWxqXy1aQlJ2Und2dWlLaXZnOGxaUE0yWjJkWWtZVjRtN0Y0OG9zMmdoM2o1aGJtbzlUZmc1SWdQX1NnaS1ORy1CeVU?oc=5,Google News,Biocon insulin biosimilar,"Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi5wFBVV95cUxNeVFmRjZpczFvYk5IZEg2dUJnNjFDV2JlcXhQOTloM2ktQWtVdnZQeG91QWd4bTEtVFpjRlh2ZUwzWlVDaDdIYkh2WVh3ZE9xQU9TeDQ0ZkgxM1I3UGg0R3lJWmFNRktFVU9BeHlfczRSczFuYTZTMmU1blIwdFNhejB6R1VFWTFZUDJncFB3WTdiRHp6YU9CY1I1cHl0T1RFZEFsWWxqXy1aQlJ2Und2dWlLaXZnOGxaUE0yWjJkWWtZVjRtN0Y0OG9zMmdoM2o1aGJtbzlUZmc1SWdQX1NnaS1ORy1CeVU?oc=5"" target=""_blank"">Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.7902548313140869,positive,0.7902548313140869,0.0,neutral,0.0,0.8481,0.242,0.0,0.758,0.0,0.0,0.4515741893223354,0.8191774156570435,other,0.0,[],False,True,6,0.0
2024-12-05,2024-12-05 08:00:00,"Growth Trends in the Insulin Biosimilar Market, Forecast to 2034 - GlobeNewswire","<a href=""https://news.google.com/rss/articles/CBMi1gFBVV95cUxOTVlPYjZxMnd4Y2w5TW1POGJVZ2dFWXpDek5kSkJwdHpUMXZUemc2Yk83c3Z2S1JzU3dUeU9RcTA2R1JNVFFRbWFyN3RBY2F3X0RaellfaDl1TTZYeC1BVzJTbmMzNUlmakxnbXB0UkozQzg5ZXhOemFIdTNXVnNaSVlCemttS292RmhrVGNrbkZ3cGpWT3JGaVpld3dwdmt4WlNYY3VlbzNsdVc3bmF4SzZBc1dZRDlyYloxd3lubVUza2FoVWNrN29zRWJQd1plQ2NSVklR?oc=5"" target=""_blank"">Growth Trends in the Insulin Biosimilar Market, Forecast to 2034</a>&nbsp;&nbsp;<font color=""#6f6f6f"">GlobeNewswire</font>",https://news.google.com/rss/articles/CBMi1gFBVV95cUxOTVlPYjZxMnd4Y2w5TW1POGJVZ2dFWXpDek5kSkJwdHpUMXZUemc2Yk83c3Z2S1JzU3dUeU9RcTA2R1JNVFFRbWFyN3RBY2F3X0RaellfaDl1TTZYeC1BVzJTbmMzNUlmakxnbXB0UkozQzg5ZXhOemFIdTNXVnNaSVlCemttS292RmhrVGNrbkZ3cGpWT3JGaVpld3dwdmt4WlNYY3VlbzNsdVc3bmF4SzZBc1dZRDlyYloxd3lubVUza2FoVWNrN29zRWJQd1plQ2NSVklR?oc=5,Google News,Biocon insulin biosimilar,"Growth Trends in the Insulin Biosimilar Market, Forecast to 2034 - GlobeNewswire <a href=""https://news.google.com/rss/articles/CBMi1gFBVV95cUxOTVlPYjZxMnd4Y2w5TW1POGJVZ2dFWXpDek5kSkJwdHpUMXZUemc2Yk83c3Z2S1JzU3dUeU9RcTA2R1JNVFFRbWFyN3RBY2F3X0RaellfaDl1TTZYeC1BVzJTbmMzNUlmakxnbXB0UkozQzg5ZXhOemFIdTNXVnNaSVlCemttS292RmhrVGNrbkZ3cGpWT3JGaVpld3dwdmt4WlNYY3VlbzNsdVc3bmF4SzZBc1dZRDlyYloxd3lubVUza2FoVWNrN29zRWJQd1plQ2NSVklR?oc=5"" target=""_blank"">Growth Trends in the Insulin Biosimilar Market, Forecast to 2034</a>&nbsp;&nbsp;<font color=""#6f6f6f"">GlobeNewswire</font>",0.0,neutral,0.7995593547821045,0.0,neutral,0.0,0.3818,0.102,0.0,0.898,0.0,0.0,0.0,0.5906796773910522,other,0.0,[],False,False,1,0.0
2025-05-06,2025-05-06 07:00:00,Biocon Biologics secures market access coverage for Stelara biosimilar - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxQY1ZOdDZQZS1ibFVESUkzNUEtbE83ZmZTWFhycTN6TWtmb0l2T2p2bkZfeXkwS0l6SzFGeXRNMGJxQWhJV2kyQktqbXZiTHhQbXVvTk0wakFlWGxfcDBWTFJRc19RdGtMdjgtS2NQckdVeF9BcGcxMkNJQ2s5SWRpTjd1WHBJd0RwNjVSSm5rY2FZMjhEUllR?oc=5"" target=""_blank"">Biocon Biologics secures market access coverage for Stelara biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxQY1ZOdDZQZS1ibFVESUkzNUEtbE83ZmZTWFhycTN6TWtmb0l2T2p2bkZfeXkwS0l6SzFGeXRNMGJxQWhJV2kyQktqbXZiTHhQbXVvTk0wakFlWGxfcDBWTFJRc19RdGtMdjgtS2NQckdVeF9BcGcxMkNJQ2s5SWRpTjd1WHBJd0RwNjVSSm5rY2FZMjhEUllR?oc=5,Google News,Biocon insulin biosimilar,"Biocon Biologics secures market access coverage for Stelara biosimilar - Drug Store News <a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxQY1ZOdDZQZS1ibFVESUkzNUEtbE83ZmZTWFhycTN6TWtmb0l2T2p2bkZfeXkwS0l6SzFGeXRNMGJxQWhJV2kyQktqbXZiTHhQbXVvTk0wakFlWGxfcDBWTFJRc19RdGtMdjgtS2NQckdVeF9BcGcxMkNJQ2s5SWRpTjd1WHBJd0RwNjVSSm5rY2FZMjhEUllR?oc=5"" target=""_blank"">Biocon Biologics secures market access coverage for Stelara biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",0.0,neutral,0.6504703164100647,0.0,neutral,0.0,0.5574,0.161,0.0,0.839,0.0,0.0,0.0,0.6039351582050323,other,0.0,[],False,True,6,0.0
2025-05-13,2025-05-13 07:00:00,India's Biocon could fill gap created by reported Novo insulin pen retreat which risks drug access to kids with diabetes - newsindiatimes.com,"<a href=""https://news.google.com/rss/articles/CBMi5gFBVV95cUxPbmVRbVd5czZVTkJFanQwMjlnZm5yS3VLSFhhRURQWThiUmtueTVyYlFVOWRpZ0NlanFId3lWZC12ZHhCWjU0VGFMTVlNVlBMSDl1RzlkSE5BUloyUWRmcFNtMlhQNk1QMl9zUTllUktwb0MzaWxSZ192UWQ3cThxNlVaTTdmT1RSMDNQRjkwc3dEZWNtcXFMSnEzWHF1RWk5eWllLTE3UnRiTENoV2ZtVjBvd051TVRXVm1QZnBBa0JKNS1IZlRwTUZSMHNsakVxLVdsRlJoc0ZTb2g0Y2NySU9zU2VGdw?oc=5"" target=""_blank"">India's Biocon could fill gap created by reported Novo insulin pen retreat which risks drug access to kids with diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newsindiatimes.com</font>",https://news.google.com/rss/articles/CBMi5gFBVV95cUxPbmVRbVd5czZVTkJFanQwMjlnZm5yS3VLSFhhRURQWThiUmtueTVyYlFVOWRpZ0NlanFId3lWZC12ZHhCWjU0VGFMTVlNVlBMSDl1RzlkSE5BUloyUWRmcFNtMlhQNk1QMl9zUTllUktwb0MzaWxSZ192UWQ3cThxNlVaTTdmT1RSMDNQRjkwc3dEZWNtcXFMSnEzWHF1RWk5eWllLTE3UnRiTENoV2ZtVjBvd051TVRXVm1QZnBBa0JKNS1IZlRwTUZSMHNsakVxLVdsRlJoc0ZTb2g0Y2NySU9zU2VGdw?oc=5,Google News,Biocon insulin biosimilar,"India's Biocon could fill gap created by reported Novo insulin pen retreat which risks drug access to kids with diabetes - newsindiatimes.com <a href=""https://news.google.com/rss/articles/CBMi5gFBVV95cUxPbmVRbVd5czZVTkJFanQwMjlnZm5yS3VLSFhhRURQWThiUmtueTVyYlFVOWRpZ0NlanFId3lWZC12ZHhCWjU0VGFMTVlNVlBMSDl1RzlkSE5BUloyUWRmcFNtMlhQNk1QMl9zUTllUktwb0MzaWxSZ192UWQ3cThxNlVaTTdmT1RSMDNQRjkwc3dEZWNtcXFMSnEzWHF1RWk5eWllLTE3UnRiTENoV2ZtVjBvd051TVRXVm1QZnBBa0JKNS1IZlRwTUZSMHNsakVxLVdsRlJoc0ZTb2g0Y2NySU9zU2VGdw?oc=5"" target=""_blank"">India's Biocon could fill gap created by reported Novo insulin pen retreat which risks drug access to kids with diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newsindiatimes.com</font>",-0.7707032561302185,negative,0.7707032561302185,0.0,neutral,0.0,0.34,0.153,0.084,0.763,0.0,0.0,-0.4404018606458391,0.5553516280651093,other,0.0,[],False,True,6,0.0
2025-05-14,2025-05-14 07:00:00,"Biocon’s Kiran Mazumdar-Shaw looking at biosimilar unit merger, IPO plans on hold - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon’s Kiran Mazumdar-Shaw looking at biosimilar unit merger, IPO plans on hold</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon insulin biosimilar,"Biocon’s Kiran Mazumdar-Shaw looking at biosimilar unit merger, IPO plans on hold - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon’s Kiran Mazumdar-Shaw looking at biosimilar unit merger, IPO plans on hold</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.9156740307807922,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9156740307807922,other,0.0,[],False,True,6,0.0
2024-08-26,2024-08-26 07:00:00,Minister: Biocon Failed Human Insulin Supply Contractual Obligations - Galen Centre,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPRUFpUWpvaW1mX3d2TVlfbzRNclRHdk5IaDlqSzF0VzUtaV9EU2FWWVk5VXAxRHlMNkptNnZkTHBaM1JtdUdDNVJCMnMtYmI1ck5Rc18xV2YwX01BdlR5M1otelMxWjVPcDJmWDhMT3d3NW11RGl3VE9UUVZ4V1M0WXpUR3B2bW9CanFramF2djM1amFTTTNpZnpqa05tMF9xdjljWThIMWR1eXluY2c?oc=5"" target=""_blank"">Minister: Biocon Failed Human Insulin Supply Contractual Obligations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Galen Centre</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPRUFpUWpvaW1mX3d2TVlfbzRNclRHdk5IaDlqSzF0VzUtaV9EU2FWWVk5VXAxRHlMNkptNnZkTHBaM1JtdUdDNVJCMnMtYmI1ck5Rc18xV2YwX01BdlR5M1otelMxWjVPcDJmWDhMT3d3NW11RGl3VE9UUVZ4V1M0WXpUR3B2bW9CanFramF2djM1amFTTTNpZnpqa05tMF9xdjljWThIMWR1eXluY2c?oc=5,Google News,Biocon insulin biosimilar,"Minister: Biocon Failed Human Insulin Supply Contractual Obligations - Galen Centre <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPRUFpUWpvaW1mX3d2TVlfbzRNclRHdk5IaDlqSzF0VzUtaV9EU2FWWVk5VXAxRHlMNkptNnZkTHBaM1JtdUdDNVJCMnMtYmI1ck5Rc18xV2YwX01BdlR5M1otelMxWjVPcDJmWDhMT3d3NW11RGl3VE9UUVZ4V1M0WXpUR3B2bW9CanFramF2djM1amFTTTNpZnpqa05tMF9xdjljWThIMWR1eXluY2c?oc=5"" target=""_blank"">Minister: Biocon Failed Human Insulin Supply Contractual Obligations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Galen Centre</font>",0.0,neutral,0.739933431148529,0.0,neutral,0.0,-0.765,0.0,0.248,0.752,-0.2,0.15999999999999998,0.0,0.5683111437161764,other,0.0,[],False,True,6,0.0
2024-04-09,2024-04-09 07:00:00,"Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future - PharmaVoice","<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQVnV5ZXhReV9pVTMzSHpjN0ZDaUpKa0VaZHNxQzU2LUpMUnVQbnU3WG5rTkkzYzJ3ZEdfMHJIamF4aWwtcDNEN2taMXdocDRoY0duYkxTVkQwV1VKSDZ5U2NYMHEyaWNac3NYOGFEa0FrODIzRTBDV2M1ZElpSERCeng4SEhPYmxTX1ZMdHNPTnNJdlB5V3d6d3Jqbw?oc=5"" target=""_blank"">Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PharmaVoice</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxQVnV5ZXhReV9pVTMzSHpjN0ZDaUpKa0VaZHNxQzU2LUpMUnVQbnU3WG5rTkkzYzJ3ZEdfMHJIamF4aWwtcDNEN2taMXdocDRoY0duYkxTVkQwV1VKSDZ5U2NYMHEyaWNac3NYOGFEa0FrODIzRTBDV2M1ZElpSERCeng4SEhPYmxTX1ZMdHNPTnNJdlB5V3d6d3Jqbw?oc=5,Google News,Biocon insulin biosimilar,"Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future - PharmaVoice <a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQVnV5ZXhReV9pVTMzSHpjN0ZDaUpKa0VaZHNxQzU2LUpMUnVQbnU3WG5rTkkzYzJ3ZEdfMHJIamF4aWwtcDNEN2taMXdocDRoY0duYkxTVkQwV1VKSDZ5U2NYMHEyaWNac3NYOGFEa0FrODIzRTBDV2M1ZElpSERCeng4SEhPYmxTX1ZMdHNPTnNJdlB5V3d6d3Jqbw?oc=5"" target=""_blank"">Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PharmaVoice</font>",0.5625401139259338,positive,0.5625401139259338,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.53125,0.3214514936719622,0.5625401139259338,other,0.0,[],False,True,6,0.0
2024-10-17,2024-10-17 07:58:44,Biocon And Mylan's Fulphila And Insulin Plans On Track - insights.citeline.com,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxPZXl5VnR1SGlyQ3AxTDlQcUxPSnJfLXBoa3NBXzVIWVF0OHo2enhVMi1hRVU0U1J6d0lGeFVmR1oteEppMWpyYWxpMEtqckxxUkFMWUtHTkg4V3hKYk9mNEFJNVpqUWpwSTZJSXlfYWtLdzU3UV9vemYtTGh1T1VzZnIySk5GVFFkRXB4MXpKSXBlaFJ5NG1VZw?oc=5"" target=""_blank"">Biocon And Mylan's Fulphila And Insulin Plans On Track</a>&nbsp;&nbsp;<font color=""#6f6f6f"">insights.citeline.com</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxPZXl5VnR1SGlyQ3AxTDlQcUxPSnJfLXBoa3NBXzVIWVF0OHo2enhVMi1hRVU0U1J6d0lGeFVmR1oteEppMWpyYWxpMEtqckxxUkFMWUtHTkg4V3hKYk9mNEFJNVpqUWpwSTZJSXlfYWtLdzU3UV9vemYtTGh1T1VzZnIySk5GVFFkRXB4MXpKSXBlaFJ5NG1VZw?oc=5,Google News,Biocon insulin biosimilar,"Biocon And Mylan's Fulphila And Insulin Plans On Track - insights.citeline.com <a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxPZXl5VnR1SGlyQ3AxTDlQcUxPSnJfLXBoa3NBXzVIWVF0OHo2enhVMi1hRVU0U1J6d0lGeFVmR1oteEppMWpyYWxpMEtqckxxUkFMWUtHTkg4V3hKYk9mNEFJNVpqUWpwSTZJSXlfYWtLdzU3UV9vemYtTGh1T1VzZnIySk5GVFFkRXB4MXpKSXBlaFJ5NG1VZw?oc=5"" target=""_blank"">Biocon And Mylan's Fulphila And Insulin Plans On Track</a>&nbsp;&nbsp;<font color=""#6f6f6f"">insights.citeline.com</font>",0.0,neutral,0.9131475687026978,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9131475687026978,other,0.0,[],False,True,6,0.0
2024-03-14,2024-03-14 07:00:00,Biocon continues to divest with $150M sale of insulin and other brands to Eris - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5"" target=""_blank"">Biocon continues to divest with $150M sale of insulin and other brands to Eris</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5,Google News,Biocon insulin biosimilar,"Biocon continues to divest with $150M sale of insulin and other brands to Eris - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5"" target=""_blank"">Biocon continues to divest with $150M sale of insulin and other brands to Eris</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.9201367497444153,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.08333333333333333,0.25,0.0,0.5017350415388743,other,0.0,[],False,True,6,0.0
2023-11-30,2023-11-30 08:00:00,Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxPMVczdGtVNV93TDlNQXd6cG14a2FRX3Z2M0ZsVzA1bzVraEcyMFNPV3k3SktsSGdFcHhSMVJiTkRiS3FLempiWVQ4Nk9PeEZyX0dDVVNYbHRQMWpBMTZTdG5HNGRxdWZzUDlWbm5wYmpBc0ZDcmxCamhJRkEwVG1IUEZZZlpQRnNnaVBQWlhReGVVTGFpdU1xUTdObVBNLXIyUVh5UFJQSUgyUmItd1VlSjRKUHgzSzloYU5uMGtoVEhWZjFmUmUxS3lSbDFwT3NER09fQlZmeHVnY2Rrdy01VEFFZ2RPeDRzdlZQT1pBRDJJejJzSmU4TVJRdw?oc=5"" target=""_blank"">Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi-wFBVV95cUxPMVczdGtVNV93TDlNQXd6cG14a2FRX3Z2M0ZsVzA1bzVraEcyMFNPV3k3SktsSGdFcHhSMVJiTkRiS3FLempiWVQ4Nk9PeEZyX0dDVVNYbHRQMWpBMTZTdG5HNGRxdWZzUDlWbm5wYmpBc0ZDcmxCamhJRkEwVG1IUEZZZlpQRnNnaVBQWlhReGVVTGFpdU1xUTdObVBNLXIyUVh5UFJQSUgyUmItd1VlSjRKUHgzSzloYU5uMGtoVEhWZjFmUmUxS3lSbDFwT3NER09fQlZmeHVnY2Rrdy01VEFFZ2RPeDRzdlZQT1pBRDJJejJzSmU4TVJRdw?oc=5,Google News,Biocon insulin biosimilar,"Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxPMVczdGtVNV93TDlNQXd6cG14a2FRX3Z2M0ZsVzA1bzVraEcyMFNPV3k3SktsSGdFcHhSMVJiTkRiS3FLempiWVQ4Nk9PeEZyX0dDVVNYbHRQMWpBMTZTdG5HNGRxdWZzUDlWbm5wYmpBc0ZDcmxCamhJRkEwVG1IUEZZZlpQRnNnaVBQWlhReGVVTGFpdU1xUTdObVBNLXIyUVh5UFJQSUgyUmItd1VlSjRKUHgzSzloYU5uMGtoVEhWZjFmUmUxS3lSbDFwT3NER09fQlZmeHVnY2Rrdy01VEFFZ2RPeDRzdlZQT1pBRDJJejJzSmU4TVJRdw?oc=5"" target=""_blank"">Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.8307552933692932,positive,0.8307552933692932,0.0,neutral,0.0,0.7506,0.167,0.0,0.833,0.5,0.6333333333333333,0.474717310496739,0.6937850977897644,other,0.0,[],False,True,6,0.0
2023-08-10,2023-08-10 07:00:00,"Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5"" target=""_blank"">Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5,Google News,Biocon insulin biosimilar,"Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25% - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5"" target=""_blank"">Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.9453070163726807,positive,0.9453070163726807,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5401754379272461,0.9453070163726807,other,0.0,[],False,True,6,0.0
2023-02-17,2023-02-17 08:00:00,"Fierce Pharma Asia—Takeda's trial win, Biogen's pipeline pivot and Astellas' Super Bowl debut - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxPVG9vVlI3UkRtU0s1N2FKZjZES1dIbUZXUDhfX2ZQZFh5ZUxKZTNQUzRrMWpEX1lqYmk0ZTZ6MVNzb3dzUnliSTZDd2M0M1FxcEo4N3VJbVZPR05oMGtfQTl2dHBHc1ZmOEpsWjZPTW4xOFhWQ3NIaWRrWFNVazU2b2JhZThBMkYxWDRSQkV4SHJrRDFyaEMxOWxqelY3NTNraFNSLU5yZ0ptY1JJZVQ1UjN6OEhQdE5ZMGlzeDMwMnhoeDQ?oc=5"" target=""_blank"">Fierce Pharma Asia—Takeda's trial win, Biogen's pipeline pivot and Astellas' Super Bowl debut</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxPVG9vVlI3UkRtU0s1N2FKZjZES1dIbUZXUDhfX2ZQZFh5ZUxKZTNQUzRrMWpEX1lqYmk0ZTZ6MVNzb3dzUnliSTZDd2M0M1FxcEo4N3VJbVZPR05oMGtfQTl2dHBHc1ZmOEpsWjZPTW4xOFhWQ3NIaWRrWFNVazU2b2JhZThBMkYxWDRSQkV4SHJrRDFyaEMxOWxqelY3NTNraFNSLU5yZ0ptY1JJZVQ1UjN6OEhQdE5ZMGlzeDMwMnhoeDQ?oc=5,Google News,Biocon insulin biosimilar,"Fierce Pharma Asia—Takeda's trial win, Biogen's pipeline pivot and Astellas' Super Bowl debut - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxPVG9vVlI3UkRtU0s1N2FKZjZES1dIbUZXUDhfX2ZQZFh5ZUxKZTNQUzRrMWpEX1lqYmk0ZTZ6MVNzb3dzUnliSTZDd2M0M1FxcEo4N3VJbVZPR05oMGtfQTl2dHBHc1ZmOEpsWjZPTW4xOFhWQ3NIaWRrWFNVazU2b2JhZThBMkYxWDRSQkV4SHJrRDFyaEMxOWxqelY3NTNraFNSLU5yZ0ptY1JJZVQ1UjN6OEhQdE5ZMGlzeDMwMnhoeDQ?oc=5"" target=""_blank"">Fierce Pharma Asia—Takeda's trial win, Biogen's pipeline pivot and Astellas' Super Bowl debut</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.7825018763542175,0.0,neutral,0.0,0.9468,0.355,0.0,0.645,0.4533333333333333,0.42666666666666664,0.0,0.7275450698958502,other,0.0,[],False,False,1,0.0
2023-07-04,2023-07-04 07:00:00,Biosimilar Humira likely to boost US revenues for Biocon Biologics - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biosimilar Humira likely to boost US revenues for Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon insulin biosimilar,"Biosimilar Humira likely to boost US revenues for Biocon Biologics - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biosimilar Humira likely to boost US revenues for Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9488270878791809,positive,0.9488270878791809,0.0,neutral,0.0,0.6597,0.184,0.0,0.816,0.0,0.5,0.542186907359532,0.8042635439395904,other,0.0,[],False,True,6,0.0
2022-04-01,2022-04-01 07:00:00,"European Medicines Agency adopts positive opinion on Biocon Biologics, Inpremzia - ET HealthWorld","<a href=""https://news.google.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?oc=5"" target=""_blank"">European Medicines Agency adopts positive opinion on Biocon Biologics, Inpremzia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News,Biocon insulin biosimilar,"European Medicines Agency adopts positive opinion on Biocon Biologics, Inpremzia - ET HealthWorld <a href=""https://news.google.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?oc=5"" target=""_blank"">European Medicines Agency adopts positive opinion on Biocon Biologics, Inpremzia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.7956807017326355,positive,0.7956807017326355,0.0,neutral,0.0,0.8625,0.325,0.0,0.675,0.11363636363636363,0.2727272727272727,0.4546746867043632,0.590605688456333,other,0.0,[],False,True,6,0.0
2024-06-24,2024-06-24 07:00:00,Biocon Biologics Receives EMA Approval for New Biosimilar Facility - newskarnataka.com,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxOVkg4Z2c3bWp6N2pCTzVxMlBUXzNHTkIwNjgzRmZHazhsdExKNV9sYjQ5Q3NJWm5KbXpBMUk5MHRUbWlSZUxWOEc5Um1ETzZLMTBLWk9ZXzI4MUU1aDVuV2pxTnBfR3V5M01BUlJreFVpVjRxdkllY1FIcldSQ2ZvanNnVm1yQ1Rzb1gzZm9LTUFSa3hwNEw3YUh2dno5WUJBcVByc3hSc1dmbGRRMTV3?oc=5"" target=""_blank"">Biocon Biologics Receives EMA Approval for New Biosimilar Facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newskarnataka.com</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxOVkg4Z2c3bWp6N2pCTzVxMlBUXzNHTkIwNjgzRmZHazhsdExKNV9sYjQ5Q3NJWm5KbXpBMUk5MHRUbWlSZUxWOEc5Um1ETzZLMTBLWk9ZXzI4MUU1aDVuV2pxTnBfR3V5M01BUlJreFVpVjRxdkllY1FIcldSQ2ZvanNnVm1yQ1Rzb1gzZm9LTUFSa3hwNEw3YUh2dno5WUJBcVByc3hSc1dmbGRRMTV3?oc=5,Google News,Biocon insulin biosimilar,"Biocon Biologics Receives EMA Approval for New Biosimilar Facility - newskarnataka.com <a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxOVkg4Z2c3bWp6N2pCTzVxMlBUXzNHTkIwNjgzRmZHazhsdExKNV9sYjQ5Q3NJWm5KbXpBMUk5MHRUbWlSZUxWOEc5Um1ETzZLMTBLWk9ZXzI4MUU1aDVuV2pxTnBfR3V5M01BUlJreFVpVjRxdkllY1FIcldSQ2ZvanNnVm1yQ1Rzb1gzZm9LTUFSa3hwNEw3YUh2dno5WUJBcVByc3hSc1dmbGRRMTV3?oc=5"" target=""_blank"">Biocon Biologics Receives EMA Approval for New Biosimilar Facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newskarnataka.com</font>",0.6617307662963867,positive,0.6617307662963867,0.0,neutral,0.0,0.7351,0.237,0.0,0.763,0.0909090909090909,0.30303030303030304,0.37813186645507807,0.4959132857351592,approval_process,1.0,"['FDA approval', 'drug approval', 'biosimilar approval', 'interchangeable designation', 'marketing authorization', 'regulatory approval', 'FDA clearance']",False,True,21,0.7133358716964722
2024-12-02,2024-12-02 08:00:00,Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNaFJkbmZMcXBWSTBXcktrelhhbnBDOEFjMkRmRzg4M0Z3VmZxRjFhekc4U21YRmlvNUtmSG5tRDN4OVVyVV9MZDdpNkJrSnZvV2ZaTDRsZ3JsR2s3VUFoRW5YWWRaMEdqWEdPckpRaGhkamF6UmRSNllKWWlub1BVVEFWaHVJMGlNNzZQWWotbS1tOGM?oc=5"" target=""_blank"">Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxNaFJkbmZMcXBWSTBXcktrelhhbnBDOEFjMkRmRzg4M0Z3VmZxRjFhekc4U21YRmlvNUtmSG5tRDN4OVVyVV9MZDdpNkJrSnZvV2ZaTDRsZ3JsR2s3VUFoRW5YWWRaMEdqWEdPckpRaGhkamF6UmRSNllKWWlub1BVVEFWaHVJMGlNNzZQWWotbS1tOGM?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval - Equitypandit <a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNaFJkbmZMcXBWSTBXcktrelhhbnBDOEFjMkRmRzg4M0Z3VmZxRjFhekc4U21YRmlvNUtmSG5tRDN4OVVyVV9MZDdpNkJrSnZvV2ZaTDRsZ3JsR2s3VUFoRW5YWWRaMEdqWEdPckpRaGhkamF6UmRSNllKWWlub1BVVEFWaHVJMGlNNzZQWWotbS1tOGM?oc=5"" target=""_blank"">Biocon Shares Rally 4% as Subsidiary Receives USFDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.9109441041946411,positive,0.9109441041946411,0.0,neutral,0.0,0.7579,0.283,0.0,0.717,0.0,0.0,0.5205394881112235,0.8344220520973206,approval_process,0.7370373159646988,['FDA approval'],False,True,16,0.4740746319293976
2025-01-20,2025-01-20 08:00:00,India’s first global CAR T-cell therapy for Non-Hodgkin’s Lymphoma launched - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">India’s first global CAR T-cell therapy for Non-Hodgkin’s Lymphoma launched</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"India’s first global CAR T-cell therapy for Non-Hodgkin’s Lymphoma launched - The New Indian Express <a href=""https://news.google.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?oc=5"" target=""_blank"">India’s first global CAR T-cell therapy for Non-Hodgkin’s Lymphoma launched</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",0.0,neutral,0.6650047898292542,0.0,neutral,0.0,0.128,0.049,0.0,0.951,0.11038961038961038,0.2251082251082251,0.0,0.3011314667396215,other,0.0,[],False,False,1,0.0
2022-07-21,2022-07-21 07:00:00,"Biocon gets US FDA observations, says it’s committed to quality - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets US FDA observations, says it’s committed to quality</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Biocon gets US FDA observations, says it’s committed to quality - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets US FDA observations, says it’s committed to quality</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.5409818291664124,0.0,neutral,0.0,0.4939,0.16,0.0,0.84,0.0,0.0,0.0,0.5174409145832062,other,0.0,[],False,True,6,0.0
2023-09-27,2023-09-27 07:00:00,6 Immuno-oncology Startups Attracting the Biggest VC Cash - Genetic Engineering and Biotechnology News,"<a href=""https://news.google.com/rss/articles/CBMioAFBVV95cUxNNmxIemcwZTA3UjZoUXNZY0hpcVlFeENPNnhhRVV5amFZSG1kWXdsdWRPTzBGZG9faXZPbXk1Y2V4ME5NWTNJenZYSklnTlFudjdUVkx3VmhiS293dXlKZTAxYmFxbkhvODdiWDNsUmtsQ1RNRUd5aHVlNlczYXpsbUhvV05leTMwT0dxQ2hRdlZJaWFwSC1kbXRSWjdBT2hF?oc=5"" target=""_blank"">6 Immuno-oncology Startups Attracting the Biggest VC Cash</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Genetic Engineering and Biotechnology News</font>",https://news.google.com/rss/articles/CBMioAFBVV95cUxNNmxIemcwZTA3UjZoUXNZY0hpcVlFeENPNnhhRVV5amFZSG1kWXdsdWRPTzBGZG9faXZPbXk1Y2V4ME5NWTNJenZYSklnTlFudjdUVkx3VmhiS293dXlKZTAxYmFxbkhvODdiWDNsUmtsQ1RNRUd5aHVlNlczYXpsbUhvV05leTMwT0dxQ2hRdlZJaWFwSC1kbXRSWjdBT2hF?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"6 Immuno-oncology Startups Attracting the Biggest VC Cash - Genetic Engineering and Biotechnology News <a href=""https://news.google.com/rss/articles/CBMioAFBVV95cUxNNmxIemcwZTA3UjZoUXNZY0hpcVlFeENPNnhhRVV5amFZSG1kWXdsdWRPTzBGZG9faXZPbXk1Y2V4ME5NWTNJenZYSklnTlFudjdUVkx3VmhiS293dXlKZTAxYmFxbkhvODdiWDNsUmtsQ1RNRUd5aHVlNlczYXpsbUhvV05leTMwT0dxQ2hRdlZJaWFwSC1kbXRSWjdBT2hF?oc=5"" target=""_blank"">6 Immuno-oncology Startups Attracting the Biggest VC Cash</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Genetic Engineering and Biotechnology News</font>",0.0,neutral,0.5363659858703613,0.0,neutral,0.0,0.7351,0.199,0.0,0.801,0.0,0.0,0.0,0.6357329929351807,other,0.0,[],False,False,1,0.0
2023-09-20,2023-09-20 07:00:00,"For Biocon Biologics' CEO, the Humira biosimilar clash isn't only about market share - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxNLV9vb1c1Qlp6YTZ6NjhrZVlyeW5lNWV6LV9DczRPYU9CSml0V2RNNWFLTzlGUVpiLVotRktvUnV4Z1dPZ0c2ZnRjU1JteHRoUkZpNUNwOTI0RWFyWVIwaC1QNVlnWkxKNVRGb3QxUDJLUlhrZTdDWE1tY1NFY2NEMXFvbmZma3I3YWxLY3Z1RzU5bzBScVV1M0pZbjVaSk5NdGdHWkV0Qlk?oc=5"" target=""_blank"">For Biocon Biologics' CEO, the Humira biosimilar clash isn't only about market share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxNLV9vb1c1Qlp6YTZ6NjhrZVlyeW5lNWV6LV9DczRPYU9CSml0V2RNNWFLTzlGUVpiLVotRktvUnV4Z1dPZ0c2ZnRjU1JteHRoUkZpNUNwOTI0RWFyWVIwaC1QNVlnWkxKNVRGb3QxUDJLUlhrZTdDWE1tY1NFY2NEMXFvbmZma3I3YWxLY3Z1RzU5bzBScVV1M0pZbjVaSk5NdGdHWkV0Qlk?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"For Biocon Biologics' CEO, the Humira biosimilar clash isn't only about market share - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxNLV9vb1c1Qlp6YTZ6NjhrZVlyeW5lNWV6LV9DczRPYU9CSml0V2RNNWFLTzlGUVpiLVotRktvUnV4Z1dPZ0c2ZnRjU1JteHRoUkZpNUNwOTI0RWFyWVIwaC1QNVlnWkxKNVRGb3QxUDJLUlhrZTdDWE1tY1NFY2NEMXFvbmZma3I3YWxLY3Z1RzU5bzBScVV1M0pZbjVaSk5NdGdHWkV0Qlk?oc=5"" target=""_blank"">For Biocon Biologics' CEO, the Humira biosimilar clash isn't only about market share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.8852996230125427,0.0,neutral,0.0,0.296,0.066,0.0,0.934,0.0,0.6666666666666666,0.0,0.5906498115062714,other,0.0,[],False,True,6,0.0
2022-10-24,2022-10-24 07:00:00,Breaking: Kiran Mazumdar Shaw’s husband John Shaw passes away - Business Today,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxPaF9lN3c1c3NSYjZiMHgwbktIdXpGZ3Ywd2FfaXR5aFRBVjJOTmwyVnFOSDlzc3BYUXVGb1RvMjhTdHNISDZNeUQ3RHV5RFNyMkhrMWVqeGpGdW5UcnRvLTkyTnZWeWhVbUZRQVdLa0dYV0FqQkRBNDZWNG84RVhyOVpPSFZWcDl1alhBZFJQZnBWX1ktWDRWUmQwSUNKU2F6UDBIZnlmQ3BrX2NLb0lKdWhaNFBBZmJzU2ZWM3FwUF8xX3RWdHBmbFhMVXJPSWl3WWlNTUM3TGo?oc=5"" target=""_blank"">Breaking: Kiran Mazumdar Shaw’s husband John Shaw passes away</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxPaF9lN3c1c3NSYjZiMHgwbktIdXpGZ3Ywd2FfaXR5aFRBVjJOTmwyVnFOSDlzc3BYUXVGb1RvMjhTdHNISDZNeUQ3RHV5RFNyMkhrMWVqeGpGdW5UcnRvLTkyTnZWeWhVbUZRQVdLa0dYV0FqQkRBNDZWNG84RVhyOVpPSFZWcDl1alhBZFJQZnBWX1ktWDRWUmQwSUNKU2F6UDBIZnlmQ3BrX2NLb0lKdWhaNFBBZmJzU2ZWM3FwUF8xX3RWdHBmbFhMVXJPSWl3WWlNTUM3TGo?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Breaking: Kiran Mazumdar Shaw’s husband John Shaw passes away - Business Today <a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxPaF9lN3c1c3NSYjZiMHgwbktIdXpGZ3Ywd2FfaXR5aFRBVjJOTmwyVnFOSDlzc3BYUXVGb1RvMjhTdHNISDZNeUQ3RHV5RFNyMkhrMWVqeGpGdW5UcnRvLTkyTnZWeWhVbUZRQVdLa0dYV0FqQkRBNDZWNG84RVhyOVpPSFZWcDl1alhBZFJQZnBWX1ktWDRWUmQwSUNKU2F6UDBIZnlmQ3BrX2NLb0lKdWhaNFBBZmJzU2ZWM3FwUF8xX3RWdHBmbFhMVXJPSWl3WWlNTUM3TGo?oc=5"" target=""_blank"">Breaking: Kiran Mazumdar Shaw’s husband John Shaw passes away</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.5373478531837463,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.5373478531837463,other,0.0,[],False,True,6,0.0
2023-09-22,2023-09-22 07:00:00,Fierce Pharma Asia—Novartis and BeiGene's PD-1 breakup; Genentech's PeptiDream deal; Biocon's new CEO - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOYXpoT3FBci1xdktEelhMWUcwWm1BRy1TRFcyODJJRW1fdmgxdU5oRzVsZnJpcHJJX1dqZE05cUxzdHFwSEZZaVZNWXEwOUJjOElqTzBqVjBMLUJWRVdBaEhWaWtzR2lDVWFUOXdDQmtuZGYwTWFoeTFWMlEzZHhKaC15OWVOcTg0cjNzdDA3eGcwQ1Z3MTZWN2prSjRxNnpTRnBkek1fUUgwRUxpZ2c?oc=5"" target=""_blank"">Fierce Pharma Asia—Novartis and BeiGene's PD-1 breakup; Genentech's PeptiDream deal; Biocon's new CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxOYXpoT3FBci1xdktEelhMWUcwWm1BRy1TRFcyODJJRW1fdmgxdU5oRzVsZnJpcHJJX1dqZE05cUxzdHFwSEZZaVZNWXEwOUJjOElqTzBqVjBMLUJWRVdBaEhWaWtzR2lDVWFUOXdDQmtuZGYwTWFoeTFWMlEzZHhKaC15OWVOcTg0cjNzdDA3eGcwQ1Z3MTZWN2prSjRxNnpTRnBkek1fUUgwRUxpZ2c?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Fierce Pharma Asia—Novartis and BeiGene's PD-1 breakup; Genentech's PeptiDream deal; Biocon's new CEO - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOYXpoT3FBci1xdktEelhMWUcwWm1BRy1TRFcyODJJRW1fdmgxdU5oRzVsZnJpcHJJX1dqZE05cUxzdHFwSEZZaVZNWXEwOUJjOElqTzBqVjBMLUJWRVdBaEhWaWtzR2lDVWFUOXdDQmtuZGYwTWFoeTFWMlEzZHhKaC15OWVOcTg0cjNzdDA3eGcwQ1Z3MTZWN2prSjRxNnpTRnBkek1fUUgwRUxpZ2c?oc=5"" target=""_blank"">Fierce Pharma Asia—Novartis and BeiGene's PD-1 breakup; Genentech's PeptiDream deal; Biocon's new CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.745310366153717,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0909090909090909,0.30303030303030304,0.0,0.418109728531404,other,0.0,[],False,True,6,0.0
2024-12-16,2024-12-16 08:00:00,Approval of Biocon Biologics Yesintek recommended by EMA Committee - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Approval of Biocon Biologics Yesintek recommended by EMA Committee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Approval of Biocon Biologics Yesintek recommended by EMA Committee - Medical Dialogues <a href=""https://news.google.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?oc=5"" target=""_blank"">Approval of Biocon Biologics Yesintek recommended by EMA Committee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.0,neutral,0.8597530722618103,0.0,neutral,0.0,0.6908,0.242,0.0,0.758,0.0,0.0,0.0,0.7752765361309051,other,0.0,[],False,True,6,0.0
2022-03-14,2022-03-14 07:00:00,Niramai receives FDA clearance for SMILE-100 System - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Niramai receives FDA clearance for SMILE-100 System</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Niramai receives FDA clearance for SMILE-100 System - ET HealthWorld <a href=""https://news.google.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?oc=5"" target=""_blank"">Niramai receives FDA clearance for SMILE-100 System</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.7774776220321655,positive,0.7774776220321655,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.4442729268755231,0.7774776220321655,approval_process,0.8167530596256256,['FDA clearance'],False,False,11,0.6335061192512512
2025-01-12,2025-01-12 08:00:00,Biocon shares jump 4% as USFDA classifies Biocon Biologics site in Malaysia as voluntary action indicated; all you need to know - Upstox,"<a href=""https://news.google.com/rss/articles/CBMilAJBVV95cUxOWkdvaVNRTTNvcEwybG4zMlplQjBkV2cxOEdMdWhkcWppOHo0cGlWeDJTZEdOUV9Tcm96ZUNLT2dQb2h1U1FWdDJsSHdyOEJ6eVVHalFodVBaaE16MERnUjdxWV9KejhjZ19pV3ltVGJVZGRJV1h6QzdMUEdIVVd1RHJrSlRZQTRDRlJqSkE3ZDRkaVdRc3RndkktQ05VTk9RYjZhSWhGaWtvWmJzY0JuaHZ3OHRRcmVBYzBPbF9OcFpSeE1uY2w5Y09wWnVpQllkODlkNWxxT1RqV3ZIeVBvMGp4YkdBVWZOQmVFci00ZFZ2YkFnUU01MHdlOUQzVFBEN2x2T1pqUDJ0V3licEIyMk93bTM?oc=5"" target=""_blank"">Biocon shares jump 4% as USFDA classifies Biocon Biologics site in Malaysia as voluntary action indicated; all you need to know</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMilAJBVV95cUxOWkdvaVNRTTNvcEwybG4zMlplQjBkV2cxOEdMdWhkcWppOHo0cGlWeDJTZEdOUV9Tcm96ZUNLT2dQb2h1U1FWdDJsSHdyOEJ6eVVHalFodVBaaE16MERnUjdxWV9KejhjZ19pV3ltVGJVZGRJV1h6QzdMUEdIVVd1RHJrSlRZQTRDRlJqSkE3ZDRkaVdRc3RndkktQ05VTk9RYjZhSWhGaWtvWmJzY0JuaHZ3OHRRcmVBYzBPbF9OcFpSeE1uY2w5Y09wWnVpQllkODlkNWxxT1RqV3ZIeVBvMGp4YkdBVWZOQmVFci00ZFZ2YkFnUU01MHdlOUQzVFBEN2x2T1pqUDJ0V3licEIyMk93bTM?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Biocon shares jump 4% as USFDA classifies Biocon Biologics site in Malaysia as voluntary action indicated; all you need to know - Upstox <a href=""https://news.google.com/rss/articles/CBMilAJBVV95cUxOWkdvaVNRTTNvcEwybG4zMlplQjBkV2cxOEdMdWhkcWppOHo0cGlWeDJTZEdOUV9Tcm96ZUNLT2dQb2h1U1FWdDJsSHdyOEJ6eVVHalFodVBaaE16MERnUjdxWV9KejhjZ19pV3ltVGJVZGRJV1h6QzdMUEdIVVd1RHJrSlRZQTRDRlJqSkE3ZDRkaVdRc3RndkktQ05VTk9RYjZhSWhGaWtvWmJzY0JuaHZ3OHRRcmVBYzBPbF9OcFpSeE1uY2w5Y09wWnVpQllkODlkNWxxT1RqV3ZIeVBvMGp4YkdBVWZOQmVFci00ZFZ2YkFnUU01MHdlOUQzVFBEN2x2T1pqUDJ0V3licEIyMk93bTM?oc=5"" target=""_blank"">Biocon shares jump 4% as USFDA classifies Biocon Biologics site in Malaysia as voluntary action indicated; all you need to know</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.6306166052818298,positive,0.6306166052818298,0.0,neutral,0.0,0.5267,0.091,0.0,0.909,0.06666666666666667,0.06666666666666667,0.3603523458753313,0.40799442398283214,other,0.0,[],False,True,6,0.0
2024-09-12,2024-09-12 07:00:00,Lagarde says govts must act 'now' to reduce deficits - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Lagarde says govts must act 'now' to reduce deficits</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Lagarde says govts must act 'now' to reduce deficits - Moneycontrol <a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxQZHNPSTJfQ045S1g0VDlQX2FjMC10NFRnV0NBWkJsZHdqaVhpRkxRdmVhMkVmX3hfRldlRWhfQWZYbnc4UDJtQWZZbDFMT2dMV1VsZW50NXNSUExKem9MQ1NOVWdwdHVaRTE2dHhDVUF0VFloeUJVYkpicmdpcHFIVkpaM3NFV2o1ZFI1TDlwSFRfd2xwOERnV2ZRR01YMW94dUk4NHVKUnFJd1VmU3FFVGMzaGNOa2Foekd3bTB5aFlLWlVQZEJLZmVvT3plclRxWkh1ZEptMzFUWGh3UjJsam53TGvSAeoBQVVfeXFMUGR0Sk9zWWpqQ1M2X2NWWTVocTlsS1RiRmVCVGYtSU5mRHJENXhpT2g5WV85dVhyMnlaUlZESXdHcXVIZjRLajNRNzlVS21idGJad2lsSGdNc18yLWZkcFg3N0FxWmlMeWJicVdjN2hZNTFpakc3M3BqMUhuT3I1eURubnRTbkZHUW5xckg4cU1WSC1ZNnE2ZlFYajdtc0o1ZDBRalhfbnp6WmRNNEFoYVJaWlNEOXU2UmRXcDhXci1UX21UdGY3aWpuazdXSGVLTkdubnF1X2hTZ3d1YkN3S0gwQXpHWGY5Wi1n?oc=5"" target=""_blank"">Lagarde says govts must act 'now' to reduce deficits</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.7486808896064758,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7486808896064758,other,0.0,[],False,False,1,0.0
2024-06-24,2024-06-24 07:00:00,Biocon Biologics gets EMA nod to manufacture cancer drug in India - IBTimes India,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxNQ3J5WmFicEdTNkU1bkh6cFp4cVRXaUFGTVlBSmluVmlsX3d5dkJ1VjROWFpwdndkRHBvaUVaZ1lTVV81VFVMQ29FTWhpbWRlbDFUWlJNSFY1YWJIRHRzdjl6YlNSTzM5a0piTEhQRTRCLU9TS1k1NDBIRzUwenZfSUstVXJFZkV0MlNQVkl4OHZVOFVzdnNJ?oc=5"" target=""_blank"">Biocon Biologics gets EMA nod to manufacture cancer drug in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IBTimes India</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxNQ3J5WmFicEdTNkU1bkh6cFp4cVRXaUFGTVlBSmluVmlsX3d5dkJ1VjROWFpwdndkRHBvaUVaZ1lTVV81VFVMQ29FTWhpbWRlbDFUWlJNSFY1YWJIRHRzdjl6YlNSTzM5a0piTEhQRTRCLU9TS1k1NDBIRzUwenZfSUstVXJFZkV0MlNQVkl4OHZVOFVzdnNJ?oc=5,Google News,Kiran Mazumdar-Shaw FDA,"Biocon Biologics gets EMA nod to manufacture cancer drug in India - IBTimes India <a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxNQ3J5WmFicEdTNkU1bkh6cFp4cVRXaUFGTVlBSmluVmlsX3d5dkJ1VjROWFpwdndkRHBvaUVaZ1lTVV81VFVMQ29FTWhpbWRlbDFUWlJNSFY1YWJIRHRzdjl6YlNSTzM5a0piTEhQRTRCLU9TS1k1NDBIRzUwenZfSUstVXJFZkV0MlNQVkl4OHZVOFVzdnNJ?oc=5"" target=""_blank"">Biocon Biologics gets EMA nod to manufacture cancer drug in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IBTimes India</font>",0.6060309410095215,positive,0.6060309410095215,0.0,neutral,0.0,-0.8689,0.0,0.253,0.747,0.0,0.0,0.3463033948625837,0.7374654705047607,other,0.0,[],False,True,6,0.0
2025-03-07,2025-03-07 08:00:00,Biocon Biologics Announces Positive Results from Phase 3 Study of Yesintek™ Biosimilar to Ustekinumab for Chronic Plaque Psoriasis - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMikwJBVV95cUxQR1hrbHNMY2ZCQURrM0dmc2pKd3lmNG81SXRkWkFBOUN1M1R3WlUwa2c4UXZ0M1N0NmFfWlpTdUVsUnFJa0prY295OGhqV2syeDJRS3RWS0Q0ZXZ3dEJIRVF0WDRFMVhCRjBfMTlwTUJQeG9RSWdfc1l0bzljb3h2UG8zNC1WWFZGVkdNMlBLWXNvaC1BcGNUczlqMGVKZC0xNzNITF9EdUh3T09JUVQ5RkpKN2FHNlAxXy1LZkFubXdydjVUbVM2U09BSDkzYkxuOTFnV0xZY3g0aEhVTFBjTE9uU1pTOGdvNTA2N28zWnU1b1BycDJyYWV6bXRnaXdreG1LdF85dlJXaEJIRFJLSC1mbw?oc=5"" target=""_blank"">Biocon Biologics Announces Positive Results from Phase 3 Study of Yesintek™ Biosimilar to Ustekinumab for Chronic Plaque Psoriasis</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMikwJBVV95cUxQR1hrbHNMY2ZCQURrM0dmc2pKd3lmNG81SXRkWkFBOUN1M1R3WlUwa2c4UXZ0M1N0NmFfWlpTdUVsUnFJa0prY295OGhqV2syeDJRS3RWS0Q0ZXZ3dEJIRVF0WDRFMVhCRjBfMTlwTUJQeG9RSWdfc1l0bzljb3h2UG8zNC1WWFZGVkdNMlBLWXNvaC1BcGNUczlqMGVKZC0xNzNITF9EdUh3T09JUVQ5RkpKN2FHNlAxXy1LZkFubXdydjVUbVM2U09BSDkzYkxuOTFnV0xZY3g0aEhVTFBjTE9uU1pTOGdvNTA2N28zWnU1b1BycDJyYWV6bXRnaXdreG1LdF85dlJXaEJIRFJLSC1mbw?oc=5,Google News,Biocon biosimilarity study,"Biocon Biologics Announces Positive Results from Phase 3 Study of Yesintek™ Biosimilar to Ustekinumab for Chronic Plaque Psoriasis - PR Newswire <a href=""https://news.google.com/rss/articles/CBMikwJBVV95cUxQR1hrbHNMY2ZCQURrM0dmc2pKd3lmNG81SXRkWkFBOUN1M1R3WlUwa2c4UXZ0M1N0NmFfWlpTdUVsUnFJa0prY295OGhqV2syeDJRS3RWS0Q0ZXZ3dEJIRVF0WDRFMVhCRjBfMTlwTUJQeG9RSWdfc1l0bzljb3h2UG8zNC1WWFZGVkdNMlBLWXNvaC1BcGNUczlqMGVKZC0xNzNITF9EdUh3T09JUVQ5RkpKN2FHNlAxXy1LZkFubXdydjVUbVM2U09BSDkzYkxuOTFnV0xZY3g0aEhVTFBjTE9uU1pTOGdvNTA2N28zWnU1b1BycDJyYWV6bXRnaXdreG1LdF85dlJXaEJIRFJLSC1mbw?oc=5"" target=""_blank"">Biocon Biologics Announces Positive Results from Phase 3 Study of Yesintek™ Biosimilar to Ustekinumab for Chronic Plaque Psoriasis</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.8573395609855652,positive,0.8573395609855652,0.0,neutral,0.0,0.802,0.159,0.0,0.841,0.15151515151515152,0.3636363636363636,0.48990832056318007,0.6036182375002389,other,0.0,[],False,True,6,0.0
2025-04-10,2025-04-10 07:00:00,FDA Approves Biocon’s Avastin Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxOMHFSOXp6VmFjWTRHYV9uai1FV1FVcHB6dHgxT25ZWVBVem55cUtYMmRRa19pUEhjQUNNeUw2aE9qaDJtLVlkMWdRaUU1d1FEbm9IbWp5NHdkUndJZm44Nnlja0hfd0VFT1c0WVdLOExtaU5PYlJjWnZsM2c4dDN3YkxhVzNvUkM3a0R0cEVmaDJidw?oc=5"" target=""_blank"">FDA Approves Biocon’s Avastin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxOMHFSOXp6VmFjWTRHYV9uai1FV1FVcHB6dHgxT25ZWVBVem55cUtYMmRRa19pUEhjQUNNeUw2aE9qaDJtLVlkMWdRaUU1d1FEbm9IbWp5NHdkUndJZm44Nnlja0hfd0VFT1c0WVdLOExtaU5PYlJjWnZsM2c4dDN3YkxhVzNvUkM3a0R0cEVmaDJidw?oc=5,Google News,Biocon biosimilarity study,"FDA Approves Biocon’s Avastin Biosimilar - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxOMHFSOXp6VmFjWTRHYV9uai1FV1FVcHB6dHgxT25ZWVBVem55cUtYMmRRa19pUEhjQUNNeUw2aE9qaDJtLVlkMWdRaUU1d1FEbm9IbWp5NHdkUndJZm44Nnlja0hfd0VFT1c0WVdLOExtaU5PYlJjWnZsM2c4dDN3YkxhVzNvUkM3a0R0cEVmaDJidw?oc=5"" target=""_blank"">FDA Approves Biocon’s Avastin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.5403483510017395,positive,0.5403483510017395,0.0,neutral,0.0,0.6597,0.252,0.0,0.748,0.0,0.0,0.3087704862867083,0.6000241755008697,approval_process,0.8434768915176392,['FDA approval'],False,True,16,0.6869537830352783
2025-02-24,2025-02-24 08:00:00,Two New Stelara Biosimilars Now Available in US - Drug Topics,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOX1hJT052aGFOdEZndVFHTUp2T0FYYjNBZjdwY3VVSHZjQWItTTNmU1pIQ3BCYzZKUFI0ZFpOZVpMdW1OaWFKLWZrOUEtU0JDTjJEUUdGYXlOeTUyZXAwbzZGQnJYb1UtQVVMVXNGWHVNQUE0ci1GdGRwYTNzaExLZGpkTWRZdw?oc=5"" target=""_blank"">Two New Stelara Biosimilars Now Available in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Topics</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxOX1hJT052aGFOdEZndVFHTUp2T0FYYjNBZjdwY3VVSHZjQWItTTNmU1pIQ3BCYzZKUFI0ZFpOZVpMdW1OaWFKLWZrOUEtU0JDTjJEUUdGYXlOeTUyZXAwbzZGQnJYb1UtQVVMVXNGWHVNQUE0ci1GdGRwYTNzaExLZGpkTWRZdw?oc=5,Google News,Biocon biosimilarity study,"Two New Stelara Biosimilars Now Available in US - Drug Topics <a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOX1hJT052aGFOdEZndVFHTUp2T0FYYjNBZjdwY3VVSHZjQWItTTNmU1pIQ3BCYzZKUFI0ZFpOZVpMdW1OaWFKLWZrOUEtU0JDTjJEUUdGYXlOeTUyZXAwbzZGQnJYb1UtQVVMVXNGWHVNQUE0ci1GdGRwYTNzaExLZGpkTWRZdw?oc=5"" target=""_blank"">Two New Stelara Biosimilars Now Available in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Topics</font>",0.0,neutral,0.7575334906578064,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.21454545454545454,0.3418181818181818,0.0,0.4860394726016305,other,0.0,[],False,False,1,0.0
2025-03-07,2025-03-07 08:00:00,Biocon Biologics’ biosimilar Yesintek shows positive phase 3 results for psoriasis treatment - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics’ biosimilar Yesintek shows positive phase 3 results for psoriasis treatment</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon biosimilarity study,"Biocon Biologics’ biosimilar Yesintek shows positive phase 3 results for psoriasis treatment - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics’ biosimilar Yesintek shows positive phase 3 results for psoriasis treatment</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.7544798254966736,positive,0.7544798254966736,0.0,neutral,0.0,0.802,0.217,0.0,0.783,0.15151515151515152,0.3636363636363636,0.431131328855242,0.5693316590039418,other,0.0,[],False,True,6,0.0
2024-12-02,2024-12-02 08:00:00,"FDA Approves Biocon Biologics Ustekinumab Biosimilar, Yesintek - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxOMVVUc0JjMzRfeWZuWUJWS1B5cl9XQi1CZ3ZkZVVJVHEtR3hrbHRKUnpRR25lSzJyQjJqc2VCVlo2N2QwZk0yUkZWY1I4dDNObkFDVEN3Z3hMdXNTNGNuY0lQZ3B4VXFRUm9kNWIzdlc4ZnJSVGNOVGlINHk5MjNJVXNfb1FOYmd5UTNFSkpHU1l5bUl6ZUNPUzdoTzlKVmQtTXppNFhB?oc=5"" target=""_blank"">FDA Approves Biocon Biologics Ustekinumab Biosimilar, Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxOMVVUc0JjMzRfeWZuWUJWS1B5cl9XQi1CZ3ZkZVVJVHEtR3hrbHRKUnpRR25lSzJyQjJqc2VCVlo2N2QwZk0yUkZWY1I4dDNObkFDVEN3Z3hMdXNTNGNuY0lQZ3B4VXFRUm9kNWIzdlc4ZnJSVGNOVGlINHk5MjNJVXNfb1FOYmd5UTNFSkpHU1l5bUl6ZUNPUzdoTzlKVmQtTXppNFhB?oc=5,Google News,Biocon biosimilarity study,"FDA Approves Biocon Biologics Ustekinumab Biosimilar, Yesintek - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxOMVVUc0JjMzRfeWZuWUJWS1B5cl9XQi1CZ3ZkZVVJVHEtR3hrbHRKUnpRR25lSzJyQjJqc2VCVlo2N2QwZk0yUkZWY1I4dDNObkFDVEN3Z3hMdXNTNGNuY0lQZ3B4VXFRUm9kNWIzdlc4ZnJSVGNOVGlINHk5MjNJVXNfb1FOYmd5UTNFSkpHU1l5bUl6ZUNPUzdoTzlKVmQtTXppNFhB?oc=5"" target=""_blank"">FDA Approves Biocon Biologics Ustekinumab Biosimilar, Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.7611715793609619,0.0,neutral,0.0,0.6597,0.213,0.0,0.787,-0.05,0.05,0.0,0.49029052645365395,approval_process,1.0,"['FDA approval', 'drug approval', 'biosimilar approval', 'interchangeable designation', 'marketing authorization', 'regulatory approval', 'FDA clearance']",False,True,21,0.716026246547699
2025-02-24,2025-02-24 08:00:00,Biocon Biologics Launches Yesintek™ (ustekinumab-kfce) Biosimilar to Stelara® in the United States - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxPVVAwQXhELXZfWVVDdGhjRVh1U3lIMDIzVHlxYUl3RXA2azlGX3VDRUo4Znc1X1BITzV4MHZwLXRBQXNfTTdKQTJXd05jSGEwZHpvZVFJYjVlMjU0bE8xY1pXWG5vYTU5NGxpeUhoeXJRSi1uTFRTaDBNQkR5WW9jY2U2cHA5enlJMDZxc3RlWVVKRUwzNXJzYVQwVC1NVm1uMEhFQUIzREc2WkdPOFp6MkhwVk5EaDl0ME9POG9SUTdmUFhJN0xEQURsWjhVbmJPSWJKZkxpV204TEZwUlEyLUQ3bDg?oc=5"" target=""_blank"">Biocon Biologics Launches Yesintek™ (ustekinumab-kfce) Biosimilar to Stelara® in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxPVVAwQXhELXZfWVVDdGhjRVh1U3lIMDIzVHlxYUl3RXA2azlGX3VDRUo4Znc1X1BITzV4MHZwLXRBQXNfTTdKQTJXd05jSGEwZHpvZVFJYjVlMjU0bE8xY1pXWG5vYTU5NGxpeUhoeXJRSi1uTFRTaDBNQkR5WW9jY2U2cHA5enlJMDZxc3RlWVVKRUwzNXJzYVQwVC1NVm1uMEhFQUIzREc2WkdPOFp6MkhwVk5EaDl0ME9POG9SUTdmUFhJN0xEQURsWjhVbmJPSWJKZkxpV204TEZwUlEyLUQ3bDg?oc=5,Google News,Biocon biosimilarity study,"Biocon Biologics Launches Yesintek™ (ustekinumab-kfce) Biosimilar to Stelara® in the United States - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxPVVAwQXhELXZfWVVDdGhjRVh1U3lIMDIzVHlxYUl3RXA2azlGX3VDRUo4Znc1X1BITzV4MHZwLXRBQXNfTTdKQTJXd05jSGEwZHpvZVFJYjVlMjU0bE8xY1pXWG5vYTU5NGxpeUhoeXJRSi1uTFRTaDBNQkR5WW9jY2U2cHA5enlJMDZxc3RlWVVKRUwzNXJzYVQwVC1NVm1uMEhFQUIzREc2WkdPOFp6MkhwVk5EaDl0ME9POG9SUTdmUFhJN0xEQURsWjhVbmJPSWJKZkxpV204TEZwUlEyLUQ3bDg?oc=5"" target=""_blank"">Biocon Biologics Launches Yesintek™ (ustekinumab-kfce) Biosimilar to Stelara® in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.0,neutral,0.7775675058364868,0.0,neutral,0.0,0.6808,0.167,0.0,0.833,0.0,0.0,0.0,0.7291837529182434,other,0.0,[],False,True,6,0.0
2025-03-08,2025-03-08 08:00:00,Biocon Biologics announces positive results from Phase 3 Study of Yesintek biosimilar to Ustekinumab for chronic plaque psoriasis - Express Pharma,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics announces positive results from Phase 3 Study of Yesintek biosimilar to Ustekinumab for chronic plaque psoriasis</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News,Biocon biosimilarity study,"Biocon Biologics announces positive results from Phase 3 Study of Yesintek biosimilar to Ustekinumab for chronic plaque psoriasis - Express Pharma <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics announces positive results from Phase 3 Study of Yesintek biosimilar to Ustekinumab for chronic plaque psoriasis</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",0.8913295269012451,positive,0.8913295269012451,0.0,neutral,0.0,0.802,0.159,0.0,0.841,0.15151515151515152,0.3636363636363636,0.5093311582292829,0.614948226138799,other,0.0,[],False,True,6,0.0
2024-09-13,2024-09-13 07:00:00,Biosimilar Matches Aflibercept for Diabetic Macular Edema - Medscape,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxNdWVaRnNuakdZOGFpaG41WXNvYlhPUzZNYUFQa0t4cThrUVhCTDZ1cDNiMVl3RFVEMVctbl9lZ1NVVDA4QjZVeFhIVGVSUVpPRDNKU3hNWXJCMHF0djBiOVV6SXU3NkxPX0IwTjYtQ0Vub1FJaVphVnJ5TFpZN1l6S3dwSkpPRi1pOW11UlRCbWltRlNWcTBMZG5MbnpKRUVxdzhKdl93?oc=5"" target=""_blank"">Biosimilar Matches Aflibercept for Diabetic Macular Edema</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medscape</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxNdWVaRnNuakdZOGFpaG41WXNvYlhPUzZNYUFQa0t4cThrUVhCTDZ1cDNiMVl3RFVEMVctbl9lZ1NVVDA4QjZVeFhIVGVSUVpPRDNKU3hNWXJCMHF0djBiOVV6SXU3NkxPX0IwTjYtQ0Vub1FJaVphVnJ5TFpZN1l6S3dwSkpPRi1pOW11UlRCbWltRlNWcTBMZG5MbnpKRUVxdzhKdl93?oc=5,Google News,Biocon biosimilarity study,"Biosimilar Matches Aflibercept for Diabetic Macular Edema - Medscape <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxNdWVaRnNuakdZOGFpaG41WXNvYlhPUzZNYUFQa0t4cThrUVhCTDZ1cDNiMVl3RFVEMVctbl9lZ1NVVDA4QjZVeFhIVGVSUVpPRDNKU3hNWXJCMHF0djBiOVV6SXU3NkxPX0IwTjYtQ0Vub1FJaVphVnJ5TFpZN1l6S3dwSkpPRi1pOW11UlRCbWltRlNWcTBMZG5MbnpKRUVxdzhKdl93?oc=5"" target=""_blank"">Biosimilar Matches Aflibercept for Diabetic Macular Edema</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medscape</font>",0.0,neutral,0.8537660241127014,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8537660241127014,other,0.0,[],False,False,1,0.0
2024-09-25,2024-09-25 07:00:00,Results from Biocon Biologics supports interchangeability of psoriasis cure - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Results from Biocon Biologics supports interchangeability of psoriasis cure</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon biosimilarity study,"Results from Biocon Biologics supports interchangeability of psoriasis cure - Business Standard <a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxOcXFyT2wwNFdOc3ZhOEwyVms2MC1OVVZJaWx5bHBLQlgyT2UwSl9Fb0dCX3ZPNjRqeVQ0cG5mdjNUS3dBd0RsUmVWRllOUFF5cWtxQ0NCR2ZETXBKSkJZVFJJWFZfSWJPRmRWaEtaZnc4ZTlUTW1NNmtEdEVTRU1NOTVlN0RwWkRlU1N1MGxJQUlmZ0NsS2tfV0g2bmRITXFlMUlFWXVqbDE5RldSUV83UWFQeHZrWE9iREJhNG9SWGZZY0Joc2hkbkJpSW5ZRmlSMGREQnBoelR0bEXSAeABQVVfeXFMTXRiSHdUUUxiQWRkdUVoX29hRFlVR2VNUzRMZTFjLXdYSjRFZnlHT3poaUpLMWNCekpPeHBHVzF4WEE5Q1F3QWViYjktU0Y5SHAwamVtNUJOR1NwQVRqYVZSNG5sdURNdTBzZlU4dmpkek9pa016MF8wcFpwNktkaFhFVHo5VUdtUWRIYUMtRUYtMXFwZnA0U0QtT0NYT1Jfb0lUT1ZIS2xzMWhIdm9jX0c2a21UZk9objlxZnE0QjlDU3g3LTk1NllrVHlBclJFZDBnNXpqbXdHeXlQRG9GRGw?oc=5"" target=""_blank"">Results from Biocon Biologics supports interchangeability of psoriasis cure</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.7579692602157593,positive,0.7579692602157593,0.0,neutral,0.0,0.6124,0.185,0.0,0.815,0.0,0.0,0.43312529155186247,0.6851846301078797,other,0.0,[],False,True,6,0.0
2024-09-25,2024-09-25 07:00:00,Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024 - The Manila Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Manila Times</font>",https://news.google.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?oc=5,Google News,Biocon biosimilarity study,"Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024 - The Manila Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics Announces New Dermatology Data to Be Presented at EADV Congress 2024</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Manila Times</font>",0.0,neutral,0.9406890869140625,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0909090909090909,0.30303030303030304,0.0,0.5157990889115767,other,0.0,[],False,True,6,0.0
2025-03-10,2025-03-10 07:00:00,"This new study offers greater relief to India's psoriasis patients, hopefully - The New Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">This new study offers greater relief to India's psoriasis patients, hopefully</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News,Biocon biosimilarity study,"This new study offers greater relief to India's psoriasis patients, hopefully - The New Indian Express <a href=""https://news.google.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?oc=5"" target=""_blank"">This new study offers greater relief to India's psoriasis patients, hopefully</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",0.8257483243942261,positive,0.8257483243942261,0.0,neutral,0.0,0.9169,0.34,0.0,0.66,0.19393939393939397,0.31313131313131315,0.4718561853681292,0.64552923944454,other,0.0,[],False,False,1,0.0
2025-03-07,2025-03-07 08:00:00,Biosimilar Ustekinumab-Kfce Shows Equivalence to Stelara - Drug Topics,"<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxPZDVrbFkwdjdJT1h6ZjAyZDBpZk85VWtDemYwemNxN2U3Z2VqRmJxNUNSUTBvbE1ZZ01WcHMyYlFyMGVWSS1rZlZEWWtEME0wNm0yY1N2bDRUTU5nMlNrYnZrTzBvZVFwMkM0cDBCZ2dMb0VPTlhWZU9kNmszZ0VEQm0tMlczSU9sdU11QnBrVFVGdw?oc=5"" target=""_blank"">Biosimilar Ustekinumab-Kfce Shows Equivalence to Stelara</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Topics</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxPZDVrbFkwdjdJT1h6ZjAyZDBpZk85VWtDemYwemNxN2U3Z2VqRmJxNUNSUTBvbE1ZZ01WcHMyYlFyMGVWSS1rZlZEWWtEME0wNm0yY1N2bDRUTU5nMlNrYnZrTzBvZVFwMkM0cDBCZ2dMb0VPTlhWZU9kNmszZ0VEQm0tMlczSU9sdU11QnBrVFVGdw?oc=5,Google News,Biocon biosimilarity study,"Biosimilar Ustekinumab-Kfce Shows Equivalence to Stelara - Drug Topics <a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxPZDVrbFkwdjdJT1h6ZjAyZDBpZk85VWtDemYwemNxN2U3Z2VqRmJxNUNSUTBvbE1ZZ01WcHMyYlFyMGVWSS1rZlZEWWtEME0wNm0yY1N2bDRUTU5nMlNrYnZrTzBvZVFwMkM0cDBCZ2dMb0VPTlhWZU9kNmszZ0VEQm0tMlczSU9sdU11QnBrVFVGdw?oc=5"" target=""_blank"">Biosimilar Ustekinumab-Kfce Shows Equivalence to Stelara</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Topics</font>",0.7275333404541016,positive,0.7275333404541016,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.41573333740234375,0.7275333404541016,other,0.0,[],False,False,1,0.0
2025-05-09,2025-05-09 07:00:00,"Eye on Pharma: Interchangeability, Private Labels, and Patent Settlements for Biosimilars - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxPSkVKWkZGWlZyaFNGLWdiMmVkNUpnY0tMVWc3Sld1YVdBbzlxQV9TcUdGZk0xQW9EWFlKSElockpCWE1BNnFtNzdOckdNYXlCU0gwTDJOOUJzUF95b2dmSVc2YXFnLXA1ZE45Z29TeTVuLW5Ec2NiOUhycVo4d2RGbkhMSDZSbktKSGcwbXNqTFRFdjYtS1ltemhZS1NjZWt3WlVDdDNEd2l3cUFEdTdkUHhBWWc4OTFyMU1tSXJ6SEtuU3UyWkZz?oc=5"" target=""_blank"">Eye on Pharma: Interchangeability, Private Labels, and Patent Settlements for Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxPSkVKWkZGWlZyaFNGLWdiMmVkNUpnY0tMVWc3Sld1YVdBbzlxQV9TcUdGZk0xQW9EWFlKSElockpCWE1BNnFtNzdOckdNYXlCU0gwTDJOOUJzUF95b2dmSVc2YXFnLXA1ZE45Z29TeTVuLW5Ec2NiOUhycVo4d2RGbkhMSDZSbktKSGcwbXNqTFRFdjYtS1ltemhZS1NjZWt3WlVDdDNEd2l3cUFEdTdkUHhBWWc4OTFyMU1tSXJ6SEtuU3UyWkZz?oc=5,Google News,Biocon biosimilarity study,"Eye on Pharma: Interchangeability, Private Labels, and Patent Settlements for Biosimilars - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxPSkVKWkZGWlZyaFNGLWdiMmVkNUpnY0tMVWc3Sld1YVdBbzlxQV9TcUdGZk0xQW9EWFlKSElockpCWE1BNnFtNzdOckdNYXlCU0gwTDJOOUJzUF95b2dmSVc2YXFnLXA1ZE45Z29TeTVuLW5Ec2NiOUhycVo4d2RGbkhMSDZSbktKSGcwbXNqTFRFdjYtS1ltemhZS1NjZWt3WlVDdDNEd2l3cUFEdTdkUHhBWWc4OTFyMU1tSXJ6SEtuU3UyWkZz?oc=5"" target=""_blank"">Eye on Pharma: Interchangeability, Private Labels, and Patent Settlements for Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.8797520399093628,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.025,0.2125,0.0,0.4523760199546814,other,0.0,[],False,False,1,0.0
2025-04-15,2025-04-15 07:00:00,"Biocon reaches settlement agreement with Regeneron to launch aflibercept biosimilar, Yesafili, in the US - Ophthalmology Times","<a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxNVm9YZXd4M1BUVW1HdmhyNEN2QlZQQnBLMDJ4cXVPclJJbWRQN01FZEc3UnM5b2tVWmxSUWJ1aVItSU8zNm5UdmxFZmYwbk4xMXU2ekhCdUtLVjB5WnVmRXBTRF9zdG1veDd5X1djeHB0em55M1J4YWU4S2NZdDNGNzRUR0FXLXN5d3dfb1Y1V01LLUNFWGRmTkl2UERlbnNMNUNET1dJcDJ3T1QtUk9CMF9nbVRndFBZa3c1SUppc3ZDWmR4V2Z1S2JiNXJ5Mi14MExyVkk2WVlUbTg?oc=5"" target=""_blank"">Biocon reaches settlement agreement with Regeneron to launch aflibercept biosimilar, Yesafili, in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Ophthalmology Times</font>",https://news.google.com/rss/articles/CBMi2wFBVV95cUxNVm9YZXd4M1BUVW1HdmhyNEN2QlZQQnBLMDJ4cXVPclJJbWRQN01FZEc3UnM5b2tVWmxSUWJ1aVItSU8zNm5UdmxFZmYwbk4xMXU2ekhCdUtLVjB5WnVmRXBTRF9zdG1veDd5X1djeHB0em55M1J4YWU4S2NZdDNGNzRUR0FXLXN5d3dfb1Y1V01LLUNFWGRmTkl2UERlbnNMNUNET1dJcDJ3T1QtUk9CMF9nbVRndFBZa3c1SUppc3ZDWmR4V2Z1S2JiNXJ5Mi14MExyVkk2WVlUbTg?oc=5,Google News,Biocon biosimilarity study,"Biocon reaches settlement agreement with Regeneron to launch aflibercept biosimilar, Yesafili, in the US - Ophthalmology Times <a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxNVm9YZXd4M1BUVW1HdmhyNEN2QlZQQnBLMDJ4cXVPclJJbWRQN01FZEc3UnM5b2tVWmxSUWJ1aVItSU8zNm5UdmxFZmYwbk4xMXU2ekhCdUtLVjB5WnVmRXBTRF9zdG1veDd5X1djeHB0em55M1J4YWU4S2NZdDNGNzRUR0FXLXN5d3dfb1Y1V01LLUNFWGRmTkl2UERlbnNMNUNET1dJcDJ3T1QtUk9CMF9nbVRndFBZa3c1SUppc3ZDWmR4V2Z1S2JiNXJ5Mi14MExyVkk2WVlUbTg?oc=5"" target=""_blank"">Biocon reaches settlement agreement with Regeneron to launch aflibercept biosimilar, Yesafili, in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Ophthalmology Times</font>",0.9213704466819763,positive,0.9213704466819763,0.0,neutral,0.0,0.7783,0.227,0.0,0.773,0.0,0.0,0.5264973981039864,0.8498352233409882,other,0.0,[],False,True,6,0.0
2025-04-07,2025-04-07 07:00:00,Unlocking the full potential of biosimilars - The Pharma Letter,"<a href=""https://news.google.com/rss/articles/CBMigAFBVV95cUxNRjc4SnhpUUtsSEh6VEMzajYxdE9OdXhlaWJLeDNOWWplbmZWRERKbjNzcUZMYUFRMHQ2cFlHTWdxR3UteVRfYUpOd1h0X1BtUVBqanBNNmpXVXJhbjhfY08wbG1lUzZlbURtSmRFa0g3Q09LMW9mY1QwSlBkWUhkcQ?oc=5"" target=""_blank"">Unlocking the full potential of biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Pharma Letter</font>",https://news.google.com/rss/articles/CBMigAFBVV95cUxNRjc4SnhpUUtsSEh6VEMzajYxdE9OdXhlaWJLeDNOWWplbmZWRERKbjNzcUZMYUFRMHQ2cFlHTWdxR3UteVRfYUpOd1h0X1BtUVBqanBNNmpXVXJhbjhfY08wbG1lUzZlbURtSmRFa0g3Q09LMW9mY1QwSlBkWUhkcQ?oc=5,Google News,Biocon biosimilarity study,"Unlocking the full potential of biosimilars - The Pharma Letter <a href=""https://news.google.com/rss/articles/CBMigAFBVV95cUxNRjc4SnhpUUtsSEh6VEMzajYxdE9OdXhlaWJLeDNOWWplbmZWRERKbjNzcUZMYUFRMHQ2cFlHTWdxR3UteVRfYUpOd1h0X1BtUVBqanBNNmpXVXJhbjhfY08wbG1lUzZlbURtSmRFa0g3Q09LMW9mY1QwSlBkWUhkcQ?oc=5"" target=""_blank"">Unlocking the full potential of biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Pharma Letter</font>",0.0,neutral,0.7495571374893188,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13999999999999999,0.62,0.0,0.44477856874465943,other,0.0,[],False,False,1,0.0
2025-03-18,2025-03-18 07:00:00,"Promising Results for Ustekinumab, Adalimumab Biosimilars Presented at AAD - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxOUmpOR05HMkt2N05EZWxpY1FDS3pqM3ZuM0Jkdm5pSmtHcERzUGlRRnI4RW5fSkZZc1JTNXNFblczWkFtVDJrN05DVS16Zl84bjRjV1BrektmSWs5Qnl6THJaZ3JDU3RjRDR1V0ZBYjVnZXhxa1ZLTkM4RnlJUUtFVm1zUFRfdzVDZl82VVlBNk5NY0VVNHJhYTdIUUdvOVVxZlZOT2d6ck5QMTZRbktFWHRZc1dXdw?oc=5"" target=""_blank"">Promising Results for Ustekinumab, Adalimumab Biosimilars Presented at AAD</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxOUmpOR05HMkt2N05EZWxpY1FDS3pqM3ZuM0Jkdm5pSmtHcERzUGlRRnI4RW5fSkZZc1JTNXNFblczWkFtVDJrN05DVS16Zl84bjRjV1BrektmSWs5Qnl6THJaZ3JDU3RjRDR1V0ZBYjVnZXhxa1ZLTkM4RnlJUUtFVm1zUFRfdzVDZl82VVlBNk5NY0VVNHJhYTdIUUdvOVVxZlZOT2d6ck5QMTZRbktFWHRZc1dXdw?oc=5,Google News,Biocon biosimilarity study,"Promising Results for Ustekinumab, Adalimumab Biosimilars Presented at AAD - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxOUmpOR05HMkt2N05EZWxpY1FDS3pqM3ZuM0Jkdm5pSmtHcERzUGlRRnI4RW5fSkZZc1JTNXNFblczWkFtVDJrN05DVS16Zl84bjRjV1BrektmSWs5Qnl6THJaZ3JDU3RjRDR1V0ZBYjVnZXhxa1ZLTkM4RnlJUUtFVm1zUFRfdzVDZl82VVlBNk5NY0VVNHJhYTdIUUdvOVVxZlZOT2d6ck5QMTZRbktFWHRZc1dXdw?oc=5"" target=""_blank"">Promising Results for Ustekinumab, Adalimumab Biosimilars Presented at AAD</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.8790819644927979,positive,0.8790819644927979,0.0,neutral,0.0,0.4019,0.097,0.0,0.903,0.03333333333333333,0.19999999999999998,0.5023325511387416,0.43810509927537705,other,0.0,[],False,False,1,0.0
2024-05-21,2024-05-21 07:00:00,Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeGRuOEpEaURCa1IyQjZsSzkydERHN2VJYmdHSm1pZFRhMFN4SzdJcDZCVERQbHZJQVczVVJjQUFQNXNyZWpLLTBiVjhuMUhwWWZkVHVPNjlUUUh0X3RHQTAxdHE0WHdhdGVJWDZ5U0ZVMzZydjMxRmtWUng3OWFQSFpIUmw4ME1MYjNiNHEtOEd5aUtFRDh3N3dvd0xfQmNSQmRMNFcxV2ZyWlZFUEFxNUdIOHFMWktOMFgyLTJmVC1pUWxwQUVjVEJVS2xiNnhTRWJCSEZUNzFBbzdCNHNVWTZhMFJqNzYwa0gxVTRBRUlQVmVuZUxFajNKcw?oc=5"" target=""_blank"">Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeGRuOEpEaURCa1IyQjZsSzkydERHN2VJYmdHSm1pZFRhMFN4SzdJcDZCVERQbHZJQVczVVJjQUFQNXNyZWpLLTBiVjhuMUhwWWZkVHVPNjlUUUh0X3RHQTAxdHE0WHdhdGVJWDZ5U0ZVMzZydjMxRmtWUng3OWFQSFpIUmw4ME1MYjNiNHEtOEd5aUtFRDh3N3dvd0xfQmNSQmRMNFcxV2ZyWlZFUEFxNUdIOHFMWktOMFgyLTJmVC1pUWxwQUVjVEJVS2xiNnhTRWJCSEZUNzFBbzdCNHNVWTZhMFJqNzYwa0gxVTRBRUlQVmVuZUxFajNKcw?oc=5,Google News,Biocon biosimilarity study,"Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxOeGRuOEpEaURCa1IyQjZsSzkydERHN2VJYmdHSm1pZFRhMFN4SzdJcDZCVERQbHZJQVczVVJjQUFQNXNyZWpLLTBiVjhuMUhwWWZkVHVPNjlUUUh0X3RHQTAxdHE0WHdhdGVJWDZ5U0ZVMzZydjMxRmtWUng3OWFQSFpIUmw4ME1MYjNiNHEtOEd5aUtFRDh3N3dvd0xfQmNSQmRMNFcxV2ZyWlZFUEFxNUdIOHFMWktOMFgyLTJmVC1pUWxwQUVjVEJVS2xiNnhTRWJCSEZUNzFBbzdCNHNVWTZhMFJqNzYwa0gxVTRBRUlQVmVuZUxFajNKcw?oc=5"" target=""_blank"">Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S. Ophthalmology Market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.6510518789291382,positive,0.6510518789291382,0.0,neutral,0.0,0.7351,0.154,0.0,0.846,0.0,0.0,0.37202964510236464,0.6930759394645691,approval_process,0.8232651948928833,['FDA approval'],False,True,16,0.6465303897857666
2025-04-13,2025-04-13 07:00:00,"The Global Biosimilar Development and Approval of Yesintek With Elena Wolff-Holz, MD - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxPLTM1MlB0SWIyRXJfeTQ1Qm41WkVHOXpUZ2xWWDQxSGhib2V0OFNJTm9aZjRZVW1xVEZTX09BazI1YWN4UC16a2NIczdsVi1GM0RfZEJYTnhTa291LW9saTQ2WVhncGRTcWpRTnpILTc4S2Z3bnp0a2I0X2ttRWdMOXI3V2s3OEdwT29IMk9JRV9lYzYxSUtaVGlJQUFSeHYtU3Z0UUh4SGprdVlzbGZWVERYOGZzSjlfS2JGcmhEOGNsRmc?oc=5"" target=""_blank"">The Global Biosimilar Development and Approval of Yesintek With Elena Wolff-Holz, MD</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxPLTM1MlB0SWIyRXJfeTQ1Qm41WkVHOXpUZ2xWWDQxSGhib2V0OFNJTm9aZjRZVW1xVEZTX09BazI1YWN4UC16a2NIczdsVi1GM0RfZEJYTnhTa291LW9saTQ2WVhncGRTcWpRTnpILTc4S2Z3bnp0a2I0X2ttRWdMOXI3V2s3OEdwT29IMk9JRV9lYzYxSUtaVGlJQUFSeHYtU3Z0UUh4SGprdVlzbGZWVERYOGZzSjlfS2JGcmhEOGNsRmc?oc=5,Google News,Biocon biosimilarity study,"The Global Biosimilar Development and Approval of Yesintek With Elena Wolff-Holz, MD - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxPLTM1MlB0SWIyRXJfeTQ1Qm41WkVHOXpUZ2xWWDQxSGhib2V0OFNJTm9aZjRZVW1xVEZTX09BazI1YWN4UC16a2NIczdsVi1GM0RfZEJYTnhTa291LW9saTQ2WVhncGRTcWpRTnpILTc4S2Z3bnp0a2I0X2ttRWdMOXI3V2s3OEdwT29IMk9JRV9lYzYxSUtaVGlJQUFSeHYtU3Z0UUh4SGprdVlzbGZWVERYOGZzSjlfS2JGcmhEOGNsRmc?oc=5"" target=""_blank"">The Global Biosimilar Development and Approval of Yesintek With Elena Wolff-Holz, MD</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.8261350989341736,0.0,neutral,0.0,0.7351,0.171,0.0,0.829,-0.025,0.025,0.0,0.5287450329780579,other,0.0,[],False,False,1,0.0
2024-10-08,2024-10-08 07:00:00,Pharma stock in action after company to provide biological drugs for low income countries - Trade Brains,"<a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxQZXBxTTQxcmVuYzQwSjZWYnBHdEs2TzFBVG5yUGRyeFdRejBOSjBxYzlJazI5S0pWbDNTbVRJOG9OSUNGWXYteTVCTm1rU3pXdHBRallCNFhvSGZjUWM4Ml9zazdGN2dKTzQ5S3FZUmJQVkl5T28xdDJXZDJ2anpQdkpJSllnRThWSkJBSlAxYXlQQkdHWGtxbVBJeWVhR2pkeHVCYmoxRGRJMnRiN3ZSblZ4N3Uya3lIemN5MlRxRQ?oc=5"" target=""_blank"">Pharma stock in action after company to provide biological drugs for low income countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",https://news.google.com/rss/articles/CBMivwFBVV95cUxQZXBxTTQxcmVuYzQwSjZWYnBHdEs2TzFBVG5yUGRyeFdRejBOSjBxYzlJazI5S0pWbDNTbVRJOG9OSUNGWXYteTVCTm1rU3pXdHBRallCNFhvSGZjUWM4Ml9zazdGN2dKTzQ5S3FZUmJQVkl5T28xdDJXZDJ2anpQdkpJSllnRThWSkJBSlAxYXlQQkdHWGtxbVBJeWVhR2pkeHVCYmoxRGRJMnRiN3ZSblZ4N3Uya3lIemN5MlRxRQ?oc=5,Google News,Biocon biosimilarity study,"Pharma stock in action after company to provide biological drugs for low income countries - Trade Brains <a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxQZXBxTTQxcmVuYzQwSjZWYnBHdEs2TzFBVG5yUGRyeFdRejBOSjBxYzlJazI5S0pWbDNTbVRJOG9OSUNGWXYteTVCTm1rU3pXdHBRallCNFhvSGZjUWM4Ml9zazdGN2dKTzQ5S3FZUmJQVkl5T28xdDJXZDJ2anpQdkpJSllnRThWSkJBSlAxYXlQQkdHWGtxbVBJeWVhR2pkeHVCYmoxRGRJMnRiN3ZSblZ4N3Uya3lIemN5MlRxRQ?oc=5"" target=""_blank"">Pharma stock in action after company to provide biological drugs for low income countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",0.0,neutral,0.7659595012664795,0.0,neutral,0.0,-0.4939,0.0,0.116,0.884,0.04,0.16,0.0,0.4332865004221598,other,0.0,[],False,False,1,0.0
2025-02-24,2025-02-24 08:00:00,3 Ustekinumab Biosimilars Launch on US Market - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxONS0ybkJzaDEtWldiNHRyUWJYTHBSZmwzdFdOMm94cm5vd1FITzk5NWdSQWJEREVFVmgwSlliejRSRVZ2VXVzTU5PSTJtSHB0YkNuODduY0VheGtUWW90OVRfcUJJWFk4LXgtRjJNbUYzMHJwb0E0blJsUF9EcnFFRkM5eXlnQTdYUGVIV1E3Vm0?oc=5"" target=""_blank"">3 Ustekinumab Biosimilars Launch on US Market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxONS0ybkJzaDEtWldiNHRyUWJYTHBSZmwzdFdOMm94cm5vd1FITzk5NWdSQWJEREVFVmgwSlliejRSRVZ2VXVzTU5PSTJtSHB0YkNuODduY0VheGtUWW90OVRfcUJJWFk4LXgtRjJNbUYzMHJwb0E0blJsUF9EcnFFRkM5eXlnQTdYUGVIV1E3Vm0?oc=5,Google News,Biocon biosimilarity study,"3 Ustekinumab Biosimilars Launch on US Market - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxONS0ybkJzaDEtWldiNHRyUWJYTHBSZmwzdFdOMm94cm5vd1FITzk5NWdSQWJEREVFVmgwSlliejRSRVZ2VXVzTU5PSTJtSHB0YkNuODduY0VheGtUWW90OVRfcUJJWFk4LXgtRjJNbUYzMHJwb0E0blJsUF9EcnFFRkM5eXlnQTdYUGVIV1E3Vm0?oc=5"" target=""_blank"">3 Ustekinumab Biosimilars Launch on US Market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.8697865605354309,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.0,0.4598932802677155,other,0.0,[],False,False,1,0.0
2024-02-21,2024-02-21 08:00:00,"Eye on Pharma: VA Picks Hadlima; Biocon, Sandoz Partnership; A Stelara Settlement Abroad - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxOZFFHbUlST2g3U0dXS1RxU1hBQ3NUV2hmbFNBNnpGa0ItLWc2Y1o3TjhYMHdxeWhibzBuYVhVRXdBYlYwUFV4WnctaXRMSktfZEdkN050QW9HVFFPRjVXcHRfWFh6UWtFOVZFaWN4RXZkWllMeWVtR3l5VkZ6STFobUxaWldzSWNwVW9PSWw2aHlnc0NUb3FWMUJHYnNaR0MwaVlOV2xKVnFqRjZMT3FFRmp5TlFDNDRhRU5KMFp3UzVnREl1?oc=5"" target=""_blank"">Eye on Pharma: VA Picks Hadlima; Biocon, Sandoz Partnership; A Stelara Settlement Abroad</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxOZFFHbUlST2g3U0dXS1RxU1hBQ3NUV2hmbFNBNnpGa0ItLWc2Y1o3TjhYMHdxeWhibzBuYVhVRXdBYlYwUFV4WnctaXRMSktfZEdkN050QW9HVFFPRjVXcHRfWFh6UWtFOVZFaWN4RXZkWllMeWVtR3l5VkZ6STFobUxaWldzSWNwVW9PSWw2aHlnc0NUb3FWMUJHYnNaR0MwaVlOV2xKVnFqRjZMT3FFRmp5TlFDNDRhRU5KMFp3UzVnREl1?oc=5,Google News,Biocon biosimilarity study,"Eye on Pharma: VA Picks Hadlima; Biocon, Sandoz Partnership; A Stelara Settlement Abroad - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxOZFFHbUlST2g3U0dXS1RxU1hBQ3NUV2hmbFNBNnpGa0ItLWc2Y1o3TjhYMHdxeWhibzBuYVhVRXdBYlYwUFV4WnctaXRMSktfZEdkN050QW9HVFFPRjVXcHRfWFh6UWtFOVZFaWN4RXZkWllMeWVtR3l5VkZ6STFobUxaWldzSWNwVW9PSWw2aHlnc0NUb3FWMUJHYnNaR0MwaVlOV2xKVnFqRjZMT3FFRmp5TlFDNDRhRU5KMFp3UzVnREl1?oc=5"" target=""_blank"">Eye on Pharma: VA Picks Hadlima; Biocon, Sandoz Partnership; A Stelara Settlement Abroad</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.5174174308776855,positive,0.5174174308776855,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.2956671033586774,0.2837087154388428,other,0.0,[],False,True,6,0.0
2024-05-21,2024-05-21 07:00:00,US FDA issues approval for two aflibercept biosimilars - Ophthalmology Times,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxOU0xZYXBpQVBmZXNFLWpZS0c4Z1Y3YXNaUjl0dWpUd2NXc2pqcFlCVGVjaVV3SzFXV1NxRTVORXdad2gyX1REZXdEVVE4OWNBQkx1VzBxTjdhN3RYUThHdm93NXRMNWk0dHlmTnJkVU5YbkR6bkNpdGFqUm55TUVUNmNBdGhMZ0J4bnczMFh3UklwOFB5cHlsWTdCbVVyQTZSS2Nmb2tYeUZWblVaOU5V?oc=5"" target=""_blank"">US FDA issues approval for two aflibercept biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Ophthalmology Times</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxOU0xZYXBpQVBmZXNFLWpZS0c4Z1Y3YXNaUjl0dWpUd2NXc2pqcFlCVGVjaVV3SzFXV1NxRTVORXdad2gyX1REZXdEVVE4OWNBQkx1VzBxTjdhN3RYUThHdm93NXRMNWk0dHlmTnJkVU5YbkR6bkNpdGFqUm55TUVUNmNBdGhMZ0J4bnczMFh3UklwOFB5cHlsWTdCbVVyQTZSS2Nmb2tYeUZWblVaOU5V?oc=5,Google News,Biocon biosimilarity study,"US FDA issues approval for two aflibercept biosimilars - Ophthalmology Times <a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxOU0xZYXBpQVBmZXNFLWpZS0c4Z1Y3YXNaUjl0dWpUd2NXc2pqcFlCVGVjaVV3SzFXV1NxRTVORXdad2gyX1REZXdEVVE4OWNBQkx1VzBxTjdhN3RYUThHdm93NXRMNWk0dHlmTnJkVU5YbkR6bkNpdGFqUm55TUVUNmNBdGhMZ0J4bnczMFh3UklwOFB5cHlsWTdCbVVyQTZSS2Nmb2tYeUZWblVaOU5V?oc=5"" target=""_blank"">US FDA issues approval for two aflibercept biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Ophthalmology Times</font>",0.6728278994560242,positive,0.6728278994560242,0.0,neutral,0.0,0.7351,0.237,0.0,0.763,0.0,0.0,0.3844730854034424,0.7039639497280121,other,0.0,[],False,False,1,0.0
2023-07-03,2023-07-03 07:00:00,"After Five Years of Successful Experience Internationally, Biocon Biologics’ Hulio® Biosimilar to Humira®, Now Available in the United States - Biocon","<a href=""https://news.google.com/rss/articles/CBMi8gFBVV95cUxQNGlnUTZrU1BKeFdPT2xhblFnRkhReFlMT2Iwai16S3h3ZDN1QVRmU1Z0bjhzZ1BJa1ZkWkVxd2p0c0RtSVlaQkc5UC1uTGo5UENnZXVIeDczbDZ4VC1EbFZSOGtVVHY2c3NSOGtBOHZmb29va01rVTZlbFlWamZpTFJWbjF1U1dEMlVUNFloOWxXSWRmdlozUFRuT3lGcHlMcmtIX2pHUUFRWlNUYnNGV21lRDJmRnJxN2lUNExnSUE2RUFnWmNjRTVTTFVXSU1nOGFoZ2pmYjRwN0IzOGJsNUV1U016NUlGX0VtTURNcVV2Zw?oc=5"" target=""_blank"">After Five Years of Successful Experience Internationally, Biocon Biologics’ Hulio® Biosimilar to Humira®, Now Available in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMi8gFBVV95cUxQNGlnUTZrU1BKeFdPT2xhblFnRkhReFlMT2Iwai16S3h3ZDN1QVRmU1Z0bjhzZ1BJa1ZkWkVxd2p0c0RtSVlaQkc5UC1uTGo5UENnZXVIeDczbDZ4VC1EbFZSOGtVVHY2c3NSOGtBOHZmb29va01rVTZlbFlWamZpTFJWbjF1U1dEMlVUNFloOWxXSWRmdlozUFRuT3lGcHlMcmtIX2pHUUFRWlNUYnNGV21lRDJmRnJxN2lUNExnSUE2RUFnWmNjRTVTTFVXSU1nOGFoZ2pmYjRwN0IzOGJsNUV1U016NUlGX0VtTURNcVV2Zw?oc=5,Google News,Biocon biosimilarity study,"After Five Years of Successful Experience Internationally, Biocon Biologics’ Hulio® Biosimilar to Humira®, Now Available in the United States - Biocon <a href=""https://news.google.com/rss/articles/CBMi8gFBVV95cUxQNGlnUTZrU1BKeFdPT2xhblFnRkhReFlMT2Iwai16S3h3ZDN1QVRmU1Z0bjhzZ1BJa1ZkWkVxd2p0c0RtSVlaQkc5UC1uTGo5UENnZXVIeDczbDZ4VC1EbFZSOGtVVHY2c3NSOGtBOHZmb29va01rVTZlbFlWamZpTFJWbjF1U1dEMlVUNFloOWxXSWRmdlozUFRuT3lGcHlMcmtIX2pHUUFRWlNUYnNGV21lRDJmRnJxN2lUNExnSUE2RUFnWmNjRTVTTFVXSU1nOGFoZ2pmYjRwN0IzOGJsNUV1U016NUlGX0VtTURNcVV2Zw?oc=5"" target=""_blank"">After Five Years of Successful Experience Internationally, Biocon Biologics’ Hulio® Biosimilar to Humira®, Now Available in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.6884812712669373,positive,0.6884812712669373,0.0,neutral,0.0,0.9217,0.258,0.0,0.742,0.32857142857142857,0.3857142857142857,0.39341786929539274,0.646250899946122,other,0.0,[],False,True,6,0.0
2022-03-01,2022-03-01 08:00:00,Biocon Biologics Acquires Viatris’ Biosimilar Portfolio - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxNWXlidXE5elVHajM4S1V5UklBSE5WVEFKM0pFSkp2X0hScjVLSUx5dFgzQWZZbXpCMDVzVXhmWmdIU09oN3drNHVnbHhCdDBwVUVKTmYxM0ZXVXYzSTMzTlRUZXU4dGlOY3kyYVpHcHJiWklvZjhpZkFKUFlOVTZ6UE9pRlBSZmh1MTBUVzduLWRiSU02TERJX0FxNHE?oc=5"" target=""_blank"">Biocon Biologics Acquires Viatris’ Biosimilar Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxNWXlidXE5elVHajM4S1V5UklBSE5WVEFKM0pFSkp2X0hScjVLSUx5dFgzQWZZbXpCMDVzVXhmWmdIU09oN3drNHVnbHhCdDBwVUVKTmYxM0ZXVXYzSTMzTlRUZXU4dGlOY3kyYVpHcHJiWklvZjhpZkFKUFlOVTZ6UE9pRlBSZmh1MTBUVzduLWRiSU02TERJX0FxNHE?oc=5,Google News,Biocon biosimilarity study,"Biocon Biologics Acquires Viatris’ Biosimilar Portfolio - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxNWXlidXE5elVHajM4S1V5UklBSE5WVEFKM0pFSkp2X0hScjVLSUx5dFgzQWZZbXpCMDVzVXhmWmdIU09oN3drNHVnbHhCdDBwVUVKTmYxM0ZXVXYzSTMzTlRUZXU4dGlOY3kyYVpHcHJiWklvZjhpZkFKUFlOVTZ6UE9pRlBSZmh1MTBUVzduLWRiSU02TERJX0FxNHE?oc=5"" target=""_blank"">Biocon Biologics Acquires Viatris’ Biosimilar Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.9105812907218933,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.0,0.4802906453609467,other,0.0,[],False,True,6,0.0
2025-02-24,2025-02-24 08:00:00,"Ustekinumab Biosimilar Yestintek Launches in the US, Expanding Treatment Access for Chronic Autoimmune Diseases - Dermatology Times","<a href=""https://news.google.com/rss/articles/CBMi4gFBVV95cUxOWDMtLXZuSnh3TllicUIyVy1pLXROTE1FaWtaUFpJNnJVY3VjVVppUkpZQkQ0eFE0YkZYeFhhS0NCOVAzaDJMMW9abHNEZjRUQUE4VGRFVFUzSFFLdGFPazBBZUk2WnFRU3k5M0FEWkdSSWhGTnBrUHlWOUtRdVVFLVRsY21JUXpsUTdaQ2EwZDlwbG1MR0xIRnhIYi1BcXJtamxjVXQ2UXVfTGRiMlNVZnpYMXhHWkE3Zk5waEV6X0dBNmdGWWNVSUJBc1pET09tNnpXb1duY0NKXzdQc0ZSTFZn?oc=5"" target=""_blank"">Ustekinumab Biosimilar Yestintek Launches in the US, Expanding Treatment Access for Chronic Autoimmune Diseases</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Dermatology Times</font>",https://news.google.com/rss/articles/CBMi4gFBVV95cUxOWDMtLXZuSnh3TllicUIyVy1pLXROTE1FaWtaUFpJNnJVY3VjVVppUkpZQkQ0eFE0YkZYeFhhS0NCOVAzaDJMMW9abHNEZjRUQUE4VGRFVFUzSFFLdGFPazBBZUk2WnFRU3k5M0FEWkdSSWhGTnBrUHlWOUtRdVVFLVRsY21JUXpsUTdaQ2EwZDlwbG1MR0xIRnhIYi1BcXJtamxjVXQ2UXVfTGRiMlNVZnpYMXhHWkE3Zk5waEV6X0dBNmdGWWNVSUJBc1pET09tNnpXb1duY0NKXzdQc0ZSTFZn?oc=5,Google News,Biocon biosimilarity study,"Ustekinumab Biosimilar Yestintek Launches in the US, Expanding Treatment Access for Chronic Autoimmune Diseases - Dermatology Times <a href=""https://news.google.com/rss/articles/CBMi4gFBVV95cUxOWDMtLXZuSnh3TllicUIyVy1pLXROTE1FaWtaUFpJNnJVY3VjVVppUkpZQkQ0eFE0YkZYeFhhS0NCOVAzaDJMMW9abHNEZjRUQUE4VGRFVFUzSFFLdGFPazBBZUk2WnFRU3k5M0FEWkdSSWhGTnBrUHlWOUtRdVVFLVRsY21JUXpsUTdaQ2EwZDlwbG1MR0xIRnhIYi1BcXJtamxjVXQ2UXVfTGRiMlNVZnpYMXhHWkE3Zk5waEV6X0dBNmdGWWNVSUJBc1pET09tNnpXb1duY0NKXzdQc0ZSTFZn?oc=5"" target=""_blank"">Ustekinumab Biosimilar Yestintek Launches in the US, Expanding Treatment Access for Chronic Autoimmune Diseases</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Dermatology Times</font>",0.8819261193275452,positive,0.8819261193275452,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5039577824728829,0.8819261193275452,other,0.0,[],False,False,1,0.0
2022-10-18,2022-10-18 07:00:00,Biosimilar Business News Recap: Mepolizumab Study; New Licensing Deal; Hukyndra Launches in Switzerland - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNZHZ0bFlhSDNVSHMxN3RVRzlITk9QM3cyY0xOcDZqS3pYekxwZEt2M0JuUUthU1VEZUszOEM0b0RydFZPc3VmbDdJTThhX1dPOW1zU2pUbkZ6LUlyZmtENFVpVTNNcGxhT2FfYTlHaDd1SVdkY3FMQm1kNENPcGF3NXJVbFdqNFVVQUVSOVotOEdJemlJRmROd2cyOXpIV05pSjNndlZzQVVCbzUweGFCalJ1alJldnNnZUpzZ0NULUVyS1NHSmZlNXdPQWZyQmZ2dWtCM0pIUUhIZw?oc=5"" target=""_blank"">Biosimilar Business News Recap: Mepolizumab Study; New Licensing Deal; Hukyndra Launches in Switzerland</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxNZHZ0bFlhSDNVSHMxN3RVRzlITk9QM3cyY0xOcDZqS3pYekxwZEt2M0JuUUthU1VEZUszOEM0b0RydFZPc3VmbDdJTThhX1dPOW1zU2pUbkZ6LUlyZmtENFVpVTNNcGxhT2FfYTlHaDd1SVdkY3FMQm1kNENPcGF3NXJVbFdqNFVVQUVSOVotOEdJemlJRmROd2cyOXpIV05pSjNndlZzQVVCbzUweGFCalJ1alJldnNnZUpzZ0NULUVyS1NHSmZlNXdPQWZyQmZ2dWtCM0pIUUhIZw?oc=5,Google News,Biocon biosimilarity study,"Biosimilar Business News Recap: Mepolizumab Study; New Licensing Deal; Hukyndra Launches in Switzerland - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNZHZ0bFlhSDNVSHMxN3RVRzlITk9QM3cyY0xOcDZqS3pYekxwZEt2M0JuUUthU1VEZUszOEM0b0RydFZPc3VmbDdJTThhX1dPOW1zU2pUbkZ6LUlyZmtENFVpVTNNcGxhT2FfYTlHaDd1SVdkY3FMQm1kNENPcGF3NXJVbFdqNFVVQUVSOVotOEdJemlJRmROd2cyOXpIV05pSjNndlZzQVVCbzUweGFCalJ1alJldnNnZUpzZ0NULUVyS1NHSmZlNXdPQWZyQmZ2dWtCM0pIUUhIZw?oc=5"" target=""_blank"">Biosimilar Business News Recap: Mepolizumab Study; New Licensing Deal; Hukyndra Launches in Switzerland</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.798348069190979,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.043181818181818175,0.25227272727272726,0.0,0.4207649436863986,other,0.0,[],False,False,1,0.0
2024-12-02,2024-12-02 08:00:00,"FDA Approves Sixth Ustekinumab Biosimilar, Yesintek - AJMC","<a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxQNXRQRjFDQTJ4ak1zSzllem55U0tINW1iRmRJckY3djJYN2ZZMGJpT0hVNVM2TVRDQXN3YzFYYkViQ2V1ZHQ1YjRHUXBlUnN3Mkc2OTZ2aUo1U1hHMElya0M2dTFlNTlnaC0tSWtkaWxwa3p4X3VuQjRVcmNrUFRUVDZ3?oc=5"" target=""_blank"">FDA Approves Sixth Ustekinumab Biosimilar, Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMiggFBVV95cUxQNXRQRjFDQTJ4ak1zSzllem55U0tINW1iRmRJckY3djJYN2ZZMGJpT0hVNVM2TVRDQXN3YzFYYkViQ2V1ZHQ1YjRHUXBlUnN3Mkc2OTZ2aUo1U1hHMElya0M2dTFlNTlnaC0tSWtkaWxwa3p4X3VuQjRVcmNrUFRUVDZ3?oc=5,Google News,Biocon biosimilarity study,"FDA Approves Sixth Ustekinumab Biosimilar, Yesintek - AJMC <a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxQNXRQRjFDQTJ4ak1zSzllem55U0tINW1iRmRJckY3djJYN2ZZMGJpT0hVNVM2TVRDQXN3YzFYYkViQ2V1ZHQ1YjRHUXBlUnN3Mkc2OTZ2aUo1U1hHMElya0M2dTFlNTlnaC0tSWtkaWxwa3p4X3VuQjRVcmNrUFRUVDZ3?oc=5"" target=""_blank"">FDA Approves Sixth Ustekinumab Biosimilar, Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",0.0,neutral,0.6054099202156067,0.0,neutral,0.0,0.6597,0.278,0.0,0.722,0.0,0.0,0.0,0.6325549601078033,approval_process,0.8384490013122559,['FDA approval'],False,False,11,0.6768980026245117
2023-05-23,2023-05-23 07:00:00,"Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5"" target=""_blank"">Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5,Google News,Biocon biosimilarity study,"Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31% - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5"" target=""_blank"">Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.9450389742851257,positive,0.9450389742851257,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5400222710200718,0.9450389742851257,other,0.0,[],False,True,6,0.0
2023-02-14,2023-02-14 08:00:00,"Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5"" target=""_blank"">Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5,Google News,Biocon biosimilarity study,"Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18% - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5"" target=""_blank"">Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.9489200711250305,positive,0.9489200711250305,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5422400406428746,0.9489200711250305,other,0.0,[],False,True,6,0.0
2022-09-02,2022-09-02 07:00:00,Fierce Pharma Asia—Biocon's biosimilar production faults; Fosun unit's PD-1 plan; Takeda-Finch IBD severance - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOX0dTWERCNTJlTS1namhfVjZmdFhvQVdmZzFxdHBIeTBDenNmdlQ0RWxCOWxhaDJPcVlKQ0hOcjEzakhTdS1CVFV6SjYySDF0bHB2ZnpFVmVGQ2VGOExoREUxS1pxWFEtM2x0a0szWWZMYXc1b01xWldQRzkxT0pCRS1XbjEtak5IYzZ3c3NoZUhSYldDYW50N09OMUJEUmFDcUswUkYtOUV2ckNUby1ENGw4MkdwZmJrekNEX1V3?oc=5"" target=""_blank"">Fierce Pharma Asia—Biocon's biosimilar production faults; Fosun unit's PD-1 plan; Takeda-Finch IBD severance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOX0dTWERCNTJlTS1namhfVjZmdFhvQVdmZzFxdHBIeTBDenNmdlQ0RWxCOWxhaDJPcVlKQ0hOcjEzakhTdS1CVFV6SjYySDF0bHB2ZnpFVmVGQ2VGOExoREUxS1pxWFEtM2x0a0szWWZMYXc1b01xWldQRzkxT0pCRS1XbjEtak5IYzZ3c3NoZUhSYldDYW50N09OMUJEUmFDcUswUkYtOUV2ckNUby1ENGw4MkdwZmJrekNEX1V3?oc=5,Google News,Biocon biosimilarity study,"Fierce Pharma Asia—Biocon's biosimilar production faults; Fosun unit's PD-1 plan; Takeda-Finch IBD severance - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOX0dTWERCNTJlTS1namhfVjZmdFhvQVdmZzFxdHBIeTBDenNmdlQ0RWxCOWxhaDJPcVlKQ0hOcjEzakhTdS1CVFV6SjYySDF0bHB2ZnpFVmVGQ2VGOExoREUxS1pxWFEtM2x0a0szWWZMYXc1b01xWldQRzkxT0pCRS1XbjEtak5IYzZ3c3NoZUhSYldDYW50N09OMUJEUmFDcUswUkYtOUV2ckNUby1ENGw4MkdwZmJrekNEX1V3?oc=5"" target=""_blank"">Fierce Pharma Asia—Biocon's biosimilar production faults; Fosun unit's PD-1 plan; Takeda-Finch IBD severance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.9384056329727173,negative,0.9384056329727173,0.0,neutral,0.0,-0.7351,0.0,0.171,0.829,0.0,0.0,-0.5362317902701241,0.8367528164863587,other,0.0,[],False,True,6,0.0
2024-12-17,2024-12-17 08:00:00,European agency endorses approval of Biocon Biologics’ biosimilar Ustekinumab - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">European agency endorses approval of Biocon Biologics’ biosimilar Ustekinumab</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News,Biocon biosimilarity study,"European agency endorses approval of Biocon Biologics’ biosimilar Ustekinumab - The New Indian Express <a href=""https://news.google.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?oc=5"" target=""_blank"">European agency endorses approval of Biocon Biologics’ biosimilar Ustekinumab</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",0.0,neutral,0.5521013736724854,0.0,neutral,0.0,0.875,0.314,0.0,0.686,0.06818181818181818,0.22727272727272727,0.0,0.49842773061810114,other,0.0,[],False,True,6,0.0
2025-03-08,2025-03-08 08:00:00,Phase 3 study comparing Yesintek with Stelara in adult patients with chronic plaque psoriasis shows... - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Phase 3 study comparing Yesintek with Stelara in adult patients with chronic plaque psoriasis shows...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News,Biocon biosimilarity study,"Phase 3 study comparing Yesintek with Stelara in adult patients with chronic plaque psoriasis shows... - Medical Dialogues <a href=""https://news.google.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?oc=5"" target=""_blank"">Phase 3 study comparing Yesintek with Stelara in adult patients with chronic plaque psoriasis shows...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.0,neutral,0.8199664950370789,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.05,0.15,0.0,0.43498324751853945,other,0.0,[],False,False,1,0.0
2024-02-29,2024-02-29 08:00:00,Biocon Biologics inks licence pact with Janssen for biosimilar product - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics inks licence pact with Janssen for biosimilar product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon biosimilarity study,"Biocon Biologics inks licence pact with Janssen for biosimilar product - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics inks licence pact with Janssen for biosimilar product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.570129930973053,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.0,0.35173163215319314,other,0.0,[],False,True,6,0.0
2025-04-28,2025-04-28 07:00:00,Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe - PR Newswire UK,"<a href=""https://news.google.com/rss/articles/CBMi6AFBVV95cUxNRGZCYXhiWXhiRFpNQkc4MTNGbmZZVkhodF9uX3M3YW5GWjRiSVdURm1EbzViblFkb053Njk3eGlLWHdFNnAzX2ZVWEdUQnFIRzZFcVlGUmRZMjIxbF9TMENSazZxWjAxSlNrb2JpWG82WVZEVDZ1VHNnSGp3UjBZTjlOQmV2Q0s2a2NhZnExY29BdnZBeTVRVVBhWDRsUDc5R1BMSUstWld4TWtBWm5MSHRHTEh3cmx3NENDN1dTZlN4MThnWGc2bFNQZTM0TTdjM2oxb0t2bmxRLWxmLXdwT3k5TmI5Q0xU?oc=5"" target=""_blank"">Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire UK</font>",https://news.google.com/rss/articles/CBMi6AFBVV95cUxNRGZCYXhiWXhiRFpNQkc4MTNGbmZZVkhodF9uX3M3YW5GWjRiSVdURm1EbzViblFkb053Njk3eGlLWHdFNnAzX2ZVWEdUQnFIRzZFcVlGUmRZMjIxbF9TMENSazZxWjAxSlNrb2JpWG82WVZEVDZ1VHNnSGp3UjBZTjlOQmV2Q0s2a2NhZnExY29BdnZBeTVRVVBhWDRsUDc5R1BMSUstWld4TWtBWm5MSHRHTEh3cmx3NENDN1dTZlN4MThnWGc2bFNQZTM0TTdjM2oxb0t2bmxRLWxmLXdwT3k5TmI5Q0xU?oc=5,Google News,Biocon biosimilarity study,"Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe - PR Newswire UK <a href=""https://news.google.com/rss/articles/CBMi6AFBVV95cUxNRGZCYXhiWXhiRFpNQkc4MTNGbmZZVkhodF9uX3M3YW5GWjRiSVdURm1EbzViblFkb053Njk3eGlLWHdFNnAzX2ZVWEdUQnFIRzZFcVlGUmRZMjIxbF9TMENSazZxWjAxSlNrb2JpWG82WVZEVDZ1VHNnSGp3UjBZTjlOQmV2Q0s2a2NhZnExY29BdnZBeTVRVVBhWDRsUDc5R1BMSUstWld4TWtBWm5MSHRHTEh3cmx3NENDN1dTZlN4MThnWGc2bFNQZTM0TTdjM2oxb0t2bmxRLWxmLXdwT3k5TmI5Q0xU?oc=5"" target=""_blank"">Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire UK</font>",0.9160293936729431,positive,0.9160293936729431,0.0,neutral,0.0,0.802,0.184,0.0,0.816,0.15151515151515152,0.3636363636363636,0.5234453678131104,0.6231815150626983,other,0.0,[],False,True,6,0.0
2023-11-10,2023-11-10 08:00:00,"Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5"" target=""_blank"">Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5,Google News,Biocon biosimilarity study,"Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168% - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5"" target=""_blank"">Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.9546969532966614,positive,0.9546969532966614,0.0,neutral,0.0,0.7003,0.068,0.0,0.932,0.0,0.0,0.5455411161695208,0.8274984766483306,other,0.0,[],False,True,6,0.0
2024-03-04,2024-03-04 08:00:00,Biocon Biologics settles patent issue; paves way for launch of biosimilar product in Canada - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics settles patent issue; paves way for launch of biosimilar product in Canada</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMilwJBVV95cUxOUXBERmEzaG1mRWZwX21qUzRVRmpiNUctZGNpMmdXZTJEV2RfRS1BSndvTU52cmpxaFpZdWVDYll2ejBuS1FPRWhEMHZxVTJLRjZGWmRlTkF4SDFQOUROcktvVEdCZFNyZGN3eERVbk5QcDBQc2tEODE4b21VSTZXNF9kTmZQUkx2dWpjR1RTX3djZ1AzNlZqTmVxRFlPbFJ2UjdNMklscGw3bEhPWnp3T1lkckpZYWUtOElKSDJBSzEzajFBUXEwZ212dlAtUDNYZktEQVMwM0xMTEhmb3RSekxLYm1DLWFNR25wNHE0Yld3Y1BSMmU1QjNydGpqdEJ5eHM4Vy1nc2RrckJFOTdtRlVQRzNDeFXSAZwCQVVfeXFMUHJEbm42eXF5dU9CRGZFaDA2NV9qMXV6NG8xbHNDbVBLLXRvWG56UEwwUzVmQUZ6eElRVVlsMVI1bGR5TDA5eUtEVGh5dUVsZVN3eDhqWjFfTXp0VlVoZ1dDUy1BS1NsRWZST084U2dwX213bXg0UDBERmtQNGRxNXdBUm9XeW93Ql9KSTItNEE2WFlNc3dYRGRvYk1XLVl3cm1weHNKdVNVQ2s2X19tckVpZFVCdkJyQm5IRHZHalVOMnBhNEdCQUQ1UkY2Tl9MaGpwaTNOZ0F0V0Z2Q09xNERIVy1KUjJEODJSelk4RjVnMk1zVk14dmZzVW9IeWw3dVlBdzgzOUhuaXc0NnFWNThnQ1FPY2lzOFlURDE?oc=5,Google News,Biocon biosimilarity study,"Biocon Biologics settles patent issue; paves way for launch of biosimilar product in Canada - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics settles patent issue; paves way for launch of biosimilar product in Canada</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.6730281710624695,positive,0.6730281710624695,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.38458752632141113,0.4031807521979014,other,0.0,[],False,True,6,0.0
2022-11-14,2022-11-14 08:00:00,"Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&D Spend at Rs 252 Crore, Up 52% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5"" target=""_blank"">Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&amp;D Spend at Rs 252 Crore, Up 52%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5,Google News,Biocon biosimilarity study,"Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&D Spend at Rs 252 Crore, Up 52% - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5"" target=""_blank"">Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&amp;D Spend at Rs 252 Crore, Up 52%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.9520589113235474,positive,0.9520589113235474,0.0,neutral,0.0,-0.7351,0.0,0.103,0.897,0.0,0.0,0.5440336636134556,0.8435794556617737,other,0.0,[],False,True,6,0.0
2024-02-13,2024-02-13 08:00:00,Biocon Biologics focusing on market share gains of biosimilars in key markets - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMihgJBVV95cUxNYnExOWE1bF9rM0VGdlowcEFFbTlqQVhkUnlDeXFGZW9XZzFRazh5elYwazcwUkVLUkJMU2lXRDl0VVRyTVpPdDA4U0ltbG5MN3oyRXNkN1RwQjVOYkRGTjJaZVFDeXpxakFZYmVmczNocWpiX1E2WXpDWnBWbmhqcU5pQjBVUS1KWkE4dVFCRGVPOUpFOERyV2pRN01PRjdFbklya2ljMHM2aWw5TWNHdEhqNy1FdXhjMi1XeUVHZ2VrZWY2ZkdqZC16UjdKWUhjT0J3b3Z4d3RPaW1zR19NMFVzQjktcjA5MUR1X1BZNjQ3RU1wNVRQczBvbU1mZFhWRGpJd0VB0gGLAkFVX3lxTE0zUTVTbkJoRWRZVmVyMTZubHJHQlpyMnZoaGVWbzBlRmo4c0JGZWc0RFRtZjZBX0ViYmw4dmtmeU55cW1hVF9Nd1BPeloySlNlNzZMVWR6ZC1SUU9SR19oZ2xXYlJ3aWx3eUhrSDRWV0ptU20zcVVCMWtkNGRQTUVBUm04VUNBT0FFaEVOeFdzN0R0d19HczJDSmZSM051cXpZVkJ3azcxMVhuTEFPcF9VeDRtZzAtanFSRUdyWlZrQmRFNnZuenk2akRucE52bFZDeGtNY2JhWHAwT3ZPQWJqd1N4NW9iOUV2WUNrelpZQVB0emZjMS1NcmRqTmxSbHVmM2ZOb2s5clI3UQ?oc=5"" target=""_blank"">Biocon Biologics focusing on market share gains of biosimilars in key markets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon biosimilarity study,"Biocon Biologics focusing on market share gains of biosimilars in key markets - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics focusing on market share gains of biosimilars in key markets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.6905178427696228,positive,0.6905178427696228,0.0,neutral,0.0,0.802,0.247,0.0,0.753,0.08,0.4800000000000001,0.3945816244397844,0.5241726142565409,other,0.0,[],False,True,6,0.0
2025-06-17,2025-06-17 05:48:00,"Pharma stock jumps after receiving approval to raise ₹4,500 Cr via QIP - Trade Brains","<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxPdHpHeU1uNGdKZ2tob1VibHFmVzBxdmlZUEZocXVnaXRpOHoweUUwOEhkTG5PQnR0VG5mYW9Iel94Y2x0N2p3NnRLM1NhVXdwQW1uNmVxN3daUWUwc25fdTlqYVhia0RkbEw0eDFqbGRPZnB6cF9neEc5VkNXRzM0M1dGTzFxMmFTOWYyM1l3UUNwUEZFdDJv?oc=5"" target=""_blank"">Pharma stock jumps after receiving approval to raise ₹4,500 Cr via QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxPdHpHeU1uNGdKZ2tob1VibHFmVzBxdmlZUEZocXVnaXRpOHoweUUwOEhkTG5PQnR0VG5mYW9Iel94Y2x0N2p3NnRLM1NhVXdwQW1uNmVxN3daUWUwc25fdTlqYVhia0RkbEw0eDFqbGRPZnB6cF9neEc5VkNXRzM0M1dGTzFxMmFTOWYyM1l3UUNwUEZFdDJv?oc=5,Google News,Biocon regulatory filing,"Pharma stock jumps after receiving approval to raise ₹4,500 Cr via QIP - Trade Brains <a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxPdHpHeU1uNGdKZ2tob1VibHFmVzBxdmlZUEZocXVnaXRpOHoweUUwOEhkTG5PQnR0VG5mYW9Iel94Y2x0N2p3NnRLM1NhVXdwQW1uNmVxN3daUWUwc25fdTlqYVhia0RkbEw0eDFqbGRPZnB6cF9neEc5VkNXRzM0M1dGTzFxMmFTOWYyM1l3UUNwUEZFdDJv?oc=5"" target=""_blank"">Pharma stock jumps after receiving approval to raise ₹4,500 Cr via QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",0.9090197682380676,positive,0.9090197682380676,0.0,neutral,0.0,0.7351,0.181,0.0,0.819,0.0,0.0,0.51943986756461,0.8220598841190339,other,0.0,[],False,False,1,0.0
2024-12-10,2024-12-10 08:00:00,"Biocon sells 80,00,000 equity shares of subsidiary Syngene for Rs.686 crore - The Hindu","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon sells 80,00,000 equity shares of subsidiary Syngene for Rs.686 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon sells 80,00,000 equity shares of subsidiary Syngene for Rs.686 crore - The Hindu <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon sells 80,00,000 equity shares of subsidiary Syngene for Rs.686 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",0.0,neutral,0.926193118095398,0.0,neutral,0.0,0.5267,0.145,0.0,0.855,0.0,0.0,0.0,0.726446559047699,other,0.0,[],False,True,6,0.0
2024-09-02,2024-09-02 07:00:00,Biocon unit gets USFDA nod for generic drug - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon unit gets USFDA nod for generic drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon unit gets USFDA nod for generic drug - ET HealthWorld <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon unit gets USFDA nod for generic drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.5247365236282349,positive,0.5247365236282349,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.2998494420732771,0.5247365236282349,other,0.0,[],False,True,6,0.0
2025-01-28,2025-01-28 08:00:00,Biocon approves raising Rs 570 cr - BizzBuzz,"<a href=""https://news.google.com/rss/articles/CBMif0FVX3lxTE9la2xJYnV1aDVrUmw5ZVE2Z3RBWFBDMDNtRFMzcTZiQTczaDZWeGlHYkZNeXJqR096MWxGcXRoT2RuVlFIUTVvMlpYbXV4MUZBODVvQkRpY1hucmh6M016aHlYWVZpX3JJYkpPb0Z6TDJzYk9WX3pOX2tUZ0tINEk?oc=5"" target=""_blank"">Biocon approves raising Rs 570 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BizzBuzz</font>",https://news.google.com/rss/articles/CBMif0FVX3lxTE9la2xJYnV1aDVrUmw5ZVE2Z3RBWFBDMDNtRFMzcTZiQTczaDZWeGlHYkZNeXJqR096MWxGcXRoT2RuVlFIUTVvMlpYbXV4MUZBODVvQkRpY1hucmh6M016aHlYWVZpX3JJYkpPb0Z6TDJzYk9WX3pOX2tUZ0tINEk?oc=5,Google News,Biocon regulatory filing,"Biocon approves raising Rs 570 cr - BizzBuzz <a href=""https://news.google.com/rss/articles/CBMif0FVX3lxTE9la2xJYnV1aDVrUmw5ZVE2Z3RBWFBDMDNtRFMzcTZiQTczaDZWeGlHYkZNeXJqR096MWxGcXRoT2RuVlFIUTVvMlpYbXV4MUZBODVvQkRpY1hucmh6M016aHlYWVZpX3JJYkpPb0Z6TDJzYk9WX3pOX2tUZ0tINEk?oc=5"" target=""_blank"">Biocon approves raising Rs 570 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BizzBuzz</font>",0.648579478263855,positive,0.648579478263855,0.0,neutral,0.0,0.6597,0.278,0.0,0.722,0.0,0.0,0.37061684472220285,0.6541397391319275,other,0.0,[],False,True,6,0.0
2024-08-29,2024-08-29 07:00:00,"Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMi_wFBVV95cUxPR0hCT1RPc3EzTzc5ZFNycUN1VFlTa3FvR1NvVU9LN3Uya1dqamZjMjNrWDloVnBDSVF6VmFQUmxpS1FQT2d1X1k0TzRsdjVlbkpvQURralVGUU5mcDVlNWdqRjBuWjNwekZ6T3NVY1ZodFZPVVBGdVhkM1B4Vmt6ZTFvVXZ0c3c1OXRHNzdNcnhiSzdKcll1dVRnOFk1TTZSSllfbTlaT1RPY3FSZ0VLelo4X0RaalZ0cFRRUEVJZGZaQmVMZVVfS3Y3QVJNTzJRWU9BWDJmYlZaX2ttZVhQOEtTQTBUOFJVdGVrdnI4Y3plemx6SjVHWWJKR0wyZ0k?oc=5"" target=""_blank"">Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi_wFBVV95cUxPR0hCT1RPc3EzTzc5ZFNycUN1VFlTa3FvR1NvVU9LN3Uya1dqamZjMjNrWDloVnBDSVF6VmFQUmxpS1FQT2d1X1k0TzRsdjVlbkpvQURralVGUU5mcDVlNWdqRjBuWjNwekZ6T3NVY1ZodFZPVVBGdVhkM1B4Vmt6ZTFvVXZ0c3c1OXRHNzdNcnhiSzdKcll1dVRnOFk1TTZSSllfbTlaT1RPY3FSZ0VLelo4X0RaalZ0cFRRUEVJZGZaQmVMZVVfS3Y3QVJNTzJRWU9BWDJmYlZaX2ttZVhQOEtTQTBUOFJVdGVrdnI4Y3plemx6SjVHWWJKR0wyZ0k?oc=5,Google News,Biocon regulatory filing,"Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi_wFBVV95cUxPR0hCT1RPc3EzTzc5ZFNycUN1VFlTa3FvR1NvVU9LN3Uya1dqamZjMjNrWDloVnBDSVF6VmFQUmxpS1FQT2d1X1k0TzRsdjVlbkpvQURralVGUU5mcDVlNWdqRjBuWjNwekZ6T3NVY1ZodFZPVVBGdVhkM1B4Vmt6ZTFvVXZ0c3c1OXRHNzdNcnhiSzdKcll1dVRnOFk1TTZSSllfbTlaT1RPY3FSZ0VLelo4X0RaalZ0cFRRUEVJZGZaQmVMZVVfS3Y3QVJNTzJRWU9BWDJmYlZaX2ttZVhQOEtTQTBUOFJVdGVrdnI4Y3plemx6SjVHWWJKR0wyZ0k?oc=5"" target=""_blank"">Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.6496573686599731,positive,0.6496573686599731,0.0,neutral,0.0,0.5574,0.103,0.0,0.897,0.0,0.0,0.3712327820914132,0.6035286843299865,other,0.0,[],False,True,6,0.0
2024-08-29,2024-08-29 07:00:00,Biocon Biologics signs agreement with Janssen to market Bmab 1200 - Pharmaceutical Technology,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPNVVhWVVuNXpsTXhXWTlORV9mZmFiT0tQd2N5amJjQ3JreG1DVHcyelpLbVJFVEstaVR5UTF1eWxxemFJRDUwWW4yYV9BaXpDYjVkSkN0QkM1OUM0cFRQSVA5X2NFTVNlMzJxX3lhWmN6R1d0S1kxZnY3SXJIWTd6UnU5dHdSOGxHMVE?oc=5"" target=""_blank"">Biocon Biologics signs agreement with Janssen to market Bmab 1200</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxPNVVhWVVuNXpsTXhXWTlORV9mZmFiT0tQd2N5amJjQ3JreG1DVHcyelpLbVJFVEstaVR5UTF1eWxxemFJRDUwWW4yYV9BaXpDYjVkSkN0QkM1OUM0cFRQSVA5X2NFTVNlMzJxX3lhWmN6R1d0S1kxZnY3SXJIWTd6UnU5dHdSOGxHMVE?oc=5,Google News,Biocon regulatory filing,"Biocon Biologics signs agreement with Janssen to market Bmab 1200 - Pharmaceutical Technology <a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPNVVhWVVuNXpsTXhXWTlORV9mZmFiT0tQd2N5amJjQ3JreG1DVHcyelpLbVJFVEstaVR5UTF1eWxxemFJRDUwWW4yYV9BaXpDYjVkSkN0QkM1OUM0cFRQSVA5X2NFTVNlMzJxX3lhWmN6R1d0S1kxZnY3SXJIWTd6UnU5dHdSOGxHMVE?oc=5"" target=""_blank"">Biocon Biologics signs agreement with Janssen to market Bmab 1200</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",0.8600618243217468,positive,0.8600618243217468,0.0,neutral,0.0,0.7506,0.211,0.0,0.789,0.0,0.0,0.4914638996124267,0.8053309121608734,other,0.0,[],False,True,6,0.0
2024-08-09,2024-08-09 07:00:00,"Biocon Q1 Results: Net profit jumps 14% to Rs 660 crore, revenue up 30% to Rs 4,567 crore - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxOaWVEdEs3Qko5UjFWUGdXSEE1OC1DRkhObjZ1WjV5cE1NT2UzWjZNakVMc3lmMklNWG5PdmN0dXRid2c3dEhXQTBZcjhUcGw0ZGpnSS1BMHpoSGkwaUhKSlZ2V2U5eHZxV09mWmNia0hZM0lyR3FxY0dfX2pSMHJ0b1FsaWhGZjBHTFNiYXEtdTl3Q2g3YmMyc1Z3Q3FtbmFqTkNpSkdsbXd5Q0hkdFR1c0NYd3RPd3JFQjRQVEVzSWRNMVFKQlN0dVNaSlRMMVhvRDFxMktRM3BFMXhR?oc=5"" target=""_blank"">Biocon Q1 Results: Net profit jumps 14% to Rs 660 crore, revenue up 30% to Rs 4,567 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi3AFBVV95cUxOaWVEdEs3Qko5UjFWUGdXSEE1OC1DRkhObjZ1WjV5cE1NT2UzWjZNakVMc3lmMklNWG5PdmN0dXRid2c3dEhXQTBZcjhUcGw0ZGpnSS1BMHpoSGkwaUhKSlZ2V2U5eHZxV09mWmNia0hZM0lyR3FxY0dfX2pSMHJ0b1FsaWhGZjBHTFNiYXEtdTl3Q2g3YmMyc1Z3Q3FtbmFqTkNpSkdsbXd5Q0hkdFR1c0NYd3RPd3JFQjRQVEVzSWRNMVFKQlN0dVNaSlRMMVhvRDFxMktRM3BFMXhR?oc=5,Google News,Biocon regulatory filing,"Biocon Q1 Results: Net profit jumps 14% to Rs 660 crore, revenue up 30% to Rs 4,567 crore - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxOaWVEdEs3Qko5UjFWUGdXSEE1OC1DRkhObjZ1WjV5cE1NT2UzWjZNakVMc3lmMklNWG5PdmN0dXRid2c3dEhXQTBZcjhUcGw0ZGpnSS1BMHpoSGkwaUhKSlZ2V2U5eHZxV09mWmNia0hZM0lyR3FxY0dfX2pSMHJ0b1FsaWhGZjBHTFNiYXEtdTl3Q2g3YmMyc1Z3Q3FtbmFqTkNpSkdsbXd5Q0hkdFR1c0NYd3RPd3JFQjRQVEVzSWRNMVFKQlN0dVNaSlRMMVhvRDFxMktRM3BFMXhR?oc=5"" target=""_blank"">Biocon Q1 Results: Net profit jumps 14% to Rs 660 crore, revenue up 30% to Rs 4,567 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.9464155435562134,positive,0.9464155435562134,0.0,neutral,0.0,0.7003,0.132,0.0,0.868,0.0,0.0,0.5408088820321219,0.8233577717781067,other,0.0,[],False,True,6,0.0
2025-04-15,2025-04-15 07:00:00,Biocon share price jumps 4% as subsidiary secures market entry for Yesafili in US - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price jumps 4% as subsidiary secures market entry for Yesafili in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon share price jumps 4% as subsidiary secures market entry for Yesafili in US - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price jumps 4% as subsidiary secures market entry for Yesafili in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.9294179081916809,positive,0.9294179081916809,0.0,neutral,0.0,0.7906,0.243,0.0,0.757,0.0,0.0,0.5310959475381033,0.8600089540958404,other,0.0,[],False,True,6,0.0
2025-05-05,2025-05-05 07:00:00,Biocon Biologics Secures US Market Access for Yesintek - Rediff MoneyWiz,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxPSjdSSXIzdjBTTmFEVWd1OFRqWGV5RGVDbVV4R2lQSzFiYzB1SU5UeWhsNEV0SXRvb1pqSEZBOGYxUXRkTzk2Y0tYMnhJVF9ZUEVINVQ1MlVaZnF0TTVuRWNTQmVvVEx3R1VXYXdJcm9LM1pVRjZfUzh2SjlUcXlBaUgxMl91QzVmS21LZjdmT001X2R2YXJfZHRaZXB3QzVXYk43VFNKS1daZ9IBrwFBVV95cUxQdUhVRy1mZUNlMnBkcEtpQzhfZ3hQalVWR0xfZXNYYVh1SkFfTXkwbW1EZXhlU01zZkxnclVfRld3aEJuWTZETTRraUdKazZZbUVEUlZ0OUZtckM2b2wtVXRCclJzdmdJTWtManNCTmlhaXJ1SWRNVF92RW5ZaDUySXVfdTY4bkVjbzZxbHF5WExfVmlCRGE2dXQtRExZYzV3czNwcHMyYjctOGxqdW5v?oc=5"" target=""_blank"">Biocon Biologics Secures US Market Access for Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Rediff MoneyWiz</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxPSjdSSXIzdjBTTmFEVWd1OFRqWGV5RGVDbVV4R2lQSzFiYzB1SU5UeWhsNEV0SXRvb1pqSEZBOGYxUXRkTzk2Y0tYMnhJVF9ZUEVINVQ1MlVaZnF0TTVuRWNTQmVvVEx3R1VXYXdJcm9LM1pVRjZfUzh2SjlUcXlBaUgxMl91QzVmS21LZjdmT001X2R2YXJfZHRaZXB3QzVXYk43VFNKS1daZ9IBrwFBVV95cUxQdUhVRy1mZUNlMnBkcEtpQzhfZ3hQalVWR0xfZXNYYVh1SkFfTXkwbW1EZXhlU01zZkxnclVfRld3aEJuWTZETTRraUdKazZZbUVEUlZ0OUZtckM2b2wtVXRCclJzdmdJTWtManNCTmlhaXJ1SWRNVF92RW5ZaDUySXVfdTY4bkVjbzZxbHF5WExfVmlCRGE2dXQtRExZYzV3czNwcHMyYjctOGxqdW5v?oc=5,Google News,Biocon regulatory filing,"Biocon Biologics Secures US Market Access for Yesintek - Rediff MoneyWiz <a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxPSjdSSXIzdjBTTmFEVWd1OFRqWGV5RGVDbVV4R2lQSzFiYzB1SU5UeWhsNEV0SXRvb1pqSEZBOGYxUXRkTzk2Y0tYMnhJVF9ZUEVINVQ1MlVaZnF0TTVuRWNTQmVvVEx3R1VXYXdJcm9LM1pVRjZfUzh2SjlUcXlBaUgxMl91QzVmS21LZjdmT001X2R2YXJfZHRaZXB3QzVXYk43VFNKS1daZ9IBrwFBVV95cUxQdUhVRy1mZUNlMnBkcEtpQzhfZ3hQalVWR0xfZXNYYVh1SkFfTXkwbW1EZXhlU01zZkxnclVfRld3aEJuWTZETTRraUdKazZZbUVEUlZ0OUZtckM2b2wtVXRCclJzdmdJTWtManNCTmlhaXJ1SWRNVF92RW5ZaDUySXVfdTY4bkVjbzZxbHF5WExfVmlCRGE2dXQtRExZYzV3czNwcHMyYjctOGxqdW5v?oc=5"" target=""_blank"">Biocon Biologics Secures US Market Access for Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Rediff MoneyWiz</font>",0.777108907699585,positive,0.777108907699585,0.0,neutral,0.0,0.5574,0.187,0.0,0.813,0.0,0.0,0.4440622329711914,0.6672544538497924,other,0.0,[],False,True,6,0.0
2025-04-02,2025-04-02 16:15:05,"Biocon CEO Peter Bains resigns, board to discuss next steps - People Matters - HR News","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPdVQxaktUS3FuNFd3aXhwTXlRTUMzUUw2RTVzRFNIeTlTcWotWnlUZ0xJRlc0a0xsRWw0X3VVU2R2RHQyanlnSFB3RDhqcUpYSFRoVkwzMEpEZ0NvbGViNHdnam9yQWRUUVN5U0pYSVVJSGVmY1JwMjl0cmhYUnRYQmNWaTMzYlZ6UVZOTXk4OU4tV1paX3dFY2NRVGZFdlJ5cC1KUXc1UDlxQWxfWFHSAawBQVVfeXFMTXppWGEtNEpQSF8wak42Tkw2c3NycXc0WTdKdC1kUW9rT2NINndnWkVpZ3RzUkp3OXRCY21mNWxtOU9jSUZremxZbWxmeEE4NnFmQk05NUZpcVVIT0pTZk1MVDdHaGpvYVViN0VUN1k4OVZYUFgxSHZQVFhaNkNfU2VrdHBnazQyM29SWWFTaFZDVGNmS1YtajZRTHdOanB1WEs1ay1leUFjdFhUSQ?oc=5"" target=""_blank"">Biocon CEO Peter Bains resigns, board to discuss next steps</a>&nbsp;&nbsp;<font color=""#6f6f6f"">People Matters - HR News</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPdVQxaktUS3FuNFd3aXhwTXlRTUMzUUw2RTVzRFNIeTlTcWotWnlUZ0xJRlc0a0xsRWw0X3VVU2R2RHQyanlnSFB3RDhqcUpYSFRoVkwzMEpEZ0NvbGViNHdnam9yQWRUUVN5U0pYSVVJSGVmY1JwMjl0cmhYUnRYQmNWaTMzYlZ6UVZOTXk4OU4tV1paX3dFY2NRVGZFdlJ5cC1KUXc1UDlxQWxfWFHSAawBQVVfeXFMTXppWGEtNEpQSF8wak42Tkw2c3NycXc0WTdKdC1kUW9rT2NINndnWkVpZ3RzUkp3OXRCY21mNWxtOU9jSUZremxZbWxmeEE4NnFmQk05NUZpcVVIT0pTZk1MVDdHaGpvYVViN0VUN1k4OVZYUFgxSHZQVFhaNkNfU2VrdHBnazQyM29SWWFTaFZDVGNmS1YtajZRTHdOanB1WEs1ay1leUFjdFhUSQ?oc=5,Google News,Biocon regulatory filing,"Biocon CEO Peter Bains resigns, board to discuss next steps - People Matters - HR News <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPdVQxaktUS3FuNFd3aXhwTXlRTUMzUUw2RTVzRFNIeTlTcWotWnlUZ0xJRlc0a0xsRWw0X3VVU2R2RHQyanlnSFB3RDhqcUpYSFRoVkwzMEpEZ0NvbGViNHdnam9yQWRUUVN5U0pYSVVJSGVmY1JwMjl0cmhYUnRYQmNWaTMzYlZ6UVZOTXk4OU4tV1paX3dFY2NRVGZFdlJ5cC1KUXc1UDlxQWxfWFHSAawBQVVfeXFMTXppWGEtNEpQSF8wak42Tkw2c3NycXc0WTdKdC1kUW9rT2NINndnWkVpZ3RzUkp3OXRCY21mNWxtOU9jSUZremxZbWxmeEE4NnFmQk05NUZpcVVIT0pTZk1MVDdHaGpvYVViN0VUN1k4OVZYUFgxSHZQVFhaNkNfU2VrdHBnazQyM29SWWFTaFZDVGNmS1YtajZRTHdOanB1WEs1ay1leUFjdFhUSQ?oc=5"" target=""_blank"">Biocon CEO Peter Bains resigns, board to discuss next steps</a>&nbsp;&nbsp;<font color=""#6f6f6f"">People Matters - HR News</font>",-0.6377816200256348,negative,0.6377816200256348,0.0,neutral,0.0,-0.5267,0.067,0.14,0.793,0.0,0.0,-0.3644466400146484,0.5822408100128174,other,0.0,[],False,True,6,0.0
2023-09-07,2023-09-07 07:00:00,Biocon Biologics completes integration of Viatris biosimilars business in North America - ET HealthWorld,"<a href=""https://news.google.com/rss/articles/CBMi6AFBVV95cUxPQW5zVm1wMGhTb3BMb3E5Vm10Q05QOVlVcTEyRUJLZGxBb0IzN0FfdUg4MFJaUG9NTWJ2UVNSMFlKTDJtLU5jcVNnY01MQkhZdmdJZTN4dlR3eV9EZzUzMUZYZElnZXk4dVFVRy12RmtnQXdMTWJWdU80T2o0RW5WYWtFTzNLeWJId3FmaWE0Q1hQQWtLQmhaUFYzbFBMQV9TeV96bFBGd1BGejNOV2xWLXhMQ1g2cHpoX2t2SVZsUU41TTRwY0hGdzZRWXE4TzJDT0oyd3VVV2NEMG1OdDh2RU4xVEtkYTV30gHuAUFVX3lxTE5ORklVZHFBdVBSRFNpSXBmS0RpOG9sUkI2UmNkQ2VRR1JyMURJRzR5TnRJaUZxU3MtM0JfRF9zT2N0b29VYUlLcnl5WGpPTTJSYVJkYlE3dXBTSmVuZ013TkN3THhWd0xRek9XbjROcm9YMGt3VmFjQ3FkSENhVTFyRzdrc1E1bTdIYjhsT3JKLVEtdzJwVzdlVWZPWHJvYzBxS1BlV1gxQlE3RlZiaE1nbjZHNElKOVBrN0xyNXh3V3M0bHM3MS1zTl9uRzFxTXNBYVAtQmhkZmVPanhLUi1id1d3R3dxeGhMS3lWclE?oc=5"" target=""_blank"">Biocon Biologics completes integration of Viatris biosimilars business in North America</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon Biologics completes integration of Viatris biosimilars business in North America - ET HealthWorld <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics completes integration of Viatris biosimilars business in North America</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.0,neutral,0.8072972297668457,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8072972297668457,other,0.0,[],False,True,6,0.0
2024-12-24,2024-12-24 08:00:00,"Biocon stock settles 5% higher after US drug regulator clears Bengaluru API facility unit, stock up 35% YTD - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock settles 5% higher after US drug regulator clears Bengaluru API facility unit, stock up 35% YTD</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon stock settles 5% higher after US drug regulator clears Bengaluru API facility unit, stock up 35% YTD - Mint <a href=""https://news.google.com/rss/articles/CBMihAJBVV95cUxQSll3a1dKd0ppd0E1bTVHMmNkdi1BMDJfb3FvWE94MDZKbW5vYzlCNE1IQThDYl9Scm9EdTB2UGVZQlluY3pWTU9BY3VGVVU2cnVvVmpNVXJhTFQzbzZ5Q0VGNm5EeGFMQ2pnS1pJbWVyWEozN1VHSGdYTHdRajF6LXdaNnRhSEtrN19LVjdmTVkyenRWTUVyYWo1SDVKeExKem1jZHp2YWtsQU5ZY1FRTEwwSGtpdHNGMEpKWWZYRG9VQVZ5cm5NRl9JZ09xZ0ZabWFjdHdTWHd4REF2akEzaWlGRXdhNklldUFFQTJOamFmSElSaEtrTWFHakRNbXNpdGRwN9IBigJBVV95cUxNbkdxOVI5NF9pUHhVSHZwbkhHTW90amF0T25kOEpfNjlUUWZLc0tNZG9MUng1UHNLYlZOSTJEaEhFUjRZdlhDRFJENTFMakdFRW1uTjJGTmhvUUF5SFJKa1VZUEdYNnZtMGM0WUZIYzhWZl8tZk1RTGVXTFpRNFlLV3Z5Qzd6UFVtbWc4QmVQeG56ZGZOX280YjFsSHphZVA0NGMzWHdXcXh4MW03VUpWc0dZUzdBU0FHQkh1TEZEbkNjczZIVk9qYmtkSl9adXR2WUxmOUE2WTNoX0cxclJwakxhSjRKeGRKYVB0cUpkWXpHSEN1YW1NUXdnRmhwdDRZY3RhSFNyMG9NQQ?oc=5"" target=""_blank"">Biocon stock settles 5% higher after US drug regulator clears Bengaluru API facility unit, stock up 35% YTD</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.9220922589302063,positive,0.9220922589302063,0.0,neutral,0.0,0.1531,0.064,0.0,0.936,0.16666666666666666,0.3333333333333333,0.5269098622458321,0.4139529751989577,other,0.0,[],False,True,6,0.0
2023-09-19,2023-09-19 07:00:00,Biocon appoints Peter Bains as group CEO - ET CIO,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxQMnZlZDcyNVJoRXNncUZZcktHM25sdHJoR0ZveGRBY2NmTmFjUk9SRWpISzRhSnVDa2NIRkVnU0VNWEo5T1p1NTZEU3h2ZjVVZks2NkFxc0dQSGRUanE4UGMxQ21oUFlkVnplSUFCVFNLNmo0a1dyZU5sVHhCMXlvTTdYd1dhODdQY0VISUZXWGdGc01rR3lxMXBtSFNsUnM3LTdQLWhMNDhPVHotdmdZQg?oc=5"" target=""_blank"">Biocon appoints Peter Bains as group CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET CIO</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxQMnZlZDcyNVJoRXNncUZZcktHM25sdHJoR0ZveGRBY2NmTmFjUk9SRWpISzRhSnVDa2NIRkVnU0VNWEo5T1p1NTZEU3h2ZjVVZks2NkFxc0dQSGRUanE4UGMxQ21oUFlkVnplSUFCVFNLNmo0a1dyZU5sVHhCMXlvTTdYd1dhODdQY0VISUZXWGdGc01rR3lxMXBtSFNsUnM3LTdQLWhMNDhPVHotdmdZQg?oc=5,Google News,Biocon regulatory filing,"Biocon appoints Peter Bains as group CEO - ET CIO <a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxQMnZlZDcyNVJoRXNncUZZcktHM25sdHJoR0ZveGRBY2NmTmFjUk9SRWpISzRhSnVDa2NIRkVnU0VNWEo5T1p1NTZEU3h2ZjVVZks2NkFxc0dQSGRUanE4UGMxQ21oUFlkVnplSUFCVFNLNmo0a1dyZU5sVHhCMXlvTTdYd1dhODdQY0VISUZXWGdGc01rR3lxMXBtSFNsUnM3LTdQLWhMNDhPVHotdmdZQg?oc=5"" target=""_blank"">Biocon appoints Peter Bains as group CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET CIO</font>",0.0,neutral,0.9076359868049622,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9076359868049622,other,0.0,[],False,True,6,0.0
2022-07-05,2022-07-05 07:00:00,Biocon's biologics arm gets EU GMP certificate for new facility in Bengaluru - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's biologics arm gets EU GMP certificate for new facility in Bengaluru</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon's biologics arm gets EU GMP certificate for new facility in Bengaluru - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's biologics arm gets EU GMP certificate for new facility in Bengaluru</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.82448410987854,positive,0.82448410987854,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0909090909090909,0.30303030303030304,0.47113377707345144,0.4576966003938155,other,0.0,[],False,True,6,0.0
2022-09-01,2022-09-01 07:00:00,Biocon Biologics receives observations from USFDA: Biocon - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics receives observations from USFDA: Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon Biologics receives observations from USFDA: Biocon - ET HealthWorld <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics receives observations from USFDA: Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.0,neutral,0.9364289045333862,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9364289045333862,other,0.0,[],False,True,6,0.0
2024-06-23,2024-06-23 07:00:00,Biocon gets 4 observations from USFDA for Andhra facility - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets 4 observations from USFDA for Andhra facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon gets 4 observations from USFDA for Andhra facility - ET HealthWorld <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets 4 observations from USFDA for Andhra facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.5006682872772217,positive,0.5006682872772217,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.2860961641584124,0.5006682872772217,other,0.0,[],False,True,6,0.0
2024-09-26,2024-09-26 07:00:00,"Biocon inks licensing, supply pact with Tabuk Pharmaceutical Manufacturing - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon inks licensing, supply pact with Tabuk Pharmaceutical Manufacturing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon inks licensing, supply pact with Tabuk Pharmaceutical Manufacturing - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon inks licensing, supply pact with Tabuk Pharmaceutical Manufacturing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.6660128831863403,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.6660128831863403,other,0.0,[],False,True,6,0.0
2024-09-30,2024-09-30 07:00:00,Biocon Share Price: Pharma stock drops ahead of Q2 results; Macquarie has a say - ET Now,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Share Price: Pharma stock drops ahead of Q2 results; Macquarie has a say</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon Share Price: Pharma stock drops ahead of Q2 results; Macquarie has a say - ET Now <a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxOYThVZ2R1aUpNQkNnalA3eFVWSlZfbGw1UzJaa0RidzEtRnRBOEpuNlMzYmZzeEI5OGNHVWRaZERGTE1DelpEcU43UmdxNi1jS010T1BJVHI4Qm14TDhDaWN0NHhualFHa09vSlc0S1p0Sm55SG1WTENzM0o1ajBod09HWXJseW9wcUZWWVN4bmVERWUzWlpyUG5nOS10QkhRbV9mNWhjUmc3ekwtSFItWkNmWlR2enpnMG5SSWxNaWt4QmpCUnV30gHMAUFVX3lxTE5PTDFXSm1rWllnT0cxMkVpeWFQXzJGTXM4RmNYRVVrdWhLTHg1cXRLNkdMU1EyckJOaHkyRlBHY0lTdHcxcTlZUlpTTk9QUVJJNzhUNUVvMjc3MjY0MldpbWNxOUJGR0RPd0t2SUlMLXJYaTdzX003WUV6OE9JM1BrYmM0b0xmY2VZLURWN3FMdmhWVjdHTkE4OFoxQnlleGpiRDY1MmgxTlhzcExOTEtwM0FuXzB5c1RFQzNjWmtHOVhCQVFuRTFNTXREZw?oc=5"" target=""_blank"">Biocon Share Price: Pharma stock drops ahead of Q2 results; Macquarie has a say</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",-0.9670872688293457,negative,0.9670872688293457,0.0,neutral,0.0,0.5267,0.128,0.0,0.872,0.0,0.0,-0.5526212964739119,0.7468936344146728,other,0.0,[],False,True,6,0.0
2024-12-10,2024-12-10 08:00:00,Biocon confirms sale of 80 lakh Syngene Intl shares for ₹686 crore via open market block deal - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon confirms sale of 80 lakh Syngene Intl shares for ₹686 crore via open market block deal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News,Biocon regulatory filing,"Biocon confirms sale of 80 lakh Syngene Intl shares for ₹686 crore via open market block deal - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon confirms sale of 80 lakh Syngene Intl shares for ₹686 crore via open market block deal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.8762609362602234,0.0,neutral,0.0,-0.34,0.095,0.126,0.779,0.0,0.3333333333333333,0.0,0.6081304681301117,other,0.0,[],False,True,6,0.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared - Mint","<a href=""https://news.google.com/rss/articles/CBMi6wFBVV95cUxQaWF1dExQRnRqLS1sdkxISXNaWDAxNzdaeXpRQk95cGY1bmF6WGpMZE5wTEViTHBxZXAxS3VSX09EM0Y5UktaM3RNb1RYdHZ4Q003OENfbnlkbUdJSDFUZFIyTFpmbzBTZHhscDA5Z0dlTlNfRV9HTW5UMWxHVG1pWmF0VV9GLWxqV1ByTWRsOE9VTWtVVjhnQzlUMmUtMGg3czQ0X3d2OFR2TWhtdEhpN3ZoeVhSUkM5LWtNY1lTTDlFQms5bDlyOEpmUEhDTlQxMFFzenNqSXpocFhUWVlwN2oxQzVtVHF5Tk9n0gHwAUFVX3lxTE5XQ2NaSWFvbHFHMWdNYlA5RzduWXdHV0FreTBZU3F6T2ZGU2ZBN2Z1eVRDTVZ4MmRjUDNzaWFUMGk5bURkOFlvSzN1SV9PeV9CR2tZMWhJMUtzT2FZMUhoYUhzOUNyb3c4NVBHbHgyenRaaWh2VWNXenBpdGNMSHJSTHRyaURTLV9BMmpvWlprNGhiS29UTlNvbXBqNGxQWW9UUmFDNFJnclN6S0lfWk1HeFZqNnM0Yk5nVVd2SXhaWS1DN3JvT1dNMVBBU1lMaG4waEx3VndpemM1NHJDVEh3SDNXVGlCT2VaMzF5SWY2Sw?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",-0.9731054902076721,negative,0.9731054902076721,0.0,neutral,0.0,0.7003,0.153,0.0,0.847,0.0,0.0,-0.5560602801186698,0.836702745103836,other,0.0,[],False,True,6,0.0
2022-05-04,2022-05-04 07:00:00,Ireland regulator reports manufacturing deficiency at Biocon's plant - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxOV3g3cFBxcmtLQU1WT2NmZVdlQUNpN0lobWx2OUFNNHM5VjNiSVR2YXk3bk0zZnlxXzJZWEtrbzVPdW5OUkNFdzJsYTFWRmxnblZ2MTlDNk5fVWlRdWRETmFVN183ZHM2bXV4TlZvX0tvdGFGSjlER1h2VEZDeDlmWFBhWG5FamMtYUFNVk9FTFktNmVRWnQ1OTNBQktpZjVOUXNrN1ZZSW1uLTU2b1lNLTRLWUJNR205SXIzVTNWbXcxZmZYZ2xldVJTSURLaWhKZVpaQnlSZy1VV1Vr0gHiAUFVX3lxTE10RFdSRWpIXzg1blhMUVRPeTI1TTg4dm5vZEl5a0xsaUhPWGdXZW4xQm84QVVKX1RkUm1fWWxxZ3JxVnlGMHRocWpwZGFtRXFwZjAxc1k1QkN5MlZpeDlGcHR2OXVXQW1qQlpZU1dsVVZkY3Y2Tkp5OGtjWndUZ2gxSWtxdWtWS3hmS1VCTWV2WWdUNTNrbDB0elRnc3VsSDhHWUJ6UHdfaWo4eWdaSGhuU3k2U3pUcElPUW5rNHpwWE83ZUNBSEFxZkM4SmpJLXdwN0ZCWnNOcVRraWU3d01fb2c?oc=5"" target=""_blank"">Ireland regulator reports manufacturing deficiency at Biocon's plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Ireland regulator reports manufacturing deficiency at Biocon's plant - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Ireland regulator reports manufacturing deficiency at Biocon's plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9662314653396606,negative,0.9662314653396606,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.5521322659083775,0.9662314653396606,other,0.0,[],False,True,6,0.0
2025-03-05,2025-03-05 08:00:00,Biocon Shares Shot Up 3% on Securing Final Approvals from USFDA - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxQMUpYaG9BaDdSYWE1ODBNdmpDRzRGMm9fOWd3NW5LX2Mwd2FXR0cyUUZGMnN3UHNDVjl2X0w5VmVNT2VDeWRFejlmbExhdDhZWGFkM0t4RHFrMjNjM0RzR2VWQVJZMlB2RWFrWU02NmIyakhyR0ttUkZfaVJnbnAzcXVSbGk3eFdCT09TRlRaMU50a05Bc3dV?oc=5"" target=""_blank"">Biocon Shares Shot Up 3% on Securing Final Approvals from USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxQMUpYaG9BaDdSYWE1ODBNdmpDRzRGMm9fOWd3NW5LX2Mwd2FXR0cyUUZGMnN3UHNDVjl2X0w5VmVNT2VDeWRFejlmbExhdDhZWGFkM0t4RHFrMjNjM0RzR2VWQVJZMlB2RWFrWU02NmIyakhyR0ttUkZfaVJnbnAzcXVSbGk3eFdCT09TRlRaMU50a05Bc3dV?oc=5,Google News,Biocon regulatory filing,"Biocon Shares Shot Up 3% on Securing Final Approvals from USFDA - Equitypandit <a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxQMUpYaG9BaDdSYWE1ODBNdmpDRzRGMm9fOWd3NW5LX2Mwd2FXR0cyUUZGMnN3UHNDVjl2X0w5VmVNT2VDeWRFejlmbExhdDhZWGFkM0t4RHFrMjNjM0RzR2VWQVJZMlB2RWFrWU02NmIyakhyR0ttUkZfaVJnbnAzcXVSbGk3eFdCT09TRlRaMU50a05Bc3dV?oc=5"" target=""_blank"">Biocon Shares Shot Up 3% on Securing Final Approvals from USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.9510890245437622,positive,0.9510890245437622,0.0,neutral,0.0,0.7906,0.29,0.0,0.71,0.0,0.6666666666666666,0.5434794425964355,0.8708445122718811,other,0.0,[],False,True,6,0.0
2022-06-29,2022-06-29 07:00:00,Biocon to buy 26% stake in AMPYR Renewable Energy Resources Eleven - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to buy 26% stake in AMPYR Renewable Energy Resources Eleven</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon to buy 26% stake in AMPYR Renewable Energy Resources Eleven - Business Standard <a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxOdGhvUUNJWEN2NEI5TktzV3Z3dGtQVHJLUzNkVHQ3VFdsVmdITk5yQW1GQVZfY0JiV3ZBOWRFSTI2aXIzT3BiR0djc0w0THBqc1RFdm5xYTZLM1MxcEhPOUIxM0lBSEhCdGxrd0NZQUVSbVV4cUk1ck10QUtfWnduV3ZTcjlMakxHVWlPYVJKS0tGZ0tlWXowZjEzcThsa3AwVzMtem1kQmFpVWQ0X1QycVNmVEFucktqVTlGY3VNMF9sT0VJNnpONENDS2pZai1vX3pj0gHYAUFVX3lxTE52XzlaVnVSSHY1NDFFQ3Bpb2NTZmpUZVhwY2RJOVdZSHBueW5tWGpCQmpKcU1IamxIYm9oNkF0LWFhRFVVSF85LXJyU1I0bkd4QThkbXpJbW5NOXdPdmFrdHpJNE1jUFBvakpmLWJ3Q1AtVjBFakwzSjJYUS0tYjJxX3kzcUIxNG05NnQ0TU1selYtR1FFZlB5MktEOUsxcWdqbFB6Q00yZV9uRE9XV0hPVHVMV0hKQmtWN0lCYW44aUtSb2RZY212R1N3UXZ6Njlxd19WYlV1dQ?oc=5"" target=""_blank"">Biocon to buy 26% stake in AMPYR Renewable Energy Resources Eleven</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.8830408453941345,0.0,neutral,0.0,0.4939,0.139,0.0,0.861,0.0,0.0,0.0,0.6884704226970673,other,0.0,[],False,True,6,0.0
2025-06-20,2025-06-20 15:39:46,"Biocon Raises Rs 4,500 Cr via QIP - Rediff MoneyWiz","<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxOVldmb2VCWkJQRkZLSFRsbUFIWWJoSkJ1Q25CZE9EblMyTnFyUm9zMTNKOE9PVUtVNVFtUDFzZjVSdzhBM1JSc2VGS2dxRzNJQnVoa0FkQ093SFB3YlI2Sk1wVWNGR2Q3V251bk1iY2hpNmxnLUtkWEN2aGxwRURyV1QwbWoxLWVXQnUxSkhR0gGTAUFVX3lxTE9ja2szRXhMVkNjZC1oTXBTTGlCaTB0TzhJUmthMEhNVFdtWTFrRFd6MVUyaGVrQkRKZlF4Vm5zUjQ4c1JLdmI1OUVrbUhEc1MzMGEzczNMMFJtYmNoSGQ4U1NFOHY2UHdOZmo5dXVDTGFSSElRblJ5VENGUTFPZnk3c0cxYzJpREVPV003U1ZSMDlJWQ?oc=5"" target=""_blank"">Biocon Raises Rs 4,500 Cr via QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Rediff MoneyWiz</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxOVldmb2VCWkJQRkZLSFRsbUFIWWJoSkJ1Q25CZE9EblMyTnFyUm9zMTNKOE9PVUtVNVFtUDFzZjVSdzhBM1JSc2VGS2dxRzNJQnVoa0FkQ093SFB3YlI2Sk1wVWNGR2Q3V251bk1iY2hpNmxnLUtkWEN2aGxwRURyV1QwbWoxLWVXQnUxSkhR0gGTAUFVX3lxTE9ja2szRXhMVkNjZC1oTXBTTGlCaTB0TzhJUmthMEhNVFdtWTFrRFd6MVUyaGVrQkRKZlF4Vm5zUjQ4c1JLdmI1OUVrbUhEc1MzMGEzczNMMFJtYmNoSGQ4U1NFOHY2UHdOZmo5dXVDTGFSSElRblJ5VENGUTFPZnk3c0cxYzJpREVPV003U1ZSMDlJWQ?oc=5,Google News,Biocon regulatory filing,"Biocon Raises Rs 4,500 Cr via QIP - Rediff MoneyWiz <a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxOVldmb2VCWkJQRkZLSFRsbUFIWWJoSkJ1Q25CZE9EblMyTnFyUm9zMTNKOE9PVUtVNVFtUDFzZjVSdzhBM1JSc2VGS2dxRzNJQnVoa0FkQ093SFB3YlI2Sk1wVWNGR2Q3V251bk1iY2hpNmxnLUtkWEN2aGxwRURyV1QwbWoxLWVXQnUxSkhR0gGTAUFVX3lxTE9ja2szRXhMVkNjZC1oTXBTTGlCaTB0TzhJUmthMEhNVFdtWTFrRFd6MVUyaGVrQkRKZlF4Vm5zUjQ4c1JLdmI1OUVrbUhEc1MzMGEzczNMMFJtYmNoSGQ4U1NFOHY2UHdOZmo5dXVDTGFSSElRblJ5VENGUTFPZnk3c0cxYzJpREVPV003U1ZSMDlJWQ?oc=5"" target=""_blank"">Biocon Raises Rs 4,500 Cr via QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Rediff MoneyWiz</font>",0.0,neutral,0.9288954734802246,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9288954734802246,other,0.0,[],False,True,6,0.0
2023-09-19,2023-09-19 07:00:00,Biocon appoints Peter Bains as Group CEO - Manufacturing Today India,"<a href=""https://news.google.com/rss/articles/CBMihwFBVV95cUxPTnRjaGd5cmVaX3gwNjBHT05RUnVnYVE4R2RzYmFKUlpQRWRzTGhoMWEtR0ZyLU1hRzJaak42NG9fVGZXaTIyczZWZS1HUlBFOHpnT21iclNsNlkzclZkSkJFQ2QzMGZDdEpwSVEzVUdVUXUyc09qU1pCWTJZMlNqaG1oTHRiaFU?oc=5"" target=""_blank"">Biocon appoints Peter Bains as Group CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Manufacturing Today India</font>",https://news.google.com/rss/articles/CBMihwFBVV95cUxPTnRjaGd5cmVaX3gwNjBHT05RUnVnYVE4R2RzYmFKUlpQRWRzTGhoMWEtR0ZyLU1hRzJaak42NG9fVGZXaTIyczZWZS1HUlBFOHpnT21iclNsNlkzclZkSkJFQ2QzMGZDdEpwSVEzVUdVUXUyc09qU1pCWTJZMlNqaG1oTHRiaFU?oc=5,Google News,Biocon regulatory filing,"Biocon appoints Peter Bains as Group CEO - Manufacturing Today India <a href=""https://news.google.com/rss/articles/CBMihwFBVV95cUxPTnRjaGd5cmVaX3gwNjBHT05RUnVnYVE4R2RzYmFKUlpQRWRzTGhoMWEtR0ZyLU1hRzJaak42NG9fVGZXaTIyczZWZS1HUlBFOHpnT21iclNsNlkzclZkSkJFQ2QzMGZDdEpwSVEzVUdVUXUyc09qU1pCWTJZMlNqaG1oTHRiaFU?oc=5"" target=""_blank"">Biocon appoints Peter Bains as Group CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Manufacturing Today India</font>",0.0,neutral,0.8774513602256775,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8774513602256775,other,0.0,[],False,True,6,0.0
2024-02-23,2024-02-23 08:00:00,Biocon gets over Rs 3 crore penalty over GST related issues - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets over Rs 3 crore penalty over GST related issues</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi7gFBVV95cUxOTkFkOFdCVlVrUW5obmJEUk1IN2VydDY2ekRWRDN4R2dUOHpMejh3LUMxYVZJd0lQMzhPQkl3XzFGOUo5VTNqcEJoUlhVMDNxTFhMbzM5d2VKNnV1V3VBNndpUVEwM2x4ZW5ONFU2X0JRMWQyeGpJd2ZVcGJQeE1Lb3JScXp2WWFtUDhhZGxtZFdlODJuNFF5RFdtNUpwQ1hrQWh6NTQ4b1FpZWcyM3RZN2JMTE5HSElVRTdWcG1rNDJFX0RzcFNFdlpaQjNSakhmLUZ3dFAwSENOYVZmX0VXNmlhLXdiY1ExZmVNdUVR0gHzAUFVX3lxTFAzT0hYc0ZpaEd3RVFWMEYwTGVCQ2NjMEZFaS00NnoxV2Y0U2FlRWd4TVhmbWU2b3k4Q29DSktmazBsd3hlZU9MdTBZVHd4VnpLT1hudzhVQTJJMi1fZTdFWFBxbHpwbXBFdElMVkZJMlQyREY2RUJWR0RpLUNvYl81RWVVWVRHU3B6U1lzU2xadkZZd3VRb3FUVjJCRm8wMFFIbzlZTHJmU1N6N3lCdzJzMU1kQk9KYTN1R3FJb1hNRWtkVUgwVVZmbXVpbVE0Ql9MeEZfNU01UllVQ1JXQUI5SGFPQXdISE9hWjNaOEx5ZVc5MA?oc=5,Google News,Biocon regulatory filing,"Biocon gets over Rs 3 crore penalty over GST related issues - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets over Rs 3 crore penalty over GST related issues</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",-0.9367443323135376,negative,0.9367443323135376,0.0,neutral,0.0,-0.7184,0.0,0.188,0.812,0.08,0.24,-0.5352824756077358,0.5783814441045125,other,0.0,[],False,True,6,0.0
2022-10-07,2022-10-07 07:00:00,Biocon shares fall as European agency finds major deficiency at firm's Bengaluru plant - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall as European agency finds major deficiency at firm's Bengaluru plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon shares fall as European agency finds major deficiency at firm's Bengaluru plant - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall as European agency finds major deficiency at firm's Bengaluru plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",-0.966609001159668,negative,0.966609001159668,0.0,neutral,0.0,0.5267,0.128,0.0,0.872,-0.03928571428571429,0.2571428571428571,-0.5523480006626674,0.5108649051484607,other,0.0,[],False,True,6,0.0
2025-06-17,2025-06-17 07:00:00,Biocon QIP floor price: Rs 4500 crore fundraise by BSE 200 pharma company - details - ET Now,"<a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxNU0ZJcUh6OF9JUGZUSktMS3BGX1ZxRXdwaW9HR2JxbTlUeGd3Z01NN1RPNlhTY25oZF9VRFpNTmtIQjZjN1dKU0xDV0YxUk5pY3g3OWFpZlhLWmhsbXVmY0FwVmFoODRESUE0bnNwMVN2QV9DVHZZTnZUQzhXTm9hMl9RVEktUlZRUlFxOFN6czY3cEtkZmVKZloyanVrbWlQNUFvNnBzazVTbkFmdm9IMXVzcTUteEVFWGtlTlMxdEhoT2JLMnUxYThGOWw?oc=5"" target=""_blank"">Biocon QIP floor price: Rs 4500 crore fundraise by BSE 200 pharma company - details</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMizAFBVV95cUxNU0ZJcUh6OF9JUGZUSktMS3BGX1ZxRXdwaW9HR2JxbTlUeGd3Z01NN1RPNlhTY25oZF9VRFpNTmtIQjZjN1dKU0xDV0YxUk5pY3g3OWFpZlhLWmhsbXVmY0FwVmFoODRESUE0bnNwMVN2QV9DVHZZTnZUQzhXTm9hMl9RVEktUlZRUlFxOFN6czY3cEtkZmVKZloyanVrbWlQNUFvNnBzazVTbkFmdm9IMXVzcTUteEVFWGtlTlMxdEhoT2JLMnUxYThGOWw?oc=5,Google News,Biocon regulatory filing,"Biocon QIP floor price: Rs 4500 crore fundraise by BSE 200 pharma company - details - ET Now <a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxNU0ZJcUh6OF9JUGZUSktMS3BGX1ZxRXdwaW9HR2JxbTlUeGd3Z01NN1RPNlhTY25oZF9VRFpNTmtIQjZjN1dKU0xDV0YxUk5pY3g3OWFpZlhLWmhsbXVmY0FwVmFoODRESUE0bnNwMVN2QV9DVHZZTnZUQzhXTm9hMl9RVEktUlZRUlFxOFN6czY3cEtkZmVKZloyanVrbWlQNUFvNnBzazVTbkFmdm9IMXVzcTUteEVFWGtlTlMxdEhoT2JLMnUxYThGOWw?oc=5"" target=""_blank"">Biocon QIP floor price: Rs 4500 crore fundraise by BSE 200 pharma company - details</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",0.0,neutral,0.9424996376037598,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9424996376037598,other,0.0,[],False,True,6,0.0
2025-06-04,2025-06-04 07:00:00,Biocon gets CDSCO nod for generic diabetes drug - The Hans India,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxOQWFLMzQ3WG1ZekI5RDlGbE5Kb2JIYWFtNDNlN0dJVmZqaWRyR3ZrSUI1OS1zemlWWFVfTUduUEF4WVhoN3FuOHBMNFpGTFBvLXA5N0Q2ekFleWxZTWZjam4tbmpPRXdoQVUwQW1TMFEzZnhTc0JwSzNiNGZkdmVucHBoQVNQdzQxYXgxWVFjWWNyVEFKY2dF?oc=5"" target=""_blank"">Biocon gets CDSCO nod for generic diabetes drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hans India</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxOQWFLMzQ3WG1ZekI5RDlGbE5Kb2JIYWFtNDNlN0dJVmZqaWRyR3ZrSUI1OS1zemlWWFVfTUduUEF4WVhoN3FuOHBMNFpGTFBvLXA5N0Q2ekFleWxZTWZjam4tbmpPRXdoQVUwQW1TMFEzZnhTc0JwSzNiNGZkdmVucHBoQVNQdzQxYXgxWVFjWWNyVEFKY2dF?oc=5,Google News,Biocon regulatory filing,"Biocon gets CDSCO nod for generic diabetes drug - The Hans India <a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxOQWFLMzQ3WG1ZekI5RDlGbE5Kb2JIYWFtNDNlN0dJVmZqaWRyR3ZrSUI1OS1zemlWWFVfTUduUEF4WVhoN3FuOHBMNFpGTFBvLXA5N0Q2ekFleWxZTWZjam4tbmpPRXdoQVUwQW1TMFEzZnhTc0JwSzNiNGZkdmVucHBoQVNQdzQxYXgxWVFjWWNyVEFKY2dF?oc=5"" target=""_blank"">Biocon gets CDSCO nod for generic diabetes drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hans India</font>",0.6221825480461121,positive,0.6221825480461121,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3555328845977783,0.6221825480461121,other,0.0,[],False,True,6,0.0
2025-04-11,2025-04-11 07:00:00,Biocon gains over 5%: Why is the pharma stock surging? - Upstox,"<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxOc0VQLUpMU0w1TU1hRHVHZjY2QWFndEJmcTMzM3BWaXMyWTgyWkNsejlObmQyQlNNcXIzbHZNRWR6Tm91NHllS2x1LUpLX1VtT0FsWDVFY19FejVJeFlLZlNJWlA3ZXJ1WjhZbTdXaG8tY0xEQkFFTDB5VnNITHpTNVBEblQwT0pGb2JJYWM1ckR4YXNoQVVSSUpwOGVjZXBMQzExWXJLMnBmNFB0M0RPTUdvc3NkMXg4Z2pYaA?oc=5"" target=""_blank"">Biocon gains over 5%: Why is the pharma stock surging?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxOc0VQLUpMU0w1TU1hRHVHZjY2QWFndEJmcTMzM3BWaXMyWTgyWkNsejlObmQyQlNNcXIzbHZNRWR6Tm91NHllS2x1LUpLX1VtT0FsWDVFY19FejVJeFlLZlNJWlA3ZXJ1WjhZbTdXaG8tY0xEQkFFTDB5VnNITHpTNVBEblQwT0pGb2JJYWM1ckR4YXNoQVVSSUpwOGVjZXBMQzExWXJLMnBmNFB0M0RPTUdvc3NkMXg4Z2pYaA?oc=5,Google News,Biocon regulatory filing,"Biocon gains over 5%: Why is the pharma stock surging? - Upstox <a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxOc0VQLUpMU0w1TU1hRHVHZjY2QWFndEJmcTMzM3BWaXMyWTgyWkNsejlObmQyQlNNcXIzbHZNRWR6Tm91NHllS2x1LUpLX1VtT0FsWDVFY19FejVJeFlLZlNJWlA3ZXJ1WjhZbTdXaG8tY0xEQkFFTDB5VnNITHpTNVBEblQwT0pGb2JJYWM1ckR4YXNoQVVSSUpwOGVjZXBMQzExWXJLMnBmNFB0M0RPTUdvc3NkMXg4Z2pYaA?oc=5"" target=""_blank"">Biocon gains over 5%: Why is the pharma stock surging?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.775057315826416,positive,0.775057315826416,0.0,neutral,0.0,0.6531,0.195,0.0,0.805,0.0,0.0,0.44288989475795204,0.714078657913208,other,0.0,[],False,True,6,0.0
2023-11-10,2023-11-10 08:00:00,Biocon Q2 results: Net profit zooms over two-fold to Rs 173 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 results: Net profit zooms over two-fold to Rs 173 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon Q2 results: Net profit zooms over two-fold to Rs 173 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 results: Net profit zooms over two-fold to Rs 173 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9218800663948059,positive,0.9218800663948059,0.0,neutral,0.0,0.7003,0.172,0.0,0.828,0.0,0.0,0.5267886093684605,0.8110900331974029,other,0.0,[],False,True,6,0.0
2024-09-18,2024-09-18 07:00:00,Biocon Share Price Could be in Focus Tomorrow as LIC Raises Stake to 5.02 Percent - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxOQXhPUFNFemJIMjhSTTFzcVlBYUloTElqVU5OR1BIcjRxMVFWNm5Lbzg5RWFXLWVOOENpMnBUT2pnVFZicFFwUzNsYmJJTjdVYUYyZUwxT3dtQXNJUC15RERJdnRYNlN0QWxqb1BGOUhZaWZLSUlySUR3dTFZdF93blBpQTBfSkZjaG5Zd0xtUXd4QkdHN1ZHNWZEZ1hDYXc?oc=5"" target=""_blank"">Biocon Share Price Could be in Focus Tomorrow as LIC Raises Stake to 5.02 Percent</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxOQXhPUFNFemJIMjhSTTFzcVlBYUloTElqVU5OR1BIcjRxMVFWNm5Lbzg5RWFXLWVOOENpMnBUT2pnVFZicFFwUzNsYmJJTjdVYUYyZUwxT3dtQXNJUC15RERJdnRYNlN0QWxqb1BGOUhZaWZLSUlySUR3dTFZdF93blBpQTBfSkZjaG5Zd0xtUXd4QkdHN1ZHNWZEZ1hDYXc?oc=5,Google News,Biocon regulatory filing,"Biocon Share Price Could be in Focus Tomorrow as LIC Raises Stake to 5.02 Percent - topnews.in <a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxOQXhPUFNFemJIMjhSTTFzcVlBYUloTElqVU5OR1BIcjRxMVFWNm5Lbzg5RWFXLWVOOENpMnBUT2pnVFZicFFwUzNsYmJJTjdVYUYyZUwxT3dtQXNJUC15RERJdnRYNlN0QWxqb1BGOUhZaWZLSUlySUR3dTFZdF93blBpQTBfSkZjaG5Zd0xtUXd4QkdHN1ZHNWZEZ1hDYXc?oc=5"" target=""_blank"">Biocon Share Price Could be in Focus Tomorrow as LIC Raises Stake to 5.02 Percent</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",0.0,neutral,0.5425441265106201,0.0,neutral,0.0,0.5267,0.121,0.0,0.879,0.0,0.0,0.0,0.53462206325531,other,0.0,[],False,True,6,0.0
2023-12-01,2023-12-01 08:00:00,Biocons subsidiary completes integration of Viatris biosimilars business; stock rises - Zee Business,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocons subsidiary completes integration of Viatris biosimilars business; stock rises</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocons subsidiary completes integration of Viatris biosimilars business; stock rises - Zee Business <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocons subsidiary completes integration of Viatris biosimilars business; stock rises</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",0.5795831084251404,positive,0.5795831084251404,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3311903476715088,0.5795831084251404,other,0.0,[],False,True,6,0.0
2025-06-17,2025-06-17 07:00:00,"Stocks To Watch Today On June 17: Biocon, Vishal Mega Mart, NTPC, TCS, Sona Comstar, and others - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Watch Today On June 17: Biocon, Vishal Mega Mart, NTPC, TCS, Sona Comstar, and others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Stocks To Watch Today On June 17: Biocon, Vishal Mega Mart, NTPC, TCS, Sona Comstar, and others - ET Now <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Watch Today On June 17: Biocon, Vishal Mega Mart, NTPC, TCS, Sona Comstar, and others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",0.0,neutral,0.9379129409790039,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9379129409790039,other,0.0,[],False,True,6,0.0
2024-12-15,2024-12-15 08:00:00,"Stocks to watch on December 16: Reliance Industries, Dixon Tech, Vedanta, Biocon, 63 Moons, Godrej Agrovet, and more - Upstox","<a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxOR2g4b08xYkE3QTRHZXhjVkY3MWE4eEJMLVM0dS15RTR1c1dyYkdubkJWbFcwcmtRYnJ0SGU1WE5jWUlhRTY5SHBHbnpZRUNJc1pvVVpvblRFa0JKTkxRTjhWUVhaenJFYTdOWFRxVVFXTXdqTUtTLVI1SlZtX2hIYWlGYm5pVnA4NlBvV2VBZ3NYTlBveW16UkprYmxJTHRPMV9EUUtpZG9ndmwyS0FYSlZZU3FqeGs2Zm53a25STGZ1TGo4WlRXNG55NGRGNHZZVVAteXg4QUZoLTM2MHJlQkxfc0ZuejVoT0h6RGRGMHNITU9TTm1kYnNhZWs?oc=5"" target=""_blank"">Stocks to watch on December 16: Reliance Industries, Dixon Tech, Vedanta, Biocon, 63 Moons, Godrej Agrovet, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi_AFBVV95cUxOR2g4b08xYkE3QTRHZXhjVkY3MWE4eEJMLVM0dS15RTR1c1dyYkdubkJWbFcwcmtRYnJ0SGU1WE5jWUlhRTY5SHBHbnpZRUNJc1pvVVpvblRFa0JKTkxRTjhWUVhaenJFYTdOWFRxVVFXTXdqTUtTLVI1SlZtX2hIYWlGYm5pVnA4NlBvV2VBZ3NYTlBveW16UkprYmxJTHRPMV9EUUtpZG9ndmwyS0FYSlZZU3FqeGs2Zm53a25STGZ1TGo4WlRXNG55NGRGNHZZVVAteXg4QUZoLTM2MHJlQkxfc0ZuejVoT0h6RGRGMHNITU9TTm1kYnNhZWs?oc=5,Google News,Biocon regulatory filing,"Stocks to watch on December 16: Reliance Industries, Dixon Tech, Vedanta, Biocon, 63 Moons, Godrej Agrovet, and more - Upstox <a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxOR2g4b08xYkE3QTRHZXhjVkY3MWE4eEJMLVM0dS15RTR1c1dyYkdubkJWbFcwcmtRYnJ0SGU1WE5jWUlhRTY5SHBHbnpZRUNJc1pvVVpvblRFa0JKTkxRTjhWUVhaenJFYTdOWFRxVVFXTXdqTUtTLVI1SlZtX2hIYWlGYm5pVnA4NlBvV2VBZ3NYTlBveW16UkprYmxJTHRPMV9EUUtpZG9ndmwyS0FYSlZZU3FqeGs2Zm53a25STGZ1TGo4WlRXNG55NGRGNHZZVVAteXg4QUZoLTM2MHJlQkxfc0ZuejVoT0h6RGRGMHNITU9TTm1kYnNhZWs?oc=5"" target=""_blank"">Stocks to watch on December 16: Reliance Industries, Dixon Tech, Vedanta, Biocon, 63 Moons, Godrej Agrovet, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.0,neutral,0.927195131778717,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.25,0.25,0.0,0.5885975658893585,other,0.0,[],False,True,6,0.0
2025-06-16,2025-06-16 07:00:00,"Biocon QIP: Firm sets floor price of ₹340.2 per share for ₹4,500 crore fundraising - Upstox","<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxOdVhpdzNsams2VzFjemNKanJhN0d0Z01sUXNNRFFVektrbjJxRUJFa2FXSTljUHNScGxCQ21LcW1CU0NLd0VsR0gydjRvNnlkdTk4ZGxUYjhZcVpMTktUWnU4RlJkamhhZ0dwX0pjbGdScjE1RzEwc1RFTFh1SGphaE1WT1JGQjNybnpOeGdvYzJ1bWl2WmVwSWUwb05nVG1yZDF6Unk0Ul9KUzh3b0JiS1Z6UGh5SWFpZjJQWXRESWtUaGd1WEQtaXBnTVVHNWtXRDVTQw?oc=5"" target=""_blank"">Biocon QIP: Firm sets floor price of ₹340.2 per share for ₹4,500 crore fundraising</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi1AFBVV95cUxOdVhpdzNsams2VzFjemNKanJhN0d0Z01sUXNNRFFVektrbjJxRUJFa2FXSTljUHNScGxCQ21LcW1CU0NLd0VsR0gydjRvNnlkdTk4ZGxUYjhZcVpMTktUWnU4RlJkamhhZ0dwX0pjbGdScjE1RzEwc1RFTFh1SGphaE1WT1JGQjNybnpOeGdvYzJ1bWl2WmVwSWUwb05nVG1yZDF6Unk0Ul9KUzh3b0JiS1Z6UGh5SWFpZjJQWXRESWtUaGd1WEQtaXBnTVVHNWtXRDVTQw?oc=5,Google News,Biocon regulatory filing,"Biocon QIP: Firm sets floor price of ₹340.2 per share for ₹4,500 crore fundraising - Upstox <a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxOdVhpdzNsams2VzFjemNKanJhN0d0Z01sUXNNRFFVektrbjJxRUJFa2FXSTljUHNScGxCQ21LcW1CU0NLd0VsR0gydjRvNnlkdTk4ZGxUYjhZcVpMTktUWnU4RlJkamhhZ0dwX0pjbGdScjE1RzEwc1RFTFh1SGphaE1WT1JGQjNybnpOeGdvYzJ1bWl2WmVwSWUwb05nVG1yZDF6Unk0Ul9KUzh3b0JiS1Z6UGh5SWFpZjJQWXRESWtUaGd1WEQtaXBnTVVHNWtXRDVTQw?oc=5"" target=""_blank"">Biocon QIP: Firm sets floor price of ₹340.2 per share for ₹4,500 crore fundraising</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.0,neutral,0.8014401197433472,0.0,neutral,0.0,0.5267,0.128,0.0,0.872,-0.13333333333333333,0.26666666666666666,0.0,0.4871578176922268,other,0.0,[],False,True,6,0.0
2025-02-25,2025-02-25 08:00:00,"Tata Investment, Zomato, M&M, Biocon, NTPC Green: Check top buzzing stocks of the day - Upstox","<a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxNMEw3Mkc2TGZ1cEl3MENRUE0wMUVEbU5pbHVrN2lRdE52NzNJay1FT0V3NkR4c0NyZ2VXX19ZaWxyNjBZMktFVnJBY25IOWlybjFjc0g3dzhwclBrTnV0cnk3eXYtd2k0UURkSGVLR2dNUktWSG5DN3U4Uk9sRG1aRGJhT3ZQa1FWV0VaWXNuUmc0QUllRHJtMnZGRi10V241RlRTYWowYkNnVjJQcUI3RERPN05IUm9mM3lOdkh2YlZua2RHeHJpeVFDV1NjMFFVSG9TbjFCMUVmVnM?oc=5"" target=""_blank"">Tata Investment, Zomato, M&amp;M, Biocon, NTPC Green: Check top buzzing stocks of the day</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi2wFBVV95cUxNMEw3Mkc2TGZ1cEl3MENRUE0wMUVEbU5pbHVrN2lRdE52NzNJay1FT0V3NkR4c0NyZ2VXX19ZaWxyNjBZMktFVnJBY25IOWlybjFjc0g3dzhwclBrTnV0cnk3eXYtd2k0UURkSGVLR2dNUktWSG5DN3U4Uk9sRG1aRGJhT3ZQa1FWV0VaWXNuUmc0QUllRHJtMnZGRi10V241RlRTYWowYkNnVjJQcUI3RERPN05IUm9mM3lOdkh2YlZua2RHeHJpeVFDV1NjMFFVSG9TbjFCMUVmVnM?oc=5,Google News,Biocon regulatory filing,"Tata Investment, Zomato, M&M, Biocon, NTPC Green: Check top buzzing stocks of the day - Upstox <a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxNMEw3Mkc2TGZ1cEl3MENRUE0wMUVEbU5pbHVrN2lRdE52NzNJay1FT0V3NkR4c0NyZ2VXX19ZaWxyNjBZMktFVnJBY25IOWlybjFjc0g3dzhwclBrTnV0cnk3eXYtd2k0UURkSGVLR2dNUktWSG5DN3U4Uk9sRG1aRGJhT3ZQa1FWV0VaWXNuUmc0QUllRHJtMnZGRi10V241RlRTYWowYkNnVjJQcUI3RERPN05IUm9mM3lOdkh2YlZua2RHeHJpeVFDV1NjMFFVSG9TbjFCMUVmVnM?oc=5"" target=""_blank"">Tata Investment, Zomato, M&amp;M, Biocon, NTPC Green: Check top buzzing stocks of the day</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.0,neutral,0.9094750881195068,0.0,neutral,0.0,0.3818,0.107,0.0,0.893,0.12,0.32,0.0,0.4704250293731689,other,0.0,[],False,True,6,0.0
2025-06-27,2025-06-27 07:40:38,Biocon Biologics gets Health Canada nod for biosimilar Yesafili - NewsDrum,"<a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxNYURLYlZUZy12YjFtWm5SNUNqbFZHalZRMDdCLVEySEFydVNvZENvemRUdVRCMC13eTRRenktakRVZHNPYjlEMGZSdnBVaWw3ZzJvVjdfdHB6RWE0cGdGUk0tQzJoQTN1aGlmdXRiVTJ6LU5Pa3RCWDNKbWRQY2Y5MURlYlZ1T2dndjRxYlN2WXY2MkQ4OWw4RDFQN0hySHM3bC1yWFFPd9IBpwFBVV95cUxNYURLYlZUZy12YjFtWm5SNUNqbFZHalZRMDdCLVEySEFydVNvZENvemRUdVRCMC13eTRRenktakRVZHNPYjlEMGZSdnBVaWw3ZzJvVjdfdHB6RWE0cGdGUk0tQzJoQTN1aGlmdXRiVTJ6LU5Pa3RCWDNKbWRQY2Y5MURlYlZ1T2dndjRxYlN2WXY2MkQ4OWw4RDFQN0hySHM3bC1yWFFPdw?oc=5"" target=""_blank"">Biocon Biologics gets Health Canada nod for biosimilar Yesafili</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NewsDrum</font>",https://news.google.com/rss/articles/CBMipwFBVV95cUxNYURLYlZUZy12YjFtWm5SNUNqbFZHalZRMDdCLVEySEFydVNvZENvemRUdVRCMC13eTRRenktakRVZHNPYjlEMGZSdnBVaWw3ZzJvVjdfdHB6RWE0cGdGUk0tQzJoQTN1aGlmdXRiVTJ6LU5Pa3RCWDNKbWRQY2Y5MURlYlZ1T2dndjRxYlN2WXY2MkQ4OWw4RDFQN0hySHM3bC1yWFFPd9IBpwFBVV95cUxNYURLYlZUZy12YjFtWm5SNUNqbFZHalZRMDdCLVEySEFydVNvZENvemRUdVRCMC13eTRRenktakRVZHNPYjlEMGZSdnBVaWw3ZzJvVjdfdHB6RWE0cGdGUk0tQzJoQTN1aGlmdXRiVTJ6LU5Pa3RCWDNKbWRQY2Y5MURlYlZ1T2dndjRxYlN2WXY2MkQ4OWw4RDFQN0hySHM3bC1yWFFPdw?oc=5,Google News,Biocon regulatory filing,"Biocon Biologics gets Health Canada nod for biosimilar Yesafili - NewsDrum <a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxNYURLYlZUZy12YjFtWm5SNUNqbFZHalZRMDdCLVEySEFydVNvZENvemRUdVRCMC13eTRRenktakRVZHNPYjlEMGZSdnBVaWw3ZzJvVjdfdHB6RWE0cGdGUk0tQzJoQTN1aGlmdXRiVTJ6LU5Pa3RCWDNKbWRQY2Y5MURlYlZ1T2dndjRxYlN2WXY2MkQ4OWw4RDFQN0hySHM3bC1yWFFPd9IBpwFBVV95cUxNYURLYlZUZy12YjFtWm5SNUNqbFZHalZRMDdCLVEySEFydVNvZENvemRUdVRCMC13eTRRenktakRVZHNPYjlEMGZSdnBVaWw3ZzJvVjdfdHB6RWE0cGdGUk0tQzJoQTN1aGlmdXRiVTJ6LU5Pa3RCWDNKbWRQY2Y5MURlYlZ1T2dndjRxYlN2WXY2MkQ4OWw4RDFQN0hySHM3bC1yWFFPdw?oc=5"" target=""_blank"">Biocon Biologics gets Health Canada nod for biosimilar Yesafili</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NewsDrum</font>",0.5899588465690613,positive,0.5899588465690613,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.33711934089660645,0.5899588465690613,other,0.0,[],False,True,6,0.0
2025-04-07,2025-04-07 07:00:00,Biocon shares drop over 6% today; Board approves Rs 600 crore fundraise via commercial papers - Business Upturn,"<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxPSzBNSWNTOURZX2pCZEZPNFlZaEd2VkllaVJTWTBEQjFSSHdNdmNTcHhNMVFxWkZNelczVGtYd0tWRW9lZUdwZkxGME5mTjFhS0c1Tm5DMkdEbmdybUVnU1dNMnFWeDFDa0NHLUNXOG01QjJjd3BjaDM3bTZWU3ZKVUJXMnpzdmRtLVFSalB3cC1QZE81UmZfVFVkRjNKUnZGVmNPay03Y1hfVHh3SjVZeVJUM1BkdzVOZ1p5dXRkSEEyYTZYX0QxazlaTloyRG5VMl9CMVRKNlp3N2FE?oc=5"" target=""_blank"">Biocon shares drop over 6% today; Board approves Rs 600 crore fundraise via commercial papers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",https://news.google.com/rss/articles/CBMi3AFBVV95cUxPSzBNSWNTOURZX2pCZEZPNFlZaEd2VkllaVJTWTBEQjFSSHdNdmNTcHhNMVFxWkZNelczVGtYd0tWRW9lZUdwZkxGME5mTjFhS0c1Tm5DMkdEbmdybUVnU1dNMnFWeDFDa0NHLUNXOG01QjJjd3BjaDM3bTZWU3ZKVUJXMnpzdmRtLVFSalB3cC1QZE81UmZfVFVkRjNKUnZGVmNPay03Y1hfVHh3SjVZeVJUM1BkdzVOZ1p5dXRkSEEyYTZYX0QxazlaTloyRG5VMl9CMVRKNlp3N2FE?oc=5,Google News,Biocon regulatory filing,"Biocon shares drop over 6% today; Board approves Rs 600 crore fundraise via commercial papers - Business Upturn <a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxPSzBNSWNTOURZX2pCZEZPNFlZaEd2VkllaVJTWTBEQjFSSHdNdmNTcHhNMVFxWkZNelczVGtYd0tWRW9lZUdwZkxGME5mTjFhS0c1Tm5DMkdEbmdybUVnU1dNMnFWeDFDa0NHLUNXOG01QjJjd3BjaDM3bTZWU3ZKVUJXMnpzdmRtLVFSalB3cC1QZE81UmZfVFVkRjNKUnZGVmNPay03Y1hfVHh3SjVZeVJUM1BkdzVOZ1p5dXRkSEEyYTZYX0QxazlaTloyRG5VMl9CMVRKNlp3N2FE?oc=5"" target=""_blank"">Biocon shares drop over 6% today; Board approves Rs 600 crore fundraise via commercial papers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",-0.9705909490585327,negative,0.9705909490585327,0.0,neutral,0.0,0.6808,0.223,0.095,0.682,0.0,0.0,-0.5546233994620187,0.8256954745292664,other,0.0,[],False,True,6,0.0
2025-06-26,2025-06-26 15:45:47,Biocon to acquire debentures of Biocon Biologics from Goldman Sachs for USD 198.5 mn - NewsDrum,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to acquire debentures of Biocon Biologics from Goldman Sachs for USD 198.5 mn</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NewsDrum</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Biocon to acquire debentures of Biocon Biologics from Goldman Sachs for USD 198.5 mn - NewsDrum <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to acquire debentures of Biocon Biologics from Goldman Sachs for USD 198.5 mn</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NewsDrum</font>",0.0,neutral,0.9084212779998779,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9084212779998779,other,0.0,[],False,True,6,0.0
2025-06-26,2025-06-26 15:44:06,Latest News | Biocon to Acquire Debentures of Biocon Biologics from Goldman Sachs for USD 198.5 Mn - LatestLY,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Latest News | Biocon to Acquire Debentures of Biocon Biologics from Goldman Sachs for USD 198.5 Mn</a>&nbsp;&nbsp;<font color=""#6f6f6f"">LatestLY</font>",https://news.google.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?oc=5,Google News,Biocon regulatory filing,"Latest News | Biocon to Acquire Debentures of Biocon Biologics from Goldman Sachs for USD 198.5 Mn - LatestLY <a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxQS1g1WkNQUnpsTXdCV1h1T0lSeGdPZk1KU1h5YWt5QnJrY2RXUWRTeklaR1VhTkJ3dFJ4cHdjV18xR21xMmI4M05FVDNVaWY1ZHlBbkoyMkZwaWRMMzZyXzBaUV9zZ2o0UXBQeUhWaGpndU9DdWhfbWNpVFAzUHRWQldGYWFLSHZfZ3NrbzlIbkdmRDJxaDJWbDUwYW1Gb2FSV05rbmtZVlBxQVZONmoyYVdvZGk0dnRoeXpIdkc1aTBhZWFzUUttWXA0a2dHTlF2b1Bldk5QSkdicEluRVhz0gHkAUFVX3lxTFBJay1zYVB0alpqTVhhUHNraGFwYjVuS3podkZyTDFPbWo4NkFYSHJwU1J3MFI5LW9PT0lLY3dzWTVmbGFnd3FBNWNJaFhqZW5WcWdWRXl4R1h3ejRCTnNVbDdfLThmRmRTUWJUcV9EVElkQ1V6SEVTcnZQM2pxS0lCMFR5Z3M2TEpBSmdaTjM4akdQQmM3bDRCMS1iamV5ZXFPZzVqdUxmTzUwN0pMRXVtTmNaQmRZa3hJV094OFRjRE0zVHJndWc0SjU4MlpmNlJ5OWV5S09HcFVjV2VRZGpncGVnbA?oc=5"" target=""_blank"">Latest News | Biocon to Acquire Debentures of Biocon Biologics from Goldman Sachs for USD 198.5 Mn</a>&nbsp;&nbsp;<font color=""#6f6f6f"">LatestLY</font>",0.0,neutral,0.9151713848114014,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.3333333333333333,0.6,0.0,0.6242523590723673,other,0.0,[],False,True,6,0.0
2025-06-20,2025-06-20 15:36:20,"Latest News | Biocon Completes Raising Rs 4,500 Cr Via QIP - LatestLY","<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxPbm9zdW1HajdSQzdkM0tGWG4tWlBScVBGYk9CNk80U21VQjJmZ0pSWHJWdldZS1FickhSd0VSUFFncjFnMHJCY1U3NVNxbmJUSm9scmFaTTVIUTJyLTlyT2lfYVdPVUl6U1B2OVRyb2JGUktvMktxdmNyOXljZjh2QWlFam1FaU5COWVkal9UY0Y2QWJGbUdfZ3RIbHhhbEM3OGJGbEMyYnfSAa4BQVVfeXFMUG5xaW5vcWhhRU5MOEctMEYtYTE0UHhIUmI4Um9HWkR5dUVjZWZGbUx3bFlBVURwRHVyWUc4U2RSYnc0OEpEUXdIR3BFLTRtdVVuRjZFR09EdGY3M211WTdlWVZCM3lvRXo3VmFzeExxSGlDX25lWGpSV0lUVFRZemRlaFVWNnpfSWlzN3B2ckFTT3l0OXdaTDdpZWdnbWRtMXd4R3NKODAyZ3RmZEZB?oc=5"" target=""_blank"">Latest News | Biocon Completes Raising Rs 4,500 Cr Via QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">LatestLY</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxPbm9zdW1HajdSQzdkM0tGWG4tWlBScVBGYk9CNk80U21VQjJmZ0pSWHJWdldZS1FickhSd0VSUFFncjFnMHJCY1U3NVNxbmJUSm9scmFaTTVIUTJyLTlyT2lfYVdPVUl6U1B2OVRyb2JGUktvMktxdmNyOXljZjh2QWlFam1FaU5COWVkal9UY0Y2QWJGbUdfZ3RIbHhhbEM3OGJGbEMyYnfSAa4BQVVfeXFMUG5xaW5vcWhhRU5MOEctMEYtYTE0UHhIUmI4Um9HWkR5dUVjZWZGbUx3bFlBVURwRHVyWUc4U2RSYnc0OEpEUXdIR3BFLTRtdVVuRjZFR09EdGY3M211WTdlWVZCM3lvRXo3VmFzeExxSGlDX25lWGpSV0lUVFRZemRlaFVWNnpfSWlzN3B2ckFTT3l0OXdaTDdpZWdnbWRtMXd4R3NKODAyZ3RmZEZB?oc=5,Google News,Biocon regulatory filing,"Latest News | Biocon Completes Raising Rs 4,500 Cr Via QIP - LatestLY <a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxPbm9zdW1HajdSQzdkM0tGWG4tWlBScVBGYk9CNk80U21VQjJmZ0pSWHJWdldZS1FickhSd0VSUFFncjFnMHJCY1U3NVNxbmJUSm9scmFaTTVIUTJyLTlyT2lfYVdPVUl6U1B2OVRyb2JGUktvMktxdmNyOXljZjh2QWlFam1FaU5COWVkal9UY0Y2QWJGbUdfZ3RIbHhhbEM3OGJGbEMyYnfSAa4BQVVfeXFMUG5xaW5vcWhhRU5MOEctMEYtYTE0UHhIUmI4Um9HWkR5dUVjZWZGbUx3bFlBVURwRHVyWUc4U2RSYnc0OEpEUXdIR3BFLTRtdVVuRjZFR09EdGY3M211WTdlWVZCM3lvRXo3VmFzeExxSGlDX25lWGpSV0lUVFRZemRlaFVWNnpfSWlzN3B2ckFTT3l0OXdaTDdpZWdnbWRtMXd4R3NKODAyZ3RmZEZB?oc=5"" target=""_blank"">Latest News | Biocon Completes Raising Rs 4,500 Cr Via QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">LatestLY</font>",0.0,neutral,0.8392789959907532,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.3333333333333333,0.6,0.0,0.5863061646620432,other,0.0,[],False,True,6,0.0
2022-06-30,2022-06-30 07:00:00,Biopharmaceutical player Biocon to acquire 26% stake in AMPYR Renewable Energy Resources Eleven for solar power - Business Outreach,"<a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxNWnVEUGUtQ0ExaTdDclRwT0lma01fNVZyLXNpVWx5SnBzcFZCaXRjQ25jRDJ1VHNWeEI5WGk4TUZNMGRxZDQyMFpUOUd3TEs0STVEb2s4czdyckt1Z2REeUNwUVJrT1BRel9HVC1reExSUnZOcEUxM3k1YkZKRnlMRFotbm4yRTcxQ0tFRVlSaThMSC00RWtxZm03U1AwN05IYUhIb1lUZDNUUXlqUDBhSlBaaU9oT1lNWWN1dlRUc2RUTDM3T1R0OXI3Q0IwUHZXeGx5blFkU3p4T0U?oc=5"" target=""_blank"">Biopharmaceutical player Biocon to acquire 26% stake in AMPYR Renewable Energy Resources Eleven for solar power</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Outreach</font>",https://news.google.com/rss/articles/CBMi2wFBVV95cUxNWnVEUGUtQ0ExaTdDclRwT0lma01fNVZyLXNpVWx5SnBzcFZCaXRjQ25jRDJ1VHNWeEI5WGk4TUZNMGRxZDQyMFpUOUd3TEs0STVEb2s4czdyckt1Z2REeUNwUVJrT1BRel9HVC1reExSUnZOcEUxM3k1YkZKRnlMRFotbm4yRTcxQ0tFRVlSaThMSC00RWtxZm03U1AwN05IYUhIb1lUZDNUUXlqUDBhSlBaaU9oT1lNWWN1dlRUc2RUTDM3T1R0OXI3Q0IwUHZXeGx5blFkU3p4T0U?oc=5,Google News,Biocon regulatory filing,"Biopharmaceutical player Biocon to acquire 26% stake in AMPYR Renewable Energy Resources Eleven for solar power - Business Outreach <a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxNWnVEUGUtQ0ExaTdDclRwT0lma01fNVZyLXNpVWx5SnBzcFZCaXRjQ25jRDJ1VHNWeEI5WGk4TUZNMGRxZDQyMFpUOUd3TEs0STVEb2s4czdyckt1Z2REeUNwUVJrT1BRel9HVC1reExSUnZOcEUxM3k1YkZKRnlMRFotbm4yRTcxQ0tFRVlSaThMSC00RWtxZm03U1AwN05IYUhIb1lUZDNUUXlqUDBhSlBaaU9oT1lNWWN1dlRUc2RUTDM3T1R0OXI3Q0IwUHZXeGx5blFkU3p4T0U?oc=5"" target=""_blank"">Biopharmaceutical player Biocon to acquire 26% stake in AMPYR Renewable Energy Resources Eleven for solar power</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Outreach</font>",0.0,neutral,0.7374083399772644,0.0,neutral,0.0,0.6486,0.153,0.0,0.847,0.0,0.0,0.0,0.6930041699886322,other,0.0,[],False,True,6,0.0
2021-11-16,2021-11-16 08:00:00,Viatris launched 2 versions of its interchangeable insulin biosimilar. Why? - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxOdFpTLV9rQ25MZF9wZEJla0dmOFlnbFhRV2RSZU91ZzNwTUt4U2RjRi1jRm5saEgtYUgycjJnT0hib3kxQmRuYmdtTWIzVDVfUmkwQkg1Y21XTDFJalAxUGpUc01ETV9JLVBEaWowenp3X0tfY1RBNVd3eUVKUFl1RXZvLTFsTnZkR2NIYVFiMTJiOGpGWXRxSWFNTUVpRW1GZ3pEb1NXN1BjcGNQT2labUJEV0JQcXBSTjdKcEtnU1hQcmNP?oc=5"" target=""_blank"">Viatris launched 2 versions of its interchangeable insulin biosimilar. Why?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxOdFpTLV9rQ25MZF9wZEJla0dmOFlnbFhRV2RSZU91ZzNwTUt4U2RjRi1jRm5saEgtYUgycjJnT0hib3kxQmRuYmdtTWIzVDVfUmkwQkg1Y21XTDFJalAxUGpUc01ETV9JLVBEaWowenp3X0tfY1RBNVd3eUVKUFl1RXZvLTFsTnZkR2NIYVFiMTJiOGpGWXRxSWFNTUVpRW1GZ3pEb1NXN1BjcGNQT2labUJEV0JQcXBSTjdKcEtnU1hQcmNP?oc=5,Google News,Biocon Semglee launch,"Viatris launched 2 versions of its interchangeable insulin biosimilar. Why? - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxOdFpTLV9rQ25MZF9wZEJla0dmOFlnbFhRV2RSZU91ZzNwTUt4U2RjRi1jRm5saEgtYUgycjJnT0hib3kxQmRuYmdtTWIzVDVfUmkwQkg1Y21XTDFJalAxUGpUc01ETV9JLVBEaWowenp3X0tfY1RBNVd3eUVKUFl1RXZvLTFsTnZkR2NIYVFiMTJiOGpGWXRxSWFNTUVpRW1GZ3pEb1NXN1BjcGNQT2labUJEV0JQcXBSTjdKcEtnU1hQcmNP?oc=5"" target=""_blank"">Viatris launched 2 versions of its interchangeable insulin biosimilar. Why?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.6762497425079346,0.0,neutral,0.0,0.3695,0.139,0.0,0.861,0.0,0.0,0.0,0.5228748712539673,other,0.0,[],False,False,1,0.0
2022-11-24,2022-11-24 08:00:00,Biocon inches up on signing semi-exclusive partnership agreement with Zentiva - udaipurkiran.com,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxNa2RQSXYtYkRHWUlZa3hnakNUV3NQbXhTQlFpTEsxaFp0cDRQSVM1b0dkTGR3ZnhmV1o1V3RRYlU3eDFYVi11R2N5RzVGLWRSaTYycjdlYmN4bXJKcTVqTVh4OUJIbmlZQjNSZlg2LWdfd1NnaFJ4cXUwN2ViVFRYdHplM3h3VkgxVVBxSnJpaHp5V0hBUFVEbDV0eHR2MGo1MXRKMUJ3?oc=5"" target=""_blank"">Biocon inches up on signing semi-exclusive partnership agreement with Zentiva</a>&nbsp;&nbsp;<font color=""#6f6f6f"">udaipurkiran.com</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxNa2RQSXYtYkRHWUlZa3hnakNUV3NQbXhTQlFpTEsxaFp0cDRQSVM1b0dkTGR3ZnhmV1o1V3RRYlU3eDFYVi11R2N5RzVGLWRSaTYycjdlYmN4bXJKcTVqTVh4OUJIbmlZQjNSZlg2LWdfd1NnaFJ4cXUwN2ViVFRYdHplM3h3VkgxVVBxSnJpaHp5V0hBUFVEbDV0eHR2MGo1MXRKMUJ3?oc=5,Google News,Biocon Semglee launch,"Biocon inches up on signing semi-exclusive partnership agreement with Zentiva - udaipurkiran.com <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxNa2RQSXYtYkRHWUlZa3hnakNUV3NQbXhTQlFpTEsxaFp0cDRQSVM1b0dkTGR3ZnhmV1o1V3RRYlU3eDFYVi11R2N5RzVGLWRSaTYycjdlYmN4bXJKcTVqTVh4OUJIbmlZQjNSZlg2LWdfd1NnaFJ4cXUwN2ViVFRYdHplM3h3VkgxVVBxSnJpaHp5V0hBUFVEbDV0eHR2MGo1MXRKMUJ3?oc=5"" target=""_blank"">Biocon inches up on signing semi-exclusive partnership agreement with Zentiva</a>&nbsp;&nbsp;<font color=""#6f6f6f"">udaipurkiran.com</font>",0.946168839931488,positive,0.946168839931488,0.0,neutral,0.0,0.7506,0.225,0.0,0.775,0.0,0.0,0.5406679085322789,0.848384419965744,other,0.0,[],False,True,6,0.0
2025-06-27,2025-06-27 07:31:59,Biocon moves up as its arm receives NOC from Health Canada for Yesafili - udaipurkiran.com,"<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQa1ZKaDN1MW5lckdTNU0ySG1sRFpPTE9XZ3hZRW5YbXBJYWtHX0ZGUkhLNVN2Qk1kZmduWkxXbUFtRzRKSHZwdXdKWWowbHVQdEI3WkswekNsc3pfOHVUZ21pdTNVNUhHTnFBU2hrdVltS3FfNnFNZXBVOUQ3Y0NuVjBWTUwyQnpLTWhyWHkzNWlmcXA3SjRXTmh4Vlg0Zw?oc=5"" target=""_blank"">Biocon moves up as its arm receives NOC from Health Canada for Yesafili</a>&nbsp;&nbsp;<font color=""#6f6f6f"">udaipurkiran.com</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQa1ZKaDN1MW5lckdTNU0ySG1sRFpPTE9XZ3hZRW5YbXBJYWtHX0ZGUkhLNVN2Qk1kZmduWkxXbUFtRzRKSHZwdXdKWWowbHVQdEI3WkswekNsc3pfOHVUZ21pdTNVNUhHTnFBU2hrdVltS3FfNnFNZXBVOUQ3Y0NuVjBWTUwyQnpLTWhyWHkzNWlmcXA3SjRXTmh4Vlg0Zw?oc=5,Google News,Biocon Semglee launch,"Biocon moves up as its arm receives NOC from Health Canada for Yesafili - udaipurkiran.com <a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQa1ZKaDN1MW5lckdTNU0ySG1sRFpPTE9XZ3hZRW5YbXBJYWtHX0ZGUkhLNVN2Qk1kZmduWkxXbUFtRzRKSHZwdXdKWWowbHVQdEI3WkswekNsc3pfOHVUZ21pdTNVNUhHTnFBU2hrdVltS3FfNnFNZXBVOUQ3Y0NuVjBWTUwyQnpLTWhyWHkzNWlmcXA3SjRXTmh4Vlg0Zw?oc=5"" target=""_blank"">Biocon moves up as its arm receives NOC from Health Canada for Yesafili</a>&nbsp;&nbsp;<font color=""#6f6f6f"">udaipurkiran.com</font>",0.9354779720306396,positive,0.9354779720306396,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5345588411603654,0.9354779720306396,other,0.0,[],False,True,6,0.0
2021-08-06,2021-08-06 07:00:00,Biosimilar and Interchangeable Semglee Insulin Could Save U.S. Healthcare Hundreds of Millions - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxNd2xqMW5ndHp6VVV2cDdFaTV2QzFWbk9TTU9oSmwzU3puc3k0Vm5sLVhfQUVSSzdTLUxobmtmbS1CN0drTGhISGF1cFhYZGJ2N0t6ZjVsOU00M05MQk1aWFVjOXNsWXo1NWpmM0VoYlJyS19rVDd2eHhHSU9seGNERFhrS3ZMWm5JRXdQb1NXcWIzTlBydEJGNF9mSGpyaDVNcnlTU1EwcmNHVG5JcDJBamlIQVY1Z0tKMzBGZEpWUFd6enZ2VUR1ZTVsaGZQZ2IyR0hwdWlYWEk?oc=5"" target=""_blank"">Biosimilar and Interchangeable Semglee Insulin Could Save U.S. Healthcare Hundreds of Millions</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxNd2xqMW5ndHp6VVV2cDdFaTV2QzFWbk9TTU9oSmwzU3puc3k0Vm5sLVhfQUVSSzdTLUxobmtmbS1CN0drTGhISGF1cFhYZGJ2N0t6ZjVsOU00M05MQk1aWFVjOXNsWXo1NWpmM0VoYlJyS19rVDd2eHhHSU9seGNERFhrS3ZMWm5JRXdQb1NXcWIzTlBydEJGNF9mSGpyaDVNcnlTU1EwcmNHVG5JcDJBamlIQVY1Z0tKMzBGZEpWUFd6enZ2VUR1ZTVsaGZQZ2IyR0hwdWlYWEk?oc=5,Google News,Biocon Semglee sales,"Biosimilar and Interchangeable Semglee Insulin Could Save U.S. Healthcare Hundreds of Millions - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxNd2xqMW5ndHp6VVV2cDdFaTV2QzFWbk9TTU9oSmwzU3puc3k0Vm5sLVhfQUVSSzdTLUxobmtmbS1CN0drTGhISGF1cFhYZGJ2N0t6ZjVsOU00M05MQk1aWFVjOXNsWXo1NWpmM0VoYlJyS19rVDd2eHhHSU9seGNERFhrS3ZMWm5JRXdQb1NXcWIzTlBydEJGNF9mSGpyaDVNcnlTU1EwcmNHVG5JcDJBamlIQVY1Z0tKMzBGZEpWUFd6enZ2VUR1ZTVsaGZQZ2IyR0hwdWlYWEk?oc=5"" target=""_blank"">Biosimilar and Interchangeable Semglee Insulin Could Save U.S. Healthcare Hundreds of Millions</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.0,neutral,0.6989189982414246,0.0,neutral,0.0,0.7506,0.176,0.0,0.824,0.0,0.0,0.0,0.7247594991207122,other,0.0,[],True,False,11,0.0
2023-04-20,2023-04-20 07:00:00,"What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPY0ppb2ZGUVBKV1dlMDVlYXBEODlPeklQLTJmLXJiS29RRHlreUZKMVpNYm84TkZxVE4tVkxCRVM5aGIydDIwNE1LdXVaSTE1OEJnRFBtV1Y0c1FCbUtBd2JMTkZYNkJyR1FyZnJ4ejBoczRQaDZOUXF6VVA4TGs2YzNMVG9sRHJDWkU3OXZuMlJ2amF6TEVxeERpMXdiVVdraWZyWXpjMFJQclFLRFE?oc=5"" target=""_blank"">What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPY0ppb2ZGUVBKV1dlMDVlYXBEODlPeklQLTJmLXJiS29RRHlreUZKMVpNYm84TkZxVE4tVkxCRVM5aGIydDIwNE1LdXVaSTE1OEJnRFBtV1Y0c1FCbUtBd2JMTkZYNkJyR1FyZnJ4ejBoczRQaDZOUXF6VVA4TGs2YzNMVG9sRHJDWkU3OXZuMlJ2amF6TEVxeERpMXdiVVdraWZyWXpjMFJQclFLRFE?oc=5,Google News,Biocon Semglee sales,"What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPY0ppb2ZGUVBKV1dlMDVlYXBEODlPeklQLTJmLXJiS29RRHlreUZKMVpNYm84TkZxVE4tVkxCRVM5aGIydDIwNE1LdXVaSTE1OEJnRFBtV1Y0c1FCbUtBd2JMTkZYNkJyR1FyZnJ4ejBoczRQaDZOUXF6VVA4TGs2YzNMVG9sRHJDWkU3OXZuMlJ2amF6TEVxeERpMXdiVVdraWZyWXpjMFJQclFLRFE?oc=5"" target=""_blank"">What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.8171497583389282,0.0,neutral,0.0,-0.5775,0.0,0.129,0.871,0.0,0.0,0.0,0.6973248791694642,other,0.0,[],False,False,1,0.0
2025-02-14,2025-02-14 08:00:00,Biosimilars Fuel Price Cuts in European Insulin Glargine Markets - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTGpvd2U2SkdRUnRwNE9ERGpKQlVBX2d1ck5aY1RNQU5TZlNuLXJkdmtlZGdWV2czQ2lkcHl4VVFtb1d2YzIxWUplVmxUYVRzdkdXX0h2ZGRwWkNmTTR2M0pKZmpuVzcycjVTb1ZOVUdyOVhXaDJoNVh6R1ZaQUZoSDByS0lKazB2RWdjaUpUWnBEZ1ZWemVyT0JFOGxKV29RWWpxbVdYU0xEQQ?oc=5"" target=""_blank"">Biosimilars Fuel Price Cuts in European Insulin Glargine Markets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTGpvd2U2SkdRUnRwNE9ERGpKQlVBX2d1ck5aY1RNQU5TZlNuLXJkdmtlZGdWV2czQ2lkcHl4VVFtb1d2YzIxWUplVmxUYVRzdkdXX0h2ZGRwWkNmTTR2M0pKZmpuVzcycjVTb1ZOVUdyOVhXaDJoNVh6R1ZaQUZoSDByS0lKazB2RWdjaUpUWnBEZ1ZWemVyT0JFOGxKV29RWWpxbVdYU0xEQQ?oc=5,Google News,Semglee market share,"Biosimilars Fuel Price Cuts in European Insulin Glargine Markets - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTGpvd2U2SkdRUnRwNE9ERGpKQlVBX2d1ck5aY1RNQU5TZlNuLXJkdmtlZGdWV2czQ2lkcHl4VVFtb1d2YzIxWUplVmxUYVRzdkdXX0h2ZGRwWkNmTTR2M0pKZmpuVzcycjVTb1ZOVUdyOVhXaDJoNVh6R1ZaQUZoSDByS0lKazB2RWdjaUpUWnBEZ1ZWemVyT0JFOGxKV29RWWpxbVdYU0xEQQ?oc=5"" target=""_blank"">Biosimilars Fuel Price Cuts in European Insulin Glargine Markets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",-0.7212088704109192,negative,0.7212088704109192,0.0,neutral,0.0,-0.5267,0.0,0.155,0.845,-0.025,0.025,-0.41211935452052517,0.42430295680363966,other,0.0,[],False,False,1,0.0
2023-07-18,2023-07-18 07:00:00,Payer Controls Limiting Semglee Uptake Despite Patient Demand - AJMC,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5,Google News,Semglee market share,"Payer Controls Limiting Semglee Uptake Despite Patient Demand - AJMC <a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",0.0,neutral,0.8872051239013672,0.0,neutral,0.0,0.0951,0.067,0.0,0.933,0.0,0.0,0.0,0.4911525619506836,other,0.0,[],True,False,11,0.0
2024-06-12,2024-06-12 07:00:00,Global Insulin Glargine Market Size To Worth USD 2.50 Billion By 2033 | CAGR OF 6.12% - Yahoo Finance,"<a href=""https://news.google.com/rss/articles/CBMiiAFBVV95cUxOUGppSFBLNmtQTG40YkJfV2JBNnd6ZE1Jblg5eFJRLWMyb2toYV9tNFA2dU4tdkl2cHhDQk01SU9NdnZvdG5EbmE2TzM3dFpVcUNveWlwMW02Ql9RMEU5VXVqdkV3LTJuSy1TelZLa1ppSldfb1ZoRnVPRVJuZTRNeXBWZ3VxcGRI?oc=5"" target=""_blank"">Global Insulin Glargine Market Size To Worth USD 2.50 Billion By 2033 | CAGR OF 6.12%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo Finance</font>",https://news.google.com/rss/articles/CBMiiAFBVV95cUxOUGppSFBLNmtQTG40YkJfV2JBNnd6ZE1Jblg5eFJRLWMyb2toYV9tNFA2dU4tdkl2cHhDQk01SU9NdnZvdG5EbmE2TzM3dFpVcUNveWlwMW02Ql9RMEU5VXVqdkV3LTJuSy1TelZLa1ppSldfb1ZoRnVPRVJuZTRNeXBWZ3VxcGRI?oc=5,Google News,Semglee market share,"Global Insulin Glargine Market Size To Worth USD 2.50 Billion By 2033 | CAGR OF 6.12% - Yahoo Finance <a href=""https://news.google.com/rss/articles/CBMiiAFBVV95cUxOUGppSFBLNmtQTG40YkJfV2JBNnd6ZE1Jblg5eFJRLWMyb2toYV9tNFA2dU4tdkl2cHhDQk01SU9NdnZvdG5EbmE2TzM3dFpVcUNveWlwMW02Ql9RMEU5VXVqdkV3LTJuSy1TelZLa1ppSldfb1ZoRnVPRVJuZTRNeXBWZ3VxcGRI?oc=5"" target=""_blank"">Global Insulin Glargine Market Size To Worth USD 2.50 Billion By 2033 | CAGR OF 6.12%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo Finance</font>",0.7058808207511902,positive,0.7058808207511902,0.0,neutral,0.0,0.4215,0.101,0.0,0.899,0.15,0.05,0.40336046900068007,0.42579360691706336,other,0.0,[],False,False,1,0.0
2022-07-19,2022-07-19 07:00:00,Insulin Market Size to Worth Around USD 23.57 Billion by 2030 - BioSpace,"<a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxObllKRDBZUExGRTk1SnF0QlJmcXNpN3JRdzdid1YtMEllcUFCc29HSGNKOWtCb0RMMGJVRy1wbzcxZ2o4cEUxbWFjQ1VMZko1eVpRSFhSSUJZcnlNbzRMZmlDS3VycUlIU2xEMUlYNHF1U3JiLUdnQndmX1NKdTVfWkJpaWlCSUZXLXk1ZS1Ocw?oc=5"" target=""_blank"">Insulin Market Size to Worth Around USD 23.57 Billion by 2030</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpace</font>",https://news.google.com/rss/articles/CBMijwFBVV95cUxObllKRDBZUExGRTk1SnF0QlJmcXNpN3JRdzdid1YtMEllcUFCc29HSGNKOWtCb0RMMGJVRy1wbzcxZ2o4cEUxbWFjQ1VMZko1eVpRSFhSSUJZcnlNbzRMZmlDS3VycUlIU2xEMUlYNHF1U3JiLUdnQndmX1NKdTVfWkJpaWlCSUZXLXk1ZS1Ocw?oc=5,Google News,Semglee market share,"Insulin Market Size to Worth Around USD 23.57 Billion by 2030 - BioSpace <a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxObllKRDBZUExGRTk1SnF0QlJmcXNpN3JRdzdid1YtMEllcUFCc29HSGNKOWtCb0RMMGJVRy1wbzcxZ2o4cEUxbWFjQ1VMZko1eVpRSFhSSUJZcnlNbzRMZmlDS3VycUlIU2xEMUlYNHF1U3JiLUdnQndmX1NKdTVfWkJpaWlCSUZXLXk1ZS1Ocw?oc=5"" target=""_blank"">Insulin Market Size to Worth Around USD 23.57 Billion by 2030</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpace</font>",0.7956199645996094,positive,0.7956199645996094,0.0,neutral,0.0,0.4215,0.137,0.0,0.863,0.19999999999999998,0.06666666666666667,0.45463997977120535,0.4723733215332031,other,0.0,[],False,False,1,0.0
2021-11-23,2021-11-23 08:00:00,"High Cost, Low Access Still Plague Insulin Market at 100-Year Anniversary - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxOQ2xFVFhBYWZFOWozVTNvRWlmd0NuNTVpckpGajdRSnl6WHZXVWNIRmptNWNLOEYwRE1meXcyNnhJVW9qVlU2ZlBPNEFSMUJEZWp3RmF0X1VPZHFKbXJvTnJoMVJjcnRCYVY0Rk5NVUc5MlVXMFp4enhrVzk3alRwRlBnNEpHNzM1OEtqWHN2cWFIVDFzVk5OaXVfY1pST3g2eTlHdFluUmUxbU5fRnB0ejBSME0?oc=5"" target=""_blank"">High Cost, Low Access Still Plague Insulin Market at 100-Year Anniversary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxOQ2xFVFhBYWZFOWozVTNvRWlmd0NuNTVpckpGajdRSnl6WHZXVWNIRmptNWNLOEYwRE1meXcyNnhJVW9qVlU2ZlBPNEFSMUJEZWp3RmF0X1VPZHFKbXJvTnJoMVJjcnRCYVY0Rk5NVUc5MlVXMFp4enhrVzk3alRwRlBnNEpHNzM1OEtqWHN2cWFIVDFzVk5OaXVfY1pST3g2eTlHdFluUmUxbU5fRnB0ejBSME0?oc=5,Google News,Semglee market share,"High Cost, Low Access Still Plague Insulin Market at 100-Year Anniversary - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxOQ2xFVFhBYWZFOWozVTNvRWlmd0NuNTVpckpGajdRSnl6WHZXVWNIRmptNWNLOEYwRE1meXcyNnhJVW9qVlU2ZlBPNEFSMUJEZWp3RmF0X1VPZHFKbXJvTnJoMVJjcnRCYVY0Rk5NVUc5MlVXMFp4enhrVzk3alRwRlBnNEpHNzM1OEtqWHN2cWFIVDFzVk5OaXVfY1pST3g2eTlHdFluUmUxbU5fRnB0ejBSME0?oc=5"" target=""_blank"">High Cost, Low Access Still Plague Insulin Market at 100-Year Anniversary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.8964071869850159,0.0,neutral,0.0,-0.4939,0.0,0.13,0.87,0.012,0.248,0.0,0.4674357289950053,other,0.0,[],False,False,1,0.0
2022-12-24,2022-12-24 08:00:00,Basaglar Is Not Associated With Lower Out-of-pocket Costs Than the Reference Product - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxNRFpqQWRtcHdIRE5tT1haVzJTQ2luSlNVYjJYV21qSjRoOEktd2R3dFl6eU9VSUFFNnQzYjQ4VFZsa1pQREhuSEc1MzBYVVd5MURCcW16dXkxd25ZQ1ByRFpJMHl2MzRydXVVd1ZVcEVWU2lYLUJwbExTUjlGRTUzUnVxcW5Oa0dnSFJya0FJZE5GdHNISXhXVGduemxnbmlyM2NxS2JfdmZuTGxrcHZOa0p6Mzk1YWRrbnhjZlV3WDFfbHNC?oc=5"" target=""_blank"">Basaglar Is Not Associated With Lower Out-of-pocket Costs Than the Reference Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxNRFpqQWRtcHdIRE5tT1haVzJTQ2luSlNVYjJYV21qSjRoOEktd2R3dFl6eU9VSUFFNnQzYjQ4VFZsa1pQREhuSEc1MzBYVVd5MURCcW16dXkxd25ZQ1ByRFpJMHl2MzRydXVVd1ZVcEVWU2lYLUJwbExTUjlGRTUzUnVxcW5Oa0dnSFJya0FJZE5GdHNISXhXVGduemxnbmlyM2NxS2JfdmZuTGxrcHZOa0p6Mzk1YWRrbnhjZlV3WDFfbHNC?oc=5,Google News,Semglee market share,"Basaglar Is Not Associated With Lower Out-of-pocket Costs Than the Reference Product - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxNRFpqQWRtcHdIRE5tT1haVzJTQ2luSlNVYjJYV21qSjRoOEktd2R3dFl6eU9VSUFFNnQzYjQ4VFZsa1pQREhuSEc1MzBYVVd5MURCcW16dXkxd25ZQ1ByRFpJMHl2MzRydXVVd1ZVcEVWU2lYLUJwbExTUjlGRTUzUnVxcW5Oa0dnSFJya0FJZE5GdHNISXhXVGduemxnbmlyM2NxS2JfdmZuTGxrcHZOa0p6Mzk1YWRrbnhjZlV3WDFfbHNC?oc=5"" target=""_blank"">Basaglar Is Not Associated With Lower Out-of-pocket Costs Than the Reference Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.6557396054267883,0.0,neutral,0.0,0.4168,0.112,0.0,0.888,-0.05,0.05,0.0,0.37417986847559614,other,0.0,[],False,False,1,0.0
2021-08-19,2021-08-19 07:00:00,Semglee approval to provide huge opportunities in the US insulin biosimilar market - Indian Pharma Post,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee approval to provide huge opportunities in the US insulin biosimilar market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxOMHYxbU1zZElISUlTdHZyRHdOWXR1S1RNTk1ETllEY2Q2RWRpSkdlWjlNdUh0amJsYnZKRDB0bWYyM0xDbDBHLTJSVUpnanlwWUYxY0xIYjdSMllieWZ6N2FuYWRhZVFEWUNrNS1mM0h6aFJjZk8za0R6bi0zeE4wc0E3WGI4VkpKWkVpWFFJT2NpcEFhRGQ0LVI2NmRrY3doaXN1Y0dfUk1VNS1Mck9iTnAyOFlQMXUzWTY2ZC1aYTNZUEpsNVJuWNIBzwFBVV95cUxQOGdOb2hjTWNMT1VDdUZTUzVTbEJMd3oyVmZEQy1xUTlPX0pWaGNMWTlQTFdiSlJKQkFTd3hpeXgxRVFPbC0tMU1SYW92UXdHekhrTXhnOHdJNDV1MWlqdEhXSm83b3BZVzJCMjJGTWhDS0NtVGVfd1RzWTA4TDVTeXNhR0c3ZkZQRkdYRTRsZVMzOFMzVFJ0UExmWERDQ050MVJMMlFrN0FudVltUG9CaXgtZVh6c05DUnc5eVhXd3ZBOUJSdm02bm0zQ18wQ0U?oc=5,Google News,Semglee market share,"Semglee approval to provide huge opportunities in the US insulin biosimilar market - Indian Pharma Post <a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee approval to provide huge opportunities in the US insulin biosimilar market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",0.7106620073318481,positive,0.7106620073318481,0.0,neutral,0.0,0.9325,0.381,0.0,0.619,0.26666666666666666,0.6,0.4060925756181989,0.6366095579995049,other,0.0,[],True,False,11,0.0
2022-06-09,2022-06-09 07:00:00,Can biosimilars tear down AbbVie's Humira rebate wall? Just look at Viatris' Lantus copy: analyst - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxOOF83TkZjRHhYUE4yOTJYZFVBQkZGWHFudWJkWXZMOFRtdTJDSDNhMHJBVVhhZ3c3WWNBZ25JNTVkLUxuMk9rZXBkR3Ewc3oxTXJzd3RXNWRnUS1BQlhzZ1pUTzFFY3ZGZWRhcVhiYURlU2l4WktaM29UWV9Ldmc4Z0NCUHJSb3NxdlVkdEpGR1ZuNmVfSEI4YzZQZEpBWkN6YkhsSFVmVGpFTTlaTUZRRFVuWEl3VVVFWjU5dWpuSTJHX2p1?oc=5"" target=""_blank"">Can biosimilars tear down AbbVie's Humira rebate wall? Just look at Viatris' Lantus copy: analyst</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxOOF83TkZjRHhYUE4yOTJYZFVBQkZGWHFudWJkWXZMOFRtdTJDSDNhMHJBVVhhZ3c3WWNBZ25JNTVkLUxuMk9rZXBkR3Ewc3oxTXJzd3RXNWRnUS1BQlhzZ1pUTzFFY3ZGZWRhcVhiYURlU2l4WktaM29UWV9Ldmc4Z0NCUHJSb3NxdlVkdEpGR1ZuNmVfSEI4YzZQZEpBWkN6YkhsSFVmVGpFTTlaTUZRRFVuWEl3VVVFWjU5dWpuSTJHX2p1?oc=5,Google News,Semglee market share,"Can biosimilars tear down AbbVie's Humira rebate wall? Just look at Viatris' Lantus copy: analyst - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxOOF83TkZjRHhYUE4yOTJYZFVBQkZGWHFudWJkWXZMOFRtdTJDSDNhMHJBVVhhZ3c3WWNBZ25JNTVkLUxuMk9rZXBkR3Ewc3oxTXJzd3RXNWRnUS1BQlhzZ1pUTzFFY3ZGZWRhcVhiYURlU2l4WktaM29UWV9Ldmc4Z0NCUHJSb3NxdlVkdEpGR1ZuNmVfSEI4YzZQZEpBWkN6YkhsSFVmVGpFTTlaTUZRRFVuWEl3VVVFWjU5dWpuSTJHX2p1?oc=5"" target=""_blank"">Can biosimilars tear down AbbVie's Humira rebate wall? Just look at Viatris' Lantus copy: analyst</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.9358527660369873,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.1037037037037037,0.19259259259259262,0.0,0.5197782348703455,other,0.0,[],False,False,1,0.0
2023-08-08,2023-08-08 07:00:00,What Do the Humira Biosimilar / Interchangeable Launches Mean for the Adalimumab Market? - JD Supra,"<a href=""https://news.google.com/rss/articles/CBMifEFVX3lxTFAwM25TTnhSM2xUMmFVcDRuU1V5bzFVZ1ZHZXJ5RHVvX1BVZlJDNE5NUFIwblNBUWREWUJvdUxZTnByaENERWw4RlBuZVVOS2NIQ1pQWWxDZ0NoUURvbGVhaWpYdWtIeWVPc0t0MjhBN3ZFVEx6NlRZb2Q4WUQ?oc=5"" target=""_blank"">What Do the Humira Biosimilar / Interchangeable Launches Mean for the Adalimumab Market?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">JD Supra</font>",https://news.google.com/rss/articles/CBMifEFVX3lxTFAwM25TTnhSM2xUMmFVcDRuU1V5bzFVZ1ZHZXJ5RHVvX1BVZlJDNE5NUFIwblNBUWREWUJvdUxZTnByaENERWw4RlBuZVVOS2NIQ1pQWWxDZ0NoUURvbGVhaWpYdWtIeWVPc0t0MjhBN3ZFVEx6NlRZb2Q4WUQ?oc=5,Google News,Semglee market share,"What Do the Humira Biosimilar / Interchangeable Launches Mean for the Adalimumab Market? - JD Supra <a href=""https://news.google.com/rss/articles/CBMifEFVX3lxTFAwM25TTnhSM2xUMmFVcDRuU1V5bzFVZ1ZHZXJ5RHVvX1BVZlJDNE5NUFIwblNBUWREWUJvdUxZTnByaENERWw4RlBuZVVOS2NIQ1pQWWxDZ0NoUURvbGVhaWpYdWtIeWVPc0t0MjhBN3ZFVEx6NlRZb2Q4WUQ?oc=5"" target=""_blank"">What Do the Humira Biosimilar / Interchangeable Launches Mean for the Adalimumab Market?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">JD Supra</font>",0.0,neutral,0.9454702138900757,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.20833333333333334,0.4583333333333333,0.0,0.5769017736117045,other,0.0,[],False,False,1,0.0
2024-02-10,2024-02-10 08:00:00,FY25 to be year of consolidation for Biocon Biologics: CEO Tambe - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxNS2x0M1JOM1EwUmZzZTl3UGdxU040U1Q3U1hUSEF1MDBEX3ViZl9veXZZbHJ4QmwxUmduVVBINUVSSnlxa0JJc1RFSWdmY0kxYmM1LUNUWHlUNDIyQ2ZkZmFEa095Q2Y0U05rS2JJTzdpNE9HLUFJaDA1VGE3cEpsQ2ZleVh2S2JVcVZHZDMwVDVCUERMZnRmYnVsT3htV0ZxYTBYdURpcm1UMjJTVWprWkR4TnlvYmlGX2VKNDVYY0w?oc=5"" target=""_blank"">FY25 to be year of consolidation for Biocon Biologics: CEO Tambe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiwAFBVV95cUxNS2x0M1JOM1EwUmZzZTl3UGdxU040U1Q3U1hUSEF1MDBEX3ViZl9veXZZbHJ4QmwxUmduVVBINUVSSnlxa0JJc1RFSWdmY0kxYmM1LUNUWHlUNDIyQ2ZkZmFEa095Q2Y0U05rS2JJTzdpNE9HLUFJaDA1VGE3cEpsQ2ZleVh2S2JVcVZHZDMwVDVCUERMZnRmYnVsT3htV0ZxYTBYdURpcm1UMjJTVWprWkR4TnlvYmlGX2VKNDVYY0w?oc=5,Google News,Semglee market share,"FY25 to be year of consolidation for Biocon Biologics: CEO Tambe - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxNS2x0M1JOM1EwUmZzZTl3UGdxU040U1Q3U1hUSEF1MDBEX3ViZl9veXZZbHJ4QmwxUmduVVBINUVSSnlxa0JJc1RFSWdmY0kxYmM1LUNUWHlUNDIyQ2ZkZmFEa095Q2Y0U05rS2JJTzdpNE9HLUFJaDA1VGE3cEpsQ2ZleVh2S2JVcVZHZDMwVDVCUERMZnRmYnVsT3htV0ZxYTBYdURpcm1UMjJTVWprWkR4TnlvYmlGX2VKNDVYY0w?oc=5"" target=""_blank"">FY25 to be year of consolidation for Biocon Biologics: CEO Tambe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.8620517253875732,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8620517253875732,other,0.0,[],False,True,6,0.0
2021-07-29,2021-07-29 07:00:00,Welspun Corp Q1 consolidated net profit jumps 80% to Rs 97.28 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Welspun Corp Q1 consolidated net profit jumps 80% to Rs 97.28 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Semglee revenue,"Welspun Corp Q1 consolidated net profit jumps 80% to Rs 97.28 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Welspun Corp Q1 consolidated net profit jumps 80% to Rs 97.28 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9208050966262817,positive,0.9208050966262817,0.0,neutral,0.0,0.7003,0.172,0.0,0.828,0.0,0.0,0.5261743409293038,0.8105525483131408,other,0.0,[],False,False,1,0.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5"" target=""_blank"">Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5,Google News,Biocon Semglee revenue,"Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5"" target=""_blank"">Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.9491440057754517,positive,0.9491440057754517,0.0,neutral,0.0,0.7003,0.112,0.0,0.888,0.0,0.0,0.5423680033002581,0.8247220028877258,other,0.0,[],False,True,6,0.0
2024-11-25,2024-11-25 08:00:00,CVS Caremark Makes Changes in Diabetes Coverage for 2025 - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxQR1pYN1ZZeGZ6MzRLZFZ5QWg0OU1odzcxWW0zLUp4RTJiWTFEVGtLblI4LS1lbmhlSXNXd1RJX0g5Q0lmUEltUVF6bVpmQnBMYzdSLXViUmJtZzRyU25iSmFYWHZobEdGc0pfT1lpSXluTnI4eUQtcGpTUXQ2b3JvMkIwWHJBYXk4QXVXbHVNWnUtNFlFU0ZJbjhUcnllcE9kbWNkckhDYw?oc=5"" target=""_blank"">CVS Caremark Makes Changes in Diabetes Coverage for 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMipwFBVV95cUxQR1pYN1ZZeGZ6MzRLZFZ5QWg0OU1odzcxWW0zLUp4RTJiWTFEVGtLblI4LS1lbmhlSXNXd1RJX0g5Q0lmUEltUVF6bVpmQnBMYzdSLXViUmJtZzRyU25iSmFYWHZobEdGc0pfT1lpSXluTnI4eUQtcGpTUXQ2b3JvMkIwWHJBYXk4QXVXbHVNWnUtNFlFU0ZJbjhUcnllcE9kbWNkckhDYw?oc=5,Google News,Semglee prescription volume,"CVS Caremark Makes Changes in Diabetes Coverage for 2025 - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxQR1pYN1ZZeGZ6MzRLZFZ5QWg0OU1odzcxWW0zLUp4RTJiWTFEVGtLblI4LS1lbmhlSXNXd1RJX0g5Q0lmUEltUVF6bVpmQnBMYzdSLXViUmJtZzRyU25iSmFYWHZobEdGc0pfT1lpSXluTnI4eUQtcGpTUXQ2b3JvMkIwWHJBYXk4QXVXbHVNWnUtNFlFU0ZJbjhUcnllcE9kbWNkckhDYw?oc=5"" target=""_blank"">CVS Caremark Makes Changes in Diabetes Coverage for 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.0,neutral,0.8734593987464905,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8734593987464905,other,0.0,[],False,False,1,0.0
2025-03-06,2025-03-06 08:00:00,Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News,Biocon commercial success,"Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.552623987197876,positive,0.552623987197876,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3157851355416434,0.552623987197876,other,0.0,[],False,True,6,0.0
2025-02-12,2025-02-12 00:56:45,"Biocon Biologics Appoints Shreehas Tambe As Managing Director, CEO - BW Healthcare","<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQcVhaZF9sbjRSZjNxNmtSM2dyMHFWMjl5VzJmNXFjNDBoeFFteXdBVXNLTFhNTERqNktnLWNHRlpoSm5WMXB1RVdrdlB4MDdpbkZ6VXJKdjByZ1N1dndLTGFneVU4bXAxQUlYZVZaNFNtRW1hUW5MSTFOMmY3QVV2Qkx4X3NYVXE4REJ1TW9Kbms1N0M1dDFhY2NLSllxMUNxMVZEUHdrdFU3R3NMdGt1dW1odVU?oc=5"" target=""_blank"">Biocon Biologics Appoints Shreehas Tambe As Managing Director, CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Healthcare</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQcVhaZF9sbjRSZjNxNmtSM2dyMHFWMjl5VzJmNXFjNDBoeFFteXdBVXNLTFhNTERqNktnLWNHRlpoSm5WMXB1RVdrdlB4MDdpbkZ6VXJKdjByZ1N1dndLTGFneVU4bXAxQUlYZVZaNFNtRW1hUW5MSTFOMmY3QVV2Qkx4X3NYVXE4REJ1TW9Kbms1N0M1dDFhY2NLSllxMUNxMVZEUHdrdFU3R3NMdGt1dW1odVU?oc=5,Google News,Biocon commercial success,"Biocon Biologics Appoints Shreehas Tambe As Managing Director, CEO - BW Healthcare <a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQcVhaZF9sbjRSZjNxNmtSM2dyMHFWMjl5VzJmNXFjNDBoeFFteXdBVXNLTFhNTERqNktnLWNHRlpoSm5WMXB1RVdrdlB4MDdpbkZ6VXJKdjByZ1N1dndLTGFneVU4bXAxQUlYZVZaNFNtRW1hUW5MSTFOMmY3QVV2Qkx4X3NYVXE4REJ1TW9Kbms1N0M1dDFhY2NLSllxMUNxMVZEUHdrdFU3R3NMdGt1dW1odVU?oc=5"" target=""_blank"">Biocon Biologics Appoints Shreehas Tambe As Managing Director, CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Healthcare</font>",0.0,neutral,0.917019248008728,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.917019248008728,other,0.0,[],False,True,6,0.0
2024-03-15,2024-03-15 07:00:00,Biocon Biologics enters a commercial collaboration with Eris Lifesciences - European Pharmaceutical Manufacturer,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics enters a commercial collaboration with Eris Lifesciences</a>&nbsp;&nbsp;<font color=""#6f6f6f"">European Pharmaceutical Manufacturer</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"Biocon Biologics enters a commercial collaboration with Eris Lifesciences - European Pharmaceutical Manufacturer <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics enters a commercial collaboration with Eris Lifesciences</a>&nbsp;&nbsp;<font color=""#6f6f6f"">European Pharmaceutical Manufacturer</font>",0.684163510799408,positive,0.684163510799408,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3909505775996617,0.684163510799408,other,0.0,[],False,True,6,0.0
2024-12-04,2024-12-04 08:00:00,"Meet woman, who failed to get a good job, banks refused to give her loan, started business with Rs 10000, bui - India.Com","<a href=""https://news.google.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?oc=5"" target=""_blank"">Meet woman, who failed to get a good job, banks refused to give her loan, started business with Rs 10000, bui</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India.Com</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"Meet woman, who failed to get a good job, banks refused to give her loan, started business with Rs 10000, bui - India.Com <a href=""https://news.google.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?oc=5"" target=""_blank"">Meet woman, who failed to get a good job, banks refused to give her loan, started business with Rs 10000, bui</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India.Com</font>",0.0,neutral,0.8899338245391846,0.0,neutral,0.0,-0.6369,0.106,0.201,0.693,0.07999999999999999,0.36000000000000004,0.0,0.5356112748463949,other,0.0,[],False,False,1,0.0
2023-02-28,2023-02-28 08:00:00,Viatris Earnings Top $1 Billion Thanks to Sale of Its Biosimilar Portfolio - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxORGtFOTNKMWRVVUxPTVBXZUpjZGhtd25GSjdUaW1lRERHNl85SjFxaVVyb1hmRGpVaHpCVDE3VFNRdmJhNm9xaDBvNHdoS3B2OXZYVlJySDNFM3VBTzI1QThEQjlYS2tDLW5rU3UwYXRjMm81RmRJOFlGak53NnhabkhHQlJLWnJrVFNfRzZXdlpEYTZ0VzJZZ2NxbDMzMWd5VWUyR2I3QnRBcDZwLTJRN245ODU4UQ?oc=5"" target=""_blank"">Viatris Earnings Top $1 Billion Thanks to Sale of Its Biosimilar Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxORGtFOTNKMWRVVUxPTVBXZUpjZGhtd25GSjdUaW1lRERHNl85SjFxaVVyb1hmRGpVaHpCVDE3VFNRdmJhNm9xaDBvNHdoS3B2OXZYVlJySDNFM3VBTzI1QThEQjlYS2tDLW5rU3UwYXRjMm81RmRJOFlGak53NnhabkhHQlJLWnJrVFNfRzZXdlpEYTZ0VzJZZ2NxbDMzMWd5VWUyR2I3QnRBcDZwLTJRN245ODU4UQ?oc=5,Google News,Biocon commercial success,"Viatris Earnings Top $1 Billion Thanks to Sale of Its Biosimilar Portfolio - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxORGtFOTNKMWRVVUxPTVBXZUpjZGhtd25GSjdUaW1lRERHNl85SjFxaVVyb1hmRGpVaHpCVDE3VFNRdmJhNm9xaDBvNHdoS3B2OXZYVlJySDNFM3VBTzI1QThEQjlYS2tDLW5rU3UwYXRjMm81RmRJOFlGak53NnhabkhHQlJLWnJrVFNfRzZXdlpEYTZ0VzJZZ2NxbDMzMWd5VWUyR2I3QnRBcDZwLTJRN245ODU4UQ?oc=5"" target=""_blank"">Viatris Earnings Top $1 Billion Thanks to Sale of Its Biosimilar Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.7393357157707214,positive,0.7393357157707214,0.0,neutral,0.0,0.8126,0.251,0.0,0.749,0.21666666666666667,0.24999999999999997,0.4224775518689836,0.5895341274791294,other,0.0,[],False,False,1,0.0
2025-02-04,2025-02-04 08:00:00,Meet the five entrepreneurs leading India’s business transformation - YourStory.com,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxPZzNGalVkUkpFbGVMNUViTkFWcnRhT2JQclRLSVBKcE5wZ3hRbEFfdlBpbjNLMEY3TFVEeXlfaVlXcUkzT3BIMVVKZERqbHZfQnd0TERCZUY2N09EMUtzQ0dzcWZjQndYOFBaVUtQQTRzY2RjVlRUczFjQ0o3SEdUeHJpY0RNcmFudTN1cUVvcG9sRW5ERlJn?oc=5"" target=""_blank"">Meet the five entrepreneurs leading India’s business transformation</a>&nbsp;&nbsp;<font color=""#6f6f6f"">YourStory.com</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxPZzNGalVkUkpFbGVMNUViTkFWcnRhT2JQclRLSVBKcE5wZ3hRbEFfdlBpbjNLMEY3TFVEeXlfaVlXcUkzT3BIMVVKZERqbHZfQnd0TERCZUY2N09EMUtzQ0dzcWZjQndYOFBaVUtQQTRzY2RjVlRUczFjQ0o3SEdUeHJpY0RNcmFudTN1cUVvcG9sRW5ERlJn?oc=5,Google News,Biocon commercial success,"Meet the five entrepreneurs leading India’s business transformation - YourStory.com <a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxPZzNGalVkUkpFbGVMNUViTkFWcnRhT2JQclRLSVBKcE5wZ3hRbEFfdlBpbjNLMEY3TFVEeXlfaVlXcUkzT3BIMVVKZERqbHZfQnd0TERCZUY2N09EMUtzQ0dzcWZjQndYOFBaVUtQQTRzY2RjVlRUczFjQ0o3SEdUeHJpY0RNcmFudTN1cUVvcG9sRW5ERlJn?oc=5"" target=""_blank"">Meet the five entrepreneurs leading India’s business transformation</a>&nbsp;&nbsp;<font color=""#6f6f6f"">YourStory.com</font>",0.0,neutral,0.9080493450164795,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9080493450164795,other,0.0,[],False,False,1,0.0
2024-10-07,2024-10-07 07:00:00,‘Quiet Giant’ Biocon Sets Out Vision For Biosimilars - insights.citeline.com,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxNUUVtRWpRQmdPZENRd1lvYmZnX0gyS0MxbXY1XzlyRTBFYm1uY0ptUnp3eWxkS3FFV01ZcC1JaU0zWE1uTkVYMGhNMm1HUlhQR2ZNcUhhTFVTSms5VHM2eDVFTWp5XzRETGFVM1VUOWRTUEc0RnBmQzdMbUtTZ09wYWhpV3V0WXFSQTBNcGdEa1hiOWNk?oc=5"" target=""_blank"">‘Quiet Giant’ Biocon Sets Out Vision For Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">insights.citeline.com</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxNUUVtRWpRQmdPZENRd1lvYmZnX0gyS0MxbXY1XzlyRTBFYm1uY0ptUnp3eWxkS3FFV01ZcC1JaU0zWE1uTkVYMGhNMm1HUlhQR2ZNcUhhTFVTSms5VHM2eDVFTWp5XzRETGFVM1VUOWRTUEc0RnBmQzdMbUtTZ09wYWhpV3V0WXFSQTBNcGdEa1hiOWNk?oc=5,Google News,Biocon commercial success,"‘Quiet Giant’ Biocon Sets Out Vision For Biosimilars - insights.citeline.com <a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxNUUVtRWpRQmdPZENRd1lvYmZnX0gyS0MxbXY1XzlyRTBFYm1uY0ptUnp3eWxkS3FFV01ZcC1JaU0zWE1uTkVYMGhNMm1HUlhQR2ZNcUhhTFVTSms5VHM2eDVFTWp5XzRETGFVM1VUOWRTUEc0RnBmQzdMbUtTZ09wYWhpV3V0WXFSQTBNcGdEa1hiOWNk?oc=5"" target=""_blank"">‘Quiet Giant’ Biocon Sets Out Vision For Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">insights.citeline.com</font>",0.0,neutral,0.9283120036125183,0.0,neutral,0.0,0.4588,0.182,0.0,0.818,0.0,0.5333333333333333,0.0,0.6935560018062592,other,0.0,[],False,True,6,0.0
2024-12-09,2024-12-09 08:00:00,"Stocks in news: Wipro, Paytm, RITES, Welspun Corp, CEAT, Biocon, JSW Energy & Suven Pharma - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Wipro, Paytm, RITES, Welspun Corp, CEAT, Biocon, JSW Energy & Suven Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"Stocks in news: Wipro, Paytm, RITES, Welspun Corp, CEAT, Biocon, JSW Energy & Suven Pharma - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Wipro, Paytm, RITES, Welspun Corp, CEAT, Biocon, JSW Energy & Suven Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.9330119490623474,0.0,neutral,0.0,0.4939,0.116,0.0,0.884,0.0,0.0,0.0,0.7134559745311737,other,0.0,[],False,True,6,0.0
2025-01-08,2025-01-08 08:00:00,Biocon Biologics embarks on a three-stage strategic journey - Indian Pharma Post,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxPZU9OOTdNaVp3SllOaGlpY1F5RS11T3k4cUFmd2Zvcm9Bc2NES1FRQzRqWDk1OHVWbzRieGhsTG0wbUw2QkhpWDU5Q1p0TFltS3ptN2xKYVU4Qm9ubHZoUFVVZG1zOHhYLWU5U1JDUzlNSlFGcnF5Wl95THdnOTFwbVYwWDNaQlJ2TklZcnQ4cjRDVkItZnowbEFmRGxaVWFLY1ZFSHNR0gGsAUFVX3lxTFBKX2ZJS1p3WlRMVTR4U2ZfaWNaTVkweGxGb01ubGVDNzdJMGtheFlwUUtMS1RtUUlOMl9WMk1PNmRDbjdWdzdZTjNBWng4WnRnSkNtUEhKdGg0LUVyREFxX3RfdVdiVldMc0NuY3B4RHhldjB5YzUxRXI1b3JwRVBmbTVsZ3l6bVBNMW1EeVBsMlJHUldUYVpKTTdEa1NfWGNZRWFqbVpCZFJ4TV8?oc=5"" target=""_blank"">Biocon Biologics embarks on a three-stage strategic journey</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxPZU9OOTdNaVp3SllOaGlpY1F5RS11T3k4cUFmd2Zvcm9Bc2NES1FRQzRqWDk1OHVWbzRieGhsTG0wbUw2QkhpWDU5Q1p0TFltS3ptN2xKYVU4Qm9ubHZoUFVVZG1zOHhYLWU5U1JDUzlNSlFGcnF5Wl95THdnOTFwbVYwWDNaQlJ2TklZcnQ4cjRDVkItZnowbEFmRGxaVWFLY1ZFSHNR0gGsAUFVX3lxTFBKX2ZJS1p3WlRMVTR4U2ZfaWNaTVkweGxGb01ubGVDNzdJMGtheFlwUUtMS1RtUUlOMl9WMk1PNmRDbjdWdzdZTjNBWng4WnRnSkNtUEhKdGg0LUVyREFxX3RfdVdiVldMc0NuY3B4RHhldjB5YzUxRXI1b3JwRVBmbTVsZ3l6bVBNMW1EeVBsMlJHUldUYVpKTTdEa1NfWGNZRWFqbVpCZFJ4TV8?oc=5,Google News,Biocon commercial success,"Biocon Biologics embarks on a three-stage strategic journey - Indian Pharma Post <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxPZU9OOTdNaVp3SllOaGlpY1F5RS11T3k4cUFmd2Zvcm9Bc2NES1FRQzRqWDk1OHVWbzRieGhsTG0wbUw2QkhpWDU5Q1p0TFltS3ptN2xKYVU4Qm9ubHZoUFVVZG1zOHhYLWU5U1JDUzlNSlFGcnF5Wl95THdnOTFwbVYwWDNaQlJ2TklZcnQ4cjRDVkItZnowbEFmRGxaVWFLY1ZFSHNR0gGsAUFVX3lxTFBKX2ZJS1p3WlRMVTR4U2ZfaWNaTVkweGxGb01ubGVDNzdJMGtheFlwUUtMS1RtUUlOMl9WMk1PNmRDbjdWdzdZTjNBWng4WnRnSkNtUEhKdGg0LUVyREFxX3RfdVdiVldMc0NuY3B4RHhldjB5YzUxRXI1b3JwRVBmbTVsZ3l6bVBNMW1EeVBsMlJHUldUYVpKTTdEa1NfWGNZRWFqbVpCZFJ4TV8?oc=5"" target=""_blank"">Biocon Biologics embarks on a three-stage strategic journey</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",0.0,neutral,0.49558886885643005,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.49558886885643005,other,0.0,[],False,True,6,0.0
2022-04-13,2022-04-13 07:00:00,"Biocon's high-risk, high-rewards biosimilars strategy unpacked - Forbes India","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's high-risk, high-rewards biosimilars strategy unpacked</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Forbes India</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"Biocon's high-risk, high-rewards biosimilars strategy unpacked - Forbes India <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's high-risk, high-rewards biosimilars strategy unpacked</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Forbes India</font>",0.0,neutral,0.8598509430885315,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8598509430885315,other,0.0,[],False,True,6,0.0
2022-03-18,2022-03-18 10:47:59,Transformational Deal to Acquire Viatris' Global Biosimilars Business - Biocon,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ3RvSDIzeG1YSDUxSHBLM2VGZzlBVWhRMXJJd0tORDlkUGtOSTQ2eUJpX3dmazI1d3BvYVdqaTJVOWwtUXdwYWh0WDNsUXJtYmZLU0NENURoXzJ4V05QX2ZPT3ZPSG1WSTN2VGhQNDl1eHVvbEZYSXZVYVJRVUlwdE1ETUczUVQ2aE9sZzNwaGVXUU84NWgtOWotMUExQzlLRmV1Ul92bHRqeDhOZTA0?oc=5"" target=""_blank"">Transformational Deal to Acquire Viatris' Global Biosimilars Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ3RvSDIzeG1YSDUxSHBLM2VGZzlBVWhRMXJJd0tORDlkUGtOSTQ2eUJpX3dmazI1d3BvYVdqaTJVOWwtUXdwYWh0WDNsUXJtYmZLU0NENURoXzJ4V05QX2ZPT3ZPSG1WSTN2VGhQNDl1eHVvbEZYSXZVYVJRVUlwdE1ETUczUVQ2aE9sZzNwaGVXUU84NWgtOWotMUExQzlLRmV1Ul92bHRqeDhOZTA0?oc=5,Google News,Biocon commercial success,"Transformational Deal to Acquire Viatris' Global Biosimilars Business - Biocon <a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ3RvSDIzeG1YSDUxSHBLM2VGZzlBVWhRMXJJd0tORDlkUGtOSTQ2eUJpX3dmazI1d3BvYVdqaTJVOWwtUXdwYWh0WDNsUXJtYmZLU0NENURoXzJ4V05QX2ZPT3ZPSG1WSTN2VGhQNDl1eHVvbEZYSXZVYVJRVUlwdE1ETUczUVQ2aE9sZzNwaGVXUU84NWgtOWotMUExQzlLRmV1Ul92bHRqeDhOZTA0?oc=5"" target=""_blank"">Transformational Deal to Acquire Viatris' Global Biosimilars Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.6175272464752197,positive,0.6175272464752197,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3528727122715541,0.6175272464752197,other,0.0,[],False,True,6,0.0
2024-03-14,2024-03-14 07:00:00,"Biocon Biologics, Eris Lifesciences announce long-term collaboration to expand patient access to metabolics, oncology, critical care products - ET HealthWorld","<a href=""https://news.google.com/rss/articles/CBMiwgJBVV95cUxPTE9MRFFaNWlERFM1QmFYUjVPOWVpUkJHVjg3a1RvUHBXLTM3ZzBQem42MFUxQzZFSmdfekFiMjQ5VXk2bklvdGtVZVNDZWlxdFJFbWxnS1M2aGg1Y3pMNVROeTk0MVdvV1MxclRZcnQyVkpNZGdYWXNEZDRpVGREaHBGOHAybU96Zmc4clBpVlI0VnMtSS1rZWUtY1hGRWxyNUFyYVEyTUN0SHM0akNSdm5SREYzTlVZTFE1SEN5T2M5SHFTeHVRZmdIM1VZbnBpdFhJWVFXdnhiY3RRN0ZjLVhWcE9RclFRT283Mnk4TTBWVUR0N2cwUmVOTHVlUlJLUERNQkdqaVJhLU1fempjeGFuZ21iUTM1NmxCdUJQLWxZanRCbHZMcVlETnpIQ0ZKNlZpaXZWN2d1LVNLblVhc2Rn?oc=5"" target=""_blank"">Biocon Biologics, Eris Lifesciences announce long-term collaboration to expand patient access to metabolics, oncology, critical care products</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.com/rss/articles/CBMiwgJBVV95cUxPTE9MRFFaNWlERFM1QmFYUjVPOWVpUkJHVjg3a1RvUHBXLTM3ZzBQem42MFUxQzZFSmdfekFiMjQ5VXk2bklvdGtVZVNDZWlxdFJFbWxnS1M2aGg1Y3pMNVROeTk0MVdvV1MxclRZcnQyVkpNZGdYWXNEZDRpVGREaHBGOHAybU96Zmc4clBpVlI0VnMtSS1rZWUtY1hGRWxyNUFyYVEyTUN0SHM0akNSdm5SREYzTlVZTFE1SEN5T2M5SHFTeHVRZmdIM1VZbnBpdFhJWVFXdnhiY3RRN0ZjLVhWcE9RclFRT283Mnk4TTBWVUR0N2cwUmVOTHVlUlJLUERNQkdqaVJhLU1fempjeGFuZ21iUTM1NmxCdUJQLWxZanRCbHZMcVlETnpIQ0ZKNlZpaXZWN2d1LVNLblVhc2Rn?oc=5,Google News,Biocon commercial success,"Biocon Biologics, Eris Lifesciences announce long-term collaboration to expand patient access to metabolics, oncology, critical care products - ET HealthWorld <a href=""https://news.google.com/rss/articles/CBMiwgJBVV95cUxPTE9MRFFaNWlERFM1QmFYUjVPOWVpUkJHVjg3a1RvUHBXLTM3ZzBQem42MFUxQzZFSmdfekFiMjQ5VXk2bklvdGtVZVNDZWlxdFJFbWxnS1M2aGg1Y3pMNVROeTk0MVdvV1MxclRZcnQyVkpNZGdYWXNEZDRpVGREaHBGOHAybU96Zmc4clBpVlI0VnMtSS1rZWUtY1hGRWxyNUFyYVEyTUN0SHM0akNSdm5SREYzTlVZTFE1SEN5T2M5SHFTeHVRZmdIM1VZbnBpdFhJWVFXdnhiY3RRN0ZjLVhWcE9RclFRT283Mnk4TTBWVUR0N2cwUmVOTHVlUlJLUERNQkdqaVJhLU1fempjeGFuZ21iUTM1NmxCdUJQLWxZanRCbHZMcVlETnpIQ0ZKNlZpaXZWN2d1LVNLblVhc2Rn?oc=5"" target=""_blank"">Biocon Biologics, Eris Lifesciences announce long-term collaboration to expand patient access to metabolics, oncology, critical care products</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.798938512802124,positive,0.798938512802124,0.0,neutral,0.0,0.7506,0.222,0.093,0.685,0.0,0.5333333333333333,0.45653629302978516,0.774769256401062,other,0.0,[],False,True,6,0.0
2022-12-05,2022-12-05 08:00:00,Biocon Biologics appoints Shreehas Tambe as managing director and CEO - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics appoints Shreehas Tambe as managing director and CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMiywFBVV95cUxNeVZJa0FzbGNyM2lkWnN4TVNrU0FwYVpOS05ubTl1TjA0Q01POGhRTmNRM3BEQXlhQ3VEcklJUlVEczhxdEgtcW1JTUpqOTNmNER1UVlFNE52eDNzdVRpMWtkY01YbGVZeGxBVmNydFByRDc2VVYwbEZVR0xvTmJLVDNZV3ExNHNyYXI0eklCOEVMMEdvQ25aQm9XU0x2cWJLTXU1SnN5Q0xLdVh5YnRWX1g5Z294TW13QllFQVVzSXU5b0lILUlXdUlKa9IB0AFBVV95cUxOdVVtQVZVSEx6VVA1OVVQVVVzVFBscXJONVh5SkJfbGhSSWhxeXBqYWx1SFpfR09tUXgydU5EcWp4Si1rcC1QMldnQ09UejBzbTB2RGdMcV9WY3pILS1YdGxNcUtvbDZyRU5pNHdGU09kY3Jva01JdHdjbXgwTDZTTHJma1BBODdnbHpuc1BuS1c0RUFiajFCUVhBNWt4TGpmSHRQQ1prbUx2SWktS3hfVnpSRHdWc0NXYkdDSTBpckNhUXRNOGdLdkFtckJuWW1Z?oc=5,Google News,Biocon commercial success,"Biocon Biologics appoints Shreehas Tambe as managing director and CEO - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics appoints Shreehas Tambe as managing director and CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.9210361242294312,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9210361242294312,other,0.0,[],False,True,6,0.0
2025-05-31,2025-05-31 07:00:00,Nintendo aims to match Switch success with new console - Yahoo,"<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxPTllwRllfQ1B5VnNlQlJoT3dvMEZheVQ5OEY2cWhaY2lSNGZSRXpjTGdnckRTenJ4bWZwS3plRW1FTEZxSGotbDRUQ2d1alV3eEhJeF9YTHdRUU5KYXlDSmE0dnpMWS1TQnBWSGVYQWhvN0NOUXNCdkY1bXZlVE5tRWJydDZTajZlVF9V?oc=5"" target=""_blank"">Nintendo aims to match Switch success with new console</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxPTllwRllfQ1B5VnNlQlJoT3dvMEZheVQ5OEY2cWhaY2lSNGZSRXpjTGdnckRTenJ4bWZwS3plRW1FTEZxSGotbDRUQ2d1alV3eEhJeF9YTHdRUU5KYXlDSmE0dnpMWS1TQnBWSGVYQWhvN0NOUXNCdkY1bXZlVE5tRWJydDZTajZlVF9V?oc=5,Google News,Biocon commercial success,"Nintendo aims to match Switch success with new console - Yahoo <a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxPTllwRllfQ1B5VnNlQlJoT3dvMEZheVQ5OEY2cWhaY2lSNGZSRXpjTGdnckRTenJ4bWZwS3plRW1FTEZxSGotbDRUQ2d1alV3eEhJeF9YTHdRUU5KYXlDSmE0dnpMWS1TQnBWSGVYQWhvN0NOUXNCdkY1bXZlVE5tRWJydDZTajZlVF9V?oc=5"" target=""_blank"">Nintendo aims to match Switch success with new console</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",0.9020421504974365,positive,0.9020421504974365,0.0,neutral,0.0,0.8126,0.27,0.0,0.73,0.17454545454545453,0.18181818181818182,0.5154526574271066,0.6297292016809637,other,0.0,[],False,False,1,0.0
2022-12-05,2022-12-05 08:00:00,Shreehas Tambe appointed managing director and CEO of BBL - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Shreehas Tambe appointed managing director and CEO of BBL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"Shreehas Tambe appointed managing director and CEO of BBL - ET HealthWorld <a href=""https://news.google.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?oc=5"" target=""_blank"">Shreehas Tambe appointed managing director and CEO of BBL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",0.0,neutral,0.9178081750869751,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9178081750869751,other,0.0,[],False,False,1,0.0
2025-06-27,2025-06-27 17:00:00,PrideStaff Named to Staffing Industry Analysts' 2025 List of Largest Industrial Staffing Firms for Eighth Consecutive Year - Yahoo,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxPQmhlb0dpZEdWU1lsWThfU0c2bVBzeTYyRDI5VTFhQXA3QkktSkhJZ05WU1Q3LWgzTFdMakQ1WmZvQUlDZnNXZjh1RGtIdGs1T1dDZDRJUldRSldGMWtYanFta1ZTSXlaSE9kR2M1MXd4WHRDREt5YU5NdWlQRE5oNlRyNE1YYmJxQXJUWEZuSnlYMVNQbmpZ?oc=5"" target=""_blank"">PrideStaff Named to Staffing Industry Analysts' 2025 List of Largest Industrial Staffing Firms for Eighth Consecutive Year</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxPQmhlb0dpZEdWU1lsWThfU0c2bVBzeTYyRDI5VTFhQXA3QkktSkhJZ05WU1Q3LWgzTFdMakQ1WmZvQUlDZnNXZjh1RGtIdGs1T1dDZDRJUldRSldGMWtYanFta1ZTSXlaSE9kR2M1MXd4WHRDREt5YU5NdWlQRE5oNlRyNE1YYmJxQXJUWEZuSnlYMVNQbmpZ?oc=5,Google News,Biocon commercial success,"PrideStaff Named to Staffing Industry Analysts' 2025 List of Largest Industrial Staffing Firms for Eighth Consecutive Year - Yahoo <a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxPQmhlb0dpZEdWU1lsWThfU0c2bVBzeTYyRDI5VTFhQXA3QkktSkhJZ05WU1Q3LWgzTFdMakQ1WmZvQUlDZnNXZjh1RGtIdGs1T1dDZDRJUldRSldGMWtYanFta1ZTSXlaSE9kR2M1MXd4WHRDREt5YU5NdWlQRE5oNlRyNE1YYmJxQXJUWEZuSnlYMVNQbmpZ?oc=5"" target=""_blank"">PrideStaff Named to Staffing Industry Analysts' 2025 List of Largest Industrial Staffing Firms for Eighth Consecutive Year</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",0.0,neutral,0.63321852684021,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.63321852684021,other,0.0,[],False,False,1,0.0
2022-12-05,2022-12-05 08:00:00,Shreehas Tambe named MD and CEO of Biocon Biologics - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Shreehas Tambe named MD and CEO of Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxOczZxZU9IVEVLS0k3ZUQzMDRObDdGZDFnVElEZERoczY2S29oNGQ0UGlUVXFjVlF6amdQNWRkRWtad0ZtTHFJYlZyWHc2UTJaOC0ySnRSdUtDbkNEN2RmbG5sNkdTSXhFUVVWck5VcjMteFVPYXY5OUpWSGI2Mlg1YVlRbHR6ci1YNkdMbkhua3I0elVXbXNwdlhnLVYxZ29UekQ0b2ZmVF9SSkJLM094bzlnVHA0MFNnR3fSAccBQVVfeXFMUDZ2NVg0Nmg4U2lrbm1HT3o5SVhBaHJ2M2VmRVdWRGdZZjBKQzdUa29JY3c5bTlrbHp4bU5FdW5xMXVyblNPNGtIX1Q0TUJUWVBSV3lfM0FyX3psYWpUckVKMm9xWVM2NE1XV0lDYXB5RlFyS3FxbkdROFZCQkpFOUlHQlh3SlN5UldQZVhpMWkxWHpZbU0zSWdQdE9sdnc0V1EzYWhrYUFlZTZNZFNBSkxNQmhwYktIRVY3aHZRYXliUDNybTh5dw?oc=5,Google News,Biocon commercial success,"Shreehas Tambe named MD and CEO of Biocon Biologics - The New Indian Express <a href=""https://news.google.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?oc=5"" target=""_blank"">Shreehas Tambe named MD and CEO of Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",0.0,neutral,0.9256423711776733,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0909090909090909,0.30303030303030304,0.0,0.5082757310433821,other,0.0,[],False,True,6,0.0
2025-05-11,2025-05-11 07:00:00,Biocon bullish on US market share with over 70% payer access - BusinessLine,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon bullish on US market share with over 70% payer access</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"Biocon bullish on US market share with over 70% payer access - BusinessLine <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon bullish on US market share with over 70% payer access</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",0.5112786889076233,positive,0.5112786889076233,0.0,neutral,0.0,0.5267,0.155,0.0,0.845,0.0,0.0,0.2921592508043562,0.5189893444538116,other,0.0,[],False,True,6,0.0
2025-01-10,2025-01-10 08:00:00,Future Proofing Supply Chains For Global Success – The Biocon Way - Logistics Insider,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxON3NnTnZ0dVhYNmFfZjkzZXhzQnVHS0VsdWtwZWlGYmdxZ29iU1BQbXk1TFl1MVlpSC1MUVp2VjBOMU5ITkphbEJmYUlSanUxcXo3QWdhcjRXX2tMTFl0Uk16Tm52U3p1T1JiOW1LUzRtWlBvaDNBUTZfa2JJYlBYdncxekg5Ui1TcndUOHRNM2JPbG1Hc2IxbklsM0s?oc=5"" target=""_blank"">Future Proofing Supply Chains For Global Success – The Biocon Way</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Logistics Insider</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxON3NnTnZ0dVhYNmFfZjkzZXhzQnVHS0VsdWtwZWlGYmdxZ29iU1BQbXk1TFl1MVlpSC1MUVp2VjBOMU5ITkphbEJmYUlSanUxcXo3QWdhcjRXX2tMTFl0Uk16Tm52U3p1T1JiOW1LUzRtWlBvaDNBUTZfa2JJYlBYdncxekg5Ui1TcndUOHRNM2JPbG1Hc2IxbklsM0s?oc=5,Google News,Biocon commercial success,"Future Proofing Supply Chains For Global Success – The Biocon Way - Logistics Insider <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxON3NnTnZ0dVhYNmFfZjkzZXhzQnVHS0VsdWtwZWlGYmdxZ29iU1BQbXk1TFl1MVlpSC1MUVp2VjBOMU5ITkphbEJmYUlSanUxcXo3QWdhcjRXX2tMTFl0Uk16Tm52U3p1T1JiOW1LUzRtWlBvaDNBUTZfa2JJYlBYdncxekg5Ui1TcndUOHRNM2JPbG1Hc2IxbklsM0s?oc=5"" target=""_blank"">Future Proofing Supply Chains For Global Success – The Biocon Way</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Logistics Insider</font>",0.0,neutral,0.6326344609260559,0.0,neutral,0.0,0.8126,0.236,0.0,0.764,0.09999999999999999,0.020833333333333332,0.0,0.5150781536420187,other,0.0,[],False,True,6,0.0
2025-03-07,2025-03-07 08:00:00,Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi_gFBVV95cUxPV1VQUlR3MU9sLW9HRlJaUUJYSTBLRlBESDhjZ0VDWDFtUW52MEZtRVBMV0NjYUJQNnY4MWxzUURYRV9nU05CNXl1c3c5S3g2LVd0YkI4cklQOWRDNjFIZXBDTGM4S3lNTVdQM1hyVmJEenViR1RNZ0hiTm5KT01VUXppenhrWGFCa2o1ZFZfamU0eXNSUXJYWHRRY1RKZl9tYk04TGRhYnl6UXp4djRsb2o0eTN2Q0xxMWdlXzBMRUpKblhPUHlaQ0hQak9wNVIwMG9DWDdVX1lONnVFUGU5cnI3RVAyTVRxTktzWVNVQV9yUDQ5LWdTQmNrWVh2d9IBgwJBVV95cUxOYm8yQXN5OE16a2hmRmdtN2owUU5aS3hkejFDdFFsY2FKNGdzQmgtbUNOUVZQWk5zWHVObFMxZEd2Z3o2aG1HdlAtZmZVdjI2Wk0yRTkzZ0cyRXBEYlEtaGhsa19YMHVWbS11b1AtamlTVGU1aXlQVUJDT29wS0JlVzRPeXpRenVncFoya1JhVlpaOU9rdWxtcGtMNjVZeGQtY0VwRWYyNm1FOHdTLW5DbW5YWDRKbl9LVVdURm1oYUZNeGtjb2JfWWZYc2JYMjJFRkNHQ1ItTGJRUjRJV3ZaaThMZ3Z3VzFqNFFsV3MtS3lYcmVXNW1IYjZNS3I3VGQwdnl3?oc=5"" target=""_blank"">Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News,Biocon commercial success,"Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US - The Economic Times <a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.9454984664916992,positive,0.9454984664916992,0.0,neutral,0.0,0.8316,0.214,0.0,0.786,0.13333333333333333,0.13333333333333333,0.5402848379952567,0.6368105999416774,other,0.0,[],False,True,6,0.0
2024-03-14,2024-03-14 07:00:00,Biocon Biologics Signs 10-year Deal With Eris Lifesciences To Expand Patient Access - BW Businessworld,"<a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxPYnYxTWtBNERFZTdYbWVuaGkwV2x4UkJ4SHlDdmdWSnBrbTR1dGRxbmhHRHpWTUl2TzQ4WkphenloYm9IR3d1eUk5bi0xSUxUOTg2SDRzNFZTU2dxVVBJRmZxTWZqa1M5Qk1LR1pXNG9tQmVsd3VOdnlmQWxhMGl6RGNJNm92NTV1ci1qY2ZTbnh1ZDMwVnYwNG5PQlhHWl82anktMEpBa3hPUE5MUGVqV0pWaDAzQ2FDWmJxSThqR2loYWRfeFE?oc=5"" target=""_blank"">Biocon Biologics Signs 10-year Deal With Eris Lifesciences To Expand Patient Access</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Businessworld</font>",https://news.google.com/rss/articles/CBMixgFBVV95cUxPYnYxTWtBNERFZTdYbWVuaGkwV2x4UkJ4SHlDdmdWSnBrbTR1dGRxbmhHRHpWTUl2TzQ4WkphenloYm9IR3d1eUk5bi0xSUxUOTg2SDRzNFZTU2dxVVBJRmZxTWZqa1M5Qk1LR1pXNG9tQmVsd3VOdnlmQWxhMGl6RGNJNm92NTV1ci1qY2ZTbnh1ZDMwVnYwNG5PQlhHWl82anktMEpBa3hPUE5MUGVqV0pWaDAzQ2FDWmJxSThqR2loYWRfeFE?oc=5,Google News,Biocon commercial success,"Biocon Biologics Signs 10-year Deal With Eris Lifesciences To Expand Patient Access - BW Businessworld <a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxPYnYxTWtBNERFZTdYbWVuaGkwV2x4UkJ4SHlDdmdWSnBrbTR1dGRxbmhHRHpWTUl2TzQ4WkphenloYm9IR3d1eUk5bi0xSUxUOTg2SDRzNFZTU2dxVVBJRmZxTWZqa1M5Qk1LR1pXNG9tQmVsd3VOdnlmQWxhMGl6RGNJNm92NTV1ci1qY2ZTbnh1ZDMwVnYwNG5PQlhHWl82anktMEpBa3hPUE5MUGVqV0pWaDAzQ2FDWmJxSThqR2loYWRfeFE?oc=5"" target=""_blank"">Biocon Biologics Signs 10-year Deal With Eris Lifesciences To Expand Patient Access</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Businessworld</font>",0.9349473118782043,positive,0.9349473118782043,0.0,neutral,0.0,0.5574,0.141,0.0,0.859,0.0,0.0,0.5342556067875454,0.7461736559391021,other,0.0,[],False,True,6,0.0
2023-12-18,2023-12-18 08:00:00,Biocon Biologics completes integration of Viatris' biosimilars business - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics completes integration of Viatris' biosimilars business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"Biocon Biologics completes integration of Viatris' biosimilars business - Business Standard <a href=""https://news.google.com/rss/articles/CBMi1gFBVV95cUxPaTg4SFVRTnlCVEd3V0FQbXlWQ0NERjJUT1poSDhZTm5JcG1CNzV3TFdzYVpNWkhteWdWTENhWnNmOTl1azJFU2VEazNvX0RjTDA1LTFlblZsR1lVUkI5c3NrTmQxZm1LZ1BMSVk5NGtNbDBNdVVkOW16VFN3WXRuSExWY2JGWmNEejI2a21Kb2gtMm9fVmFGaS1iZUZPa2NlUWhHQ0tNQW9wNm9OYllreFBPb2xkVGpKQkVoLTE2bzZwTG4yd0ZNMnRwVDI4aUF6dHZjdTdR0gHbAUFVX3lxTE1MVkdhRkVIYTZYNVJXczRqZlhMWEZ4WEZZTlQxSWpBWHU0RlczY1RmaENpWmFEUDkycHg1ak5rTURhLXp3YnRDaEN6NWlzTTV1a3dVdXRKRE1SbUZlQVo1OC1PVlFUVmhyUm5xdWxwZmlCcVU5dlc4WlZoNi1pdjVnYzVQVThJX1AzSE5fNFJEMWRtWmpwNTl2N1RyR2xBSldZRVh6a1JPX1g4dHk5OFBNWHVGNXFOeW9EVGRNRjE5STVoc2JETUhfMVdOS2FMVVcxbE1ORzZQR2ViRQ?oc=5"" target=""_blank"">Biocon Biologics completes integration of Viatris' biosimilars business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.6628670692443848,positive,0.6628670692443848,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.37878118242536274,0.6628670692443848,other,0.0,[],False,True,6,0.0
2023-09-18,2023-09-18 07:00:00,"Biocon names Peter Bains as group CEO, will report to Kiran Mazumdar-Shaw - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon names Peter Bains as group CEO, will report to Kiran Mazumdar-Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"Biocon names Peter Bains as group CEO, will report to Kiran Mazumdar-Shaw - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon names Peter Bains as group CEO, will report to Kiran Mazumdar-Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.9437951445579529,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9437951445579529,other,0.0,[],False,True,6,0.0
2024-09-01,2024-09-01 07:00:00,Majority of Singaporeans surveyed by Prudential prioritise health over financial success - Yahoo,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxQeE1IaGt6cEp0LVpkQmlEYWl6b2FxVFMyb1VoLU9lWFE5R0d6eVI1MEdpS1NfYlhSRTBxRFBGWC04T2Qyc0hLWTFZRkpxcW5BYWIzVFM1dWpDcDFYNklKcHlEU1RUNURwbGktQko4dUttT3BNVTNBenBKUjFJa05qQXdJMUxjcVhaOThub0RTSlpva21Zc1hvNk1adEhjcFAyQ2E0?oc=5"" target=""_blank"">Majority of Singaporeans surveyed by Prudential prioritise health over financial success</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxQeE1IaGt6cEp0LVpkQmlEYWl6b2FxVFMyb1VoLU9lWFE5R0d6eVI1MEdpS1NfYlhSRTBxRFBGWC04T2Qyc0hLWTFZRkpxcW5BYWIzVFM1dWpDcDFYNklKcHlEU1RUNURwbGktQko4dUttT3BNVTNBenBKUjFJa05qQXdJMUxjcVhaOThub0RTSlpva21Zc1hvNk1adEhjcFAyQ2E0?oc=5,Google News,Biocon commercial success,"Majority of Singaporeans surveyed by Prudential prioritise health over financial success - Yahoo <a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxQeE1IaGt6cEp0LVpkQmlEYWl6b2FxVFMyb1VoLU9lWFE5R0d6eVI1MEdpS1NfYlhSRTBxRFBGWC04T2Qyc0hLWTFZRkpxcW5BYWIzVFM1dWpDcDFYNklKcHlEU1RUNURwbGktQko4dUttT3BNVTNBenBKUjFJa05qQXdJMUxjcVhaOThub0RTSlpva21Zc1hvNk1adEhjcFAyQ2E0?oc=5"" target=""_blank"">Majority of Singaporeans surveyed by Prudential prioritise health over financial success</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",0.0,neutral,0.8598456978797913,0.0,neutral,0.0,0.5719,0.129,0.0,0.871,0.075,0.0,0.0,0.5022485659599304,other,0.0,[],False,False,1,0.0
2022-03-11,2022-03-11 08:00:00,I took buses across the country and met customers. My early days taught me to fend for myself and be brave: Kiran Mazumdar Shaw - YourStory.com,"<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxOblB2TGl4RWxndnJDTnlMYzlkbUEwQVpEOHYxNkNFWlQxcHpnbzl0d3V5V1l0LUJLWmJFdUR1YnFtTHh5cGFmMUo2NHFmTkRTMzZJOTNuUmlraXJrX05TODVQeW5UNGh1cU9US1oxRkNXMTJDcG1OZVhMTXgtYWdpM2JZSVRDREVoM2Q4Y2o0T1E5cGVkY09qOTNaRWN6Q2dZMkhSYm9ZcmpMNkk?oc=5"" target=""_blank"">I took buses across the country and met customers. My early days taught me to fend for myself and be brave: Kiran Mazumdar Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">YourStory.com</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxOblB2TGl4RWxndnJDTnlMYzlkbUEwQVpEOHYxNkNFWlQxcHpnbzl0d3V5V1l0LUJLWmJFdUR1YnFtTHh5cGFmMUo2NHFmTkRTMzZJOTNuUmlraXJrX05TODVQeW5UNGh1cU9US1oxRkNXMTJDcG1OZVhMTXgtYWdpM2JZSVRDREVoM2Q4Y2o0T1E5cGVkY09qOTNaRWN6Q2dZMkhSYm9ZcmpMNkk?oc=5,Google News,Biocon commercial success,"I took buses across the country and met customers. My early days taught me to fend for myself and be brave: Kiran Mazumdar Shaw - YourStory.com <a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxOblB2TGl4RWxndnJDTnlMYzlkbUEwQVpEOHYxNkNFWlQxcHpnbzl0d3V5V1l0LUJLWmJFdUR1YnFtTHh5cGFmMUo2NHFmTkRTMzZJOTNuUmlraXJrX05TODVQeW5UNGh1cU9US1oxRkNXMTJDcG1OZVhMTXgtYWdpM2JZSVRDREVoM2Q4Y2o0T1E5cGVkY09qOTNaRWN6Q2dZMkhSYm9ZcmpMNkk?oc=5"" target=""_blank"">I took buses across the country and met customers. My early days taught me to fend for myself and be brave: Kiran Mazumdar Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">YourStory.com</font>",0.0,neutral,0.8678873777389526,0.0,neutral,0.0,0.7783,0.122,0.0,0.878,0.36,0.52,0.0,0.6687291259129843,other,0.0,[],False,True,6,0.0
2024-03-14,2024-03-14 07:00:00,"Eris Lifesciences enters Rs 30,000 cr injectables market with Biocon Biologics acquisition - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences enters Rs 30,000 cr injectables market with Biocon Biologics acquisition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"Eris Lifesciences enters Rs 30,000 cr injectables market with Biocon Biologics acquisition - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences enters Rs 30,000 cr injectables market with Biocon Biologics acquisition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.6212325096130371,positive,0.6212325096130371,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.35499000549316406,0.6212325096130371,other,0.0,[],False,True,6,0.0
2023-11-24,2023-11-24 08:00:00,Biocon bets big on new class of weight-loss drugs - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon bets big on new class of weight-loss drugs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"Biocon bets big on new class of weight-loss drugs - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon bets big on new class of weight-loss drugs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.680578351020813,positive,0.680578351020813,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.05454545454545454,0.22181818181818183,0.38890191486903597,0.3675619027831338,other,0.0,[],False,True,6,0.0
2023-06-19,2023-06-19 07:00:00,"She Started Her Company With Rs 10,000 From A Garage; Today, Her Fortune Is Over Rs 24,000 Crore - Zee News","<a href=""https://news.google.com/rss/articles/CBMi_gFBVV95cUxQN3lNc25lXzE5UkJzS3cxaFVtcWF4RUdMaGpZbUQzNmVuLXBfZjlIWExadnJhYVVDVENtR013RzlkUU85cS13dnBDMXlyYng5ZmNkUkd6N0x3NlVkNEFEbUt4QXlDRV91MGhIdnFQSjdTeGR2Q3FOUFFvZlh3aGVfNWNEYkZ3VVBzcjNzb1F2WlNMTDd0NF9MMnZuREtDNVk3VHNDZmUzT1JNMDJKRnBnZU5VcWhlV1JDZk50ZlJXUzJYSDBVMnJkY29pX2czaGkwdXVGc3JQTldzR2pSVXNJQWI3Tms2Mm1DdTdvdU5WeVZtazlsdGtXNHpNWWlTQQ?oc=5"" target=""_blank"">She Started Her Company With Rs 10,000 From A Garage; Today, Her Fortune Is Over Rs 24,000 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee News</font>",https://news.google.com/rss/articles/CBMi_gFBVV95cUxQN3lNc25lXzE5UkJzS3cxaFVtcWF4RUdMaGpZbUQzNmVuLXBfZjlIWExadnJhYVVDVENtR013RzlkUU85cS13dnBDMXlyYng5ZmNkUkd6N0x3NlVkNEFEbUt4QXlDRV91MGhIdnFQSjdTeGR2Q3FOUFFvZlh3aGVfNWNEYkZ3VVBzcjNzb1F2WlNMTDd0NF9MMnZuREtDNVk3VHNDZmUzT1JNMDJKRnBnZU5VcWhlV1JDZk50ZlJXUzJYSDBVMnJkY29pX2czaGkwdXVGc3JQTldzR2pSVXNJQWI3Tms2Mm1DdTdvdU5WeVZtazlsdGtXNHpNWWlTQQ?oc=5,Google News,Biocon commercial success,"She Started Her Company With Rs 10,000 From A Garage; Today, Her Fortune Is Over Rs 24,000 Crore - Zee News <a href=""https://news.google.com/rss/articles/CBMi_gFBVV95cUxQN3lNc25lXzE5UkJzS3cxaFVtcWF4RUdMaGpZbUQzNmVuLXBfZjlIWExadnJhYVVDVENtR013RzlkUU85cS13dnBDMXlyYng5ZmNkUkd6N0x3NlVkNEFEbUt4QXlDRV91MGhIdnFQSjdTeGR2Q3FOUFFvZlh3aGVfNWNEYkZ3VVBzcjNzb1F2WlNMTDd0NF9MMnZuREtDNVk3VHNDZmUzT1JNMDJKRnBnZU5VcWhlV1JDZk50ZlJXUzJYSDBVMnJkY29pX2czaGkwdXVGc3JQTldzR2pSVXNJQWI3Tms2Mm1DdTdvdU5WeVZtazlsdGtXNHpNWWlTQQ?oc=5"" target=""_blank"">She Started Her Company With Rs 10,000 From A Garage; Today, Her Fortune Is Over Rs 24,000 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee News</font>",0.0,neutral,0.9069485068321228,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9069485068321228,other,0.0,[],False,False,1,0.0
2024-03-18,2024-03-18 07:00:00,"Eris Lifesciences acquires Biocon's branded division for Rs 1,242 cr - Value Research","<a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxPQmF6TktFMlR2ZWJXZWUtQXZodzVQUk1mZDdxSmR0Uy1Lc0pVUl9ZUGpzWWFpVlVSRFF0MFF0SVUtaWZRUWhBUW5YSkxTd3QwZHdyRU96eTZYcC1lVGx1ZmtCeS1lbjFhOEdTMW1PMHBGamo0TkU5c3IwV0NiSG80UWVYMk1wMWppZ0N3YjdqeVQ1cUdIWm40TUNIVkkwdFlxTldzT2RZRmwtN2w5UWJuOUFEaWI5OTdDZGtTOWNsTEFfQQ?oc=5"" target=""_blank"">Eris Lifesciences acquires Biocon's branded division for Rs 1,242 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Value Research</font>",https://news.google.com/rss/articles/CBMiwgFBVV95cUxPQmF6TktFMlR2ZWJXZWUtQXZodzVQUk1mZDdxSmR0Uy1Lc0pVUl9ZUGpzWWFpVlVSRFF0MFF0SVUtaWZRUWhBUW5YSkxTd3QwZHdyRU96eTZYcC1lVGx1ZmtCeS1lbjFhOEdTMW1PMHBGamo0TkU5c3IwV0NiSG80UWVYMk1wMWppZ0N3YjdqeVQ1cUdIWm40TUNIVkkwdFlxTldzT2RZRmwtN2w5UWJuOUFEaWI5OTdDZGtTOWNsTEFfQQ?oc=5,Google News,Biocon commercial success,"Eris Lifesciences acquires Biocon's branded division for Rs 1,242 cr - Value Research <a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxPQmF6TktFMlR2ZWJXZWUtQXZodzVQUk1mZDdxSmR0Uy1Lc0pVUl9ZUGpzWWFpVlVSRFF0MFF0SVUtaWZRUWhBUW5YSkxTd3QwZHdyRU96eTZYcC1lVGx1ZmtCeS1lbjFhOEdTMW1PMHBGamo0TkU5c3IwV0NiSG80UWVYMk1wMWppZ0N3YjdqeVQ1cUdIWm40TUNIVkkwdFlxTldzT2RZRmwtN2w5UWJuOUFEaWI5OTdDZGtTOWNsTEFfQQ?oc=5"" target=""_blank"">Eris Lifesciences acquires Biocon's branded division for Rs 1,242 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Value Research</font>",0.0,neutral,0.890798807144165,0.0,neutral,0.0,0.34,0.088,0.0,0.912,0.0,0.0,0.0,0.6153994035720826,other,0.0,[],False,True,6,0.0
2025-06-24,2025-06-24 04:41:44,National Cancer Malaysia Partners Biocon In Offering Affordable Cancer Care For The Underserved - BusinessToday Malaysia,"<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxObllOQVNINDRHdkd6aWVtbGVJU24tZEwtcjN2NU9HUTM0S0UtdnVwcnBzVkVNRThQNHNQUDNwUm5hT01SbjR3THpyTnFuRUFNcTdUUXhxU0NNMTlOOVRZcTJmTkVheUZBbjNEdGRuOVNNZF9adGptR3h3ekZubjk2X3BDTkR2X3BUTjRQOUJiODFsdV8xTlJxQVNnZVBuN2Q0UkQ3c2J1WUg0Vlp1bXNrc29QdGVoUWhIYUEyTHprU0twRkRWTjVnRThCdTdBTnk4eUd6aC1lZw?oc=5"" target=""_blank"">National Cancer Malaysia Partners Biocon In Offering Affordable Cancer Care For The Underserved</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessToday Malaysia</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxObllOQVNINDRHdkd6aWVtbGVJU24tZEwtcjN2NU9HUTM0S0UtdnVwcnBzVkVNRThQNHNQUDNwUm5hT01SbjR3THpyTnFuRUFNcTdUUXhxU0NNMTlOOVRZcTJmTkVheUZBbjNEdGRuOVNNZF9adGptR3h3ekZubjk2X3BDTkR2X3BUTjRQOUJiODFsdV8xTlJxQVNnZVBuN2Q0UkQ3c2J1WUg0Vlp1bXNrc29QdGVoUWhIYUEyTHprU0twRkRWTjVnRThCdTdBTnk4eUd6aC1lZw?oc=5,Google News,Biocon commercial success,"National Cancer Malaysia Partners Biocon In Offering Affordable Cancer Care For The Underserved - BusinessToday Malaysia <a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxObllOQVNINDRHdkd6aWVtbGVJU24tZEwtcjN2NU9HUTM0S0UtdnVwcnBzVkVNRThQNHNQUDNwUm5hT01SbjR3THpyTnFuRUFNcTdUUXhxU0NNMTlOOVRZcTJmTkVheUZBbjNEdGRuOVNNZF9adGptR3h3ekZubjk2X3BDTkR2X3BUTjRQOUJiODFsdV8xTlJxQVNnZVBuN2Q0UkQ3c2J1WUg0Vlp1bXNrc29QdGVoUWhIYUEyTHprU0twRkRWTjVnRThCdTdBTnk4eUd6aC1lZw?oc=5"" target=""_blank"">National Cancer Malaysia Partners Biocon In Offering Affordable Cancer Care For The Underserved</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessToday Malaysia</font>",0.8259990215301514,positive,0.8259990215301514,0.0,neutral,0.0,-0.9217,0.128,0.352,0.52,0.0,0.0,0.47199944087437223,0.8738495107650757,other,0.0,[],False,True,6,0.0
2024-11-19,2024-11-19 08:00:00,"Industry, govt, academia collaboration in focus at Bengaluru Tech Summit - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Industry, govt, academia collaboration in focus at Bengaluru Tech Summit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"Industry, govt, academia collaboration in focus at Bengaluru Tech Summit - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Industry, govt, academia collaboration in focus at Bengaluru Tech Summit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.919350266456604,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.919350266456604,other,0.0,[],False,False,1,0.0
2023-08-02,2023-08-02 07:00:00,"'No biz experience, Rs 10,000 in bank': How Kiran Mazumdar-Shaw struggled to start Biocon - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">'No biz experience, Rs 10,000 in bank': How Kiran Mazumdar-Shaw struggled to start Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"'No biz experience, Rs 10,000 in bank': How Kiran Mazumdar-Shaw struggled to start Biocon - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">'No biz experience, Rs 10,000 in bank': How Kiran Mazumdar-Shaw struggled to start Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.8728356957435608,0.0,neutral,0.0,-0.7184,0.0,0.184,0.816,0.0,0.0,0.0,0.7956178478717804,other,0.0,[],False,True,6,0.0
2021-02-17,2021-02-17 08:00:00,10 business qualities you can learn from Priyanka Chopra Jonas - Yahoo,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxOV2NmenpZNU1ldlg0OWFZVTBLZzlpeDhtTkwxbzBjZzBJSlF2ajB4dWN4SFEtU0htWFI4TnVWNTBvelNPSFdhMFNEdVQzVVNVX3AtdHNzUnQ2dHVVMnFBMUFtLUl1M1RNYjRFX3BIODdQdkZVTG1IX3BIRVl1cm5nTGx2Vm5BWUxFMEtac1FqaU92TXRCSVl3ZWVBVktNUzVIZVQwcWdmWVFqMmRkYzBfdw?oc=5"" target=""_blank"">10 business qualities you can learn from Priyanka Chopra Jonas</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxOV2NmenpZNU1ldlg0OWFZVTBLZzlpeDhtTkwxbzBjZzBJSlF2ajB4dWN4SFEtU0htWFI4TnVWNTBvelNPSFdhMFNEdVQzVVNVX3AtdHNzUnQ2dHVVMnFBMUFtLUl1M1RNYjRFX3BIODdQdkZVTG1IX3BIRVl1cm5nTGx2Vm5BWUxFMEtac1FqaU92TXRCSVl3ZWVBVktNUzVIZVQwcWdmWVFqMmRkYzBfdw?oc=5,Google News,Biocon commercial success,"10 business qualities you can learn from Priyanka Chopra Jonas - Yahoo <a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxOV2NmenpZNU1ldlg0OWFZVTBLZzlpeDhtTkwxbzBjZzBJSlF2ajB4dWN4SFEtU0htWFI4TnVWNTBvelNPSFdhMFNEdVQzVVNVX3AtdHNzUnQ2dHVVMnFBMUFtLUl1M1RNYjRFX3BIODdQdkZVTG1IX3BIRVl1cm5nTGx2Vm5BWUxFMEtac1FqaU92TXRCSVl3ZWVBVktNUzVIZVQwcWdmWVFqMmRkYzBfdw?oc=5"" target=""_blank"">10 business qualities you can learn from Priyanka Chopra Jonas</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",0.0,neutral,0.8341860175132751,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8341860175132751,other,0.0,[],False,False,1,0.0
2025-04-07,2025-04-07 07:00:00,Top 7 leadership lessons from India’s most successful CEOs - DNA India,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Top 7 leadership lessons from India’s most successful CEOs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">DNA India</font>",https://news.google.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?oc=5,Google News,Biocon commercial success,"Top 7 leadership lessons from India’s most successful CEOs - DNA India <a href=""https://news.google.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?oc=5"" target=""_blank"">Top 7 leadership lessons from India’s most successful CEOs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">DNA India</font>",0.0,neutral,0.6620262861251831,0.0,neutral,0.0,0.8746,0.345,0.0,0.655,0.5,0.5666666666666668,0.0,0.6788754287083943,other,0.0,[],False,False,1,0.0
2025-02-19,2025-02-19 08:00:00,Breaking Barriers: Kiran Mazumdar-Shaw’s Pioneering Journey In Indian Biotechnology - inventiva.co.in,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxPWUlXNzVpeXJUV1dpcENtTFI4c1VIc3NkSHdVdmVHOHBXVUo4Z09JVl9uSVpDR2N1eVl0d1g5TXNzR0g1eGRBaDVTaERZUkVwUTJkZWVPaC0xOWJMcFhldnNEZUlhRWpLS2pZR2F3SnNRRUw3TVRsNzR0Ny1US2lOZFZBV3lBejV1aV9jOTJGNU1tS2c2TDJTRmphWktHdnc1WmU4?oc=5"" target=""_blank"">Breaking Barriers: Kiran Mazumdar-Shaw’s Pioneering Journey In Indian Biotechnology</a>&nbsp;&nbsp;<font color=""#6f6f6f"">inventiva.co.in</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxPWUlXNzVpeXJUV1dpcENtTFI4c1VIc3NkSHdVdmVHOHBXVUo4Z09JVl9uSVpDR2N1eVl0d1g5TXNzR0g1eGRBaDVTaERZUkVwUTJkZWVPaC0xOWJMcFhldnNEZUlhRWpLS2pZR2F3SnNRRUw3TVRsNzR0Ny1US2lOZFZBV3lBejV1aV9jOTJGNU1tS2c2TDJTRmphWktHdnc1WmU4?oc=5,Google News,Biocon commercial success,"Breaking Barriers: Kiran Mazumdar-Shaw’s Pioneering Journey In Indian Biotechnology - inventiva.co.in <a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxPWUlXNzVpeXJUV1dpcENtTFI4c1VIc3NkSHdVdmVHOHBXVUo4Z09JVl9uSVpDR2N1eVl0d1g5TXNzR0g1eGRBaDVTaERZUkVwUTJkZWVPaC0xOWJMcFhldnNEZUlhRWpLS2pZR2F3SnNRRUw3TVRsNzR0Ny1US2lOZFZBV3lBejV1aV9jOTJGNU1tS2c2TDJTRmphWktHdnc1WmU4?oc=5"" target=""_blank"">Breaking Barriers: Kiran Mazumdar-Shaw’s Pioneering Journey In Indian Biotechnology</a>&nbsp;&nbsp;<font color=""#6f6f6f"">inventiva.co.in</font>",0.0,neutral,0.7461929321289062,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7461929321289062,other,0.0,[],False,True,6,0.0
2024-03-12,2024-03-12 07:00:00,Top 20 Successful Women Entrepreneurs in India 2025 - Business Outreach,"<a href=""https://news.google.com/rss/articles/CBMifEFVX3lxTE40S3dkVi1OOE9WQ2IwQWxaSW05UzlsMTNtcENuVTMtOHdyb1lBWDJ3bTlib0xnaFNjNVdmOHpYR2xTVlhuQ2xRV19sdjUxa2lUeDl1WHA3cnk3VzdtbWN6cTYyY0pfekdZNUdyTnlfb3h1dzc0YWhjTFh2MkY?oc=5"" target=""_blank"">Top 20 Successful Women Entrepreneurs in India 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Outreach</font>",https://news.google.com/rss/articles/CBMifEFVX3lxTE40S3dkVi1OOE9WQ2IwQWxaSW05UzlsMTNtcENuVTMtOHdyb1lBWDJ3bTlib0xnaFNjNVdmOHpYR2xTVlhuQ2xRV19sdjUxa2lUeDl1WHA3cnk3VzdtbWN6cTYyY0pfekdZNUdyTnlfb3h1dzc0YWhjTFh2MkY?oc=5,Google News,Biocon commercial success,"Top 20 Successful Women Entrepreneurs in India 2025 - Business Outreach <a href=""https://news.google.com/rss/articles/CBMifEFVX3lxTE40S3dkVi1OOE9WQ2IwQWxaSW05UzlsMTNtcENuVTMtOHdyb1lBWDJ3bTlib0xnaFNjNVdmOHpYR2xTVlhuQ2xRV19sdjUxa2lUeDl1WHA3cnk3VzdtbWN6cTYyY0pfekdZNUdyTnlfb3h1dzc0YWhjTFh2MkY?oc=5"" target=""_blank"">Top 20 Successful Women Entrepreneurs in India 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Outreach</font>",0.0,neutral,0.8710573315620422,0.0,neutral,0.0,0.8885,0.39,0.0,0.61,0.5,0.6,0.0,0.7531857771873475,other,0.0,[],False,False,1,0.0
2023-09-30,2023-09-30 02:22:25,11 Inspirational Women Entrepreneurs in India - SugerMint,"<a href=""https://news.google.com/rss/articles/CBMid0FVX3lxTE12NzVuV2ZQOFNnbF9oQVJHUVdGWmpENGhuR1hiNkRBdzBlNlpyY250aHNnR0xMLVU2dDVIai1kdzR4WVJjcVZ2UmFRcFFhQ2ZaMkpPeDFwY2ZTVDdSX1FFXzhMODRaX1psREdZX3JfcnlhQWZta29V?oc=5"" target=""_blank"">11 Inspirational Women Entrepreneurs in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">SugerMint</font>",https://news.google.com/rss/articles/CBMid0FVX3lxTE12NzVuV2ZQOFNnbF9oQVJHUVdGWmpENGhuR1hiNkRBdzBlNlpyY250aHNnR0xMLVU2dDVIai1kdzR4WVJjcVZ2UmFRcFFhQ2ZaMkpPeDFwY2ZTVDdSX1FFXzhMODRaX1psREdZX3JfcnlhQWZta29V?oc=5,Google News,Biocon commercial success,"11 Inspirational Women Entrepreneurs in India - SugerMint <a href=""https://news.google.com/rss/articles/CBMid0FVX3lxTE12NzVuV2ZQOFNnbF9oQVJHUVdGWmpENGhuR1hiNkRBdzBlNlpyY250aHNnR0xMLVU2dDVIai1kdzR4WVJjcVZ2UmFRcFFhQ2ZaMkpPeDFwY2ZTVDdSX1FFXzhMODRaX1psREdZX3JfcnlhQWZta29V?oc=5"" target=""_blank"">11 Inspirational Women Entrepreneurs in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">SugerMint</font>",0.0,neutral,0.9005253314971924,0.0,neutral,0.0,0.765,0.32,0.0,0.68,0.3333333333333333,0.6666666666666666,0.0,0.6662862216101753,other,0.0,[],False,False,1,0.0
2021-10-20,2021-10-20 07:00:00,Viatris' First-Ever Interchangeable Insulin Biosimilar Preferred on Express Scripts' Largest Formulary - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi7AFBVV95cUxQRjVSVzYyZWpQYi04ZWc1SWFLRUQ3amw4dTdqMUZQYU5pMTJJcEE5U291MVVlUEFNZkdyeFQxejRDLTdKQ1Ezc3BvVnBMcHR6T3YycXBGMDhQLWhjZ29GNHFmZmpFSm8wbzdhQnpfQWd1Sk55Sm5GZzFNMTVLQW1aNE1BOUdSRzZ6cDFiOGJwdVgwRGlqcjhOQXk2UnNzd0d0ZkQwMHBEdFRBcGM0UzY1bXpBMXNvMVVuajJaUlB0M3NVYkZkX1dFdmw0dlZhV05IRTRpaG0xVUY3WG03NVE5SURGQm9SZ3hGLVFGeQ?oc=5"" target=""_blank"">Viatris' First-Ever Interchangeable Insulin Biosimilar Preferred on Express Scripts' Largest Formulary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi7AFBVV95cUxQRjVSVzYyZWpQYi04ZWc1SWFLRUQ3amw4dTdqMUZQYU5pMTJJcEE5U291MVVlUEFNZkdyeFQxejRDLTdKQ1Ezc3BvVnBMcHR6T3YycXBGMDhQLWhjZ29GNHFmZmpFSm8wbzdhQnpfQWd1Sk55Sm5GZzFNMTVLQW1aNE1BOUdSRzZ6cDFiOGJwdVgwRGlqcjhOQXk2UnNzd0d0ZkQwMHBEdFRBcGM0UzY1bXpBMXNvMVVuajJaUlB0M3NVYkZkX1dFdmw0dlZhV05IRTRpaG0xVUY3WG03NVE5SURGQm9SZ3hGLVFGeQ?oc=5,Google News,Semglee formulary inclusion,"Viatris' First-Ever Interchangeable Insulin Biosimilar Preferred on Express Scripts' Largest Formulary - PR Newswire <a href=""https://news.google.com/rss/articles/CBMi7AFBVV95cUxQRjVSVzYyZWpQYi04ZWc1SWFLRUQ3amw4dTdqMUZQYU5pMTJJcEE5U291MVVlUEFNZkdyeFQxejRDLTdKQ1Ezc3BvVnBMcHR6T3YycXBGMDhQLWhjZ29GNHFmZmpFSm8wbzdhQnpfQWd1Sk55Sm5GZzFNMTVLQW1aNE1BOUdSRzZ6cDFiOGJwdVgwRGlqcjhOQXk2UnNzd0d0ZkQwMHBEdFRBcGM0UzY1bXpBMXNvMVVuajJaUlB0M3NVYkZkX1dFdmw0dlZhV05IRTRpaG0xVUY3WG03NVE5SURGQm9SZ3hGLVFGeQ?oc=5"" target=""_blank"">Viatris' First-Ever Interchangeable Insulin Biosimilar Preferred on Express Scripts' Largest Formulary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.0,neutral,0.7627230882644653,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7627230882644653,other,0.0,[],False,False,1,0.0
2025-01-24,2025-01-24 08:00:00,‘Knock out the middlemen’: A campaign promise Donald Trump should keep - The Boston Globe,"<a href=""https://news.google.com/rss/articles/CBMihwFBVV95cUxPc1ZsTjNscGE4d0JHWTJhM0lLeVJDSklLemNyM2FpWms4ZV91QWdOWm1MYXNkM05hd1NVWlNjZFFueld6NjMzWFZtS0RVdTlTRWpXNGQtTm9NZ1k3OXBZTWI1ZkNYWVNpZ2F0aXNzV1pNVlpKd1FzLXRxdjRqcDdocGRxQzZHZVU?oc=5"" target=""_blank"">‘Knock out the middlemen’: A campaign promise Donald Trump should keep</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Boston Globe</font>",https://news.google.com/rss/articles/CBMihwFBVV95cUxPc1ZsTjNscGE4d0JHWTJhM0lLeVJDSklLemNyM2FpWms4ZV91QWdOWm1MYXNkM05hd1NVWlNjZFFueld6NjMzWFZtS0RVdTlTRWpXNGQtTm9NZ1k3OXBZTWI1ZkNYWVNpZ2F0aXNzV1pNVlpKd1FzLXRxdjRqcDdocGRxQzZHZVU?oc=5,Google News,Semglee insurance coverage,"‘Knock out the middlemen’: A campaign promise Donald Trump should keep - The Boston Globe <a href=""https://news.google.com/rss/articles/CBMihwFBVV95cUxPc1ZsTjNscGE4d0JHWTJhM0lLeVJDSklLemNyM2FpWms4ZV91QWdOWm1MYXNkM05hd1NVWlNjZFFueld6NjMzWFZtS0RVdTlTRWpXNGQtTm9NZ1k3OXBZTWI1ZkNYWVNpZ2F0aXNzV1pNVlpKd1FzLXRxdjRqcDdocGRxQzZHZVU?oc=5"" target=""_blank"">‘Knock out the middlemen’: A campaign promise Donald Trump should keep</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Boston Globe</font>",0.0,neutral,0.8842066526412964,0.0,neutral,0.0,0.5574,0.15,0.0,0.85,0.0,0.0,0.0,0.7208033263206481,other,0.0,[],False,False,1,0.0
2021-08-02,2021-08-02 07:00:00,FDA Propels Insulin Affordability with Semglee - diaTribe,"<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5"" target=""_blank"">FDA Propels Insulin Affordability with Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5,Google News,Semglee insurance coverage,"FDA Propels Insulin Affordability with Semglee - diaTribe <a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5"" target=""_blank"">FDA Propels Insulin Affordability with Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",0.7422772645950317,positive,0.7422772645950317,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.4241584369114467,0.7422772645950317,other,0.0,[],True,False,11,0.0
2021-12-13,2021-12-13 08:00:00,'It is legal extortion': Diabetics pay steep price for insulin as rebates drive up costs - USA Today,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxQdWgzMWNOM256eWp6M3Q0eFBJUTVfV25RMlFtWEtzaEpSSHRTX0w5d3E5T0t3UW41VUlsQ216TnFRZHNiQnROa3J3SGtiejVNMXdrWnkzYzFXWGgxUGs4Wl83RThZZ0hxY3ZNT1YwUEMzcGhOT0c3RG1HQ2ZzXzlHUWsteFFsWWlvMHZjakViWlRRcEZYUl9MQmdETEU?oc=5"" target=""_blank"">'It is legal extortion': Diabetics pay steep price for insulin as rebates drive up costs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">USA Today</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxQdWgzMWNOM256eWp6M3Q0eFBJUTVfV25RMlFtWEtzaEpSSHRTX0w5d3E5T0t3UW41VUlsQ216TnFRZHNiQnROa3J3SGtiejVNMXdrWnkzYzFXWGgxUGs4Wl83RThZZ0hxY3ZNT1YwUEMzcGhOT0c3RG1HQ2ZzXzlHUWsteFFsWWlvMHZjakViWlRRcEZYUl9MQmdETEU?oc=5,Google News,Semglee insurance coverage,"'It is legal extortion': Diabetics pay steep price for insulin as rebates drive up costs - USA Today <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxQdWgzMWNOM256eWp6M3Q0eFBJUTVfV25RMlFtWEtzaEpSSHRTX0w5d3E5T0t3UW41VUlsQ216TnFRZHNiQnROa3J3SGtiejVNMXdrWnkzYzFXWGgxUGs4Wl83RThZZ0hxY3ZNT1YwUEMzcGhOT0c3RG1HQ2ZzXzlHUWsteFFsWWlvMHZjakViWlRRcEZYUl9MQmdETEU?oc=5"" target=""_blank"">'It is legal extortion': Diabetics pay steep price for insulin as rebates drive up costs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">USA Today</font>",0.0,neutral,0.751737654209137,0.0,neutral,0.0,0.0516,0.079,0.074,0.847,0.13333333333333333,0.13333333333333333,0.0,0.31222366251415673,other,0.0,[],False,False,1,0.0
2024-04-15,2024-04-15 07:00:00,Switching Away From Levemir: What Are the Options? - diaTribe,"<a href=""https://news.google.com/rss/articles/CBMiiAFBVV95cUxPeU9GY1ZNNnRIZ2VPZEhfT1ViZkwySy16TWdhZTdUaUZqTG5qM0NKaFk0Mm03QTdKUXFCVEhWRFlfbHBJclo4Tjg2dWhjeE9oTWRCeDJTN1ZlaDdPUXlEbDVnLTdkYV9LVUZyeG8xYWJJWDhuTzdyQmg0MDV1UXpBVV9ST21ERGV6?oc=5"" target=""_blank"">Switching Away From Levemir: What Are the Options?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",https://news.google.com/rss/articles/CBMiiAFBVV95cUxPeU9GY1ZNNnRIZ2VPZEhfT1ViZkwySy16TWdhZTdUaUZqTG5qM0NKaFk0Mm03QTdKUXFCVEhWRFlfbHBJclo4Tjg2dWhjeE9oTWRCeDJTN1ZlaDdPUXlEbDVnLTdkYV9LVUZyeG8xYWJJWDhuTzdyQmg0MDV1UXpBVV9ST21ERGV6?oc=5,Google News,Semglee insurance coverage,"Switching Away From Levemir: What Are the Options? - diaTribe <a href=""https://news.google.com/rss/articles/CBMiiAFBVV95cUxPeU9GY1ZNNnRIZ2VPZEhfT1ViZkwySy16TWdhZTdUaUZqTG5qM0NKaFk0Mm03QTdKUXFCVEhWRFlfbHBJclo4Tjg2dWhjeE9oTWRCeDJTN1ZlaDdPUXlEbDVnLTdkYV9LVUZyeG8xYWJJWDhuTzdyQmg0MDV1UXpBVV9ST21ERGV6?oc=5"" target=""_blank"">Switching Away From Levemir: What Are the Options?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",0.0,neutral,0.8990488648414612,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8990488648414612,other,0.0,[],False,False,1,0.0
2021-07-28,2021-07-28 07:00:00,FDA allows automatic ‘generic’ swap for brand-name insulin - The Detroit News,"<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxPbGg3czM2Tkg2dFNZQnUwY2VrN1g2Vzg4ZDJVU3pyT0pVVmJpRW93ZzEwMkRtQUU3ZWNJSURYSHY3al9fMS15b3JDdHJ1bVJVWVNJTFdud05tX3Z5MEVTQ2xFOWFGdHRuVEttcEhBWXZaQUNuY0s1cmdCU2xXaDl6bnJmckh2OFZhbG9LaUZLSGc4TDBCZkhRWEtWSFZIRERXZjZkZHAxb0FRbVJtU2FIb3hYZllWZWVRc3Bobll2Z04?oc=5"" target=""_blank"">FDA allows automatic ‘generic’ swap for brand-name insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Detroit News</font>",https://news.google.com/rss/articles/CBMiwAFBVV95cUxPbGg3czM2Tkg2dFNZQnUwY2VrN1g2Vzg4ZDJVU3pyT0pVVmJpRW93ZzEwMkRtQUU3ZWNJSURYSHY3al9fMS15b3JDdHJ1bVJVWVNJTFdud05tX3Z5MEVTQ2xFOWFGdHRuVEttcEhBWXZaQUNuY0s1cmdCU2xXaDl6bnJmckh2OFZhbG9LaUZLSGc4TDBCZkhRWEtWSFZIRERXZjZkZHAxb0FRbVJtU2FIb3hYZllWZWVRc3Bobll2Z04?oc=5,Google News,Semglee insurance coverage,"FDA allows automatic ‘generic’ swap for brand-name insulin - The Detroit News <a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxPbGg3czM2Tkg2dFNZQnUwY2VrN1g2Vzg4ZDJVU3pyT0pVVmJpRW93ZzEwMkRtQUU3ZWNJSURYSHY3al9fMS15b3JDdHJ1bVJVWVNJTFdud05tX3Z5MEVTQ2xFOWFGdHRuVEttcEhBWXZaQUNuY0s1cmdCU2xXaDl6bnJmckh2OFZhbG9LaUZLSGc4TDBCZkhRWEtWSFZIRERXZjZkZHAxb0FRbVJtU2FIb3hYZllWZWVRc3Bobll2Z04?oc=5"" target=""_blank"">FDA allows automatic ‘generic’ swap for brand-name insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Detroit News</font>",0.0,neutral,0.8326982259750366,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8326982259750366,other,0.0,[],False,False,1,0.0
2025-04-15,2025-04-15 07:00:00,"Biocon Biologics' Yesafili to enter US market, following agreement with Regeneron - Times of India","<a href=""https://news.google.com/rss/articles/CBMi-AFBVV95cUxNYndZUktwNWthcG5nNGZjOXR2cTkxdEZKUmJqVnlkc0JKQVlLX0F1TVU5S1hXdHNVN1Z1OGZvZl9wUWlNWjM0b2hlR1BoZ2F6Z0U5ZWNTeElEXzhJUXpfUEJZbEg3SFRxLW1sTU9Od3l6UlM5LXhGZUltUGZQM3BaZDdQcFUyRHlEMGVjTDNjbllPei13OUphVW1SZUdTRHcyRDdlaGtZZU94dWQtcmJaa2JYaF9aVlAtQXhpaU5LNkRyXy1JMmlLWWZqd0ZvNzNxdjBOUFF1V2dtNXJxVEpVZU9DMVdTbFpqRFJkMl9ZY0pTcC1kU081T9IB_gFBVV95cUxPemJCOHlCZ3hrdldGUU9ncFA3SFJDd1NRbEl3OXI3SFlKdFhQZk15T0E0RHZBUFNEeEluLUlMdEhneVNFeUFTY2tnckJ1V2luMzVONk8ySnR4Sk1QaS16QTFwdkNYZ0xxZExLY3R1WWhGNUNER2RrMzFCWmlhNFVHTFJCd19VbktURDVENEdJb2ktQWZvSlljWFpFcDZnYWw2MjBlZ2Q0Yk9nZThUckg3X3Q2NjFId05oMDNxOHQ5TWNiVGVjc2ZJQzd6clp5d2RyeTRfNTFLcGlZcWZNdkJING4xaWNvNkdMcVNYS3BCU1BhNHYwUmtKa0ZQTTByQQ?oc=5"" target=""_blank"">Biocon Biologics' Yesafili to enter US market, following agreement with Regeneron</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.com/rss/articles/CBMi-AFBVV95cUxNYndZUktwNWthcG5nNGZjOXR2cTkxdEZKUmJqVnlkc0JKQVlLX0F1TVU5S1hXdHNVN1Z1OGZvZl9wUWlNWjM0b2hlR1BoZ2F6Z0U5ZWNTeElEXzhJUXpfUEJZbEg3SFRxLW1sTU9Od3l6UlM5LXhGZUltUGZQM3BaZDdQcFUyRHlEMGVjTDNjbllPei13OUphVW1SZUdTRHcyRDdlaGtZZU94dWQtcmJaa2JYaF9aVlAtQXhpaU5LNkRyXy1JMmlLWWZqd0ZvNzNxdjBOUFF1V2dtNXJxVEpVZU9DMVdTbFpqRFJkMl9ZY0pTcC1kU081T9IB_gFBVV95cUxPemJCOHlCZ3hrdldGUU9ncFA3SFJDd1NRbEl3OXI3SFlKdFhQZk15T0E0RHZBUFNEeEluLUlMdEhneVNFeUFTY2tnckJ1V2luMzVONk8ySnR4Sk1QaS16QTFwdkNYZ0xxZExLY3R1WWhGNUNER2RrMzFCWmlhNFVHTFJCd19VbktURDVENEdJb2ktQWZvSlljWFpFcDZnYWw2MjBlZ2Q0Yk9nZThUckg3X3Q2NjFId05oMDNxOHQ5TWNiVGVjc2ZJQzd6clp5d2RyeTRfNTFLcGlZcWZNdkJING4xaWNvNkdMcVNYS3BCU1BhNHYwUmtKa0ZQTTByQQ?oc=5,Google News,Biocon market expansion,"Biocon Biologics' Yesafili to enter US market, following agreement with Regeneron - Times of India <a href=""https://news.google.com/rss/articles/CBMi-AFBVV95cUxNYndZUktwNWthcG5nNGZjOXR2cTkxdEZKUmJqVnlkc0JKQVlLX0F1TVU5S1hXdHNVN1Z1OGZvZl9wUWlNWjM0b2hlR1BoZ2F6Z0U5ZWNTeElEXzhJUXpfUEJZbEg3SFRxLW1sTU9Od3l6UlM5LXhGZUltUGZQM3BaZDdQcFUyRHlEMGVjTDNjbllPei13OUphVW1SZUdTRHcyRDdlaGtZZU94dWQtcmJaa2JYaF9aVlAtQXhpaU5LNkRyXy1JMmlLWWZqd0ZvNzNxdjBOUFF1V2dtNXJxVEpVZU9DMVdTbFpqRFJkMl9ZY0pTcC1kU081T9IB_gFBVV95cUxPemJCOHlCZ3hrdldGUU9ncFA3SFJDd1NRbEl3OXI3SFlKdFhQZk15T0E0RHZBUFNEeEluLUlMdEhneVNFeUFTY2tnckJ1V2luMzVONk8ySnR4Sk1QaS16QTFwdkNYZ0xxZExLY3R1WWhGNUNER2RrMzFCWmlhNFVHTFJCd19VbktURDVENEdJb2ktQWZvSlljWFpFcDZnYWw2MjBlZ2Q0Yk9nZThUckg3X3Q2NjFId05oMDNxOHQ5TWNiVGVjc2ZJQzd6clp5d2RyeTRfNTFLcGlZcWZNdkJING4xaWNvNkdMcVNYS3BCU1BhNHYwUmtKa0ZQTTByQQ?oc=5"" target=""_blank"">Biocon Biologics' Yesafili to enter US market, following agreement with Regeneron</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",0.7792752385139465,positive,0.7792752385139465,0.0,neutral,0.0,0.7506,0.186,0.0,0.814,0.0,0.06666666666666667,0.44530013629368376,0.7649376192569732,other,0.0,[],False,True,6,0.0
2025-02-01,2025-02-01 08:00:00,Biocon Biologics sees diversified global expansion offsetting US localisation risks - BusinessLine,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics sees diversified global expansion offsetting US localisation risks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon Biologics sees diversified global expansion offsetting US localisation risks - BusinessLine <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics sees diversified global expansion offsetting US localisation risks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",0.0,neutral,0.661830723285675,0.0,neutral,0.0,-0.2732,0.0,0.084,0.916,0.0,0.0,0.0,0.4675153616428375,other,0.0,[],False,True,6,0.0
2025-04-24,2025-04-24 07:00:00,Biosimilars Market Expansion in 2025: The Next Big Thing - openPR.com,"<a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxNenlqNGQ3MVdoS0RCT1hoMGpUNVhNcUdBOHpKbldTd2I3NlpMTHJDWnMySzVZTTliSHdNRklHcjA0RldrOC1qWHZ3UU5kNEJyOTFXOFJJazVJb2VvY3hxUUk5d0x4blprMk9OQVlXVV9WQU9PLVBqUkF5M2Y4UWdtMkltMHdyRjBHV0FJZzN2cjRKdmVPSUE?oc=5"" target=""_blank"">Biosimilars Market Expansion in 2025: The Next Big Thing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",https://news.google.com/rss/articles/CBMilgFBVV95cUxNenlqNGQ3MVdoS0RCT1hoMGpUNVhNcUdBOHpKbldTd2I3NlpMTHJDWnMySzVZTTliSHdNRklHcjA0RldrOC1qWHZ3UU5kNEJyOTFXOFJJazVJb2VvY3hxUUk5d0x4blprMk9OQVlXVV9WQU9PLVBqUkF5M2Y4UWdtMkltMHdyRjBHV0FJZzN2cjRKdmVPSUE?oc=5,Google News,Biocon market expansion,"Biosimilars Market Expansion in 2025: The Next Big Thing - openPR.com <a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxNenlqNGQ3MVdoS0RCT1hoMGpUNVhNcUdBOHpKbldTd2I3NlpMTHJDWnMySzVZTTliSHdNRklHcjA0RldrOC1qWHZ3UU5kNEJyOTFXOFJJazVJb2VvY3hxUUk5d0x4blprMk9OQVlXVV9WQU9PLVBqUkF5M2Y4UWdtMkltMHdyRjBHV0FJZzN2cjRKdmVPSUE?oc=5"" target=""_blank"">Biosimilars Market Expansion in 2025: The Next Big Thing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",0.0,neutral,0.8369675874710083,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.04,0.0,0.8369675874710083,post_approval,0.4940561532974243,['market expansion'],False,False,7,0.38811230659484863
2025-01-30,2025-01-30 17:56:20,Biocon Makes Strategic Moves Despite Third-Quarter Revenue Dip - Finimize,"<a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxNd3hhb0tvZWluY2kzVGVGRjR6M3Q0NWJvYkRJR0dITmNoY1pSLVFWbDl1Yk1oQmFUbFliMzNSVjBxUG1nNHlBVFdzOGRTTUVRVzZOdi1TdVRWcVR5TjZNTUhZRHZSQWVTSkt2cTg4TXBndzc0WEZQMzEyVUtNUVRucXBzUVNvNzNtdFNQTnFSVmJOT3k5a3c?oc=5"" target=""_blank"">Biocon Makes Strategic Moves Despite Third-Quarter Revenue Dip</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Finimize</font>",https://news.google.com/rss/articles/CBMilgFBVV95cUxNd3hhb0tvZWluY2kzVGVGRjR6M3Q0NWJvYkRJR0dITmNoY1pSLVFWbDl1Yk1oQmFUbFliMzNSVjBxUG1nNHlBVFdzOGRTTUVRVzZOdi1TdVRWcVR5TjZNTUhZRHZSQWVTSkt2cTg4TXBndzc0WEZQMzEyVUtNUVRucXBzUVNvNzNtdFNQTnFSVmJOT3k5a3c?oc=5,Google News,Biocon market expansion,"Biocon Makes Strategic Moves Despite Third-Quarter Revenue Dip - Finimize <a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxNd3hhb0tvZWluY2kzVGVGRjR6M3Q0NWJvYkRJR0dITmNoY1pSLVFWbDl1Yk1oQmFUbFliMzNSVjBxUG1nNHlBVFdzOGRTTUVRVzZOdi1TdVRWcVR5TjZNTUhZRHZSQWVTSkt2cTg4TXBndzc0WEZQMzEyVUtNUVRucXBzUVNvNzNtdFNQTnFSVmJOT3k5a3c?oc=5"" target=""_blank"">Biocon Makes Strategic Moves Despite Third-Quarter Revenue Dip</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Finimize</font>",0.604422390460968,positive,0.604422390460968,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3453842231205531,0.604422390460968,other,0.0,[],False,True,6,0.0
2025-02-11,2025-02-11 08:00:00,Biocon betting big on new product launches for growth - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi5gFBVV95cUxPaVVnWExkOUxpLVk3Wm9JVGF5dmlDTE1xMkVQbVFJYmEtcDNmZWhGTFlLTWNxcjBvdWlOcGFlVHNkME9xajNIRXRUMFBoNGxKVGp3WDk4UVNaMGgzSzVRY3FFMHdKeEJzWi1yOU13WThIQUlUNmpwSDFTVWI1U2V2UmthUjlQYXYxTVI3U0tYa3cyYjlXZTFqd2F2blVQZlZiY2pzQ1l0Z1lqazFGMS00UWFiWGhPNUpMVEhXR01xNlVtcmNQdkttbHdHNWJjQzJOZEJHRU1FRUFqWmw5V2JDM0l2WWMtZ9IB6wFBVV95cUxPeTBZSFJIcXNKM2E3T1Fqbjl4dDZ2Ymx3NmY2TnJyTm5nUnExTS1fSlZXaWFGMkJaX1ZMRlhCTW93Qi16bnNsV3pla1lZaEJ0dzZabGI0Rm9OMURkbjdNYjVzbm5HSTZxSm1hRWZfemE1di1ER2JTcHY3bnpFLUtUSXNXRjEwVGRGcDVLamtOd1dSYVh2dEttUmlHc05nSU9XdTBlR2NEWW9xYWo2dVo2cHN0M05Xd0JfbmZYWS1lcGZUR25Kakdpc2JRUTRPQVVrdURKX08wYmJJcjVITW1nREVMQmgzTVkyWU9R?oc=5"" target=""_blank"">Biocon betting big on new product launches for growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon betting big on new product launches for growth - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon betting big on new product launches for growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.7709921598434448,0.0,neutral,0.0,0.3818,0.094,0.0,0.906,0.09610389610389611,0.21558441558441557,0.0,0.41629868531578024,post_approval,0.5287696450948716,['product launch'],False,True,12,0.45753929018974304
2025-05-20,2025-05-20 07:00:00,Biocon Eyes Robust Growth as All Segments Gain Momentum | - Chemical Industry Digest,"<a href=""https://news.google.com/rss/articles/CBMiiAFBVV95cUxON1I0c3dSdEdpYURZek1IZy1JUjNwZnloaHMyTVVCaWcwd1lLREdlcUUzb1dxTGI4MHdNa29TZjludzFnWTRockNDeDBEeTRBaGJ4aUFvTV9ienY1cVg5V01vOEh1Sm1DYl85aG1tZ2hYUndzRExYQWpPcHBlM21GdHYxVzFCRUpL?oc=5"" target=""_blank"">Biocon Eyes Robust Growth as All Segments Gain Momentum |</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Chemical Industry Digest</font>",https://news.google.com/rss/articles/CBMiiAFBVV95cUxON1I0c3dSdEdpYURZek1IZy1JUjNwZnloaHMyTVVCaWcwd1lLREdlcUUzb1dxTGI4MHdNa29TZjludzFnWTRockNDeDBEeTRBaGJ4aUFvTV9ienY1cVg5V01vOEh1Sm1DYl85aG1tZ2hYUndzRExYQWpPcHBlM21GdHYxVzFCRUpL?oc=5,Google News,Biocon market expansion,"Biocon Eyes Robust Growth as All Segments Gain Momentum | - Chemical Industry Digest <a href=""https://news.google.com/rss/articles/CBMiiAFBVV95cUxON1I0c3dSdEdpYURZek1IZy1JUjNwZnloaHMyTVVCaWcwd1lLREdlcUUzb1dxTGI4MHdNa29TZjludzFnWTRockNDeDBEeTRBaGJ4aUFvTV9ienY1cVg5V01vOEh1Sm1DYl85aG1tZ2hYUndzRExYQWpPcHBlM21GdHYxVzFCRUpL?oc=5"" target=""_blank"">Biocon Eyes Robust Growth as All Segments Gain Momentum |</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Chemical Industry Digest</font>",0.9090374708175659,positive,0.9090374708175659,0.0,neutral,0.0,0.9413,0.444,0.0,0.556,0.0,0.0,0.5194499833243233,0.925168735408783,other,0.0,[],False,True,6,0.0
2025-03-10,2025-03-10 07:00:00,Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't - Simply Wall Street,"<a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxQdEh4cHJfSW1ZaHhyZHBFSUZCQi1ON1NGeFk0VU05dFJWU0E2Tk02aDI1TWFGdnRSNjVDQkhmb2ZLdEFXQXJrZjkzRlJmSGI4SDhJMy1Pd181X2d5bVBybndqWGJLS2J0NTJDc2szdHdlVHY4b1hGeW1lNFZGeDlzUWZhbEZKVkVqTzdfMXl4eFJyRUVIb3BpVzY0VFF2cEVSN1pBQ1hWR0VsVzAzTm1LSE9fT0F4QlJmaUNJeERiaVZlOGNYRkpUczVqZnRNSXNlZWhIeHNVUFZTaWNXNVo00gHkAUFVX3lxTE1haTBZZEczSzNISW1xLVRocnJhR0U1bGdWdzZjcVJUYndYS0JTUms3NzZxOENSMEdISFluem1pN0ljakV5d1dZUFBxTnlaUFIteVItaGFyanZPUnhUWVktWl8xNzE4NTI0MFdoR0xoVi1RWHVHbXhUOEs1NlFoaUgwQndNdUN1UFd0a3NVYkU4QnhZUThiR2Nub1NtUk1EVm9IOF8zZXcwTjdkRTFfUzRIOVF6d3Qyd1gtNGQ4WEx2WVFLMVZaemNwMmVtRjFjUGJGY0NIY1J6X0c5RVYxZ1JWNldJeg?oc=5"" target=""_blank"">Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Simply Wall Street</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't - Simply Wall Street <a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxQdEh4cHJfSW1ZaHhyZHBFSUZCQi1ON1NGeFk0VU05dFJWU0E2Tk02aDI1TWFGdnRSNjVDQkhmb2ZLdEFXQXJrZjkzRlJmSGI4SDhJMy1Pd181X2d5bVBybndqWGJLS2J0NTJDc2szdHdlVHY4b1hGeW1lNFZGeDlzUWZhbEZKVkVqTzdfMXl4eFJyRUVIb3BpVzY0VFF2cEVSN1pBQ1hWR0VsVzAzTm1LSE9fT0F4QlJmaUNJeERiaVZlOGNYRkpUczVqZnRNSXNlZWhIeHNVUFZTaWNXNVo00gHkAUFVX3lxTE1haTBZZEczSzNISW1xLVRocnJhR0U1bGdWdzZjcVJUYndYS0JTUms3NzZxOENSMEdISFluem1pN0ljakV5d1dZUFBxTnlaUFIteVItaGFyanZPUnhUWVktWl8xNzE4NTI0MFdoR0xoVi1RWHVHbXhUOEs1NlFoaUgwQndNdUN1UFd0a3NVYkU4QnhZUThiR2Nub1NtUk1EVm9IOF8zZXcwTjdkRTFfUzRIOVF6d3Qyd1gtNGQ4WEx2WVFLMVZaemNwMmVtRjFjUGJGY0NIY1J6X0c5RVYxZ1JWNldJeg?oc=5"" target=""_blank"">Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Simply Wall Street</font>",-0.5167021155357361,negative,0.5167021155357361,0.0,neutral,0.0,0.6808,0.157,0.0,0.843,-0.03571428571428571,0.1607142857142857,-0.2952583517347063,0.41107213375000734,other,0.0,[],False,True,6,0.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4 net profit surges 153%, biosimilars, generics drive growth - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 net profit surges 153%, biosimilars, generics drive growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon Q4 net profit surges 153%, biosimilars, generics drive growth - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 net profit surges 153%, biosimilars, generics drive growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.879266619682312,positive,0.879266619682312,0.0,neutral,0.0,0.8126,0.286,0.0,0.714,0.0,0.0,0.5024380683898926,0.845933309841156,other,0.0,[],False,True,6,0.0
2025-05-13,2025-05-13 11:31:34,Biocon to Invest $200 Million This Year in Growth and Expansion - IndiaMedToday,"<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxORENXejRyMEVWVm1lOGtCenU1amV2LVBTTkJyWVZ1TE5RVnY3WHdkMWdFcEdCYW84d1hFeDFHem1uMFlsenYyZ0ZtVFlwb2lUTFl6NHJLWGNLQ1JSSUtZZ1E0cm1FNUhKMXprNk9UQWUxMi1ReVNVamtENHVFSzJGd2ZycHVJT1gyYmZsOTUyUzEwVkk?oc=5"" target=""_blank"">Biocon to Invest $200 Million This Year in Growth and Expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IndiaMedToday</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxORENXejRyMEVWVm1lOGtCenU1amV2LVBTTkJyWVZ1TE5RVnY3WHdkMWdFcEdCYW84d1hFeDFHem1uMFlsenYyZ0ZtVFlwb2lUTFl6NHJLWGNLQ1JSSUtZZ1E0cm1FNUhKMXprNk9UQWUxMi1ReVNVamtENHVFSzJGd2ZycHVJT1gyYmZsOTUyUzEwVkk?oc=5,Google News,Biocon market expansion,"Biocon to Invest $200 Million This Year in Growth and Expansion - IndiaMedToday <a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxORENXejRyMEVWVm1lOGtCenU1amV2LVBTTkJyWVZ1TE5RVnY3WHdkMWdFcEdCYW84d1hFeDFHem1uMFlsenYyZ0ZtVFlwb2lUTFl6NHJLWGNLQ1JSSUtZZ1E0cm1FNUhKMXprNk9UQWUxMi1ReVNVamtENHVFSzJGd2ZycHVJT1gyYmZsOTUyUzEwVkk?oc=5"" target=""_blank"">Biocon to Invest $200 Million This Year in Growth and Expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IndiaMedToday</font>",0.5446547269821167,positive,0.5446547269821167,0.0,neutral,0.0,0.6369,0.178,0.0,0.822,0.0,0.0,0.3112312725612095,0.5907773634910584,other,0.0,[],False,True,6,0.0
2025-03-06,2025-03-06 08:00:00,Biocon Biologics partners with Civica to expand Insulin Aspart access in United States - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi4gFBVV95cUxQeHlHRmZrcGl0UDNpZEhfSGZiUUFtc3FEb2JLR1hVcnczeXVWclo0VXBfY3VZdUNKaXRHNkppR216MXdfcWFsZnlKWEZkMHF6YWExWkVJcVZjQVpLX1cwcDBXNFVwcnJ2OUgyZG1KOWVYSmI3US1Ra0p0WlI0U1htTUoyUjR5NUpNRFRpR0oyaGVNMDVWNE9FTmltYU15VXlJVFBxanFLWmlOcHdVOFlPbjRlZ1FDcHJRZzRGVmd2dVdDQmtLS1FQRkg4LUhsc3ZleFQtRDg1S1BabnF1ZHlKWlhR?oc=5"" target=""_blank"">Biocon Biologics partners with Civica to expand Insulin Aspart access in United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi4gFBVV95cUxQeHlHRmZrcGl0UDNpZEhfSGZiUUFtc3FEb2JLR1hVcnczeXVWclo0VXBfY3VZdUNKaXRHNkppR216MXdfcWFsZnlKWEZkMHF6YWExWkVJcVZjQVpLX1cwcDBXNFVwcnJ2OUgyZG1KOWVYSmI3US1Ra0p0WlI0U1htTUoyUjR5NUpNRFRpR0oyaGVNMDVWNE9FTmltYU15VXlJVFBxanFLWmlOcHdVOFlPbjRlZ1FDcHJRZzRGVmd2dVdDQmtLS1FQRkg4LUhsc3ZleFQtRDg1S1BabnF1ZHlKWlhR?oc=5,Google News,Biocon market expansion,"Biocon Biologics partners with Civica to expand Insulin Aspart access in United States - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi4gFBVV95cUxQeHlHRmZrcGl0UDNpZEhfSGZiUUFtc3FEb2JLR1hVcnczeXVWclo0VXBfY3VZdUNKaXRHNkppR216MXdfcWFsZnlKWEZkMHF6YWExWkVJcVZjQVpLX1cwcDBXNFVwcnJ2OUgyZG1KOWVYSmI3US1Ra0p0WlI0U1htTUoyUjR5NUpNRFRpR0oyaGVNMDVWNE9FTmltYU15VXlJVFBxanFLWmlOcHdVOFlPbjRlZ1FDcHJRZzRGVmd2dVdDQmtLS1FQRkg4LUhsc3ZleFQtRDg1S1BabnF1ZHlKWlhR?oc=5"" target=""_blank"">Biocon Biologics partners with Civica to expand Insulin Aspart access in United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.7986224293708801,positive,0.7986224293708801,0.0,neutral,0.0,0.8481,0.282,0.0,0.718,0.0,0.0,0.45635567392621723,0.8233612146854401,other,0.0,[],False,True,6,0.0
2025-02-11,2025-02-11 08:00:00,Biocon's growth formula: Generics & biosimilars - Times of India,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's growth formula: Generics & biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon's growth formula: Generics & biosimilars - Times of India <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's growth formula: Generics & biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",0.0,neutral,0.8768486976623535,0.0,neutral,0.0,0.6369,0.245,0.0,0.755,0.0,0.0,0.0,0.7568743488311768,other,0.0,[],False,True,6,0.0
2025-05-14,2025-05-14 07:00:00,Biocon Unveils Investment Plan to Drive Growth | - Chemical Industry Digest,"<a href=""https://news.google.com/rss/articles/CBMifEFVX3lxTE1fWlhuZUZPUlZROTc3UVVtdlVlVm1zZkJfdHJUU2VZNkdoSF9OMXZqMHFMdThSRmJqQ0c2WVh3V0daaGxPZlJEeDRHNVRjUUh6cU45Rkg4SFppa1lLandXSEhvc0dQS0hEZmE3RjBTY2hHYUlFbjBWeGtocjc?oc=5"" target=""_blank"">Biocon Unveils Investment Plan to Drive Growth |</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Chemical Industry Digest</font>",https://news.google.com/rss/articles/CBMifEFVX3lxTE1fWlhuZUZPUlZROTc3UVVtdlVlVm1zZkJfdHJUU2VZNkdoSF9OMXZqMHFMdThSRmJqQ0c2WVh3V0daaGxPZlJEeDRHNVRjUUh6cU45Rkg4SFppa1lLandXSEhvc0dQS0hEZmE3RjBTY2hHYUlFbjBWeGtocjc?oc=5,Google News,Biocon market expansion,"Biocon Unveils Investment Plan to Drive Growth | - Chemical Industry Digest <a href=""https://news.google.com/rss/articles/CBMifEFVX3lxTE1fWlhuZUZPUlZROTc3UVVtdlVlVm1zZkJfdHJUU2VZNkdoSF9OMXZqMHFMdThSRmJqQ0c2WVh3V0daaGxPZlJEeDRHNVRjUUh6cU45Rkg4SFppa1lLandXSEhvc0dQS0hEZmE3RjBTY2hHYUlFbjBWeGtocjc?oc=5"" target=""_blank"">Biocon Unveils Investment Plan to Drive Growth |</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Chemical Industry Digest</font>",0.5563342571258545,positive,0.5563342571258545,0.0,neutral,0.0,0.6369,0.198,0.0,0.802,0.0,0.0,0.3179052897862025,0.5966171285629273,other,0.0,[],False,True,6,0.0
2025-03-04,2025-03-04 08:00:00,Biocon targets mid-teen revenue growth with new product pipeline - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon targets mid-teen revenue growth with new product pipeline</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon targets mid-teen revenue growth with new product pipeline - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon targets mid-teen revenue growth with new product pipeline</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.6426068544387817,0.0,neutral,0.0,0.6369,0.191,0.0,0.809,0.0909090909090909,0.30303030303030304,0.0,0.4568053151159575,other,0.0,[],False,True,6,0.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5"" target=""_blank"">Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5,Google News,Biocon market expansion,"Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5"" target=""_blank"">Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.9489234089851379,positive,0.9489234089851379,0.0,neutral,0.0,0.7003,0.112,0.0,0.888,0.0,0.0,0.5422419479915074,0.8246117044925689,other,0.0,[],False,True,6,0.0
2025-05-13,2025-05-13 07:00:00,Trump’s drug pricing order boosts case for generics and biosimilars: Kiran Mazumdar-Shaw - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi4gFBVV95cUxQWHpWazU3VXpiTzdYUlEtcnBoSVhHb2VwT0pXOTNPTHJCMV94cHVDb2JUZ0lvOGI5OGRXd1Q1T0F4bXhhZU5fY1gtem4zN0RwbjBuUnJXN2w3V3hUSGZ2RmlOdGQwUkxBemxOOTFvSDhXbERVbk54VE8xTjZ1WWJzRU9VRjNiQlJWcXRmWTViMUJGTHEyb0ZYNDczRHFDM2FlWFhiUDcya2Vidm5ya1hTZEY0ajdySVZHOGFScXl3OFRNNXpiSzFrcTRDTkdWY1RqMlBsS0JRY2xCc3ZLaTlaYjRn?oc=5"" target=""_blank"">Trump’s drug pricing order boosts case for generics and biosimilars: Kiran Mazumdar-Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi4gFBVV95cUxQWHpWazU3VXpiTzdYUlEtcnBoSVhHb2VwT0pXOTNPTHJCMV94cHVDb2JUZ0lvOGI5OGRXd1Q1T0F4bXhhZU5fY1gtem4zN0RwbjBuUnJXN2w3V3hUSGZ2RmlOdGQwUkxBemxOOTFvSDhXbERVbk54VE8xTjZ1WWJzRU9VRjNiQlJWcXRmWTViMUJGTHEyb0ZYNDczRHFDM2FlWFhiUDcya2Vidm5ya1hTZEY0ajdySVZHOGFScXl3OFRNNXpiSzFrcTRDTkdWY1RqMlBsS0JRY2xCc3ZLaTlaYjRn?oc=5,Google News,Biocon market expansion,"Trump’s drug pricing order boosts case for generics and biosimilars: Kiran Mazumdar-Shaw - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi4gFBVV95cUxQWHpWazU3VXpiTzdYUlEtcnBoSVhHb2VwT0pXOTNPTHJCMV94cHVDb2JUZ0lvOGI5OGRXd1Q1T0F4bXhhZU5fY1gtem4zN0RwbjBuUnJXN2w3V3hUSGZ2RmlOdGQwUkxBemxOOTFvSDhXbERVbk54VE8xTjZ1WWJzRU9VRjNiQlJWcXRmWTViMUJGTHEyb0ZYNDczRHFDM2FlWFhiUDcya2Vidm5ya1hTZEY0ajdySVZHOGFScXl3OFRNNXpiSzFrcTRDTkdWY1RqMlBsS0JRY2xCc3ZLaTlaYjRn?oc=5"" target=""_blank"">Trump’s drug pricing order boosts case for generics and biosimilars: Kiran Mazumdar-Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.9171497821807861,positive,0.9171497821807861,0.0,neutral,0.0,0.5574,0.15,0.0,0.85,0.0,0.0,0.524085589817592,0.737274891090393,other,0.0,[],False,True,6,0.0
2024-08-09,2024-08-09 07:00:00,"Biocon plans to expand margins to 25%, led by new products and markets: Group CEO Peter Bains - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon plans to expand margins to 25%, led by new products and markets: Group CEO Peter Bains</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon plans to expand margins to 25%, led by new products and markets: Group CEO Peter Bains - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon plans to expand margins to 25%, led by new products and markets: Group CEO Peter Bains</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.9307122230529785,positive,0.9307122230529785,0.0,neutral,0.0,0.5574,0.113,0.0,0.887,0.0909090909090909,0.30303030303030304,0.5318355560302734,0.5263404379873564,other,0.0,[],False,True,6,0.0
2024-11-08,2024-11-08 08:00:00,Not anticipating any immediate impact on our business due to US election result: Biocon CEO - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Not anticipating any immediate impact on our business due to US election result: Biocon CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxPQnprRXY4UnFONGNpcXZiYV9vdVEwTzNoYUhCTlAzNjdwaU1OSWRwUGxIck9QcVhRNzFtQzlZVnE5bUlGSkdRMEt5WDBRTVhwN1V6dl92ZjYzRkQ0dGxvdjFralNJRmJ1TmRCMDdpYjY4eWFlSkU4dW9GeWRna1pLbmdZQU5IT3NlM0JzM2gyRUhjX3gtcnd5aXlZUVFZNml1V2lGa0VhbnBEQkxfQTlyZDNud3FBcV8tSmxITEFOM3Q3cXNWaDlNdFVXaTZ0VnRoLV9IZ0N0N1RhbUMwdzlnRNIB5gFBVV95cUxNeGlJc1NoWWhBMi02aDk0T0JvQl9EYjkzTzdpRGhSV3FGSXRxOTVyNlVwMm5obFVGUEtEczY0OWJkcFh2Z0hvRHJTZEdXRDAxSXVEN0FKalFBRE9fbV9JWjRuTUdZLTExVnlyamZDRDk3Z0Q2amQwQy1xUFZSTEtqN0hXck12bHo0cFkwZWMxTVNJNVNQU29nRGNYb2taODJtS0NTT016SGV6eUlqVlJFYkVqTm85REI1TFZTOEFKSlVPSmFzMlhhR2xDVHB5R3M3MnhZWkg0RVQtSG5uUDhyRkRfeGJzUQ?oc=5,Google News,Biocon market expansion,"Not anticipating any immediate impact on our business due to US election result: Biocon CEO - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Not anticipating any immediate impact on our business due to US election result: Biocon CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.9267429113388062,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.08333333333333333,0.25,0.0,0.5050381223360697,other,0.0,[],False,True,6,0.0
2024-09-12,2024-09-12 07:00:00,"'I’ve built this business to last, not for sale', says Biocon's Kiran Mazumdar-Shaw on sellout rumours - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxQcXFBNGtJNW1KSUpfNFotekoxR200OG50eHVIaGVtMUtibDBON1NyUDJLNzZtZlowVzFqN3psajlydW0weEd3WWYwdGxPWE5CWW9XZmNlZkw0ZWFMVzF4b3R4UWxHSEluMktWNTBycWVycTlGVFZILWczUTdMUEhUQWRhTFFPMnhRQWRvYlljUUxwNTYyRDhQa2cyOWtxTko5SVpGUEgycGtrRVRBYkpDWjJvM0dMdzlERGJ5TU5JYm9icE9laWZ3OF9JaDhPS29aYlN1YW5QT19HYy1tU1Nv0gHkAUFVX3lxTE81Z0FaUzNscWZfOVA5NVhOemJwZUlqWm5aWkRnV2lWRXdrdXJ6OGNub2I3cmlGR3ZHZXdteE5aejFHVWFRZFpOOTJvTGZPcEpvVHVYMEtWZHAzblRXalMwaXFHY0I3ZGNaVTEzWmJvYTFzUjVRN1B3STExX1dTNERfMEJmZXFUSkNOQVI5YVJkLXFvX1NvZWJTejd5cFl1STZ3SlY1YTg0SXlkUnFHYWxVb2g4cFB5cHNlOFZEdmV1SDllMmVrdl9HYmJjdk1YQXRmNEMyNG5XX200LTk4SHhYMzNfeA?oc=5"" target=""_blank"">'I’ve built this business to last, not for sale', says Biocon's Kiran Mazumdar-Shaw on sellout rumours</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"'I’ve built this business to last, not for sale', says Biocon's Kiran Mazumdar-Shaw on sellout rumours - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">'I’ve built this business to last, not for sale', says Biocon's Kiran Mazumdar-Shaw on sellout rumours</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.720283567905426,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.044444444444444446,0.0,0.720283567905426,other,0.0,[],False,True,6,0.0
2025-01-07,2025-01-07 08:00:00,Biocon Biologics Is Committed To Business Development In Malaysia - PM Anwar - Bernama,"<a href=""https://news.google.com/rss/articles/CBMiWkFVX3lxTE9LWTN2S0h5R1NUQWpaZHpXUnBEZmZVbmp1WXpZaU1WdV9DZ3VOU2dpMi1kT3JlTEo2OGxSVGR1cllhOWY1Sm1IS0VyNER2eUw4VzBoNEgxdXFmUQ?oc=5"" target=""_blank"">Biocon Biologics Is Committed To Business Development In Malaysia - PM Anwar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Bernama</font>",https://news.google.com/rss/articles/CBMiWkFVX3lxTE9LWTN2S0h5R1NUQWpaZHpXUnBEZmZVbmp1WXpZaU1WdV9DZ3VOU2dpMi1kT3JlTEo2OGxSVGR1cllhOWY1Sm1IS0VyNER2eUw4VzBoNEgxdXFmUQ?oc=5,Google News,Biocon market expansion,"Biocon Biologics Is Committed To Business Development In Malaysia - PM Anwar - Bernama <a href=""https://news.google.com/rss/articles/CBMiWkFVX3lxTE9LWTN2S0h5R1NUQWpaZHpXUnBEZmZVbmp1WXpZaU1WdV9DZ3VOU2dpMi1kT3JlTEo2OGxSVGR1cllhOWY1Sm1IS0VyNER2eUw4VzBoNEgxdXFmUQ?oc=5"" target=""_blank"">Biocon Biologics Is Committed To Business Development In Malaysia - PM Anwar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Bernama</font>",0.0,neutral,0.8625332117080688,0.0,neutral,0.0,0.4939,0.149,0.0,0.851,0.0,0.0,0.0,0.6782166058540344,other,0.0,[],False,True,6,0.0
2024-12-02,2024-12-02 08:00:00,Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5"" target=""_blank"">Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5,Google News,Biocon market expansion,"Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels - topnews.in <a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5"" target=""_blank"">Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",0.9212486147880554,positive,0.9212486147880554,0.0,neutral,0.0,0.8625,0.275,0.0,0.725,0.0,0.06666666666666667,0.5264277798788888,0.8918743073940277,approval_process,0.7271521091461182,['FDA approval'],False,True,16,0.45430421829223633
2023-09-06,2023-09-06 07:00:00,"Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMipAJBVV95cUxONkplbm56SHNtcElRSWN3cnpqMWo0MnZTc2dBcDcxSV9iNlFIZFFCbjV5dm42Sjd2cDVSclFvNHpJNTRMU3o0Wm1uYVFpV2VQZDN6SWtrTkpjcnpma0FSR1ByaXZHcVllM0VOdlF0RXhYSTBFSFd6VGUwaVlkQUduRkNuSUtDQ0RsbGdSUTBwelpoYTdwVGV6d1dob2NxWmRJMjYwZXJVVWZObTFHRzZKNWhZX0h2VFZZclJ5Yk14VndFZVRqSF9OWGdJaUNvYkZqS1hsNTVUbFVVVVBGWTgxMHNrclhDeC1fQlF4V3pwQ09JR0pVLWNlYV95dlAtU2V4ajl6M09ZRGxMMnFUYUozVHNSeVVwQXJFRzd6b0ZhRG1GWFg3?oc=5"" target=""_blank"">Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMipAJBVV95cUxONkplbm56SHNtcElRSWN3cnpqMWo0MnZTc2dBcDcxSV9iNlFIZFFCbjV5dm42Sjd2cDVSclFvNHpJNTRMU3o0Wm1uYVFpV2VQZDN6SWtrTkpjcnpma0FSR1ByaXZHcVllM0VOdlF0RXhYSTBFSFd6VGUwaVlkQUduRkNuSUtDQ0RsbGdSUTBwelpoYTdwVGV6d1dob2NxWmRJMjYwZXJVVWZObTFHRzZKNWhZX0h2VFZZclJ5Yk14VndFZVRqSF9OWGdJaUNvYkZqS1hsNTVUbFVVVVBGWTgxMHNrclhDeC1fQlF4V3pwQ09JR0pVLWNlYV95dlAtU2V4ajl6M09ZRGxMMnFUYUozVHNSeVVwQXJFRzd6b0ZhRG1GWFg3?oc=5,Google News,Biocon market expansion,"Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule - PR Newswire <a href=""https://news.google.com/rss/articles/CBMipAJBVV95cUxONkplbm56SHNtcElRSWN3cnpqMWo0MnZTc2dBcDcxSV9iNlFIZFFCbjV5dm42Sjd2cDVSclFvNHpJNTRMU3o0Wm1uYVFpV2VQZDN6SWtrTkpjcnpma0FSR1ByaXZHcVllM0VOdlF0RXhYSTBFSFd6VGUwaVlkQUduRkNuSUtDQ0RsbGdSUTBwelpoYTdwVGV6d1dob2NxWmRJMjYwZXJVVWZObTFHRzZKNWhZX0h2VFZZclJ5Yk14VndFZVRqSF9OWGdJaUNvYkZqS1hsNTVUbFVVVVBGWTgxMHNrclhDeC1fQlF4V3pwQ09JR0pVLWNlYV95dlAtU2V4ajl6M09ZRGxMMnFUYUozVHNSeVVwQXJFRzd6b0ZhRG1GWFg3?oc=5"" target=""_blank"">Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.6634714603424072,positive,0.6634714603424072,0.0,neutral,0.0,0.5574,0.099,0.0,0.901,0.0,0.0,0.37912654876708984,0.6104357301712036,other,0.0,[],False,True,6,0.0
2024-08-30,2024-08-30 07:00:00,Akums Drugs strengthens global presence with European market expansion - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Akums Drugs strengthens global presence with European market expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi1gFBVV95cUxOajA0YTZkMlZ0b1NUYk1PT1ZoaVJrZHduZFp5M1FScnMtMnlJeE1tTUg4N2lwLTJ2bGpoUW1oQ0ZTUXhaS3BuUWl3Tzkta2pQRTZTTnpMSVhiamcyQ3ZibjZueWJjSFlyTzlLaEtZUEtYaWpNT09qSW1uMG9uTUgwVWhMaXdmSUdISFliOXVzNVRlSXdfRGZteDNfODA1YjlPWmxOM183ZlRnaldqS2F1MWlPN0FVa1gwU3RlWmZGbGFhZHBlTUIzbXNQeUxkblBqWGJfbVdB0gHbAUFVX3lxTE9tU3NxemJUMl9odkwxWjhYN2s2eHl3bmpNUDlsclUzS1l3M25Na2NESnZwaUt2M2FpczNxUTBERjlvbmQyeHlKZHcwSXo5eTNsRUNtMmR1VjMwVUlQRXdGUEJxSE53WjJBellxWEFOaUlZUVZtVFlDMHFlMWRmLXh4RE1qYTJHdnVwODM3ZzRmdlE3Vk10akJnaF9JMnlyWEJnVDM5SXg3NlRubFdFcV9HeGIxUmt1SUZpR2lhcTZtWXVmSzZkT1duM20yZk1KRkQ1QnliRzdPa0M5OA?oc=5,Google News,Biocon market expansion,"Akums Drugs strengthens global presence with European market expansion - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Akums Drugs strengthens global presence with European market expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9094298481941223,positive,0.9094298481941223,0.0,neutral,0.0,0.7184,0.214,0.0,0.786,0.0,0.0,0.5196741989680699,0.8139149240970611,post_approval,0.5041160464286805,['market expansion'],False,False,7,0.40823209285736084
2023-09-19,2023-09-19 07:00:00,Biocon's Peter Bains jumps from the board to group CEO amid company's expansion push - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxNU0FKNHRpaWJFTFJLRGhfOUxHY2hlNnJYR0hVQ0pTQTR1Q0IxUTZjanpnUUludVRWY2NVWDVQQnNTRHJ4VHEtdlhDRGpzUFJrYWJHQ2NuZmI3VU1tUHJyRmctY1Btbl84WWpiR2tObXJMWDVzY0F3a0x3X2l6T3R1Z2xVZGdYZEFQREdkQzAyVUJZM0RuTE8w?oc=5"" target=""_blank"">Biocon's Peter Bains jumps from the board to group CEO amid company's expansion push</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxNU0FKNHRpaWJFTFJLRGhfOUxHY2hlNnJYR0hVQ0pTQTR1Q0IxUTZjanpnUUludVRWY2NVWDVQQnNTRHJ4VHEtdlhDRGpzUFJrYWJHQ2NuZmI3VU1tUHJyRmctY1Btbl84WWpiR2tObXJMWDVzY0F3a0x3X2l6T3R1Z2xVZGdYZEFQREdkQzAyVUJZM0RuTE8w?oc=5,Google News,Biocon market expansion,"Biocon's Peter Bains jumps from the board to group CEO amid company's expansion push - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxNU0FKNHRpaWJFTFJLRGhfOUxHY2hlNnJYR0hVQ0pTQTR1Q0IxUTZjanpnUUludVRWY2NVWDVQQnNTRHJ4VHEtdlhDRGpzUFJrYWJHQ2NuZmI3VU1tUHJyRmctY1Btbl84WWpiR2tObXJMWDVzY0F3a0x3X2l6T3R1Z2xVZGdYZEFQREdkQzAyVUJZM0RuTE8w?oc=5"" target=""_blank"">Biocon's Peter Bains jumps from the board to group CEO amid company's expansion push</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.4826860725879669,positive,0.4826860725879669,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.27582061290740967,0.4826860725879669,other,0.0,[],False,True,6,0.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5"" target=""_blank"">Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5,Google News,Biocon market expansion,"Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153% - Biocon <a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5"" target=""_blank"">Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.949874758720398,positive,0.949874758720398,0.0,neutral,0.0,0.7003,0.104,0.0,0.896,0.0,0.0,0.5427855764116559,0.8250873793601989,other,0.0,[],False,True,6,0.0
2025-06-27,2025-06-27 07:00:23,Rethinking the Future: Nasopharyngeal Cancer Market Expansion - openPR.com,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPTFRzcF9zdTBlaFl3TG52aEI0Z2JzTDJROEFHLWxWTHZwYk14YUJSbFpYblZDMmlQbE1aN1hnR25wY1hWRnpGU0pkZUxLUmlpdVpBNFJ5TVVSOHdoZUc4cy1jd2lIZFdPc3FWZkUyakVoM0RkUjNEaGtTTmlBZGRiNmRmeHFyY09sd1R0VkN4NUNRbHlfZzVBY1JVM04?oc=5"" target=""_blank"">Rethinking the Future: Nasopharyngeal Cancer Market Expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxPTFRzcF9zdTBlaFl3TG52aEI0Z2JzTDJROEFHLWxWTHZwYk14YUJSbFpYblZDMmlQbE1aN1hnR25wY1hWRnpGU0pkZUxLUmlpdVpBNFJ5TVVSOHdoZUc4cy1jd2lIZFdPc3FWZkUyakVoM0RkUjNEaGtTTmlBZGRiNmRmeHFyY09sd1R0VkN4NUNRbHlfZzVBY1JVM04?oc=5,Google News,Biocon market expansion,"Rethinking the Future: Nasopharyngeal Cancer Market Expansion - openPR.com <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPTFRzcF9zdTBlaFl3TG52aEI0Z2JzTDJROEFHLWxWTHZwYk14YUJSbFpYblZDMmlQbE1aN1hnR25wY1hWRnpGU0pkZUxLUmlpdVpBNFJ5TVVSOHdoZUc4cy1jd2lIZFdPc3FWZkUyakVoM0RkUjNEaGtTTmlBZGRiNmRmeHFyY09sd1R0VkN4NUNRbHlfZzVBY1JVM04?oc=5"" target=""_blank"">Rethinking the Future: Nasopharyngeal Cancer Market Expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",0.0,neutral,0.8748514652252197,0.0,neutral,0.0,-0.8689,0.0,0.355,0.645,0.0,0.08333333333333333,0.0,0.8718757326126099,post_approval,0.517023327946663,['market expansion'],False,False,7,0.4340466558933258
2021-03-02,2021-03-02 08:00:00,Biocon Biologics Appoints Susheel Umesh as Chief Commercial Officer for Emerging Markets - Biocon,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxQM3htejltal9CT29oYmlhVWNyTGYzUTVEaTFDdllsTy02VlhSdzI4TENUeTF2cGhFdVpVTXlHVEdQRjFLZjlRVHkyN1pyNmVXQTVUUjExV3ZuVFVXOHVycXdEaUpkV09HMDFKRFFsWUV6ZjBpWlFTOENDNUQ2Sk9Rb1dmX3BZUHliRVVVNl8xa3QzMnFoOHZNcVgxemNkLS1BMUFHQlA3Qm82T045Z1hMRFhR?oc=5"" target=""_blank"">Biocon Biologics Appoints Susheel Umesh as Chief Commercial Officer for Emerging Markets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxQM3htejltal9CT29oYmlhVWNyTGYzUTVEaTFDdllsTy02VlhSdzI4TENUeTF2cGhFdVpVTXlHVEdQRjFLZjlRVHkyN1pyNmVXQTVUUjExV3ZuVFVXOHVycXdEaUpkV09HMDFKRFFsWUV6ZjBpWlFTOENDNUQ2Sk9Rb1dmX3BZUHliRVVVNl8xa3QzMnFoOHZNcVgxemNkLS1BMUFHQlA3Qm82T045Z1hMRFhR?oc=5,Google News,Biocon market expansion,"Biocon Biologics Appoints Susheel Umesh as Chief Commercial Officer for Emerging Markets - Biocon <a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxQM3htejltal9CT29oYmlhVWNyTGYzUTVEaTFDdllsTy02VlhSdzI4TENUeTF2cGhFdVpVTXlHVEdQRjFLZjlRVHkyN1pyNmVXQTVUUjExV3ZuVFVXOHVycXdEaUpkV09HMDFKRFFsWUV6ZjBpWlFTOENDNUQ2Sk9Rb1dmX3BZUHliRVVVNl8xa3QzMnFoOHZNcVgxemNkLS1BMUFHQlA3Qm82T045Z1hMRFhR?oc=5"" target=""_blank"">Biocon Biologics Appoints Susheel Umesh as Chief Commercial Officer for Emerging Markets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",0.0,neutral,0.9070730805397034,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9070730805397034,other,0.0,[],False,True,6,0.0
2024-08-28,2024-08-28 07:00:00,Annatto Global Market Research Report 2023-2030 with Focus - GlobeNewswire,"<a href=""https://news.google.com/rss/articles/CBMi0AJBVV95cUxNcV9qVTR5c25jdWV5VnR3eWpNaTAwRi10OWpmUUhIbXN1OUdqczQxQWl5MmMtTmZTTUVMMURyV0JuSExOMTROZDVxVlJsdEpkWFVuZmRTWmFLb1FWYXpUYThvMk41TEhVazZCQnQ4TkZpSGFiYVY4bUFfVHZISFNvaEljbURzeVlLTHpVUmNVUTFuT3BaVnlhdlFRSFpOMW1xMHdWNE8xUUtfRnVHenVnWUlla2JMaVFQVFZuQ1BraW5pZV9HaHM4Q2syeUhrXzlKV0Y3OXNHNEFGeEFJX2pWdm5Sa3BXQkoyNVNCQk4wWl9DdVA3SkhkWjlxM05mR25Ma3h2SE5nYUNYUjJxdngzVjJnRlNjY3EyRUJJYW1xWEVZWmZqT1NKS05ldXRVNkZOaHc1S3BIbnQ0UFVwSFIyX091T041eGVZaFhRQVU4ZFk?oc=5"" target=""_blank"">Annatto Global Market Research Report 2023-2030 with Focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">GlobeNewswire</font>",https://news.google.com/rss/articles/CBMi0AJBVV95cUxNcV9qVTR5c25jdWV5VnR3eWpNaTAwRi10OWpmUUhIbXN1OUdqczQxQWl5MmMtTmZTTUVMMURyV0JuSExOMTROZDVxVlJsdEpkWFVuZmRTWmFLb1FWYXpUYThvMk41TEhVazZCQnQ4TkZpSGFiYVY4bUFfVHZISFNvaEljbURzeVlLTHpVUmNVUTFuT3BaVnlhdlFRSFpOMW1xMHdWNE8xUUtfRnVHenVnWUlla2JMaVFQVFZuQ1BraW5pZV9HaHM4Q2syeUhrXzlKV0Y3OXNHNEFGeEFJX2pWdm5Sa3BXQkoyNVNCQk4wWl9DdVA3SkhkWjlxM05mR25Ma3h2SE5nYUNYUjJxdngzVjJnRlNjY3EyRUJJYW1xWEVZWmZqT1NKS05ldXRVNkZOaHc1S3BIbnQ0UFVwSFIyX091T041eGVZaFhRQVU4ZFk?oc=5,Google News,Biocon market expansion,"Annatto Global Market Research Report 2023-2030 with Focus - GlobeNewswire <a href=""https://news.google.com/rss/articles/CBMi0AJBVV95cUxNcV9qVTR5c25jdWV5VnR3eWpNaTAwRi10OWpmUUhIbXN1OUdqczQxQWl5MmMtTmZTTUVMMURyV0JuSExOMTROZDVxVlJsdEpkWFVuZmRTWmFLb1FWYXpUYThvMk41TEhVazZCQnQ4TkZpSGFiYVY4bUFfVHZISFNvaEljbURzeVlLTHpVUmNVUTFuT3BaVnlhdlFRSFpOMW1xMHdWNE8xUUtfRnVHenVnWUlla2JMaVFQVFZuQ1BraW5pZV9HaHM4Q2syeUhrXzlKV0Y3OXNHNEFGeEFJX2pWdm5Sa3BXQkoyNVNCQk4wWl9DdVA3SkhkWjlxM05mR25Ma3h2SE5nYUNYUjJxdngzVjJnRlNjY3EyRUJJYW1xWEVZWmZqT1NKS05ldXRVNkZOaHc1S3BIbnQ0UFVwSFIyX091T041eGVZaFhRQVU4ZFk?oc=5"" target=""_blank"">Annatto Global Market Research Report 2023-2030 with Focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">GlobeNewswire</font>",0.0,neutral,0.93343585729599,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.93343585729599,other,0.0,[],False,False,1,0.0
2025-06-26,2025-06-26 11:08:12,"Type 1 Diabetes Market Projected To Witness Massive Growth, - openPR.com","<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxPMzhHT3QxaWxlZGtLc1FvZXhaWDV5ZWk1WmtnSzJTeDdnZTdCaGg3bEE5d2xYUUhmdGxPTGU5cFNxc3FfZVlxZUU0S0xaWW9TSEhBa2h1bkJvbE9sRjJrZERUX1Q3LWlaRDRzOXlyQVhYbGl6WDg0azdDVjJhaFRKQlFhVjlJb0RGVW81TjhwYk1SRDNwR0lNU2Nn?oc=5"" target=""_blank"">Type 1 Diabetes Market Projected To Witness Massive Growth,</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxPMzhHT3QxaWxlZGtLc1FvZXhaWDV5ZWk1WmtnSzJTeDdnZTdCaGg3bEE5d2xYUUhmdGxPTGU5cFNxc3FfZVlxZUU0S0xaWW9TSEhBa2h1bkJvbE9sRjJrZERUX1Q3LWlaRDRzOXlyQVhYbGl6WDg0azdDVjJhaFRKQlFhVjlJb0RGVW81TjhwYk1SRDNwR0lNU2Nn?oc=5,Google News,Biocon market expansion,"Type 1 Diabetes Market Projected To Witness Massive Growth, - openPR.com <a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxPMzhHT3QxaWxlZGtLc1FvZXhaWDV5ZWk1WmtnSzJTeDdnZTdCaGg3bEE5d2xYUUhmdGxPTGU5cFNxc3FfZVlxZUU0S0xaWW9TSEhBa2h1bkJvbE9sRjJrZERUX1Q3LWlaRDRzOXlyQVhYbGl6WDg0azdDVjJhaFRKQlFhVjlJb0RGVW81TjhwYk1SRDNwR0lNU2Nn?oc=5"" target=""_blank"">Type 1 Diabetes Market Projected To Witness Massive Growth,</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",0.6835933327674866,positive,0.6835933327674866,0.0,neutral,0.0,0.3818,0.12,0.0,0.88,0.0,0.6666666666666666,0.3906247615814209,0.5326966663837432,other,0.0,[],False,False,1,0.0
2025-04-15,2025-04-15 07:00:00,"Biocon Biologics signs deal, gets market entry for Yesafili in US by 2026 - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics signs deal, gets market entry for Yesafili in US by 2026</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon Biologics signs deal, gets market entry for Yesafili in US by 2026 - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics signs deal, gets market entry for Yesafili in US by 2026</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.7683285474777222,positive,0.7683285474777222,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.4390448842729841,0.7683285474777222,other,0.0,[],False,True,6,0.0
2025-03-07,2025-03-07 08:00:00,Dental Implant Market Forecast Report and Company Analysis - GlobeNewswire,"<a href=""https://news.google.com/rss/articles/CBMi7wJBVV95cUxOX1ZEbW9HSG9LU0JoX1ZwZW9Vdy1WZWN0dkV6S2VGS3lTY28yU1Q2YkNqdnhBMWIwX1NsZGl6eC1paEVobDRRbk9RV3puUXBUaEdzS21VeHJlaHd2RktYMWFoQjdzMXhxMnJ2bGRqRHNmaTNDakg5aUVycFB6Um0xZndaMEZqMlhoT3VRa1d2eGh0dm5Nb3JpRWNVUlVXaG5xRm9QMEx4UWdUZ21Gc2MzbnRxQXo0OEVMU05TZU1mdXd5WnBUQ3AxNWQwT25uYkpmdG16UVhfeWZiX1RvLVdIT1VRWVBCenlBODNhYkNxY2lNNVJaOEdWcHZYNEt5eTAyTXhEZURfVU1yTjUxdFpfQVBSeEJrRXlRWXFtYXVmN3JuTmpOWkgydXpTQnlzZ2p3a2t2WVVXWW4ycUR3YUIyTjJFYm5YTEFDbjNHaDdDd1U5SmFQUnEwY1A3cC0zU1JDY1NrcWVZM2dhNTUyM1lV?oc=5"" target=""_blank"">Dental Implant Market Forecast Report and Company Analysis</a>&nbsp;&nbsp;<font color=""#6f6f6f"">GlobeNewswire</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Dental Implant Market Forecast Report and Company Analysis - GlobeNewswire <a href=""https://news.google.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?oc=5"" target=""_blank"">Dental Implant Market Forecast Report and Company Analysis</a>&nbsp;&nbsp;<font color=""#6f6f6f"">GlobeNewswire</font>",0.0,neutral,0.9386847615242004,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9386847615242004,other,0.0,[],False,False,1,0.0
2025-02-28,2025-02-28 06:34:02,Enduring Appeal of Japan's Healthcare Sector for Global Business - jetro.go.jp,"<a href=""https://news.google.com/rss/articles/CBMif0FVX3lxTE9BSndfWTktX1NlTnVvS3dPdFROSXRuaVQ5bXdUY0lkcnpTbWVMMXdIWV8yamxUV0tIM21JSWlrNTNZQnVNUHNOWXBEanB3dHZiVk94ZDllRVpuaVBKZmtMSG9CVEJiLU83a19yQW1mX2UzbnYzekRfSXVhM1ZONFk?oc=5"" target=""_blank"">Enduring Appeal of Japan's Healthcare Sector for Global Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">jetro.go.jp</font>",https://news.google.com/rss/articles/CBMif0FVX3lxTE9BSndfWTktX1NlTnVvS3dPdFROSXRuaVQ5bXdUY0lkcnpTbWVMMXdIWV8yamxUV0tIM21JSWlrNTNZQnVNUHNOWXBEanB3dHZiVk94ZDllRVpuaVBKZmtMSG9CVEJiLU83a19yQW1mX2UzbnYzekRfSXVhM1ZONFk?oc=5,Google News,Biocon market expansion,"Enduring Appeal of Japan's Healthcare Sector for Global Business - jetro.go.jp <a href=""https://news.google.com/rss/articles/CBMif0FVX3lxTE9BSndfWTktX1NlTnVvS3dPdFROSXRuaVQ5bXdUY0lkcnpTbWVMMXdIWV8yamxUV0tIM21JSWlrNTNZQnVNUHNOWXBEanB3dHZiVk94ZDllRVpuaVBKZmtMSG9CVEJiLU83a19yQW1mX2UzbnYzekRfSXVhM1ZONFk?oc=5"" target=""_blank"">Enduring Appeal of Japan's Healthcare Sector for Global Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">jetro.go.jp</font>",0.8500803112983704,positive,0.8500803112983704,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.48576017788478304,0.8500803112983704,other,0.0,[],False,False,1,0.0
2024-03-17,2024-03-17 07:00:00,"Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr - Indian Pharma Post","<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxNMjd0UW5NMURvYzMwUkcwZXdRdnJCVzNvMWlpeVd4dkpDc1V2cGxZMGozTTdQbE1IWWdZNXhIQ09KdzFCVEFPUXhTYkk1MmdFdERfUVdWbTB2aXB5akk3YW4xcWlZU0hiSHdfemh3WHZidVd5ODJOSnQ5WUdlRGVKeHloMDhGQnI1bnRqU01ESlF4NWQ3SFBCbmRINXMwZmZILUtNMWdvOTNiYkFnT2kyWDc5a1ZVZHd3R2ZyVFgwbHlkOFJlWi1B0gHOAUFVX3lxTFBteTlBdHk1cGE5ZWFaT0F5RVVMWlJCWk1BcHJNcWE5d1BiMi1zcGtfTXJOdmFNbGFpNWtkR3kxWmdjUFRkV245WkhsU2tPdldhMG5IMlozcENXQ2JobU1PSlBVeVV6NEFZVjFBMjJfdHNrZDhaT3h2YWpVUEx2djVJQXFLbEZ4Y2Iwb3hfN3B1eXB2T0k3aDA3WFA2dm10cmJ5cjVJbDd3RHVhMkRrdkFHYkplbHFNMzJ6ZzJXUWpBV2tfUW5pNFAySVJhTHRR?oc=5"" target=""_blank"">Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr - Indian Pharma Post <a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",0.0,neutral,0.9011898636817932,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9011898636817932,other,0.0,[],False,True,6,0.0
2025-06-06,2025-06-06 07:00:00,"Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins - TradingView","<a href=""https://news.google.com/rss/articles/CBMikAJBVV95cUxQZTEySHRBVFhWYkdaOVFwQmlmRnlmT1N6Z1doQ3I5VXc0LUZNdEVUT0RrZ0RuVmNsY3c4WUo3M0dFN04xaHg0RnRONFEwSzZfOFFrQzNhUmRhS3NSYk5IZmoxQWN2Y0dfR2JZSzIwWDl5OUtaSDlVLWl5UDc0djlsMW5PSEdtMGpzLWgtejZDbHJOSUJVOXo4UzQyTk1hc2RqbDFsdDlYWER6Nml4UDE5Qko2Q29ZQTI3RGNnOEJlVC14OHVqamZKOWo2S183Q0xuWmdxVTE4V2REdkxmMlg3OUpVQ1VrYkp5eDROOEYzVjBNV1RWX0lGdFRwTy14MjNQYTcwV3VBb2VKbFk5b1RPSw?oc=5"" target=""_blank"">Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMikAJBVV95cUxQZTEySHRBVFhWYkdaOVFwQmlmRnlmT1N6Z1doQ3I5VXc0LUZNdEVUT0RrZ0RuVmNsY3c4WUo3M0dFN04xaHg0RnRONFEwSzZfOFFrQzNhUmRhS3NSYk5IZmoxQWN2Y0dfR2JZSzIwWDl5OUtaSDlVLWl5UDc0djlsMW5PSEdtMGpzLWgtejZDbHJOSUJVOXo4UzQyTk1hc2RqbDFsdDlYWER6Nml4UDE5Qko2Q29ZQTI3RGNnOEJlVC14OHVqamZKOWo2S183Q0xuWmdxVTE4V2REdkxmMlg3OUpVQ1VrYkp5eDROOEYzVjBNV1RWX0lGdFRwTy14MjNQYTcwV3VBb2VKbFk5b1RPSw?oc=5,Google News,Biocon market expansion,"Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins - TradingView <a href=""https://news.google.com/rss/articles/CBMikAJBVV95cUxQZTEySHRBVFhWYkdaOVFwQmlmRnlmT1N6Z1doQ3I5VXc0LUZNdEVUT0RrZ0RuVmNsY3c4WUo3M0dFN04xaHg0RnRONFEwSzZfOFFrQzNhUmRhS3NSYk5IZmoxQWN2Y0dfR2JZSzIwWDl5OUtaSDlVLWl5UDc0djlsMW5PSEdtMGpzLWgtejZDbHJOSUJVOXo4UzQyTk1hc2RqbDFsdDlYWER6Nml4UDE5Qko2Q29ZQTI3RGNnOEJlVC14OHVqamZKOWo2S183Q0xuWmdxVTE4V2REdkxmMlg3OUpVQ1VrYkp5eDROOEYzVjBNV1RWX0lGdFRwTy14MjNQYTcwV3VBb2VKbFk5b1RPSw?oc=5"" target=""_blank"">Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",0.7807599306106567,positive,0.7807599306106567,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0303030303030303,0.10101010101010101,0.4461485317775181,0.4055314804568435,other,0.0,[],False,True,6,0.0
2025-05-22,2025-05-22 07:00:00,Biocon Gets Six-Month Insulin Supply Contract Extension From MOH - Galen Centre,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQREpjeUlYbjgxcW1UOTN2UXRfcDBBWHRTWHJhUTFoblRZbjAzSTBObXpBNDY1NUxQR1U3ajNMN3Y0LVdxX1U1MDBMRkw0Vkcwb2dfWEpJQm94OXM0SUNzdlA5VE9FTldTNjFhcTRHaURPSnY1ZnE5djA5ZmtzMGtBTTljOXVPQTlGbHRiaGk4UWM4V3RNaFdhVjhabFNvdVI1c0JTQXd2VGlHUQ?oc=5"" target=""_blank"">Biocon Gets Six-Month Insulin Supply Contract Extension From MOH</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Galen Centre</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxQREpjeUlYbjgxcW1UOTN2UXRfcDBBWHRTWHJhUTFoblRZbjAzSTBObXpBNDY1NUxQR1U3ajNMN3Y0LVdxX1U1MDBMRkw0Vkcwb2dfWEpJQm94OXM0SUNzdlA5VE9FTldTNjFhcTRHaURPSnY1ZnE5djA5ZmtzMGtBTTljOXVPQTlGbHRiaGk4UWM4V3RNaFdhVjhabFNvdVI1c0JTQXd2VGlHUQ?oc=5,Google News,Biocon market expansion,"Biocon Gets Six-Month Insulin Supply Contract Extension From MOH - Galen Centre <a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQREpjeUlYbjgxcW1UOTN2UXRfcDBBWHRTWHJhUTFoblRZbjAzSTBObXpBNDY1NUxQR1U3ajNMN3Y0LVdxX1U1MDBMRkw0Vkcwb2dfWEpJQm94OXM0SUNzdlA5VE9FTldTNjFhcTRHaURPSnY1ZnE5djA5ZmtzMGtBTTljOXVPQTlGbHRiaGk4UWM4V3RNaFdhVjhabFNvdVI1c0JTQXd2VGlHUQ?oc=5"" target=""_blank"">Biocon Gets Six-Month Insulin Supply Contract Extension From MOH</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Galen Centre</font>",0.8570678234100342,positive,0.8570678234100342,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.489753041948591,0.8570678234100342,other,0.0,[],False,True,6,0.0
2024-05-20,2024-05-20 07:00:00,"Biocon to invest ₹2,200 crore in capex in the next 2 years - BusinessLine","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to invest ₹2,200 crore in capex in the next 2 years</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon to invest ₹2,200 crore in capex in the next 2 years - BusinessLine <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to invest ₹2,200 crore in capex in the next 2 years</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",0.0,neutral,0.9024929404258728,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9024929404258728,other,0.0,[],False,True,6,0.0
2023-10-17,2023-10-17 07:00:00,"Stocks to buy: Biocon, Dr Reddy’s, Sun Pharma, among Phillip Capital’s pharma stock picks for up to 22% upside - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy: Biocon, Dr Reddy’s, Sun Pharma, among Phillip Capital’s pharma stock picks for up to 22% upside</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Stocks to buy: Biocon, Dr Reddy’s, Sun Pharma, among Phillip Capital’s pharma stock picks for up to 22% upside - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy: Biocon, Dr Reddy’s, Sun Pharma, among Phillip Capital’s pharma stock picks for up to 22% upside</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.5938840508460999,positive,0.5938840508460999,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3393623147691999,0.5938840508460999,other,0.0,[],False,True,6,0.0
2024-05-20,2024-05-20 07:00:00,Biocon’s formulations business to outpace API share soon: CEO - Moneycontrol,"<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWkpSOXE0ckNENU44RXVTN0ZpMm9lbVIyMXNoN056LS1pZlpiLUpPZzMzSEhSaHZtdGRUS3lCcXFZSWNhRGw3M05Nc2NKMU1ieWZ4ajBXanZTLWZ2UG5hNV9ickt2eVBxMW9GVXBKY2xOeGVpWEtYMm4teFprMzhpMGY5SzlCVThVTmpuODg3NHF1SmM3eEwtM0lUMWJFS1B2NV9oWU5tUU5rMUpRZGtoa0lDRlhsN1JlY25QNnh3QTZYYW_SAcgBQVVfeXFMTVhURDZKbUlBNUJOekttVTdGS0ZDYUsyRjQ1RnVVczkxUFlSOHVRSjRYY3RYTTNFcnlfNWt5TEhZV0hMN2JFUXE1UXdKNjZFdkg4OXZHaFJza21RSXV5aEhjd1AtaXhCOGUwdGNPOEtKeUhrdUhMUno1b1FLSlNSNW1jckdLdVZCcEFTNm54TmxjbGJBRW96eU85QmduRnEwU0Q1TjVJblI3LXhLSFBaT05Lbk1FckU5MU52RzB2Tnd4QURIdUo3TXU?oc=5"" target=""_blank"">Biocon’s formulations business to outpace API share soon: CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWkpSOXE0ckNENU44RXVTN0ZpMm9lbVIyMXNoN056LS1pZlpiLUpPZzMzSEhSaHZtdGRUS3lCcXFZSWNhRGw3M05Nc2NKMU1ieWZ4ajBXanZTLWZ2UG5hNV9ickt2eVBxMW9GVXBKY2xOeGVpWEtYMm4teFprMzhpMGY5SzlCVThVTmpuODg3NHF1SmM3eEwtM0lUMWJFS1B2NV9oWU5tUU5rMUpRZGtoa0lDRlhsN1JlY25QNnh3QTZYYW_SAcgBQVVfeXFMTVhURDZKbUlBNUJOekttVTdGS0ZDYUsyRjQ1RnVVczkxUFlSOHVRSjRYY3RYTTNFcnlfNWt5TEhZV0hMN2JFUXE1UXdKNjZFdkg4OXZHaFJza21RSXV5aEhjd1AtaXhCOGUwdGNPOEtKeUhrdUhMUno1b1FLSlNSNW1jckdLdVZCcEFTNm54TmxjbGJBRW96eU85QmduRnEwU0Q1TjVJblI3LXhLSFBaT05Lbk1FckU5MU52RzB2Tnd4QURIdUo3TXU?oc=5,Google News,Biocon market expansion,"Biocon’s formulations business to outpace API share soon: CEO - Moneycontrol <a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWkpSOXE0ckNENU44RXVTN0ZpMm9lbVIyMXNoN056LS1pZlpiLUpPZzMzSEhSaHZtdGRUS3lCcXFZSWNhRGw3M05Nc2NKMU1ieWZ4ajBXanZTLWZ2UG5hNV9ickt2eVBxMW9GVXBKY2xOeGVpWEtYMm4teFprMzhpMGY5SzlCVThVTmpuODg3NHF1SmM3eEwtM0lUMWJFS1B2NV9oWU5tUU5rMUpRZGtoa0lDRlhsN1JlY25QNnh3QTZYYW_SAcgBQVVfeXFMTVhURDZKbUlBNUJOekttVTdGS0ZDYUsyRjQ1RnVVczkxUFlSOHVRSjRYY3RYTTNFcnlfNWt5TEhZV0hMN2JFUXE1UXdKNjZFdkg4OXZHaFJza21RSXV5aEhjd1AtaXhCOGUwdGNPOEtKeUhrdUhMUno1b1FLSlNSNW1jckdLdVZCcEFTNm54TmxjbGJBRW96eU85QmduRnEwU0Q1TjVJblI3LXhLSFBaT05Lbk1FckU5MU52RzB2Tnd4QURIdUo3TXU?oc=5"" target=""_blank"">Biocon’s formulations business to outpace API share soon: CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.6103538274765015,0.0,neutral,0.0,0.5267,0.18,0.0,0.82,0.0,0.0,0.0,0.5685269137382507,other,0.0,[],False,True,6,0.0
2023-07-05,2023-07-05 07:00:00,Biocon Biologics expands footprint after taking over biosimilars business from Viatris in over 70 countries - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics expands footprint after taking over biosimilars business from Viatris in over 70 countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon Biologics expands footprint after taking over biosimilars business from Viatris in over 70 countries - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics expands footprint after taking over biosimilars business from Viatris in over 70 countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.5476791858673096,positive,0.5476791858673096,0.0,neutral,0.0,0.2023,0.076,0.0,0.924,0.0,0.0,0.31295953478131977,0.3749895929336548,other,0.0,[],False,True,6,0.0
2021-01-14,2021-01-14 08:00:00,"Biotech API Market to Witness Huge Growth by 2027 | Lupin, Biocon, Cipla, Lonza - openPR.com","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxPcHp5aEJNb2hnQUhEUzJfaGk4UWNGSklkSXpoU0JlUnpRODBxQnVRR1VzU1U2TThITTBmYXo4RElaS0ZaeHUxcTlYZWs3VjhPTGNQZFhNTTNnNFRSNER1dGhIQWFsMWY1d1ZGWmZfVUd2cl9ReGRYRVJxd0QwdTA5TlhnMG5lc3FudmJ1MVozOGZQR3JmU1dMVlluUjdCZjg?oc=5"" target=""_blank"">Biotech API Market to Witness Huge Growth by 2027 | Lupin, Biocon, Cipla, Lonza</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxPcHp5aEJNb2hnQUhEUzJfaGk4UWNGSklkSXpoU0JlUnpRODBxQnVRR1VzU1U2TThITTBmYXo4RElaS0ZaeHUxcTlYZWs3VjhPTGNQZFhNTTNnNFRSNER1dGhIQWFsMWY1d1ZGWmZfVUd2cl9ReGRYRVJxd0QwdTA5TlhnMG5lc3FudmJ1MVozOGZQR3JmU1dMVlluUjdCZjg?oc=5,Google News,Biocon market expansion,"Biotech API Market to Witness Huge Growth by 2027 | Lupin, Biocon, Cipla, Lonza - openPR.com <a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxPcHp5aEJNb2hnQUhEUzJfaGk4UWNGSklkSXpoU0JlUnpRODBxQnVRR1VzU1U2TThITTBmYXo4RElaS0ZaeHUxcTlYZWs3VjhPTGNQZFhNTTNnNFRSNER1dGhIQWFsMWY1d1ZGWmZfVUd2cl9ReGRYRVJxd0QwdTA5TlhnMG5lc3FudmJ1MVozOGZQR3JmU1dMVlluUjdCZjg?oc=5"" target=""_blank"">Biotech API Market to Witness Huge Growth by 2027 | Lupin, Biocon, Cipla, Lonza</a>&nbsp;&nbsp;<font color=""#6f6f6f"">openPR.com</font>",0.5246758460998535,positive,0.5246758460998535,0.0,neutral,0.0,0.8316,0.274,0.0,0.726,0.26666666666666666,0.6,0.2998147691999163,0.54098083758884,other,0.0,[],False,True,6,0.0
2023-09-15,2023-09-15 07:00:00,"Biocon’s Syngene to invest Rs 788 Crore for campus expansion in Genome Valley, Hyderabad - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi4gFBVV95cUxOandPclBDMDhTdmpjZjBkWDFjS3JqV25La3FPanNES2F6WF9yRlpDUXViUkNNanFwRTFSZnRONnl4UmMzNDlvTGNfOFZMb0Q2VkNoUzB4azBkZlFfOGZpMGgyTUxHR3J0eHU5SlFjZmx2VHlyMUotTXpDQ2VoaDRvSmJEWkc4US1uRWdOQ0tmcGpSY3lEZTlOTXBLdDJ1UHg0V1hGMXIzaE5tVVJCY2lWVG1sRjA4QnV0LVQ5alNHVnlINGpVSlhCSGxKRUg5Z3hFWG1fVVRDYkwzb2EwU0lLdHhB?oc=5"" target=""_blank"">Biocon’s Syngene to invest Rs 788 Crore for campus expansion in Genome Valley, Hyderabad</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi4gFBVV95cUxOandPclBDMDhTdmpjZjBkWDFjS3JqV25La3FPanNES2F6WF9yRlpDUXViUkNNanFwRTFSZnRONnl4UmMzNDlvTGNfOFZMb0Q2VkNoUzB4azBkZlFfOGZpMGgyTUxHR3J0eHU5SlFjZmx2VHlyMUotTXpDQ2VoaDRvSmJEWkc4US1uRWdOQ0tmcGpSY3lEZTlOTXBLdDJ1UHg0V1hGMXIzaE5tVVJCY2lWVG1sRjA4QnV0LVQ5alNHVnlINGpVSlhCSGxKRUg5Z3hFWG1fVVRDYkwzb2EwU0lLdHhB?oc=5,Google News,Biocon market expansion,"Biocon’s Syngene to invest Rs 788 Crore for campus expansion in Genome Valley, Hyderabad - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi4gFBVV95cUxOandPclBDMDhTdmpjZjBkWDFjS3JqV25La3FPanNES2F6WF9yRlpDUXViUkNNanFwRTFSZnRONnl4UmMzNDlvTGNfOFZMb0Q2VkNoUzB4azBkZlFfOGZpMGgyTUxHR3J0eHU5SlFjZmx2VHlyMUotTXpDQ2VoaDRvSmJEWkc4US1uRWdOQ0tmcGpSY3lEZTlOTXBLdDJ1UHg0V1hGMXIzaE5tVVJCY2lWVG1sRjA4QnV0LVQ5alNHVnlINGpVSlhCSGxKRUg5Z3hFWG1fVVRDYkwzb2EwU0lLdHhB?oc=5"" target=""_blank"">Biocon’s Syngene to invest Rs 788 Crore for campus expansion in Genome Valley, Hyderabad</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.570758581161499,positive,0.570758581161499,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.3261477606637137,0.570758581161499,other,0.0,[],False,True,6,0.0
2024-02-15,2024-02-15 08:00:00,"Biocon bullish on prospects, capex to continue: Mittal - cogencis.com","<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxOSWlqSXotR2NoS2dndEVrM2Z3UXZkTnN1NW5CU0pnVlVGbGg4TUFCZW9pazR1SlNmR0pDd1hBVVpKQzV1djY2OHhoRjNOQ2paVXpNSGRxdU5tMlN0WlhnQkJ6c1BwSVJEWTg2TW9FSFF4RTZCTUdLM1RKRFhNRWZwelNqdmJ5ZDRoM1E?oc=5"" target=""_blank"">Biocon bullish on prospects, capex to continue: Mittal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">cogencis.com</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxOSWlqSXotR2NoS2dndEVrM2Z3UXZkTnN1NW5CU0pnVlVGbGg4TUFCZW9pazR1SlNmR0pDd1hBVVpKQzV1djY2OHhoRjNOQ2paVXpNSGRxdU5tMlN0WlhnQkJ6c1BwSVJEWTg2TW9FSFF4RTZCTUdLM1RKRFhNRWZwelNqdmJ5ZDRoM1E?oc=5,Google News,Biocon market expansion,"Biocon bullish on prospects, capex to continue: Mittal - cogencis.com <a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxOSWlqSXotR2NoS2dndEVrM2Z3UXZkTnN1NW5CU0pnVlVGbGg4TUFCZW9pazR1SlNmR0pDd1hBVVpKQzV1djY2OHhoRjNOQ2paVXpNSGRxdU5tMlN0WlhnQkJ6c1BwSVJEWTg2TW9FSFF4RTZCTUdLM1RKRFhNRWZwelNqdmJ5ZDRoM1E?oc=5"" target=""_blank"">Biocon bullish on prospects, capex to continue: Mittal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">cogencis.com</font>",0.0,neutral,0.8168492317199707,0.0,neutral,0.0,0.5267,0.196,0.0,0.804,0.0,0.0,0.0,0.6717746158599853,other,0.0,[],False,True,6,0.0
2025-03-07,2025-03-07 08:00:00,Pharma stock jumps after partnering with Civica to expand Insulin Aspart access in US - Trade Brains,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxQNmdhSmkxSmJVNlRGUlhiU2VhZF84S1cwTzRadjdQbXpkUzRzVDkwa3ZTLWNIWWQxS2czd1d5ZU0zQnpHLTJUZVhuM2w0T1BKSWhHemdodzZUTnVvVzVMYS1GV2NjaUFtU2RHR2ZKT1pWWGI5TnFFa2xnemxzSVJJUmRIcDV1N0t3WXhfT05IOEl1SV9jMVZpVVpOSjVfRzJJbzZDQ3R1TmlXQW1OOUE?oc=5"" target=""_blank"">Pharma stock jumps after partnering with Civica to expand Insulin Aspart access in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxQNmdhSmkxSmJVNlRGUlhiU2VhZF84S1cwTzRadjdQbXpkUzRzVDkwa3ZTLWNIWWQxS2czd1d5ZU0zQnpHLTJUZVhuM2w0T1BKSWhHemdodzZUTnVvVzVMYS1GV2NjaUFtU2RHR2ZKT1pWWGI5TnFFa2xnemxzSVJJUmRIcDV1N0t3WXhfT05IOEl1SV9jMVZpVVpOSjVfRzJJbzZDQ3R1TmlXQW1OOUE?oc=5,Google News,Biocon market expansion,"Pharma stock jumps after partnering with Civica to expand Insulin Aspart access in US - Trade Brains <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxQNmdhSmkxSmJVNlRGUlhiU2VhZF84S1cwTzRadjdQbXpkUzRzVDkwa3ZTLWNIWWQxS2czd1d5ZU0zQnpHLTJUZVhuM2w0T1BKSWhHemdodzZUTnVvVzVMYS1GV2NjaUFtU2RHR2ZKT1pWWGI5TnFFa2xnemxzSVJJUmRIcDV1N0t3WXhfT05IOEl1SV9jMVZpVVpOSjVfRzJJbzZDQ3R1TmlXQW1OOUE?oc=5"" target=""_blank"">Pharma stock jumps after partnering with Civica to expand Insulin Aspart access in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",0.9392442107200623,positive,0.9392442107200623,0.0,neutral,0.0,0.5574,0.126,0.0,0.874,0.0,0.0,0.5367109775543213,0.7483221053600311,other,0.0,[],False,False,1,0.0
2023-05-23,2023-05-23 07:00:00,"Biocon Q4 results: Consolidated PAT jumps 31% YoY, EBITDA records strong growth; declares 30% dividend - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 results: Consolidated PAT jumps 31% YoY, EBITDA records strong growth; declares 30% dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon Q4 results: Consolidated PAT jumps 31% YoY, EBITDA records strong growth; declares 30% dividend - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 results: Consolidated PAT jumps 31% YoY, EBITDA records strong growth; declares 30% dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.8962326645851135,positive,0.8962326645851135,0.0,neutral,0.0,0.8957,0.282,0.0,0.718,0.2888888888888889,0.48888888888888893,0.5121329511914935,0.6936071844913342,other,0.0,[],False,True,6,0.0
2022-11-24,2022-11-24 08:00:00,"Ex-Biocon team, Symbio Generrics completes capital raise from Ascent Capital - Times of India","<a href=""https://news.google.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?oc=5"" target=""_blank"">Ex-Biocon team, Symbio Generrics completes capital raise from Ascent Capital</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Ex-Biocon team, Symbio Generrics completes capital raise from Ascent Capital - Times of India <a href=""https://news.google.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?oc=5"" target=""_blank"">Ex-Biocon team, Symbio Generrics completes capital raise from Ascent Capital</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",0.6710335612297058,positive,0.6710335612297058,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.38344774927411757,0.6710335612297058,other,0.0,[],False,True,6,0.0
2021-03-03,2021-03-03 08:00:00,Biocon Biologics appoints Susheel Umesh as CCO for emerging markets - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics appoints Susheel Umesh as CCO for emerging markets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News,Biocon market expansion,"Biocon Biologics appoints Susheel Umesh as CCO for emerging markets - Medical Dialogues <a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxOaTVheUV6MXZMcm5zekE0eVFXTjA2VU9YTzB5dFZuZWJQMzJwMmxDa1g2SEpKVDJ5UjFLRlJNQnlIMnFvTzBwaFFHRE4zRDgyNzBIZmVBeGl5NnlTLS1uWWhlZEdlTHFtc0FvcUVDNTZFSHlGemF2VE9GY01XNTdORm5BMmQtWWdpS0VIQXNUS3BaUTR0cmo5SVJfSGs3eExjdEpJaGpCX05udmNwNkZVR0IwNU5oTDFkZkEzc0I4c9IBxAFBVV95cUxPNEtWZ0JKM3ZIb0JnU3BsZ183UFgzUDk5YXY5R1JYVWZlbEdnWGg1N2lMWm9aMlpDUkhBMDV2amo2UW1ld1dXa3FsUlV3TFE3SGk1bmp4dm95YUEtQUVsdkpNLTMweWgxbFBkVWVrc2RnNkpfZE5uS3hVbGlVRmROZ1ZmTjN5SEVyWUJWMkg3elR0ZjllaWVSbjhOajlrbjFZeUQ0VjBwYTVmeXllamNqdGFwTHpUaXcyaWVZS1FCc3hrRnR5?oc=5"" target=""_blank"">Biocon Biologics appoints Susheel Umesh as CCO for emerging markets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.0,neutral,0.9118947386741638,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9118947386741638,other,0.0,[],False,True,6,0.0
2024-01-10,2024-01-10 10:35:14,“Biocon has challenged the premise of high quality = high price” - The Dollar Business,"<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQ3ZaaUtibV8zSWg1c2lKWHEwcFlCczhwX1cwajBLSGNTdldNMXdtdm82WE1XeVBpdHpQeTV2czNRMEtpZTFwaWgxQTEzcDNMTU0zTmE3elFQXzYtazZ4Zll2ZHc1RFNTS3VrbTFNUHhaakRDZm9pSlV1NVhTY3NMRlJ0MjhZX2gybklrWHZ5LWh3eF9qWTdnZ0NzdUJTclBXTmN1SC1XUU1KSDA?oc=5"" target=""_blank"">“Biocon has challenged the premise of high quality = high price”</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Dollar Business</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQ3ZaaUtibV8zSWg1c2lKWHEwcFlCczhwX1cwajBLSGNTdldNMXdtdm82WE1XeVBpdHpQeTV2czNRMEtpZTFwaWgxQTEzcDNMTU0zTmE3elFQXzYtazZ4Zll2ZHc1RFNTS3VrbTFNUHhaakRDZm9pSlV1NVhTY3NMRlJ0MjhZX2gybklrWHZ5LWh3eF9qWTdnZ0NzdUJTclBXTmN1SC1XUU1KSDA?oc=5,Google News,Biocon market expansion,"“Biocon has challenged the premise of high quality = high price” - The Dollar Business <a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQ3ZaaUtibV8zSWg1c2lKWHEwcFlCczhwX1cwajBLSGNTdldNMXdtdm82WE1XeVBpdHpQeTV2czNRMEtpZTFwaWgxQTEzcDNMTU0zTmE3elFQXzYtazZ4Zll2ZHc1RFNTS3VrbTFNUHhaakRDZm9pSlV1NVhTY3NMRlJ0MjhZX2gybklrWHZ5LWh3eF9qWTdnZ0NzdUJTclBXTmN1SC1XUU1KSDA?oc=5"" target=""_blank"">“Biocon has challenged the premise of high quality = high price”</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Dollar Business</font>",0.0,neutral,0.5459470748901367,0.0,neutral,0.0,-0.2023,0.0,0.097,0.903,0.128,0.43200000000000005,0.0,0.29208235829671225,other,0.0,[],False,True,6,0.0
2025-05-26,2025-05-26 07:00:00,Will U.S. Tariffs Derail the Growth of Nifty Pharma in 2025? - Trade Brains,"<a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxQYklLRjBmbGhFWkpLTUplQkhWQ1hLa2xZLVFGeFVodWlPOFhKSkluTjhkZjJNX0lIQUNoa2VaM3FyR1UwUmlJRnhSUFBZUHp6NTljVjRYQlhtWktvNjY0eEpTZS0ySW5JU1N1bkltaFNMUkhlYkV0T0d0SHVfemZlRlRhcllsMW5yZDc4ZQ?oc=5"" target=""_blank"">Will U.S. Tariffs Derail the Growth of Nifty Pharma in 2025?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",https://news.google.com/rss/articles/CBMijAFBVV95cUxQYklLRjBmbGhFWkpLTUplQkhWQ1hLa2xZLVFGeFVodWlPOFhKSkluTjhkZjJNX0lIQUNoa2VaM3FyR1UwUmlJRnhSUFBZUHp6NTljVjRYQlhtWktvNjY0eEpTZS0ySW5JU1N1bkltaFNMUkhlYkV0T0d0SHVfemZlRlRhcllsMW5yZDc4ZQ?oc=5,Google News,Biocon market expansion,"Will U.S. Tariffs Derail the Growth of Nifty Pharma in 2025? - Trade Brains <a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxQYklLRjBmbGhFWkpLTUplQkhWQ1hLa2xZLVFGeFVodWlPOFhKSkluTjhkZjJNX0lIQUNoa2VaM3FyR1UwUmlJRnhSUFBZUHp6NTljVjRYQlhtWktvNjY0eEpTZS0ySW5JU1N1bkltaFNMUkhlYkV0T0d0SHVfemZlRlRhcllsMW5yZDc4ZQ?oc=5"" target=""_blank"">Will U.S. Tariffs Derail the Growth of Nifty Pharma in 2025?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",0.0,neutral,0.631019115447998,0.0,neutral,0.0,0.7744,0.297,0.117,0.586,0.0,0.0,0.0,0.702709557723999,other,0.0,[],False,False,1,0.0
2025-01-08,2025-01-08 08:00:00,Biocon Biologics Secures Japan PMDA Approval For Psoriasis Drug - IPO Central,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9QNWtGQ1N6NS14MF9UWTlDdDdrbGt4VDZUTmZYcTM4b3Ntel9BYXBSRXRYdWZWZjlnNzQzOW03dDZyejgwcmFONUIwR1JLTXFieWRaQzVNeFFBRmkxSGs4dTJ5Q21qdDZTVUd3UHkzM3E?oc=5"" target=""_blank"">Biocon Biologics Secures Japan PMDA Approval For Psoriasis Drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IPO Central</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9QNWtGQ1N6NS14MF9UWTlDdDdrbGt4VDZUTmZYcTM4b3Ntel9BYXBSRXRYdWZWZjlnNzQzOW03dDZyejgwcmFONUIwR1JLTXFieWRaQzVNeFFBRmkxSGs4dTJ5Q21qdDZTVUd3UHkzM3E?oc=5,Google News,Biocon market expansion,"Biocon Biologics Secures Japan PMDA Approval For Psoriasis Drug - IPO Central <a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9QNWtGQ1N6NS14MF9UWTlDdDdrbGt4VDZUTmZYcTM4b3Ntel9BYXBSRXRYdWZWZjlnNzQzOW03dDZyejgwcmFONUIwR1JLTXFieWRaQzVNeFFBRmkxSGs4dTJ5Q21qdDZTVUd3UHkzM3E?oc=5"" target=""_blank"">Biocon Biologics Secures Japan PMDA Approval For Psoriasis Drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IPO Central</font>",0.7035807967185974,positive,0.7035807967185974,0.0,neutral,0.0,0.8689,0.351,0.0,0.649,0.0,0.125,0.40204616955348416,0.7862403983592987,approval_process,0.7438861131668091,['FDA approval'],False,True,16,0.48777222633361816
2024-02-13,2024-02-13 08:00:00,"We will continue to deepen our presence in segments like diabetes through product portfolio expansion: Krishnakumar Vaidyanathan, Executive Director, Eris Lifesciences - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMiygJBVV95cUxQOGJ6VXFHeElFUzlOZC1RZ0FwZWF6eGdpNTlzdFBWRldGQUpERkdZNGM3RnBLTDlQUm53ZzBnU2RHUVJfZWFwVVN2YjFKU0pfS0lsMlcxclh5UWZ0WWJ4eXNzVUZWd1lfa0pvN3FoMHVwMi1EWmhOcUlEMWUzTHRiZFVZYVNra2FILWx1Q0ttaWxKV0pfazcyYUZoMXdyRDMzQjlkYVQtS09sbFYxdTJicElkSXhhNmZaYmRIMUlMU2dlc3hYdUhVLUpBQ1FDV2l4dXRtTjFpM0ROS0FyVDFINkpWVVJ0T09sbFZ2RDNYVXpGTnhfdzNuRFlZTlhJdlZjaC1Bc1p2OUliWGtqdHh2NmpNQ2QyZUJCWWZXYWF6X2ZTRUk2Wjl2cGs1anNaWUw0NTk1LTRUNV8xVXpGdW5pWUt1TXhLMFFabVE?oc=5"" target=""_blank"">We will continue to deepen our presence in segments like diabetes through product portfolio expansion: Krishnakumar Vaidyanathan, Executive Director, Eris Lifesciences</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiygJBVV95cUxQOGJ6VXFHeElFUzlOZC1RZ0FwZWF6eGdpNTlzdFBWRldGQUpERkdZNGM3RnBLTDlQUm53ZzBnU2RHUVJfZWFwVVN2YjFKU0pfS0lsMlcxclh5UWZ0WWJ4eXNzVUZWd1lfa0pvN3FoMHVwMi1EWmhOcUlEMWUzTHRiZFVZYVNra2FILWx1Q0ttaWxKV0pfazcyYUZoMXdyRDMzQjlkYVQtS09sbFYxdTJicElkSXhhNmZaYmRIMUlMU2dlc3hYdUhVLUpBQ1FDV2l4dXRtTjFpM0ROS0FyVDFINkpWVVJ0T09sbFZ2RDNYVXpGTnhfdzNuRFlZTlhJdlZjaC1Bc1p2OUliWGtqdHh2NmpNQ2QyZUJCWWZXYWF6X2ZTRUk2Wjl2cGs1anNaWUw0NTk1LTRUNV8xVXpGdW5pWUt1TXhLMFFabVE?oc=5,Google News,Biocon market expansion,"We will continue to deepen our presence in segments like diabetes through product portfolio expansion: Krishnakumar Vaidyanathan, Executive Director, Eris Lifesciences - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMiygJBVV95cUxQOGJ6VXFHeElFUzlOZC1RZ0FwZWF6eGdpNTlzdFBWRldGQUpERkdZNGM3RnBLTDlQUm53ZzBnU2RHUVJfZWFwVVN2YjFKU0pfS0lsMlcxclh5UWZ0WWJ4eXNzVUZWd1lfa0pvN3FoMHVwMi1EWmhOcUlEMWUzTHRiZFVZYVNra2FILWx1Q0ttaWxKV0pfazcyYUZoMXdyRDMzQjlkYVQtS09sbFYxdTJicElkSXhhNmZaYmRIMUlMU2dlc3hYdUhVLUpBQ1FDV2l4dXRtTjFpM0ROS0FyVDFINkpWVVJ0T09sbFZ2RDNYVXpGTnhfdzNuRFlZTlhJdlZjaC1Bc1p2OUliWGtqdHh2NmpNQ2QyZUJCWWZXYWF6X2ZTRUk2Wjl2cGs1anNaWUw0NTk1LTRUNV8xVXpGdW5pWUt1TXhLMFFabVE?oc=5"" target=""_blank"">We will continue to deepen our presence in segments like diabetes through product portfolio expansion: Krishnakumar Vaidyanathan, Executive Director, Eris Lifesciences</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.6881579756736755,positive,0.6881579756736755,0.0,neutral,0.0,0.6124,0.102,0.0,0.898,0.0,0.0,0.39323312895638596,0.6502789878368378,other,0.0,[],False,False,1,0.0
2025-04-17,2025-04-17 07:00:00,"Type 1 Diabetes Market Set to Witness Significant Growth by 2025-2032 | Biocon Ltd., Novo Nordisk - newstrail.com","<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQZkg1ZDhNTWdBSVdqQ213SFBZMFNjNkdtbXU0YzdSWnhuaS1NU01FTHdyaEs1Q3RpQldjdVpYNVl0d2hIa3lZWTlDekxYQXFvWmM1eDVNNHpkdWJydlVrSkVZMGl5bGZkLVp3Wjk5MFlxRTk3cU1Yc1VhdkkzRFlIb3o0ZFdMWXN1bm9mckFvQXY0OGZ5dGM2OC15YlZXQm9TaEtFcHpFU3FhQkREcDZjd2xaaU5YQVlNcloySQ?oc=5"" target=""_blank"">Type 1 Diabetes Market Set to Witness Significant Growth by 2025-2032 | Biocon Ltd., Novo Nordisk</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newstrail.com</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxQZkg1ZDhNTWdBSVdqQ213SFBZMFNjNkdtbXU0YzdSWnhuaS1NU01FTHdyaEs1Q3RpQldjdVpYNVl0d2hIa3lZWTlDekxYQXFvWmM1eDVNNHpkdWJydlVrSkVZMGl5bGZkLVp3Wjk5MFlxRTk3cU1Yc1VhdkkzRFlIb3o0ZFdMWXN1bm9mckFvQXY0OGZ5dGM2OC15YlZXQm9TaEtFcHpFU3FhQkREcDZjd2xaaU5YQVlNcloySQ?oc=5,Google News,Biocon market expansion,"Type 1 Diabetes Market Set to Witness Significant Growth by 2025-2032 | Biocon Ltd., Novo Nordisk - newstrail.com <a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQZkg1ZDhNTWdBSVdqQ213SFBZMFNjNkdtbXU0YzdSWnhuaS1NU01FTHdyaEs1Q3RpQldjdVpYNVl0d2hIa3lZWTlDekxYQXFvWmM1eDVNNHpkdWJydlVrSkVZMGl5bGZkLVp3Wjk5MFlxRTk3cU1Yc1VhdkkzRFlIb3o0ZFdMWXN1bm9mckFvQXY0OGZ5dGM2OC15YlZXQm9TaEtFcHpFU3FhQkREcDZjd2xaaU5YQVlNcloySQ?oc=5"" target=""_blank"">Type 1 Diabetes Market Set to Witness Significant Growth by 2025-2032 | Biocon Ltd., Novo Nordisk</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newstrail.com</font>",0.6944977641105652,positive,0.6944977641105652,0.0,neutral,0.0,0.7783,0.239,0.0,0.761,0.25,0.5833333333333334,0.3968558652060373,0.5742659213701884,other,0.0,[],False,True,6,0.0
2025-04-10,2025-04-10 07:00:00,"Biocon Share Price Target 2025, 2030, 2050 - shareprice-target.com","<a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTFAwLXM3RlFST2hYUVBnTUx6ZVJMY3M3V2hfWFhxMG80ZHRfMGNfSFJZN21vWEhxY3dmbnk2eVRsNGFwajBXb09NbnByeGtTRVBuajN0SkRZWFdIUDJyNXBQQVB3RWdOdDg?oc=5"" target=""_blank"">Biocon Share Price Target 2025, 2030, 2050</a>&nbsp;&nbsp;<font color=""#6f6f6f"">shareprice-target.com</font>",https://news.google.com/rss/articles/CBMiZ0FVX3lxTFAwLXM3RlFST2hYUVBnTUx6ZVJMY3M3V2hfWFhxMG80ZHRfMGNfSFJZN21vWEhxY3dmbnk2eVRsNGFwajBXb09NbnByeGtTRVBuajN0SkRZWFdIUDJyNXBQQVB3RWdOdDg?oc=5,Google News,Biocon market expansion,"Biocon Share Price Target 2025, 2030, 2050 - shareprice-target.com <a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTFAwLXM3RlFST2hYUVBnTUx6ZVJMY3M3V2hfWFhxMG80ZHRfMGNfSFJZN21vWEhxY3dmbnk2eVRsNGFwajBXb09NbnByeGtTRVBuajN0SkRZWFdIUDJyNXBQQVB3RWdOdDg?oc=5"" target=""_blank"">Biocon Share Price Target 2025, 2030, 2050</a>&nbsp;&nbsp;<font color=""#6f6f6f"">shareprice-target.com</font>",0.0,neutral,0.896992564201355,0.0,neutral,0.0,0.5267,0.216,0.0,0.784,0.0,0.0,0.0,0.7118462821006775,other,0.0,[],False,True,6,0.0
2025-01-31,2025-01-31 08:00:00,Biocon's Q3 revenue dips; banks on obesity drugs for future growth - Reuters,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxONGRVNGRtX0pPNGtSTmJyQ1ZEemIwZWR3TnBwY2xLTWtMZEdpUDZJQWJoaTlKZ3BuQ3lHandTV2RUQnZsLWFGMjlKNEhOS0FidVRLOURoZHNvRERtV2N5SS14d01DNlBUTmI1TWdyUDhmcmtmVHN1UXNDdktxSFJEODJEalVXbjZ0UkFsU3V0ZzJKVWE3UldYUTVYZzZfR2d6dFF0RGR6dzNadVk5b0Q2cWRwUGdtNHNXb29CMWtlTHFxam1jV3BlTQ?oc=5"" target=""_blank"">Biocon's Q3 revenue dips; banks on obesity drugs for future growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Reuters</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxONGRVNGRtX0pPNGtSTmJyQ1ZEemIwZWR3TnBwY2xLTWtMZEdpUDZJQWJoaTlKZ3BuQ3lHandTV2RUQnZsLWFGMjlKNEhOS0FidVRLOURoZHNvRERtV2N5SS14d01DNlBUTmI1TWdyUDhmcmtmVHN1UXNDdktxSFJEODJEalVXbjZ0UkFsU3V0ZzJKVWE3UldYUTVYZzZfR2d6dFF0RGR6dzNadVk5b0Q2cWRwUGdtNHNXb29CMWtlTHFxam1jV3BlTQ?oc=5,Google News,Biocon quarterly earnings,"Biocon's Q3 revenue dips; banks on obesity drugs for future growth - Reuters <a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxONGRVNGRtX0pPNGtSTmJyQ1ZEemIwZWR3TnBwY2xLTWtMZEdpUDZJQWJoaTlKZ3BuQ3lHandTV2RUQnZsLWFGMjlKNEhOS0FidVRLOURoZHNvRERtV2N5SS14d01DNlBUTmI1TWdyUDhmcmtmVHN1UXNDdktxSFJEODJEalVXbjZ0UkFsU3V0ZzJKVWE3UldYUTVYZzZfR2d6dFF0RGR6dzNadVk5b0Q2cWRwUGdtNHNXb29CMWtlTHFxam1jV3BlTQ?oc=5"" target=""_blank"">Biocon's Q3 revenue dips; banks on obesity drugs for future growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Reuters</font>",-0.9653317928314209,negative,0.9653317928314209,0.0,neutral,0.0,0.3818,0.094,0.0,0.906,0.0,0.08333333333333333,-0.5516181673322404,0.6735658964157104,other,0.0,[],False,True,6,0.0
2025-05-08,2025-05-08 07:00:00,Biocon Q4 Results: Profit More Than Doubles - NDTV Profit,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxPeUR6bldyZlp6NDFWQTVnLV81Wm1naTJfMURLb0lGVEpRMWFQTmVPRlczWFRndkk4eHhFM3MyZzF6OS1aXzk5N25paHp5S0VFMXNUbG5CM3dFOHJBaHJnRldkLTJEN0JsR0lrSExGa2x3Qm55SmVPem9PNHJfSl9oZzJkVi1rVU1Fbmx3VEhCdVVUZ1pRRHdZddIBngFBVV95cUxNbWFLblpRZTY2SVlPd1BHVmhIYjE1aU9nZFdTYlNJYzBTVjFNUUVLcXhzUFVzUFJFWlhGNkdiWEtmX01OeDdLLUFjMGJzTUJRN29VbEJ6MGs5ZkxwVTV3OTN2OFdySkllVGVOek1TcllLV0l1di0zeW16S1hfMG5GZ3VxWXotdDZWY2JRWmlsLXo5SzkwM3FSMzdVM3FTdw?oc=5"" target=""_blank"">Biocon Q4 Results: Profit More Than Doubles</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxPeUR6bldyZlp6NDFWQTVnLV81Wm1naTJfMURLb0lGVEpRMWFQTmVPRlczWFRndkk4eHhFM3MyZzF6OS1aXzk5N25paHp5S0VFMXNUbG5CM3dFOHJBaHJnRldkLTJEN0JsR0lrSExGa2x3Qm55SmVPem9PNHJfSl9oZzJkVi1rVU1Fbmx3VEhCdVVUZ1pRRHdZddIBngFBVV95cUxNbWFLblpRZTY2SVlPd1BHVmhIYjE1aU9nZFdTYlNJYzBTVjFNUUVLcXhzUFVzUFJFWlhGNkdiWEtmX01OeDdLLUFjMGJzTUJRN29VbEJ6MGs5ZkxwVTV3OTN2OFdySkllVGVOek1TcllLV0l1di0zeW16S1hfMG5GZ3VxWXotdDZWY2JRWmlsLXo5SzkwM3FSMzdVM3FTdw?oc=5,Google News,Biocon quarterly earnings,"Biocon Q4 Results: Profit More Than Doubles - NDTV Profit <a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxPeUR6bldyZlp6NDFWQTVnLV81Wm1naTJfMURLb0lGVEpRMWFQTmVPRlczWFRndkk4eHhFM3MyZzF6OS1aXzk5N25paHp5S0VFMXNUbG5CM3dFOHJBaHJnRldkLTJEN0JsR0lrSExGa2x3Qm55SmVPem9PNHJfSl9oZzJkVi1rVU1Fbmx3VEhCdVVUZ1pRRHdZddIBngFBVV95cUxNbWFLblpRZTY2SVlPd1BHVmhIYjE1aU9nZFdTYlNJYzBTVjFNUUVLcXhzUFVzUFJFWlhGNkdiWEtmX01OeDdLLUFjMGJzTUJRN29VbEJ6MGs5ZkxwVTV3OTN2OFdySkllVGVOek1TcllLV0l1di0zeW16S1hfMG5GZ3VxWXotdDZWY2JRWmlsLXo5SzkwM3FSMzdVM3FTdw?oc=5"" target=""_blank"">Biocon Q4 Results: Profit More Than Doubles</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",0.756368100643158,positive,0.756368100643158,0.0,neutral,0.0,0.8271,0.339,0.0,0.661,0.3333333333333333,0.3333333333333333,0.4322103432246617,0.6389338113254971,other,0.0,[],False,True,6,0.0
2025-05-08,2025-05-08 07:00:00,Biocon Q4FY25 results: Consolidated net profit rises 153% to ₹344 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4FY25 results: Consolidated net profit rises 153% to ₹344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon Q4FY25 results: Consolidated net profit rises 153% to ₹344 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4FY25 results: Consolidated net profit rises 153% to ₹344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9394972324371338,positive,0.9394972324371338,0.0,neutral,0.0,0.7003,0.182,0.0,0.818,0.0,0.0,0.5368555613926479,0.8198986162185669,other,0.0,[],False,True,6,0.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxOWk5tdWVrVGl6a1lkTGduOFFkTW5WWWFWVTV0MzdqbVo5ZTdxWThsS1dqQmRTR2hfM0YxUzhCQWk3M2V2YXNJRFhhU1VJTmd6RlhDM0l1V2tRWkVGUTV6WGRITXN0SHhvWC0yMnVaX3hFNUVBYlhHWGhhY29mZnd6NW91N3RfNEE0eEstemROV2E2VmVpZlVyRXZUYnV2SUZJcTEzMURjaTdfQUQydVVScFBVU2R1d9IBuwFBVV95cUxOcGxaMVl3dFQ3SEd4eHVpNzl3Ym1fWEhCUTEyUXo5ZzFDS2ZTSmkwNVQwWHhhR29OMVhOYVlIQS1TMzJBR1BXTklGTDMxVVhPUnYxZVFfWnZWazZqNWtEa3ZMVXdJVGo1WDNTVVRaV2Vab2dHWE8tWXFMMzJQNEc5RW96THdTNWhmNzlqNGkxbllDR1g3WXMxZHVRSy1HaUxDTlFTN09UVmtnRWpfUVlCc0VDVEpaZk9leUdB?oc=5,Google News,Biocon quarterly earnings,"Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7% - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.9380007386207581,positive,0.9380007386207581,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5360004220690046,0.9380007386207581,other,0.0,[],False,True,6,0.0
2024-10-31,2024-10-31 07:00:00,"Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.7596116065979004,positive,0.7596116065979004,0.0,neutral,0.0,-0.1027,0.136,0.149,0.714,0.0,0.0,0.4340637751988002,0.4311558032989502,other,0.0,[],False,True,6,0.0
2025-01-30,2025-01-30 08:00:00,"Q3 Results 2025: Tata Consumer, Adani Enterprises, L&T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5"" target=""_blank"">Q3 Results 2025: Tata Consumer, Adani Enterprises, L&amp;T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5,Google News,Biocon quarterly earnings,"Q3 Results 2025: Tata Consumer, Adani Enterprises, L&T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5"" target=""_blank"">Q3 Results 2025: Tata Consumer, Adani Enterprises, L&amp;T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9360650777816772,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9360650777816772,other,0.0,[],False,True,6,0.0
2024-10-30,2024-10-30 12:14:28,Biocon Q2 Results: Profit Falls 84% But Beats Estimates - NDTV Profit,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxQS3MzZ1Y2NVlPNTVmZ3ZDbE13RHl1b0wwaDlZX3NuUV9HWWx5S0NQSXJmcVphX2pPMHA1Ty1lUklHdXRrNGQwWm1xNE1oTkdRcm8ycURNQlp4NUgyelFkdzE4SThIMHB6VmQ1QXRESHM4TWY1aFNfc29kaXhEYkVKakE4RkZPTnpoZHZKQTJmcGo2SXk4bG1ZMjFBZ00?oc=5"" target=""_blank"">Biocon Q2 Results: Profit Falls 84% But Beats Estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxQS3MzZ1Y2NVlPNTVmZ3ZDbE13RHl1b0wwaDlZX3NuUV9HWWx5S0NQSXJmcVphX2pPMHA1Ty1lUklHdXRrNGQwWm1xNE1oTkdRcm8ycURNQlp4NUgyelFkdzE4SThIMHB6VmQ1QXRESHM4TWY1aFNfc29kaXhEYkVKakE4RkZPTnpoZHZKQTJmcGo2SXk4bG1ZMjFBZ00?oc=5,Google News,Biocon quarterly earnings,"Biocon Q2 Results: Profit Falls 84% But Beats Estimates - NDTV Profit <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxQS3MzZ1Y2NVlPNTVmZ3ZDbE13RHl1b0wwaDlZX3NuUV9HWWx5S0NQSXJmcVphX2pPMHA1Ty1lUklHdXRrNGQwWm1xNE1oTkdRcm8ycURNQlp4NUgyelFkdzE4SThIMHB6VmQ1QXRESHM4TWY1aFNfc29kaXhEYkVKakE4RkZPTnpoZHZKQTJmcGo2SXk4bG1ZMjFBZ00?oc=5"" target=""_blank"">Biocon Q2 Results: Profit Falls 84% But Beats Estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",-0.9662028551101685,negative,0.9662028551101685,0.0,neutral,0.0,0.8641,0.315,0.0,0.685,0.0,0.0,-0.5521159172058105,0.9151514275550843,other,0.0,[],False,True,6,0.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.8870142102241516,0.0,neutral,0.0,0.7003,0.153,0.0,0.847,0.0,0.0,0.0,0.7936571051120758,other,0.0,[],False,True,6,0.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4% - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4% - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",-0.9539524912834167,negative,0.9539524912834167,0.0,neutral,0.0,0.7003,0.153,0.0,0.847,0.0,0.12,-0.5451157093048096,0.8271262456417083,other,0.0,[],False,True,6,0.0
2024-10-30,2024-10-30 07:00:00,"Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",-0.9560682773590088,negative,0.9560682773590088,0.0,neutral,0.0,-0.5574,0.0,0.119,0.881,0.0,0.0,-0.5463247299194336,0.7567341386795043,other,0.0,[],False,True,6,0.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3% - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3% - Mint <a href=""https://news.google.com/rss/articles/CBMi4wFBVV95cUxQY3d5NDlNaTB3VEljQ0NGSkVxbGtWWmh2b3Q0T3dvTXJKMzlKYXZnWW4yWHJtbVFDTFZCRWlPQTRQM1p2YXFIMEVnVUZHWmlVdTIyZDZLcjVHZ3ludkM3a3pTbVktb3B6WC1SVllJVVZTcmhIdE1MUlQtdFEyaTl1Y3Z1NllOOFhYMGJHSTM4dUt6RVVHbklTY3d2U3lGcXg2ZEhzRzV1blZCdWUtMUozSEI0UEJVVUttSE5ReDFoQWljRFQ1Snk2QlE5YVBoenh5SHBKWk9MRUg2aEo5NExBU3diY9IB6AFBVV95cUxOaUhNT3IwRFVERzJUQlhhcWdUOUhiOW5jaHN0dUZGeW4xNWhCcTdHc3RDSWUzd2ctVTRZZDN2TkJCRE00bzZacVVWMWF5dk9jM2piOTlMdHg4eUdpNGNpMkt2R0JqQjhfTUxLTG1MejJKcWlWU240aTBUY0lMVzVjZnoyaExWejBrNWhPOGRXeERNdmFKbHpTcDBsN2xKc251Tm04SndfeUE1U0pSTlJzY01VbE9OeHZFQVl6ZWo2cWNOd01wZjM2MFV2Vldtal9MQlZWZHJyUEM0b1Y1YVlsTDRtajRVMEVq?oc=5"" target=""_blank"">Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.9453872442245483,positive,0.9453872442245483,0.0,neutral,0.0,0.7003,0.162,0.0,0.838,0.04,0.16,0.5402212824140276,0.5618957480748494,other,0.0,[],False,True,6,0.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxQUWxKQjZRbjBoMGdkRXRGeUwtY2V5dEpIYjVnaDFmQUdqeFVPaTE2RnNCQmpaN2FWWEVKUXpVaW1wWU9mdWw0S3ZDcG90dU1DQmMyLTg4Nzh6dzV5S1haUXdfdkZKelNLRkItUlVlQ3RPQnBNeUdsUDJscUhfZzg5ZTNjMm1FWW5LcngweDJoTF9oY1FKU0l2S2s1ODZNUFBpTVZ6dVpVYkpSejVwOEw2NHZlVWloVmN0bHcydHJONThPNS1EcmIzbmtXVVUxMzFxOUZ0aGlzN0bSAd4BQVVfeXFMTmZXNDVORnZUYVNHUXFleU82YnFFaDN2NUNwQmZkMHlNcDFqZ05GX3J1YjlSbnVyeGxXcU1uLUthaGpkSG45UXJINVFEVk83QXF5SWYwV2p3blhMMThNakEwVUh3dEZjMl9seGRFODFqRnBHa3ZXY3AtVUh0YXJoZXZ2d3UtRnI3R2dvMzg2SlpPamxqVUlCc0ZtN3FKQlBNRGRPTHlkU2RWMnVmU2lmQzVyM2dna3hudEE5VFphcnA4UFFaUnFkMWZab3FDQkROLUczcFNHVDFpUHB2Mjdn?oc=5"" target=""_blank"">Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",-0.9406448602676392,negative,0.9406448602676392,0.0,neutral,0.0,0.7003,0.146,0.0,0.854,-0.01,0.05,-0.5375113487243652,0.5503149534225463,other,0.0,[],False,True,6,0.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2 results: Net loss of Rs 16 cr on high tax, revenue at Rs 3,590 cr - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 results: Net loss of Rs 16 cr on high tax, revenue at Rs 3,590 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon Q2 results: Net loss of Rs 16 cr on high tax, revenue at Rs 3,590 cr - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 results: Net loss of Rs 16 cr on high tax, revenue at Rs 3,590 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9493246078491211,negative,0.9493246078491211,0.0,neutral,0.0,-0.5574,0.0,0.108,0.892,0.05333333333333334,0.18000000000000002,-0.542471204485212,0.5200193137274848,other,0.0,[],False,True,6,0.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9729074239730835,negative,0.9729074239730835,0.0,neutral,0.0,0.7003,0.172,0.0,0.828,0.0,0.0,-0.5559470994131905,0.8366037119865417,other,0.0,[],False,True,6,0.0
2024-08-07,2024-08-07 07:00:00,"Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch? - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5"" target=""_blank"">Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5,Google News,Biocon quarterly earnings,"Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch? - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5"" target=""_blank"">Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9447391033172607,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9447391033172607,other,0.0,[],False,True,6,0.0
2025-01-30,2025-01-30 08:00:00,"Q3 results Highlights: Bajaj Holdings' revenue up 17%, CONCOR's growth offset by margin slips - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q3 results Highlights: Bajaj Holdings' revenue up 17%, CONCOR's growth offset by margin slips</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Q3 results Highlights: Bajaj Holdings' revenue up 17%, CONCOR's growth offset by margin slips - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Q3 results Highlights: Bajaj Holdings' revenue up 17%, CONCOR's growth offset by margin slips</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.9413850903511047,positive,0.9413850903511047,0.0,neutral,0.0,0.6369,0.14,0.0,0.86,0.0,0.0,0.5379343373434884,0.7891425451755524,other,0.0,[],False,False,1,0.0
2024-10-30,2024-10-30 07:00:00,"Top Events on Oct 30: Tata Power, Biocon Q2 results, Choti Diwali, India-China resume patrolling at LAC, and more - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top Events on Oct 30: Tata Power, Biocon Q2 results, Choti Diwali, India-China resume patrolling at LAC, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Top Events on Oct 30: Tata Power, Biocon Q2 results, Choti Diwali, India-China resume patrolling at LAC, and more - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Top Events on Oct 30: Tata Power, Biocon Q2 results, Choti Diwali, India-China resume patrolling at LAC, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.9093633890151978,0.0,neutral,0.0,0.2023,0.042,0.0,0.958,0.3333333333333333,0.3333333333333333,0.0,0.481665574116177,other,0.0,[],False,True,6,0.0
2025-05-08,2025-05-08 07:00:00,"Q4 Results 2025 Highlights: Sula Vineyards net profit falls 4% to Rs 13 crore, firm announces final dividend - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Sula Vineyards net profit falls 4% to Rs 13 crore, firm announces final dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Q4 Results 2025 Highlights: Sula Vineyards net profit falls 4% to Rs 13 crore, firm announces final dividend - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Sula Vineyards net profit falls 4% to Rs 13 crore, firm announces final dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",-0.9559220671653748,negative,0.9559220671653748,0.0,neutral,0.0,0.7003,0.132,0.0,0.868,-0.05714285714285715,0.39999999999999997,-0.546241181237357,0.5711216414360772,other,0.0,[],False,False,1,0.0
2025-01-31,2025-01-31 08:00:00,"Stocks to Watch, Jan 31: L&T, Biocon, BoB, CCI, Kalyan Jewellers, Aavas Fin - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch, Jan 31: L&amp;T, Biocon, BoB, CCI, Kalyan Jewellers, Aavas Fin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Stocks to Watch, Jan 31: L&T, Biocon, BoB, CCI, Kalyan Jewellers, Aavas Fin - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch, Jan 31: L&amp;T, Biocon, BoB, CCI, Kalyan Jewellers, Aavas Fin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.9285281300544739,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9285281300544739,other,0.0,[],False,True,6,0.0
2025-05-09,2025-05-09 07:00:00,Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5,Google News,Biocon quarterly earnings,"Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15% - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",-0.956637978553772,negative,0.956637978553772,0.0,neutral,0.0,0.891,0.266,0.0,0.734,0.0,0.0,-0.5466502734592983,0.923818989276886,other,0.0,[],False,False,1,0.0
2024-10-30,2024-10-30 07:00:00,"Q2 Result 2024: L&T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5"" target=""_blank"">Q2 Result 2024: L&amp;T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5,Google News,Biocon quarterly earnings,"Q2 Result 2024: L&T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5"" target=""_blank"">Q2 Result 2024: L&amp;T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9356406927108765,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9356406927108765,other,0.0,[],False,True,6,0.0
2024-10-30,2024-10-30 02:53:53,"Tata Power, L&T, Biocon, Dabur India Among 77 Companies To Declare Q2 Results Today - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQ295cDZSLU42WGxfd0JEa2s3YXBWcWJVbUZteDVNWXZuaVhqc1gyeFZtdjZaWUg1bkRabjJkT0puVjVIMTYzMXhhdnBEcGhiSTQ2c0xZRl9mWkN5S0IxRERIY3NDZWZEd1FjbHRpU25GUmEyR0hTbmJWNjBIY3FNOW9PRzNmT1lLWl9SZEgwd3YtTlpSNXdBaHdIM256ckVtS0dDdEwwdmhxcW9iNm1vU1J2eXllTlpHU3NKSHFqdVRuems?oc=5"" target=""_blank"">Tata Power, L&amp;T, Biocon, Dabur India Among 77 Companies To Declare Q2 Results Today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQ295cDZSLU42WGxfd0JEa2s3YXBWcWJVbUZteDVNWXZuaVhqc1gyeFZtdjZaWUg1bkRabjJkT0puVjVIMTYzMXhhdnBEcGhiSTQ2c0xZRl9mWkN5S0IxRERIY3NDZWZEd1FjbHRpU25GUmEyR0hTbmJWNjBIY3FNOW9PRzNmT1lLWl9SZEgwd3YtTlpSNXdBaHdIM256ckVtS0dDdEwwdmhxcW9iNm1vU1J2eXllTlpHU3NKSHFqdVRuems?oc=5,Google News,Biocon quarterly earnings,"Tata Power, L&T, Biocon, Dabur India Among 77 Companies To Declare Q2 Results Today - NDTV Profit <a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQ295cDZSLU42WGxfd0JEa2s3YXBWcWJVbUZteDVNWXZuaVhqc1gyeFZtdjZaWUg1bkRabjJkT0puVjVIMTYzMXhhdnBEcGhiSTQ2c0xZRl9mWkN5S0IxRERIY3NDZWZEd1FjbHRpU25GUmEyR0hTbmJWNjBIY3FNOW9PRzNmT1lLWl9SZEgwd3YtTlpSNXdBaHdIM256ckVtS0dDdEwwdmhxcW9iNm1vU1J2eXllTlpHU3NKSHFqdVRuems?oc=5"" target=""_blank"">Tata Power, L&amp;T, Biocon, Dabur India Among 77 Companies To Declare Q2 Results Today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",0.0,neutral,0.5279045701026917,0.0,neutral,0.0,0.4404,0.081,0.0,0.919,0.0,0.0,0.0,0.48415228505134583,other,0.0,[],False,True,6,0.0
2024-08-09,2024-08-09 07:00:00,"Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5"" target=""_blank"">Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5,Google News,Biocon quarterly earnings,"Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5"" target=""_blank"">Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9079014658927917,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9079014658927917,other,0.0,[],False,True,6,0.0
2025-05-09,2025-05-09 07:00:00,Biocon Q4 results: Net profit surges 153% at Rs 344 crore - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 results: Net profit surges 153% at Rs 344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon Q4 results: Net profit surges 153% at Rs 344 crore - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 results: Net profit surges 153% at Rs 344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.911757230758667,positive,0.911757230758667,0.0,neutral,0.0,0.7003,0.172,0.0,0.828,0.08,0.08,0.5210041318620954,0.5640190769195557,other,0.0,[],False,True,6,0.0
2025-05-21,2025-05-21 07:00:00,"Stocks in Focus: IRCON International, United Breweries, Biocon, and Others - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxPNktoaU1NVDJNR1FQWk82SUlzbmFZQU9BUm13X1NSZmg4NFpNYlFQZlJFb1h0QjhJWUtPYXU5M2dib2tJTTNSMTZkUkVXOGF1WHI4SFNQbXE2ZTNtdHcxVklCY1M2eUE3cUVRMGIxb0JCWWNIbWxGdVJhVzQ3RDFnNGpaUmhBMm9LZll6alhMb2swaG54LXFKYzl4QkxCZFlUa0E?oc=5"" target=""_blank"">Stocks in Focus: IRCON International, United Breweries, Biocon, and Others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxPNktoaU1NVDJNR1FQWk82SUlzbmFZQU9BUm13X1NSZmg4NFpNYlFQZlJFb1h0QjhJWUtPYXU5M2dib2tJTTNSMTZkUkVXOGF1WHI4SFNQbXE2ZTNtdHcxVklCY1M2eUE3cUVRMGIxb0JCWWNIbWxGdVJhVzQ3RDFnNGpaUmhBMm9LZll6alhMb2swaG54LXFKYzl4QkxCZFlUa0E?oc=5,Google News,Biocon quarterly earnings,"Stocks in Focus: IRCON International, United Breweries, Biocon, and Others - Equitypandit <a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxPNktoaU1NVDJNR1FQWk82SUlzbmFZQU9BUm13X1NSZmg4NFpNYlFQZlJFb1h0QjhJWUtPYXU5M2dib2tJTTNSMTZkUkVXOGF1WHI4SFNQbXE2ZTNtdHcxVklCY1M2eUE3cUVRMGIxb0JCWWNIbWxGdVJhVzQ3RDFnNGpaUmhBMm9LZll6alhMb2swaG54LXFKYzl4QkxCZFlUa0E?oc=5"" target=""_blank"">Stocks in Focus: IRCON International, United Breweries, Biocon, and Others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.0,neutral,0.9314109086990356,0.0,neutral,0.0,0.6808,0.203,0.0,0.797,0.0,0.0,0.0,0.8061054543495179,other,0.0,[],False,True,6,0.0
2024-08-08,2024-08-08 07:00:00,"Q1 results today: LIC, Oil India, Bharat Forge, SAIL, Cochin Shipyard, Bayer Cropscience, ABB & more to report earnings - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q1 results today: LIC, Oil India, Bharat Forge, SAIL, Cochin Shipyard, Bayer Cropscience, ABB & more to report earnings</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Q1 results today: LIC, Oil India, Bharat Forge, SAIL, Cochin Shipyard, Bayer Cropscience, ABB & more to report earnings - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Q1 results today: LIC, Oil India, Bharat Forge, SAIL, Cochin Shipyard, Bayer Cropscience, ABB & more to report earnings</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.9064799547195435,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.3333333333333333,0.3333333333333333,0.0,0.6199066440264384,other,0.0,[],False,False,1,0.0
2024-08-09,2024-08-09 07:00:00,"Stocks in news: Ola Electric, LIC, Eicher Motors, GAIL, Sobha, SAIL, Biocon and SJVN - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Ola Electric, LIC, Eicher Motors, GAIL, Sobha, SAIL, Biocon and SJVN</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi6gFBVV95cUxNbUl2NlJvWEpaRHBrNWM2M291UHlqQTh1Y2IxRERxVmRCRjlIdEQ0M011MW5NZVlFZzY4M0dOQXZZWVUweHVua3FLQUdvSWZYeTlteUVkN3hPdTdMYXI5LThiMC03TDJya1VDM1NST0p2UVFaZWFXZ015Z182WlFHV2JTRUt4UGFTVVJESXpxcEJTUmN5Y2g5V0xlSXVHWlAzcW1Kd20zYUJoWU9EQVJxcC1hYk84d3RwN2NNRGZJNjczT21vVldJYTVWbHBlRXZTSU9zRE5LQndmN0dmNm5lVmpJeDJmU1dkQUHSAe8BQVVfeXFMTVpfZ3hBSWI3N2E3aWMyUDhmT2FhbFR1elJiWGNhUGY2d2xrVkxnMUZKdjBLMFpFMmlSdG43S3VsaEpLLWNNM2xDN0VEY19nUlFIaC1ZNG9HS3QyN3ZhU2x6UWplZ3MxUVhjMzJpLU5xYXhDMW1Odm90Y05LRFVULXJKcHBKMkNaT0VZeGg1ZDFhRDlOWkdITXpwdlprVHlrU2VjU1ZPazFpeFk5dUcxZXlJM3BtZzR2aEI2ZWNkaGJmQjlKNTJQTnRYUHRRc2puWlVVdFJFMFpwQmdabW5BQThOQWZxbmY5Y0kxWTFabE0?oc=5,Google News,Biocon quarterly earnings,"Stocks in news: Ola Electric, LIC, Eicher Motors, GAIL, Sobha, SAIL, Biocon and SJVN - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Ola Electric, LIC, Eicher Motors, GAIL, Sobha, SAIL, Biocon and SJVN</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.9358790516853333,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9358790516853333,other,0.0,[],False,True,6,0.0
2025-04-23,2025-04-23 07:00:00,"Syngene Q4 results: PAT down 3%, revenue from ops up 11% to ₹1,018 cr - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene Q4 results: PAT down 3%, revenue from ops up 11% to ₹1,018 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Syngene Q4 results: PAT down 3%, revenue from ops up 11% to ₹1,018 cr - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene Q4 results: PAT down 3%, revenue from ops up 11% to ₹1,018 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9688789248466492,negative,0.9688789248466492,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.07777777777777778,0.14444444444444446,-0.553645099912371,0.5233283513122134,other,0.0,[],False,False,1,0.0
2025-01-23,2025-01-23 08:00:00,"Syngene International Q3 results: PAT rises 17.6%, revenue up 10.6% - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene International Q3 results: PAT rises 17.6%, revenue up 10.6%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxQdEI0RGJQRzl4bXJpRnZGeGJGWFRZdFZ1NWs0YXloeEpmb3pHX0xCb0dUMlB1WGRVTFIxT25IeGw5OWJnWllNS3h6bGRmc3A3Q0puVXoySUlqQWdGWURwRWVldk5yRFJFZjZ0SUFKTXRoTnNtbE1vLXRRakVnUHhIc3BhamIxa1daR0VtbjJFOC1QUmRtOGxmQmJFN212VFMyZlc5Z0k5QV9NZnhQUURGcWlPM3N0Z2FhUDRhdzJ2XzVjbXFfN3JnODRGRDJFVEph0gHWAUFVX3lxTFBha21WOTNlR1FCbmJXcEhPeDdFUEQ1aW5kVlRxa1NPcUg1bS1xMzQ4VmZzYTFmN2k5UlBya0t3SE9sQkNlZ3dhTC1Jdm1jYldDUkM5WmM5MVhzQ25sTENuZHFydDlIRmVpV0laWHBWenA1NFhuWlZVTXp0VDFvUmpHVW1nSVQwZXlnenpXczZtenYtcF9TVi1jdVd4V2FrelNyRnhOZmsyYkczeENuWS0zRXkySDdSel9EUjN1YjU3S0YwU09TN2pqVC1zWDIzUC1FWENpMHc?oc=5,Google News,Biocon quarterly earnings,"Syngene International Q3 results: PAT rises 17.6%, revenue up 10.6% - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene International Q3 results: PAT rises 17.6%, revenue up 10.6%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9377917051315308,positive,0.9377917051315308,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5358809743608747,0.9377917051315308,other,0.0,[],False,False,1,0.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxOMmZFTGhCc2REWUZWXzB2OTBzVmRlQUV5VTloRFVrQmtTdUFlWDdZOFdUVFQtNVQ4MXczUXlvRDFVU09tc09ublpxZWN4ellZdFVpcXhCUWVROVNWbW9NYVR3ZnBlTEhYUm90R1pTdk4tLVpxYlFSczBkNUt2djdQeTBoYVcyLWwzRTlJTW1CcUY4WkNobjR2bVpnQ0V6bFRWQlBOVjRnbW9SY002U3B2REdrMkFjMGJVVTRkZ3JycEFlUWRvMVHSAcsBQVVfeXFMTUNRTmd5UXdhT0NnenFpdkxmUVZNcFk2djB6MGhvWUlXdDdJYkRlQnBfT3M2U0Y0b21taXY3Q19May1RZUdNemtRc185SXJRR1VmVnRLOVhzT1FULXdyNG45VmJ2VVpXX0FYRF9oQUxTdU1BcjNBS0dJMm02TXUtVlM5V1Z5MHl6dEFBMnhGRWt0RzhaQVFLUkZuZnQ4RXBQeWdHbldaRU9mQ2xBOXYxZEFEUnlSTVVfTGdDQnhreVhzZU9qd1lWMk5GOVk?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.5879676938056946,positive,0.5879676938056946,0.0,neutral,0.0,0.7003,0.153,0.0,0.847,0.14285714285714285,0.42857142857142855,0.33598153931753977,0.47704161222094577,other,0.0,[],False,True,6,0.0
2025-05-09,2025-05-09 07:00:00,Biocon posts more than twofold increase in Q4 profit - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMirAFBVV95cUxOTFg5SG9TTmhUR2l1TGM2OWh2NXFyeGEyV2hHMUxoZHZDbzZaNjB2eFNyVk1tZnNqcWNtNVMyeUZoYjJFeVFmdll5Y2Q2QV9ra1AxWDJGMGJOYllDcGN2X19lU2FfYkRhTnZhZkhNZFdyelkyeGxrbGFxVG42b05zdWtRcDE2WG1PcHc0d196ejZGN240bm5HaUlnMTlVXzJXN0ZXUU5LeHE4TTI30gGyAUFVX3lxTFBEM1BBanFzTUFKODNKQzFuUFpkNXIxaVVGT2Y1T0tkaXZpVHVSYmdUd3FjVEMySi1Mam52cy10Z1F6c0xRZF9QMlZvYlMtX0QwZ1VkOHcyck5JZkRVcXN4QURnZjI3Nk04clZ4OWRLODRKTTVHVm1GTThwc00yMVgwU0szLWtvN0kwWjB1MDgzMERyVkhEaERfX1JhVG0wWnFKWG1FMmNMTU1FSmJWTE9jQ1E?oc=5"" target=""_blank"">Biocon posts more than twofold increase in Q4 profit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMirAFBVV95cUxOTFg5SG9TTmhUR2l1TGM2OWh2NXFyeGEyV2hHMUxoZHZDbzZaNjB2eFNyVk1tZnNqcWNtNVMyeUZoYjJFeVFmdll5Y2Q2QV9ra1AxWDJGMGJOYllDcGN2X19lU2FfYkRhTnZhZkhNZFdyelkyeGxrbGFxVG42b05zdWtRcDE2WG1PcHc0d196ejZGN240bm5HaUlnMTlVXzJXN0ZXUU5LeHE4TTI30gGyAUFVX3lxTFBEM1BBanFzTUFKODNKQzFuUFpkNXIxaVVGT2Y1T0tkaXZpVHVSYmdUd3FjVEMySi1Mam52cy10Z1F6c0xRZF9QMlZvYlMtX0QwZ1VkOHcyck5JZkRVcXN4QURnZjI3Nk04clZ4OWRLODRKTTVHVm1GTThwc00yMVgwU0szLWtvN0kwWjB1MDgzMERyVkhEaERfX1JhVG0wWnFKWG1FMmNMTU1FSmJWTE9jQ1E?oc=5,Google News,Biocon quarterly earnings,"Biocon posts more than twofold increase in Q4 profit - Medical Dialogues <a href=""https://news.google.com/rss/articles/CBMirAFBVV95cUxOTFg5SG9TTmhUR2l1TGM2OWh2NXFyeGEyV2hHMUxoZHZDbzZaNjB2eFNyVk1tZnNqcWNtNVMyeUZoYjJFeVFmdll5Y2Q2QV9ra1AxWDJGMGJOYllDcGN2X19lU2FfYkRhTnZhZkhNZFdyelkyeGxrbGFxVG42b05zdWtRcDE2WG1PcHc0d196ejZGN240bm5HaUlnMTlVXzJXN0ZXUU5LeHE4TTI30gGyAUFVX3lxTFBEM1BBanFzTUFKODNKQzFuUFpkNXIxaVVGT2Y1T0tkaXZpVHVSYmdUd3FjVEMySi1Mam52cy10Z1F6c0xRZF9QMlZvYlMtX0QwZ1VkOHcyck5JZkRVcXN4QURnZjI3Nk04clZ4OWRLODRKTTVHVm1GTThwc00yMVgwU0szLWtvN0kwWjB1MDgzMERyVkhEaERfX1JhVG0wWnFKWG1FMmNMTU1FSmJWTE9jQ1E?oc=5"" target=""_blank"">Biocon posts more than twofold increase in Q4 profit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.944035530090332,positive,0.944035530090332,0.0,neutral,0.0,0.7922,0.277,0.0,0.723,0.25,0.25,0.5394488743373326,0.6620785100301106,other,0.0,[],False,True,6,0.0
2024-05-17,2024-05-17 07:00:00,"Biocon Q4 Results | Revenue, margins beat estimates, net profit declines - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results | Revenue, margins beat estimates, net profit declines</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon Q4 Results | Revenue, margins beat estimates, net profit declines - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results | Revenue, margins beat estimates, net profit declines</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",-0.9615808129310608,negative,0.9615808129310608,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,0.0,0.0,-0.5494747502463204,0.8309404064655304,other,0.0,[],False,True,6,0.0
2025-06-02,2025-06-02 07:00:00,"Stocks to Watch Today: HCL Technologies, Zinka Logistics, Biocon, Torrent Power, Jindal Stainless, Frontier Springs, Prostarm Info Systems in focus on 3 June - TradingView","<a href=""https://news.google.com/rss/articles/CBMiuAJBVV95cUxQRFpvWHAwam5MVmQ2di1pYTYwWkY2aWtQWXlzS19qNHRRekhsTHVfYllfUzlWM0RrY2lVUkEyV1JRNjNwbmh5QS12cTdjNTlSS0pNQ1lpdjFSVGZrVllSYXBSWmxXX1JfeW80QTlwZmlqOGh5NkpuZE1yVkp5NHNwV05wNTdROVVJZ3YzQ1Rva19FZ0hPYmJaSzcybExNYmpwYy0wM2I0dEY1Q3dHZ2JYOEpERE1nWG42Z1dMcTIwZ09JVVNJQ2V4aVd5WjVSWjFMR2x3Y1J3T05jTjRrX0tpOW1HOXJ3azlVSFFnT3EySEF1MGhmeTNzak12ek5ObFB3bVdneXcwbDR5WVpLX2dNalFwdGRpeEItdjJHZjVBZGZYdmplVHA0LW9Qakl6OFJ0eHRXOVY0RU4?oc=5"" target=""_blank"">Stocks to Watch Today: HCL Technologies, Zinka Logistics, Biocon, Torrent Power, Jindal Stainless, Frontier Springs, Prostarm Info Systems in focus on 3 June</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMiuAJBVV95cUxQRFpvWHAwam5MVmQ2di1pYTYwWkY2aWtQWXlzS19qNHRRekhsTHVfYllfUzlWM0RrY2lVUkEyV1JRNjNwbmh5QS12cTdjNTlSS0pNQ1lpdjFSVGZrVllSYXBSWmxXX1JfeW80QTlwZmlqOGh5NkpuZE1yVkp5NHNwV05wNTdROVVJZ3YzQ1Rva19FZ0hPYmJaSzcybExNYmpwYy0wM2I0dEY1Q3dHZ2JYOEpERE1nWG42Z1dMcTIwZ09JVVNJQ2V4aVd5WjVSWjFMR2x3Y1J3T05jTjRrX0tpOW1HOXJ3azlVSFFnT3EySEF1MGhmeTNzak12ek5ObFB3bVdneXcwbDR5WVpLX2dNalFwdGRpeEItdjJHZjVBZGZYdmplVHA0LW9Qakl6OFJ0eHRXOVY0RU4?oc=5,Google News,Biocon quarterly earnings,"Stocks to Watch Today: HCL Technologies, Zinka Logistics, Biocon, Torrent Power, Jindal Stainless, Frontier Springs, Prostarm Info Systems in focus on 3 June - TradingView <a href=""https://news.google.com/rss/articles/CBMiuAJBVV95cUxQRFpvWHAwam5MVmQ2di1pYTYwWkY2aWtQWXlzS19qNHRRekhsTHVfYllfUzlWM0RrY2lVUkEyV1JRNjNwbmh5QS12cTdjNTlSS0pNQ1lpdjFSVGZrVllSYXBSWmxXX1JfeW80QTlwZmlqOGh5NkpuZE1yVkp5NHNwV05wNTdROVVJZ3YzQ1Rva19FZ0hPYmJaSzcybExNYmpwYy0wM2I0dEY1Q3dHZ2JYOEpERE1nWG42Z1dMcTIwZ09JVVNJQ2V4aVd5WjVSWjFMR2x3Y1J3T05jTjRrX0tpOW1HOXJ3azlVSFFnT3EySEF1MGhmeTNzak12ek5ObFB3bVdneXcwbDR5WVpLX2dNalFwdGRpeEItdjJHZjVBZGZYdmplVHA0LW9Qakl6OFJ0eHRXOVY0RU4?oc=5"" target=""_blank"">Stocks to Watch Today: HCL Technologies, Zinka Logistics, Biocon, Torrent Power, Jindal Stainless, Frontier Springs, Prostarm Info Systems in focus on 3 June</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",0.0,neutral,0.9376488327980042,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.0,0.5354910830656687,other,0.0,[],False,True,6,0.0
2024-10-30,2024-10-30 07:00:00,"Q2 Results today: Biocon, Larsen & Toubro, Tata Power, Dabur, among 83 firms to declare earnings on October 30; check list - Upstox","<a href=""https://news.google.com/rss/articles/CBMiiwJBVV95cUxNcGR4TXlGaEF4VG5TaUNUZjcyTTZwZHZNQXctbmZOblk2dVhMNVpFVFY3aFZJODFWRjU2d3ZDSlhCZkc5OTBlQWNObThPTTBISmNMb09NeUJ4Znk3dzFDNjNZcXNDY1NiQ0ZCUUFvajVOSmxJWXEyTUJicmREWTFFMm50OWNqa0JwOEJZY0p6aFVweklwYW92TmhjWkdWQnFKNGNzM3MwYTlIcUtIZFVVRi1wSWg5WTNKOENnd0gtU2Rxay10OG40UFZ6NGw5aERtdXgzREtPS2h4czVIaTJRQnBzc0lkZ0Q4NXRwTXBvOUNnN2RRc19oZ18zYWQ5N1AzSjBZbU1wMUY1aXM?oc=5"" target=""_blank"">Q2 Results today: Biocon, Larsen & Toubro, Tata Power, Dabur, among 83 firms to declare earnings on October 30; check list</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMiiwJBVV95cUxNcGR4TXlGaEF4VG5TaUNUZjcyTTZwZHZNQXctbmZOblk2dVhMNVpFVFY3aFZJODFWRjU2d3ZDSlhCZkc5OTBlQWNObThPTTBISmNMb09NeUJ4Znk3dzFDNjNZcXNDY1NiQ0ZCUUFvajVOSmxJWXEyTUJicmREWTFFMm50OWNqa0JwOEJZY0p6aFVweklwYW92TmhjWkdWQnFKNGNzM3MwYTlIcUtIZFVVRi1wSWg5WTNKOENnd0gtU2Rxay10OG40UFZ6NGw5aERtdXgzREtPS2h4czVIaTJRQnBzc0lkZ0Q4NXRwTXBvOUNnN2RRc19oZ18zYWQ5N1AzSjBZbU1wMUY1aXM?oc=5,Google News,Biocon quarterly earnings,"Q2 Results today: Biocon, Larsen & Toubro, Tata Power, Dabur, among 83 firms to declare earnings on October 30; check list - Upstox <a href=""https://news.google.com/rss/articles/CBMiiwJBVV95cUxNcGR4TXlGaEF4VG5TaUNUZjcyTTZwZHZNQXctbmZOblk2dVhMNVpFVFY3aFZJODFWRjU2d3ZDSlhCZkc5OTBlQWNObThPTTBISmNMb09NeUJ4Znk3dzFDNjNZcXNDY1NiQ0ZCUUFvajVOSmxJWXEyTUJicmREWTFFMm50OWNqa0JwOEJZY0p6aFVweklwYW92TmhjWkdWQnFKNGNzM3MwYTlIcUtIZFVVRi1wSWg5WTNKOENnd0gtU2Rxay10OG40UFZ6NGw5aERtdXgzREtPS2h4czVIaTJRQnBzc0lkZ0Q4NXRwTXBvOUNnN2RRc19oZ18zYWQ5N1AzSjBZbU1wMUY1aXM?oc=5"" target=""_blank"">Q2 Results today: Biocon, Larsen & Toubro, Tata Power, Dabur, among 83 firms to declare earnings on October 30; check list</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.0,neutral,0.8782662153244019,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8782662153244019,other,0.0,[],False,True,6,0.0
2024-10-23,2024-10-23 07:00:00,"Syngene International Q2 results: PAT down by 8.93%, revenue drops by 2% - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene International Q2 results: PAT down by 8.93%, revenue drops by 2%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Syngene International Q2 results: PAT down by 8.93%, revenue drops by 2% - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene International Q2 results: PAT down by 8.93%, revenue drops by 2%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9720937013626099,negative,0.9720937013626099,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05185185185185185,0.09629629629629631,-0.5554821150643485,0.5119727766072308,other,0.0,[],False,False,1,0.0
2025-05-12,2025-05-12 07:00:00,Biocon shares decline even though analysts see up to 30% upside on stock — Should you buy - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares decline even though analysts see up to 30% upside on stock — Should you buy</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon shares decline even though analysts see up to 30% upside on stock — Should you buy - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxQeWtveXgzRUJEa29YTkY5clJyZmtCNlQtYUxqM3RwcGRKQmpVYjJJNzdtekJtWG1XSGlKNXZ6X2VhNVp3VXpKektDc0k2dFJfb2dUZVJ4SWRzOXV1UERURXZUYWt4MDF1TVVXNWk3ZE8yZDFqejlsOG9jRnJqQ0lXbkc0V29zU09aazh2Snh4eEdRdjNkaFlGd2xiREtZd3RoV2tTejNyYnNNSU5FMFNNSVVwcVI1MnB3Y1N6ZmFn0gHDAUFVX3lxTE1pczNzeW44N01kUFlmbmo0TFVZUmJHcGtHTDYwRkl5cm80UklxRlZobEFpTnVZTlBRVlZ6d01LTG1LYmRZdG1tcXlTTEtjVmd0WDRFNE5FbFc1ZHVPVnpNR29CX3JVbEQzd2d3WURQUTNldFllWl9LcDhGSHljVE1WYVo2NDBFWVliZ1duNUItd2syaU54ZlM0LWtKVkFqaGIzS0d3R1JIWFA2VGpYZXFqbTlDanZxdGRkSkxnbHdEYVMtUQ?oc=5"" target=""_blank"">Biocon shares decline even though analysts see up to 30% upside on stock — Should you buy</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",-0.969597339630127,negative,0.969597339630127,0.0,neutral,0.0,0.5267,0.109,0.0,0.891,0.0,0.0,-0.5540556226457868,0.7481486698150634,other,0.0,[],False,True,6,0.0
2025-05-09,2025-05-09 07:00:00,"Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51% - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.8670708537101746,positive,0.8670708537101746,0.0,neutral,0.0,0.7003,0.139,0.0,0.861,0.0,0.0,0.49546905926295687,0.7836854268550872,other,0.0,[],False,False,1,0.0
2025-05-08,2025-05-08 07:00:00,"Biocon Consolidated March 2025 Net Sales at Rs 4,417.00 crore, up 12.76% Y-o-Y - Moneycontrol","<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxNSjl0MU4zM05Qd2lwbVhZTkw2Q1pTcE1iTDczdFFyN1RQazdyd2x5azFjcTUweHlKeGctMEN3TW0zNU5oSFhoc2pyYmRNblJHZWRuRU5TN3dPa0g4XzlUR2dxZXpYS1pqNWtGU2ZKc19FcmhQaGdhaDZOOU1aMzlvUF9LN2d5XzlvYlMxeWZ6bmlhWlA2Tzk3elF4MWVVcGM4ejNlbzF5MDVRVTBianBVSmRxLXJ5aUNvMkl6RnBHOENwb2hVSERXQ3d4Qk13R0MyQklOX0RlVU_SAd4BQVVfeXFMTkdaclRST2pLMURWUktPWXYyWVNHSmlwSUF4QmJWZkdaRXJjQzZaeEJIQU5ZWXJXckdYdFpBN3RJRzlQdWQ3c296UmJCemtxdktndjhIWnl5dmxjVGlaT1J3UFdieVVsbmZONzJ0S18zRHEyT0U3bHlhLWJrMjhZN0M1eS1rVlZWNHBiYkJzQ1pINTNudEtsdjdFZnMwUDNWTThTWEN6X09PUHZHdU9wLTRDZ0JZVXFwNVZoc0lYM1FSaFZJQXFHa1psa0hhZV9rUDhySW9US0tNbFlrN1lR?oc=5"" target=""_blank"">Biocon Consolidated March 2025 Net Sales at Rs 4,417.00 crore, up 12.76% Y-o-Y</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxNSjl0MU4zM05Qd2lwbVhZTkw2Q1pTcE1iTDczdFFyN1RQazdyd2x5azFjcTUweHlKeGctMEN3TW0zNU5oSFhoc2pyYmRNblJHZWRuRU5TN3dPa0g4XzlUR2dxZXpYS1pqNWtGU2ZKc19FcmhQaGdhaDZOOU1aMzlvUF9LN2d5XzlvYlMxeWZ6bmlhWlA2Tzk3elF4MWVVcGM4ejNlbzF5MDVRVTBianBVSmRxLXJ5aUNvMkl6RnBHOENwb2hVSERXQ3d4Qk13R0MyQklOX0RlVU_SAd4BQVVfeXFMTkdaclRST2pLMURWUktPWXYyWVNHSmlwSUF4QmJWZkdaRXJjQzZaeEJIQU5ZWXJXckdYdFpBN3RJRzlQdWQ3c296UmJCemtxdktndjhIWnl5dmxjVGlaT1J3UFdieVVsbmZONzJ0S18zRHEyT0U3bHlhLWJrMjhZN0M1eS1rVlZWNHBiYkJzQ1pINTNudEtsdjdFZnMwUDNWTThTWEN6X09PUHZHdU9wLTRDZ0JZVXFwNVZoc0lYM1FSaFZJQXFHa1psa0hhZV9rUDhySW9US0tNbFlrN1lR?oc=5,Google News,Biocon quarterly earnings,"Biocon Consolidated March 2025 Net Sales at Rs 4,417.00 crore, up 12.76% Y-o-Y - Moneycontrol <a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxNSjl0MU4zM05Qd2lwbVhZTkw2Q1pTcE1iTDczdFFyN1RQazdyd2x5azFjcTUweHlKeGctMEN3TW0zNU5oSFhoc2pyYmRNblJHZWRuRU5TN3dPa0g4XzlUR2dxZXpYS1pqNWtGU2ZKc19FcmhQaGdhaDZOOU1aMzlvUF9LN2d5XzlvYlMxeWZ6bmlhWlA2Tzk3elF4MWVVcGM4ejNlbzF5MDVRVTBianBVSmRxLXJ5aUNvMkl6RnBHOENwb2hVSERXQ3d4Qk13R0MyQklOX0RlVU_SAd4BQVVfeXFMTkdaclRST2pLMURWUktPWXYyWVNHSmlwSUF4QmJWZkdaRXJjQzZaeEJIQU5ZWXJXckdYdFpBN3RJRzlQdWQ3c296UmJCemtxdktndjhIWnl5dmxjVGlaT1J3UFdieVVsbmZONzJ0S18zRHEyT0U3bHlhLWJrMjhZN0M1eS1rVlZWNHBiYkJzQ1pINTNudEtsdjdFZnMwUDNWTThTWEN6X09PUHZHdU9wLTRDZ0JZVXFwNVZoc0lYM1FSaFZJQXFHa1psa0hhZV9rUDhySW9US0tNbFlrN1lR?oc=5"" target=""_blank"">Biocon Consolidated March 2025 Net Sales at Rs 4,417.00 crore, up 12.76% Y-o-Y</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.9492645263671875,positive,0.9492645263671875,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5424368722098214,0.9492645263671875,other,0.0,[],False,True,6,0.0
2025-05-08,2025-05-08 07:00:00,"Biocon Standalone March 2025 Net Sales at Rs 643.80 crore, up 20.88% Y-o-Y - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Standalone March 2025 Net Sales at Rs 643.80 crore, up 20.88% Y-o-Y</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMi1AFBVV95cUxPRDItODFwQWZjNjJxX011VWphWlZDdW9Kc1A0VkpWa1E4YW0xY0d5OTZIb0V0NnBXbGpKOTRFQUpubDJzeDl2SjBiYmF4NExUN1llSGJRdmpUZDFtVnBxYzhLUTYxb0FhdEs0TUxfWHh3VEYtV28zT1FWRDNfS2pkeDBOenlkRTlsZlpsZzdtNU4wcnFONlZFc2NmSU1kb2o4Wm9EWjRfRV9iVGNUTVJZcUlFS3BhRWI1OFVOLThIZ3VhbHEweHAybjNuQ2FDbE1kNEZQStIB2gFBVV95cUxOZ3o4XzVaVldTdTdPWUIxZG1DVHp5TGlEdkN1U3VfbmJFQlprVGpZOHRDNjhoSjM1MnJndjB4dG5qLXhLeUlDTjJBeTh6MUVqSFZya01RVUFMZmtTbS1qQTBBVDZTbFNRV3hjTWc0R3ZnMUVCWll4NHhBOU91WXpUNVprbUh3MUxid0NDTHBGR2hLRUJGRXp6VGl5aUVjcEw5Yk5EdXZXS0dBZEFSWTBURmxLT3paN2lrYnl0M251Z2I4VHZFcjFpS19aZEJJeFJGclFxMkNsSUtBZw?oc=5,Google News,Biocon quarterly earnings,"Biocon Standalone March 2025 Net Sales at Rs 643.80 crore, up 20.88% Y-o-Y - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Standalone March 2025 Net Sales at Rs 643.80 crore, up 20.88% Y-o-Y</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.9471035599708557,positive,0.9471035599708557,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5412020342690604,0.9471035599708557,other,0.0,[],False,True,6,0.0
2025-04-28,2025-04-28 07:00:00,"Stocks to Watch Today: Reliance Industries, IDFC First Bank, Tata Tech, Tejas Networks, India Cements,... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch Today: Reliance Industries, IDFC First Bank, Tata Tech, Tejas Networks, India Cements,...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Stocks to Watch Today: Reliance Industries, IDFC First Bank, Tata Tech, Tejas Networks, India Cements,... - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch Today: Reliance Industries, IDFC First Bank, Tata Tech, Tejas Networks, India Cements,...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.9325554966926575,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.16666666666666666,0.2222222222222222,0.0,0.5496110816796621,other,0.0,[],False,False,1,0.0
2024-07-29,2024-07-29 07:00:00,"Stock Radar: ICICI Bank, India Cements, BHEL, Biocon, REC, IndusInd Bank, UltraTech in focus on Monday - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Radar: ICICI Bank, India Cements, BHEL, Biocon, REC, IndusInd Bank, UltraTech in focus on Monday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMi8gFBVV95cUxNRVdUWXVQLTdoLTlxbHJ1ejBWbTVCTi14Sk1IYjVNOUpuRTdzdDdZa0RvWmVkMlFIMGRYT0xZbnRzdGlCT2JUMGZxbnV4N043ZlI3SzN6QjdQZ0R3ci0ycU9wbUlBbktsc2NPUVhIWHIxUnhLemoyRk1lVjdGWm0zTUgyZ0dqbF9IXzlsV1BsejZYWjBqNlRVRjVzNFdtRE93OThzUzIxbkt5TmxZRWd2NzhrZEJHZlRxTHBhcmJmNGU1YWpqU3dMdU9UNFhRVDhKMlhCQkxkSG1BT2xIVGszTDU2bGhpX0VicUhKV3hQRnhzd9IB9wFBVV95cUxQaVljM2tGYXhCamVONlA5QUVVVVhSS3JFZDNFUC1sVWtfNWg0eThvQzlQOGozdXVuQllMM3puT3M2QzhBR1lDRVdqWTFMbmR2VXpRVHJoN3VjcDZ3N3pOSUE5ZFc5TXdGNm9mcTBFX1NyU2dSR2QxYWJPS0llX1dNbnlNRjdFSzlyM2lhTmIzNmMxWFpIWGJmakRWQzhTX0pLbm9SbFhsamdpYjlLUkIwOU1fQ2VBQVZYY1ZGcTFzUmhtbGdRQnRsU2JxOHZFQXdmYlN2cHZyZ0pXMFpQemVMdkV1d0ExaG8tR1NJeU83TmZQZDV4TmdZ?oc=5,Google News,Biocon quarterly earnings,"Stock Radar: ICICI Bank, India Cements, BHEL, Biocon, REC, IndusInd Bank, UltraTech in focus on Monday - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Radar: ICICI Bank, India Cements, BHEL, Biocon, REC, IndusInd Bank, UltraTech in focus on Monday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.9377578496932983,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9377578496932983,other,0.0,[],False,True,6,0.0
2024-08-27,2024-08-27 07:00:00,Top 5 High Quality Midcap Stocks Trading at Cheapest Valuations - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxPekJzMk1SaDFLWGJlalExZmEyV0M5NlZvVjBuUUZWemg1WmRSRUllMUlvTFZseEJ4SWU5a1ExZHdMY3dkRjZuSjNveFFTTWhTUmZ1NTJmdlJhajlRcTdUWDlibzZ1N3F1LWNkaFJRY1BSVEFwLVVmSVl0TTRfTnlPVEt0LW12SjlPdHc0ZVJLUFBEbTdsTjJfb0FvWlVPckd2bXhkODFteWZzTDlDbk92bkE0eFM4TEo5SHdueDQ3VWYyMjFFVmRIYm9JaVptUQ?oc=5"" target=""_blank"">Top 5 High Quality Midcap Stocks Trading at Cheapest Valuations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxPekJzMk1SaDFLWGJlalExZmEyV0M5NlZvVjBuUUZWemg1WmRSRUllMUlvTFZseEJ4SWU5a1ExZHdMY3dkRjZuSjNveFFTTWhTUmZ1NTJmdlJhajlRcTdUWDlibzZ1N3F1LWNkaFJRY1BSVEFwLVVmSVl0TTRfTnlPVEt0LW12SjlPdHc0ZVJLUFBEbTdsTjJfb0FvWlVPckd2bXhkODFteWZzTDlDbk92bkE0eFM4TEo5SHdueDQ3VWYyMjFFVmRIYm9JaVptUQ?oc=5,Google News,Biocon quarterly earnings,"Top 5 High Quality Midcap Stocks Trading at Cheapest Valuations - Equitymaster <a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxPekJzMk1SaDFLWGJlalExZmEyV0M5NlZvVjBuUUZWemg1WmRSRUllMUlvTFZseEJ4SWU5a1ExZHdMY3dkRjZuSjNveFFTTWhTUmZ1NTJmdlJhajlRcTdUWDlibzZ1N3F1LWNkaFJRY1BSVEFwLVVmSVl0TTRfTnlPVEt0LW12SjlPdHc0ZVJLUFBEbTdsTjJfb0FvWlVPckd2bXhkODFteWZzTDlDbk92bkE0eFM4TEo5SHdueDQ3VWYyMjFFVmRIYm9JaVptUQ?oc=5"" target=""_blank"">Top 5 High Quality Midcap Stocks Trading at Cheapest Valuations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",0.0,neutral,0.843562126159668,0.0,neutral,0.0,0.2023,0.079,0.0,0.921,0.20500000000000002,0.395,0.0,0.4169540420532227,other,0.0,[],False,False,1,0.0
2025-05-08,2025-05-08 07:00:00,"Pidilite Q4 results: PAT rises 41% to ₹428 cr; total income at ₹3,222 cr - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Pidilite Q4 results: PAT rises 41% to ₹428 cr; total income at ₹3,222 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Pidilite Q4 results: PAT rises 41% to ₹428 cr; total income at ₹3,222 cr - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Pidilite Q4 results: PAT rises 41% to ₹428 cr; total income at ₹3,222 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9221842885017395,positive,0.9221842885017395,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.375,0.5269624505724225,0.9221842885017395,other,0.0,[],False,False,1,0.0
2023-11-10,2023-11-10 08:00:00,Biosimilars growth props up Biocon Q2 PAT by 168% to Rs 126 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biosimilars growth props up Biocon Q2 PAT by 168% to Rs 126 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biosimilars growth props up Biocon Q2 PAT by 168% to Rs 126 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biosimilars growth props up Biocon Q2 PAT by 168% to Rs 126 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9290839433670044,positive,0.9290839433670044,0.0,neutral,0.0,0.6369,0.148,0.0,0.852,0.0,0.0,0.5309051104954311,0.7829919716835022,other,0.0,[],False,True,6,0.0
2024-05-16,2024-05-16 07:00:00,"Q4 results today: GAIL, HAL, Biocon, JK Paper, Vodafone Idea, M&M among 94 companies to post earnings on May 16 - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 results today: GAIL, HAL, Biocon, JK Paper, Vodafone Idea, M&amp;M among 94 companies to post earnings on May 16</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Q4 results today: GAIL, HAL, Biocon, JK Paper, Vodafone Idea, M&M among 94 companies to post earnings on May 16 - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 results today: GAIL, HAL, Biocon, JK Paper, Vodafone Idea, M&amp;M among 94 companies to post earnings on May 16</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.6351333856582642,0.0,neutral,0.0,0.6447,0.111,0.0,0.889,0.0,0.0,0.0,0.6399166928291321,other,0.0,[],False,True,6,0.0
2025-01-13,2025-01-13 08:00:00,"Stocks to Watch, Jan 13: HCL Tech, Avenue Supermarts, ICICI Pru, Biocon - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch, Jan 13: HCL Tech, Avenue Supermarts, ICICI Pru, Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Stocks to Watch, Jan 13: HCL Tech, Avenue Supermarts, ICICI Pru, Biocon - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch, Jan 13: HCL Tech, Avenue Supermarts, ICICI Pru, Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.9178870320320129,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9178870320320129,other,0.0,[],False,True,6,0.0
2023-11-10,2023-11-10 08:00:00,"Biocon Q2 Results 2023: Profit jumps 111% to ₹173 crore, beats estimates - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxNWHpQRml1VVo2RU83TWJiSnh1RWJFSmlManFiY01Nd0ZFWDVmUTdMZDIteFRZRG95NWJsLU54aXRzWEozSnRvZzBDQmhSdV9FQWlJZ3RTSnlRS0xqWUUzUDFUb2dJbUZYUTgwR3NoRUFwblFhSmpYWWY0Nm5fY3FqX2ZrN1M5YmpKeVgxY29FVmRmQdIBlwFBVV95cUxQSzl3Zlh0UXczNlpHM0RHeGkyakcyV09BbF9mWlRYaktXaTlSSTZVM0VqOFNvMGhiVC1QUHBxSldBOFRySElXdlJyYTRmbXY3VGM2THFMMzNRODlRNlN0SE1LQjQ5OVJLamUwS09JMGZTQUoza1V6Qnl0VS1lTkl1dHZLZTQ4QU0wM2dzaFFqQUJSc2d1amMw?oc=5"" target=""_blank"">Biocon Q2 Results 2023: Profit jumps 111% to ₹173 crore, beats estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxNWHpQRml1VVo2RU83TWJiSnh1RWJFSmlManFiY01Nd0ZFWDVmUTdMZDIteFRZRG95NWJsLU54aXRzWEozSnRvZzBDQmhSdV9FQWlJZ3RTSnlRS0xqWUUzUDFUb2dJbUZYUTgwR3NoRUFwblFhSmpYWWY0Nm5fY3FqX2ZrN1M5YmpKeVgxY29FVmRmQdIBlwFBVV95cUxQSzl3Zlh0UXczNlpHM0RHeGkyakcyV09BbF9mWlRYaktXaTlSSTZVM0VqOFNvMGhiVC1QUHBxSldBOFRySElXdlJyYTRmbXY3VGM2THFMMzNRODlRNlN0SE1LQjQ5OVJLamUwS09JMGZTQUoza1V6Qnl0VS1lTkl1dHZLZTQ4QU0wM2dzaFFqQUJSc2d1amMw?oc=5,Google News,Biocon quarterly earnings,"Biocon Q2 Results 2023: Profit jumps 111% to ₹173 crore, beats estimates - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxNWHpQRml1VVo2RU83TWJiSnh1RWJFSmlManFiY01Nd0ZFWDVmUTdMZDIteFRZRG95NWJsLU54aXRzWEozSnRvZzBDQmhSdV9FQWlJZ3RTSnlRS0xqWUUzUDFUb2dJbUZYUTgwR3NoRUFwblFhSmpYWWY0Nm5fY3FqX2ZrN1M5YmpKeVgxY29FVmRmQdIBlwFBVV95cUxQSzl3Zlh0UXczNlpHM0RHeGkyakcyV09BbF9mWlRYaktXaTlSSTZVM0VqOFNvMGhiVC1QUHBxSldBOFRySElXdlJyYTRmbXY3VGM2THFMMzNRODlRNlN0SE1LQjQ5OVJLamUwS09JMGZTQUoza1V6Qnl0VS1lTkl1dHZLZTQ4QU0wM2dzaFFqQUJSc2d1amMw?oc=5"" target=""_blank"">Biocon Q2 Results 2023: Profit jumps 111% to ₹173 crore, beats estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.9173321723937988,positive,0.9173321723937988,0.0,neutral,0.0,0.7003,0.172,0.0,0.828,0.0,0.0,0.5241898127964564,0.8088160861968994,other,0.0,[],False,True,6,0.0
2024-05-15,2024-05-15 07:00:00,"Q4 FY24 results: RVNL, MOIL, Biocon among 84 firms to post earnings today - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 FY24 results: RVNL, MOIL, Biocon among 84 firms to post earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Q4 FY24 results: RVNL, MOIL, Biocon among 84 firms to post earnings today - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 FY24 results: RVNL, MOIL, Biocon among 84 firms to post earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8060658574104309,positive,0.8060658574104309,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.46060906137738905,0.8060658574104309,other,0.0,[],False,True,6,0.0
2024-11-11,2024-11-11 08:00:00,Biocon Shares Rockets Up More Than 8% On NSE After US FDA Classifies Bengaluru Facility As Voluntary Action - Free Press Journal,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Rockets Up More Than 8% On NSE After US FDA Classifies Bengaluru Facility As Voluntary Action</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Biocon Shares Rockets Up More Than 8% On NSE After US FDA Classifies Bengaluru Facility As Voluntary Action - Free Press Journal <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Rockets Up More Than 8% On NSE After US FDA Classifies Bengaluru Facility As Voluntary Action</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",0.9431065320968628,positive,0.9431065320968628,0.0,neutral,0.0,0.7717,0.158,0.0,0.842,0.3,0.38,0.5389180183410645,0.6716021773656209,other,0.0,[],False,True,6,0.0
2025-01-31,2025-01-31 08:00:00,Q3 Results 2025: Vedanta profit surges 70.01%; Pfizer profit down 1.83% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQam5XbmE5SF83MzE2UTRLMW5mVDRKLVdtbnN2VlFGbGxwbVZRYjVqdnpNdHJQNDdHc2pzb2t4XzNxVnlfZlRUWHZUWURjbnRHVFJHNWgtU0tBN0J4QXZERXVvd1VhVTN2QWV0OVE5RERJZVNQZVNZQ2ZXSTIxak44QUhkR0ZJaWluVW1ILV9MWFRqSm4xcnpsNGpaakxuZDRFWXd2Rk9DaUEzR2Y3eDdrLVJsQ2N5Q2FUWWZBX3ZpVms1N2U0T2VlT1FheXVrX1hqU0FEX1Z6Tmtmak52ekFNWkF1LVJQSWpvSVdSb2ttT1hLOGhhWmcxUUxn?oc=5"" target=""_blank"">Q3 Results 2025: Vedanta profit surges 70.01%; Pfizer profit down 1.83%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxQam5XbmE5SF83MzE2UTRLMW5mVDRKLVdtbnN2VlFGbGxwbVZRYjVqdnpNdHJQNDdHc2pzb2t4XzNxVnlfZlRUWHZUWURjbnRHVFJHNWgtU0tBN0J4QXZERXVvd1VhVTN2QWV0OVE5RERJZVNQZVNZQ2ZXSTIxak44QUhkR0ZJaWluVW1ILV9MWFRqSm4xcnpsNGpaakxuZDRFWXd2Rk9DaUEzR2Y3eDdrLVJsQ2N5Q2FUWWZBX3ZpVms1N2U0T2VlT1FheXVrX1hqU0FEX1Z6Tmtmak52ekFNWkF1LVJQSWpvSVdSb2ttT1hLOGhhWmcxUUxn?oc=5,Google News,Biocon quarterly earnings,"Q3 Results 2025: Vedanta profit surges 70.01%; Pfizer profit down 1.83% - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQam5XbmE5SF83MzE2UTRLMW5mVDRKLVdtbnN2VlFGbGxwbVZRYjVqdnpNdHJQNDdHc2pzb2t4XzNxVnlfZlRUWHZUWURjbnRHVFJHNWgtU0tBN0J4QXZERXVvd1VhVTN2QWV0OVE5RERJZVNQZVNZQ2ZXSTIxak44QUhkR0ZJaWluVW1ILV9MWFRqSm4xcnpsNGpaakxuZDRFWXd2Rk9DaUEzR2Y3eDdrLVJsQ2N5Q2FUWWZBX3ZpVms1N2U0T2VlT1FheXVrX1hqU0FEX1Z6Tmtmak52ekFNWkF1LVJQSWpvSVdSb2ttT1hLOGhhWmcxUUxn?oc=5"" target=""_blank"">Q3 Results 2025: Vedanta profit surges 70.01%; Pfizer profit down 1.83%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",-0.9699437618255615,negative,0.9699437618255615,0.0,neutral,0.0,0.891,0.345,0.0,0.655,-0.1037037037037037,0.19259259259259262,-0.5542535781860352,0.6548824885097551,other,0.0,[],False,False,1,0.0
2024-08-09,2024-08-09 07:00:00,"Stocks To Watch: Eicher Motors, LIC, Cochin Shipyard, Biocon, Oil India, SJVN, Grasim, Alkem Lab - Market News - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxNU21FbnVlUWFhUXlhTDlBRndZczVPTTF3aEVwYWhKUHQ3ajVVem1UVTlZUE82Wk9RTWpzcGc2YW5tSk1PLUd2N1pyREFiN0xheTVDdlk1bVJJRjlUdllXWC1oVkpqSmN2cXdaTF9IVEtoR3BBQ3I3V0tfakJNelVwZzlNaTg4OGd0M2tZaE9BejRpRmZuSGJxdk1fR2hKX05lSGFjb3psZVFFWGFZV3lWWFA1NVBZWGJ6YU9JbDBSWXF5NTZVbjNWeDV2ZGRBZXRpQkRj?oc=5"" target=""_blank"">Stocks To Watch: Eicher Motors, LIC, Cochin Shipyard, Biocon, Oil India, SJVN, Grasim, Alkem Lab - Market News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi0wFBVV95cUxNU21FbnVlUWFhUXlhTDlBRndZczVPTTF3aEVwYWhKUHQ3ajVVem1UVTlZUE82Wk9RTWpzcGc2YW5tSk1PLUd2N1pyREFiN0xheTVDdlk1bVJJRjlUdllXWC1oVkpqSmN2cXdaTF9IVEtoR3BBQ3I3V0tfakJNelVwZzlNaTg4OGd0M2tZaE9BejRpRmZuSGJxdk1fR2hKX05lSGFjb3psZVFFWGFZV3lWWFA1NVBZWGJ6YU9JbDBSWXF5NTZVbjNWeDV2ZGRBZXRpQkRj?oc=5,Google News,Biocon quarterly earnings,"Stocks To Watch: Eicher Motors, LIC, Cochin Shipyard, Biocon, Oil India, SJVN, Grasim, Alkem Lab - Market News - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxNU21FbnVlUWFhUXlhTDlBRndZczVPTTF3aEVwYWhKUHQ3ajVVem1UVTlZUE82Wk9RTWpzcGc2YW5tSk1PLUd2N1pyREFiN0xheTVDdlk1bVJJRjlUdllXWC1oVkpqSmN2cXdaTF9IVEtoR3BBQ3I3V0tfakJNelVwZzlNaTg4OGd0M2tZaE9BejRpRmZuSGJxdk1fR2hKX05lSGFjb3psZVFFWGFZV3lWWFA1NVBZWGJ6YU9JbDBSWXF5NTZVbjNWeDV2ZGRBZXRpQkRj?oc=5"" target=""_blank"">Stocks To Watch: Eicher Motors, LIC, Cochin Shipyard, Biocon, Oil India, SJVN, Grasim, Alkem Lab - Market News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9484571218490601,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9484571218490601,other,0.0,[],False,True,6,0.0
2024-10-30,2024-10-30 07:00:00,Unity Small Finance Bank Q2: Net profit rises 36% to Rs 187 crore - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxNYzJTc056WUdRZXFCOFdyMDZ2cDEyUzNFcTkwVE11NGNrVGdhejRTQ1hULXpLNVNMR0VWZzF3Tl9zNnFablptaThacHgtVzRDbERoX2g1R2FKU25kZDFtdUF4N0VhVGZ5WnlKeGFJcTVHZ011NGFGeXhVRUNoc2J3ZjBuUVQ5S3ZBVGdyUDdMeDlkYzc1aTlldnl6aHJyREhlNGgzNjFZcEw5RHVlUHdtZDhKa0VlbTF5MXhkR21wYTBNUFE3TndEZkdZWVk5MmZW0gHWAUFVX3lxTE5Id1Z1bkRMUndSZzMyS3hsVmZDU0pFR1JPYnFpQXhzNGlydHhtX0oyOUY0MWpTUTJ0Z2VNUzh1U2pHeE1tSmtLS1lad2FwcThjRGtCZHN3UEZvQWxDVExPYTBubm9GRzMzbzJ2V3FPYmZweDVvLTVYQ3otSklQTzM5YktSOXZFZHNmQkZtQktTN0N5RjU2X1FWWGZsNkNidl90SkZuQk1Ram50UDd1eUcxT3o2X01iWThDdzZvOElnQmUxMmxIcUkzY0lXR0ZyX1BzSUVUVkE?oc=5"" target=""_blank"">Unity Small Finance Bank Q2: Net profit rises 36% to Rs 187 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon quarterly earnings,"Unity Small Finance Bank Q2: Net profit rises 36% to Rs 187 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Unity Small Finance Bank Q2: Net profit rises 36% to Rs 187 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9397957921028137,positive,0.9397957921028137,0.0,neutral,0.0,-0.5267,0.138,0.195,0.667,-0.08333333333333333,0.13333333333333333,0.5370261669158936,0.5166097084787157,other,0.0,[],False,False,1,0.0
2024-02-08,2024-02-08 08:00:00,"Q3 Results 2024: LIC, Grasim Industries, Patanjali Foods, Biocon, Schneider Electric Infrastructure and more to post earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMihAJBVV95cUxOcGRaTC0wUlEwb3FHZUJsTzhreVExNVpYb1FacHhCbnRLQVlQRmYxV2NPS2hLdUVRV0tqeUxYcHZOeVE3ZDYwV2V2RmdMTVo3MUdxckx2YkU4NXR6U0JzdG9saERmY1B1TFZhaGZaZ0luaDJnSHBSU19HazduM1RfeEdoNW9ON3Rva3loTW9OLTNmSEJUdXZhbGNRNTdaQngyQTlPbFRRel9QODAydHZGYkJxNUs0QlZSRlkxNkk3V2dpR0pPUVlDTUgxVGU1VkFhc3ZhWGJEc05oZW94UTFLR1ZCaVN5SnNObDNILXVLbkE0U3pENEZKcDZfM3lwMENOa2VWQg?oc=5"" target=""_blank"">Q3 Results 2024: LIC, Grasim Industries, Patanjali Foods, Biocon, Schneider Electric Infrastructure and more to post earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMihAJBVV95cUxOcGRaTC0wUlEwb3FHZUJsTzhreVExNVpYb1FacHhCbnRLQVlQRmYxV2NPS2hLdUVRV0tqeUxYcHZOeVE3ZDYwV2V2RmdMTVo3MUdxckx2YkU4NXR6U0JzdG9saERmY1B1TFZhaGZaZ0luaDJnSHBSU19HazduM1RfeEdoNW9ON3Rva3loTW9OLTNmSEJUdXZhbGNRNTdaQngyQTlPbFRRel9QODAydHZGYkJxNUs0QlZSRlkxNkk3V2dpR0pPUVlDTUgxVGU1VkFhc3ZhWGJEc05oZW94UTFLR1ZCaVN5SnNObDNILXVLbkE0U3pENEZKcDZfM3lwMENOa2VWQg?oc=5,Google News,Biocon quarterly earnings,"Q3 Results 2024: LIC, Grasim Industries, Patanjali Foods, Biocon, Schneider Electric Infrastructure and more to post earnings today - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMihAJBVV95cUxOcGRaTC0wUlEwb3FHZUJsTzhreVExNVpYb1FacHhCbnRLQVlQRmYxV2NPS2hLdUVRV0tqeUxYcHZOeVE3ZDYwV2V2RmdMTVo3MUdxckx2YkU4NXR6U0JzdG9saERmY1B1TFZhaGZaZ0luaDJnSHBSU19HazduM1RfeEdoNW9ON3Rva3loTW9OLTNmSEJUdXZhbGNRNTdaQngyQTlPbFRRel9QODAydHZGYkJxNUs0QlZSRlkxNkk3V2dpR0pPUVlDTUgxVGU1VkFhc3ZhWGJEc05oZW94UTFLR1ZCaVN5SnNObDNILXVLbkE0U3pENEZKcDZfM3lwMENOa2VWQg?oc=5"" target=""_blank"">Q3 Results 2024: LIC, Grasim Industries, Patanjali Foods, Biocon, Schneider Electric Infrastructure and more to post earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.5406522154808044,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.3333333333333333,0.3333333333333333,0.0,0.43699277440706885,other,0.0,[],False,True,6,0.0
2025-01-29,2025-01-29 08:00:00,"Stocks to watch, January 30: Biocon, GAIL, Blue Star, Bajaj Finance, L&T, Tata Motors, Adani Enterprises, Bajaj Finserv, Raymond, and more - Upstox","<a href=""https://news.google.com/rss/articles/CBMimgJBVV95cUxQRUduekV6UkpSczVVNFdqaXRvVTAyLW5Ya0EtbDRkNm5UVEpSTjBWbHNuS0czWEZrb1d5aWpYb3BZWUxERlJWUWFoS2hGRDlTUEREZDZFdU5GSDZpRG9OT3plTm9wbWF3dW5Ta0htVk81Y3A0enNsR1dITllrdkNNZjNTczJHWEhZVFlHNkRWeTFfMlJfbENhQjJCOXo3R0xvUlZoVUhIUmtUeXZvRk5INnltbE9NY01BTEF5ZVRNcEFDekcxbjNXOHNwZmN6bnZ1TDZxamIwTVVGOTR6SXhuYlV0OFc4UU9CRWsydU5JbEZhZFlWR28wb094TndweHQ5V2ZkWVZSYmVNZmVDdHVMR19POVdYX2Q0Q2c?oc=5"" target=""_blank"">Stocks to watch, January 30: Biocon, GAIL, Blue Star, Bajaj Finance, L&amp;T, Tata Motors, Adani Enterprises, Bajaj Finserv, Raymond, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMimgJBVV95cUxQRUduekV6UkpSczVVNFdqaXRvVTAyLW5Ya0EtbDRkNm5UVEpSTjBWbHNuS0czWEZrb1d5aWpYb3BZWUxERlJWUWFoS2hGRDlTUEREZDZFdU5GSDZpRG9OT3plTm9wbWF3dW5Ta0htVk81Y3A0enNsR1dITllrdkNNZjNTczJHWEhZVFlHNkRWeTFfMlJfbENhQjJCOXo3R0xvUlZoVUhIUmtUeXZvRk5INnltbE9NY01BTEF5ZVRNcEFDekcxbjNXOHNwZmN6bnZ1TDZxamIwTVVGOTR6SXhuYlV0OFc4UU9CRWsydU5JbEZhZFlWR28wb094TndweHQ5V2ZkWVZSYmVNZmVDdHVMR19POVdYX2Q0Q2c?oc=5,Google News,Biocon quarterly earnings,"Stocks to watch, January 30: Biocon, GAIL, Blue Star, Bajaj Finance, L&T, Tata Motors, Adani Enterprises, Bajaj Finserv, Raymond, and more - Upstox <a href=""https://news.google.com/rss/articles/CBMimgJBVV95cUxQRUduekV6UkpSczVVNFdqaXRvVTAyLW5Ya0EtbDRkNm5UVEpSTjBWbHNuS0czWEZrb1d5aWpYb3BZWUxERlJWUWFoS2hGRDlTUEREZDZFdU5GSDZpRG9OT3plTm9wbWF3dW5Ta0htVk81Y3A0enNsR1dITllrdkNNZjNTczJHWEhZVFlHNkRWeTFfMlJfbENhQjJCOXo3R0xvUlZoVUhIUmtUeXZvRk5INnltbE9NY01BTEF5ZVRNcEFDekcxbjNXOHNwZmN6bnZ1TDZxamIwTVVGOTR6SXhuYlV0OFc4UU9CRWsydU5JbEZhZFlWR28wb094TndweHQ5V2ZkWVZSYmVNZmVDdHVMR19POVdYX2Q0Q2c?oc=5"" target=""_blank"">Stocks to watch, January 30: Biocon, GAIL, Blue Star, Bajaj Finance, L&amp;T, Tata Motors, Adani Enterprises, Bajaj Finserv, Raymond, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.0,neutral,0.9436908960342407,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.125,0.175,0.0,0.5343454480171204,other,0.0,[],False,True,6,0.0
2025-06-25,2025-06-25 05:09:00,"Biocon Shares Gain Amid High Volume, Up by 0.47% - TradingView","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxNMUV4NjAwQWRUUmNka1VNVDh1ZXpMTTRzaklTZXZlVXhqRXRVYUQwelVlYWprSDZHbGFqRUhScmlNY0ZJeF9fdkdabnJFLWU1QkZtUUxvSU00UUw2RUtDdHVoWXlUWUhJck9LVHZpYkNidl9PWFpfNTlPc1RwdFZjQ0pHeVRiQ3F3MEE4ZWdJMlFuMzFveXVzWnRZX2xqVGZzN0swR29JcWJDQkFpb1E?oc=5"" target=""_blank"">Biocon Shares Gain Amid High Volume, Up by 0.47%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxNMUV4NjAwQWRUUmNka1VNVDh1ZXpMTTRzaklTZXZlVXhqRXRVYUQwelVlYWprSDZHbGFqRUhScmlNY0ZJeF9fdkdabnJFLWU1QkZtUUxvSU00UUw2RUtDdHVoWXlUWUhJck9LVHZpYkNidl9PWFpfNTlPc1RwdFZjQ0pHeVRiQ3F3MEE4ZWdJMlFuMzFveXVzWnRZX2xqVGZzN0swR29JcWJDQkFpb1E?oc=5,Google News,Biocon financial results,"Biocon Shares Gain Amid High Volume, Up by 0.47% - TradingView <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxNMUV4NjAwQWRUUmNka1VNVDh1ZXpMTTRzaklTZXZlVXhqRXRVYUQwelVlYWprSDZHbGFqRUhScmlNY0ZJeF9fdkdabnJFLWU1QkZtUUxvSU00UUw2RUtDdHVoWXlUWUhJck9LVHZpYkNidl9PWFpfNTlPc1RwdFZjQ0pHeVRiQ3F3MEE4ZWdJMlFuMzFveXVzWnRZX2xqVGZzN0swR29JcWJDQkFpb1E?oc=5"" target=""_blank"">Biocon Shares Gain Amid High Volume, Up by 0.47%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",0.9457570910453796,positive,0.9457570910453796,0.0,neutral,0.0,0.8807,0.384,0.0,0.616,0.10666666666666667,0.36000000000000004,0.5404326234545026,0.6443745859040154,other,0.0,[],False,True,6,0.0
2025-05-09,2025-05-09 03:50:34,"Biocon Reports Strong Financial Results, Indicating Improved Operational Performance and Growth Potential - MarketsMojo","<a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxNY3RWSVNWcVBvV2NvNzJYR2U2VU5oYnNUTExoLWhKM3JZR29jTkNHaTJCSTZSYlVpTHVCZDZ4ZGFhc2QyQ0xyeEtIMHhIZWVhZlRMZm1PRXg3NXQxWmVnbkZNZEQ5M1pfcXJuZXNkYl9QSC1lcUhFelZMVmdzSVpCMDNjTTliLS02TDZDWUVDblN0aTIwRENKR3E5VG5SbFd4UjM0UGF0aGRubTBhb2FQWFJzMHU1Vk5Yc1BROVdMSQ?oc=5"" target=""_blank"">Biocon Reports Strong Financial Results, Indicating Improved Operational Performance and Growth Potential</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMivwFBVV95cUxNY3RWSVNWcVBvV2NvNzJYR2U2VU5oYnNUTExoLWhKM3JZR29jTkNHaTJCSTZSYlVpTHVCZDZ4ZGFhc2QyQ0xyeEtIMHhIZWVhZlRMZm1PRXg3NXQxWmVnbkZNZEQ5M1pfcXJuZXNkYl9QSC1lcUhFelZMVmdzSVpCMDNjTTliLS02TDZDWUVDblN0aTIwRENKR3E5VG5SbFd4UjM0UGF0aGRubTBhb2FQWFJzMHU1Vk5Yc1BROVdMSQ?oc=5,Google News,Biocon financial results,"Biocon Reports Strong Financial Results, Indicating Improved Operational Performance and Growth Potential - MarketsMojo <a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxNY3RWSVNWcVBvV2NvNzJYR2U2VU5oYnNUTExoLWhKM3JZR29jTkNHaTJCSTZSYlVpTHVCZDZ4ZGFhc2QyQ0xyeEtIMHhIZWVhZlRMZm1PRXg3NXQxWmVnbkZNZEQ5M1pfcXJuZXNkYl9QSC1lcUhFelZMVmdzSVpCMDNjTTliLS02TDZDWUVDblN0aTIwRENKR3E5VG5SbFd4UjM0UGF0aGRubTBhb2FQWFJzMHU1Vk5Yc1BROVdMSQ?oc=5"" target=""_blank"">Biocon Reports Strong Financial Results, Indicating Improved Operational Performance and Growth Potential</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",0.9563901424407959,positive,0.9563901424407959,0.0,neutral,0.0,0.9517,0.45,0.0,0.55,0.14444444444444446,0.41111111111111115,0.546508652823312,0.6841781956284135,other,0.0,[],False,True,6,0.0
2025-05-12,2025-05-12 07:00:00,Biocon Shares Dip 2.36% in Today's Trade; Among Top Losers in NIFTY MIDCAP 150 - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Dip 2.36% in Today's Trade; Among Top Losers in NIFTY MIDCAP 150</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon financial results,"Biocon Shares Dip 2.36% in Today's Trade; Among Top Losers in NIFTY MIDCAP 150 - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Dip 2.36% in Today's Trade; Among Top Losers in NIFTY MIDCAP 150</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",-0.9703115224838257,negative,0.9703115224838257,0.0,neutral,0.0,0.7241,0.326,0.149,0.526,0.12000000000000002,0.27999999999999997,-0.5544637271336147,0.6048038408279419,other,0.0,[],False,True,6,0.0
2025-04-11,2025-04-11 07:00:00,Biocon Share Price Today: Stock Up Nearly 6% - Here's Why - Republic World,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOYjhqZlpuaHdaMEZLVnNhNzFRdl82ek9JX2xBcnZEMHkwVTdEUDBuaEFNc2xvX3NFbXNoQk1hY2dOa0hMT2h0cDYySnhLOHQ3cDg4ZFY5clhvZDRXT0puMUYya1RRQ09JVG84b0kzNEZfOFRUcFJUMC1zN1liN3RIODNfcUtGTzJWUDFWNGwyTDk0RWxqNTRHdkZ0RnBSaGlEYUNHUg?oc=5"" target=""_blank"">Biocon Share Price Today: Stock Up Nearly 6% - Here's Why</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Republic World</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOYjhqZlpuaHdaMEZLVnNhNzFRdl82ek9JX2xBcnZEMHkwVTdEUDBuaEFNc2xvX3NFbXNoQk1hY2dOa0hMT2h0cDYySnhLOHQ3cDg4ZFY5clhvZDRXT0puMUYya1RRQ09JVG84b0kzNEZfOFRUcFJUMC1zN1liN3RIODNfcUtGTzJWUDFWNGwyTDk0RWxqNTRHdkZ0RnBSaGlEYUNHUg?oc=5,Google News,Biocon financial results,"Biocon Share Price Today: Stock Up Nearly 6% - Here's Why - Republic World <a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOYjhqZlpuaHdaMEZLVnNhNzFRdl82ek9JX2xBcnZEMHkwVTdEUDBuaEFNc2xvX3NFbXNoQk1hY2dOa0hMT2h0cDYySnhLOHQ3cDg4ZFY5clhvZDRXT0puMUYya1RRQ09JVG84b0kzNEZfOFRUcFJUMC1zN1liN3RIODNfcUtGTzJWUDFWNGwyTDk0RWxqNTRHdkZ0RnBSaGlEYUNHUg?oc=5"" target=""_blank"">Biocon Share Price Today: Stock Up Nearly 6% - Here's Why</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Republic World</font>",0.9332885146141052,positive,0.9332885146141052,0.0,neutral,0.0,0.5267,0.155,0.0,0.845,0.06666666666666667,0.26666666666666666,0.5333077226366315,0.5088850604269239,other,0.0,[],False,True,6,0.0
2025-01-31,2025-01-31 08:00:00,Here's why Biocon share price gained 4% despite fall in profits in Q3 - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Here's why Biocon share price gained 4% despite fall in profits in Q3</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon financial results,"Here's why Biocon share price gained 4% despite fall in profits in Q3 - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Here's why Biocon share price gained 4% despite fall in profits in Q3</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.6821986436843872,negative,0.6821986436843872,0.0,neutral,0.0,0.5842,0.238,0.119,0.643,0.0,0.0,-0.3898277963910784,0.6331993218421936,other,0.0,[],False,True,6,0.0
2025-04-24,2025-04-24 07:00:00,"Top Stocks to watch: Bajaj Finance, Adani Green, TCPL, LTIMindTree, BPCL, Bajaj Housing & Biocon - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top Stocks to watch: Bajaj Finance, Adani Green, TCPL, LTIMindTree, BPCL, Bajaj Housing & Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon financial results,"Top Stocks to watch: Bajaj Finance, Adani Green, TCPL, LTIMindTree, BPCL, Bajaj Housing & Biocon - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Top Stocks to watch: Bajaj Finance, Adani Green, TCPL, LTIMindTree, BPCL, Bajaj Housing & Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.9347623586654663,0.0,neutral,0.0,0.2023,0.052,0.0,0.948,0.024999999999999994,0.275,0.0,0.38735411955515536,other,0.0,[],False,True,6,0.0
2022-05-09,2022-05-09 07:00:00,Viatris warns war in Ukraine could squeeze future financials - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQUzMyOU9xdjJBV2o0U0wtdGJ1cVlSd0tXT3B5MGp0aXpXeG5ybGNhWGl4WTRMamYzSmJ2VU5vTGZRTHdobkFKOTZtbWNld3NkN3NqNU5HN0l6M3I1RUxMc0xxMFJucm45VER2VjNVOXJ4ZkRnMVZBaVJVVExqc1o3QjdDd2I3eWo2cGJNLXZCQWJiTDBnZTZ4alBQVXFkbFZfdk5kX0ltR2JLVFEzWTdCc1Z0T2NjXzd3N3R1LQ?oc=5"" target=""_blank"">Viatris warns war in Ukraine could squeeze future financials</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxQUzMyOU9xdjJBV2o0U0wtdGJ1cVlSd0tXT3B5MGp0aXpXeG5ybGNhWGl4WTRMamYzSmJ2VU5vTGZRTHdobkFKOTZtbWNld3NkN3NqNU5HN0l6M3I1RUxMc0xxMFJucm45VER2VjNVOXJ4ZkRnMVZBaVJVVExqc1o3QjdDd2I3eWo2cGJNLXZCQWJiTDBnZTZ4alBQVXFkbFZfdk5kX0ltR2JLVFEzWTdCc1Z0T2NjXzd3N3R1LQ?oc=5,Google News,Biocon financial results,"Viatris warns war in Ukraine could squeeze future financials - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQUzMyOU9xdjJBV2o0U0wtdGJ1cVlSd0tXT3B5MGp0aXpXeG5ybGNhWGl4WTRMamYzSmJ2VU5vTGZRTHdobkFKOTZtbWNld3NkN3NqNU5HN0l6M3I1RUxMc0xxMFJucm45VER2VjNVOXJ4ZkRnMVZBaVJVVExqc1o3QjdDd2I3eWo2cGJNLXZCQWJiTDBnZTZ4alBQVXFkbFZfdk5kX0ltR2JLVFEzWTdCc1Z0T2NjXzd3N3R1LQ?oc=5"" target=""_blank"">Viatris warns war in Ukraine could squeeze future financials</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.9229544997215271,negative,0.9229544997215271,0.0,neutral,0.0,-0.8625,0.0,0.346,0.654,0.0,0.08333333333333333,-0.5274025712694441,0.8927272498607636,other,0.0,[],False,False,1,0.0
2025-06-22,2025-06-22 04:15:35,Biocon Full Year 2025 Earnings: Beats Expectations - Simply Wall Street,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Full Year 2025 Earnings: Beats Expectations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Simply Wall Street</font>",https://news.google.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?oc=5,Google News,Biocon financial results,"Biocon Full Year 2025 Earnings: Beats Expectations - Simply Wall Street <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Full Year 2025 Earnings: Beats Expectations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Simply Wall Street</font>",0.0,neutral,0.6079647541046143,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.175,0.3642857142857143,0.0,0.39148237705230715,other,0.0,[],False,True,6,0.0
2024-06-04,2024-06-04 07:00:00,"Stocks to watch: M&M Finance, Dr Reddy's, Welspun, Biocon, JP Associates, Zee - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch: M&amp;M Finance, Dr Reddy's, Welspun, Biocon, JP Associates, Zee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon financial results,"Stocks to watch: M&M Finance, Dr Reddy's, Welspun, Biocon, JP Associates, Zee - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch: M&amp;M Finance, Dr Reddy's, Welspun, Biocon, JP Associates, Zee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.9393351674079895,0.0,neutral,0.0,0.6207,0.163,0.0,0.837,0.0,0.0,0.0,0.7800175837039948,other,0.0,[],False,True,6,0.0
2025-01-16,2025-01-16 08:00:00,"Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon financial results,"Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430 - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.5451065897941589,positive,0.5451065897941589,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.08,0.08,0.3114894798823765,0.31255329489707945,other,0.0,[],False,True,6,0.0
2024-05-17,2024-05-17 07:00:00,Biocon shares: Why brokerages divided on this pharma counter after Q4 results - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: Why brokerages divided on this pharma counter after Q4 results</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi5gFBVV95cUxNM2Q0RmU2Sjl1bnhwQWVyZXdnVGRZdmgwTG52V0xwWm9LSXg0RkVvMnZqLTBNSVgzUEVyS19IRWU0TldtRkZBWmVoeEdPRWZlNUFDd2RMcWpOenZ4Q2hKalFKb3k3UzBQcmRDUXM5dmZIaFhiVUt1a3pERnJaYmlvdVhNY19hODJiNmhLVkcwVXhHem5qbTNGbHdMNWxjWkZLbW5WWER1OHhkcjM2R2tRYUVMYXRpUlJEdVd4MVV6MTBZMk5zQUpPWnd4LUZJQXBfZEgtUlRzUE1EWnFFQ0RCNWZHMkVmQdIB6wFBVV95cUxOQ0lqSC1QMzZVX2xaM3JSZHkyUkdsR2YzQndET3NPSFhSSHRZaVdEVUllLWpjMjMtaEh4c0JlZTE3dFlkYm1PdjNrc29xQkpIOFhaWFdLd0Q4d0hUVXdGZTNVTTYtTnFRSFlseGxQZ2ZKbjI1TDloT0NSVF9sYThqZlptSXctek1qczNheVBBVzFpRWlWV3JQNzlCTEdGWDFQUWVXU1liNlM0aEVWWl9PRHJtSDdGaGtGYldUMUNXZERHeFE3X1NrQlpPbHgycGc1c193QXlCdThONG5MR1VvREJoWld0THpvRURN?oc=5,Google News,Biocon financial results,"Biocon shares: Why brokerages divided on this pharma counter after Q4 results - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: Why brokerages divided on this pharma counter after Q4 results</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",-0.4961874186992645,negative,0.4961874186992645,0.0,neutral,0.0,0.5267,0.136,0.0,0.864,0.0,0.0,-0.28353566782815115,0.5114437093496322,other,0.0,[],False,True,6,0.0
2025-05-22,2025-05-22 07:00:00,Biocon Shares Decline by 2.05% in Today's Trading Session - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Decline by 2.05% in Today's Trading Session</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon financial results,"Biocon Shares Decline by 2.05% in Today's Trading Session - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Decline by 2.05% in Today's Trading Session</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",-0.972821056842804,negative,0.972821056842804,0.0,neutral,0.0,0.5267,0.18,0.0,0.82,0.0,0.0,-0.5558977467673165,0.749760528421402,other,0.0,[],False,True,6,0.0
2023-05-24,2023-05-24 07:00:00,Biocon net profit up 31 percent in Q4 - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNSnpnaEM0b0hkaGEtOGdMR1RiWVAwUjljckJONjBXOFh1MUtzZVdOdVFxclRFNzNkX2E2eklxZ2R1OGUzQWpTd2IwSElodTF0WjhTaGJtZkNzSG9GQ2x2YjloSWQ4Y1BlVFVBVVRPOVY0NGFfLUJuUlFPbTlEOUN6bmFNa3RtQ2k4Y21YVndfVHZ2eGU0djNZT9IBngFBVV95cUxPR09Tc0ZDdWxiT0FHNmNPMXMzWDRUWW5OdFZ0YWZMLVM5WXA5UWUwNmN4MnMwQmtqN3pIc1RRc05RQnFORFRBdG13bV9tRndVYTBmajNnNkFCY0l4R3BoTlpqbDBiaWgzRmhWQU5wNV92SC10SU96MkZFRnJXME5RVzFxTldTYkFUMUk1Mzd3VTdzNjhOM2R3ZHFYUFY4QQ?oc=5"" target=""_blank"">Biocon net profit up 31 percent in Q4</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxNSnpnaEM0b0hkaGEtOGdMR1RiWVAwUjljckJONjBXOFh1MUtzZVdOdVFxclRFNzNkX2E2eklxZ2R1OGUzQWpTd2IwSElodTF0WjhTaGJtZkNzSG9GQ2x2YjloSWQ4Y1BlVFVBVVRPOVY0NGFfLUJuUlFPbTlEOUN6bmFNa3RtQ2k4Y21YVndfVHZ2eGU0djNZT9IBngFBVV95cUxPR09Tc0ZDdWxiT0FHNmNPMXMzWDRUWW5OdFZ0YWZMLVM5WXA5UWUwNmN4MnMwQmtqN3pIc1RRc05RQnFORFRBdG13bV9tRndVYTBmajNnNkFCY0l4R3BoTlpqbDBiaWgzRmhWQU5wNV92SC10SU96MkZFRnJXME5RVzFxTldTYkFUMUk1Mzd3VTdzNjhOM2R3ZHFYUFY4QQ?oc=5,Google News,Biocon financial results,"Biocon net profit up 31 percent in Q4 - Medical Dialogues <a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNSnpnaEM0b0hkaGEtOGdMR1RiWVAwUjljckJONjBXOFh1MUtzZVdOdVFxclRFNzNkX2E2eklxZ2R1OGUzQWpTd2IwSElodTF0WjhTaGJtZkNzSG9GQ2x2YjloSWQ4Y1BlVFVBVVRPOVY0NGFfLUJuUlFPbTlEOUN6bmFNa3RtQ2k4Y21YVndfVHZ2eGU0djNZT9IBngFBVV95cUxPR09Tc0ZDdWxiT0FHNmNPMXMzWDRUWW5OdFZ0YWZMLVM5WXA5UWUwNmN4MnMwQmtqN3pIc1RRc05RQnFORFRBdG13bV9tRndVYTBmajNnNkFCY0l4R3BoTlpqbDBiaWgzRmhWQU5wNV92SC10SU96MkZFRnJXME5RVzFxTldTYkFUMUk1Mzd3VTdzNjhOM2R3ZHFYUFY4QQ?oc=5"" target=""_blank"">Biocon net profit up 31 percent in Q4</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.9453242421150208,positive,0.9453242421150208,0.0,neutral,0.0,0.7003,0.225,0.0,0.775,0.0,0.0,0.5401852812085833,0.8228121210575103,other,0.0,[],False,True,6,0.0
2024-11-11,2024-11-11 08:00:00,USFDA grants ‘VAI’ tag to Biocon’s Bengaluru facility - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxQMy1WRGVmS29vVFh1NFVFNmVNV3ZGaWRfdC1JNGRFVGFGWUZLdTN5blBsOFZ6Ry1JNXpPX1FtMU9NS1VxMU5tRjBpT280YmRsMzZUUkVaYnRnY1Q0NUFyQ0JUYkJfTHVmUjhXOW9oX2lYaFB6RnVfRzZEeHNlYjFqaEljd3l6M1ByX1dLNVVWRS1YcW9EYkF5QzN5ck51RmhieEMtSWdBdklvMkNmZnRvekZB?oc=5"" target=""_blank"">USFDA grants ‘VAI’ tag to Biocon’s Bengaluru facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxQMy1WRGVmS29vVFh1NFVFNmVNV3ZGaWRfdC1JNGRFVGFGWUZLdTN5blBsOFZ6Ry1JNXpPX1FtMU9NS1VxMU5tRjBpT280YmRsMzZUUkVaYnRnY1Q0NUFyQ0JUYkJfTHVmUjhXOW9oX2lYaFB6RnVfRzZEeHNlYjFqaEljd3l6M1ByX1dLNVVWRS1YcW9EYkF5QzN5ck51RmhieEMtSWdBdklvMkNmZnRvekZB?oc=5,Google News,Biocon financial results,"USFDA grants ‘VAI’ tag to Biocon’s Bengaluru facility - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxQMy1WRGVmS29vVFh1NFVFNmVNV3ZGaWRfdC1JNGRFVGFGWUZLdTN5blBsOFZ6Ry1JNXpPX1FtMU9NS1VxMU5tRjBpT280YmRsMzZUUkVaYnRnY1Q0NUFyQ0JUYkJfTHVmUjhXOW9oX2lYaFB6RnVfRzZEeHNlYjFqaEljd3l6M1ByX1dLNVVWRS1YcW9EYkF5QzN5ck51RmhieEMtSWdBdklvMkNmZnRvekZB?oc=5"" target=""_blank"">USFDA grants ‘VAI’ tag to Biocon’s Bengaluru facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.5352485775947571,positive,0.5352485775947571,0.0,neutral,0.0,0.4215,0.174,0.0,0.826,0.0,0.0,0.3058563300541469,0.47837428879737853,other,0.0,[],False,True,6,0.0
2025-01-31,2025-01-31 08:00:00,"Biocon shares up 4% despite sharp fall in profit, find out why? - Market News - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOWTViNFRFcUJOVXU4SlpVWUxwS0dCY1VQRktkMjhfWVFOejNZOExMYl9jc0RUMkZOY2lYUWtXMjVHUk1HazNxVkppMWVGV2VJOEtRY3o2QlV3eFp3dnRoN1ZzbEptcWFwalVJT1N1VTgxUnJ5TDhOU2lHeXdHV2JucC1BOXJMZVE2ZjNuN0ZUTHdFSktmSlpwa1ViWmVhVmw0em43ci1WU0ZSYlRDUWc?oc=5"" target=""_blank"">Biocon shares up 4% despite sharp fall in profit, find out why? - Market News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxOWTViNFRFcUJOVXU4SlpVWUxwS0dCY1VQRktkMjhfWVFOejNZOExMYl9jc0RUMkZOY2lYUWtXMjVHUk1HazNxVkppMWVGV2VJOEtRY3o2QlV3eFp3dnRoN1ZzbEptcWFwalVJT1N1VTgxUnJ5TDhOU2lHeXdHV2JucC1BOXJMZVE2ZjNuN0ZUTHdFSktmSlpwa1ViWmVhVmw0em43ci1WU0ZSYlRDUWc?oc=5,Google News,Biocon financial results,"Biocon shares up 4% despite sharp fall in profit, find out why? - Market News - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOWTViNFRFcUJOVXU4SlpVWUxwS0dCY1VQRktkMjhfWVFOejNZOExMYl9jc0RUMkZOY2lYUWtXMjVHUk1HazNxVkppMWVGV2VJOEtRY3o2QlV3eFp3dnRoN1ZzbEptcWFwalVJT1N1VTgxUnJ5TDhOU2lHeXdHV2JucC1BOXJMZVE2ZjNuN0ZUTHdFSktmSlpwa1ViWmVhVmw0em43ci1WU0ZSYlRDUWc?oc=5"" target=""_blank"">Biocon shares up 4% despite sharp fall in profit, find out why? - Market News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.8010919094085693,positive,0.8010919094085693,0.0,neutral,0.0,0.867,0.277,0.0,0.723,-0.08333333333333333,0.5,0.45776680537632536,0.5838084142473009,other,0.0,[],False,True,6,0.0
2024-06-11,2024-06-11 07:00:00,Biocon appoints Mukesh Kamath as interim CFO - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxNalJ3cVAyZFFXcVA1X2MxNjI2bk5EZXdSNTUySHAyY1BBVWFfN1gteEhoQUV1RjVqa053aG81aldFUFVSZ0FxZ0FmVXZTR1VZeGZpR3hrTU1Bd2NUS2xUNnVOTG94amI5Rk5waEJsUm1OSU5fMTFnMG53QlZZUHE0bmk5ZEQ1VEFzeDdQMEZKeXFXSHRwa3B1cm1aaFI4UFNuYmR2OXNWNA?oc=5"" target=""_blank"">Biocon appoints Mukesh Kamath as interim CFO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMipwFBVV95cUxNalJ3cVAyZFFXcVA1X2MxNjI2bk5EZXdSNTUySHAyY1BBVWFfN1gteEhoQUV1RjVqa053aG81aldFUFVSZ0FxZ0FmVXZTR1VZeGZpR3hrTU1Bd2NUS2xUNnVOTG94amI5Rk5waEJsUm1OSU5fMTFnMG53QlZZUHE0bmk5ZEQ1VEFzeDdQMEZKeXFXSHRwa3B1cm1aaFI4UFNuYmR2OXNWNA?oc=5,Google News,Biocon financial results,"Biocon appoints Mukesh Kamath as interim CFO - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxNalJ3cVAyZFFXcVA1X2MxNjI2bk5EZXdSNTUySHAyY1BBVWFfN1gteEhoQUV1RjVqa053aG81aldFUFVSZ0FxZ0FmVXZTR1VZeGZpR3hrTU1Bd2NUS2xUNnVOTG94amI5Rk5waEJsUm1OSU5fMTFnMG53QlZZUHE0bmk5ZEQ1VEFzeDdQMEZKeXFXSHRwa3B1cm1aaFI4UFNuYmR2OXNWNA?oc=5"" target=""_blank"">Biocon appoints Mukesh Kamath as interim CFO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.882844865322113,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.882844865322113,other,0.0,[],False,True,6,0.0
2025-02-25,2025-02-25 08:00:00,"Stocks in news: ONGC, NTPC, SBI Life, Manappuram Finance, Biocon - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: ONGC, NTPC, SBI Life, Manappuram Finance, Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon financial results,"Stocks in news: ONGC, NTPC, SBI Life, Manappuram Finance, Biocon - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: ONGC, NTPC, SBI Life, Manappuram Finance, Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.9376670718193054,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.0,0.5355002025763194,other,0.0,[],False,True,6,0.0
2025-04-24,2025-04-24 07:00:00,"Stocks to Watch Today, 24th April 2025: LTIMindtree, Bajaj Housing Finance, Tata Consumer Products, Biocon, and more - Groww","<a href=""https://news.google.com/rss/articles/CBMia0FVX3lxTE5rVW9HSjVvNDBvVmpiMkZCaEtfZi02OGpmdS00X0ZxVVpQTEUxRHBqc015bVN4TWJTTjBHMmFSaGpUckVsLUdKcWhoeWgxTkRzSzV1NFhSVGVTUjJTWHl3TFBEaE44V19wX1Zj?oc=5"" target=""_blank"">Stocks to Watch Today, 24th April 2025: LTIMindtree, Bajaj Housing Finance, Tata Consumer Products, Biocon, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Groww</font>",https://news.google.com/rss/articles/CBMia0FVX3lxTE5rVW9HSjVvNDBvVmpiMkZCaEtfZi02OGpmdS00X0ZxVVpQTEUxRHBqc015bVN4TWJTTjBHMmFSaGpUckVsLUdKcWhoeWgxTkRzSzV1NFhSVGVTUjJTWHl3TFBEaE44V19wX1Zj?oc=5,Google News,Biocon financial results,"Stocks to Watch Today, 24th April 2025: LTIMindtree, Bajaj Housing Finance, Tata Consumer Products, Biocon, and more - Groww <a href=""https://news.google.com/rss/articles/CBMia0FVX3lxTE5rVW9HSjVvNDBvVmpiMkZCaEtfZi02OGpmdS00X0ZxVVpQTEUxRHBqc015bVN4TWJTTjBHMmFSaGpUckVsLUdKcWhoeWgxTkRzSzV1NFhSVGVTUjJTWHl3TFBEaE44V19wX1Zj?oc=5"" target=""_blank"">Stocks to Watch Today, 24th April 2025: LTIMindtree, Bajaj Housing Finance, Tata Consumer Products, Biocon, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Groww</font>",0.0,neutral,0.9357165098190308,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.25,0.25,0.0,0.5928582549095154,other,0.0,[],False,True,6,0.0
2025-04-23,2025-04-23 07:00:00,"Bajaj Housing Finance, LTIMindTree, Biocon: How to trade these 3 buzzing stocks - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Bajaj Housing Finance, LTIMindTree, Biocon: How to trade these 3 buzzing stocks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon financial results,"Bajaj Housing Finance, LTIMindTree, Biocon: How to trade these 3 buzzing stocks - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Bajaj Housing Finance, LTIMindTree, Biocon: How to trade these 3 buzzing stocks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.9230621457099915,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9230621457099915,other,0.0,[],False,True,6,0.0
2025-04-23,2025-04-23 07:00:00,"Stocks to Watch: LTIMindtree, Bajaj Housing Finance, Biocon, 360 ONE WAM and more - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: LTIMindtree, Bajaj Housing Finance, Biocon, 360 ONE WAM and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon financial results,"Stocks to Watch: LTIMindtree, Bajaj Housing Finance, Biocon, 360 ONE WAM and more - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: LTIMindtree, Bajaj Housing Finance, Biocon, 360 ONE WAM and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.9385954737663269,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.25,0.25,0.0,0.5942977368831635,other,0.0,[],False,True,6,0.0
2023-05-23,2023-05-23 07:00:00,"Stock Market Highlight: Sensex, Nifty 50 end flat amid volatility, financials drag - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Market Highlight: Sensex, Nifty 50 end flat amid volatility, financials drag</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon financial results,"Stock Market Highlight: Sensex, Nifty 50 end flat amid volatility, financials drag - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Market Highlight: Sensex, Nifty 50 end flat amid volatility, financials drag</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",-0.8819319009780884,negative,0.8819319009780884,0.0,neutral,0.0,0.8074,0.275,0.051,0.674,-0.0375,0.08020833333333333,-0.5039610862731934,0.5756106336593628,other,0.0,[],False,False,1,0.0
2025-05-03,2025-05-03 07:00:00,"Q4 Results Next Week: Dabur, Britannia, Biocon, Paytm, Swiggy Others to Steal Spotlight From May 5 to 11 - Goodreturns","<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxQd2gzWXREMWY1OWpfT01maWpUek1vWTBzYXdPdmdId3NYYml3SEw0MDdTdHp3Q19CQlpZLTdyRWE2b1Jqdk5uS3lweU1LZEdJNGY4eXc5d2xjM3lMNExLWUJ2QXRPR2czaGRBZXQ1aVBmU1Y0VEJDY04xOHhiMTJnekcya1FKZnlmTUI5VzJvbDVrSV9tdlU3VWNmb0xhYjVIaktQLXNqLXhRZjVQMDd6LVdkei1SWkdKQU1RY0p1a3RKcWNDbHlYeWEtd3FOQQ?oc=5"" target=""_blank"">Q4 Results Next Week: Dabur, Britannia, Biocon, Paytm, Swiggy Others to Steal Spotlight From May 5 to 11</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Goodreturns</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxQd2gzWXREMWY1OWpfT01maWpUek1vWTBzYXdPdmdId3NYYml3SEw0MDdTdHp3Q19CQlpZLTdyRWE2b1Jqdk5uS3lweU1LZEdJNGY4eXc5d2xjM3lMNExLWUJ2QXRPR2czaGRBZXQ1aVBmU1Y0VEJDY04xOHhiMTJnekcya1FKZnlmTUI5VzJvbDVrSV9tdlU3VWNmb0xhYjVIaktQLXNqLXhRZjVQMDd6LVdkei1SWkdKQU1RY0p1a3RKcWNDbHlYeWEtd3FOQQ?oc=5,Google News,Biocon financial results,"Q4 Results Next Week: Dabur, Britannia, Biocon, Paytm, Swiggy Others to Steal Spotlight From May 5 to 11 - Goodreturns <a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxQd2gzWXREMWY1OWpfT01maWpUek1vWTBzYXdPdmdId3NYYml3SEw0MDdTdHp3Q19CQlpZLTdyRWE2b1Jqdk5uS3lweU1LZEdJNGY4eXc5d2xjM3lMNExLWUJ2QXRPR2czaGRBZXQ1aVBmU1Y0VEJDY04xOHhiMTJnekcya1FKZnlmTUI5VzJvbDVrSV9tdlU3VWNmb0xhYjVIaktQLXNqLXhRZjVQMDd6LVdkei1SWkdKQU1RY0p1a3RKcWNDbHlYeWEtd3FOQQ?oc=5"" target=""_blank"">Q4 Results Next Week: Dabur, Britannia, Biocon, Paytm, Swiggy Others to Steal Spotlight From May 5 to 11</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Goodreturns</font>",0.0,neutral,0.8035931587219238,0.0,neutral,0.0,-0.7506,0.0,0.151,0.849,0.0,0.0,0.0,0.7770965793609619,other,0.0,[],False,True,6,0.0
2025-05-08,2025-05-08 07:00:00,"Stocks in focus: Asian Paints, Titan, LT, Britannia, Biocon among key firms to announce Q4 results today - Business Upturn","<a href=""https://news.google.com/rss/articles/CBMi5wFBVV95cUxQam1HUHhBSWpieVhsVlNnVkFKbmtENk4yaFliZzVCM0c3UmY4bTVVR3VjVjlKZk5hVVpjMHljX1BxalZNcVpoMk40YUZ0cTByZVQwTjZVMHY2YVg4aDhabExYNVlBZUJrM1BYOEZvSFJOUW1YRlh3RHFVLVNWMThvcW5nVHN3ZTNHVlk1SHdIaTJ3NFQ3Tm5ZMTZzNl91QnJNWENkR19LQ2otNDJSMHdWVGFpclpFS0l3VUV3NE11Wk0wQk5vRUxncnZkRi1pbEZGaW1IRTVMN0JUT0M3SjBLeEk0MHJjSDQ?oc=5"" target=""_blank"">Stocks in focus: Asian Paints, Titan, LT, Britannia, Biocon among key firms to announce Q4 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",https://news.google.com/rss/articles/CBMi5wFBVV95cUxQam1HUHhBSWpieVhsVlNnVkFKbmtENk4yaFliZzVCM0c3UmY4bTVVR3VjVjlKZk5hVVpjMHljX1BxalZNcVpoMk40YUZ0cTByZVQwTjZVMHY2YVg4aDhabExYNVlBZUJrM1BYOEZvSFJOUW1YRlh3RHFVLVNWMThvcW5nVHN3ZTNHVlk1SHdIaTJ3NFQ3Tm5ZMTZzNl91QnJNWENkR19LQ2otNDJSMHdWVGFpclpFS0l3VUV3NE11Wk0wQk5vRUxncnZkRi1pbEZGaW1IRTVMN0JUT0M3SjBLeEk0MHJjSDQ?oc=5,Google News,Biocon financial results,"Stocks in focus: Asian Paints, Titan, LT, Britannia, Biocon among key firms to announce Q4 results today - Business Upturn <a href=""https://news.google.com/rss/articles/CBMi5wFBVV95cUxQam1HUHhBSWpieVhsVlNnVkFKbmtENk4yaFliZzVCM0c3UmY4bTVVR3VjVjlKZk5hVVpjMHljX1BxalZNcVpoMk40YUZ0cTByZVQwTjZVMHY2YVg4aDhabExYNVlBZUJrM1BYOEZvSFJOUW1YRlh3RHFVLVNWMThvcW5nVHN3ZTNHVlk1SHdIaTJ3NFQ3Tm5ZMTZzNl91QnJNWENkR19LQ2otNDJSMHdWVGFpclpFS0l3VUV3NE11Wk0wQk5vRUxncnZkRi1pbEZGaW1IRTVMN0JUT0M3SjBLeEk0MHJjSDQ?oc=5"" target=""_blank"">Stocks in focus: Asian Paints, Titan, LT, Britannia, Biocon among key firms to announce Q4 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",0.0,neutral,0.7926801443099976,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.4,0.0,0.7926801443099976,other,0.0,[],False,True,6,0.0
2025-06-24,2025-06-24 07:01:46,"After a $3.3 bn acquisition, is it finally time to look at Biocon? - The Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">After a $3.3 bn acquisition, is it finally time to look at Biocon?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Express</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"After a $3.3 bn acquisition, is it finally time to look at Biocon? - The Indian Express <a href=""https://news.google.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?oc=5"" target=""_blank"">After a $3.3 bn acquisition, is it finally time to look at Biocon?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Express</font>",0.0,neutral,0.9024499654769897,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.6666666666666666,0.0,0.9024499654769897,other,0.0,[],False,True,6,0.0
2025-05-13,2025-05-13 07:00:00,"Biocon sees mid-teens revenue growth on biosimilars, generics push - Mint","<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxPZUgzNl80Mm1nM0xFb3hZVXJtTkNfUUNBV0YwMGdfZDB4N2tNYWo4V0RYeDhtMjJLaEc1QVRSUHRXLTBMaHdsMU50bTFwcFlQeWRwMG1pR1Y0Z2hyQ1djdDJMbW1KcGwtQ1NYVEdUdmJmVWNPeUpBRkNydm9wdHl3aEpnTFpIM2x2QVF4OG5hdGNpeXNtbUlDU3B3bGpEZzM2LU5sTmpaWVVDc1AxTmxkdS1B?oc=5"" target=""_blank"">Biocon sees mid-teens revenue growth on biosimilars, generics push</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxPZUgzNl80Mm1nM0xFb3hZVXJtTkNfUUNBV0YwMGdfZDB4N2tNYWo4V0RYeDhtMjJLaEc1QVRSUHRXLTBMaHdsMU50bTFwcFlQeWRwMG1pR1Y0Z2hyQ1djdDJMbW1KcGwtQ1NYVEdUdmJmVWNPeUpBRkNydm9wdHl3aEpnTFpIM2x2QVF4OG5hdGNpeXNtbUlDU3B3bGpEZzM2LU5sTmpaWVVDc1AxTmxkdS1B?oc=5,Google News,Biocon revenue growth,"Biocon sees mid-teens revenue growth on biosimilars, generics push - Mint <a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxPZUgzNl80Mm1nM0xFb3hZVXJtTkNfUUNBV0YwMGdfZDB4N2tNYWo4V0RYeDhtMjJLaEc1QVRSUHRXLTBMaHdsMU50bTFwcFlQeWRwMG1pR1Y0Z2hyQ1djdDJMbW1KcGwtQ1NYVEdUdmJmVWNPeUpBRkNydm9wdHl3aEpnTFpIM2x2QVF4OG5hdGNpeXNtbUlDU3B3bGpEZzM2LU5sTmpaWVVDc1AxTmxkdS1B?oc=5"" target=""_blank"">Biocon sees mid-teens revenue growth on biosimilars, generics push</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.8516781330108643,positive,0.8516781330108643,0.0,neutral,0.0,0.6369,0.206,0.0,0.794,0.0,0.0,0.48667321886335096,0.7442890665054321,other,0.0,[],False,True,6,0.0
2025-05-09,2025-05-09 07:00:00,Biocon targets high-teens generics growth in FY26 - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQRDRmVUdTd1VOOWEzSjg0YmcwME4wQkMtMHVCSV9tempUQV9yYnBxdzZnU3JsMlRobmItTzhaVV90cEZ1NXJDR05wSEI4MnNDdTA4Ty1IaXg1RGh1YWt0VHdnYUI2NHg3bDV1ZnUwbUVBV0kycERVWloxRUM5ZUxLbW9TY2M3Wk1KdG1ONEYwZzFaQXhBWU04bHVSZVo2SThWQ1ZzRlFB0gGrAUFVX3lxTE1kX096dXk0UGlnR3U1Q2s2SWs5OC1oa0hkc1k1U0VrdHNMOG1Ka1BDdktMQ2EyNDRJXzR4Yktmb01JcFRTc0xfckR1d0E3WkNrY1FDNXp3XzRZWG5GNFRpa09JRXdMOFJmUVcwRlRWc2YzeWtsczZwcVFISmFZTGRJSFBNN1BhUWtVeVNTQ000X3AzdmN6azBQX2cybDVNMG5Pd2V6Q2Nrb1M4dw?oc=5"" target=""_blank"">Biocon targets high-teens generics growth in FY26</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQRDRmVUdTd1VOOWEzSjg0YmcwME4wQkMtMHVCSV9tempUQV9yYnBxdzZnU3JsMlRobmItTzhaVV90cEZ1NXJDR05wSEI4MnNDdTA4Ty1IaXg1RGh1YWt0VHdnYUI2NHg3bDV1ZnUwbUVBV0kycERVWloxRUM5ZUxLbW9TY2M3Wk1KdG1ONEYwZzFaQXhBWU04bHVSZVo2SThWQ1ZzRlFB0gGrAUFVX3lxTE1kX096dXk0UGlnR3U1Q2s2SWs5OC1oa0hkc1k1U0VrdHNMOG1Ka1BDdktMQ2EyNDRJXzR4Yktmb01JcFRTc0xfckR1d0E3WkNrY1FDNXp3XzRZWG5GNFRpa09JRXdMOFJmUVcwRlRWc2YzeWtsczZwcVFISmFZTGRJSFBNN1BhUWtVeVNTQ000X3AzdmN6azBQX2cybDVNMG5Pd2V6Q2Nrb1M4dw?oc=5,Google News,Biocon revenue growth,"Biocon targets high-teens generics growth in FY26 - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQRDRmVUdTd1VOOWEzSjg0YmcwME4wQkMtMHVCSV9tempUQV9yYnBxdzZnU3JsMlRobmItTzhaVV90cEZ1NXJDR05wSEI4MnNDdTA4Ty1IaXg1RGh1YWt0VHdnYUI2NHg3bDV1ZnUwbUVBV0kycERVWloxRUM5ZUxLbW9TY2M3Wk1KdG1ONEYwZzFaQXhBWU04bHVSZVo2SThWQ1ZzRlFB0gGrAUFVX3lxTE1kX096dXk0UGlnR3U1Q2s2SWs5OC1oa0hkc1k1U0VrdHNMOG1Ka1BDdktMQ2EyNDRJXzR4Yktmb01JcFRTc0xfckR1d0E3WkNrY1FDNXp3XzRZWG5GNFRpa09JRXdMOFJmUVcwRlRWc2YzeWtsczZwcVFISmFZTGRJSFBNN1BhUWtVeVNTQ000X3AzdmN6azBQX2cybDVNMG5Pd2V6Q2Nrb1M4dw?oc=5"" target=""_blank"">Biocon targets high-teens generics growth in FY26</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.8054482340812683,0.0,neutral,0.0,0.6369,0.224,0.0,0.776,0.0,0.0,0.0,0.7211741170406342,other,0.0,[],False,True,6,0.0
2025-06-19,2025-06-19 00:37:29,Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next - Simply Wall Street,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Simply Wall Street</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next - Simply Wall Street <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Simply Wall Street</font>",0.0,neutral,0.7236683964729309,0.0,neutral,0.0,-0.4215,0.0,0.106,0.894,-0.02857142857142857,0.12857142857142856,0.0,0.3912466083481198,other,0.0,[],False,True,6,0.0
2025-02-01,2025-02-01 08:00:00,Biocon Biologics investors are more confident after revenue growth: Mittal - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics investors are more confident after revenue growth: Mittal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"Biocon Biologics investors are more confident after revenue growth: Mittal - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics investors are more confident after revenue growth: Mittal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.540623664855957,0.0,neutral,0.0,0.9039,0.356,0.0,0.644,0.3333333333333333,0.4444444444444445,0.0,0.5926189993964301,other,0.0,[],False,True,6,0.0
2025-05-19,2025-05-19 07:00:00,"5 products to be launched in 18 mths, US insulin mkt share up: BBL MD & CEO - Business Standard","<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxNaUtZT2hyRl9KQW9QMGtZVmlMTXVDRVYyRWQtUTY1Vk8zNFFLYlYzbklWUDFwd2dsc2FTbHkxWHlfYUdnUjVSQUxMS0Q4N0hFeUJhX2xjMm9UYUVpZEtqRXRPOWRDRVNuTUw2MEU5Z1Blb0xvN2hRZFNkTkNRNzZrRjVQazlhb2tiNW9xaDhCU09rM3laYTE2eTdWMHotbEpISC1QUkxXVVlpRm1sTVZDelpkckEydlp3Q09NbkE1VWU3Y1FtbkZNZ01hYVJlMlltckgwNWd1a9IB3AFBVV95cUxNQlJGXzhOUWZ2TGxXV0hpUndBY09XV2lDdEJJZ19BVWpDMlRTT2QxLUVNQ0p6Y3puSkdVSEtUQVNBYWNabGVhbFF4T21KVjA0ZjlOWkRZS1h5WkE4X2huUkpwT3VlUnMyWkVUd0NvcVBOeTQ0N2JlTG5FU3lMWmJMWE9GQkozWmNhYVpHVENPM0M4OUpaRWx0b2NTZ3paOUVHSFI4SGhvRVJYTHVWSHpOOUtjUGxyWS1TaktGWFFlckJaLWE5MEpORUdNc0tTa0FFS1dlVThFYUJWYnBn?oc=5"" target=""_blank"">5 products to be launched in 18 mths, US insulin mkt share up: BBL MD & CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"5 products to be launched in 18 mths, US insulin mkt share up: BBL MD & CEO - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">5 products to be launched in 18 mths, US insulin mkt share up: BBL MD & CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.6810817718505859,0.0,neutral,0.0,0.6597,0.183,0.0,0.817,0.0,0.0,0.0,0.670390885925293,other,0.0,[],False,False,1,0.0
2025-05-11,2025-05-11 07:00:00,Are Biocon Limited's (NSE:BIOCON) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - Simply Wall Street,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Are Biocon Limited's (NSE:BIOCON) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Simply Wall Street</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"Are Biocon Limited's (NSE:BIOCON) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - Simply Wall Street <a href=""https://news.google.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?oc=5"" target=""_blank"">Are Biocon Limited's (NSE:BIOCON) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Simply Wall Street</font>",-0.6056941151618958,negative,0.6056941151618958,0.0,neutral,0.0,0.5484,0.144,0.063,0.793,0.12571428571428572,0.3342857142857143,-0.34611092294965473,0.4266028002920605,other,0.0,[],False,True,6,0.0
2025-01-19,2025-01-19 08:00:00,Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist? - Simply Wall Street,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Simply Wall Street</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist? - Simply Wall Street <a href=""https://news.google.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?oc=5"" target=""_blank"">Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Simply Wall Street</font>",0.0,neutral,0.9201735854148865,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.17857142857142858,0.0,0.9201735854148865,other,0.0,[],False,True,6,0.0
2025-01-31,2025-01-31 08:00:00,Is Biocon on the track to recovery? - Trade Brains,"<a href=""https://news.google.com/rss/articles/CBMiakFVX3lxTE5aLTVmNEd5UTl4eXZBUjF6UC1NeHJpa1lxN1FldHRpZTZPMHV1QzVLMWZuV2hlN2xscFR6ci1tclVocEpyZlVkeU9mTDU1RXZ0Y21YSHV2Wml0bzBVeFdlMGh3clFYZDZjcGc?oc=5"" target=""_blank"">Is Biocon on the track to recovery?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",https://news.google.com/rss/articles/CBMiakFVX3lxTE5aLTVmNEd5UTl4eXZBUjF6UC1NeHJpa1lxN1FldHRpZTZPMHV1QzVLMWZuV2hlN2xscFR6ci1tclVocEpyZlVkeU9mTDU1RXZ0Y21YSHV2Wml0bzBVeFdlMGh3clFYZDZjcGc?oc=5,Google News,Biocon revenue growth,"Is Biocon on the track to recovery? - Trade Brains <a href=""https://news.google.com/rss/articles/CBMiakFVX3lxTE5aLTVmNEd5UTl4eXZBUjF6UC1NeHJpa1lxN1FldHRpZTZPMHV1QzVLMWZuV2hlN2xscFR6ci1tclVocEpyZlVkeU9mTDU1RXZ0Y21YSHV2Wml0bzBVeFdlMGh3clFYZDZjcGc?oc=5"" target=""_blank"">Is Biocon on the track to recovery?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",0.0,neutral,0.8726016283035278,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8726016283035278,other,0.0,[],False,True,6,0.0
2023-08-11,2023-08-11 07:00:00,Biocon may list biosimilars business by 2025 first half - CEO - Reuters,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxQQnBDN2NoaDRiN3lPdjFLQXlnMXNTT0ZUUi01Zm5QVk50S19WLUhPRVRBR0FxYWt4NHBDT1k2Z1JoS1ltZ1JVOFhPcXlHVHFnQlpBRTRQc1F2aWhGenBsRldoMWxhUS1LOFNmenJscUpOTXNEMDltR2M3S2xqM19LdzJ0Q3dIZ3Q4OWVFTTZCcTdmai1mOEZKci1KUTU0ejdiNVNoNDZyY19RYmN4MkE?oc=5"" target=""_blank"">Biocon may list biosimilars business by 2025 first half - CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Reuters</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxQQnBDN2NoaDRiN3lPdjFLQXlnMXNTT0ZUUi01Zm5QVk50S19WLUhPRVRBR0FxYWt4NHBDT1k2Z1JoS1ltZ1JVOFhPcXlHVHFnQlpBRTRQc1F2aWhGenBsRldoMWxhUS1LOFNmenJscUpOTXNEMDltR2M3S2xqM19LdzJ0Q3dIZ3Q4OWVFTTZCcTdmai1mOEZKci1KUTU0ejdiNVNoNDZyY19RYmN4MkE?oc=5,Google News,Biocon revenue growth,"Biocon may list biosimilars business by 2025 first half - CEO - Reuters <a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxQQnBDN2NoaDRiN3lPdjFLQXlnMXNTT0ZUUi01Zm5QVk50S19WLUhPRVRBR0FxYWt4NHBDT1k2Z1JoS1ltZ1JVOFhPcXlHVHFnQlpBRTRQc1F2aWhGenBsRldoMWxhUS1LOFNmenJscUpOTXNEMDltR2M3S2xqM19LdzJ0Q3dIZ3Q4OWVFTTZCcTdmai1mOEZKci1KUTU0ejdiNVNoNDZyY19RYmN4MkE?oc=5"" target=""_blank"">Biocon may list biosimilars business by 2025 first half - CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Reuters</font>",0.0,neutral,0.9411484599113464,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.03333333333333334,0.19999999999999998,0.0,0.4872408966223399,other,0.0,[],False,True,6,0.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9525013566017151,positive,0.9525013566017151,0.0,neutral,0.0,0.9118,0.31,0.0,0.69,0.0,0.0,0.5442864894866943,0.9321506783008575,other,0.0,[],False,True,6,0.0
2024-07-29,2024-07-29 07:00:00,"Stocks to watch: Ultratech Cements, Maruti Suzuki, Biocon, Dr Reddy's and BHEL shares in focus - Firstpost","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch: Ultratech Cements, Maruti Suzuki, Biocon, Dr Reddy's and BHEL shares in focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Firstpost</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"Stocks to watch: Ultratech Cements, Maruti Suzuki, Biocon, Dr Reddy's and BHEL shares in focus - Firstpost <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch: Ultratech Cements, Maruti Suzuki, Biocon, Dr Reddy's and BHEL shares in focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Firstpost</font>",0.0,neutral,0.9168186187744141,0.0,neutral,0.0,0.5267,0.121,0.0,0.879,0.0,0.0,0.0,0.721759309387207,other,0.0,[],False,True,6,0.0
2024-02-21,2024-02-21 08:00:00,"Jefferies downgrades Biocon to ‘underperform’, sees 11% downside; here's why - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Jefferies downgrades Biocon to ‘underperform’, sees 11% downside; here's why</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"Jefferies downgrades Biocon to ‘underperform’, sees 11% downside; here's why - Mint <a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxOdVdNV1gyZGVvandycWh4dE1tSkN0YnBOVVRrdW9HTE5sZDJlbHg1S0M3dndITWQtcDNoUjZYd1FvSS1scWJjVlFOcHFuZjhEdWtwUkI5ckhXRjJOZi1KV3p6NmdUN0VkWlRZeWNJd0dqUWdTaXh4LXloYmc5V3N2V29MaUFCbHB3bDhUZnh4MllOZkdrVzVrYnFBN2djcnRmaTFXOFZzYzlaR29NN2x4aDZKelYta0JSX0c3cEE0SVl3QWhnOGVDSWw4VmZhdHJMZ01oX1FXQdIB3AFBVV95cUxOWXVtQU5nYTY0MVMyVFNXcUdMSGhsY0E5ZmoxUXZlQ2FhaU8wdHlLc1NHTHI2UTc5Nmtka1ItUDBMTkJqYWRwZ0I3U0EyVkVPejJKT2FkM01qTEZGV0RiNVJGOG1iSV96elJuM1ZXVkJrdlJLU1ZVcTdLZXVFUFNNYlRNdDc2NHlkTGt5VnFMdWhhbEtwS1Jna3FxTVAyN0Y2YUdvSExDVzN4ZjNRRDk3aUJrUlp2R0dWWF9xVWVCSWhmZlpLQVlHNEpBcDhRZUpxelFUQmdfVGZyeUxB?oc=5"" target=""_blank"">Jefferies downgrades Biocon to ‘underperform’, sees 11% downside; here's why</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",-0.9244130849838257,negative,0.9244130849838257,0.0,neutral,0.0,-0.4588,0.0,0.154,0.846,0.0,0.0,-0.5282360485621861,0.6916065424919129,other,0.0,[],False,True,6,0.0
2023-05-24,2023-05-24 07:00:00,"Biocon Biologics crosses $1 billion revenue, Kiran Mazumdar-Shaw says biosimilars a key growth driver - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics crosses $1 billion revenue, Kiran Mazumdar-Shaw says biosimilars a key growth driver</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"Biocon Biologics crosses $1 billion revenue, Kiran Mazumdar-Shaw says biosimilars a key growth driver - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics crosses $1 billion revenue, Kiran Mazumdar-Shaw says biosimilars a key growth driver</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.566048800945282,positive,0.566048800945282,0.0,neutral,0.0,0.6369,0.148,0.0,0.852,0.0,0.6666666666666666,0.3234564576830183,0.601474400472641,other,0.0,[],False,True,6,0.0
2023-08-11,2023-08-11 07:00:00,"Biocon registers Rs 3,516 crore revenues in Q1, up 59% YoY - The Statesman","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon registers Rs 3,516 crore revenues in Q1, up 59% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"Biocon registers Rs 3,516 crore revenues in Q1, up 59% YoY - The Statesman <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon registers Rs 3,516 crore revenues in Q1, up 59% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",0.9431890249252319,positive,0.9431890249252319,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5389651571001325,0.9431890249252319,other,0.0,[],False,True,6,0.0
2022-04-29,2022-04-29 07:00:00,Biocon Q4 results show Consolidated revenue up by 21% - The Statesman,"<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxPYzV0OXJ4ZU1xLUJVRXFSVWdPYlloUG0wb25jcHZTam5RV2prX2NPWVAtNm1paHRvWGtDd2hmcUxhZ0NkMjJmVFUtc2NxZk85NklGa3dVMUE4T2EtalNqblotVldYVUF3U0M4aXNfMlA1OVk3U3M0Y2JJNXlFMXQwSE9TQTB2aGFFOGhFc3pCbkJHN1I2N0VCZUFWLUgwRjdiU3fSAacBQVVfeXFMTUR6ak1pd2hLUVB5WFkwbnB0eXU1OGU1UnpCelUwRlJLSmdHQ2trTzh0bUpmNDBGOW9rWjZtV2RpVlVOSF82Y2lzbnlUNHdFLTdZRk9NYUxubWxyUnF1Sm5tQWdqMjJnYkQ0N191cG9oU0c1YVlnUDlHTjdKN1F3MGl4dUdWWkktU29nLVFwcDhNQ2VnR0k5LXV4QWZSMWVDbUZmMi04bmM?oc=5"" target=""_blank"">Biocon Q4 results show Consolidated revenue up by 21%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxPYzV0OXJ4ZU1xLUJVRXFSVWdPYlloUG0wb25jcHZTam5RV2prX2NPWVAtNm1paHRvWGtDd2hmcUxhZ0NkMjJmVFUtc2NxZk85NklGa3dVMUE4T2EtalNqblotVldYVUF3U0M4aXNfMlA1OVk3U3M0Y2JJNXlFMXQwSE9TQTB2aGFFOGhFc3pCbkJHN1I2N0VCZUFWLUgwRjdiU3fSAacBQVVfeXFMTUR6ak1pd2hLUVB5WFkwbnB0eXU1OGU1UnpCelUwRlJLSmdHQ2trTzh0bUpmNDBGOW9rWjZtV2RpVlVOSF82Y2lzbnlUNHdFLTdZRk9NYUxubWxyUnF1Sm5tQWdqMjJnYkQ0N191cG9oU0c1YVlnUDlHTjdKN1F3MGl4dUdWWkktU29nLVFwcDhNQ2VnR0k5LXV4QWZSMWVDbUZmMi04bmM?oc=5,Google News,Biocon revenue growth,"Biocon Q4 results show Consolidated revenue up by 21% - The Statesman <a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxPYzV0OXJ4ZU1xLUJVRXFSVWdPYlloUG0wb25jcHZTam5RV2prX2NPWVAtNm1paHRvWGtDd2hmcUxhZ0NkMjJmVFUtc2NxZk85NklGa3dVMUE4T2EtalNqblotVldYVUF3U0M4aXNfMlA1OVk3U3M0Y2JJNXlFMXQwSE9TQTB2aGFFOGhFc3pCbkJHN1I2N0VCZUFWLUgwRjdiU3fSAacBQVVfeXFMTUR6ak1pd2hLUVB5WFkwbnB0eXU1OGU1UnpCelUwRlJLSmdHQ2trTzh0bUpmNDBGOW9rWjZtV2RpVlVOSF82Y2lzbnlUNHdFLTdZRk9NYUxubWxyUnF1Sm5tQWdqMjJnYkQ0N191cG9oU0c1YVlnUDlHTjdKN1F3MGl4dUdWWkktU29nLVFwcDhNQ2VnR0k5LXV4QWZSMWVDbUZmMi04bmM?oc=5"" target=""_blank"">Biocon Q4 results show Consolidated revenue up by 21%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",0.9538040161132812,positive,0.9538040161132812,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5450308663504464,0.9538040161132812,other,0.0,[],False,True,6,0.0
2024-02-21,2024-02-21 08:00:00,Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform' - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform'</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon revenue growth,"Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform' - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform'</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",-0.929850697517395,negative,0.929850697517395,0.0,neutral,0.0,0.5267,0.167,0.0,0.833,0.0,0.0,-0.5313432557242257,0.7282753487586975,other,0.0,[],False,True,6,0.0
2024-11-11,2024-11-11 08:00:00,"Stocks to watch today: Divi’s Laboratories, JSW Steel, LIC, Biocon in focus; Asian Paints, Tata Motors, Aurobindo Pharma, Ola Electric under pressure - Business Upturn","<a href=""https://news.google.com/rss/articles/CBMingJBVV95cUxORlBVM3AtcVZERC1WR3V5SGl2eWN0S1ZVZ29GR2IyYjJGUUNYS0ZtdVpfdnVrR0IyUDhTTlZtenFadDFwWXEyQU5kRnRBUnJIOUVkeVFIcTVnU2xLYVJXY1lUWFdBSGRkV0tMa1lock1ENnpHQlFyUjNDSlF4cFlhVGt5cDdSdE1EUDdNelpnVk5YNjBMVkNmUjNQZExqanFwR3cwVFQ3dW1rUEdSV2dKaHRnMzhGbHRzMjZVQWROOEoydWxnN1FSQS0wRmQtUlczZVZCY1RlZjVvVnlWMDZuVTVSQjRqU0hoQ3RHWjJiandUQVNKV2JlcnNIejgtNGxFLV9aRk1PWHFxQlRnR2FIcE16MGMwdVFteHRERFhn?oc=5"" target=""_blank"">Stocks to watch today: Divi’s Laboratories, JSW Steel, LIC, Biocon in focus; Asian Paints, Tata Motors, Aurobindo Pharma, Ola Electric under pressure</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",https://news.google.com/rss/articles/CBMingJBVV95cUxORlBVM3AtcVZERC1WR3V5SGl2eWN0S1ZVZ29GR2IyYjJGUUNYS0ZtdVpfdnVrR0IyUDhTTlZtenFadDFwWXEyQU5kRnRBUnJIOUVkeVFIcTVnU2xLYVJXY1lUWFdBSGRkV0tMa1lock1ENnpHQlFyUjNDSlF4cFlhVGt5cDdSdE1EUDdNelpnVk5YNjBMVkNmUjNQZExqanFwR3cwVFQ3dW1rUEdSV2dKaHRnMzhGbHRzMjZVQWROOEoydWxnN1FSQS0wRmQtUlczZVZCY1RlZjVvVnlWMDZuVTVSQjRqU0hoQ3RHWjJiandUQVNKV2JlcnNIejgtNGxFLV9aRk1PWHFxQlRnR2FIcE16MGMwdVFteHRERFhn?oc=5,Google News,Biocon revenue growth,"Stocks to watch today: Divi’s Laboratories, JSW Steel, LIC, Biocon in focus; Asian Paints, Tata Motors, Aurobindo Pharma, Ola Electric under pressure - Business Upturn <a href=""https://news.google.com/rss/articles/CBMingJBVV95cUxORlBVM3AtcVZERC1WR3V5SGl2eWN0S1ZVZ29GR2IyYjJGUUNYS0ZtdVpfdnVrR0IyUDhTTlZtenFadDFwWXEyQU5kRnRBUnJIOUVkeVFIcTVnU2xLYVJXY1lUWFdBSGRkV0tMa1lock1ENnpHQlFyUjNDSlF4cFlhVGt5cDdSdE1EUDdNelpnVk5YNjBMVkNmUjNQZExqanFwR3cwVFQ3dW1rUEdSV2dKaHRnMzhGbHRzMjZVQWROOEoydWxnN1FSQS0wRmQtUlczZVZCY1RlZjVvVnlWMDZuVTVSQjRqU0hoQ3RHWjJiandUQVNKV2JlcnNIejgtNGxFLV9aRk1PWHFxQlRnR2FIcE16MGMwdVFteHRERFhn?oc=5"" target=""_blank"">Stocks to watch today: Divi’s Laboratories, JSW Steel, LIC, Biocon in focus; Asian Paints, Tata Motors, Aurobindo Pharma, Ola Electric under pressure</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",-0.5569274425506592,negative,0.5569274425506592,0.0,neutral,0.0,-0.296,0.0,0.043,0.957,0.0,0.0,-0.31824425288609093,0.4264637212753296,other,0.0,[],False,True,6,0.0
2025-06-19,2025-06-19 07:00:00,"Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar - NDTV Profit","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar - NDTV Profit <a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",0.0,neutral,0.9295912384986877,0.0,neutral,0.0,0.7269,0.236,0.0,0.764,0.0,0.0,0.0,0.8282456192493439,other,0.0,[],False,True,6,0.0
2025-01-30,2025-01-30 08:00:00,"Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25 - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News,Biocon profit,"Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25 - The Economic Times <a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.861152708530426,0.0,neutral,0.0,0.7003,0.127,0.0,0.873,0.05714285714285715,0.05714285714285715,0.0,0.5395318552244277,other,0.0,[],False,True,6,0.0
2025-06-19,2025-06-19 07:00:00,Biocon Gets Target Price Cut From HSBC Over Likely Impact On Earnings Per Share Post QIP - NDTV Profit,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Gets Target Price Cut From HSBC Over Likely Impact On Earnings Per Share Post QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Biocon Gets Target Price Cut From HSBC Over Likely Impact On Earnings Per Share Post QIP - NDTV Profit <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Gets Target Price Cut From HSBC Over Likely Impact On Earnings Per Share Post QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",-0.9542520046234131,negative,0.9542520046234131,0.0,neutral,0.0,0.4767,0.164,0.094,0.742,0.0,0.6666666666666666,-0.5452868597848075,0.7154760023117066,other,0.0,[],False,True,6,0.0
2025-06-19,2025-06-19 16:46:06,"Buy, Sell Or Hold: ICICI Bank, Premier Energies, Tata Motors, Biocon — Ask Profit - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMirAFBVV95cUxQTWlkb0FtWTRLX0VNbjZJb1lMbnFadXRCZGhwalZLaUZUQ1JLSHNOUVRsU2htRHpCbWktZFN1c0thMTVmM0RfTnlrV2IzX0dfZ1VQcVloVHhSVXBxWGU1a29RMlNQTG9fQjRROEZvSU5Ia0VBcEVENTBKT3ZHaTZ6blJxYzBpSjRjLTYtdTVaZFJGZTdkM01WUFN4TDJ2eXNfdUlQb2Z5clhqUE9j0gGyAUFVX3lxTE1QQ3ZOMWNTV3R1RjJLMFFkaVVTcnBZelJjY25pendSSFFwZWdzNkpXMFM2anFPQkJtZWNpNmI1TjNOV0tzd1hhbVBsT251NEFCOHo4ZzFmeTRIT3F6eHEwSTV1Q1dLc2hZR2Ywc3JYUzRveF9aZEdLM0t0dG55bHpxX1BrSkVld00wZXhvd3pMVEhRYWdJUWdNb2VYZDhIMlhVYTluZjlsQlFVM1R0ZW4zRnc?oc=5"" target=""_blank"">Buy, Sell Or Hold: ICICI Bank, Premier Energies, Tata Motors, Biocon — Ask Profit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMirAFBVV95cUxQTWlkb0FtWTRLX0VNbjZJb1lMbnFadXRCZGhwalZLaUZUQ1JLSHNOUVRsU2htRHpCbWktZFN1c0thMTVmM0RfTnlrV2IzX0dfZ1VQcVloVHhSVXBxWGU1a29RMlNQTG9fQjRROEZvSU5Ia0VBcEVENTBKT3ZHaTZ6blJxYzBpSjRjLTYtdTVaZFJGZTdkM01WUFN4TDJ2eXNfdUlQb2Z5clhqUE9j0gGyAUFVX3lxTE1QQ3ZOMWNTV3R1RjJLMFFkaVVTcnBZelJjY25pendSSFFwZWdzNkpXMFM2anFPQkJtZWNpNmI1TjNOV0tzd1hhbVBsT251NEFCOHo4ZzFmeTRIT3F6eHEwSTV1Q1dLc2hZR2Ywc3JYUzRveF9aZEdLM0t0dG55bHpxX1BrSkVld00wZXhvd3pMVEhRYWdJUWdNb2VYZDhIMlhVYTluZjlsQlFVM1R0ZW4zRnc?oc=5,Google News,Biocon profit,"Buy, Sell Or Hold: ICICI Bank, Premier Energies, Tata Motors, Biocon — Ask Profit - NDTV Profit <a href=""https://news.google.com/rss/articles/CBMirAFBVV95cUxQTWlkb0FtWTRLX0VNbjZJb1lMbnFadXRCZGhwalZLaUZUQ1JLSHNOUVRsU2htRHpCbWktZFN1c0thMTVmM0RfTnlrV2IzX0dfZ1VQcVloVHhSVXBxWGU1a29RMlNQTG9fQjRROEZvSU5Ia0VBcEVENTBKT3ZHaTZ6blJxYzBpSjRjLTYtdTVaZFJGZTdkM01WUFN4TDJ2eXNfdUlQb2Z5clhqUE9j0gGyAUFVX3lxTE1QQ3ZOMWNTV3R1RjJLMFFkaVVTcnBZelJjY25pendSSFFwZWdzNkpXMFM2anFPQkJtZWNpNmI1TjNOV0tzd1hhbVBsT251NEFCOHo4ZzFmeTRIT3F6eHEwSTV1Q1dLc2hZR2Ywc3JYUzRveF9aZEdLM0t0dG55bHpxX1BrSkVld00wZXhvd3pMVEhRYWdJUWdNb2VYZDhIMlhVYTluZjlsQlFVM1R0ZW4zRnc?oc=5"" target=""_blank"">Buy, Sell Or Hold: ICICI Bank, Premier Energies, Tata Motors, Biocon — Ask Profit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",0.0,neutral,0.9309561848640442,0.0,neutral,0.0,0.8225,0.255,0.0,0.745,0.0,0.0,0.0,0.8767280924320221,other,0.0,[],False,True,6,0.0
2025-06-18,2025-06-18 07:00:00,"Buy, Sell Or Hold: BSE, Bajaj Finance, Biocon, UCO Bank — Ask Profit - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxON2x6TXR4ck82TndHS3ExX0hjTWM2Szk0bjQwRFdqLV9fQ1VVekFpS2dCM2RnUzJjcTRyMmYyODdlMlN6NFkzaFFwY0NUaC1TQVdib0tnMU1GMTc2dUxJMy1JU25QRVJoZ2tIM2txQUZmczFDN1hjeEk0RGNEeERBV0VVZk5WY2JlZ2Z4d240Smk5OWtkLXNFcU1zY1rSAaIBQVVfeXFMT3J0RGQ4cGtJYUtvV0lJc0I4MXpYZFoxakg3NVV1TzB5Q0tKbFFrZThhMlVDUm5ydHBrR1FrMHJWOXVIRFY5azZOb05ZYjdNMEg1ODlCUGxhTjZRbElsWEUta2psREdoQXoyTG8yOUtYSGZXOWRMLVJseUJaR2ZMVWtjSWVIX3g5cHhQa2hOQ045VXVJTi1FZVRxR0MzUF93bm1B?oc=5"" target=""_blank"">Buy, Sell Or Hold: BSE, Bajaj Finance, Biocon, UCO Bank — Ask Profit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxON2x6TXR4ck82TndHS3ExX0hjTWM2Szk0bjQwRFdqLV9fQ1VVekFpS2dCM2RnUzJjcTRyMmYyODdlMlN6NFkzaFFwY0NUaC1TQVdib0tnMU1GMTc2dUxJMy1JU25QRVJoZ2tIM2txQUZmczFDN1hjeEk0RGNEeERBV0VVZk5WY2JlZ2Z4d240Smk5OWtkLXNFcU1zY1rSAaIBQVVfeXFMT3J0RGQ4cGtJYUtvV0lJc0I4MXpYZFoxakg3NVV1TzB5Q0tKbFFrZThhMlVDUm5ydHBrR1FrMHJWOXVIRFY5azZOb05ZYjdNMEg1ODlCUGxhTjZRbElsWEUta2psREdoQXoyTG8yOUtYSGZXOWRMLVJseUJaR2ZMVWtjSWVIX3g5cHhQa2hOQ045VXVJTi1FZVRxR0MzUF93bm1B?oc=5,Google News,Biocon profit,"Buy, Sell Or Hold: BSE, Bajaj Finance, Biocon, UCO Bank — Ask Profit - NDTV Profit <a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxON2x6TXR4ck82TndHS3ExX0hjTWM2Szk0bjQwRFdqLV9fQ1VVekFpS2dCM2RnUzJjcTRyMmYyODdlMlN6NFkzaFFwY0NUaC1TQVdib0tnMU1GMTc2dUxJMy1JU25QRVJoZ2tIM2txQUZmczFDN1hjeEk0RGNEeERBV0VVZk5WY2JlZ2Z4d240Smk5OWtkLXNFcU1zY1rSAaIBQVVfeXFMT3J0RGQ4cGtJYUtvV0lJc0I4MXpYZFoxakg3NVV1TzB5Q0tKbFFrZThhMlVDUm5ydHBrR1FrMHJWOXVIRFY5azZOb05ZYjdNMEg1ODlCUGxhTjZRbElsWEUta2psREdoQXoyTG8yOUtYSGZXOWRMLVJseUJaR2ZMVWtjSWVIX3g5cHhQa2hOQ045VXVJTi1FZVRxR0MzUF93bm1B?oc=5"" target=""_blank"">Buy, Sell Or Hold: BSE, Bajaj Finance, Biocon, UCO Bank — Ask Profit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",0.0,neutral,0.9354828000068665,0.0,neutral,0.0,0.7003,0.172,0.0,0.828,0.0,0.0,0.0,0.8178914000034332,other,0.0,[],False,True,6,0.0
2025-05-09,2025-05-09 07:00:00,Biocon consolidated net profit rises 154.24% in the March 2025 quarter - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon consolidated net profit rises 154.24% in the March 2025 quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Biocon consolidated net profit rises 154.24% in the March 2025 quarter - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon consolidated net profit rises 154.24% in the March 2025 quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8812820315361023,positive,0.8812820315361023,0.0,neutral,0.0,0.7003,0.182,0.0,0.818,0.0,0.0,0.5035897323063442,0.7907910157680511,other,0.0,[],False,True,6,0.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 net profit declines 84 per cent to Rs 27.1 crore - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 net profit declines 84 per cent to Rs 27.1 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Biocon Q2 net profit declines 84 per cent to Rs 27.1 crore - The New Indian Express <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 net profit declines 84 per cent to Rs 27.1 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",-0.9727660417556763,negative,0.9727660417556763,0.0,neutral,0.0,0.7003,0.153,0.0,0.847,0.05454545454545454,0.18181818181818182,-0.5558663095746721,0.5758704987670435,other,0.0,[],False,True,6,0.0
2025-04-16,2025-04-16 07:00:00,Biocon Faces Profitability Challenges Amidst Strong Stock Performance and Investor Interest - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxPSFBLYVV0ay03bWp0NGZuMzhGckgtVXEzaXZkMC01YTdTbzMtWW9iM0pwcFhiM2gweGtDQ3lGY05CdzdGX1NkWmVlSjJkYjMzOTJDTG5tUHM0ZnR0ZFhOc1dOcG1ac2tyOF9nckpnQWgyWTh4cXZmSWlQRldiQU81aUpWWkw0ZlhPRlpyWW45dGJ6NnZGbGdveUVNb0QwdDNrU3Rfcm5LdzI0TFZfeVNmaUhYTVdnV29oeDRyVllNYmxlb3FOeTJ3Tm1CdE9SZ09OaGZndXY5OA?oc=5"" target=""_blank"">Biocon Faces Profitability Challenges Amidst Strong Stock Performance and Investor Interest</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxPSFBLYVV0ay03bWp0NGZuMzhGckgtVXEzaXZkMC01YTdTbzMtWW9iM0pwcFhiM2gweGtDQ3lGY05CdzdGX1NkWmVlSjJkYjMzOTJDTG5tUHM0ZnR0ZFhOc1dOcG1ac2tyOF9nckpnQWgyWTh4cXZmSWlQRldiQU81aUpWWkw0ZlhPRlpyWW45dGJ6NnZGbGdveUVNb0QwdDNrU3Rfcm5LdzI0TFZfeVNmaUhYTVdnV29oeDRyVllNYmxlb3FOeTJ3Tm1CdE9SZ09OaGZndXY5OA?oc=5,Google News,Biocon profit,"Biocon Faces Profitability Challenges Amidst Strong Stock Performance and Investor Interest - MarketsMojo <a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxPSFBLYVV0ay03bWp0NGZuMzhGckgtVXEzaXZkMC01YTdTbzMtWW9iM0pwcFhiM2gweGtDQ3lGY05CdzdGX1NkWmVlSjJkYjMzOTJDTG5tUHM0ZnR0ZFhOc1dOcG1ac2tyOF9nckpnQWgyWTh4cXZmSWlQRldiQU81aUpWWkw0ZlhPRlpyWW45dGJ6NnZGbGdveUVNb0QwdDNrU3Rfcm5LdzI0TFZfeVNmaUhYTVdnV29oeDRyVllNYmxlb3FOeTJ3Tm1CdE9SZ09OaGZndXY5OA?oc=5"" target=""_blank"">Biocon Faces Profitability Challenges Amidst Strong Stock Performance and Investor Interest</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",-0.9121958017349243,negative,0.9121958017349243,0.0,neutral,0.0,0.9246,0.463,0.0,0.537,0.2888888888888889,0.48888888888888893,-0.5212547438485282,0.708561563541271,other,0.0,[],False,True,6,0.0
2025-02-26,2025-02-26 08:00:00,Natural Biocon (India) standalone net profit rises 212.50% in the December 2024 quarter - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQekxTMVk2bTB3dkJNdTBPdUtQeFZrZFJpNnc5UFdrTU5aUFYwbzNPTE9mQ2pva3JmMXliRVB0OTBHWEcwQ1JEY2prWEN1UTFSTlg4TFR6NVNvVzJGMm5tREZIcnh3Sm9LZzc3Q3k4ZFNQM0o4dWtMdndpaE9QNnpNcG1QQ0xPY2RtQnVrM3JMSXFRcFhha1dYeW81VnlFaXR2MzNzOGJtMnlIWDZ3VjFHZFh5a00wdW1HWU9yTlhYbjVPU3NFZzNvMnFrM01kMU5mdWJGRjhWWXZwOWpLWFBvZG1YaWZVckNzU29nUmV6U3Nud0tXOVlNeGJn0gH_AUFVX3lxTE1LOGJ3dzVNbzIyemlZWnduZkpnc2NwSVpXZmV1cGZaN2JQZE9OWDJxejZ4dUdoeXo0WUE0MmpubHVUSXQ1ZVBYdW13dHJkNHUtM0lfb3BDcGN6Z1ZNSFpRb0JxM0Rkd2UxeHRUQmxtTGxxQ2lmMExjT3p6QXpQdXdvMzB2dE1mNUR3NVZIX1pWVDRCVEZ3a2x6ZHZZNHFsblRTd2w3cHZLbElxd1c2dFRKSFR6ZUhtWjVaU0hER2M4Yi0tYVhSZUp1eUJ5eDFSVWpvUzluRS1FeFFTcTc5T2twWktDbGt3RFItQkgxa3lpQkxOeWdHelFEYzBudjloUQ?oc=5"" target=""_blank"">Natural Biocon (India) standalone net profit rises 212.50% in the December 2024 quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxQekxTMVk2bTB3dkJNdTBPdUtQeFZrZFJpNnc5UFdrTU5aUFYwbzNPTE9mQ2pva3JmMXliRVB0OTBHWEcwQ1JEY2prWEN1UTFSTlg4TFR6NVNvVzJGMm5tREZIcnh3Sm9LZzc3Q3k4ZFNQM0o4dWtMdndpaE9QNnpNcG1QQ0xPY2RtQnVrM3JMSXFRcFhha1dYeW81VnlFaXR2MzNzOGJtMnlIWDZ3VjFHZFh5a00wdW1HWU9yTlhYbjVPU3NFZzNvMnFrM01kMU5mdWJGRjhWWXZwOWpLWFBvZG1YaWZVckNzU29nUmV6U3Nud0tXOVlNeGJn0gH_AUFVX3lxTE1LOGJ3dzVNbzIyemlZWnduZkpnc2NwSVpXZmV1cGZaN2JQZE9OWDJxejZ4dUdoeXo0WUE0MmpubHVUSXQ1ZVBYdW13dHJkNHUtM0lfb3BDcGN6Z1ZNSFpRb0JxM0Rkd2UxeHRUQmxtTGxxQ2lmMExjT3p6QXpQdXdvMzB2dE1mNUR3NVZIX1pWVDRCVEZ3a2x6ZHZZNHFsblRTd2w3cHZLbElxd1c2dFRKSFR6ZUhtWjVaU0hER2M4Yi0tYVhSZUp1eUJ5eDFSVWpvUzluRS1FeFFTcTc5T2twWktDbGt3RFItQkgxa3lpQkxOeWdHelFEYzBudjloUQ?oc=5,Google News,Biocon profit,"Natural Biocon (India) standalone net profit rises 212.50% in the December 2024 quarter - Business Standard <a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQekxTMVk2bTB3dkJNdTBPdUtQeFZrZFJpNnc5UFdrTU5aUFYwbzNPTE9mQ2pva3JmMXliRVB0OTBHWEcwQ1JEY2prWEN1UTFSTlg4TFR6NVNvVzJGMm5tREZIcnh3Sm9LZzc3Q3k4ZFNQM0o4dWtMdndpaE9QNnpNcG1QQ0xPY2RtQnVrM3JMSXFRcFhha1dYeW81VnlFaXR2MzNzOGJtMnlIWDZ3VjFHZFh5a00wdW1HWU9yTlhYbjVPU3NFZzNvMnFrM01kMU5mdWJGRjhWWXZwOWpLWFBvZG1YaWZVckNzU29nUmV6U3Nud0tXOVlNeGJn0gH_AUFVX3lxTE1LOGJ3dzVNbzIyemlZWnduZkpnc2NwSVpXZmV1cGZaN2JQZE9OWDJxejZ4dUdoeXo0WUE0MmpubHVUSXQ1ZVBYdW13dHJkNHUtM0lfb3BDcGN6Z1ZNSFpRb0JxM0Rkd2UxeHRUQmxtTGxxQ2lmMExjT3p6QXpQdXdvMzB2dE1mNUR3NVZIX1pWVDRCVEZ3a2x6ZHZZNHFsblRTd2w3cHZLbElxd1c2dFRKSFR6ZUhtWjVaU0hER2M4Yi0tYVhSZUp1eUJ5eDFSVWpvUzluRS1FeFFTcTc5T2twWktDbGt3RFItQkgxa3lpQkxOeWdHelFEYzBudjloUQ?oc=5"" target=""_blank"">Natural Biocon (India) standalone net profit rises 212.50% in the December 2024 quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8908107280731201,positive,0.8908107280731201,0.0,neutral,0.0,0.8074,0.223,0.0,0.777,0.02,0.08,0.5090347017560687,0.5727369093577067,other,0.0,[],False,True,6,0.0
2025-05-08,2025-05-08 07:00:00,Biocon Q4 profit rises two-fold to Rs 344 cr - theweek.in,"<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxPWGZEdWYyTUNRb0lZRm5EbGw1VDhLNU9aTmJYWXNNRE9kWjNmLU1MYVNzd2NFSERqazJDMkZZMjhpVWdpeGhGei1meWhNS1dBQ3A0OHNnUlB6bEVCdTV4VmFwYVhzaWZrSmpIdzI0M0lUSkotOVlUMC11NzNsZUR1Qm5uVmsxQUZtUGcyZEdn0gGTAUFVX3lxTE1Eam1uU3ZKNnBkcHJoTS1GQU9QOGdJdGJ3UDFWWW8xTEhBc0FRdWF6Tm4wZmxfUVE4Nkk1SFlwVmNNb3NrWnNqMGpxRGxUQllxeFhYazFmdDlRWEt6aWN2aEtRdEl1QmFBLWtmWHRXSTB3dEdfeXBEb3ItLThZSmlvV08tRk9hRC1CS1NRSmtfNXV6RQ?oc=5"" target=""_blank"">Biocon Q4 profit rises two-fold to Rs 344 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theweek.in</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxPWGZEdWYyTUNRb0lZRm5EbGw1VDhLNU9aTmJYWXNNRE9kWjNmLU1MYVNzd2NFSERqazJDMkZZMjhpVWdpeGhGei1meWhNS1dBQ3A0OHNnUlB6bEVCdTV4VmFwYVhzaWZrSmpIdzI0M0lUSkotOVlUMC11NzNsZUR1Qm5uVmsxQUZtUGcyZEdn0gGTAUFVX3lxTE1Eam1uU3ZKNnBkcHJoTS1GQU9QOGdJdGJ3UDFWWW8xTEhBc0FRdWF6Tm4wZmxfUVE4Nkk1SFlwVmNNb3NrWnNqMGpxRGxUQllxeFhYazFmdDlRWEt6aWN2aEtRdEl1QmFBLWtmWHRXSTB3dEdfeXBEb3ItLThZSmlvV08tRk9hRC1CS1NRSmtfNXV6RQ?oc=5,Google News,Biocon profit,"Biocon Q4 profit rises two-fold to Rs 344 cr - theweek.in <a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxPWGZEdWYyTUNRb0lZRm5EbGw1VDhLNU9aTmJYWXNNRE9kWjNmLU1MYVNzd2NFSERqazJDMkZZMjhpVWdpeGhGei1meWhNS1dBQ3A0OHNnUlB6bEVCdTV4VmFwYVhzaWZrSmpIdzI0M0lUSkotOVlUMC11NzNsZUR1Qm5uVmsxQUZtUGcyZEdn0gGTAUFVX3lxTE1Eam1uU3ZKNnBkcHJoTS1GQU9QOGdJdGJ3UDFWWW8xTEhBc0FRdWF6Tm4wZmxfUVE4Nkk1SFlwVmNNb3NrWnNqMGpxRGxUQllxeFhYazFmdDlRWEt6aWN2aEtRdEl1QmFBLWtmWHRXSTB3dEdfeXBEb3ItLThZSmlvV08tRk9hRC1CS1NRSmtfNXV6RQ?oc=5"" target=""_blank"">Biocon Q4 profit rises two-fold to Rs 344 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theweek.in</font>",0.9355973601341248,positive,0.9355973601341248,0.0,neutral,0.0,0.7003,0.225,0.0,0.775,0.0,0.0,0.5346270629337856,0.8179486800670623,other,0.0,[],False,True,6,0.0
2025-04-08,2025-04-08 03:37:33,Biocon Faces Technical Shift Amid Declining Profits and Mixed Market Signals - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxONjNLNnVYNllDM2FlaHBuU1BHeGktY1Zqcl9LYVhacmkzdVoxUTBMNHZJdGozMWwzczdhZTF3b2FYMkhrOWtGMTFieERza05jeVBGQXE4RUt1dU1KUzIyX3JOQTg3WHd3Sk5ZYzI4a1Q0bnBDUTFHUk1vOWFMRWltZnJHdGFJaUcwT3dCTzc5WWYybTk0ZjdweVpPR3ZWZXJOdDU1SDVwd1JibmtENllvQ0lNRVd4OHloUDZqYjJVZlB1VW5zRXpzUERNUlhSRUE?oc=5"" target=""_blank"">Biocon Faces Technical Shift Amid Declining Profits and Mixed Market Signals</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxONjNLNnVYNllDM2FlaHBuU1BHeGktY1Zqcl9LYVhacmkzdVoxUTBMNHZJdGozMWwzczdhZTF3b2FYMkhrOWtGMTFieERza05jeVBGQXE4RUt1dU1KUzIyX3JOQTg3WHd3Sk5ZYzI4a1Q0bnBDUTFHUk1vOWFMRWltZnJHdGFJaUcwT3dCTzc5WWYybTk0ZjdweVpPR3ZWZXJOdDU1SDVwd1JibmtENllvQ0lNRVd4OHloUDZqYjJVZlB1VW5zRXpzUERNUlhSRUE?oc=5,Google News,Biocon profit,"Biocon Faces Technical Shift Amid Declining Profits and Mixed Market Signals - MarketsMojo <a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxONjNLNnVYNllDM2FlaHBuU1BHeGktY1Zqcl9LYVhacmkzdVoxUTBMNHZJdGozMWwzczdhZTF3b2FYMkhrOWtGMTFieERza05jeVBGQXE4RUt1dU1KUzIyX3JOQTg3WHd3Sk5ZYzI4a1Q0bnBDUTFHUk1vOWFMRWltZnJHdGFJaUcwT3dCTzc5WWYybTk0ZjdweVpPR3ZWZXJOdDU1SDVwd1JibmtENllvQ0lNRVd4OHloUDZqYjJVZlB1VW5zRXpzUERNUlhSRUE?oc=5"" target=""_blank"">Biocon Faces Technical Shift Amid Declining Profits and Mixed Market Signals</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",-0.9716156721115112,negative,0.9716156721115112,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,0.0,0.13999999999999999,-0.5552089554922921,0.8359578360557556,other,0.0,[],False,True,6,0.0
2025-03-28,2025-03-28 07:00:00,Biocon Faces Technical Adjustments Amidst Strong Institutional Confidence and Profit Decline - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxQUkdkcng4X3VKTVNpbHhVa0wtcExXSEtPb04taDJTYS1NTjZDamNzdE9VdEVPdzJwUFpiX2tKYU9wYllpRjFjM0J2VUI3VThxbjB2MEpmRDJZQ01mSHdjYTB1eWtpbzN5eV9PekJhTlZ2bTZENWZ5M1FRa21WQmR5Tm0xeWF2ZTlZTU5VdVBLbmRSOFE1T00xbzkzTzc1WWE5ME1RdXI5a2FIeFdTSTFUZTVvTUptX0t4ZENoWXF0bnBqNWpoZlljc0JOVGJUeTJTR2JaZw?oc=5"" target=""_blank"">Biocon Faces Technical Adjustments Amidst Strong Institutional Confidence and Profit Decline</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMi1AFBVV95cUxQUkdkcng4X3VKTVNpbHhVa0wtcExXSEtPb04taDJTYS1NTjZDamNzdE9VdEVPdzJwUFpiX2tKYU9wYllpRjFjM0J2VUI3VThxbjB2MEpmRDJZQ01mSHdjYTB1eWtpbzN5eV9PekJhTlZ2bTZENWZ5M1FRa21WQmR5Tm0xeWF2ZTlZTU5VdVBLbmRSOFE1T00xbzkzTzc1WWE5ME1RdXI5a2FIeFdTSTFUZTVvTUptX0t4ZENoWXF0bnBqNWpoZlljc0JOVGJUeTJTR2JaZw?oc=5,Google News,Biocon profit,"Biocon Faces Technical Adjustments Amidst Strong Institutional Confidence and Profit Decline - MarketsMojo <a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxQUkdkcng4X3VKTVNpbHhVa0wtcExXSEtPb04taDJTYS1NTjZDamNzdE9VdEVPdzJwUFpiX2tKYU9wYllpRjFjM0J2VUI3VThxbjB2MEpmRDJZQ01mSHdjYTB1eWtpbzN5eV9PekJhTlZ2bTZENWZ5M1FRa21WQmR5Tm0xeWF2ZTlZTU5VdVBLbmRSOFE1T00xbzkzTzc1WWE5ME1RdXI5a2FIeFdTSTFUZTVvTUptX0t4ZENoWXF0bnBqNWpoZlljc0JOVGJUeTJTR2JaZw?oc=5"" target=""_blank"">Biocon Faces Technical Adjustments Amidst Strong Institutional Confidence and Profit Decline</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",-0.9679783582687378,negative,0.9679783582687378,0.0,neutral,0.0,0.9584,0.487,0.0,0.513,0.17333333333333334,0.33333333333333337,-0.5531304904392788,0.6999038972006905,other,0.0,[],False,True,6,0.0
2025-01-31,2025-01-31 08:00:00,"Biocon Q3 Revenue Up 10%, EBITDA Rises 16% - India Infoline","<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSksyYm4tUU1MNHJ5ZEVhNkRTdWwxb0tjZVdoa1VGQUpva3hYNDNUa095dDI2cC02S256Y2Fqd0tNTmFBbDFsVm4yS0U0WjdSZC1tQkU5SVdCck5PYVZjdEx6R2VXM3lOV3dqd2pjd0VlZ0FmbGg5YUMxY2NobmE0MFdBdkhtXy01VW8w?oc=5"" target=""_blank"">Biocon Q3 Revenue Up 10%, EBITDA Rises 16%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Infoline</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSksyYm4tUU1MNHJ5ZEVhNkRTdWwxb0tjZVdoa1VGQUpva3hYNDNUa095dDI2cC02S256Y2Fqd0tNTmFBbDFsVm4yS0U0WjdSZC1tQkU5SVdCck5PYVZjdEx6R2VXM3lOV3dqd2pjd0VlZ0FmbGg5YUMxY2NobmE0MFdBdkhtXy01VW8w?oc=5,Google News,Biocon profit,"Biocon Q3 Revenue Up 10%, EBITDA Rises 16% - India Infoline <a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSksyYm4tUU1MNHJ5ZEVhNkRTdWwxb0tjZVdoa1VGQUpva3hYNDNUa095dDI2cC02S256Y2Fqd0tNTmFBbDFsVm4yS0U0WjdSZC1tQkU5SVdCck5PYVZjdEx6R2VXM3lOV3dqd2pjd0VlZ0FmbGg5YUMxY2NobmE0MFdBdkhtXy01VW8w?oc=5"" target=""_blank"">Biocon Q3 Revenue Up 10%, EBITDA Rises 16%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Infoline</font>",0.9438971877098083,positive,0.9438971877098083,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5393698215484619,0.9438971877098083,other,0.0,[],False,True,6,0.0
2025-02-10,2025-02-10 08:00:00,Profit Booked: How Fair Value Unlocked a 50.4% Gain in Biocon - Investing.com India,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxPM2ZXdlQ1LUtQRm0weWt3UTJkTTZpOWtUblVvN1dqZVdMWHN2ajRyNVdfVXZrbUpUdDRKQjQtbGZPRUcwSTk3LUxNYXZERi16MWdPTE1JclVnV190dXdVbFRMVmFJazBsX2N5anFLRDF0R090QTZ4cXdaRzE2SlNYR2MwVFRLZkJPaUF4cFNvUDJsM2ZFaGZUR0wwZUlRTV9GTUM4Vg?oc=5"" target=""_blank"">Profit Booked: How Fair Value Unlocked a 50.4% Gain in Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com India</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxPM2ZXdlQ1LUtQRm0weWt3UTJkTTZpOWtUblVvN1dqZVdMWHN2ajRyNVdfVXZrbUpUdDRKQjQtbGZPRUcwSTk3LUxNYXZERi16MWdPTE1JclVnV190dXdVbFRMVmFJazBsX2N5anFLRDF0R090QTZ4cXdaRzE2SlNYR2MwVFRLZkJPaUF4cFNvUDJsM2ZFaGZUR0wwZUlRTV9GTUM4Vg?oc=5,Google News,Biocon profit,"Profit Booked: How Fair Value Unlocked a 50.4% Gain in Biocon - Investing.com India <a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxPM2ZXdlQ1LUtQRm0weWt3UTJkTTZpOWtUblVvN1dqZVdMWHN2ajRyNVdfVXZrbUpUdDRKQjQtbGZPRUcwSTk3LUxNYXZERi16MWdPTE1JclVnV190dXdVbFRMVmFJazBsX2N5anFLRDF0R090QTZ4cXdaRzE2SlNYR2MwVFRLZkJPaUF4cFNvUDJsM2ZFaGZUR0wwZUlRTV9GTUM4Vg?oc=5"" target=""_blank"">Profit Booked: How Fair Value Unlocked a 50.4% Gain in Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com India</font>",0.9330856800079346,positive,0.9330856800079346,0.0,neutral,0.0,0.9524,0.501,0.0,0.499,0.4666666666666666,0.6,0.5331918171473912,0.7840507822248671,other,0.0,[],False,True,6,0.0
2024-11-04,2024-11-04 08:00:00,Biocon's Q2 Results Decoded. Exclusive Interview With Biocon's Management On Earnings & Plans Ahead - Business Today,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxNOFRSeV9RYjNvX2d3aVBjTDdyY3Z4N1FPVUxqZzROVnAyZ1VmUldDLUdsSUNpeUdncG9MT2tuOF8wdUtwQXRyNjNDWXlPOXdvVnJ1U2hqRnYyVUQ0Z1ZaRkEwNDBUZ3FSNWxPT1lPZzBvN05iVjUwRnpBQjNyR0lYdTdYLUJ4THFSajIyS0NkYVZpaTQxN2h3b3JBN0k2TVlqNUl3WG9GSl9XSzk0QVM2cXJBSUFFWm5CTy03cUwzVTR6S2VSQldwUnBxZUE0MVJ3dnlwYzJFM2sxV1RMZk9mTjlKbTBLaHFRSXdYcEJORXl5d3ZXcHoydWl30gH_AUFVX3lxTE9ael95d0tPbmxvZHNhZndFM1lMREt2aGVXN2pFT2lYWEpzb3pTUVF1N05KZE1mcHNpdEJYX0dvNDFSVVUwV0Q4NWtNblQ4TUVFcFVFNzJOb3VZSkRBaGFmd3dqMkxnYzBsRWpWZ212N2FNR1p2MGl4NnJ1MHdkUHNfQ3kyazNHSEptUmtoQWx5aDBhR3J0SVVVeVpTZnBsUkxhSG5WZERtM0RpT2poUTBSMnlGbDJBSlVpNDZ5cV85U2dpWDdJTWxCZ1lTM2x3NS1WdGhKNVdpWXl5b0l6Sm1GeUl4N1VneXZxaUpDN2ZUUjhXUjZOV2s1TlZIYW1XTQ?oc=5"" target=""_blank"">Biocon's Q2 Results Decoded. Exclusive Interview With Biocon's Management On Earnings & Plans Ahead</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxNOFRSeV9RYjNvX2d3aVBjTDdyY3Z4N1FPVUxqZzROVnAyZ1VmUldDLUdsSUNpeUdncG9MT2tuOF8wdUtwQXRyNjNDWXlPOXdvVnJ1U2hqRnYyVUQ0Z1ZaRkEwNDBUZ3FSNWxPT1lPZzBvN05iVjUwRnpBQjNyR0lYdTdYLUJ4THFSajIyS0NkYVZpaTQxN2h3b3JBN0k2TVlqNUl3WG9GSl9XSzk0QVM2cXJBSUFFWm5CTy03cUwzVTR6S2VSQldwUnBxZUE0MVJ3dnlwYzJFM2sxV1RMZk9mTjlKbTBLaHFRSXdYcEJORXl5d3ZXcHoydWl30gH_AUFVX3lxTE9ael95d0tPbmxvZHNhZndFM1lMREt2aGVXN2pFT2lYWEpzb3pTUVF1N05KZE1mcHNpdEJYX0dvNDFSVVUwV0Q4NWtNblQ4TUVFcFVFNzJOb3VZSkRBaGFmd3dqMkxnYzBsRWpWZ212N2FNR1p2MGl4NnJ1MHdkUHNfQ3kyazNHSEptUmtoQWx5aDBhR3J0SVVVeVpTZnBsUkxhSG5WZERtM0RpT2poUTBSMnlGbDJBSlVpNDZ5cV85U2dpWDdJTWxCZ1lTM2x3NS1WdGhKNVdpWXl5b0l6Sm1GeUl4N1VneXZxaUpDN2ZUUjhXUjZOV2s1TlZIYW1XTQ?oc=5,Google News,Biocon profit,"Biocon's Q2 Results Decoded. Exclusive Interview With Biocon's Management On Earnings & Plans Ahead - Business Today <a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxNOFRSeV9RYjNvX2d3aVBjTDdyY3Z4N1FPVUxqZzROVnAyZ1VmUldDLUdsSUNpeUdncG9MT2tuOF8wdUtwQXRyNjNDWXlPOXdvVnJ1U2hqRnYyVUQ0Z1ZaRkEwNDBUZ3FSNWxPT1lPZzBvN05iVjUwRnpBQjNyR0lYdTdYLUJ4THFSajIyS0NkYVZpaTQxN2h3b3JBN0k2TVlqNUl3WG9GSl9XSzk0QVM2cXJBSUFFWm5CTy03cUwzVTR6S2VSQldwUnBxZUE0MVJ3dnlwYzJFM2sxV1RMZk9mTjlKbTBLaHFRSXdYcEJORXl5d3ZXcHoydWl30gH_AUFVX3lxTE9ael95d0tPbmxvZHNhZndFM1lMREt2aGVXN2pFT2lYWEpzb3pTUVF1N05KZE1mcHNpdEJYX0dvNDFSVVUwV0Q4NWtNblQ4TUVFcFVFNzJOb3VZSkRBaGFmd3dqMkxnYzBsRWpWZ212N2FNR1p2MGl4NnJ1MHdkUHNfQ3kyazNHSEptUmtoQWx5aDBhR3J0SVVVeVpTZnBsUkxhSG5WZERtM0RpT2poUTBSMnlGbDJBSlVpNDZ5cV85U2dpWDdJTWxCZ1lTM2x3NS1WdGhKNVdpWXl5b0l6Sm1GeUl4N1VneXZxaUpDN2ZUUjhXUjZOV2s1TlZIYW1XTQ?oc=5"" target=""_blank"">Biocon's Q2 Results Decoded. Exclusive Interview With Biocon's Management On Earnings & Plans Ahead</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.9343966841697693,0.0,neutral,0.0,0.25,0.091,0.0,0.909,0.0,0.0,0.0,0.5921983420848846,other,0.0,[],False,True,6,0.0
2025-01-30,2025-01-30 08:00:00,"Stocks to watch, January 31: ONGC, Nestle, Vedanta, L&T, Biocon, Tata Consumer and more - Upstox","<a href=""https://news.google.com/rss/articles/CBMi7wFBVV95cUxNUURFcHhBWHEtZ3kydlE2M3U1R3U3T09oRDVqQldyRnNKbWVna1BJdDVkTmhBSDF0Z3l0dldCeVdZbk9EZzU0dXpSM2dGX0UtaUVmLVFFeDUyeGZNWERLcUNDNW9DM0M4WkdyVUFDeTE2d3ZrMzZNTjRRT2tWWllSajBYSl9wRGtvYUc5eTMxWnQ2R2xWbkpWb2p4WUVTa3BtRmo5NHM5dkdSaVdjNk8yb2Q1YkZaRDNjLS1raEhuRXZja0Y5WVB0TUItSWZGS3F3Uk1aeE5qV2tLUEt2SjBmNDJLQlJPbS16bTJhWkh3Zw?oc=5"" target=""_blank"">Stocks to watch, January 31: ONGC, Nestle, Vedanta, L&amp;T, Biocon, Tata Consumer and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi7wFBVV95cUxNUURFcHhBWHEtZ3kydlE2M3U1R3U3T09oRDVqQldyRnNKbWVna1BJdDVkTmhBSDF0Z3l0dldCeVdZbk9EZzU0dXpSM2dGX0UtaUVmLVFFeDUyeGZNWERLcUNDNW9DM0M4WkdyVUFDeTE2d3ZrMzZNTjRRT2tWWllSajBYSl9wRGtvYUc5eTMxWnQ2R2xWbkpWb2p4WUVTa3BtRmo5NHM5dkdSaVdjNk8yb2Q1YkZaRDNjLS1raEhuRXZja0Y5WVB0TUItSWZGS3F3Uk1aeE5qV2tLUEt2SjBmNDJLQlJPbS16bTJhWkh3Zw?oc=5,Google News,Biocon profit,"Stocks to watch, January 31: ONGC, Nestle, Vedanta, L&T, Biocon, Tata Consumer and more - Upstox <a href=""https://news.google.com/rss/articles/CBMi7wFBVV95cUxNUURFcHhBWHEtZ3kydlE2M3U1R3U3T09oRDVqQldyRnNKbWVna1BJdDVkTmhBSDF0Z3l0dldCeVdZbk9EZzU0dXpSM2dGX0UtaUVmLVFFeDUyeGZNWERLcUNDNW9DM0M4WkdyVUFDeTE2d3ZrMzZNTjRRT2tWWllSajBYSl9wRGtvYUc5eTMxWnQ2R2xWbkpWb2p4WUVTa3BtRmo5NHM5dkdSaVdjNk8yb2Q1YkZaRDNjLS1raEhuRXZja0Y5WVB0TUItSWZGS3F3Uk1aeE5qV2tLUEt2SjBmNDJLQlJPbS16bTJhWkh3Zw?oc=5"" target=""_blank"">Stocks to watch, January 31: ONGC, Nestle, Vedanta, L&amp;T, Biocon, Tata Consumer and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.0,neutral,0.9170987606048584,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.25,0.25,0.0,0.5835493803024292,other,0.0,[],False,True,6,0.0
2024-05-17,2024-05-17 07:00:00,Biocon profit falls 57% to Rs 136 crore; revenue at Rs 4K crore - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon profit falls 57% to Rs 136 crore; revenue at Rs 4K crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Biocon profit falls 57% to Rs 136 crore; revenue at Rs 4K crore - The New Indian Express <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon profit falls 57% to Rs 136 crore; revenue at Rs 4K crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",-0.9649448394775391,negative,0.9649448394775391,0.0,neutral,0.0,0.7003,0.146,0.0,0.854,0.0909090909090909,0.30303030303030304,-0.5513970511300222,0.58538464346221,other,0.0,[],False,True,6,0.0
2024-10-31,2024-10-31 07:00:00,"Wipro, Biocon , IRB Infrastructure Developers , Larsen & Toubro, Tata Power Company In Focus - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Wipro, Biocon , IRB Infrastructure Developers , Larsen & Toubro, Tata Power Company In Focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMi7gFBVV95cUxONzVCeUcwSGVKaEFJRks0Ty1ybjhOdkhwOFRaTFNQNGw5eVR2c0FpMjhzZHh0VmVQUHVCZzRZR2FUZlFIZHZ4MnBDalJtVjU5X3RKSkRXazhRU3lMNUM0V3lJRE5nUVhDZV8xYnBqNTQ1T1RYMW5femxJLWhlVy1qRm9PNlVyQmVkN3BvVE8ydWg4TEsxM0J5SHJyRkFRTWVLb2hnUjNqeF82cHp0MzhwdVlpbkJLUnlieEM4cGxHa19Eb0NZV19YOVFQN2VSVlUxNXFMLTd1QVdPcTBjSi1JcHVJbHJzRDJuZllyVHJ30gHzAUFVX3lxTE11SHdOVWw1Qi02cmhfaVJWY3FrSDU1bnJ5N3dKaGhnZFpDdFBWSFdKQkFTb2J3Z0psZG1vQlR2MU40ZGxHeVYxcGhrTks1em5saUdBRV9hcEQtQzdZS2JXVEVsUkYwdGRNLXNHbF9zQk9ERXNEU3p1N3lHeFJab0pwaWtKVnN5bnhmeUJiM0o4eXE1X2FNclQwMDByV2NVZ00yRUFMR0wzdUlhNnJ0bmRiX0xZVHk2ZkRiZF82Mk40bmNRNlF5Y0MwQUhTV2JjaU1ZU28tWFhWMW1TU1NBNTJjX2I1VkZlbk9DS1VtT2VzRFE1Zw?oc=5,Google News,Biocon profit,"Wipro, Biocon , IRB Infrastructure Developers , Larsen & Toubro, Tata Power Company In Focus - Moneycontrol <a href=""https://news.google.com/rss/articles/CBMi7gFBVV95cUxONzVCeUcwSGVKaEFJRks0Ty1ybjhOdkhwOFRaTFNQNGw5eVR2c0FpMjhzZHh0VmVQUHVCZzRZR2FUZlFIZHZ4MnBDalJtVjU5X3RKSkRXazhRU3lMNUM0V3lJRE5nUVhDZV8xYnBqNTQ1T1RYMW5femxJLWhlVy1qRm9PNlVyQmVkN3BvVE8ydWg4TEsxM0J5SHJyRkFRTWVLb2hnUjNqeF82cHp0MzhwdVlpbkJLUnlieEM4cGxHa19Eb0NZV19YOVFQN2VSVlUxNXFMLTd1QVdPcTBjSi1JcHVJbHJzRDJuZllyVHJ30gHzAUFVX3lxTE11SHdOVWw1Qi02cmhfaVJWY3FrSDU1bnJ5N3dKaGhnZFpDdFBWSFdKQkFTb2J3Z0psZG1vQlR2MU40ZGxHeVYxcGhrTks1em5saUdBRV9hcEQtQzdZS2JXVEVsUkYwdGRNLXNHbF9zQk9ERXNEU3p1N3lHeFJab0pwaWtKVnN5bnhmeUJiM0o4eXE1X2FNclQwMDByV2NVZ00yRUFMR0wzdUlhNnJ0bmRiX0xZVHk2ZkRiZF82Mk40bmNRNlF5Y0MwQUhTV2JjaU1ZU28tWFhWMW1TU1NBNTJjX2I1VkZlbk9DS1VtT2VzRFE1Zw?oc=5"" target=""_blank"">Wipro, Biocon , IRB Infrastructure Developers , Larsen & Toubro, Tata Power Company In Focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.928715705871582,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.928715705871582,other,0.0,[],False,True,6,0.0
2024-04-12,2024-04-12 07:00:00,Will Biocon Lead Indian Pharma's Rare 'Patent Cliff' Opportunity - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxNMkZ0QUdwbEZjelpWVDk3bm1kd2I5ZmtTT19SZjZ1YkM4VjdSTXlsakt2ZFA4ekdBZGxlM3VOQVBNcExhUDg3aEl4MHU4ZTh4SkZnSF9nX05GTVpFaTI5emUzYVo2RWdfWFBVNGxJbGRvNm9wVTVfVUMyb1BJQkxKbGw4XzVnblN3YWtRM3VoZE1fYWx4b1lsOXAtY2pCX0lOMkRpOWRLSTRGTlF1OEswXzZoWHdvR0xCb2ZmQS1KZjlnZU1mbmdiYko0cWRibjMyZGdTWE5VSjBoUzNGOWc?oc=5"" target=""_blank"">Will Biocon Lead Indian Pharma's Rare 'Patent Cliff' Opportunity</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMi3gFBVV95cUxNMkZ0QUdwbEZjelpWVDk3bm1kd2I5ZmtTT19SZjZ1YkM4VjdSTXlsakt2ZFA4ekdBZGxlM3VOQVBNcExhUDg3aEl4MHU4ZTh4SkZnSF9nX05GTVpFaTI5emUzYVo2RWdfWFBVNGxJbGRvNm9wVTVfVUMyb1BJQkxKbGw4XzVnblN3YWtRM3VoZE1fYWx4b1lsOXAtY2pCX0lOMkRpOWRLSTRGTlF1OEswXzZoWHdvR0xCb2ZmQS1KZjlnZU1mbmdiYko0cWRibjMyZGdTWE5VSjBoUzNGOWc?oc=5,Google News,Biocon profit,"Will Biocon Lead Indian Pharma's Rare 'Patent Cliff' Opportunity - Equitymaster <a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxNMkZ0QUdwbEZjelpWVDk3bm1kd2I5ZmtTT19SZjZ1YkM4VjdSTXlsakt2ZFA4ekdBZGxlM3VOQVBNcExhUDg3aEl4MHU4ZTh4SkZnSF9nX05GTVpFaTI5emUzYVo2RWdfWFBVNGxJbGRvNm9wVTVfVUMyb1BJQkxKbGw4XzVnblN3YWtRM3VoZE1fYWx4b1lsOXAtY2pCX0lOMkRpOWRLSTRGTlF1OEswXzZoWHdvR0xCb2ZmQS1KZjlnZU1mbmdiYko0cWRibjMyZGdTWE5VSjBoUzNGOWc?oc=5"" target=""_blank"">Will Biocon Lead Indian Pharma's Rare 'Patent Cliff' Opportunity</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",0.0,neutral,0.7715004086494446,0.0,neutral,0.0,0.4215,0.118,0.0,0.882,0.19999999999999998,0.6,0.0,0.46433346954981486,other,0.0,[],False,True,6,0.0
2023-04-25,2023-04-25 07:00:00,Serum Institute of India doubles Biocon investment to $300 million - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Serum Institute of India doubles Biocon investment to $300 million</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Serum Institute of India doubles Biocon investment to $300 million - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Serum Institute of India doubles Biocon investment to $300 million</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8266372084617615,positive,0.8266372084617615,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.47236411912100656,0.8266372084617615,other,0.0,[],False,True,6,0.0
2024-05-17,2024-05-17 07:00:00,"Siddharth Mittal, CEO & MD, Biocon, On Q4 Earnings, Pharma Market & Plans For Overseas Markets - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Siddharth Mittal, CEO & MD, Biocon, On Q4 Earnings, Pharma Market & Plans For Overseas Markets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon profit,"Siddharth Mittal, CEO & MD, Biocon, On Q4 Earnings, Pharma Market & Plans For Overseas Markets - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Siddharth Mittal, CEO & MD, Biocon, On Q4 Earnings, Pharma Market & Plans For Overseas Markets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.9261135458946228,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9261135458946228,other,0.0,[],False,True,6,0.0
2024-05-17,2024-05-17 07:00:00,Biocon rises nearly 2% even as Q4 net profit drops 57% - Upstox,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxOOHA5VTk0alhXblRnbXdFTFVtZFQzX3FyRDF3MUpkM0MwQnFGbC1uMlh2MG5OazZGdGpkR0xCemFNdjB2V2gxeDVnckhGY3FMejBSVkRTSU5xV1ljUFpxOHRfdHpzNkRsdnRQX2VILVFvOEhKeGNXazQ3SGwtQVpXeDZIT3NEMmpsZ0NWOHp2bFlQa0h5LUpQcV9xQ1EwT3k4WDE4ZW03LWFfZjQ2LUYwdjhNVGZZdms?oc=5"" target=""_blank"">Biocon rises nearly 2% even as Q4 net profit drops 57%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxOOHA5VTk0alhXblRnbXdFTFVtZFQzX3FyRDF3MUpkM0MwQnFGbC1uMlh2MG5OazZGdGpkR0xCemFNdjB2V2gxeDVnckhGY3FMejBSVkRTSU5xV1ljUFpxOHRfdHpzNkRsdnRQX2VILVFvOEhKeGNXazQ3SGwtQVpXeDZIT3NEMmpsZ0NWOHp2bFlQa0h5LUpQcV9xQ1EwT3k4WDE4ZW03LWFfZjQ2LUYwdjhNVGZZdms?oc=5,Google News,Biocon profit,"Biocon rises nearly 2% even as Q4 net profit drops 57% - Upstox <a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxOOHA5VTk0alhXblRnbXdFTFVtZFQzX3FyRDF3MUpkM0MwQnFGbC1uMlh2MG5OazZGdGpkR0xCemFNdjB2V2gxeDVnckhGY3FMejBSVkRTSU5xV1ljUFpxOHRfdHpzNkRsdnRQX2VILVFvOEhKeGNXazQ3SGwtQVpXeDZIT3NEMmpsZ0NWOHp2bFlQa0h5LUpQcV9xQ1EwT3k4WDE4ZW03LWFfZjQ2LUYwdjhNVGZZdms?oc=5"" target=""_blank"">Biocon rises nearly 2% even as Q4 net profit drops 57%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",-0.7195786237716675,negative,0.7195786237716675,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,0.04,0.16,-0.4111877850123814,0.48662620792388916,other,0.0,[],False,True,6,0.0
2025-02-13,2025-02-13 08:00:00,Biosimilars: expanding access to essential biologic therapies - World Health Organization (WHO),"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxNZHF3Y01BRThZeDd5WWFRYnFYaWNDZlh3OW1TTDlqM3l4YWt4dnF3UFBjSVNGSW9DZU1UWFo2WXhnZlNicnhIOGpOZ1BSay1ISFA1bG13RmN6VGNFRElrcEJEbmtJeVRPTGNLZGg4U2gtcHVHQkk5YXhqRThBdGVLc013b3VQdmc5VUpicW5XNjE0aFNRa1B0WHVQR0hUdDc4X01yYg?oc=5"" target=""_blank"">Biosimilars: expanding access to essential biologic therapies</a>&nbsp;&nbsp;<font color=""#6f6f6f"">World Health Organization (WHO)</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxNZHF3Y01BRThZeDd5WWFRYnFYaWNDZlh3OW1TTDlqM3l4YWt4dnF3UFBjSVNGSW9DZU1UWFo2WXhnZlNicnhIOGpOZ1BSay1ISFA1bG13RmN6VGNFRElrcEJEbmtJeVRPTGNLZGg4U2gtcHVHQkk5YXhqRThBdGVLc013b3VQdmc5VUpicW5XNjE0aFNRa1B0WHVQR0hUdDc4X01yYg?oc=5,Google News,Biocon guidance,"Biosimilars: expanding access to essential biologic therapies - World Health Organization (WHO) <a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxNZHF3Y01BRThZeDd5WWFRYnFYaWNDZlh3OW1TTDlqM3l4YWt4dnF3UFBjSVNGSW9DZU1UWFo2WXhnZlNicnhIOGpOZ1BSay1ISFA1bG13RmN6VGNFRElrcEJEbmtJeVRPTGNLZGg4U2gtcHVHQkk5YXhqRThBdGVLc013b3VQdmc5VUpicW5XNjE0aFNRa1B0WHVQR0hUdDc4X01yYg?oc=5"" target=""_blank"">Biosimilars: expanding access to essential biologic therapies</a>&nbsp;&nbsp;<font color=""#6f6f6f"">World Health Organization (WHO)</font>",0.6973593831062317,positive,0.6973593831062317,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.19999999999999998,0.39849107606070383,0.6973593831062317,other,0.0,[],False,False,1,0.0
2025-06-20,2025-06-20 16:24:08,"Biocon closes ₹4,500 crore QIP to boost innovation, expand global access - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon closes ₹4,500 crore QIP to boost innovation, expand global access</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi1gFBVV95cUxNZVp6cW84YWZsZmRUaU5ZUmpXN05JaTlZeW5XWlJaZGN0VDZLbWNkWUpaSjJfQV9aYi1DMk50bTJkU18xQTd3cEN6ZkFZTUl0cUthWmswM1hJWXpUczlEQ2VsU3lndklGRXl5UzZCOGlYSDhQUVlTWDgxa293MUVtMlQzS2w0V1N6TWgzS05neWFhSjZLVU1QVTZaTE5DVV9zVkFtX19XNkJTTTBVMFg3Um1FMHQwVTQxSElqMTVYMHpqckR3cG9XMlpXR2Rfb3o1a0pVLXVR0gHbAUFVX3lxTE1oUmlkREpKQnZUdXg2ZDdkV19QNThLX0x1RGpuZ29iN1FtZnpOdDZIUnBpNmN2UUh5VEdmX0pfQ053ODUtakJCODhpZEpwNTlWdURRRVd1RGFCVEJxUnoydExoX2ZaQ3laTTFRTTlaSnNGSFhRa0VOb3U1aVNmS0traTBKWENwdmUtUE5qLVJoYm5rVlhKcFVHRnZBeEV3dG5jVEVKV2o1MXlUcm1Fc3ZEZS1jR2VQVmNvWGdzT2N4dlBNV2xoWDRQcElpWmlMbWRkNjRpSlFWSGZDcw?oc=5,Google News,Biocon guidance,"Biocon closes ₹4,500 crore QIP to boost innovation, expand global access - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon closes ₹4,500 crore QIP to boost innovation, expand global access</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8355758190155029,positive,0.8355758190155029,0.0,neutral,0.0,0.9217,0.409,0.0,0.591,0.0,0.0,0.4774718965802874,0.8786379095077514,other,0.0,[],False,True,6,0.0
2025-06-10,2025-06-10 07:00:00,Helping women steer careers in life sciences - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Helping women steer careers in life sciences</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Helping women steer careers in life sciences - The New Indian Express <a href=""https://news.google.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?oc=5"" target=""_blank"">Helping women steer careers in life sciences</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",0.0,neutral,0.825557291507721,0.0,neutral,0.0,0.296,0.087,0.0,0.913,0.0909090909090909,0.30303030303030304,0.0,0.40415546080560394,other,0.0,[],False,False,1,0.0
2025-04-24,2025-04-24 07:00:00,"Syngene Shares Nosedive 10% On Q4 Profit Drop, Subdued FY26 Outlook - outlookbusiness.com","<a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene Shares Nosedive 10% On Q4 Profit Drop, Subdued FY26 Outlook</a>&nbsp;&nbsp;<font color=""#6f6f6f"">outlookbusiness.com</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Syngene Shares Nosedive 10% On Q4 Profit Drop, Subdued FY26 Outlook - outlookbusiness.com <a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene Shares Nosedive 10% On Q4 Profit Drop, Subdued FY26 Outlook</a>&nbsp;&nbsp;<font color=""#6f6f6f"">outlookbusiness.com</font>",-0.9681705236434937,negative,0.9681705236434937,0.0,neutral,0.0,0.7184,0.297,0.122,0.581,0.0,0.0,-0.5532402992248535,0.8432852618217468,other,0.0,[],False,False,1,0.0
2025-06-12,2025-06-12 07:00:00,"Stocks to buy today (June 12): Infosys, L&T, Biocon and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today (June 12): Infosys, L&amp;T, Biocon and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Stocks to buy today (June 12): Infosys, L&T, Biocon and more - ET Now <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today (June 12): Infosys, L&amp;T, Biocon and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",0.0,neutral,0.902681827545166,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.25,0.25,0.0,0.576340913772583,other,0.0,[],False,True,6,0.0
2025-04-24,2025-04-24 07:00:00,Stock Crash: Syngene shares fall 10% after revenue miss; disappointing FY26 guidance - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Crash: Syngene shares fall 10% after revenue miss; disappointing FY26 guidance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Stock Crash: Syngene shares fall 10% after revenue miss; disappointing FY26 guidance - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxPQmpwcDBrRWMxYXd4bkxla1lhSmRKdmJMU3JmaURMRWw3UHVObkFPQ2pKQWRpMk1WX1FkdjMzQ21LQmJHNlY2WTYxSkx2UVBRX0JCN0RjSnp2VXgxUVdCa3JjR05jdkVCSFQxR1ZDTVlzeDNkckQwNkoxc3dfMGNQN19LcjV1Rkx0RHpjTC1HVG5xemVJdzRGUHJOU1NZN2wwZ0lxYUtuXzhpOExLN2k5UHpfUjVfMGRtRUgtZ3RZNThVd19KTjlqc1RSSHBkUjhIeUVleVA0OEtpZnA4bEHSAeMBQVVfeXFMTXdRdTF0dER6c1lRNmVtdUc0NjJka0RObElwM2NHMnNvZ3A0cy1xcGU0ZmdxXy1ZVy1OWUFFNVJfRERKVnYwT2MyUUE0emR6aC1id09LY1E4T2hidjZmZDdYRmNuV2ZvNTFZRjFGSDNLcjRraHVqNW5GQUhNcktVLWR2QUpNekQ0ZXFnd2J1NkNyRlRNZUlzdzRIaEpyeHlmQVgzLXp1bkgxd2hBbktJa1hwQ2ZjTHhuWEl1YWIwOXNyOUd2ZXNGdnlsOTJTT2otQWsxY2REaVFaMzJnVnpvY0ljVW8?oc=5"" target=""_blank"">Stock Crash: Syngene shares fall 10% after revenue miss; disappointing FY26 guidance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",-0.9709864258766174,negative,0.9709864258766174,0.0,neutral,0.0,-0.8625,0.106,0.362,0.531,-0.39999999999999997,0.4666666666666666,-0.55484938621521,0.7444954752922058,other,0.0,[],False,False,1,0.0
2025-04-26,2025-04-26 07:06:40,Biocon Biologics receives EMA Committee positive opinions for Biosimilar Denosumab for bone health - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics receives EMA Committee positive opinions for Biosimilar Denosumab for bone health</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Biocon Biologics receives EMA Committee positive opinions for Biosimilar Denosumab for bone health - Medical Dialogues <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics receives EMA Committee positive opinions for Biosimilar Denosumab for bone health</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",0.6710932850837708,positive,0.6710932850837708,0.0,neutral,0.0,0.802,0.194,0.0,0.806,0.11363636363636363,0.2727272727272727,0.3834818771907261,0.5289098829067115,other,0.0,[],False,True,6,0.0
2024-08-09,2024-08-09 05:58:34,Biocon Share Price Falls As Q1 Revenue Misses Estimates - NDTV Profit,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxNRThTUmV5ZWtNaHp5NnFEYnNSSjVfSmZDMEZGU05QSi13UDNubFlrT1ZqQkh5ZmRKOUp1UmltWGxBLWZIdTJRUkJLQklTckVhZWR5eWtybXpMQkNsWXBMNDJxQnhJSDRJOG44NjYydW16el82cXJrMXBwTXRZekwyMTZ3Z0FrWHJVbHZYV25BcXRoOC1q?oc=5"" target=""_blank"">Biocon Share Price Falls As Q1 Revenue Misses Estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxNRThTUmV5ZWtNaHp5NnFEYnNSSjVfSmZDMEZGU05QSi13UDNubFlrT1ZqQkh5ZmRKOUp1UmltWGxBLWZIdTJRUkJLQklTckVhZWR5eWtybXpMQkNsWXBMNDJxQnhJSDRJOG44NjYydW16el82cXJrMXBwTXRZekwyMTZ3Z0FrWHJVbHZYV25BcXRoOC1q?oc=5,Google News,Biocon guidance,"Biocon Share Price Falls As Q1 Revenue Misses Estimates - NDTV Profit <a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxNRThTUmV5ZWtNaHp5NnFEYnNSSjVfSmZDMEZGU05QSi13UDNubFlrT1ZqQkh5ZmRKOUp1UmltWGxBLWZIdTJRUkJLQklTckVhZWR5eWtybXpMQkNsWXBMNDJxQnhJSDRJOG44NjYydW16el82cXJrMXBwTXRZekwyMTZ3Z0FrWHJVbHZYV25BcXRoOC1q?oc=5"" target=""_blank"">Biocon Share Price Falls As Q1 Revenue Misses Estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",-0.9709585309028625,negative,0.9709585309028625,0.0,neutral,0.0,0.5423,0.243,0.126,0.631,0.0,0.0,-0.5548334462302071,0.7566292654514313,other,0.0,[],False,True,6,0.0
2025-04-09,2025-04-09 07:00:00,"Pharma Stocks Crash: Gland, Aurobindo, Biocon, Sun Pharma slump up to 6% as Trump eyes import tariffs - Zee Business","<a href=""https://news.google.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?oc=5"" target=""_blank"">Pharma Stocks Crash: Gland, Aurobindo, Biocon, Sun Pharma slump up to 6% as Trump eyes import tariffs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.com/rss/articles/CBMi3wFBVV95cUxQV2hnNjBhRWVybUdZYkQ0b29wakdwU3dzQTRIU2tFRGd0dzhqenJ0a1hadXdLek9BVVFIcDFKNU1kaTJCTDN3NDF0V1ctamlfWXFhbms5aF93ckswNkhKWl9LLVlfNXRTdUxrcldZcHdNQTZDODFUS0NfSUlpajhlM0lGLVlUUzZDRk42b0hNNmlzRmVLM1JnQ0tLMjFDX2hVTjVlQkkxLXFISnRnTGpwVDRpMVFNX0ZVaE9aWmhaQ1RUdXRrVWxyYTBRU3laZzF0T1RCeTRSX1ZSb3pKREFB0gHkAUFVX3lxTE9oZWdQOVpRV3NPWm9TY3lrMlZWQmJOOEVfZXpMUjdhdGR0RUpMX0dodHAzWjRadnRPQkxxTFROR0EzNC1LVVpBRVFFRmIzMEhFSktPM1Z0VTBUXy1UN0tpLThjMFk2MVVYM1RoN1JtME4wTkdfZWhNVlVyT0daVmY1QXptQk1OWHAxQWc3VktyOWJ0ZERobTFQWmlFZVdRQ0ZIQkN6ejI3OGcwM01FalRIVjBjM3R3anNKbW5OME4yc0JiWDVwUjQza05BQW9jZGtiNEdBZEw2LVNhZHA1eWxXMzRkZQ?oc=5,Google News,Biocon guidance,"Pharma Stocks Crash: Gland, Aurobindo, Biocon, Sun Pharma slump up to 6% as Trump eyes import tariffs - Zee Business <a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxQV2hnNjBhRWVybUdZYkQ0b29wakdwU3dzQTRIU2tFRGd0dzhqenJ0a1hadXdLek9BVVFIcDFKNU1kaTJCTDN3NDF0V1ctamlfWXFhbms5aF93ckswNkhKWl9LLVlfNXRTdUxrcldZcHdNQTZDODFUS0NfSUlpajhlM0lGLVlUUzZDRk42b0hNNmlzRmVLM1JnQ0tLMjFDX2hVTjVlQkkxLXFISnRnTGpwVDRpMVFNX0ZVaE9aWmhaQ1RUdXRrVWxyYTBRU3laZzF0T1RCeTRSX1ZSb3pKREFB0gHkAUFVX3lxTE9oZWdQOVpRV3NPWm9TY3lrMlZWQmJOOEVfZXpMUjdhdGR0RUpMX0dodHAzWjRadnRPQkxxTFROR0EzNC1LVVpBRVFFRmIzMEhFSktPM1Z0VTBUXy1UN0tpLThjMFk2MVVYM1RoN1JtME4wTkdfZWhNVlVyT0daVmY1QXptQk1OWHAxQWc3VktyOWJ0ZERobTFQWmlFZVdRQ0ZIQkN6ejI3OGcwM01FalRIVjBjM3R3anNKbW5OME4yc0JiWDVwUjQza05BQW9jZGtiNEdBZEw2LVNhZHA1eWxXMzRkZQ?oc=5"" target=""_blank"">Pharma Stocks Crash: Gland, Aurobindo, Biocon, Sun Pharma slump up to 6% as Trump eyes import tariffs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",-0.9700106978416443,negative,0.9700106978416443,0.0,neutral,0.0,-0.6597,0.0,0.124,0.876,0.0,0.0,-0.5542918273380825,0.8148553489208221,other,0.0,[],False,True,6,0.0
2024-09-26,2024-09-26 07:00:00,Accenture raises FY25 revenue growth guidance to 3-6% despite FY24 miss - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Accenture raises FY25 revenue growth guidance to 3-6% despite FY24 miss</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Accenture raises FY25 revenue growth guidance to 3-6% despite FY24 miss - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Accenture raises FY25 revenue growth guidance to 3-6% despite FY24 miss</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9448971748352051,positive,0.9448971748352051,0.0,neutral,0.0,0.6852,0.21,0.0,0.79,0.0,0.0,0.5399412427629743,0.8150485874176026,other,0.0,[],False,False,1,0.0
2025-05-29,2025-05-29 07:00:00,Eye on Pharma: Interchangeability Labels and Expanded Biosimilar Partnerships - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNdUxWQk5OcF91eGg4elZ0aUJnWC1zUDFFLUZEY2RFZGRWd1VDOXlCWVhBWEFyWUQzUk5pLTBtSmlHcUxPMlRuZ1c2N1pxamljMTFzVEJNUm9DdnV0X2xmTi1GQjZNLTlBX1pNLUdmbmswWjhUQU0wbkYtUzFDRWNUSjhBVjFwMzJvX3diNTNMNllIekRUZ1JiMkU3MFhhRzZHRXhpd3FCanpuQ1JZSngyNXMtN1ZoTGJ4VWc?oc=5"" target=""_blank"">Eye on Pharma: Interchangeability Labels and Expanded Biosimilar Partnerships</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNdUxWQk5OcF91eGg4elZ0aUJnWC1zUDFFLUZEY2RFZGRWd1VDOXlCWVhBWEFyWUQzUk5pLTBtSmlHcUxPMlRuZ1c2N1pxamljMTFzVEJNUm9DdnV0X2xmTi1GQjZNLTlBX1pNLUdmbmswWjhUQU0wbkYtUzFDRWNUSjhBVjFwMzJvX3diNTNMNllIekRUZ1JiMkU3MFhhRzZHRXhpd3FCanpuQ1JZSngyNXMtN1ZoTGJ4VWc?oc=5,Google News,Biocon guidance,"Eye on Pharma: Interchangeability Labels and Expanded Biosimilar Partnerships - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNdUxWQk5OcF91eGg4elZ0aUJnWC1zUDFFLUZEY2RFZGRWd1VDOXlCWVhBWEFyWUQzUk5pLTBtSmlHcUxPMlRuZ1c2N1pxamljMTFzVEJNUm9DdnV0X2xmTi1GQjZNLTlBX1pNLUdmbmswWjhUQU0wbkYtUzFDRWNUSjhBVjFwMzJvX3diNTNMNllIekRUZ1JiMkU3MFhhRzZHRXhpd3FCanpuQ1JZSngyNXMtN1ZoTGJ4VWc?oc=5"" target=""_blank"">Eye on Pharma: Interchangeability Labels and Expanded Biosimilar Partnerships</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.0,neutral,0.7469326853752136,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.05,0.05,0.0,0.39846634268760683,other,0.0,[],False,False,1,0.0
2025-02-27,2025-02-27 08:00:00,"DCGI streamlines drug export approval, plans revised biosimilar guidelines - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">DCGI streamlines drug export approval, plans revised biosimilar guidelines</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"DCGI streamlines drug export approval, plans revised biosimilar guidelines - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">DCGI streamlines drug export approval, plans revised biosimilar guidelines</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.9194045662879944,0.0,neutral,0.0,0.7351,0.22,0.0,0.78,0.0,0.0,0.0,0.8272522831439972,other,0.0,[],False,False,1,0.0
2025-02-05,2025-02-05 08:00:00,Eris Life soars 13% on strong Q3 revenue; Co reduces debt ahead of guidance - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Life soars 13% on strong Q3 revenue; Co reduces debt ahead of guidance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Eris Life soars 13% on strong Q3 revenue; Co reduces debt ahead of guidance - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Life soars 13% on strong Q3 revenue; Co reduces debt ahead of guidance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9164989590644836,positive,0.9164989590644836,0.0,neutral,0.0,0.3818,0.159,0.12,0.721,0.21666666666666667,0.3666666666666667,0.5237136908939907,0.5049885419103833,other,0.0,[],False,False,1,0.0
2022-11-29,2022-11-29 08:00:00,Viatris Completes Biosimilars Transaction with Biocon Biologics - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMiuwFBVV95cUxOcjE1TGJPaHcwSlVwUXFPaDZCOTZfYy13OXhYZzN0ajFtcDRGSjFEYjM0TEp6aFNkVERBeFpWNlk1Ym9oRkJDR1JiWlpMcVJkOUZfQ182MGxPNUd0cEdfSFhQelRGRHRSMWxHSlZSTVpMaGNwaGdHWmdBcUJUZFF2NnFUUndaLUNyTnJaYkVKdy14NUJYT0F3RHB4TXB6TlpISG9LS3NjT3VZamJUbGIxMm96czI0TXFpVHk4?oc=5"" target=""_blank"">Viatris Completes Biosimilars Transaction with Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMiuwFBVV95cUxOcjE1TGJPaHcwSlVwUXFPaDZCOTZfYy13OXhYZzN0ajFtcDRGSjFEYjM0TEp6aFNkVERBeFpWNlk1Ym9oRkJDR1JiWlpMcVJkOUZfQ182MGxPNUd0cEdfSFhQelRGRHRSMWxHSlZSTVpMaGNwaGdHWmdBcUJUZFF2NnFUUndaLUNyTnJaYkVKdy14NUJYT0F3RHB4TXB6TlpISG9LS3NjT3VZamJUbGIxMm96czI0TXFpVHk4?oc=5,Google News,Biocon guidance,"Viatris Completes Biosimilars Transaction with Biocon Biologics - PR Newswire <a href=""https://news.google.com/rss/articles/CBMiuwFBVV95cUxOcjE1TGJPaHcwSlVwUXFPaDZCOTZfYy13OXhYZzN0ajFtcDRGSjFEYjM0TEp6aFNkVERBeFpWNlk1Ym9oRkJDR1JiWlpMcVJkOUZfQ182MGxPNUd0cEdfSFhQelRGRHRSMWxHSlZSTVpMaGNwaGdHWmdBcUJUZFF2NnFUUndaLUNyTnJaYkVKdy14NUJYT0F3RHB4TXB6TlpISG9LS3NjT3VZamJUbGIxMm96czI0TXFpVHk4?oc=5"" target=""_blank"">Viatris Completes Biosimilars Transaction with Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",0.0,neutral,0.6660998463630676,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.6660998463630676,other,0.0,[],False,True,6,0.0
2024-07-03,2024-07-03 07:00:00,FDA Seeks to Dispense With Switching Studies for Interchangeable Biosi - AIS Health,"<a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxQLXQ1bXZZTGU1TmNYVGU5OHgzRXlWeWZHNUxoME9fYS1nc3VnZ0pjYm5YQ0M3RFdtQmNKTXBaRERjaWw0cnZHLS1XX2xIOUluaFdwbFpiREtrMmE0dHBJSW5ES0JrakNvUlpla1pQUnNaMktxSTUxbVg2Qkg3ZEZqb0h3V1Rzc1ZuN011X0hlaFcxVHVKZllEOGFEXzJyQ1N3NGVYSWF0bm55MFp4c1VUUmFuV0JhMmRqR3dMYU1VV3kwY3hxWXRuUEhjS0ljcHlrNUJGaFJBWFA2Rnc?oc=5"" target=""_blank"">FDA Seeks to Dispense With Switching Studies for Interchangeable Biosi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AIS Health</font>",https://news.google.com/rss/articles/CBMi2wFBVV95cUxQLXQ1bXZZTGU1TmNYVGU5OHgzRXlWeWZHNUxoME9fYS1nc3VnZ0pjYm5YQ0M3RFdtQmNKTXBaRERjaWw0cnZHLS1XX2xIOUluaFdwbFpiREtrMmE0dHBJSW5ES0JrakNvUlpla1pQUnNaMktxSTUxbVg2Qkg3ZEZqb0h3V1Rzc1ZuN011X0hlaFcxVHVKZllEOGFEXzJyQ1N3NGVYSWF0bm55MFp4c1VUUmFuV0JhMmRqR3dMYU1VV3kwY3hxWXRuUEhjS0ljcHlrNUJGaFJBWFA2Rnc?oc=5,Google News,Biocon guidance,"FDA Seeks to Dispense With Switching Studies for Interchangeable Biosi - AIS Health <a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxQLXQ1bXZZTGU1TmNYVGU5OHgzRXlWeWZHNUxoME9fYS1nc3VnZ0pjYm5YQ0M3RFdtQmNKTXBaRERjaWw0cnZHLS1XX2xIOUluaFdwbFpiREtrMmE0dHBJSW5ES0JrakNvUlpla1pQUnNaMktxSTUxbVg2Qkg3ZEZqb0h3V1Rzc1ZuN011X0hlaFcxVHVKZllEOGFEXzJyQ1N3NGVYSWF0bm55MFp4c1VUUmFuV0JhMmRqR3dMYU1VV3kwY3hxWXRuUEhjS0ljcHlrNUJGaFJBWFA2Rnc?oc=5"" target=""_blank"">FDA Seeks to Dispense With Switching Studies for Interchangeable Biosi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AIS Health</font>",0.0,neutral,0.867617130279541,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.867617130279541,other,0.0,[],False,False,1,0.0
2024-05-18,2024-05-18 07:00:00,"Acceleration of biosimilar business, debt reduction to be key priorties in FY25: Biocon Chief - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Acceleration of biosimilar business, debt reduction to be key priorties in FY25: Biocon Chief</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Acceleration of biosimilar business, debt reduction to be key priorties in FY25: Biocon Chief - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Acceleration of biosimilar business, debt reduction to be key priorties in FY25: Biocon Chief</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.853419303894043,0.0,neutral,0.0,-0.6124,0.0,0.128,0.872,0.08,0.4800000000000001,0.0,0.5152731012980144,other,0.0,[],False,True,6,0.0
2024-09-23,2024-09-23 07:00:00,"The Food By-Products Bioprocess Wheel: A Guidance Tool For The Food Industry By Vilas-Franquesa Et Al, (2024) - Free Press Journal","<a href=""https://news.google.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?oc=5"" target=""_blank"">The Food By-Products Bioprocess Wheel: A Guidance Tool For The Food Industry By Vilas-Franquesa Et Al, (2024)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"The Food By-Products Bioprocess Wheel: A Guidance Tool For The Food Industry By Vilas-Franquesa Et Al, (2024) - Free Press Journal <a href=""https://news.google.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?oc=5"" target=""_blank"">The Food By-Products Bioprocess Wheel: A Guidance Tool For The Food Industry By Vilas-Franquesa Et Al, (2024)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",0.0,neutral,0.8546277284622192,0.0,neutral,0.0,0.5106,0.078,0.0,0.922,0.2,0.4,0.0,0.5217425761540732,other,0.0,[],False,False,1,0.0
2024-07-31,2024-07-31 07:00:00,Biocon Foundation and IISc organise OCTF conference on AI in oral cancer - Express Healthcare,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Foundation and IISc organise OCTF conference on AI in oral cancer</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Healthcare</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Biocon Foundation and IISc organise OCTF conference on AI in oral cancer - Express Healthcare <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Foundation and IISc organise OCTF conference on AI in oral cancer</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Healthcare</font>",0.0,neutral,0.9209482073783875,0.0,neutral,0.0,-0.6597,0.0,0.132,0.868,0.0,0.0,0.0,0.7903241036891937,other,0.0,[],False,True,6,0.0
2022-02-28,2022-02-28 08:00:00,Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results; Issues 2022 Financial Guidance; Completes Comprehensive Strategic Review; Unveils Plan to Reshape the Company for the Future; Announces Combination of its Biosimilars Portfol - Viatris,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results; Issues 2022 Financial Guidance; Completes Comprehensive Strategic Review; Unveils Plan to Reshape the Company for the Future; Announces Combination of its Biosimilars Portfol</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Viatris</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results; Issues 2022 Financial Guidance; Completes Comprehensive Strategic Review; Unveils Plan to Reshape the Company for the Future; Announces Combination of its Biosimilars Portfol - Viatris <a href=""https://news.google.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?oc=5"" target=""_blank"">Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results; Issues 2022 Financial Guidance; Completes Comprehensive Strategic Review; Unveils Plan to Reshape the Company for the Future; Announces Combination of its Biosimilars Portfol</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Viatris</font>",0.9156263470649719,positive,0.9156263470649719,0.0,neutral,0.0,0.8625,0.138,0.0,0.862,0.0787878787878788,0.15606060606060607,0.5232150554656982,0.6189714086176169,other,0.0,[],False,False,1,0.0
2024-11-01,2024-11-01 07:00:00,Fierce Pharma Asia—AZ exec under investigation in China; GSK's lupus deal; Takeda's orexin hiccup - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxOamUtSGQxQ0JYNWRXcnRtNHVmYWRzNk9tSTl3U1dRTFh3TGtUTWdyYk53SFR3TEVaYnVtcVR3VmNrTzhiY05aalZBTU0zRU9IZHItWFdVVHdWTldLcGVuWndUcHdBRjNHSmgyaFlhV3kyYVVUcm1JVERlQ0JLM3dzb2JXQWs2dk9idVBMeDE0YVIwOFFIV21RX0hDMEI5WlFyYWxyRDNOZw?oc=5"" target=""_blank"">Fierce Pharma Asia—AZ exec under investigation in China; GSK's lupus deal; Takeda's orexin hiccup</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMipwFBVV95cUxOamUtSGQxQ0JYNWRXcnRtNHVmYWRzNk9tSTl3U1dRTFh3TGtUTWdyYk53SFR3TEVaYnVtcVR3VmNrTzhiY05aalZBTU0zRU9IZHItWFdVVHdWTldLcGVuWndUcHdBRjNHSmgyaFlhV3kyYVVUcm1JVERlQ0JLM3dzb2JXQWs2dk9idVBMeDE0YVIwOFFIV21RX0hDMEI5WlFyYWxyRDNOZw?oc=5,Google News,Biocon guidance,"Fierce Pharma Asia—AZ exec under investigation in China; GSK's lupus deal; Takeda's orexin hiccup - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxOamUtSGQxQ0JYNWRXcnRtNHVmYWRzNk9tSTl3U1dRTFh3TGtUTWdyYk53SFR3TEVaYnVtcVR3VmNrTzhiY05aalZBTU0zRU9IZHItWFdVVHdWTldLcGVuWndUcHdBRjNHSmgyaFlhV3kyYVVUcm1JVERlQ0JLM3dzb2JXQWs2dk9idVBMeDE0YVIwOFFIV21RX0hDMEI5WlFyYWxyRDNOZw?oc=5"" target=""_blank"">Fierce Pharma Asia—AZ exec under investigation in China; GSK's lupus deal; Takeda's orexin hiccup</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",0.0,neutral,0.5685425996780396,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.5685425996780396,other,0.0,[],False,False,1,0.0
2025-04-02,2025-04-02 19:20:50,Another Cholesterol Drug Has Been Recalled - MSN,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNaGhnX3kyMjMyN2R3bTh0Q2VFb3c0Z01mLTVZRXZvZ3pCaWhaWldfX3F5MzRkQU5xYzBBSERUVU5lajBRMTJRRU1WaEI1X2VUVzNBZlRKNFpjS2I2c3o2dVlxdVRSQllQQ2h6S1B2WS1CMlRQanZwRldiRnY1QVJMNTJjOEdqUHI3Y3Z1ODRLRDJ1SWwxX2NWTQ?oc=5"" target=""_blank"">Another Cholesterol Drug Has Been Recalled</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxNaGhnX3kyMjMyN2R3bTh0Q2VFb3c0Z01mLTVZRXZvZ3pCaWhaWldfX3F5MzRkQU5xYzBBSERUVU5lajBRMTJRRU1WaEI1X2VUVzNBZlRKNFpjS2I2c3o2dVlxdVRSQllQQ2h6S1B2WS1CMlRQanZwRldiRnY1QVJMNTJjOEdqUHI3Y3Z1ODRLRDJ1SWwxX2NWTQ?oc=5,Google News,Biocon guidance,"Another Cholesterol Drug Has Been Recalled - MSN <a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNaGhnX3kyMjMyN2R3bTh0Q2VFb3c0Z01mLTVZRXZvZ3pCaWhaWldfX3F5MzRkQU5xYzBBSERUVU5lajBRMTJRRU1WaEI1X2VUVzNBZlRKNFpjS2I2c3o2dVlxdVRSQllQQ2h6S1B2WS1CMlRQanZwRldiRnY1QVJMNTJjOEdqUHI3Y3Z1ODRLRDJ1SWwxX2NWTQ?oc=5"" target=""_blank"">Another Cholesterol Drug Has Been Recalled</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",-0.9301250576972961,negative,0.9301250576972961,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.5315000329698835,0.9301250576972961,regulatory_issues,0.6166024297475815,['recall'],False,False,9,0.43320485949516296
2022-09-08,2022-09-08 07:00:00,CBI chargesheet in Biocon case raises questions about how India manages drug trials - ThePrint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">CBI chargesheet in Biocon case raises questions about how India manages drug trials</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNSVhKWnNVSXdPSUMzVzAyUGdkSk9sOWtidWkxQjk4MmtrenI4TWRpN19QajNvUE1sQ0U0ZEVOQ0pHdjR3MERjOW00dmlwRXJEOERiX0VrM3FGOVRtSHZ6UU1SQWRjMm1fX24zUGdPWjJKWUtkVFA3NDFwa2JrUi0xYWppZHNEUE5fenByb3k3ZVVpQlZOZ185Z0kzWDBLcXUzUFE1TjY4U1pyeDdVc2JDbXctTlFYMzV3U2fSAb8BQVVfeXFMUDNzWjdMcjhjS0tVVjRRZkdIb3RUYlF2ZWJNc3lvQ1lpekRVQzY0bVJnMFJTckpsYTV2OExCenppdTVvaTBBTkMzYS1DaFJ5MjlTS0ZvLVNmeHdnNnlTVXBzNVpXdHF4VkRjT193bFN2V1pEWkpjcTNtMVBrc3lEdkVuTGUtdWdLU1pNbXhMbTRFZld6dHpoYTNCdTNJT3prNVczOU1LQTRhT09VM255cXZqQ1FlT1puVGdWTXBLS1k?oc=5,Google News,Biocon guidance,"CBI chargesheet in Biocon case raises questions about how India manages drug trials - ThePrint <a href=""https://news.google.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?oc=5"" target=""_blank"">CBI chargesheet in Biocon case raises questions about how India manages drug trials</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",-0.6242398023605347,negative,0.6242398023605347,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.3567084584917341,0.6242398023605347,other,0.0,[],False,True,6,0.0
2023-03-23,2023-03-23 07:00:00,Biocon's Kiran Mazumdar-Shaw retires from Infosys board - Hindustan Times - Hindustan Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Kiran Mazumdar-Shaw retires from Infosys board - Hindustan Times</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Hindustan Times</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxQanp5Zks1eEwwcVM4SVlJcTRwbU41UmJ1N1IyNTQwdnB6bmF3N3o4MzNjYWNkS2hodVpzcldsR2ZBR2tzMmw1RnhhYWxfamVuV09qblRyUXNCMjBkc2p2bzBJSTM4Uk1Qd1NRdWIzcVZMblNhdWIxeTY5UDhXdFh2dnVLSFhwZE5EWDhSLXZwakhEeFpqQVNndE1CRVNzZ2o2Smt4MldIR01KdktKMXRtZTlVNlQ1QdIBuwFBVV95cUxQSmV6VlFUa2RJNjhoazJSN0tJdkF1N1BVTHRzd09XQTBhTkJUU0E4YmdvdTM1MTItWlYwNHoxbzJmcFR5Nm5Qd3I3YVlIQTNzeVdrV1NXZUFpSG0zckpYTVp2eExCajQwZU9MRnlQVVJRMm40WEFaMEVWanUyUEtIWEU1M1pOLUVrZW1zdkRjSG1xaU96STByaXdKSXFjSWV1ZU1DZ0VrdndfU215V2RhUk9DUmZXYVZTd1FV?oc=5,Google News,Biocon guidance,"Biocon's Kiran Mazumdar-Shaw retires from Infosys board - Hindustan Times - Hindustan Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Kiran Mazumdar-Shaw retires from Infosys board - Hindustan Times</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Hindustan Times</font>",0.0,neutral,0.8176577687263489,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8176577687263489,other,0.0,[],False,True,6,0.0
2025-05-13,2025-05-13 07:00:00,"Top stocks to buy today: Stock recommendations for May 13, 2025 - Times of India","<a href=""https://news.google.com/rss/articles/CBMi4AFBVV95cUxOekhubzhrRkhCLVFybEpjQjF0Tk14M1MtVGxaNE9aSFpYQ211T3IzOUhyd0FLellyQ09RSlViUmdxamF4eVkxcDljWFM2Z1V1MjBpN0twYmdiSzRFdzI0bDk5WkVrZ2dlLWkyRHNSSGk2eDM5UTRXVHFOOHVrQUlhZFc0SDV3SzRnNEVlemtWQjVtTjYxbC01amVLdXBRVWIzVGdpaWRPd3o2aGZkU1lNTWFVcnFiZ3doa29ETTlzRkFuZDE0akRBSWhfQ184M0JfQWp6bXpLTDFhUGJUbTZ5UdIB5gFBVV95cUxOODBtbDB3RnBvUTZsTkhoTlZtQXpKU2g3MWd4aTNCYU0tNGNnS2d1WWc3VTVnS051eFA1WWtuS1N6RTdsTDhmd1ExTVFyRzlKRnBQNzB4RHlHcjh4UGlIaFRneGN6OWlCWFROMHpOcG5LdWp1ZlpTYzZQaTkwckpVTjhxcUhTR1FxaUg4c0dLeTBuMTdpYkxvb2ZkeFpJWGowbjBoVFlnTUZYQzNnS1F0UFRsV0h0X09sdXZSdHVqRVBSTTgyVVFRakdhR1hiS2NYck9MNVhkR2FCT0k0VldXWTNnc25jdw?oc=5"" target=""_blank"">Top stocks to buy today: Stock recommendations for May 13, 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Top stocks to buy today: Stock recommendations for May 13, 2025 - Times of India <a href=""https://news.google.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?oc=5"" target=""_blank"">Top stocks to buy today: Stock recommendations for May 13, 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",0.0,neutral,0.9218000173568726,0.0,neutral,0.0,0.2023,0.058,0.0,0.942,0.25,0.25,0.0,0.4580333391189575,other,0.0,[],False,False,1,0.0
2022-06-22,2022-06-22 07:00:00,Bound By Code Of Conduct: Biocon Refutes Bribery Allegations - newindian.in,"<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxOa1RXZkhrSk1SaUpkRXJneC1QREZ6Z0ladk1MenQtNlZJanM0Rm1vaEhaandmTDBndFNzN0VIV1dac2ZMMFo0bnRCZEh5Wm5JTkQwLUpHYmxwajZxV2kzbWtlcUNXU29WLXVtLXVzTTlYakRDYWtUQWxlRlpGNlhmT2hrVU1NdzZCMEoxdXVB?oc=5"" target=""_blank"">Bound By Code Of Conduct: Biocon Refutes Bribery Allegations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newindian.in</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxOa1RXZkhrSk1SaUpkRXJneC1QREZ6Z0ladk1MenQtNlZJanM0Rm1vaEhaandmTDBndFNzN0VIV1dac2ZMMFo0bnRCZEh5Wm5JTkQwLUpHYmxwajZxV2kzbWtlcUNXU29WLXVtLXVzTTlYakRDYWtUQWxlRlpGNlhmT2hrVU1NdzZCMEoxdXVB?oc=5,Google News,Biocon guidance,"Bound By Code Of Conduct: Biocon Refutes Bribery Allegations - newindian.in <a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxOa1RXZkhrSk1SaUpkRXJneC1QREZ6Z0ladk1MenQtNlZJanM0Rm1vaEhaandmTDBndFNzN0VIV1dac2ZMMFo0bnRCZEh5Wm5JTkQwLUpHYmxwajZxV2kzbWtlcUNXU29WLXVtLXVzTTlYakRDYWtUQWxlRlpGNlhmT2hrVU1NdzZCMEoxdXVB?oc=5"" target=""_blank"">Bound By Code Of Conduct: Biocon Refutes Bribery Allegations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newindian.in</font>",0.0,neutral,0.9027891755104065,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9027891755104065,other,0.0,[],False,True,6,0.0
2023-10-18,2023-10-18 07:00:00,Syngene shares plunge after contract research firm trims revenue guidance - Zee Business,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene shares plunge after contract research firm trims revenue guidance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxOMWNUaExLWE5NX0c4QktQVy1jMGNjYVZqSjI1NXY4aWczWFhoeS1IT1NCVTliOFduVndmTnlvY1FydHVzOWNnVVVHbjdlVXlJd1dBOFMzU1pNY1BEWE9NZ1hESW1VdkJ6bFhPekJ3TkQybk1GWGtyWDFZanZJNk9oYlBLTEh6Rm12d2xMMjNWakx1U0Y2bExYMWcxOTVYNUNFTHVNVHRWa2xEVHFYRk9RMGFfQUhzeFNYbHBOM052Uy1oVnFrTlg3amJ1MklPSk9S0gHWAUFVX3lxTFA4OWhtTThvUWZGdnRCemtxem13SVFJWjQtTklBMEZxUldFcEFnSllSRmJJUDBRM2xMVmh5MnJlcnJRUk1tYlAxVmVrNnI5aVkyclgwWllFN2JFcm5mWDJsbUN1UkpnV0pva3NaNkxJRF83LWVsOU51LVVVQVlCc2tDblpHNU41eE5EVVdXR3AxREpPWHdmTWFFSHRqMkcwcTllZkVEeEM3OFR4enQ1OFZWZ0Q2Vm1SWGlHaHZFQkhSS2x4bkExYm9tM2RGQnBuQzRSOVVldVE?oc=5,Google News,Biocon guidance,"Syngene shares plunge after contract research firm trims revenue guidance - Zee Business <a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene shares plunge after contract research firm trims revenue guidance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",-0.9672620296478271,negative,0.9672620296478271,0.0,neutral,0.0,0.5267,0.155,0.0,0.845,-0.13333333333333333,0.26666666666666666,-0.5527211597987584,0.5424317876603868,other,0.0,[],False,False,1,0.0
2024-01-31,2024-01-31 08:00:00,Dr. Kiran Mazumdar-Shaw Supports the establishment of the School of Biosciences at Chanakya University - The Asian Age,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Dr. Kiran Mazumdar-Shaw Supports the establishment of the School of Biosciences at Chanakya University</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Asian Age</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Dr. Kiran Mazumdar-Shaw Supports the establishment of the School of Biosciences at Chanakya University - The Asian Age <a href=""https://news.google.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?oc=5"" target=""_blank"">Dr. Kiran Mazumdar-Shaw Supports the establishment of the School of Biosciences at Chanakya University</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Asian Age</font>",0.0,neutral,0.8253471255302429,0.0,neutral,0.0,0.6124,0.128,0.0,0.872,0.0,0.0,0.0,0.7188735627651215,other,0.0,[],False,True,6,0.0
2025-04-15,2025-04-15 07:00:00,Macrotech Developers surges after Lodha Brothers settle business dispute - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi6gFBVV95cUxNQ2V4NVp0U1pDaVBRU3FfUnlMTmlhOFYxLTJ6Q3VMVktpbmRwZ3lVWXU1Q3VEOXY2NURnNkYtSFN0NWZHWTFYTkRnaVJkdDFqeERGRHEySnZyRlRmczhPS2FheUdxQlFJR0JmV21NekpxUkpnN3lSb040aU1RcEJmN1V6STFfV3o3cEpfeUtBSlhDVnlJLUhvbEFQRGRkNVBBbTd0a0Y5SjhKWFdMN05Oa0MtOHpkU21QZnFSb2tpLTIyZ1NQbVJ0WU9LYVlubEF2b0R0bEJPMG0yWEk3X0FLNFZrY3hQMHBhTFHSAe8BQVVfeXFMTmhlLUhIU0hCZGdyT1hFX0V5WUlSdWVHdW1qcTlSdjV3Mm1LSVFWUF8xSTlsX0ZFUU81V3lvRDVxaWdsVkZrcFBzZ1VGYXNBcXBHU3dwWkdoZzl1ZFVtSEhDRFp4TkNuX2M2VW5uTUZxZUd2UFZhRFZOOE1ZSHhuWGpiU2J0V01CUjVZZXJTckJrOWZNY3FFWUFtZFQyMmd5U2hkWDJPZzczd2hVdjVjZmVXRHh2QkZ3QURScFQ1YVBkUjJpMkdDZ0RzdDNVY2ZiRFlUY2FwVWY4WE9hc3hzdEFpRTdfWDFwZUVrdnJ4M1U?oc=5"" target=""_blank"">Macrotech Developers surges after Lodha Brothers settle business dispute</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Macrotech Developers surges after Lodha Brothers settle business dispute - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Macrotech Developers surges after Lodha Brothers settle business dispute</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8022038340568542,positive,0.8022038340568542,0.0,neutral,0.0,-0.4019,0.0,0.105,0.895,0.0,0.0,0.458402190889631,0.6020519170284271,other,0.0,[],False,False,1,0.0
2024-10-30,2024-10-30 07:00:00,"L&T, Tata Power, Biocon, DCM Shriram, IRB Infrastructure, Wipro and more: Stocks to watch on October 31 - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">L&amp;T, Tata Power, Biocon, DCM Shriram, IRB Infrastructure, Wipro and more: Stocks to watch on October 31</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMigAJBVV95cUxPX2t0TldxRmJWcmlkZGhWNUZqaHRoYTdvVUhELU1QbVQ0SXpJR19ERVhlSldQUHltcko2aUwwNDdDMEU0MUYzcHlXWUp1V2FqYTd6U19vVHBOTXRVUlR0YUV0OWtNQlA3QllpLWZWQzBnU3dCRWVhNzBaNDVOeE5hS0NXd0p2Y2M1ODJ4SEx3eWRVMTd4TDRLUVV5Zi1XeEEzSEpCd3hjNTQ3aHJMVzUtWmkxNWc4TEVvR0dmYzdubzlLaUFWTXNRbk1jVTNzeEVxS1dKaWx5aFNPYU52UmJ4aXBabE1Ed0FUNjRaUjRoWDRCdURsT1VfaUptaDJHaXJB0gGGAkFVX3lxTFBjeUpEVmxhWGdDeHlPWlZsamY2MkFQMEVaUEhhM3RHbnlna2U3Nk9Zd0lwSk02R1puYWhQMm9FRFp2SnRzQ3lfeTAzdHRpMWx5YXJ4LUhrZGlwbi1VOWljcWM5TzIzZHNIZHR5UHcya2ZJbGpCSnFlb1hVTURFSnFwME03WUpJUDYxX0V6S2luMm5Rc2h3b1pTTVN3dThhWXVKWDJ4SXRralBGQUo5QnBadlhmaENDNDgtOWwycWtMUHM5ZEllcmxMN3JSSlJJVU1sOThpVjYzT3lTbDE5V3NLS1dkRW43WjBwa09KRnRLUXJ2ZTh1Ql85MFQyU3A3M2dMSEwxYlE?oc=5,Google News,Biocon guidance,"L&T, Tata Power, Biocon, DCM Shriram, IRB Infrastructure, Wipro and more: Stocks to watch on October 31 - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">L&amp;T, Tata Power, Biocon, DCM Shriram, IRB Infrastructure, Wipro and more: Stocks to watch on October 31</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.936838686466217,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.3333333333333333,0.3333333333333333,0.0,0.6350860098997752,other,0.0,[],False,True,6,0.0
2023-03-08,2023-03-08 08:00:00,"Nykaa, Westlife Foodworld, Biocon: Should you invest in stocks of these 7 women-led companies - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Nykaa, Westlife Foodworld, Biocon: Should you invest in stocks of these 7 women-led companies</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Nykaa, Westlife Foodworld, Biocon: Should you invest in stocks of these 7 women-led companies - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Nykaa, Westlife Foodworld, Biocon: Should you invest in stocks of these 7 women-led companies</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.9253979921340942,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9253979921340942,other,0.0,[],False,True,6,0.0
2023-11-17,2023-11-17 08:00:00,Eight firms provide land to Bengaluru Metro free of cost - Deccan Herald,"<a href=""https://news.google.com/rss/articles/CBMiuwFBVV95cUxOZVRFX2g2T2MwbGJjWnNXSFpSY1JZdzRROTVPMUxSM0szVlFwZTJvbDlUMnltbzRHZnlJOFNlUFNtd2NDa1lJeEFKYmJmejJMbXBXWGpjWVFrSEpFb0hMQXJUbEM3RVF0Y19yZ0s3bVBncExIVkV5T0pqckZoRTk0aU14OUJ5d1BrTlBGQVZsQzR2b0p4TUQ1eVZRXzF4SmktWmJFWWFjQ2NpOVZiUjJncDZqc2FFZzRMaUdz?oc=5"" target=""_blank"">Eight firms provide land to Bengaluru Metro free of cost</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Deccan Herald</font>",https://news.google.com/rss/articles/CBMiuwFBVV95cUxOZVRFX2g2T2MwbGJjWnNXSFpSY1JZdzRROTVPMUxSM0szVlFwZTJvbDlUMnltbzRHZnlJOFNlUFNtd2NDa1lJeEFKYmJmejJMbXBXWGpjWVFrSEpFb0hMQXJUbEM3RVF0Y19yZ0s3bVBncExIVkV5T0pqckZoRTk0aU14OUJ5d1BrTlBGQVZsQzR2b0p4TUQ1eVZRXzF4SmktWmJFWWFjQ2NpOVZiUjJncDZqc2FFZzRMaUdz?oc=5,Google News,Biocon guidance,"Eight firms provide land to Bengaluru Metro free of cost - Deccan Herald <a href=""https://news.google.com/rss/articles/CBMiuwFBVV95cUxOZVRFX2g2T2MwbGJjWnNXSFpSY1JZdzRROTVPMUxSM0szVlFwZTJvbDlUMnltbzRHZnlJOFNlUFNtd2NDa1lJeEFKYmJmejJMbXBXWGpjWVFrSEpFb0hMQXJUbEM3RVF0Y19yZ0s3bVBncExIVkV5T0pqckZoRTk0aU14OUJ5d1BrTlBGQVZsQzR2b0p4TUQ1eVZRXzF4SmktWmJFWWFjQ2NpOVZiUjJncDZqc2FFZzRMaUdz?oc=5"" target=""_blank"">Eight firms provide land to Bengaluru Metro free of cost</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Deccan Herald</font>",0.0,neutral,0.8634141683578491,0.0,neutral,0.0,0.765,0.216,0.0,0.784,0.26666666666666666,0.5333333333333333,0.0,0.6316936116748386,other,0.0,[],False,False,1,0.0
2023-10-18,2023-10-18 07:00:00,Glenmark Pharma launches triple-combination drug for Type 2 Diabetes - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Glenmark Pharma launches triple-combination drug for Type 2 Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Glenmark Pharma launches triple-combination drug for Type 2 Diabetes - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Glenmark Pharma launches triple-combination drug for Type 2 Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.8040132522583008,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8040132522583008,other,0.0,[],False,False,1,0.0
2024-10-30,2024-10-30 07:00:00,"L&T Q2 FY25 results: Net profit increases 5.4% to Rs 3,395 crore - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">L&amp;T Q2 FY25 results: Net profit increases 5.4% to Rs 3,395 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"L&T Q2 FY25 results: Net profit increases 5.4% to Rs 3,395 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">L&amp;T Q2 FY25 results: Net profit increases 5.4% to Rs 3,395 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9442736506462097,positive,0.9442736506462097,0.0,neutral,0.0,0.7003,0.172,0.0,0.828,0.0,0.0,0.5395849432264055,0.8222868253231048,other,0.0,[],False,False,1,0.0
2024-10-31,2024-10-31 07:00:00,"Sensex Today | Stock Market Highlights: Indices slide near day's low on weak global cues; Nifty holds 24,200 d - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Sensex Today | Stock Market Highlights: Indices slide near day's low on weak global cues; Nifty holds 24,200 d</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Sensex Today | Stock Market Highlights: Indices slide near day's low on weak global cues; Nifty holds 24,200 d - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Sensex Today | Stock Market Highlights: Indices slide near day's low on weak global cues; Nifty holds 24,200 d</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",-0.9600489139556885,negative,0.9600489139556885,0.0,neutral,0.0,-0.5574,0.107,0.198,0.694,-0.061111111111111116,0.29444444444444445,-0.5485993794032505,0.5261866750222665,other,0.0,[],False,False,1,0.0
2024-05-21,2024-05-21 07:00:00,"Gensol Engineering appoints Shilpa Urhekar as CEO of Solar EPC, India - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Gensol Engineering appoints Shilpa Urhekar as CEO of Solar EPC, India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"Gensol Engineering appoints Shilpa Urhekar as CEO of Solar EPC, India - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Gensol Engineering appoints Shilpa Urhekar as CEO of Solar EPC, India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.9209268093109131,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9209268093109131,other,0.0,[],False,False,1,0.0
2024-09-25,2024-09-25 07:00:00,"State-owned Bank of India raises Rs 2,500 crore at 7.49% via tier-II bonds - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">State-owned Bank of India raises Rs 2,500 crore at 7.49% via tier-II bonds</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon guidance,"State-owned Bank of India raises Rs 2,500 crore at 7.49% via tier-II bonds - Business Standard <a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxPdG9seU9KYmVQQlJZLVVGSkVwTmR3ZElXVEdhYTVNaTNaQzFTTnp1VjVvS1pLNmZPc05lOVFCdnRSNVN6YlM1dWxyUVBha1VRTnk1V1RraUhIbC1hbE9lRW5tdGlwVHppZzNvQWE1dmhhTzlsREpUcVRsTGhkNmJTUl81S3VWdTN4bzNEQjUzVEJnQTg0M1ptUUNMWWZjZGRzdThFVnlPUjJJUXB3OVhwSXcwRUMzQ3JLVG1oX0t1QnBaQUJ5U3MtLU9HS1NMeVVJcVliUGNOWG1tQdIB3wFBVV95cUxNWmVIdjRCdWdtVXpuNVlITGV0MENXbGtjdEdtVE1EVGFLc3AyZ0h6TVpzTVFUQ0RjdUstOU5QeGpkUzA3SG0tS0RMS0xDRFJSZUNqRTQxQVN6V1JpaEhjWnVMQ0FFd2RSVWFQWEduQmVFNDdHbkhhVmd0eVUyN2JESmJxQjY5TTYzVG56TExqT21WV29sVmRHZ2Y0Tk11LXF2UmZaWEFTZFZQczlVZ2toSm9uWXE2cndOTG8wV2hZUUZXUm5UQkd6YVl5V2s5YklaZU9sQ3pXZEpkcVlwekFJ?oc=5"" target=""_blank"">State-owned Bank of India raises Rs 2,500 crore at 7.49% via tier-II bonds</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.782797634601593,positive,0.782797634601593,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.4473129340580531,0.782797634601593,other,0.0,[],False,False,1,0.0
2025-04-29,2025-04-29 07:00:00,"BTech Biotechnology: Scope, Salary & Careers - LPU","<a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9HdEV6Q0k5N2k0SHhPejQ2LWUyaUgxTjRFZHVFU2J0MDlweGxjb182M05wNnp4R1Z6YzktdjhCekZ5UG5XNmVmcncyMW0wSFRKMFljbjBUUHQ5d09VS2pVcDNESERIOWs?oc=5"" target=""_blank"">BTech Biotechnology: Scope, Salary & Careers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">LPU</font>",https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9HdEV6Q0k5N2k0SHhPejQ2LWUyaUgxTjRFZHVFU2J0MDlweGxjb182M05wNnp4R1Z6YzktdjhCekZ5UG5XNmVmcncyMW0wSFRKMFljbjBUUHQ5d09VS2pVcDNESERIOWs?oc=5,Google News,Biocon guidance,"BTech Biotechnology: Scope, Salary & Careers - LPU <a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9HdEV6Q0k5N2k0SHhPejQ2LWUyaUgxTjRFZHVFU2J0MDlweGxjb182M05wNnp4R1Z6YzktdjhCekZ5UG5XNmVmcncyMW0wSFRKMFljbjBUUHQ5d09VS2pVcDNESERIOWs?oc=5"" target=""_blank"">BTech Biotechnology: Scope, Salary & Careers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">LPU</font>",0.0,neutral,0.9188368320465088,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9188368320465088,other,0.0,[],False,False,1,0.0
2025-01-03,2025-01-03 08:00:00,"STOCKS IN NEWS: ITC, Afcons Infrastructure Ltd, KPI Green Energy, Wockhardt, Indian Railway Finance Corporation, Pricol, Biocon, Citichem India Ltd, Rites, Honasa Consumer Ltd, Varun Beverages ltd, Indian Oil Corporation and others - MarketSmith India","<a href=""https://news.google.com/rss/articles/CBMixAJBVV95cUxPQTJwMnJmOWVmZHhGbzNiUHBsbGhpVXZhYUhMMURXTndSck1KWDI4MzBPVUNBbU9RamRYM0tWOHpxX1p4Q2V2ZWpMemNZaXpFQmw4dC0yQk1mOTV3SXRYTEttSkt1TG40eWwza01LSUdaWm1oMmk5LWg3X1QzanJOT2NjRGszV2pUYUhiV2tWVHU2OW9RbmpyRDdLLVdqcWs1aHlHR3ZNT1ZpVlgyUk1NVkotajE1ZlB1NXowSW5lZG1paHItaHZrYVB1eU1Fb1lvRXFXeU5mdVRDZjgyYWJVdXhkY2lZVFhOWDktcGFkNWx4cTdHLVRZcWZCUkZ0dUxUcVp5U2UxZnBGUC1XVDFFQTNROWhMclBFa0drYVBYbGlRNUFnZUNFYi1zd3phLW0tWkJOaHV3ellmX05CZ29lMDE2Skk?oc=5"" target=""_blank"">STOCKS IN NEWS: ITC, Afcons Infrastructure Ltd, KPI Green Energy, Wockhardt, Indian Railway Finance Corporation, Pricol, Biocon, Citichem India Ltd, Rites, Honasa Consumer Ltd, Varun Beverages ltd, Indian Oil Corporation and others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketSmith India</font>",https://news.google.com/rss/articles/CBMixAJBVV95cUxPQTJwMnJmOWVmZHhGbzNiUHBsbGhpVXZhYUhMMURXTndSck1KWDI4MzBPVUNBbU9RamRYM0tWOHpxX1p4Q2V2ZWpMemNZaXpFQmw4dC0yQk1mOTV3SXRYTEttSkt1TG40eWwza01LSUdaWm1oMmk5LWg3X1QzanJOT2NjRGszV2pUYUhiV2tWVHU2OW9RbmpyRDdLLVdqcWs1aHlHR3ZNT1ZpVlgyUk1NVkotajE1ZlB1NXowSW5lZG1paHItaHZrYVB1eU1Fb1lvRXFXeU5mdVRDZjgyYWJVdXhkY2lZVFhOWDktcGFkNWx4cTdHLVRZcWZCUkZ0dUxUcVp5U2UxZnBGUC1XVDFFQTNROWhMclBFa0drYVBYbGlRNUFnZUNFYi1zd3phLW0tWkJOaHV3ellmX05CZ29lMDE2Skk?oc=5,Google News,Biocon guidance,"STOCKS IN NEWS: ITC, Afcons Infrastructure Ltd, KPI Green Energy, Wockhardt, Indian Railway Finance Corporation, Pricol, Biocon, Citichem India Ltd, Rites, Honasa Consumer Ltd, Varun Beverages ltd, Indian Oil Corporation and others - MarketSmith India <a href=""https://news.google.com/rss/articles/CBMixAJBVV95cUxPQTJwMnJmOWVmZHhGbzNiUHBsbGhpVXZhYUhMMURXTndSck1KWDI4MzBPVUNBbU9RamRYM0tWOHpxX1p4Q2V2ZWpMemNZaXpFQmw4dC0yQk1mOTV3SXRYTEttSkt1TG40eWwza01LSUdaWm1oMmk5LWg3X1QzanJOT2NjRGszV2pUYUhiV2tWVHU2OW9RbmpyRDdLLVdqcWs1aHlHR3ZNT1ZpVlgyUk1NVkotajE1ZlB1NXowSW5lZG1paHItaHZrYVB1eU1Fb1lvRXFXeU5mdVRDZjgyYWJVdXhkY2lZVFhOWDktcGFkNWx4cTdHLVRZcWZCUkZ0dUxUcVp5U2UxZnBGUC1XVDFFQTNROWhMclBFa0drYVBYbGlRNUFnZUNFYi1zd3phLW0tWkJOaHV3ellmX05CZ29lMDE2Skk?oc=5"" target=""_blank"">STOCKS IN NEWS: ITC, Afcons Infrastructure Ltd, KPI Green Energy, Wockhardt, Indian Railway Finance Corporation, Pricol, Biocon, Citichem India Ltd, Rites, Honasa Consumer Ltd, Varun Beverages ltd, Indian Oil Corporation and others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketSmith India</font>",0.0,neutral,0.9356222748756409,0.0,neutral,0.0,0.4939,0.058,0.0,0.942,-0.13333333333333333,0.19999999999999998,0.0,0.5209518694029914,other,0.0,[],False,True,6,0.0
2024-10-31,2024-10-31 07:00:00,"Stocks to watch today: L&T, Voltas, Dabur, Aditya Birla Capital, Tata Power, and Biocon post Q2 results - Brokerage reports inside - Business Upturn","<a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxOcEV2Q0hwVUxBcWEwSzdfc1FCdlZTV3pfU0pDR1BBQmFlMmdaYVQ0M0tRZEVWdHVISF9VQTBpejVxeUVVeUdnaDhZaEhMODB2YW5Dd0RTcllXMGJoWTQza2lWcjdnd1NvRWNpa2xtcmFqbC1RQ0NMd01ycUFFYWcwRFBIdzJrS1lieVpfRmpUTE9ZODBXZnpEOE9RUjN0c2N1dlJMTG8xWmpudlo4VmFXOWJmdTlCYVFhak9tbU0xQU5CZmxHUUJRa3RHc3VFR2pldmtFNE1iNENLelFGZnF3RWlwNTROc09jclQ4UlRGS3lCdUY0ZTAyMFVETXc?oc=5"" target=""_blank"">Stocks to watch today: L&amp;T, Voltas, Dabur, Aditya Birla Capital, Tata Power, and Biocon post Q2 results - Brokerage reports inside</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",https://news.google.com/rss/articles/CBMi_AFBVV95cUxOcEV2Q0hwVUxBcWEwSzdfc1FCdlZTV3pfU0pDR1BBQmFlMmdaYVQ0M0tRZEVWdHVISF9VQTBpejVxeUVVeUdnaDhZaEhMODB2YW5Dd0RTcllXMGJoWTQza2lWcjdnd1NvRWNpa2xtcmFqbC1RQ0NMd01ycUFFYWcwRFBIdzJrS1lieVpfRmpUTE9ZODBXZnpEOE9RUjN0c2N1dlJMTG8xWmpudlo4VmFXOWJmdTlCYVFhak9tbU0xQU5CZmxHUUJRa3RHc3VFR2pldmtFNE1iNENLelFGZnF3RWlwNTROc09jclQ4UlRGS3lCdUY0ZTAyMFVETXc?oc=5,Google News,Biocon guidance,"Stocks to watch today: L&T, Voltas, Dabur, Aditya Birla Capital, Tata Power, and Biocon post Q2 results - Brokerage reports inside - Business Upturn <a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxOcEV2Q0hwVUxBcWEwSzdfc1FCdlZTV3pfU0pDR1BBQmFlMmdaYVQ0M0tRZEVWdHVISF9VQTBpejVxeUVVeUdnaDhZaEhMODB2YW5Dd0RTcllXMGJoWTQza2lWcjdnd1NvRWNpa2xtcmFqbC1RQ0NMd01ycUFFYWcwRFBIdzJrS1lieVpfRmpUTE9ZODBXZnpEOE9RUjN0c2N1dlJMTG8xWmpudlo4VmFXOWJmdTlCYVFhak9tbU0xQU5CZmxHUUJRa3RHc3VFR2pldmtFNE1iNENLelFGZnF3RWlwNTROc09jclQ4UlRGS3lCdUY0ZTAyMFVETXc?oc=5"" target=""_blank"">Stocks to watch today: L&amp;T, Voltas, Dabur, Aditya Birla Capital, Tata Power, and Biocon post Q2 results - Brokerage reports inside</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",-0.8697939515113831,negative,0.8697939515113831,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.4970251151493617,0.8697939515113831,other,0.0,[],False,True,6,0.0
2025-06-17,2025-06-17 15:32:38,Biocon's Fundraise To Provide Investor Exits Closes Listing Window For Unit - MSN,"<a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxNbzQwOE1yM0pMY2dEdUhHdTZhTjlDMW5LZFBrVUFsQ2hHVnN1X2tTLXlyUGcwaWJma2RJbWFjVmFoZWVrNFpremJpcHpjSWJzX3gtMUJFRHh0dHdiOU1kYmpmWmlvSV9kZFN3QUZha0VyckxYbGFWTmpQaXJ5emwxYkQxTmVPZHp2cFN1WWlGZmRKd3BlZ29hQmtvN1VjYjlGYVJBZGFIMEMzSEEwM0lXdTRjNmxvV0pESk1IcUNGYTRsanQ5amc?oc=5"" target=""_blank"">Biocon's Fundraise To Provide Investor Exits Closes Listing Window For Unit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.com/rss/articles/CBMixgFBVV95cUxNbzQwOE1yM0pMY2dEdUhHdTZhTjlDMW5LZFBrVUFsQ2hHVnN1X2tTLXlyUGcwaWJma2RJbWFjVmFoZWVrNFpremJpcHpjSWJzX3gtMUJFRHh0dHdiOU1kYmpmWmlvSV9kZFN3QUZha0VyckxYbGFWTmpQaXJ5emwxYkQxTmVPZHp2cFN1WWlGZmRKd3BlZ29hQmtvN1VjYjlGYVJBZGFIMEMzSEEwM0lXdTRjNmxvV0pESk1IcUNGYTRsanQ5amc?oc=5,Google News,Biocon investor call,"Biocon's Fundraise To Provide Investor Exits Closes Listing Window For Unit - MSN <a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxNbzQwOE1yM0pMY2dEdUhHdTZhTjlDMW5LZFBrVUFsQ2hHVnN1X2tTLXlyUGcwaWJma2RJbWFjVmFoZWVrNFpremJpcHpjSWJzX3gtMUJFRHh0dHdiOU1kYmpmWmlvSV9kZFN3QUZha0VyckxYbGFWTmpQaXJ5emwxYkQxTmVPZHp2cFN1WWlGZmRKd3BlZ29hQmtvN1VjYjlGYVJBZGFIMEMzSEEwM0lXdTRjNmxvV0pESk1IcUNGYTRsanQ5amc?oc=5"" target=""_blank"">Biocon's Fundraise To Provide Investor Exits Closes Listing Window For Unit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",0.0,neutral,0.8976877927780151,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8976877927780151,other,0.0,[],False,True,6,0.0
2025-05-06,2025-05-06 07:00:00,Stelara Biosimilar Yesintek Gains Coverage on Leading Formularies - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxQdWlENTEwaldoVmdzTTRheTU5eEhPV2RfNXctOTlkSXpvd3ZtdHJNM0xxZF80UW1sMXdNdWRMVkVfMDkwS1E5TzV5VTRHejFYLUR6c1dpSG9SNm43RGhXZWhYenVwbmpMMFY5N2VwY2kzbnd5VDZYSHdnM3BGdm5WVUZsc1ZZdDNQWW0tUVBpblJoVDR0MF9aMzhPbUdDcFZPQ25ocTNRVmhaYkNnS1hSSG8tOA?oc=5"" target=""_blank"">Stelara Biosimilar Yesintek Gains Coverage on Leading Formularies</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxQdWlENTEwaldoVmdzTTRheTU5eEhPV2RfNXctOTlkSXpvd3ZtdHJNM0xxZF80UW1sMXdNdWRMVkVfMDkwS1E5TzV5VTRHejFYLUR6c1dpSG9SNm43RGhXZWhYenVwbmpMMFY5N2VwY2kzbnd5VDZYSHdnM3BGdm5WVUZsc1ZZdDNQWW0tUVBpblJoVDR0MF9aMzhPbUdDcFZPQ25ocTNRVmhaYkNnS1hSSG8tOA?oc=5,Google News,Biocon investor call,"Stelara Biosimilar Yesintek Gains Coverage on Leading Formularies - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxQdWlENTEwaldoVmdzTTRheTU5eEhPV2RfNXctOTlkSXpvd3ZtdHJNM0xxZF80UW1sMXdNdWRMVkVfMDkwS1E5TzV5VTRHejFYLUR6c1dpSG9SNm43RGhXZWhYenVwbmpMMFY5N2VwY2kzbnd5VDZYSHdnM3BGdm5WVUZsc1ZZdDNQWW0tUVBpblJoVDR0MF9aMzhPbUdDcFZPQ25ocTNRVmhaYkNnS1hSSG8tOA?oc=5"" target=""_blank"">Stelara Biosimilar Yesintek Gains Coverage on Leading Formularies</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.9457802176475525,positive,0.9457802176475525,0.0,neutral,0.0,0.5859,0.179,0.0,0.821,0.0,0.0,0.5404458386557442,0.7658401088237763,other,0.0,[],False,False,1,0.0
2024-10-31,2024-10-31 07:00:00,Equillium Maintains Rights to Itolizumab Following Ono Partnership - Business Wire,"<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxPOUVGQzZCYVAxQU1qZktUdjdqSG9yTjFRNjRJcEJ1alM5SzdzcFFOek5PdFdBa21RVVZxZUx1SEoxTUI2U2dvSDRBcW5XUEZxaGhMUXJCM3BfR2ExUDZaY3pKanZwMjJIWWI3ZlVsck5YLWtCdzJEVGxLajY2Nks5MGI3ZlBabVpremh6U1phX0xvNTdTRk5LMmhZemRTb0p6dnZGeXhtMXVZbVlfU2tpX3FtUTc2MHJJWUROVGFzNXU?oc=5"" target=""_blank"">Equillium Maintains Rights to Itolizumab Following Ono Partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Wire</font>",https://news.google.com/rss/articles/CBMiwAFBVV95cUxPOUVGQzZCYVAxQU1qZktUdjdqSG9yTjFRNjRJcEJ1alM5SzdzcFFOek5PdFdBa21RVVZxZUx1SEoxTUI2U2dvSDRBcW5XUEZxaGhMUXJCM3BfR2ExUDZaY3pKanZwMjJIWWI3ZlVsck5YLWtCdzJEVGxLajY2Nks5MGI3ZlBabVpremh6U1phX0xvNTdTRk5LMmhZemRTb0p6dnZGeXhtMXVZbVlfU2tpX3FtUTc2MHJJWUROVGFzNXU?oc=5,Google News,Biocon investor call,"Equillium Maintains Rights to Itolizumab Following Ono Partnership - Business Wire <a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxPOUVGQzZCYVAxQU1qZktUdjdqSG9yTjFRNjRJcEJ1alM5SzdzcFFOek5PdFdBa21RVVZxZUx1SEoxTUI2U2dvSDRBcW5XUEZxaGhMUXJCM3BfR2ExUDZaY3pKanZwMjJIWWI3ZlVsck5YLWtCdzJEVGxLajY2Nks5MGI3ZlBabVpremh6U1phX0xvNTdTRk5LMmhZemRTb0p6dnZGeXhtMXVZbVlfU2tpX3FtUTc2MHJJWUROVGFzNXU?oc=5"" target=""_blank"">Equillium Maintains Rights to Itolizumab Following Ono Partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Wire</font>",0.0,neutral,0.9079244136810303,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.06666666666666667,0.0,0.9079244136810303,other,0.0,[],False,False,1,0.0
2025-06-16,2025-06-16 07:00:00,F&O Strategy: Manappuram Finance to Biocon— Rupak De suggests buy or sell strategy for THESE stocks - 16 June - Mint,"<a href=""https://news.google.com/rss/articles/CBMihAJBVV95cUxOMVFETXg0TnVQTjlmY0FRRElpbTBPNjhWSW9qc0U0WUd5Rkd6VTZYaUdoUE1UUFhMQmt0c3VscGczMnNrWjJPMmhWYkRHeVhfekNqZkk0QWp4UzV5c2NFeXBoRThvOV94Z1Z3OTNDYW0yRkZ1SHJLMG5nLWJvenIyQXZWSU13amJGQWtZUldqX1pmQ1RNMHFMZ1o5eVFNcFpPWFQxU0tIZWF3VDFQNnNQMmNTYW0ySmhPQlU0RmJpUXVKWDVoODRVVEVJU0Q2aV9nS2tTc3FseXVERHhUdW9DaUVObERIYzhnaDZFMHNYbFdmM3N0QmVNRC0zbnUtUFBFbmhLNw?oc=5"" target=""_blank"">F&amp;O Strategy: Manappuram Finance to Biocon— Rupak De suggests buy or sell strategy for THESE stocks - 16 June</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMihAJBVV95cUxOMVFETXg0TnVQTjlmY0FRRElpbTBPNjhWSW9qc0U0WUd5Rkd6VTZYaUdoUE1UUFhMQmt0c3VscGczMnNrWjJPMmhWYkRHeVhfekNqZkk0QWp4UzV5c2NFeXBoRThvOV94Z1Z3OTNDYW0yRkZ1SHJLMG5nLWJvenIyQXZWSU13amJGQWtZUldqX1pmQ1RNMHFMZ1o5eVFNcFpPWFQxU0tIZWF3VDFQNnNQMmNTYW0ySmhPQlU0RmJpUXVKWDVoODRVVEVJU0Q2aV9nS2tTc3FseXVERHhUdW9DaUVObERIYzhnaDZFMHNYbFdmM3N0QmVNRC0zbnUtUFBFbmhLNw?oc=5,Google News,Biocon investor call,"F&O Strategy: Manappuram Finance to Biocon— Rupak De suggests buy or sell strategy for THESE stocks - 16 June - Mint <a href=""https://news.google.com/rss/articles/CBMihAJBVV95cUxOMVFETXg0TnVQTjlmY0FRRElpbTBPNjhWSW9qc0U0WUd5Rkd6VTZYaUdoUE1UUFhMQmt0c3VscGczMnNrWjJPMmhWYkRHeVhfekNqZkk0QWp4UzV5c2NFeXBoRThvOV94Z1Z3OTNDYW0yRkZ1SHJLMG5nLWJvenIyQXZWSU13amJGQWtZUldqX1pmQ1RNMHFMZ1o5eVFNcFpPWFQxU0tIZWF3VDFQNnNQMmNTYW0ySmhPQlU0RmJpUXVKWDVoODRVVEVJU0Q2aV9nS2tTc3FseXVERHhUdW9DaUVObERIYzhnaDZFMHNYbFdmM3N0QmVNRC0zbnUtUFBFbmhLNw?oc=5"" target=""_blank"">F&amp;O Strategy: Manappuram Finance to Biocon— Rupak De suggests buy or sell strategy for THESE stocks - 16 June</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.9218961596488953,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9218961596488953,other,0.0,[],False,True,6,0.0
2025-06-02,2025-06-02 07:00:00,"Stocks to Watch, June 3: Mphasis, oil-linked stocks, Torrent Power, Biocon, Zinka Logistics, Man Industries, Grasim, Vodafone Idea - Upstox","<a href=""https://news.google.com/rss/articles/CBMijAJBVV95cUxNSEFGZkRtSHk0SmJ4Q3dSalloTG5jU3QySmJqYUR6QTdveG94UWhKdUdhNFpJWWJSOXlmY2RzUFpFLVRrcmRJVHk0emw5ZUc4WU5mMW9rN0UtSUc3VFpJMzM0Z0s1ejBtUF9zZUZPSm5aaG9JV2dBc0lNRzBOSFRROG13bnBDNVp2QUNON3h1c0dtcHhvbXhXQjFCMGpNT0pVYXR3ZHhZSmxybkFpLUt2cDdmRHdYdXVrRkR3Y0VNZDd2Y1VpV2piX3BmRVgxeDhwa0I2aFp2T3ZtSHEyTXZ1Rmk0SFoxLXVSTk5pS3Rac01KUWZ1V19ITFpOcC1tSDM5TWZDdnliWm5jNElN?oc=5"" target=""_blank"">Stocks to Watch, June 3: Mphasis, oil-linked stocks, Torrent Power, Biocon, Zinka Logistics, Man Industries, Grasim, Vodafone Idea</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMijAJBVV95cUxNSEFGZkRtSHk0SmJ4Q3dSalloTG5jU3QySmJqYUR6QTdveG94UWhKdUdhNFpJWWJSOXlmY2RzUFpFLVRrcmRJVHk0emw5ZUc4WU5mMW9rN0UtSUc3VFpJMzM0Z0s1ejBtUF9zZUZPSm5aaG9JV2dBc0lNRzBOSFRROG13bnBDNVp2QUNON3h1c0dtcHhvbXhXQjFCMGpNT0pVYXR3ZHhZSmxybkFpLUt2cDdmRHdYdXVrRkR3Y0VNZDd2Y1VpV2piX3BmRVgxeDhwa0I2aFp2T3ZtSHEyTXZ1Rmk0SFoxLXVSTk5pS3Rac01KUWZ1V19ITFpOcC1tSDM5TWZDdnliWm5jNElN?oc=5,Google News,Biocon investor call,"Stocks to Watch, June 3: Mphasis, oil-linked stocks, Torrent Power, Biocon, Zinka Logistics, Man Industries, Grasim, Vodafone Idea - Upstox <a href=""https://news.google.com/rss/articles/CBMijAJBVV95cUxNSEFGZkRtSHk0SmJ4Q3dSalloTG5jU3QySmJqYUR6QTdveG94UWhKdUdhNFpJWWJSOXlmY2RzUFpFLVRrcmRJVHk0emw5ZUc4WU5mMW9rN0UtSUc3VFpJMzM0Z0s1ejBtUF9zZUZPSm5aaG9JV2dBc0lNRzBOSFRROG13bnBDNVp2QUNON3h1c0dtcHhvbXhXQjFCMGpNT0pVYXR3ZHhZSmxybkFpLUt2cDdmRHdYdXVrRkR3Y0VNZDd2Y1VpV2piX3BmRVgxeDhwa0I2aFp2T3ZtSHEyTXZ1Rmk0SFoxLXVSTk5pS3Rac01KUWZ1V19ITFpOcC1tSDM5TWZDdnliWm5jNElN?oc=5"" target=""_blank"">Stocks to Watch, June 3: Mphasis, oil-linked stocks, Torrent Power, Biocon, Zinka Logistics, Man Industries, Grasim, Vodafone Idea</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.0,neutral,0.9361651539802551,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9361651539802551,other,0.0,[],False,True,6,0.0
2025-02-24,2025-02-24 08:00:00,"Updated: Two More Stelara Biosimilars Launch, Including One that is 90% Off Stelara - Managed Healthcare Executive","<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxNZ0tjand5MmhKbjdBZkY2clVQZG5ZWTFRZ2FDaWpldGpMdjBPSVVPOEpVelhtUHppMHVFUjJsckV6NXUxUFpRVmowbmM0eWNEMjY5SDZCY1g3czVYQUxybjdGQ3FUVDRqRlJ4WEtEN3ROOWJIdXY1bWtPRkFsWUpsZHZHX3ZzUU1hSHlV?oc=5"" target=""_blank"">Updated: Two More Stelara Biosimilars Launch, Including One that is 90% Off Stelara</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxNZ0tjand5MmhKbjdBZkY2clVQZG5ZWTFRZ2FDaWpldGpMdjBPSVVPOEpVelhtUHppMHVFUjJsckV6NXUxUFpRVmowbmM0eWNEMjY5SDZCY1g3czVYQUxybjdGQ3FUVDRqRlJ4WEtEN3ROOWJIdXY1bWtPRkFsWUpsZHZHX3ZzUU1hSHlV?oc=5,Google News,Biocon investor call,"Updated: Two More Stelara Biosimilars Launch, Including One that is 90% Off Stelara - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxNZ0tjand5MmhKbjdBZkY2clVQZG5ZWTFRZ2FDaWpldGpMdjBPSVVPOEpVelhtUHppMHVFUjJsckV6NXUxUFpRVmowbmM0eWNEMjY5SDZCY1g3czVYQUxybjdGQ3FUVDRqRlJ4WEtEN3ROOWJIdXY1bWtPRkFsWUpsZHZHX3ZzUU1hSHlV?oc=5"" target=""_blank"">Updated: Two More Stelara Biosimilars Launch, Including One that is 90% Off Stelara</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.0,neutral,0.896399736404419,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.3333333333333333,0.3333333333333333,0.0,0.6148665348688761,other,0.0,[],False,False,1,0.0
2024-09-14,2024-09-14 07:00:00,Biocon Biologics is planning to raise $950 million through overseas bonds - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics is planning to raise $950 million through overseas bonds</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon investor call,"Biocon Biologics is planning to raise $950 million through overseas bonds - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics is planning to raise $950 million through overseas bonds</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.5351607799530029,positive,0.5351607799530029,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.30580615997314453,0.3342470566431681,other,0.0,[],False,True,6,0.0
2025-01-07,2025-01-07 08:00:00,Biocon Biologics marks one year as global biosimilars enterprise - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics marks one year as global biosimilars enterprise</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon investor call,"Biocon Biologics marks one year as global biosimilars enterprise - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics marks one year as global biosimilars enterprise</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.5970892310142517,positive,0.5970892310142517,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.34119384629385807,0.5970892310142517,other,0.0,[],False,True,6,0.0
2025-01-20,2025-01-20 08:00:00,"Trade Spotlight: How should you trade IRCTC, Bajaj Finance, Bajaj Auto, Biocon, Redington, Divis Laboratories, and others on January 21? - TradingView","<a href=""https://news.google.com/rss/articles/CBMimwJBVV95cUxONlJ0aEFlMkU2M3Q5S012TDBaSGgtSng2UVJRMVFQLUltbHRYNFFuSXBmSTBOb2ZZQVRKZzlHSkhaU2Z6cm5HQzU4VzFLV1dKNlVfc2VKaDVuUHkxdWpyWXNhQWdINU1sa2JKOWUydTZEUVpreEhXZGNOYXRMM1N5UnByLXczX1JMQmNuSy1XMWZCRzgzRjl2RHNpT1RCYzBVblpkNEQyVkZ4QWVvSUR4cmRhaDd2RnR2OGJmb3JqMmhpejRUSHVPOUlkUXNCVXlJRGpYOWd2Qkl1NGNkcUlNNHNlTzhKaWJiVkRLODI2dVN0NEZqcC1WMmlCTkVJNko1R0NDZi1QQUllR1lVMGZPcHZjdmhJQUdEV29R?oc=5"" target=""_blank"">Trade Spotlight: How should you trade IRCTC, Bajaj Finance, Bajaj Auto, Biocon, Redington, Divis Laboratories, and others on January 21?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMimwJBVV95cUxONlJ0aEFlMkU2M3Q5S012TDBaSGgtSng2UVJRMVFQLUltbHRYNFFuSXBmSTBOb2ZZQVRKZzlHSkhaU2Z6cm5HQzU4VzFLV1dKNlVfc2VKaDVuUHkxdWpyWXNhQWdINU1sa2JKOWUydTZEUVpreEhXZGNOYXRMM1N5UnByLXczX1JMQmNuSy1XMWZCRzgzRjl2RHNpT1RCYzBVblpkNEQyVkZ4QWVvSUR4cmRhaDd2RnR2OGJmb3JqMmhpejRUSHVPOUlkUXNCVXlJRGpYOWd2Qkl1NGNkcUlNNHNlTzhKaWJiVkRLODI2dVN0NEZqcC1WMmlCTkVJNko1R0NDZi1QQUllR1lVMGZPcHZjdmhJQUdEV29R?oc=5,Google News,Biocon investor call,"Trade Spotlight: How should you trade IRCTC, Bajaj Finance, Bajaj Auto, Biocon, Redington, Divis Laboratories, and others on January 21? - TradingView <a href=""https://news.google.com/rss/articles/CBMimwJBVV95cUxONlJ0aEFlMkU2M3Q5S012TDBaSGgtSng2UVJRMVFQLUltbHRYNFFuSXBmSTBOb2ZZQVRKZzlHSkhaU2Z6cm5HQzU4VzFLV1dKNlVfc2VKaDVuUHkxdWpyWXNhQWdINU1sa2JKOWUydTZEUVpreEhXZGNOYXRMM1N5UnByLXczX1JMQmNuSy1XMWZCRzgzRjl2RHNpT1RCYzBVblpkNEQyVkZ4QWVvSUR4cmRhaDd2RnR2OGJmb3JqMmhpejRUSHVPOUlkUXNCVXlJRGpYOWd2Qkl1NGNkcUlNNHNlTzhKaWJiVkRLODI2dVN0NEZqcC1WMmlCTkVJNko1R0NDZi1QQUllR1lVMGZPcHZjdmhJQUdEV29R?oc=5"" target=""_blank"">Trade Spotlight: How should you trade IRCTC, Bajaj Finance, Bajaj Auto, Biocon, Redington, Divis Laboratories, and others on January 21?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",0.0,neutral,0.9444164037704468,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9444164037704468,other,0.0,[],False,True,6,0.0
2025-03-04,2025-03-04 08:00:00,"Fresenius Kabi Launches Otulfi, the 4th Biosimilar of Stelara to Become Available - Managed Healthcare Executive","<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxNRDIxZFlELXVIR1dJQXZZLTQzVktYQXYtWDc0MjNPZlJ6NkdQQUg3RU84MnVjdlBOTVJfTkF2YUZtRmV2Q01hUjVlTXp3T1Zja3ZTM2R4R05VNXdNRzljUm1wZWNTRFhjcGlLalJOdXVOYkR3RUJETjJ2M3FLWHRzNmFsQl85OG1LanA1SWlwVUlJSW5VTlBaeWdtR29hcUhFcmM3T0ZSZVc0al9UUjRRTmRFZmhmSzd5eFJGTUdWMTBkRExxbDNZ?oc=5"" target=""_blank"">Fresenius Kabi Launches Otulfi, the 4th Biosimilar of Stelara to Become Available</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxNRDIxZFlELXVIR1dJQXZZLTQzVktYQXYtWDc0MjNPZlJ6NkdQQUg3RU84MnVjdlBOTVJfTkF2YUZtRmV2Q01hUjVlTXp3T1Zja3ZTM2R4R05VNXdNRzljUm1wZWNTRFhjcGlLalJOdXVOYkR3RUJETjJ2M3FLWHRzNmFsQl85OG1LanA1SWlwVUlJSW5VTlBaeWdtR29hcUhFcmM3T0ZSZVc0al9UUjRRTmRFZmhmSzd5eFJGTUdWMTBkRExxbDNZ?oc=5,Google News,Biocon investor call,"Fresenius Kabi Launches Otulfi, the 4th Biosimilar of Stelara to Become Available - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxNRDIxZFlELXVIR1dJQXZZLTQzVktYQXYtWDc0MjNPZlJ6NkdQQUg3RU84MnVjdlBOTVJfTkF2YUZtRmV2Q01hUjVlTXp3T1Zja3ZTM2R4R05VNXdNRzljUm1wZWNTRFhjcGlLalJOdXVOYkR3RUJETjJ2M3FLWHRzNmFsQl85OG1LanA1SWlwVUlJSW5VTlBaeWdtR29hcUhFcmM3T0ZSZVc0al9UUjRRTmRFZmhmSzd5eFJGTUdWMTBkRExxbDNZ?oc=5"" target=""_blank"">Fresenius Kabi Launches Otulfi, the 4th Biosimilar of Stelara to Become Available</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.0,neutral,0.739835262298584,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.2,0.2,0.0,0.46991763114929197,other,0.0,[],False,False,1,0.0
2025-05-14,2025-05-14 07:00:00,"I-Sec maintains Sell on Biocon, revises target price to Rs 270 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">I-Sec maintains Sell on Biocon, revises target price to Rs 270</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxQTWpsYy1Ldl9Tc19OQVF2b1BmRFg5bEZlQ2pTMnpKVDRyUmpZby1sMERWRVBBd2loczhTbU00M0xFeTZxamM2dGVCX3B4cDBHMFZxRmFUbEpXNFJhME9uWlNENDBUVVNRNFh2R1dpOVFoNENUZTRwYTZDUk9mNXhKbEoySTVQWEk2eWpQX0V5UmUtMVRRSjdNRW9mc0pkN2JUS29iOEhGUmcxcERzVmtiSTQ0dWF1T0JfLWQ4OE9YMmVFU2ROOVo4djFtbllZR3Qz0gHWAUFVX3lxTE5yMFk2MHU4alRRT0ViR1JDYV9IaEVubVlhTlhCY2dXcFByMUlLRlFiM1k2dS1uaElDS3U3N2hCQ0xRUUlELWFuTVRRbGVKcWtaQUhZc3lUaGlEV2M0My1YcWRFeFlRYUhBVGpveWlBM1hORk9RR2F3cS13aUZrMkttNzU4ZVEtSGp0dEJuVlhrZjRKRWJEOU1KNXpUMm1qdEJnbGFSZE5nZF9ESlY5WndUSUtOeERHaUJKQVZPM0lkWjNCWmxOMEFRVkxkUDRrZkZfRnV6cFE?oc=5,Google News,Biocon investor call,"I-Sec maintains Sell on Biocon, revises target price to Rs 270 - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">I-Sec maintains Sell on Biocon, revises target price to Rs 270</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.842377245426178,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.0,0.48785528937975564,other,0.0,[],False,True,6,0.0
2025-01-20,2025-01-20 08:00:00,Breakout Stocks: How to trade Biocon & BSE on Tuesday? - Market Summary - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOaC15Z3lQSlp3MnpBN2Ewd0ZhWVctZEJXaGR1YUJ6eE5icjZFVi1obXF4RS1Rc3E2eVk5UzZHM1EzMjRPcVA0dzN5amhXckpUSmFTNjRpVms0RWlBNGd5Y19PQUZaeUVhOVgzc0l2YUVVYUE0ZGpMNG9Qb1lMVDRXX0VKWUJVZElUclAwS0d3NFBkYzh6WUVXZEtjc2gtRTFkYTFhTmpHOEZtT0t1T1NUNC0zX3I0NWwxZlZtdnBWZmlucVpja19hTDNqbVB1VC1hVUpHWUhFTjQ?oc=5"" target=""_blank"">Breakout Stocks: How to trade Biocon & BSE on Tuesday? - Market Summary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOaC15Z3lQSlp3MnpBN2Ewd0ZhWVctZEJXaGR1YUJ6eE5icjZFVi1obXF4RS1Rc3E2eVk5UzZHM1EzMjRPcVA0dzN5amhXckpUSmFTNjRpVms0RWlBNGd5Y19PQUZaeUVhOVgzc0l2YUVVYUE0ZGpMNG9Qb1lMVDRXX0VKWUJVZElUclAwS0d3NFBkYzh6WUVXZEtjc2gtRTFkYTFhTmpHOEZtT0t1T1NUNC0zX3I0NWwxZlZtdnBWZmlucVpja19hTDNqbVB1VC1hVUpHWUhFTjQ?oc=5,Google News,Biocon investor call,"Breakout Stocks: How to trade Biocon & BSE on Tuesday? - Market Summary - The Economic Times <a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOaC15Z3lQSlp3MnpBN2Ewd0ZhWVctZEJXaGR1YUJ6eE5icjZFVi1obXF4RS1Rc3E2eVk5UzZHM1EzMjRPcVA0dzN5amhXckpUSmFTNjRpVms0RWlBNGd5Y19PQUZaeUVhOVgzc0l2YUVVYUE0ZGpMNG9Qb1lMVDRXX0VKWUJVZElUclAwS0d3NFBkYzh6WUVXZEtjc2gtRTFkYTFhTmpHOEZtT0t1T1NUNC0zX3I0NWwxZlZtdnBWZmlucVpja19hTDNqbVB1VC1hVUpHWUhFTjQ?oc=5"" target=""_blank"">Breakout Stocks: How to trade Biocon & BSE on Tuesday? - Market Summary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.9432194232940674,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.0,0.5382763783137003,other,0.0,[],False,True,6,0.0
2024-08-22,2024-08-22 07:00:00,Generic Weight-Loss Drugs Won’t Come for Years - Barron's,"<a href=""https://news.google.com/rss/articles/CBMidkFVX3lxTE1SYTktTkJPTE5kZ2xvRUxDWnBhSGoyMmpNZGc1aGVBaVlCMTRkZHBienRWSEdOcGFOOHljUzhOVUR1VUFzRjZ0WmFPS09sM2Jsa3pMUDhIaXpCaHo5V1lab2l5aVBKRGc0QVBHTXlOY2NRVDEtN1E?oc=5"" target=""_blank"">Generic Weight-Loss Drugs Won’t Come for Years</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Barron's</font>",https://news.google.com/rss/articles/CBMidkFVX3lxTE1SYTktTkJPTE5kZ2xvRUxDWnBhSGoyMmpNZGc1aGVBaVlCMTRkZHBienRWSEdOcGFOOHljUzhOVUR1VUFzRjZ0WmFPS09sM2Jsa3pMUDhIaXpCaHo5V1lab2l5aVBKRGc0QVBHTXlOY2NRVDEtN1E?oc=5,Google News,Biocon investor call,"Generic Weight-Loss Drugs Won’t Come for Years - Barron's <a href=""https://news.google.com/rss/articles/CBMidkFVX3lxTE1SYTktTkJPTE5kZ2xvRUxDWnBhSGoyMmpNZGc1aGVBaVlCMTRkZHBienRWSEdOcGFOOHljUzhOVUR1VUFzRjZ0WmFPS09sM2Jsa3pMUDhIaXpCaHo5V1lab2l5aVBKRGc0QVBHTXlOY2NRVDEtN1E?oc=5"" target=""_blank"">Generic Weight-Loss Drugs Won’t Come for Years</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Barron's</font>",0.0,neutral,0.9084984064102173,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9084984064102173,other,0.0,[],False,False,1,0.0
2025-01-31,2025-01-31 08:00:00,"Biocon Share Price Today Highlights, 31 Jan, 2025: Biocon on the radar - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxNZ3JUcnhKdVdRczAwMUxSZTBHOUVuZm5PZ3E0QlFNa0dtMU04Y0x2aDRkUVZFa0Q1ZC1CM3VDdkVCVEc5R0g2a0JPampTMi1HcllOMjlRTFpHSjRtUUZFaEk2RWQ3dGpJa25QNm1KWjh4cTFpU3E0cjBnaWdjVGxHX3RPRVdpNi13dWdtSDFJdmJCVUpfU05obmszUHhac0k?oc=5"" target=""_blank"">Biocon Share Price Today Highlights, 31 Jan, 2025: Biocon on the radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxNZ3JUcnhKdVdRczAwMUxSZTBHOUVuZm5PZ3E0QlFNa0dtMU04Y0x2aDRkUVZFa0Q1ZC1CM3VDdkVCVEc5R0g2a0JPampTMi1HcllOMjlRTFpHSjRtUUZFaEk2RWQ3dGpJa25QNm1KWjh4cTFpU3E0cjBnaWdjVGxHX3RPRVdpNi13dWdtSDFJdmJCVUpfU05obmszUHhac0k?oc=5,Google News,Biocon investor call,"Biocon Share Price Today Highlights, 31 Jan, 2025: Biocon on the radar - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxNZ3JUcnhKdVdRczAwMUxSZTBHOUVuZm5PZ3E0QlFNa0dtMU04Y0x2aDRkUVZFa0Q1ZC1CM3VDdkVCVEc5R0g2a0JPampTMi1HcllOMjlRTFpHSjRtUUZFaEk2RWQ3dGpJa25QNm1KWjh4cTFpU3E0cjBnaWdjVGxHX3RPRVdpNi13dWdtSDFJdmJCVUpfU05obmszUHhac0k?oc=5"" target=""_blank"">Biocon Share Price Today Highlights, 31 Jan, 2025: Biocon on the radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.926593542098999,0.0,neutral,0.0,0.5267,0.145,0.0,0.855,0.0,0.0,0.0,0.7266467710494995,other,0.0,[],False,True,6,0.0
2024-09-23,2024-09-23 07:00:00,"Voda Ideas mega deal, how important is Concall for investors? - Zee Business","<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxNLUltWjVuamtCajdZTmFnTG80WFp3Y2pwaVJrMEhNUWFjS2x4VXpQZXJXemJUc0MxSHptQWtCalQ3TFNza192V0pMYXJfeU5vMG9LWXRUY3pEOTBiVWIxaTVyR1R6bW90b1JoMFF2NTlCMFVzdUxRYVhUblhEbUd5T19XWEJ4TlgxVzJSTnNfVVNSQk1rNkhRay1xMUZxSFVWNWRqYmpB0gGrAUFVX3lxTE5TNkQtZzFPaHhDcHhjS1Y5MmZ4RXU0dl80a01Sc1BwZTJHT1JHVDdHUkNRaVpNb3hJNGRaVkVxaVFIX2pybWExWTJ4dktWb0YtMUxtdkRXZHZEMnhNV3NhTWtkM3NyOFRQcTdnU3pWcW5PWVN3eXNYTk1GRkVsQVlvb21tNmpmRk9aa2UybUtSN2Y4TmNtSk1Pak5jMDNFUVViZlV1QVdrQU8zdw?oc=5"" target=""_blank"">Voda Ideas mega deal, how important is Concall for investors?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxNLUltWjVuamtCajdZTmFnTG80WFp3Y2pwaVJrMEhNUWFjS2x4VXpQZXJXemJUc0MxSHptQWtCalQ3TFNza192V0pMYXJfeU5vMG9LWXRUY3pEOTBiVWIxaTVyR1R6bW90b1JoMFF2NTlCMFVzdUxRYVhUblhEbUd5T19XWEJ4TlgxVzJSTnNfVVNSQk1rNkhRay1xMUZxSFVWNWRqYmpB0gGrAUFVX3lxTE5TNkQtZzFPaHhDcHhjS1Y5MmZ4RXU0dl80a01Sc1BwZTJHT1JHVDdHUkNRaVpNb3hJNGRaVkVxaVFIX2pybWExWTJ4dktWb0YtMUxtdkRXZHZEMnhNV3NhTWtkM3NyOFRQcTdnU3pWcW5PWVN3eXNYTk1GRkVsQVlvb21tNmpmRk9aa2UybUtSN2Y4TmNtSk1Pak5jMDNFUVViZlV1QVdrQU8zdw?oc=5,Google News,Biocon investor call,"Voda Ideas mega deal, how important is Concall for investors? - Zee Business <a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxNLUltWjVuamtCajdZTmFnTG80WFp3Y2pwaVJrMEhNUWFjS2x4VXpQZXJXemJUc0MxSHptQWtCalQ3TFNza192V0pMYXJfeU5vMG9LWXRUY3pEOTBiVWIxaTVyR1R6bW90b1JoMFF2NTlCMFVzdUxRYVhUblhEbUd5T19XWEJ4TlgxVzJSTnNfVVNSQk1rNkhRay1xMUZxSFVWNWRqYmpB0gGrAUFVX3lxTE5TNkQtZzFPaHhDcHhjS1Y5MmZ4RXU0dl80a01Sc1BwZTJHT1JHVDdHUkNRaVpNb3hJNGRaVkVxaVFIX2pybWExWTJ4dktWb0YtMUxtdkRXZHZEMnhNV3NhTWtkM3NyOFRQcTdnU3pWcW5PWVN3eXNYTk1GRkVsQVlvb21tNmpmRk9aa2UybUtSN2Y4TmNtSk1Pak5jMDNFUVViZlV1QVdrQU8zdw?oc=5"" target=""_blank"">Voda Ideas mega deal, how important is Concall for investors?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",0.0,neutral,0.9201712012290955,0.0,neutral,0.0,0.4836,0.147,0.0,0.853,0.26666666666666666,0.6666666666666666,0.0,0.5568126226319207,other,0.0,[],False,False,1,0.0
2025-06-27,2025-06-27 12:00:00,PriceSmart Announces Change to Previously Scheduled Conference Call - Yahoo,"<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxOUHVSelVOX1dBUllfMkV5QVY2dlJnNDFxdXNERjR0OGNUOV9nUXlyam1xa0JGN2ZvbkJSc3lJdTB4ejlqdEdOSnE0a1FBWS1xTzA1aEw2WU1jaFVRUVZ6MEh2YXh5YmNobFNoem9sSWhGSzhYWFU4di0wZ2pjSDlKaWFFcHVOTkcwYlVWdDVFRkdSbEN1N29HTTRxSzRzZw?oc=5"" target=""_blank"">PriceSmart Announces Change to Previously Scheduled Conference Call</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxOUHVSelVOX1dBUllfMkV5QVY2dlJnNDFxdXNERjR0OGNUOV9nUXlyam1xa0JGN2ZvbkJSc3lJdTB4ejlqdEdOSnE0a1FBWS1xTzA1aEw2WU1jaFVRUVZ6MEh2YXh5YmNobFNoem9sSWhGSzhYWFU4di0wZ2pjSDlKaWFFcHVOTkcwYlVWdDVFRkdSbEN1N29HTTRxSzRzZw?oc=5,Google News,Biocon investor call,"PriceSmart Announces Change to Previously Scheduled Conference Call - Yahoo <a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxOUHVSelVOX1dBUllfMkV5QVY2dlJnNDFxdXNERjR0OGNUOV9nUXlyam1xa0JGN2ZvbkJSc3lJdTB4ejlqdEdOSnE0a1FBWS1xTzA1aEw2WU1jaFVRUVZ6MEh2YXh5YmNobFNoem9sSWhGSzhYWFU4di0wZ2pjSDlKaWFFcHVOTkcwYlVWdDVFRkdSbEN1N29HTTRxSzRzZw?oc=5"" target=""_blank"">PriceSmart Announces Change to Previously Scheduled Conference Call</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",0.0,neutral,0.7614110708236694,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.1111111111111111,0.1111111111111111,0.0,0.4362610909673903,other,0.0,[],False,False,1,0.0
2025-06-27,2025-06-27 07:01:48,Concentrix Corp (CNXC) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst Operational ... - Yahoo,"<a href=""https://news.google.com/rss/articles/CBMigwFBVV95cUxNZnVZWDVPbUNISmZWNjJNRmMyNk8za19Sb1AxaTFSYlFpaWlnbjMwSG9ya1VTQVZJUXA3bFVKV3BYQkRSUUNBMzhsNXdyV0VYMUg3dGUwWDFPRXpGOW92b3VESG5CcFAzemR2QkdDajdFV3Q5eUJ3YzVVVDZZVzhYVmx3TQ?oc=5"" target=""_blank"">Concentrix Corp (CNXC) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst Operational ...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",https://news.google.com/rss/articles/CBMigwFBVV95cUxNZnVZWDVPbUNISmZWNjJNRmMyNk8za19Sb1AxaTFSYlFpaWlnbjMwSG9ya1VTQVZJUXA3bFVKV3BYQkRSUUNBMzhsNXdyV0VYMUg3dGUwWDFPRXpGOW92b3VESG5CcFAzemR2QkdDajdFV3Q5eUJ3YzVVVDZZVzhYVmx3TQ?oc=5,Google News,Biocon investor call,"Concentrix Corp (CNXC) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst Operational ... - Yahoo <a href=""https://news.google.com/rss/articles/CBMigwFBVV95cUxNZnVZWDVPbUNISmZWNjJNRmMyNk8za19Sb1AxaTFSYlFpaWlnbjMwSG9ya1VTQVZJUXA3bFVKV3BYQkRSUUNBMzhsNXdyV0VYMUg3dGUwWDFPRXpGOW92b3VESG5CcFAzemR2QkdDajdFV3Q5eUJ3YzVVVDZZVzhYVmx3TQ?oc=5"" target=""_blank"">Concentrix Corp (CNXC) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst Operational ...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",0.0,neutral,0.8716130256652832,0.0,neutral,0.0,0.6369,0.157,0.0,0.843,0.0,0.0,0.0,0.7542565128326416,other,0.0,[],False,False,1,0.0
2024-03-11,2024-03-11 07:00:00,The top 10 drugs losing US exclusivity in 2024 - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxNOTV3aUdPNzZOV1N0SzNOVEtvMnpKZ3RXNnlod2pBZ3VvN1NMTzJFbEJCcWR0NGpxYWdaNXF0WkZnUG1iNndXeWhwcWM0M29sU1YySUMwVVU5Sy1uUTg0QXNkLTN5VEZlUTlDOFB5dE9zcDEyWHByQU5iMVRvMmtaSXpJWHR4NnJSSUtBQw?oc=5"" target=""_blank"">The top 10 drugs losing US exclusivity in 2024</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMijAFBVV95cUxNOTV3aUdPNzZOV1N0SzNOVEtvMnpKZ3RXNnlod2pBZ3VvN1NMTzJFbEJCcWR0NGpxYWdaNXF0WkZnUG1iNndXeWhwcWM0M29sU1YySUMwVVU5Sy1uUTg0QXNkLTN5VEZlUTlDOFB5dE9zcDEyWHByQU5iMVRvMmtaSXpJWHR4NnJSSUtBQw?oc=5,Google News,Biocon investor call,"The top 10 drugs losing US exclusivity in 2024 - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxNOTV3aUdPNzZOV1N0SzNOVEtvMnpKZ3RXNnlod2pBZ3VvN1NMTzJFbEJCcWR0NGpxYWdaNXF0WkZnUG1iNndXeWhwcWM0M29sU1YySUMwVVU5Sy1uUTg0QXNkLTN5VEZlUTlDOFB5dE9zcDEyWHByQU5iMVRvMmtaSXpJWHR4NnJSSUtBQw?oc=5"" target=""_blank"">The top 10 drugs losing US exclusivity in 2024</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.9184003472328186,negative,0.9184003472328186,0.0,neutral,0.0,-0.3818,0.125,0.181,0.694,0.3333333333333333,0.3333333333333333,-0.5248001984187535,0.5445112268553839,other,0.0,[],False,False,1,0.0
2022-03-03,2022-03-03 08:00:00,Viatris is Getting Out of Biosimilars Business… But Not Completely - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxNMVhzS0tZZ0Ztb1c2d0huQTBKM2dCZWFLenBuOGxUWHFoeWRkeGJUQzNxeWZpTFBNbUsxS1lMX1BHdTNIT0c5bmg5aUY1Ml9kdU9fTVNoV3hsYkotMTd5dWJzZXFPSHN0WnVuQ2ZzVHZfc2RrQV9xaXJVckZTeFZJd183cUNBel82b1VnX2xwUXZVU0hVLW0tNnVTOUVXY3NoVHpuRnZzMWhZN2dRQjRpX2NuMA?oc=5"" target=""_blank"">Viatris is Getting Out of Biosimilars Business… But Not Completely</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxNMVhzS0tZZ0Ztb1c2d0huQTBKM2dCZWFLenBuOGxUWHFoeWRkeGJUQzNxeWZpTFBNbUsxS1lMX1BHdTNIT0c5bmg5aUY1Ml9kdU9fTVNoV3hsYkotMTd5dWJzZXFPSHN0WnVuQ2ZzVHZfc2RrQV9xaXJVckZTeFZJd183cUNBel82b1VnX2xwUXZVU0hVLW0tNnVTOUVXY3NoVHpuRnZzMWhZN2dRQjRpX2NuMA?oc=5,Google News,Biocon investor call,"Viatris is Getting Out of Biosimilars Business… But Not Completely - Managed Healthcare Executive <a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxNMVhzS0tZZ0Ztb1c2d0huQTBKM2dCZWFLenBuOGxUWHFoeWRkeGJUQzNxeWZpTFBNbUsxS1lMX1BHdTNIT0c5bmg5aUY1Ml9kdU9fTVNoV3hsYkotMTd5dWJzZXFPSHN0WnVuQ2ZzVHZfc2RrQV9xaXJVckZTeFZJd183cUNBel82b1VnX2xwUXZVU0hVLW0tNnVTOUVXY3NoVHpuRnZzMWhZN2dRQjRpX2NuMA?oc=5"" target=""_blank"">Viatris is Getting Out of Biosimilars Business… But Not Completely</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",0.0,neutral,0.8516159653663635,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.025,0.2,0.0,0.4383079826831818,other,0.0,[],False,False,1,0.0
2025-03-17,2025-03-17 07:00:00,The top 10 drugs losing US exclusivity in 2025 - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxONjN6eFBIcWhJRmg1aDFJUjRwWkVkM1ZNRE5yRFJBSFZDSE1BS0taVzljUHNUeG5lbjRuWnJtQlFmVGp4R3djZnMwbVdfbjBzOW02TmUtYk16NWQ0RzhCQjFub2F1dEVXNllIeVFESU5wT1JaQ184QTJGdVRYUFlvSDcxMDV4OUxIXzJHcA?oc=5"" target=""_blank"">The top 10 drugs losing US exclusivity in 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMijAFBVV95cUxONjN6eFBIcWhJRmg1aDFJUjRwWkVkM1ZNRE5yRFJBSFZDSE1BS0taVzljUHNUeG5lbjRuWnJtQlFmVGp4R3djZnMwbVdfbjBzOW02TmUtYk16NWQ0RzhCQjFub2F1dEVXNllIeVFESU5wT1JaQ184QTJGdVRYUFlvSDcxMDV4OUxIXzJHcA?oc=5,Google News,Biocon investor call,"The top 10 drugs losing US exclusivity in 2025 - Fierce Pharma <a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxONjN6eFBIcWhJRmg1aDFJUjRwWkVkM1ZNRE5yRFJBSFZDSE1BS0taVzljUHNUeG5lbjRuWnJtQlFmVGp4R3djZnMwbVdfbjBzOW02TmUtYk16NWQ0RzhCQjFub2F1dEVXNllIeVFESU5wT1JaQ184QTJGdVRYUFlvSDcxMDV4OUxIXzJHcA?oc=5"" target=""_blank"">The top 10 drugs losing US exclusivity in 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",-0.9168078899383545,negative,0.9168078899383545,0.0,neutral,0.0,-0.3818,0.125,0.181,0.694,0.3333333333333333,0.3333333333333333,-0.5238902228219169,0.5439804077572292,other,0.0,[],False,False,1,0.0
2024-06-30,2024-06-30 07:00:00,Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you own? - Mint,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you own?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News,Biocon investor call,"Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you own? - Mint <a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you own?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.9089595079421997,0.0,neutral,0.0,0.5007,0.077,0.0,0.923,0.3,0.5,0.0,0.5698865026473999,other,0.0,[],False,True,6,0.0
2023-09-08,2023-09-08 07:00:00,Is Biocon making a comeback? - Finshots,"<a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBlMF9YTVZjZXNXa1N1RXl0elFxWWpTb3JNR0VjNlM2RFNjZklWblVhVF90MmNIV1pYdEV4UGlNQTZrdVR3YUZnejlFR01sSGVydkhFWi1KY3Vqd2I0VVhKa050TGtEM1E?oc=5"" target=""_blank"">Is Biocon making a comeback?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Finshots</font>",https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBlMF9YTVZjZXNXa1N1RXl0elFxWWpTb3JNR0VjNlM2RFNjZklWblVhVF90MmNIV1pYdEV4UGlNQTZrdVR3YUZnejlFR01sSGVydkhFWi1KY3Vqd2I0VVhKa050TGtEM1E?oc=5,Google News,Biocon investor call,"Is Biocon making a comeback? - Finshots <a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBlMF9YTVZjZXNXa1N1RXl0elFxWWpTb3JNR0VjNlM2RFNjZklWblVhVF90MmNIV1pYdEV4UGlNQTZrdVR3YUZnejlFR01sSGVydkhFWi1KY3Vqd2I0VVhKa050TGtEM1E?oc=5"" target=""_blank"">Is Biocon making a comeback?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Finshots</font>",0.0,neutral,0.9018536806106567,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9018536806106567,other,0.0,[],False,True,6,0.0
2025-01-29,2025-01-29 08:00:00,Waaree Energies share price rises ahead of Q3 results announcement - Upstox,"<a href=""https://news.google.com/rss/articles/CBMi7gFBVV95cUxNU3p4ZXpVajdrWjF3S1ZMb0RORXZ4c0p3WkQ0TkpSQ3diMHNBM0pBMXZwVmJzZTBmNldpdHdfbXR1MzdJME5UbnprOXFFZnN2QXJmdzRsQU56ajFXVERTLVNNRlpxX18xUWVMMjdtRnhXemNfbENxT2NfY1c1bmVOWlZHUnRDdXJDS0V0Q1pxU3l6NjVTUXBOdnRmRTJDWXpPQUk4MTZFS3MxcFhiejhhLTAzTUs0c1p1clBYb1NRUzJxNFhhNkFudzJheW8xSG1XSVpuMk91dUpSUG5uYlo5dUVFUVB3RGx1bnFkWjV3?oc=5"" target=""_blank"">Waaree Energies share price rises ahead of Q3 results announcement</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi7gFBVV95cUxNU3p4ZXpVajdrWjF3S1ZMb0RORXZ4c0p3WkQ0TkpSQ3diMHNBM0pBMXZwVmJzZTBmNldpdHdfbXR1MzdJME5UbnprOXFFZnN2QXJmdzRsQU56ajFXVERTLVNNRlpxX18xUWVMMjdtRnhXemNfbENxT2NfY1c1bmVOWlZHUnRDdXJDS0V0Q1pxU3l6NjVTUXBOdnRmRTJDWXpPQUk4MTZFS3MxcFhiejhhLTAzTUs0c1p1clBYb1NRUzJxNFhhNkFudzJheW8xSG1XSVpuMk91dUpSUG5uYlo5dUVFUVB3RGx1bnFkWjV3?oc=5,Google News,Biocon investor call,"Waaree Energies share price rises ahead of Q3 results announcement - Upstox <a href=""https://news.google.com/rss/articles/CBMi7gFBVV95cUxNU3p4ZXpVajdrWjF3S1ZMb0RORXZ4c0p3WkQ0TkpSQ3diMHNBM0pBMXZwVmJzZTBmNldpdHdfbXR1MzdJME5UbnprOXFFZnN2QXJmdzRsQU56ajFXVERTLVNNRlpxX18xUWVMMjdtRnhXemNfbENxT2NfY1c1bmVOWlZHUnRDdXJDS0V0Q1pxU3l6NjVTUXBOdnRmRTJDWXpPQUk4MTZFS3MxcFhiejhhLTAzTUs0c1p1clBYb1NRUzJxNFhhNkFudzJheW8xSG1XSVpuMk91dUpSUG5uYlo5dUVFUVB3RGx1bnFkWjV3?oc=5"" target=""_blank"">Waaree Energies share price rises ahead of Q3 results announcement</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.8361005783081055,positive,0.8361005783081055,0.0,neutral,0.0,0.7351,0.291,0.0,0.709,0.0,0.0,0.47777175903320307,0.7856002891540528,other,0.0,[],False,False,1,0.0
2025-01-31,2025-01-31 08:00:00,"BEL's strong Q3, promising outlook lead brokerages to issue 'Buy' call - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">BEL's strong Q3, promising outlook lead brokerages to issue 'Buy' call</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon investor call,"BEL's strong Q3, promising outlook lead brokerages to issue 'Buy' call - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">BEL's strong Q3, promising outlook lead brokerages to issue 'Buy' call</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8956745862960815,positive,0.8956745862960815,0.0,neutral,0.0,0.9001,0.333,0.0,0.667,0.2111111111111111,0.41111111111111115,0.5118140493120465,0.668961899135731,other,0.0,[],False,False,1,0.0
2025-03-02,2025-03-02 08:00:00,"Biocon Foundation marks 20 years of
transforming lives - The New Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Foundation marks 20 years of
transforming lives</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News,Biocon annual results,"Biocon Foundation marks 20 years of
transforming lives - The New Indian Express <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Foundation marks 20 years of
transforming lives</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",0.6488868594169617,positive,0.6488868594169617,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0909090909090909,0.30303030303030304,0.37079249109540663,0.3698979751630263,other,0.0,[],False,True,6,0.0
2025-05-13,2025-05-13 07:00:00,"Q4 Results 2025 Highlights: Tata Steel Q4 Profit jumps 117% to Rs 1,201 crore, announces dividend of Rs 3.60 per share - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi9AFBVV95cUxObmdvWTFDeXdVQm5lcERoQ0hYYVMwc0kyM3dlM1lqM3VsQXY4ZGhyakFRU3B3TjROX2EtYl9BVUE3RXdWVnRTRTdEUHRhUU9CV3E0ZU9OYTVKZDRtU3hmS2lmaE0yYjdvYlhRMXczRlZ0WldCM1dNUzh3UHk5aG01VGFsU1hjNkN6TjluS3doSDgwejh4SzJpTmR2SjNEZ2NrWVh3YWpCUGNfVUdoTnJrVEJRMkxPclVXb1lJZ0JnNkRGRkd5T3MtdDFjZlNpel9oSVB3VGtYWW9BSXhydmxJX2RJbERKTlUyQUpJVTNnNkdUWDhR?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Tata Steel Q4 Profit jumps 117% to Rs 1,201 crore, announces dividend of Rs 3.60 per share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi9AFBVV95cUxObmdvWTFDeXdVQm5lcERoQ0hYYVMwc0kyM3dlM1lqM3VsQXY4ZGhyakFRU3B3TjROX2EtYl9BVUE3RXdWVnRTRTdEUHRhUU9CV3E0ZU9OYTVKZDRtU3hmS2lmaE0yYjdvYlhRMXczRlZ0WldCM1dNUzh3UHk5aG01VGFsU1hjNkN6TjluS3doSDgwejh4SzJpTmR2SjNEZ2NrWVh3YWpCUGNfVUdoTnJrVEJRMkxPclVXb1lJZ0JnNkRGRkd5T3MtdDFjZlNpel9oSVB3VGtYWW9BSXhydmxJX2RJbERKTlUyQUpJVTNnNkdUWDhR?oc=5,Google News,Biocon annual results,"Q4 Results 2025 Highlights: Tata Steel Q4 Profit jumps 117% to Rs 1,201 crore, announces dividend of Rs 3.60 per share - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi9AFBVV95cUxObmdvWTFDeXdVQm5lcERoQ0hYYVMwc0kyM3dlM1lqM3VsQXY4ZGhyakFRU3B3TjROX2EtYl9BVUE3RXdWVnRTRTdEUHRhUU9CV3E0ZU9OYTVKZDRtU3hmS2lmaE0yYjdvYlhRMXczRlZ0WldCM1dNUzh3UHk5aG01VGFsU1hjNkN6TjluS3doSDgwejh4SzJpTmR2SjNEZ2NrWVh3YWpCUGNfVUdoTnJrVEJRMkxPclVXb1lJZ0JnNkRGRkd5T3MtdDFjZlNpel9oSVB3VGtYWW9BSXhydmxJX2RJbERKTlUyQUpJVTNnNkdUWDhR?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Tata Steel Q4 Profit jumps 117% to Rs 1,201 crore, announces dividend of Rs 3.60 per share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.8272079229354858,positive,0.8272079229354858,0.0,neutral,0.0,0.7906,0.157,0.0,0.843,0.0,0.0,0.47269024167742046,0.8089039614677429,other,0.0,[],False,False,1,0.0
2025-06-27,2025-06-27 04:25:07,Biocon Biologics Receives Health Canada Approval for - GlobeNewswire,"<a href=""https://news.google.com/rss/articles/CBMimAJBVV95cUxNOHROdS00MTY2STk2ZHZCOXAtN3otVUtrQmZicmVNcy1XOVhWVW81ck50aVdTcGNLR2EyS2gzbzdBTWhQN1NiZGdVVHpIWVl5bjI4RlA1TzZFWS1td21YQW1pLUZvVjdQZW9qYm5wcE9PN3ZjemNMUnRSamRKdDBrenNOMzdoaHNyLWx6ZVU1a2FKNkxNUFJvUXUxOFIxUDdWbTNDZzRIMTVnUTF1UW1HX2xnaHFwdEQ1SzAtc0g4UHNldlF5b0tYRFF2V2ZCY3BlUGc5MENvUGJEbW9LaGxzbWk0TFdhSDRaNEVGYVFMckVfSjBhYjRhdkNnS0tOQnRlaFVraFY5Nm1PaVg0dVhnQ3AtclVURHpl?oc=5"" target=""_blank"">Biocon Biologics Receives Health Canada Approval for</a>&nbsp;&nbsp;<font color=""#6f6f6f"">GlobeNewswire</font>",https://news.google.com/rss/articles/CBMimAJBVV95cUxNOHROdS00MTY2STk2ZHZCOXAtN3otVUtrQmZicmVNcy1XOVhWVW81ck50aVdTcGNLR2EyS2gzbzdBTWhQN1NiZGdVVHpIWVl5bjI4RlA1TzZFWS1td21YQW1pLUZvVjdQZW9qYm5wcE9PN3ZjemNMUnRSamRKdDBrenNOMzdoaHNyLWx6ZVU1a2FKNkxNUFJvUXUxOFIxUDdWbTNDZzRIMTVnUTF1UW1HX2xnaHFwdEQ1SzAtc0g4UHNldlF5b0tYRFF2V2ZCY3BlUGc5MENvUGJEbW9LaGxzbWk0TFdhSDRaNEVGYVFMckVfSjBhYjRhdkNnS0tOQnRlaFVraFY5Nm1PaVg0dVhnQ3AtclVURHpl?oc=5,Google News,Biocon annual results,"Biocon Biologics Receives Health Canada Approval for - GlobeNewswire <a href=""https://news.google.com/rss/articles/CBMimAJBVV95cUxNOHROdS00MTY2STk2ZHZCOXAtN3otVUtrQmZicmVNcy1XOVhWVW81ck50aVdTcGNLR2EyS2gzbzdBTWhQN1NiZGdVVHpIWVl5bjI4RlA1TzZFWS1td21YQW1pLUZvVjdQZW9qYm5wcE9PN3ZjemNMUnRSamRKdDBrenNOMzdoaHNyLWx6ZVU1a2FKNkxNUFJvUXUxOFIxUDdWbTNDZzRIMTVnUTF1UW1HX2xnaHFwdEQ1SzAtc0g4UHNldlF5b0tYRFF2V2ZCY3BlUGc5MENvUGJEbW9LaGxzbWk0TFdhSDRaNEVGYVFMckVfSjBhYjRhdkNnS0tOQnRlaFVraFY5Nm1PaVg0dVhnQ3AtclVURHpl?oc=5"" target=""_blank"">Biocon Biologics Receives Health Canada Approval for</a>&nbsp;&nbsp;<font color=""#6f6f6f"">GlobeNewswire</font>",0.722179651260376,positive,0.722179651260376,0.0,neutral,0.0,0.7351,0.279,0.0,0.721,0.0,0.0,0.41267408643450054,0.728639825630188,approval_process,0.8051066994667053,['FDA approval'],False,True,16,0.6102133989334106
2025-05-08,2025-05-08 07:00:00,Q4 Results Highlights: Titan profit rises 11% YoY to ₹870 crore - Upstox,"<a href=""https://news.google.com/rss/articles/CBMihwJBVV95cUxNM3pEWVdGcEpiYm85OHloM3hpNnktMjdKT1BJYnFWbjJKc29fR3BDNVlwTzhDT1N4T0I0Y2t0WDVidW04OUotREUzQXVmS3UwMlhTU2szeVJpOEE3ZkVxdUlLSE1XSzFkelRUZjhzX2hlN092V0htZTNOZTRmNG5KOTJaT2dNNFpsSU1fY1pmdE5TUXlTSGJWQldybllsRWNaRXVRYlVIRE9RaVVYUURKdUFxOWZaNXZpNzN5bEtUWnphRFBVRzRkWEh6QTJueldfRGluU1k2b1FrLVh5M2hVNl9ORkd2ZEFRMVk4bXhRUDdTV1BDUW9CNVR1X0YtZTkxbF9BZ04zbw?oc=5"" target=""_blank"">Q4 Results Highlights: Titan profit rises 11% YoY to ₹870 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMihwJBVV95cUxNM3pEWVdGcEpiYm85OHloM3hpNnktMjdKT1BJYnFWbjJKc29fR3BDNVlwTzhDT1N4T0I0Y2t0WDVidW04OUotREUzQXVmS3UwMlhTU2szeVJpOEE3ZkVxdUlLSE1XSzFkelRUZjhzX2hlN092V0htZTNOZTRmNG5KOTJaT2dNNFpsSU1fY1pmdE5TUXlTSGJWQldybllsRWNaRXVRYlVIRE9RaVVYUURKdUFxOWZaNXZpNzN5bEtUWnphRFBVRzRkWEh6QTJueldfRGluU1k2b1FrLVh5M2hVNl9ORkd2ZEFRMVk4bXhRUDdTV1BDUW9CNVR1X0YtZTkxbF9BZ04zbw?oc=5,Google News,Biocon annual results,"Q4 Results Highlights: Titan profit rises 11% YoY to ₹870 crore - Upstox <a href=""https://news.google.com/rss/articles/CBMihwJBVV95cUxNM3pEWVdGcEpiYm85OHloM3hpNnktMjdKT1BJYnFWbjJKc29fR3BDNVlwTzhDT1N4T0I0Y2t0WDVidW04OUotREUzQXVmS3UwMlhTU2szeVJpOEE3ZkVxdUlLSE1XSzFkelRUZjhzX2hlN092V0htZTNOZTRmNG5KOTJaT2dNNFpsSU1fY1pmdE5TUXlTSGJWQldybllsRWNaRXVRYlVIRE9RaVVYUURKdUFxOWZaNXZpNzN5bEtUWnphRFBVRzRkWEh6QTJueldfRGluU1k2b1FrLVh5M2hVNl9ORkd2ZEFRMVk4bXhRUDdTV1BDUW9CNVR1X0YtZTkxbF9BZ04zbw?oc=5"" target=""_blank"">Q4 Results Highlights: Titan profit rises 11% YoY to ₹870 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.9244529604911804,positive,0.9244529604911804,0.0,neutral,0.0,0.7003,0.195,0.0,0.805,0.0,0.0,0.5282588345663888,0.8123764802455902,other,0.0,[],False,False,1,0.0
2025-01-30,2025-01-30 08:00:00,"FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxQQ29SS0ZTRHJBU2doTXNOVzJ6X0xrYVJYbWhQQkxmNVVFd2U5ZjZJenR0ZGpoN201OERpb3o2cWFMWnJxRzBwblZLaHpXVlRuWEIyeXUxeExQOGN1MTZUaXpwdEw5N2NEeXJzV0hXQ1ZreUJyZkpXVlVia1hfU1BaMFZvbU5fVWhGVkROVjNHUmdRTk1Lc0txRFFwUy1kNUlUcEtxQm1Qcmk0ZGhwVzdvcm1IMkpUVU1Ha2IwWVlTUjRHbTVXVEN2VjdjVDdfb3VpT2tBTzA5WlA1M2Rx?oc=5"" target=""_blank"">FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMi3AFBVV95cUxQQ29SS0ZTRHJBU2doTXNOVzJ6X0xrYVJYbWhQQkxmNVVFd2U5ZjZJenR0ZGpoN201OERpb3o2cWFMWnJxRzBwblZLaHpXVlRuWEIyeXUxeExQOGN1MTZUaXpwdEw5N2NEeXJzV0hXQ1ZreUJyZkpXVlVia1hfU1BaMFZvbU5fVWhGVkROVjNHUmdRTk1Lc0txRFFwUy1kNUlUcEtxQm1Qcmk0ZGhwVzdvcm1IMkpUVU1Ha2IwWVlTUjRHbTVXVEN2VjdjVDdfb3VpT2tBTzA5WlA1M2Rx?oc=5,Google News,Biocon annual results,"FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar - Center for Biosimilars <a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxQQ29SS0ZTRHJBU2doTXNOVzJ6X0xrYVJYbWhQQkxmNVVFd2U5ZjZJenR0ZGpoN201OERpb3o2cWFMWnJxRzBwblZLaHpXVlRuWEIyeXUxeExQOGN1MTZUaXpwdEw5N2NEeXJzV0hXQ1ZreUJyZkpXVlVia1hfU1BaMFZvbU5fVWhGVkROVjNHUmdRTk1Lc0txRFFwUy1kNUlUcEtxQm1Qcmk0ZGhwVzdvcm1IMkpUVU1Ha2IwWVlTUjRHbTVXVEN2VjdjVDdfb3VpT2tBTzA5WlA1M2Rx?oc=5"" target=""_blank"">FDA Reviews Golimumab Biosimilar, Samsung Biologics Hits Record Sales, Japan Approves Stelara Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",0.6945764422416687,positive,0.6945764422416687,0.0,neutral,0.0,0.6597,0.144,0.0,0.856,-0.05,0.05,0.3969008241380964,0.46809214741388955,regulatory_review,0.7180093646049499,['FDA review'],False,False,10,0.5360187292098999
2025-05-09,2025-05-09 07:00:00,Biocon shares in focus as Q4 PAT soars 153% YoY - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus as Q4 PAT soars 153% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon annual results,"Biocon shares in focus as Q4 PAT soars 153% YoY - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus as Q4 PAT soars 153% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.5983496904373169,0.0,neutral,0.0,0.5267,0.145,0.0,0.855,0.13333333333333333,0.13333333333333333,0.0,0.41946100792355007,other,0.0,[],False,True,6,0.0
2024-01-04,2024-01-04 08:00:00,Why Biocon Share Price is Rising - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxQTkhQOExicHF1a1ZIdDExSzdYamVkWHg2bnNLU3lhTV9BeFpxLU5kbXpUNVczSVE2dl9QZW1sMGRId0pCT21KWkcxd2UyMVNYUVVCZ2ZLd0FYdmRNOHRHdnA4d1d3ZGs5VE5tZlVHSjVUUTR4OXZxOXI0bXIyZlVDaXdCZnpzNnN0WXdOc0NJeTJjMHdzbzgwOVpGeGcxOWFWWjNiQQ?oc=5"" target=""_blank"">Why Biocon Share Price is Rising</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxQTkhQOExicHF1a1ZIdDExSzdYamVkWHg2bnNLU3lhTV9BeFpxLU5kbXpUNVczSVE2dl9QZW1sMGRId0pCT21KWkcxd2UyMVNYUVVCZ2ZLd0FYdmRNOHRHdnA4d1d3ZGs5VE5tZlVHSjVUUTR4OXZxOXI0bXIyZlVDaXdCZnpzNnN0WXdOc0NJeTJjMHdzbzgwOVpGeGcxOWFWWjNiQQ?oc=5,Google News,Biocon annual results,"Why Biocon Share Price is Rising - Equitymaster <a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxQTkhQOExicHF1a1ZIdDExSzdYamVkWHg2bnNLU3lhTV9BeFpxLU5kbXpUNVczSVE2dl9QZW1sMGRId0pCT21KWkcxd2UyMVNYUVVCZ2ZLd0FYdmRNOHRHdnA4d1d3ZGs5VE5tZlVHSjVUUTR4OXZxOXI0bXIyZlVDaXdCZnpzNnN0WXdOc0NJeTJjMHdzbzgwOVpGeGcxOWFWWjNiQQ?oc=5"" target=""_blank"">Why Biocon Share Price is Rising</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",0.875948429107666,positive,0.875948429107666,0.0,neutral,0.0,0.5267,0.239,0.0,0.761,0.0,0.0,0.5005419594900948,0.701324214553833,other,0.0,[],False,True,6,0.0
2025-04-11,2025-04-11 07:00:00,"Stocks to Watch Today, April 11: Biocon, TCS, Anand Rathi, TaMo, Sun Pharma - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch Today, April 11: Biocon, TCS, Anand Rathi, TaMo, Sun Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon annual results,"Stocks to Watch Today, April 11: Biocon, TCS, Anand Rathi, TaMo, Sun Pharma - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch Today, April 11: Biocon, TCS, Anand Rathi, TaMo, Sun Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.9374382495880127,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9374382495880127,other,0.0,[],False,True,6,0.0
2023-05-31,2023-05-31 07:00:00,"Biocon Investing Heavily In Peptides, Potent Oncology APIs: MD & CEO, Siddharth Mittal - BW Businessworld","<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxOQ1VhNklYbEttUExjenRWOHM2RzZFNktiMUQ2WmR3RmNCWXlXbFpFblJydGFFNzhIU2dhUHNjd2xDUnV1aFQxX1FzOWhSTDdCMXB5YzBqUDZVU0Z4akM5RFJLSmZWRHpMRDhfQUlvck1kNUhNOWRndHlSSXZqTVlBT3ZxZkpzaXBXXzdPeWYyYUZKem42LVRaN25CMmpnclpQRlpKdkE1ZnJYdHh6QWhKN213dy1yNTF5OHBpLWFCd3U2eFU?oc=5"" target=""_blank"">Biocon Investing Heavily In Peptides, Potent Oncology APIs: MD & CEO, Siddharth Mittal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Businessworld</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxOQ1VhNklYbEttUExjenRWOHM2RzZFNktiMUQ2WmR3RmNCWXlXbFpFblJydGFFNzhIU2dhUHNjd2xDUnV1aFQxX1FzOWhSTDdCMXB5YzBqUDZVU0Z4akM5RFJLSmZWRHpMRDhfQUlvck1kNUhNOWRndHlSSXZqTVlBT3ZxZkpzaXBXXzdPeWYyYUZKem42LVRaN25CMmpnclpQRlpKdkE1ZnJYdHh6QWhKN213dy1yNTF5OHBpLWFCd3U2eFU?oc=5,Google News,Biocon annual results,"Biocon Investing Heavily In Peptides, Potent Oncology APIs: MD & CEO, Siddharth Mittal - BW Businessworld <a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxOQ1VhNklYbEttUExjenRWOHM2RzZFNktiMUQ2WmR3RmNCWXlXbFpFblJydGFFNzhIU2dhUHNjd2xDUnV1aFQxX1FzOWhSTDdCMXB5YzBqUDZVU0Z4akM5RFJLSmZWRHpMRDhfQUlvck1kNUhNOWRndHlSSXZqTVlBT3ZxZkpzaXBXXzdPeWYyYUZKem42LVRaN25CMmpnclpQRlpKdkE1ZnJYdHh6QWhKN213dy1yNTF5OHBpLWFCd3U2eFU?oc=5"" target=""_blank"">Biocon Investing Heavily In Peptides, Potent Oncology APIs: MD & CEO, Siddharth Mittal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Businessworld</font>",0.0,neutral,0.8070224523544312,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.12,0.4,0.0,0.4635112261772156,other,0.0,[],False,True,6,0.0
2025-05-08,2025-05-08 07:00:00,Q4 Results: Britannia Industries Profit Beats Estimates; Union Bank Profit Up; Rain Industries Remains In Loss - NDTV Profit,"<a href=""https://news.google.com/rss/articles/CBMiiAJBVV95cUxPWUJmRmtIMkw1eFc1bWQxY0hUU2FkSG5wQ2lPYkFLenVOa3h0Z3gySHFhVG9tS2lPMWJNODBPem5nRTd2c3VnTVEwZXFoWURQNDZMRnBIcUU1VFBnNzZGMHdJU2RNZjctX2pZODFfTFpRblJGbkxwMXc5NmdwQ0hFRm10NUY0OEtKS21DaE45T3MxbElyQ25JT3NFN3BXMXVSSklzdVdBUV9OXzJOTDRuLURRTVMzNVNTajdReC1UZURWZHo4UEM4MWVUWGJTRTlTWUdHQ1RqVzZ6cWxfQjRmejlkTEZMakI4WkZ4TWJlNXpKR0xZc3Y3SWF4UGs2ZXY5czN6c0dQUWvSAY4CQVVfeXFMTTZkZkl5TTctZnpmcWJ0OTFCd0l3T3ZDZmh2RXROd2d5c3dieWpmSENwbEhYc2Q1Wmkwd2cwYlBHa1diWk9Nc3hPNTRhLVpCa05Za1JkbXpqcjRzd2t0emlucHdUODVYcnEyS05HU3lXRnBkOVVVeUFjUWFQSnNUT0ZDSThWWFo0LTJTZ1pYbndXNm5PZG5XbE9TbjNFYU9VOUJxMzRRU2gzbFVlS3hGVGt2WkxlbVJfZzhfbWYzdGpZeU5uWmlUOFpha2JfU3I5WkhBRjdpQUNHbmpZYUZLVVRxdG1La0dnTmxXOVdNb0lhMEc2SXUtY1MyR0FDX0hQbTc3NTI1SEVndHJmUWJn?oc=5"" target=""_blank"">Q4 Results: Britannia Industries Profit Beats Estimates; Union Bank Profit Up; Rain Industries Remains In Loss</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News,Biocon annual results,"Q4 Results: Britannia Industries Profit Beats Estimates; Union Bank Profit Up; Rain Industries Remains In Loss - NDTV Profit <a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results: Britannia Industries Profit Beats Estimates; Union Bank Profit Up; Rain Industries Remains In Loss</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",-0.8612531423568726,negative,0.8612531423568726,0.0,neutral,0.0,0.9042,0.297,0.047,0.656,0.0,0.0,-0.4921446527753557,0.8827265711784362,other,0.0,[],False,False,1,0.0
2025-06-17,2025-06-17 07:00:00,"From Asian Paints, Reliance Industries, TCS to Biocon – Here are 8 stocks to watch - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi9gFBVV95cUxQVGtLWW92S2xNLVg4VGE5OFU0V3V2YVdZQkwxLXB1cTAySGNNQlp3c1NJbG43dUplalp4dWNHWWxDeHcxZGZiR3VlUTR3UTJkVm1lTGlxNGE1SFRpOUgydjdrUkdlWW5uMjFicFpYSnFSX29hWlBQTFJOTlBWQnJfaGxmRnZuRFd1a3Nkck92bzR0MzVGWnQxOHpDQmFsYWJTVUFEOFJ0VXNzTlI4M0o0UEJUQ3lLR195N0taWURHWEdYc0JsN3BYTUlVM0UtNXhMdUYySUdSOFZLUWE0NmZWX3FwVTNGck5oZFFRaHBHS01PVzBSTlE?oc=5"" target=""_blank"">From Asian Paints, Reliance Industries, TCS to Biocon – Here are 8 stocks to watch</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi9gFBVV95cUxQVGtLWW92S2xNLVg4VGE5OFU0V3V2YVdZQkwxLXB1cTAySGNNQlp3c1NJbG43dUplalp4dWNHWWxDeHcxZGZiR3VlUTR3UTJkVm1lTGlxNGE1SFRpOUgydjdrUkdlWW5uMjFicFpYSnFSX29hWlBQTFJOTlBWQnJfaGxmRnZuRFd1a3Nkck92bzR0MzVGWnQxOHpDQmFsYWJTVUFEOFJ0VXNzTlI4M0o0UEJUQ3lLR195N0taWURHWEdYc0JsN3BYTUlVM0UtNXhMdUYySUdSOFZLUWE0NmZWX3FwVTNGck5oZFFRaHBHS01PVzBSTlE?oc=5,Google News,Biocon annual results,"From Asian Paints, Reliance Industries, TCS to Biocon – Here are 8 stocks to watch - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi9gFBVV95cUxQVGtLWW92S2xNLVg4VGE5OFU0V3V2YVdZQkwxLXB1cTAySGNNQlp3c1NJbG43dUplalp4dWNHWWxDeHcxZGZiR3VlUTR3UTJkVm1lTGlxNGE1SFRpOUgydjdrUkdlWW5uMjFicFpYSnFSX29hWlBQTFJOTlBWQnJfaGxmRnZuRFd1a3Nkck92bzR0MzVGWnQxOHpDQmFsYWJTVUFEOFJ0VXNzTlI4M0o0UEJUQ3lLR195N0taWURHWEdYc0JsN3BYTUlVM0UtNXhMdUYySUdSOFZLUWE0NmZWX3FwVTNGck5oZFFRaHBHS01PVzBSTlE?oc=5"" target=""_blank"">From Asian Paints, Reliance Industries, TCS to Biocon – Here are 8 stocks to watch</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9385535717010498,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9385535717010498,other,0.0,[],False,True,6,0.0
2024-05-16,2024-05-16 07:00:00,"Q4 Results 2024 Updates: M&M, Hindustan Aeronautics, Container Corporations of India, Vodafone Idea, GAIL India, more announced earnings - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMirgJBVV95cUxNLWpRV3F0SUdpaVR5ekxKMjM2bmNtZW4wMjlNWEtEOWdNWTBEZklkQlFhdkxkYjd4eTJjc2ZLRWZZZ1BMd0NRRGVuemJHVFZla3hUeHJRZUFDUF9WMFRoc2tUWmoyVTZFa0lzbjA3bVVIaVNpd2tHZERFUS1sN0lVbFdQTUVPakFaYUVIRU04ZlFGZXVjc3hoU053b0d0SmVaSUtWWlBycjZDRXMwMlladXBsYVV2OEgxQjJMOFBXOXRpbFdvNVlkRGwxS1hGcDNkOHUySUpvQUpsVnhVZzBsZ2hpTWZSbFRiSDR6ZGF5VGxQRXM5OE1rTnBxNjlGbkdfeXpTbjdIeWxRWlVsNmdJN3B3OHplTjBJcUtsYngxRUVRQ25peWlmQUwyaU9fZw?oc=5"" target=""_blank"">Q4 Results 2024 Updates: M&amp;M, Hindustan Aeronautics, Container Corporations of India, Vodafone Idea, GAIL India, more announced earnings</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMirgJBVV95cUxNLWpRV3F0SUdpaVR5ekxKMjM2bmNtZW4wMjlNWEtEOWdNWTBEZklkQlFhdkxkYjd4eTJjc2ZLRWZZZ1BMd0NRRGVuemJHVFZla3hUeHJRZUFDUF9WMFRoc2tUWmoyVTZFa0lzbjA3bVVIaVNpd2tHZERFUS1sN0lVbFdQTUVPakFaYUVIRU04ZlFGZXVjc3hoU053b0d0SmVaSUtWWlBycjZDRXMwMlladXBsYVV2OEgxQjJMOFBXOXRpbFdvNVlkRGwxS1hGcDNkOHUySUpvQUpsVnhVZzBsZ2hpTWZSbFRiSDR6ZGF5VGxQRXM5OE1rTnBxNjlGbkdfeXpTbjdIeWxRWlVsNmdJN3B3OHplTjBJcUtsYngxRUVRQ25peWlmQUwyaU9fZw?oc=5,Google News,Biocon annual results,"Q4 Results 2024 Updates: M&M, Hindustan Aeronautics, Container Corporations of India, Vodafone Idea, GAIL India, more announced earnings - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMirgJBVV95cUxNLWpRV3F0SUdpaVR5ekxKMjM2bmNtZW4wMjlNWEtEOWdNWTBEZklkQlFhdkxkYjd4eTJjc2ZLRWZZZ1BMd0NRRGVuemJHVFZla3hUeHJRZUFDUF9WMFRoc2tUWmoyVTZFa0lzbjA3bVVIaVNpd2tHZERFUS1sN0lVbFdQTUVPakFaYUVIRU04ZlFGZXVjc3hoU053b0d0SmVaSUtWWlBycjZDRXMwMlladXBsYVV2OEgxQjJMOFBXOXRpbFdvNVlkRGwxS1hGcDNkOHUySUpvQUpsVnhVZzBsZ2hpTWZSbFRiSDR6ZGF5VGxQRXM5OE1rTnBxNjlGbkdfeXpTbjdIeWxRWlVsNmdJN3B3OHplTjBJcUtsYngxRUVRQ25peWlmQUwyaU9fZw?oc=5"" target=""_blank"">Q4 Results 2024 Updates: M&amp;M, Hindustan Aeronautics, Container Corporations of India, Vodafone Idea, GAIL India, more announced earnings</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9284823536872864,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.3333333333333333,0.3333333333333333,0.0,0.6309078435103098,other,0.0,[],False,False,1,0.0
2024-05-31,2024-05-31 07:00:00,"Q4 Results 2024 Updates: Apollo Hospitals, Godfrey Phillips, Reliance Infra, Yatra, V2 Retail, more to announce earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMixAJBVV95cUxQZGtfRXBaUWE1MlJ0MXNLNmNuRG1SMWZSVEFYSmQ4ZTEybkdXM2pBUDE2RUMtWEw1dFBDS25YTmtOQkc0ZHNPZkNFTFNlbnR3TWxyNGRVTE80UWNqcHNRWDVIZFQyQU12ei1GVmFDM0l3c3h1b05TcnpkNHFaRk1xSlNiTEIyUWZjeGV4QmxUbm9QWHp6UGNMYlo1bmpJVldTUkM4bEYxWnNoVW1BMlRTQ3dSZmVzTGU5WVg5TGxBbUpHemNTSE0tSUF6YURWNFFBOHVGajY5dWMyb3JRdDRacVdrWnpPVWxCUDBYZjlCV1IyWUQ0UERSd1RPSDQwdEl0T1pXUUxPeVBCWHotbmIzS2Jmd1NxZ1I2MW0tcmZMX0dGWHRZeDFXcnZURUxycjZTZjZIT0dCQUlWeWdzc0Zta3ZfbGs?oc=5"" target=""_blank"">Q4 Results 2024 Updates: Apollo Hospitals, Godfrey Phillips, Reliance Infra, Yatra, V2 Retail, more to announce earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMixAJBVV95cUxQZGtfRXBaUWE1MlJ0MXNLNmNuRG1SMWZSVEFYSmQ4ZTEybkdXM2pBUDE2RUMtWEw1dFBDS25YTmtOQkc0ZHNPZkNFTFNlbnR3TWxyNGRVTE80UWNqcHNRWDVIZFQyQU12ei1GVmFDM0l3c3h1b05TcnpkNHFaRk1xSlNiTEIyUWZjeGV4QmxUbm9QWHp6UGNMYlo1bmpJVldTUkM4bEYxWnNoVW1BMlRTQ3dSZmVzTGU5WVg5TGxBbUpHemNTSE0tSUF6YURWNFFBOHVGajY5dWMyb3JRdDRacVdrWnpPVWxCUDBYZjlCV1IyWUQ0UERSd1RPSDQwdEl0T1pXUUxPeVBCWHotbmIzS2Jmd1NxZ1I2MW0tcmZMX0dGWHRZeDFXcnZURUxycjZTZjZIT0dCQUlWeWdzc0Zta3ZfbGs?oc=5,Google News,Biocon annual results,"Q4 Results 2024 Updates: Apollo Hospitals, Godfrey Phillips, Reliance Infra, Yatra, V2 Retail, more to announce earnings today - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMixAJBVV95cUxQZGtfRXBaUWE1MlJ0MXNLNmNuRG1SMWZSVEFYSmQ4ZTEybkdXM2pBUDE2RUMtWEw1dFBDS25YTmtOQkc0ZHNPZkNFTFNlbnR3TWxyNGRVTE80UWNqcHNRWDVIZFQyQU12ei1GVmFDM0l3c3h1b05TcnpkNHFaRk1xSlNiTEIyUWZjeGV4QmxUbm9QWHp6UGNMYlo1bmpJVldTUkM4bEYxWnNoVW1BMlRTQ3dSZmVzTGU5WVg5TGxBbUpHemNTSE0tSUF6YURWNFFBOHVGajY5dWMyb3JRdDRacVdrWnpPVWxCUDBYZjlCV1IyWUQ0UERSd1RPSDQwdEl0T1pXUUxPeVBCWHotbmIzS2Jmd1NxZ1I2MW0tcmZMX0dGWHRZeDFXcnZURUxycjZTZjZIT0dCQUlWeWdzc0Zta3ZfbGs?oc=5"" target=""_blank"">Q4 Results 2024 Updates: Apollo Hospitals, Godfrey Phillips, Reliance Infra, Yatra, V2 Retail, more to announce earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9108058214187622,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.3333333333333333,0.3333333333333333,0.0,0.6220695773760477,other,0.0,[],False,False,1,0.0
2025-05-08,2025-05-08 07:00:00,"Q4 Results May 8 Highlights: L&T, Canara Bank, Titan post gains; Asian Paints net slips 45%; Zee Ent swings to ₹188.4 cr profit - BusinessLine","<a href=""https://news.google.com/rss/articles/CBMitwJBVV95cUxNa1VySmpLczkzYWU4UTIwYWc0dmxOOHMzTU1LUmR1VDY5ZzdYNjVWaE1tVUVxQ2ktQXd3Z2UzUnpLb01aU1JXTGh3dklza3VTYjRKTnk5b0FZWk5aVkFKMEtzNUFoc3gxYmQxR3ZkdGJlYWZWS3ZvX0U4T3loV1FrNk42c2ZqMmd1SXJrUkRIWTlNaU5SOV9MQWUxUEFJUkVZeXotUGNDTDVLYm9UaHZkd3NfN3RUR2MzVGxvSDdZNDM0bmk2MHRwbU9kdUFHcHVHTEpQeUxISFVMTFNEQjVrRnNIS0ZzaGFGcmZ5WW9nZ2RJSkxFMVNlalFUdkhwbkZtdTFjdW4waENTNGllMzNNUVFqUWlKT3RWYW9SYmNaUm1ncTRVZkNBb2xlcVczQWFJdnZZSEhKQQ?oc=5"" target=""_blank"">Q4 Results May 8 Highlights: L&amp;T, Canara Bank, Titan post gains; Asian Paints net slips 45%; Zee Ent swings to ₹188.4 cr profit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.com/rss/articles/CBMitwJBVV95cUxNa1VySmpLczkzYWU4UTIwYWc0dmxOOHMzTU1LUmR1VDY5ZzdYNjVWaE1tVUVxQ2ktQXd3Z2UzUnpLb01aU1JXTGh3dklza3VTYjRKTnk5b0FZWk5aVkFKMEtzNUFoc3gxYmQxR3ZkdGJlYWZWS3ZvX0U4T3loV1FrNk42c2ZqMmd1SXJrUkRIWTlNaU5SOV9MQWUxUEFJUkVZeXotUGNDTDVLYm9UaHZkd3NfN3RUR2MzVGxvSDdZNDM0bmk2MHRwbU9kdUFHcHVHTEpQeUxISFVMTFNEQjVrRnNIS0ZzaGFGcmZ5WW9nZ2RJSkxFMVNlalFUdkhwbkZtdTFjdW4waENTNGllMzNNUVFqUWlKT3RWYW9SYmNaUm1ncTRVZkNBb2xlcVczQWFJdnZZSEhKQQ?oc=5,Google News,Biocon annual results,"Q4 Results May 8 Highlights: L&T, Canara Bank, Titan post gains; Asian Paints net slips 45%; Zee Ent swings to ₹188.4 cr profit - BusinessLine <a href=""https://news.google.com/rss/articles/CBMitwJBVV95cUxNa1VySmpLczkzYWU4UTIwYWc0dmxOOHMzTU1LUmR1VDY5ZzdYNjVWaE1tVUVxQ2ktQXd3Z2UzUnpLb01aU1JXTGh3dklza3VTYjRKTnk5b0FZWk5aVkFKMEtzNUFoc3gxYmQxR3ZkdGJlYWZWS3ZvX0U4T3loV1FrNk42c2ZqMmd1SXJrUkRIWTlNaU5SOV9MQWUxUEFJUkVZeXotUGNDTDVLYm9UaHZkd3NfN3RUR2MzVGxvSDdZNDM0bmk2MHRwbU9kdUFHcHVHTEpQeUxISFVMTFNEQjVrRnNIS0ZzaGFGcmZ5WW9nZ2RJSkxFMVNlalFUdkhwbkZtdTFjdW4waENTNGllMzNNUVFqUWlKT3RWYW9SYmNaUm1ncTRVZkNBb2xlcVczQWFJdnZZSEhKQQ?oc=5"" target=""_blank"">Q4 Results May 8 Highlights: L&amp;T, Canara Bank, Titan post gains; Asian Paints net slips 45%; Zee Ent swings to ₹188.4 cr profit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",0.5427976846694946,positive,0.5427976846694946,0.0,neutral,0.0,0.7717,0.146,0.0,0.854,0.0,0.0,0.31017010552542545,0.6572488423347473,other,0.0,[],False,False,1,0.0
2024-05-16,2024-05-16 07:00:00,Akzo Nobel India Q4 results: Net profit rises 13.94% to Rs 108.7 cr - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Akzo Nobel India Q4 results: Net profit rises 13.94% to Rs 108.7 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon annual results,"Akzo Nobel India Q4 results: Net profit rises 13.94% to Rs 108.7 cr - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Akzo Nobel India Q4 results: Net profit rises 13.94% to Rs 108.7 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.933143138885498,positive,0.933143138885498,0.0,neutral,0.0,0.7003,0.162,0.0,0.838,0.0,0.0,0.5332246507917132,0.816721569442749,other,0.0,[],False,False,1,0.0
2025-05-04,2025-05-04 07:00:00,"Q4 Earnings This Week: Nearly 300 companies set to announce results; M&M, Asian Paints, Dr Reddys Labs, on the list - Zee Business","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Earnings This Week: Nearly 300 companies set to announce results; M&amp;M, Asian Paints, Dr Reddys Labs, on the list</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News,Biocon annual results,"Q4 Earnings This Week: Nearly 300 companies set to announce results; M&M, Asian Paints, Dr Reddys Labs, on the list - Zee Business <a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Earnings This Week: Nearly 300 companies set to announce results; M&amp;M, Asian Paints, Dr Reddys Labs, on the list</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",0.0,neutral,0.8857747912406921,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.04,0.16,0.0,0.4628873956203461,other,0.0,[],False,False,1,0.0
2024-05-15,2024-05-15 07:00:00,"Q4 results today: Mahindra & Mahindra, Vodafone Idea, GAIL, Info Edge, others to post earnings - Upstox","<a href=""https://news.google.com/rss/articles/CBMi0gFBVV95cUxQTWlqRGtGUVRlY1NJY081ZnpsdzdqQ2Y4QUpwZ0ZhbnRKaVdnWkQ5TkZoekJyb3E5aTBTNV9QMmU4emdKZVF0Yms1N2xrazh4ZVhLSlVKUTY0cG5UOVM5OFlRYmJNcmFsNmFVdlZoZksxNUJJRFB3dE8xdWIxczFLZ0hFbVZ3VDYtcW9RZmZyd1pVcGl1QlN5UXpIZUtvT3IzdDItc1lESkJleWRXMEhMbmdGNk95ekpxLWVTeE9xcVN6c1JEdk5iSE43d3A4NktaZ2c?oc=5"" target=""_blank"">Q4 results today: Mahindra & Mahindra, Vodafone Idea, GAIL, Info Edge, others to post earnings</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi0gFBVV95cUxQTWlqRGtGUVRlY1NJY081ZnpsdzdqQ2Y4QUpwZ0ZhbnRKaVdnWkQ5TkZoekJyb3E5aTBTNV9QMmU4emdKZVF0Yms1N2xrazh4ZVhLSlVKUTY0cG5UOVM5OFlRYmJNcmFsNmFVdlZoZksxNUJJRFB3dE8xdWIxczFLZ0hFbVZ3VDYtcW9RZmZyd1pVcGl1QlN5UXpIZUtvT3IzdDItc1lESkJleWRXMEhMbmdGNk95ekpxLWVTeE9xcVN6c1JEdk5iSE43d3A4NktaZ2c?oc=5,Google News,Biocon annual results,"Q4 results today: Mahindra & Mahindra, Vodafone Idea, GAIL, Info Edge, others to post earnings - Upstox <a href=""https://news.google.com/rss/articles/CBMi0gFBVV95cUxQTWlqRGtGUVRlY1NJY081ZnpsdzdqQ2Y4QUpwZ0ZhbnRKaVdnWkQ5TkZoekJyb3E5aTBTNV9QMmU4emdKZVF0Yms1N2xrazh4ZVhLSlVKUTY0cG5UOVM5OFlRYmJNcmFsNmFVdlZoZksxNUJJRFB3dE8xdWIxczFLZ0hFbVZ3VDYtcW9RZmZyd1pVcGl1QlN5UXpIZUtvT3IzdDItc1lESkJleWRXMEhMbmdGNk95ekpxLWVTeE9xcVN6c1JEdk5iSE43d3A4NktaZ2c?oc=5"" target=""_blank"">Q4 results today: Mahindra & Mahindra, Vodafone Idea, GAIL, Info Edge, others to post earnings</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.0,neutral,0.5757418870925903,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.5757418870925903,other,0.0,[],False,False,1,0.0
2025-06-24,2025-06-24 19:07:39,Biocon shares in focus after launching QIP at floor price of Rs 340.20 - MSN,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after launching QIP at floor price of Rs 340.20</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares in focus after launching QIP at floor price of Rs 340.20 - MSN <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after launching QIP at floor price of Rs 340.20</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",0.0,neutral,0.6024248003959656,0.0,neutral,0.0,0.5267,0.136,0.0,0.864,0.0,0.0,0.0,0.5645624001979828,other,0.0,[],False,True,6,0.0
2025-06-16,2025-06-16 07:00:00,"Biocon shares in focus after board opens up QIP fundraising on 16 June, sets floor price at ₹340.20/share - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after board opens up QIP fundraising on 16 June, sets floor price at ₹340.20/share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares in focus after board opens up QIP fundraising on 16 June, sets floor price at ₹340.20/share - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after board opens up QIP fundraising on 16 June, sets floor price at ₹340.20/share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.8449617624282837,0.0,neutral,0.0,0.5267,0.104,0.0,0.896,0.0,0.0,0.0,0.6858308812141418,other,0.0,[],False,True,6,0.0
2025-06-17,2025-06-17 07:00:00,Biocon shares in focus after launching QIP at floor price of Rs 340.20 - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after launching QIP at floor price of Rs 340.20</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi3AFBVV95cUxNTUlPVGpvS3BwWGd1TW1JSGZKcW15SndQbTlTdWNUS21lWVAxS1ZoWGFYQ1VKR0RDcTlLWW1mS2w2azFTUUZvY3c4ZTlINEpmLUV3ZmcyU1BZbkR4WklYd1hubVc3V3BWLWxMY25VUVpxWTcwck5mN1VHTXJnVVU1c0trYVA5ekJSMjZRSTE1NjZaMnpuVVI3dkxyZEpIcUZ0aTNsZ0sxYV9HZk5IN3R2TmVFTVBiTVgxbV9NMlpBM2lzRUdwQUFvMlZhNms3Skk3UlJ2cERHUnZPcTNJ0gHiAUFVX3lxTFB6OFdKRHp3Z1BxaEhvdGFObnhjUzBnVk5BX0xLZjYzR00zTURqU3B0ZHhneExhdUVqYWhkTHVNcllNTmhsS3Vsc3FMSHF4VFpnRDNOdXdvYm0wdmZXTGh4UUFsRmRqckhacGgwN1gxcTRkUUs3NGYycWpCT3pTOVRmQVl2OTlMWWZHbXIyWDJpSmFObngzNmYtcFRJRTNmd0YzeWVHOFdfUHRuMTMxUWNISk5mLW5xSEZzaVJuSTJGcy12b2NWcW1KanQzSkhKNzFBYjh6ZkJQVUZvX0VCX3ZBOFE?oc=5,Google News,Biocon stock price,"Biocon shares in focus after launching QIP at floor price of Rs 340.20 - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after launching QIP at floor price of Rs 340.20</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.728699266910553,0.0,neutral,0.0,0.5267,0.121,0.0,0.879,0.13333333333333333,0.13333333333333333,0.0,0.46291086674796206,other,0.0,[],False,True,6,0.0
2025-06-09,2025-06-09 07:00:00,Biocon's Stock Rebounds Amidst Broader Market Optimism and Small-Cap Gains - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxOdG1XN3J2Y0V6dFg2aFlDanhCSkJvWlBoUVlsOHhpOFhQQ1JpeGxmM1Y4NFRzRUJqYmxaYXpjcTNjQkNvZk4xLTlRSFItdkxUZ1o5NWtKcmYzUWJqcVZzTElUQkxsUU5BS0IzclA1QV9IX0xfN292UnNHOXFGa0dHdGYwUXk3Ymc5VVdNd3pSWHF2Z195SWdJaTZhb1FiSGlRYmwzS1E4Nk5ncDdHZHI2VVcxWGFZTzJRV1FPbnBOS3pRcGxmVFVN?oc=5"" target=""_blank"">Biocon's Stock Rebounds Amidst Broader Market Optimism and Small-Cap Gains</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxOdG1XN3J2Y0V6dFg2aFlDanhCSkJvWlBoUVlsOHhpOFhQQ1JpeGxmM1Y4NFRzRUJqYmxaYXpjcTNjQkNvZk4xLTlRSFItdkxUZ1o5NWtKcmYzUWJqcVZzTElUQkxsUU5BS0IzclA1QV9IX0xfN292UnNHOXFGa0dHdGYwUXk3Ymc5VVdNd3pSWHF2Z195SWdJaTZhb1FiSGlRYmwzS1E4Nk5ncDdHZHI2VVcxWGFZTzJRV1FPbnBOS3pRcGxmVFVN?oc=5,Google News,Biocon stock price,"Biocon's Stock Rebounds Amidst Broader Market Optimism and Small-Cap Gains - MarketsMojo <a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxOdG1XN3J2Y0V6dFg2aFlDanhCSkJvWlBoUVlsOHhpOFhQQ1JpeGxmM1Y4NFRzRUJqYmxaYXpjcTNjQkNvZk4xLTlRSFItdkxUZ1o5NWtKcmYzUWJqcVZzTElUQkxsUU5BS0IzclA1QV9IX0xfN292UnNHOXFGa0dHdGYwUXk3Ymc5VVdNd3pSWHF2Z195SWdJaTZhb1FiSGlRYmwzS1E4Nk5ncDdHZHI2VVcxWGFZTzJRV1FPbnBOS3pRcGxmVFVN?oc=5"" target=""_blank"">Biocon's Stock Rebounds Amidst Broader Market Optimism and Small-Cap Gains</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",-0.9327318668365479,negative,0.9327318668365479,0.0,neutral,0.0,0.8555,0.309,0.0,0.691,0.0,0.0,-0.532989638192313,0.894115933418274,other,0.0,[],False,True,6,0.0
2025-05-15,2025-05-15 07:00:00,"Investec sets Biocon stock Buy rating, INR400 target By Investing.com - Investing.com","<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxQeC1nM0E1aWVqdmNRX1dybWE0cFU3M1ozMVRGV1hzYl9iT1djWnNvT3RjVmVVaEtjcHRIZGVPZWpubU5kLWlQdzJOV3FtQXloTUhPcjM1anpvek1hYUQ2ZmQyZHdCNlhqUjkwN29JV2RRenpYTWk3NFhmS0ZHRzNlVmVyb19jV0hhOFM5dXZQVnNVMkpLNkQ0TVZ6R0d6aXpwNnl4cUhkQVFBbC1QV0JMeA?oc=5"" target=""_blank"">Investec sets Biocon stock Buy rating, INR400 target By Investing.com</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxQeC1nM0E1aWVqdmNRX1dybWE0cFU3M1ozMVRGV1hzYl9iT1djWnNvT3RjVmVVaEtjcHRIZGVPZWpubU5kLWlQdzJOV3FtQXloTUhPcjM1anpvek1hYUQ2ZmQyZHdCNlhqUjkwN29JV2RRenpYTWk3NFhmS0ZHRzNlVmVyb19jV0hhOFM5dXZQVnNVMkpLNkQ0TVZ6R0d6aXpwNnl4cUhkQVFBbC1QV0JMeA?oc=5,Google News,Biocon stock price,"Investec sets Biocon stock Buy rating, INR400 target By Investing.com - Investing.com <a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxQeC1nM0E1aWVqdmNRX1dybWE0cFU3M1ozMVRGV1hzYl9iT1djWnNvT3RjVmVVaEtjcHRIZGVPZWpubU5kLWlQdzJOV3FtQXloTUhPcjM1anpvek1hYUQ2ZmQyZHdCNlhqUjkwN29JV2RRenpYTWk3NFhmS0ZHRzNlVmVyb19jV0hhOFM5dXZQVnNVMkpLNkQ0TVZ6R0d6aXpwNnl4cUhkQVFBbC1QV0JMeA?oc=5"" target=""_blank"">Investec sets Biocon stock Buy rating, INR400 target By Investing.com</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com</font>",0.0,neutral,0.8806012868881226,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8806012868881226,other,0.0,[],False,True,6,0.0
2025-02-25,2025-02-25 08:00:00,Biocon share price up 2% as arm launches Yesintek in US; check details here - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price up 2% as arm launches Yesintek in US; check details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon share price up 2% as arm launches Yesintek in US; check details here - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price up 2% as arm launches Yesintek in US; check details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9087669849395752,positive,0.9087669849395752,0.0,neutral,0.0,0.5267,0.121,0.0,0.879,0.0,0.0,0.5192954199654715,0.7177334924697876,other,0.0,[],False,True,6,0.0
2024-11-11,2024-11-11 08:00:00,Biocon shares surge 5% after USFDA classifies Bengaluru site as VAI - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge 5% after USFDA classifies Bengaluru site as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares surge 5% after USFDA classifies Bengaluru site as VAI - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge 5% after USFDA classifies Bengaluru site as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.9035207033157349,positive,0.9035207033157349,0.0,neutral,0.0,0.5267,0.136,0.0,0.864,0.13333333333333333,0.13333333333333333,0.5162975447518485,0.5211846788830227,other,0.0,[],False,True,6,0.0
2025-06-10,2025-06-10 07:00:00,Biocon Faces Mixed Technical Signals Amidst Market Performance Challenges - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxQUWpVOUZkZGZHMW5nSTZPXzBSc2RyTEdFXzJGb19hdURuWDFtYzVmclhWVnR2UDZWbGhMQ2UtbkluNUlxZkVTV2VQYkdocXpHWGI5OG1MUUY0cW13SVEwVlFSa3Z5N0Zwd1E5M3pEMTc1cnF4TV93cUg1LW83Ml9vNTlQcTQxVnhiZUctNy1NQkhqVzNxTWNqRHNUekM4UzFxRktXNDNEX25CRWp3Zngzd1hOM25HdE5MUUtPazNaVE5PTTJBRzZYVlA0M2dsQlNOX2Q0VFNXR3VqS2RuQ2Vj?oc=5"" target=""_blank"">Biocon Faces Mixed Technical Signals Amidst Market Performance Challenges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMi3wFBVV95cUxQUWpVOUZkZGZHMW5nSTZPXzBSc2RyTEdFXzJGb19hdURuWDFtYzVmclhWVnR2UDZWbGhMQ2UtbkluNUlxZkVTV2VQYkdocXpHWGI5OG1MUUY0cW13SVEwVlFSa3Z5N0Zwd1E5M3pEMTc1cnF4TV93cUg1LW83Ml9vNTlQcTQxVnhiZUctNy1NQkhqVzNxTWNqRHNUekM4UzFxRktXNDNEX25CRWp3Zngzd1hOM25HdE5MUUtPazNaVE5PTTJBRzZYVlA0M2dsQlNOX2Q0VFNXR3VqS2RuQ2Vj?oc=5,Google News,Biocon stock price,"Biocon Faces Mixed Technical Signals Amidst Market Performance Challenges - MarketsMojo <a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxQUWpVOUZkZGZHMW5nSTZPXzBSc2RyTEdFXzJGb19hdURuWDFtYzVmclhWVnR2UDZWbGhMQ2UtbkluNUlxZkVTV2VQYkdocXpHWGI5OG1MUUY0cW13SVEwVlFSa3Z5N0Zwd1E5M3pEMTc1cnF4TV93cUg1LW83Ml9vNTlQcTQxVnhiZUctNy1NQkhqVzNxTWNqRHNUekM4UzFxRktXNDNEX25CRWp3Zngzd1hOM25HdE5MUUtPazNaVE5PTTJBRzZYVlA0M2dsQlNOX2Q0VFNXR3VqS2RuQ2Vj?oc=5"" target=""_blank"">Biocon Faces Mixed Technical Signals Amidst Market Performance Challenges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",-0.9199788570404053,negative,0.9199788570404053,0.0,neutral,0.0,0.0772,0.058,0.0,0.942,0.0,0.13999999999999999,-0.5257022040230888,0.49858942852020266,other,0.0,[],False,True,6,0.0
2025-06-12,2025-06-12 07:00:00,"Stocks to buy today: Infosys, Biocon among top 7 trading ideas for 12 June 2025 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today: Infosys, Biocon among top 7 trading ideas for 12 June 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Stocks to buy today: Infosys, Biocon among top 7 trading ideas for 12 June 2025 - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today: Infosys, Biocon among top 7 trading ideas for 12 June 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.8923887014389038,0.0,neutral,0.0,0.3818,0.096,0.0,0.904,0.27999999999999997,0.27999999999999997,0.0,0.5180629004796345,other,0.0,[],False,True,6,0.0
2025-04-11,2025-04-11 07:00:00,Biocon shares jump 5.5% as USFDA clears biosimilar Cancer drug JOBEVNE - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares jump 5.5% as USFDA clears biosimilar Cancer drug JOBEVNE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares jump 5.5% as USFDA clears biosimilar Cancer drug JOBEVNE - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares jump 5.5% as USFDA clears biosimilar Cancer drug JOBEVNE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.5542201399803162,positive,0.5542201399803162,0.0,neutral,0.0,-0.7003,0.196,0.246,0.559,0.0,0.0,0.31669722284589497,0.627260069990158,other,0.0,[],False,True,6,0.0
2025-04-24,2025-04-24 07:00:00,"Biocon shares fall 3% after board approves fundraise of up to Rs 4,500 crore - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall 3% after board approves fundraise of up to Rs 4,500 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares fall 3% after board approves fundraise of up to Rs 4,500 crore - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall 3% after board approves fundraise of up to Rs 4,500 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",-0.9645834565162659,negative,0.9645834565162659,0.0,neutral,0.0,0.8316,0.234,0.0,0.766,0.13333333333333333,0.13333333333333333,-0.5511905465807233,0.6431722632831997,other,0.0,[],False,True,6,0.0
2025-02-25,2025-02-25 08:00:00,Biocon share price in focus after arm launches product in US for autoimmune diseases - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price in focus after arm launches product in US for autoimmune diseases</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon share price in focus after arm launches product in US for autoimmune diseases - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price in focus after arm launches product in US for autoimmune diseases</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.5252272486686707,0.0,neutral,0.0,0.5267,0.128,0.0,0.872,0.0,0.0,0.0,0.5259636243343353,other,0.0,[],False,True,6,0.0
2025-06-16,2025-06-16 07:00:00,Stocks to buy for short term: From Swiggy to Biocon— Jigar Patel of Anand Rathi suggests 3 stock picks - Mint,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Stocks to buy for short term: From Swiggy to Biocon— Jigar Patel of Anand Rathi suggests 3 stock picks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News,Biocon stock price,"Stocks to buy for short term: From Swiggy to Biocon— Jigar Patel of Anand Rathi suggests 3 stock picks - Mint <a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Stocks to buy for short term: From Swiggy to Biocon— Jigar Patel of Anand Rathi suggests 3 stock picks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.8635397553443909,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.19999999999999998,0.0,0.8635397553443909,other,0.0,[],False,True,6,0.0
2025-06-17,2025-06-17 07:00:00,"Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxPWWp6Y2YyUk1veTVrdjZlN291T193LXBPNlBfNnRORGllZEZoNDdrY2xhUmpmTi1Bc1lvVWRtT1BpR1U2Z01kOVJadFhTaVpONUk1WFRkNWZFbnhpNGRzbHY4UUNqMnFHeFJvR0YwVFJQUEwxMk84RDRYSkdWSWZ5LUoxZUxIc3dJeF9DdUE4VVIzdzh0V3lsMlhkcTV5ajlBRzdHYVJ4UUlNdXBQQWlRUlZ30gG3AUFVX3lxTE5NdS1VQTRfOS1xQ0Y4QnprTVM3ODZnaVpzWFEydkRzMXRkeHhVRXJlUDZOMVNSWnVocUt5Q1dRUWhKN2x0ajVmWW5aR0ZQTGlyRG5WdUJOR0dCSGFqQ2hBZ2gzcXY5dlZjLUVlNV9jRXpsc3piM0k4cC1FUlRXd245UFRlcHhRdFByd2dQRVJQS1p6d3kzUmFBcG1LaDhXWllLNklrYlBadERSc1YtX1pyQlg1TENfUQ?oc=5"" target=""_blank"">Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxPWWp6Y2YyUk1veTVrdjZlN291T193LXBPNlBfNnRORGllZEZoNDdrY2xhUmpmTi1Bc1lvVWRtT1BpR1U2Z01kOVJadFhTaVpONUk1WFRkNWZFbnhpNGRzbHY4UUNqMnFHeFJvR0YwVFJQUEwxMk84RDRYSkdWSWZ5LUoxZUxIc3dJeF9DdUE4VVIzdzh0V3lsMlhkcTV5ajlBRzdHYVJ4UUlNdXBQQWlRUlZ30gG3AUFVX3lxTE5NdS1VQTRfOS1xQ0Y4QnprTVM3ODZnaVpzWFEydkRzMXRkeHhVRXJlUDZOMVNSWnVocUt5Q1dRUWhKN2x0ajVmWW5aR0ZQTGlyRG5WdUJOR0dCSGFqQ2hBZ2gzcXY5dlZjLUVlNV9jRXpsc3piM0k4cC1FUlRXd245UFRlcHhRdFByd2dQRVJQS1p6d3kzUmFBcG1LaDhXWllLNklrYlBadERSc1YtX1pyQlg1TENfUQ?oc=5,Google News,Biocon stock price,"Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP - NDTV Profit <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",0.9092977046966553,positive,0.9092977046966553,0.0,neutral,0.0,0.743,0.201,0.0,0.799,0.16666666666666666,0.3333333333333333,0.5195986883980888,0.6063214571211073,other,0.0,[],False,True,6,0.0
2025-01-14,2025-01-14 08:00:00,"Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.9027345776557922,positive,0.9027345776557922,0.0,neutral,0.0,0.5267,0.128,0.0,0.872,0.0,0.0,0.5158483300890241,0.7147172888278961,other,0.0,[],False,True,6,0.0
2025-03-05,2025-03-05 08:00:00,Here's why Biocon share price popped 3% in trade on March 5; details here - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Here's why Biocon share price popped 3% in trade on March 5; details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Here's why Biocon share price popped 3% in trade on March 5; details here - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Here's why Biocon share price popped 3% in trade on March 5; details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.8404282927513123,0.0,neutral,0.0,0.5267,0.121,0.0,0.879,0.0,0.0,0.0,0.6835641463756561,other,0.0,[],False,True,6,0.0
2025-05-21,2025-05-21 07:00:00,Biocon shares gain 2% as Japan partner launches Ustekinumab biosimilar - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 2% as Japan partner launches Ustekinumab biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares gain 2% as Japan partner launches Ustekinumab biosimilar - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 2% as Japan partner launches Ustekinumab biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8136581182479858,positive,0.8136581182479858,0.0,neutral,0.0,0.8807,0.337,0.0,0.663,0.0,0.0,0.46494749614170616,0.8471790591239929,other,0.0,[],False,True,6,0.0
2025-06-17,2025-06-17 05:24:32,"Biocon share price rises over 1% after Rs 4,500 crore QIP - Value Research","<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOemw3S0k5bllxWnRxZFJNblRwSTduRzhJQmo2ZzlLbWNUQ1JvYjNGWV9QR1dzX2wzQ1NnMmRFNzhLckNncGEtU1ZCbEFkOE53M0ZzQ1pwQXo5ZXlXV0FPOWEtcE1DS0I1Q1daQVVGSTdoREJ0c3JzLUVHd0duQl9QUHk4UXpnSDV2WHJBeUdBMjE5LUQwN09zbjBLXzhiSHpaemJIeA?oc=5"" target=""_blank"">Biocon share price rises over 1% after Rs 4,500 crore QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Value Research</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOemw3S0k5bllxWnRxZFJNblRwSTduRzhJQmo2ZzlLbWNUQ1JvYjNGWV9QR1dzX2wzQ1NnMmRFNzhLckNncGEtU1ZCbEFkOE53M0ZzQ1pwQXo5ZXlXV0FPOWEtcE1DS0I1Q1daQVVGSTdoREJ0c3JzLUVHd0duQl9QUHk4UXpnSDV2WHJBeUdBMjE5LUQwN09zbjBLXzhiSHpaemJIeA?oc=5,Google News,Biocon stock price,"Biocon share price rises over 1% after Rs 4,500 crore QIP - Value Research <a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOemw3S0k5bllxWnRxZFJNblRwSTduRzhJQmo2ZzlLbWNUQ1JvYjNGWV9QR1dzX2wzQ1NnMmRFNzhLckNncGEtU1ZCbEFkOE53M0ZzQ1pwQXo5ZXlXV0FPOWEtcE1DS0I1Q1daQVVGSTdoREJ0c3JzLUVHd0duQl9QUHk4UXpnSDV2WHJBeUdBMjE5LUQwN09zbjBLXzhiSHpaemJIeA?oc=5"" target=""_blank"">Biocon share price rises over 1% after Rs 4,500 crore QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Value Research</font>",0.9250399470329285,positive,0.9250399470329285,0.0,neutral,0.0,0.7003,0.214,0.0,0.786,0.0,0.0,0.5285942554473877,0.8126699735164642,other,0.0,[],False,True,6,0.0
2025-05-14,2025-05-14 07:00:00,Biocon Shares Experience Price Rise of 2.11% During Today's Session - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Experience Price Rise of 2.11% During Today's Session</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon Shares Experience Price Rise of 2.11% During Today's Session - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Experience Price Rise of 2.11% During Today's Session</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.9326944351196289,positive,0.9326944351196289,0.0,neutral,0.0,0.5267,0.167,0.0,0.833,0.0,0.0,0.532968248639788,0.7296972175598144,other,0.0,[],False,True,6,0.0
2025-06-20,2025-06-20 04:30:31,"Biocon announces closure of QIP, check details - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon announces closure of QIP, check details</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon announces closure of QIP, check details - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon announces closure of QIP, check details</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",-0.5311577916145325,negative,0.5311577916145325,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.3035187380654471,0.5311577916145325,other,0.0,[],False,True,6,0.0
2025-05-21,2025-05-21 07:00:00,Biocon shares rise after subsidiary launches psoriasis treatment drug in Japan - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares rise after subsidiary launches psoriasis treatment drug in Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares rise after subsidiary launches psoriasis treatment drug in Japan - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares rise after subsidiary launches psoriasis treatment drug in Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.6503245830535889,positive,0.6503245830535889,0.0,neutral,0.0,0.5267,0.145,0.0,0.855,0.0,0.0,0.37161404745919363,0.5885122915267944,other,0.0,[],False,True,6,0.0
2025-04-11,2025-04-11 07:00:00,Biocon share price rises 4% on US FDA approval for cancer drug - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price rises 4% on US FDA approval for cancer drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon share price rises 4% on US FDA approval for cancer drug - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price rises 4% on US FDA approval for cancer drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.8850592970848083,positive,0.8850592970848083,0.0,neutral,0.0,-0.0516,0.256,0.213,0.531,0.0,0.0,0.5057481697627476,0.46832964854240416,approval_process,0.7613287568092346,['FDA approval'],False,True,16,0.5226575136184692
2025-04-28,2025-04-28 07:00:00,Biocon shares up 2% on positive opinions for biosimilar Denosumab in Europe - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares up 2% on positive opinions for biosimilar Denosumab in Europe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares up 2% on positive opinions for biosimilar Denosumab in Europe - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares up 2% on positive opinions for biosimilar Denosumab in Europe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.9478201270103455,positive,0.9478201270103455,0.0,neutral,0.0,0.891,0.326,0.0,0.674,0.15151515151515152,0.3636363636363636,0.5416115011487688,0.6634450928418324,other,0.0,[],False,True,6,0.0
2024-11-11,2024-11-11 08:00:00,Biocon share jumps 6% on USFDA's 'VAI' tag to Bengaluru facility; details - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share jumps 6% on USFDA's 'VAI' tag to Bengaluru facility; details</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon share jumps 6% on USFDA's 'VAI' tag to Bengaluru facility; details - Business Standard <a href=""https://news.google.com/rss/articles/CBMi0gFBVV95cUxOS1M2TzI0OU5TemlSci1TOXg2dGdnREk5cVhCbDNCcWtZVjNKSzFxeGw1VlJzbzF4cFNfVl9UNHh4dU5lUWt5bEwwSTJmV1l6RGp1SlE2TjJ5dmJVWV9TRktoLWpsdkF3LTd3NklFZlpNWW16ZXZTRE9QaEpzMk9OOUFLMUU2a01XcUVVTG5xeTFXSEpGYkRBU0Zoa1NqVExGZ18wcEVwc09HSG1xUE00SXhWYVh4X0I5M3RDNkZ3S1B3S2syWFRqUkV3OHNST1JqaWfSAdcBQVVfeXFMTjBkZTJUdlp6Nk51MXN2WHBOQVJRZXVPYjQ4emotdnNETV9QSnAtZlJQV0RFWDhSSWpkWWVUODVFakY5WkpvM1pMU29OU1M5V05UNTJyLTBGTThMUEphQWEyYlJyamphTGZXcmg5SW9hRTYyN0pDVklUN3BaU2NWYVBCYmdfdEZJc0t4TXJ0T191TENnS1FacVlyTFpISFg2Q2NXTnMxVEo0ME1xdU04WFM2Njl0NFduRjVKQzZxaEV2a2dnYzk4aTdCblVsM0pNVGJuaXhodlU?oc=5"" target=""_blank"">Biocon share jumps 6% on USFDA's 'VAI' tag to Bengaluru facility; details</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.878071129322052,positive,0.878071129322052,0.0,neutral,0.0,0.5267,0.136,0.0,0.864,0.0,0.0,0.5017549310411725,0.702385564661026,other,0.0,[],False,True,6,0.0
2025-05-26,2025-05-26 07:00:00,Biocon share rises as arm secures UK MHRA nod for plaque psoriasis drug - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share rises as arm secures UK MHRA nod for plaque psoriasis drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon share rises as arm secures UK MHRA nod for plaque psoriasis drug - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share rises as arm secures UK MHRA nod for plaque psoriasis drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9207571744918823,positive,0.9207571744918823,0.0,neutral,0.0,0.7906,0.243,0.0,0.757,0.0,0.0,0.5261469568525042,0.8556785872459411,other,0.0,[],False,True,6,0.0
2025-03-24,2025-03-24 07:00:00,Biocon gains 2% on US FDA nod for ANDA Norepinephrine Bitartrate Injection - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gains 2% on US FDA nod for ANDA Norepinephrine Bitartrate Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon gains 2% on US FDA nod for ANDA Norepinephrine Bitartrate Injection - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gains 2% on US FDA nod for ANDA Norepinephrine Bitartrate Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.919821560382843,positive,0.919821560382843,0.0,neutral,0.0,0.5859,0.146,0.0,0.854,0.0,0.0,0.5256123202187674,0.7528607801914216,other,0.0,[],False,True,6,0.0
2025-06-20,2025-06-20 16:54:29,"Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP - MSN","<a href=""https://news.google.com/rss/articles/CBMiygFBVV95cUxPNi01NUJpdi1lRUtqYjh1aG1EdWxpeUpwZXFIT196ZWtrZWNzbU1yaDJDYWcxMVNvR3pwZ1V4OWlLaGZuY3BHUWtOYXdSUzJHb3ZwczUxNFc1RUJtSVlzZ0VXYVd6MUhaZVl5bEdGcTZMdXBYUXBJWEdFMVZsNTVpZnNwSXIzN2xxQkVIRXFsbktleGUzaHV4NGJEOThyZF9EbjFOUjdPYU1KeUZwcUprWmxGRER2dFhzMW9KeEl3ZTZRYm5KUVZGRFRB?oc=5"" target=""_blank"">Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.com/rss/articles/CBMiygFBVV95cUxPNi01NUJpdi1lRUtqYjh1aG1EdWxpeUpwZXFIT196ZWtrZWNzbU1yaDJDYWcxMVNvR3pwZ1V4OWlLaGZuY3BHUWtOYXdSUzJHb3ZwczUxNFc1RUJtSVlzZ0VXYVd6MUhaZVl5bEdGcTZMdXBYUXBJWEdFMVZsNTVpZnNwSXIzN2xxQkVIRXFsbktleGUzaHV4NGJEOThyZF9EbjFOUjdPYU1KeUZwcUprWmxGRER2dFhzMW9KeEl3ZTZRYm5KUVZGRFRB?oc=5,Google News,Biocon stock price,"Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP - MSN <a href=""https://news.google.com/rss/articles/CBMiygFBVV95cUxPNi01NUJpdi1lRUtqYjh1aG1EdWxpeUpwZXFIT196ZWtrZWNzbU1yaDJDYWcxMVNvR3pwZ1V4OWlLaGZuY3BHUWtOYXdSUzJHb3ZwczUxNFc1RUJtSVlzZ0VXYVd6MUhaZVl5bEdGcTZMdXBYUXBJWEdFMVZsNTVpZnNwSXIzN2xxQkVIRXFsbktleGUzaHV4NGJEOThyZF9EbjFOUjdPYU1KeUZwcUprWmxGRER2dFhzMW9KeEl3ZTZRYm5KUVZGRFRB?oc=5"" target=""_blank"">Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",0.9440678358078003,positive,0.9440678358078003,0.0,neutral,0.0,0.5267,0.136,0.0,0.864,0.16666666666666666,0.3333333333333333,0.5394673347473145,0.5458115008248223,other,0.0,[],False,True,6,0.0
2025-06-16,2025-06-16 07:00:00,Biocon shares in focus after launching QIP at floor price of Rs 340.20 - MSN,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOSGNtd3JhVm9lT19QWnJIVVBHLTlJeE9JZGdlR0lTdTRhWGZmVGVUQXZWdFo1VFZZUzdZVEFjNWJpRlNyenh4WXQtRXR1RUI4RkI0WlNKTFlfdnRjN2toVV9VWnJXV0dyM1h4NjZyMklZUjYxZkJMSC1iYjVKQ1hKQk9jNGZ3SFhPaFQ4Q2RwVWtBR2R2Q2xMX0NxemEtQ3BaakVzUzR1dElkQ0ZDUjBkUG9zdGViWVdRa2lmWnNR?oc=5"" target=""_blank"">Biocon shares in focus after launching QIP at floor price of Rs 340.20</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOSGNtd3JhVm9lT19QWnJIVVBHLTlJeE9JZGdlR0lTdTRhWGZmVGVUQXZWdFo1VFZZUzdZVEFjNWJpRlNyenh4WXQtRXR1RUI4RkI0WlNKTFlfdnRjN2toVV9VWnJXV0dyM1h4NjZyMklZUjYxZkJMSC1iYjVKQ1hKQk9jNGZ3SFhPaFQ4Q2RwVWtBR2R2Q2xMX0NxemEtQ3BaakVzUzR1dElkQ0ZDUjBkUG9zdGViWVdRa2lmWnNR?oc=5,Google News,Biocon stock price,"Biocon shares in focus after launching QIP at floor price of Rs 340.20 - MSN <a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOSGNtd3JhVm9lT19QWnJIVVBHLTlJeE9JZGdlR0lTdTRhWGZmVGVUQXZWdFo1VFZZUzdZVEFjNWJpRlNyenh4WXQtRXR1RUI4RkI0WlNKTFlfdnRjN2toVV9VWnJXV0dyM1h4NjZyMklZUjYxZkJMSC1iYjVKQ1hKQk9jNGZ3SFhPaFQ4Q2RwVWtBR2R2Q2xMX0NxemEtQ3BaakVzUzR1dElkQ0ZDUjBkUG9zdGViWVdRa2lmWnNR?oc=5"" target=""_blank"">Biocon shares in focus after launching QIP at floor price of Rs 340.20</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",0.0,neutral,0.8257145285606384,0.0,neutral,0.0,0.5267,0.136,0.0,0.864,0.0,0.0,0.0,0.6762072642803192,other,0.0,[],False,True,6,0.0
2025-06-13,2025-06-13 07:00:00,"BIOCON Outlook for the Week (June 23, 2025 – June 27, 2025) - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE9KVkdnRUhKcHA0b200cHpzZmZIQWlVakxTWm9GZ2x5TVRqU25vb1ZTUkNRMkhpRWFCdG5UZlIxNkRmb0dxMXQ3M2F3eHU2SzZzRmZ5N0tkNmRjTTloOWdXUEx4X2ZiSzRw?oc=5"" target=""_blank"">BIOCON Outlook for the Week (June 23, 2025 – June 27, 2025)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE9KVkdnRUhKcHA0b200cHpzZmZIQWlVakxTWm9GZ2x5TVRqU25vb1ZTUkNRMkhpRWFCdG5UZlIxNkRmb0dxMXQ3M2F3eHU2SzZzRmZ5N0tkNmRjTTloOWdXUEx4X2ZiSzRw?oc=5,Google News,Biocon stock price,"BIOCON Outlook for the Week (June 23, 2025 – June 27, 2025) - Equitypandit <a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE9KVkdnRUhKcHA0b200cHpzZmZIQWlVakxTWm9GZ2x5TVRqU25vb1ZTUkNRMkhpRWFCdG5UZlIxNkRmb0dxMXQ3M2F3eHU2SzZzRmZ5N0tkNmRjTTloOWdXUEx4X2ZiSzRw?oc=5"" target=""_blank"">BIOCON Outlook for the Week (June 23, 2025 – June 27, 2025)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.0,neutral,0.9065974950790405,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9065974950790405,other,0.0,[],False,True,6,0.0
2025-01-14,2025-01-14 08:00:00,Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.8506956100463867,0.0,neutral,0.0,0.5267,0.115,0.0,0.885,0.10400000000000001,0.376,0.0,0.4937985366821289,other,0.0,[],False,True,6,0.0
2025-06-12,2025-06-12 07:00:00,Biocon - Positive Breakout: These 6 stocks close cross above their 200 DMA - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxQYUdTQmNzOEtCWUdZNnhHNW5zcThvajUweDV4eXZxNlJxdm9udUFoUEVPWmt1RkpkMEhPMW5ISVNHbEVwTl9DVk02bGhtcTNwTXQwMWZYaW5lSm5Ga3lfYnNrajdjcUxiazBRbzh6ZVVuS2dXcXB1X2FMUWFwQ3lZbnBTaDRoQ3RPZlRNZ0hUUDlBM1lnWmNlelNrc1pwTjdVSjgtWkdpWVFzanlhUzdhSmtneXhOQ0JMbE5fZkhPS1pBREZBRFRlQVdITU9MQllVYm85SFZueTB6Sm8?oc=5"" target=""_blank"">Biocon - Positive Breakout: These 6 stocks close cross above their 200 DMA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi2wFBVV95cUxQYUdTQmNzOEtCWUdZNnhHNW5zcThvajUweDV4eXZxNlJxdm9udUFoUEVPWmt1RkpkMEhPMW5ISVNHbEVwTl9DVk02bGhtcTNwTXQwMWZYaW5lSm5Ga3lfYnNrajdjcUxiazBRbzh6ZVVuS2dXcXB1X2FMUWFwQ3lZbnBTaDRoQ3RPZlRNZ0hUUDlBM1lnWmNlelNrc1pwTjdVSjgtWkdpWVFzanlhUzdhSmtneXhOQ0JMbE5fZkhPS1pBREZBRFRlQVdITU9MQllVYm85SFZueTB6Sm8?oc=5,Google News,Biocon stock price,"Biocon - Positive Breakout: These 6 stocks close cross above their 200 DMA - The Economic Times <a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxQYUdTQmNzOEtCWUdZNnhHNW5zcThvajUweDV4eXZxNlJxdm9udUFoUEVPWmt1RkpkMEhPMW5ISVNHbEVwTl9DVk02bGhtcTNwTXQwMWZYaW5lSm5Ga3lfYnNrajdjcUxiazBRbzh6ZVVuS2dXcXB1X2FMUWFwQ3lZbnBTaDRoQ3RPZlRNZ0hUUDlBM1lnWmNlelNrc1pwTjdVSjgtWkdpWVFzanlhUzdhSmtneXhOQ0JMbE5fZkhPS1pBREZBRFRlQVdITU9MQllVYm85SFZueTB6Sm8?oc=5"" target=""_blank"">Biocon - Positive Breakout: These 6 stocks close cross above their 200 DMA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.5748353004455566,positive,0.5748353004455566,0.0,neutral,0.0,0.802,0.205,0.0,0.795,0.09494949494949495,0.18787878787878787,0.3284773145403181,0.4905949317983505,other,0.0,[],False,True,6,0.0
2025-05-21,2025-05-21 07:00:00,Biocon shares zoom ~2% after drug launch in Japan - India Infoline,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxNSjZrRWU2MHpyLXcwWmp6MFpfei1UZ3NJaWE4Z0tQM1JZd21YTWlmUkViaEZIbjFFcUtxV2F5YnBYVW9JSmhJZ1B6dWZOYTBpdXlxclQ5S2xta0ZvWllhRVBuOVJrMWxSWFNDUlRCR2FVTUdqaE50S0JrRWxqbm9hYzFTT1BxU2N1a0huaEpTLWpDU19RVlQ4?oc=5"" target=""_blank"">Biocon shares zoom ~2% after drug launch in Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Infoline</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxNSjZrRWU2MHpyLXcwWmp6MFpfei1UZ3NJaWE4Z0tQM1JZd21YTWlmUkViaEZIbjFFcUtxV2F5YnBYVW9JSmhJZ1B6dWZOYTBpdXlxclQ5S2xta0ZvWllhRVBuOVJrMWxSWFNDUlRCR2FVTUdqaE50S0JrRWxqbm9hYzFTT1BxU2N1a0huaEpTLWpDU19RVlQ4?oc=5,Google News,Biocon stock price,"Biocon shares zoom ~2% after drug launch in Japan - India Infoline <a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxNSjZrRWU2MHpyLXcwWmp6MFpfei1UZ3NJaWE4Z0tQM1JZd21YTWlmUkViaEZIbjFFcUtxV2F5YnBYVW9JSmhJZ1B6dWZOYTBpdXlxclQ5S2xta0ZvWllhRVBuOVJrMWxSWFNDUlRCR2FVTUdqaE50S0JrRWxqbm9hYzFTT1BxU2N1a0huaEpTLWpDU19RVlQ4?oc=5"" target=""_blank"">Biocon shares zoom ~2% after drug launch in Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Infoline</font>",0.0,neutral,0.6404032707214355,0.0,neutral,0.0,0.5267,0.167,0.0,0.833,0.0,0.0,0.0,0.5835516353607177,other,0.0,[],False,True,6,0.0
2025-01-13,2025-01-13 08:00:00,Explained: Why Biocon share price climbed over 4% in early trade today - India Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon share price climbed over 4% in early trade today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Explained: Why Biocon share price climbed over 4% in early trade today - India Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon share price climbed over 4% in early trade today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",0.6546072959899902,positive,0.6546072959899902,0.0,neutral,0.0,0.5267,0.136,0.0,0.864,0.06666666666666667,0.19999999999999998,0.3740613119942801,0.4159913208855523,other,0.0,[],False,True,6,0.0
2025-06-03,2025-06-03 07:00:00,"Stocks to watch today: From Grasim Industries, HCL Tech to Biocon – Here are 7 stocks in focus today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxNOTB5SlVRM1RmUkVVQXRlSXpmSWdMY3ZXNmo3SW16ZDRKTTU2X2hVbER3TlFvb1RLNk5lQTlhWlNwVDExclIxS0cxbURtZlV0QlloRTNxX3hILU5uYW5ZS3YtMlZERGFxUlk5S0N1YTdoZjBnc1Q4YkNmYjVhbkRrQV9ldmlsSWFJdmFFeG5ITmc1cEFXdDNFSVc1OTFQa0dMb3RsOGVUUnAtcnp5a2lYRUZyZ2JoMk0zcUFLTlNndjRPTVJ5TjZNM0VObGZxZE16by1nTjNSNkx2QklHSEE?oc=5"" target=""_blank"">Stocks to watch today: From Grasim Industries, HCL Tech to Biocon – Here are 7 stocks in focus today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi3gFBVV95cUxNOTB5SlVRM1RmUkVVQXRlSXpmSWdMY3ZXNmo3SW16ZDRKTTU2X2hVbER3TlFvb1RLNk5lQTlhWlNwVDExclIxS0cxbURtZlV0QlloRTNxX3hILU5uYW5ZS3YtMlZERGFxUlk5S0N1YTdoZjBnc1Q4YkNmYjVhbkRrQV9ldmlsSWFJdmFFeG5ITmc1cEFXdDNFSVc1OTFQa0dMb3RsOGVUUnAtcnp5a2lYRUZyZ2JoMk0zcUFLTlNndjRPTVJ5TjZNM0VObGZxZE16by1nTjNSNkx2QklHSEE?oc=5,Google News,Biocon stock price,"Stocks to watch today: From Grasim Industries, HCL Tech to Biocon – Here are 7 stocks in focus today - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxNOTB5SlVRM1RmUkVVQXRlSXpmSWdMY3ZXNmo3SW16ZDRKTTU2X2hVbER3TlFvb1RLNk5lQTlhWlNwVDExclIxS0cxbURtZlV0QlloRTNxX3hILU5uYW5ZS3YtMlZERGFxUlk5S0N1YTdoZjBnc1Q4YkNmYjVhbkRrQV9ldmlsSWFJdmFFeG5ITmc1cEFXdDNFSVc1OTFQa0dMb3RsOGVUUnAtcnp5a2lYRUZyZ2JoMk0zcUFLTlNndjRPTVJ5TjZNM0VObGZxZE16by1nTjNSNkx2QklHSEE?oc=5"" target=""_blank"">Stocks to watch today: From Grasim Industries, HCL Tech to Biocon – Here are 7 stocks in focus today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9376335740089417,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9376335740089417,other,0.0,[],False,True,6,0.0
2025-06-12,2025-06-12 07:00:00,Stock to buy today: Biocon (₹354.30) – BUY - BusinessLine,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock to buy today: Biocon (₹354.30) – BUY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Stock to buy today: Biocon (₹354.30) – BUY - BusinessLine <a href=""https://news.google.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?oc=5"" target=""_blank"">Stock to buy today: Biocon (₹354.30) – BUY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",0.0,neutral,0.9162241816520691,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9162241816520691,other,0.0,[],False,True,6,0.0
2025-01-07,2025-01-07 08:00:00,Biocon share rises 4% as arm gets Japan's PMDA approval for Psoriasis drug - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share rises 4% as arm gets Japan's PMDA approval for Psoriasis drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon share rises 4% as arm gets Japan's PMDA approval for Psoriasis drug - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share rises 4% as arm gets Japan's PMDA approval for Psoriasis drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9281152486801147,positive,0.9281152486801147,0.0,neutral,0.0,0.8625,0.275,0.0,0.725,0.0,0.0,0.5303515706743512,0.8953076243400574,other,0.0,[],False,True,6,0.0
2025-03-05,2025-03-05 08:00:00,"Stocks to buy today: Biocon, PFC among top 9 trading ideas for 5 March 2025 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today: Biocon, PFC among top 9 trading ideas for 5 March 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Stocks to buy today: Biocon, PFC among top 9 trading ideas for 5 March 2025 - The Economic Times <a href=""https://news.google.com/rss/articles/CBMi4AFBVV95cUxOcFRYMzBzWUp6OWJQOHRkZVRzRTg4OGxPUUt1VXJRSGhNVG5yRlREcWZIT3ZUWXJLZzBreklpckNCQXdDaDFqYWRBTnluQkhDNDNidXJnaGhjWDhQVUZobWpnNHpRc0VwTWlGYkNERmd1NHVyWE9Tc0NMTzh1b0pQaDE5aENJY3hOOEtPd3diSWZnQVl5YWVYQURvVVM2V3Fia1RlOXAyNDVpb3BFTDNwNjdmZkhqQjdxT25lN3ptOGtXbS1hclg3NXlpb1BJRzZWcTN2MTJXY0FfQi13TTVVZ9IB5gFBVV95cUxQS2E2YUt0RG05RzBQYmRJdkZ0elBpbU4tUTFhMVRVN2dqcm8ybE5TX1pRSlA3T0ZIbm5WZHVuUjdIMDFZZFV3OWxBWlk2MjNXN0VpN3pSZklxU1NweTJpZmZjZXhQXzBmc0gxa0h3cmpPVGJVd0t6eVdlR1Y2ZUhiUTI4TG92cGZJUTlNYTEtZWlqbVBpRkFxRXNOM0hpTEhGVEwtSVdvSU5mVWVOWVZzUXF4eFNvMmFhX3lnUm44MmhtS3M4cHZoZkg2cWJGckhhUVM3OE9BTFhDeGZ4MGxaWk0yeDVsZw?oc=5"" target=""_blank"">Stocks to buy today: Biocon, PFC among top 9 trading ideas for 5 March 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.8756627440452576,0.0,neutral,0.0,0.3818,0.101,0.0,0.899,0.27999999999999997,0.27999999999999997,0.0,0.5124875813484192,other,0.0,[],False,True,6,0.0
2024-12-02,2024-12-02 08:00:00,Biocon rises 3% after its arm gets US FDA nod for psoriasis drug YESINTEK - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon rises 3% after its arm gets US FDA nod for psoriasis drug YESINTEK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon rises 3% after its arm gets US FDA nod for psoriasis drug YESINTEK - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon rises 3% after its arm gets US FDA nod for psoriasis drug YESINTEK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9008393883705139,positive,0.9008393883705139,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5147653647831508,0.9008393883705139,other,0.0,[],False,True,6,0.0
2025-04-07,2025-04-07 05:06:39,Biocon Faces Increased Volatility Amid Broader Pharmaceuticals Sector Decline - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxOcXFqX0swdFhkdF9WWFY5OWM1M1cyUEptNEdPYmpvN1JMUy14TlBIRGdxNGN5SWwxamNGNEtPc3A0b0NaS2duZXpFNi1hTXJlNktqdHRQaXZyRXhmcUthdDBZUDBnWDNOeXQ1YTA2aGZFUU1pTGc4WGtzYjdiRlB6SmNQRlRYcEdTbDNiYmZjX0VPclpKREQ0YXN4WlJmVTZWbFRYTlVoZ2w3Q0hsNjJqV0Fma3pyd3RYN256bXdsUS03anpHSWxoZ0FnbkhiZw?oc=5"" target=""_blank"">Biocon Faces Increased Volatility Amid Broader Pharmaceuticals Sector Decline</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxOcXFqX0swdFhkdF9WWFY5OWM1M1cyUEptNEdPYmpvN1JMUy14TlBIRGdxNGN5SWwxamNGNEtPc3A0b0NaS2duZXpFNi1hTXJlNktqdHRQaXZyRXhmcUthdDBZUDBnWDNOeXQ1YTA2aGZFUU1pTGc4WGtzYjdiRlB6SmNQRlRYcEdTbDNiYmZjX0VPclpKREQ0YXN4WlJmVTZWbFRYTlVoZ2w3Q0hsNjJqV0Fma3pyd3RYN256bXdsUS03anpHSWxoZ0FnbkhiZw?oc=5,Google News,Biocon stock price,"Biocon Faces Increased Volatility Amid Broader Pharmaceuticals Sector Decline - MarketsMojo <a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxOcXFqX0swdFhkdF9WWFY5OWM1M1cyUEptNEdPYmpvN1JMUy14TlBIRGdxNGN5SWwxamNGNEtPc3A0b0NaS2duZXpFNi1hTXJlNktqdHRQaXZyRXhmcUthdDBZUDBnWDNOeXQ1YTA2aGZFUU1pTGc4WGtzYjdiRlB6SmNQRlRYcEdTbDNiYmZjX0VPclpKREQ0YXN4WlJmVTZWbFRYTlVoZ2w3Q0hsNjJqV0Fma3pyd3RYN256bXdsUS03anpHSWxoZ0FnbkhiZw?oc=5"" target=""_blank"">Biocon Faces Increased Volatility Amid Broader Pharmaceuticals Sector Decline</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",-0.963049590587616,negative,0.963049590587616,0.0,neutral,0.0,0.4939,0.174,0.0,0.826,0.0,0.0,-0.550314051764352,0.728474795293808,other,0.0,[],False,True,6,0.0
2025-01-14,2025-01-14 08:00:00,Explained: Why Biocon shares surged 7% today - India Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon shares surged 7% today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Explained: Why Biocon shares surged 7% today - India Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon shares surged 7% today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",0.7673279047012329,positive,0.7673279047012329,0.0,neutral,0.0,0.5267,0.196,0.0,0.804,0.0,0.0,0.43847308840070454,0.6470139523506164,other,0.0,[],False,True,6,0.0
2025-01-13,2025-01-13 08:00:00,Biocon shares surge over 4% after Malaysia unit gets clearance from the USFDA - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge over 4% after Malaysia unit gets clearance from the USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares surge over 4% after Malaysia unit gets clearance from the USFDA - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge over 4% after Malaysia unit gets clearance from the USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.9163140654563904,positive,0.9163140654563904,0.0,neutral,0.0,0.5267,0.121,0.0,0.879,0.13333333333333333,0.13333333333333333,0.5236080374036517,0.5254491329299079,other,0.0,[],False,True,6,0.0
2025-05-26,2025-05-26 07:00:00,Biocon Shares Gain 1% as Subsidiary Secures Approval from UK MHRA - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxOVlJZQ2Q4MXpNRkhId0ZHZzZpaTFXSkozWlBfLTRBTzRfZG9maGs2ckQ4eHVPZzQzUXFIOGh1QjFXQmpETFBnV1NEdlhmZXk2NEt4a2VaQkdMVWlHMkdMSklOLUxqTU9aTlN5ZHJFaEdVM1QtNUZCRElQZkU5Mm1fQngxRFZWWVRQanhSeGtIUV9SWWczbnA2R0ZB?oc=5"" target=""_blank"">Biocon Shares Gain 1% as Subsidiary Secures Approval from UK MHRA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxOVlJZQ2Q4MXpNRkhId0ZHZzZpaTFXSkozWlBfLTRBTzRfZG9maGs2ckQ4eHVPZzQzUXFIOGh1QjFXQmpETFBnV1NEdlhmZXk2NEt4a2VaQkdMVWlHMkdMSklOLUxqTU9aTlN5ZHJFaEdVM1QtNUZCRElQZkU5Mm1fQngxRFZWWVRQanhSeGtIUV9SWWczbnA2R0ZB?oc=5,Google News,Biocon stock price,"Biocon Shares Gain 1% as Subsidiary Secures Approval from UK MHRA - Equitypandit <a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxOVlJZQ2Q4MXpNRkhId0ZHZzZpaTFXSkozWlBfLTRBTzRfZG9maGs2ckQ4eHVPZzQzUXFIOGh1QjFXQmpETFBnV1NEdlhmZXk2NEt4a2VaQkdMVWlHMkdMSklOLUxqTU9aTlN5ZHJFaEdVM1QtNUZCRElQZkU5Mm1fQngxRFZWWVRQanhSeGtIUV9SWWczbnA2R0ZB?oc=5"" target=""_blank"">Biocon Shares Gain 1% as Subsidiary Secures Approval from UK MHRA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",0.9444044232368469,positive,0.9444044232368469,0.0,neutral,0.0,0.9638,0.55,0.0,0.45,0.0,0.0,0.5396596704210554,0.9541022116184235,other,0.0,[],False,True,6,0.0
2025-05-15,2025-05-15 07:00:00,"Investec sets Biocon stock Buy rating, INR400 target By Investing.com - Investing.com India","<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNRnJYNUVobDhfY2Jic3MzbWZ6MXJtTHhOME1TazN2bkFtc20zMTlzRng0STZCb3VTNUlzbXU0UEs1TE1GS2F4MjJ5clN1dWNNWEpDVXpNelZzR0wtdlFkTmVqb2NxaTBQLXRuaGFEb2EtYmF4amc0TG5abXVzc3IxWnlfanV2NnZVVFJZYkdBVjZKektUby1ZZjhJY19fVlJXSHNHMU9NMmhMQ210Q2lz?oc=5"" target=""_blank"">Investec sets Biocon stock Buy rating, INR400 target By Investing.com</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com India</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNRnJYNUVobDhfY2Jic3MzbWZ6MXJtTHhOME1TazN2bkFtc20zMTlzRng0STZCb3VTNUlzbXU0UEs1TE1GS2F4MjJ5clN1dWNNWEpDVXpNelZzR0wtdlFkTmVqb2NxaTBQLXRuaGFEb2EtYmF4amc0TG5abXVzc3IxWnlfanV2NnZVVFJZYkdBVjZKektUby1ZZjhJY19fVlJXSHNHMU9NMmhMQ210Q2lz?oc=5,Google News,Biocon stock price,"Investec sets Biocon stock Buy rating, INR400 target By Investing.com - Investing.com India <a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNRnJYNUVobDhfY2Jic3MzbWZ6MXJtTHhOME1TazN2bkFtc20zMTlzRng0STZCb3VTNUlzbXU0UEs1TE1GS2F4MjJ5clN1dWNNWEpDVXpNelZzR0wtdlFkTmVqb2NxaTBQLXRuaGFEb2EtYmF4amc0TG5abXVzc3IxWnlfanV2NnZVVFJZYkdBVjZKektUby1ZZjhJY19fVlJXSHNHMU9NMmhMQ210Q2lz?oc=5"" target=""_blank"">Investec sets Biocon stock Buy rating, INR400 target By Investing.com</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com India</font>",0.0,neutral,0.8728985786437988,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8728985786437988,other,0.0,[],False,True,6,0.0
2025-05-12,2025-05-12 07:00:00,Biocon Share Price Today Down 3% - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxOVXYtRlp6WUhDSy1wdTFhZW5hWGZxZlJDSXlLZjlIbFNkSjNnRGM0YUtJTnk3ODZTY2MtQWlDODZQdkZySE5fRmg3NXNQTU5aNEZGUW5GZGNvVVhFSVRFeS1IV3YydklycEhWOUpyUWQ2d1dyQ0V2dm8yalpOZlRMQVRPc1NiYzlIZUJWazNfOEo1WHBU?oc=5"" target=""_blank"">Biocon Share Price Today Down 3%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxOVXYtRlp6WUhDSy1wdTFhZW5hWGZxZlJDSXlLZjlIbFNkSjNnRGM0YUtJTnk3ODZTY2MtQWlDODZQdkZySE5fRmg3NXNQTU5aNEZGUW5GZGNvVVhFSVRFeS1IV3YydklycEhWOUpyUWQ2d1dyQ0V2dm8yalpOZlRMQVRPc1NiYzlIZUJWazNfOEo1WHBU?oc=5,Google News,Biocon stock price,"Biocon Share Price Today Down 3% - Equitymaster <a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxOVXYtRlp6WUhDSy1wdTFhZW5hWGZxZlJDSXlLZjlIbFNkSjNnRGM0YUtJTnk3ODZTY2MtQWlDODZQdkZySE5fRmg3NXNQTU5aNEZGUW5GZGNvVVhFSVRFeS1IV3YydklycEhWOUpyUWQ2d1dyQ0V2dm8yalpOZlRMQVRPc1NiYzlIZUJWazNfOEo1WHBU?oc=5"" target=""_blank"">Biocon Share Price Today Down 3%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",-0.9700602889060974,negative,0.9700602889060974,0.0,neutral,0.0,0.5267,0.239,0.0,0.761,-0.1037037037037037,0.19259259259259262,-0.5543201650891985,0.5334879975366004,other,0.0,[],False,True,6,0.0
2024-12-02,2024-12-02 08:00:00,Biocon shares rise 4% after US FDA approves Yesintek - Moneycontrol,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxPazJEQlYxR0ZERnNoS3JnbWtIMGg3QXQyMGZrMzY1Q09nRGhpRkxLM0phb2c0SGh3VGtBSzBTSnB1cUdxdmE0QzRPYnJGVmEzLW5MYmlpaUNXVHBKSWtKNm5rT2NVdmJqQThrUTM0TXRtQXMwR0l5UkNqS19SZ0M3b1R3c1JYRENEWEozMjhub2VnQWhwYUcxMndmalBaT2d2VTlCVHFycEFZa1JTTlhTVFQ4MjBfMk3SAbwBQVVfeXFMTmxSS3AtUllhaGZ1eS15Tkx2Q3hna3JxTFhENXZxMEd1dlpra205aUo4T3o0RW1GUFlMYnYwVGlMbmVpa2lnNEJWVE4xVGRodDkwTFY2aE9ockZQcHA1R1FaV0paQlBCWkZzdy1SR1dJRlZac0o1dTFkd2lRMXh6RGtNS0lqWDd1cUdWUmt4NG94MHlIUDNVRUFrMjZJZUJvWUFnZFVpc01VRngzUFdVR3JaUjUyM1ZmZGNHNjQ?oc=5"" target=""_blank"">Biocon shares rise 4% after US FDA approves Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares rise 4% after US FDA approves Yesintek - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares rise 4% after US FDA approves Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.8606922626495361,positive,0.8606922626495361,0.0,neutral,0.0,0.8316,0.353,0.0,0.647,0.0,0.0,0.49182415008544916,0.846146131324768,approval_process,0.7748345136642456,['FDA approval'],False,True,16,0.5496690273284912
2025-01-14,2025-01-14 08:00:00,"Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9104120135307312,positive,0.9104120135307312,0.0,neutral,0.0,0.25,0.091,0.0,0.909,0.0,0.0,0.520235436303275,0.5802060067653656,other,0.0,[],False,True,6,0.0
2025-04-30,2025-04-30 07:00:00,"Stocks to buy today: Havells, Biocon among top 6 trading ideas for 30 April 2025 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today: Havells, Biocon among top 6 trading ideas for 30 April 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Stocks to buy today: Havells, Biocon among top 6 trading ideas for 30 April 2025 - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today: Havells, Biocon among top 6 trading ideas for 30 April 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.8862742781639099,0.0,neutral,0.0,0.3818,0.096,0.0,0.904,0.27999999999999997,0.27999999999999997,0.0,0.51602475938797,other,0.0,[],False,True,6,0.0
2025-01-07,2025-01-07 08:00:00,Biocon Share Price Surges 7.22% to Rs 384.50 on BSE - Analytics Insight,"<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxPbE9hNG53M1BEU3JjajAyNlY4ZndMMjJBaFdLaThaRGFNazRWdTZkZTk5ZUU3SjJZempINEpyZ0hlMVJQenlHNTdCZjNGbFFRYk12bUNrMlFpamUwY1pCN3FVOUFZckxqejJZZXVtcDZKZ0ZEYVlPWk9mMHZNYm1JZzk0c29sSU1Bd0ExaWcyUjdiZ9IBnwFBVV95cUxQcnBNbG5hMU1Ua3RLSWtLb1RyYUdBV2ZTQ3g1Wnk2TVF5dkJNMjF1XzZSelJORHJmZXl2WlFNYm5naXBFR2sxeEFaUXEwaURuTXZLN2ZqT0ZwM0RfQTdUMFRJQWNTV3ozSkc3dmFESDlEQjJPRkhQQ0lpMmR4NjA5bV9xT3RZSENWdlQ2SG1tRXUtdW43VllPYlB1Z0JMaVU?oc=5"" target=""_blank"">Biocon Share Price Surges 7.22% to Rs 384.50 on BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Analytics Insight</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxPbE9hNG53M1BEU3JjajAyNlY4ZndMMjJBaFdLaThaRGFNazRWdTZkZTk5ZUU3SjJZempINEpyZ0hlMVJQenlHNTdCZjNGbFFRYk12bUNrMlFpamUwY1pCN3FVOUFZckxqejJZZXVtcDZKZ0ZEYVlPWk9mMHZNYm1JZzk0c29sSU1Bd0ExaWcyUjdiZ9IBnwFBVV95cUxQcnBNbG5hMU1Ua3RLSWtLb1RyYUdBV2ZTQ3g1Wnk2TVF5dkJNMjF1XzZSelJORHJmZXl2WlFNYm5naXBFR2sxeEFaUXEwaURuTXZLN2ZqT0ZwM0RfQTdUMFRJQWNTV3ozSkc3dmFESDlEQjJPRkhQQ0lpMmR4NjA5bV9xT3RZSENWdlQ2SG1tRXUtdW43VllPYlB1Z0JMaVU?oc=5,Google News,Biocon stock price,"Biocon Share Price Surges 7.22% to Rs 384.50 on BSE - Analytics Insight <a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxPbE9hNG53M1BEU3JjajAyNlY4ZndMMjJBaFdLaThaRGFNazRWdTZkZTk5ZUU3SjJZempINEpyZ0hlMVJQenlHNTdCZjNGbFFRYk12bUNrMlFpamUwY1pCN3FVOUFZckxqejJZZXVtcDZKZ0ZEYVlPWk9mMHZNYm1JZzk0c29sSU1Bd0ExaWcyUjdiZ9IBnwFBVV95cUxQcnBNbG5hMU1Ua3RLSWtLb1RyYUdBV2ZTQ3g1Wnk2TVF5dkJNMjF1XzZSelJORHJmZXl2WlFNYm5naXBFR2sxeEFaUXEwaURuTXZLN2ZqT0ZwM0RfQTdUMFRJQWNTV3ozSkc3dmFESDlEQjJPRkhQQ0lpMmR4NjA5bV9xT3RZSENWdlQ2SG1tRXUtdW43VllPYlB1Z0JMaVU?oc=5"" target=""_blank"">Biocon Share Price Surges 7.22% to Rs 384.50 on BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Analytics Insight</font>",0.894541323184967,positive,0.894541323184967,0.0,neutral,0.0,0.5267,0.155,0.0,0.845,0.0,0.0,0.5111664703914097,0.7106206615924835,other,0.0,[],False,True,6,0.0
2025-05-05,2025-05-05 07:00:00,Biocon Share Price Today Up 5% - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQQkYtelFiLXlMRUhBMjExZm83Ri1PajU0alZITjNpVkhHem1mMDkyWW1oRzB2RHMwNTU2Y0dSUGVQRUJtejlGTlZHX1NIeDBJWVBFSzR5eXFQVWxreHRKRE5ranNWekR1a20tQTFSWmNGSXVveTlkTER0Nms3cVFpaTluMWhMRWZsNUF6TkM0cUp5R0Js?oc=5"" target=""_blank"">Biocon Share Price Today Up 5%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQQkYtelFiLXlMRUhBMjExZm83Ri1PajU0alZITjNpVkhHem1mMDkyWW1oRzB2RHMwNTU2Y0dSUGVQRUJtejlGTlZHX1NIeDBJWVBFSzR5eXFQVWxreHRKRE5ranNWekR1a20tQTFSWmNGSXVveTlkTER0Nms3cVFpaTluMWhMRWZsNUF6TkM0cUp5R0Js?oc=5,Google News,Biocon stock price,"Biocon Share Price Today Up 5% - Equitymaster <a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQQkYtelFiLXlMRUhBMjExZm83Ri1PajU0alZITjNpVkhHem1mMDkyWW1oRzB2RHMwNTU2Y0dSUGVQRUJtejlGTlZHX1NIeDBJWVBFSzR5eXFQVWxreHRKRE5ranNWekR1a20tQTFSWmNGSXVveTlkTER0Nms3cVFpaTluMWhMRWZsNUF6TkM0cUp5R0Js?oc=5"" target=""_blank"">Biocon Share Price Today Up 5%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",0.9435640573501587,positive,0.9435640573501587,0.0,neutral,0.0,0.5267,0.239,0.0,0.761,0.0,0.0,0.5391794613429478,0.7351320286750793,other,0.0,[],False,True,6,0.0
2025-01-13,2025-01-13 08:00:00,Biocon shares gain 4% after USFDA gives VAI tag to its Malaysia unit - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 4% after USFDA gives VAI tag to its Malaysia unit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares gain 4% after USFDA gives VAI tag to its Malaysia unit - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 4% after USFDA gives VAI tag to its Malaysia unit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8671517372131348,positive,0.8671517372131348,0.0,neutral,0.0,0.8807,0.286,0.0,0.714,0.0,0.0,0.4955152784075056,0.8739258686065674,other,0.0,[],False,True,6,0.0
2025-04-09,2025-04-09 07:00:00,Biocon Share Price Today Down 4% - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxOZlY2TDFWWTVzd003alppX29xM2Vaall2SUhoOHRrN1hNd2tYRXhGeXdnRnN3UFN2WF9CNDBjZnJGRlFUQ1gtZ0pEeUN2OXY2SVdIdmxxby1PYmZHVGNNMzhiM3BrV2JCN3VvOTJUV2FvZmwycFlGNW45ZWNLRi0xOWoyRFc5a09PSGxXN3lXUEJPWW1U?oc=5"" target=""_blank"">Biocon Share Price Today Down 4%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxOZlY2TDFWWTVzd003alppX29xM2Vaall2SUhoOHRrN1hNd2tYRXhGeXdnRnN3UFN2WF9CNDBjZnJGRlFUQ1gtZ0pEeUN2OXY2SVdIdmxxby1PYmZHVGNNMzhiM3BrV2JCN3VvOTJUV2FvZmwycFlGNW45ZWNLRi0xOWoyRFc5a09PSGxXN3lXUEJPWW1U?oc=5,Google News,Biocon stock price,"Biocon Share Price Today Down 4% - Equitymaster <a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxOZlY2TDFWWTVzd003alppX29xM2Vaall2SUhoOHRrN1hNd2tYRXhGeXdnRnN3UFN2WF9CNDBjZnJGRlFUQ1gtZ0pEeUN2OXY2SVdIdmxxby1PYmZHVGNNMzhiM3BrV2JCN3VvOTJUV2FvZmwycFlGNW45ZWNLRi0xOWoyRFc5a09PSGxXN3lXUEJPWW1U?oc=5"" target=""_blank"">Biocon Share Price Today Down 4%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",-0.9701206684112549,negative,0.9701206684112549,0.0,neutral,0.0,0.5267,0.239,0.0,0.761,-0.1037037037037037,0.19259259259259262,-0.5543546676635742,0.5335081240383195,other,0.0,[],False,True,6,0.0
2025-01-23,2025-01-23 08:00:00,Biocon gains 3% after board to mull raising funds via commercial papers - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gains 3% after board to mull raising funds via commercial papers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon gains 3% after board to mull raising funds via commercial papers - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gains 3% after board to mull raising funds via commercial papers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.6242705583572388,positive,0.6242705583572388,0.0,neutral,0.0,0.5859,0.146,0.0,0.854,0.0,0.0,0.3567260333469936,0.6050852791786194,other,0.0,[],False,True,6,0.0
2025-04-28,2025-04-28 07:00:00,Biocon Shares Rise 2% Following Positive CHMP Opinion For Biosimilars - Samco,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOTGVIWFZQWWdWWDNCSnlKbDR3X2FIWHJpTzVRNUplcXc5YW5KMUZaYnF6MmM2RWl0UG9yVWFBMFAxcWFsT3FKbEhiTUNZZ2VGUjZMSE9aZ2hncjlETjBoV2NoXzVMR1pYcUFJTmtuY0FRc2NQT1ltdGNWT08yZGluNXNkU3RSYmZhR3V3Z1Ffb0VsRV9QYnFDUWNlY3B3dkxhbldJ?oc=5"" target=""_blank"">Biocon Shares Rise 2% Following Positive CHMP Opinion For Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxOTGVIWFZQWWdWWDNCSnlKbDR3X2FIWHJpTzVRNUplcXc5YW5KMUZaYnF6MmM2RWl0UG9yVWFBMFAxcWFsT3FKbEhiTUNZZ2VGUjZMSE9aZ2hncjlETjBoV2NoXzVMR1pYcUFJTmtuY0FRc2NQT1ltdGNWT08yZGluNXNkU3RSYmZhR3V3Z1Ffb0VsRV9QYnFDUWNlY3B3dkxhbldJ?oc=5,Google News,Biocon stock price,"Biocon Shares Rise 2% Following Positive CHMP Opinion For Biosimilars - Samco <a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOTGVIWFZQWWdWWDNCSnlKbDR3X2FIWHJpTzVRNUplcXc5YW5KMUZaYnF6MmM2RWl0UG9yVWFBMFAxcWFsT3FKbEhiTUNZZ2VGUjZMSE9aZ2hncjlETjBoV2NoXzVMR1pYcUFJTmtuY0FRc2NQT1ltdGNWT08yZGluNXNkU3RSYmZhR3V3Z1Ffb0VsRV9QYnFDUWNlY3B3dkxhbldJ?oc=5"" target=""_blank"">Biocon Shares Rise 2% Following Positive CHMP Opinion For Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",0.9445118308067322,positive,0.9445118308067322,0.0,neutral,0.0,0.891,0.367,0.0,0.633,0.09090909090909091,0.2581818181818182,0.5397210461752755,0.6421403072386077,other,0.0,[],False,True,6,0.0
2025-02-27,2025-02-27 06:07:13,Biocon Faces Continued Stock Decline Amid Broader Market Stability Challenges - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxQTHRuQ2ZUZzlCWGVUM0RmYnNuYldfeE90NnN1R204bjIxS1cwT2tDeXNldkk1RXA5b1VFRE1UMU02Mm9IaDNfNW1td3QwT1lpVDkyY20xbVVZdTFVSWR6TUpNVjM5WXZxWFlXRm8zNjN1bzRLNVBkUnIyQkh3SzhyOUlWdkFQNWhueWV5MWxHZ2NXNm1KRndONlBzOGRPWGl5ZGhBdy02QUJ3bmVRVEJaS3NfTHRfdVhhUGQ0cjlFTVFFVU83bVg3R294aGoyQQ?oc=5"" target=""_blank"">Biocon Faces Continued Stock Decline Amid Broader Market Stability Challenges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxQTHRuQ2ZUZzlCWGVUM0RmYnNuYldfeE90NnN1R204bjIxS1cwT2tDeXNldkk1RXA5b1VFRE1UMU02Mm9IaDNfNW1td3QwT1lpVDkyY20xbVVZdTFVSWR6TUpNVjM5WXZxWFlXRm8zNjN1bzRLNVBkUnIyQkh3SzhyOUlWdkFQNWhueWV5MWxHZ2NXNm1KRndONlBzOGRPWGl5ZGhBdy02QUJ3bmVRVEJaS3NfTHRfdVhhUGQ0cjlFTVFFVU83bVg3R294aGoyQQ?oc=5,Google News,Biocon stock price,"Biocon Faces Continued Stock Decline Amid Broader Market Stability Challenges - MarketsMojo <a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxQTHRuQ2ZUZzlCWGVUM0RmYnNuYldfeE90NnN1R204bjIxS1cwT2tDeXNldkk1RXA5b1VFRE1UMU02Mm9IaDNfNW1td3QwT1lpVDkyY20xbVVZdTFVSWR6TUpNVjM5WXZxWFlXRm8zNjN1bzRLNVBkUnIyQkh3SzhyOUlWdkFQNWhueWV5MWxHZ2NXNm1KRndONlBzOGRPWGl5ZGhBdy02QUJ3bmVRVEJaS3NfTHRfdVhhUGQ0cjlFTVFFVU83bVg3R294aGoyQQ?oc=5"" target=""_blank"">Biocon Faces Continued Stock Decline Amid Broader Market Stability Challenges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",-0.9702447652816772,negative,0.9702447652816772,0.0,neutral,0.0,0.0772,0.053,0.0,0.947,0.0,0.0,-0.5544255801609584,0.5237223826408386,other,0.0,[],False,True,6,0.0
2025-04-04,2025-04-04 07:00:00,Biocon Share Price Today Down 6% - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQOUM2MGRGWUxYZ2VvU01lM01UdGpWYUFoYlBTSzR6WjVjM2RERG1uNWJuZFktQlpsZW1BVENBMUcteVFYeXBMU1RVbmlZbmp6VFRlaW5MOFJaTlJRVFlnNGFEMnE4bVJycnAwekJvVEJqdWdldk9TOVF6ZlNnYjBFWXdEMEpUQ2hpMWkzaWdlR2VIaVpx?oc=5"" target=""_blank"">Biocon Share Price Today Down 6%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQOUM2MGRGWUxYZ2VvU01lM01UdGpWYUFoYlBTSzR6WjVjM2RERG1uNWJuZFktQlpsZW1BVENBMUcteVFYeXBMU1RVbmlZbmp6VFRlaW5MOFJaTlJRVFlnNGFEMnE4bVJycnAwekJvVEJqdWdldk9TOVF6ZlNnYjBFWXdEMEpUQ2hpMWkzaWdlR2VIaVpx?oc=5,Google News,Biocon stock price,"Biocon Share Price Today Down 6% - Equitymaster <a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQOUM2MGRGWUxYZ2VvU01lM01UdGpWYUFoYlBTSzR6WjVjM2RERG1uNWJuZFktQlpsZW1BVENBMUcteVFYeXBMU1RVbmlZbmp6VFRlaW5MOFJaTlJRVFlnNGFEMnE4bVJycnAwekJvVEJqdWdldk9TOVF6ZlNnYjBFWXdEMEpUQ2hpMWkzaWdlR2VIaVpx?oc=5"" target=""_blank"">Biocon Share Price Today Down 6%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",-0.9701914191246033,negative,0.9701914191246033,0.0,neutral,0.0,0.5267,0.239,0.0,0.761,-0.1037037037037037,0.19259259259259262,-0.5543950966426304,0.5335317076094356,other,0.0,[],False,True,6,0.0
2025-04-11,2025-04-11 07:00:00,Biocon Stock Soars 4% On USFDA Nod For Cancer Drug Jobevne - BW Businessworld,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxPZUtFR0NsSWtqazN0N2FPVUlhTENiTWlwVllZMmFJQWY0UmpHTjJoeHZacFp3czZQcVBfOXNSV2o3d1V3VVFfaHdDZWMxYllPclY2TWtLeEIzZ2c5R0FqeG1DRGs5MGh2cGZZV1Nna05yN2Y2bDk2SUNDYlZyVXJkZXgtYWlpenQ3eG5EbXdJV1BCM0tGUE1BekxZeEE5dzJrLUtR?oc=5"" target=""_blank"">Biocon Stock Soars 4% On USFDA Nod For Cancer Drug Jobevne</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Businessworld</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxPZUtFR0NsSWtqazN0N2FPVUlhTENiTWlwVllZMmFJQWY0UmpHTjJoeHZacFp3czZQcVBfOXNSV2o3d1V3VVFfaHdDZWMxYllPclY2TWtLeEIzZ2c5R0FqeG1DRGs5MGh2cGZZV1Nna05yN2Y2bDk2SUNDYlZyVXJkZXgtYWlpenQ3eG5EbXdJV1BCM0tGUE1BekxZeEE5dzJrLUtR?oc=5,Google News,Biocon stock price,"Biocon Stock Soars 4% On USFDA Nod For Cancer Drug Jobevne - BW Businessworld <a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxPZUtFR0NsSWtqazN0N2FPVUlhTENiTWlwVllZMmFJQWY0UmpHTjJoeHZacFp3czZQcVBfOXNSV2o3d1V3VVFfaHdDZWMxYllPclY2TWtLeEIzZ2c5R0FqeG1DRGs5MGh2cGZZV1Nna05yN2Y2bDk2SUNDYlZyVXJkZXgtYWlpenQ3eG5EbXdJV1BCM0tGUE1BekxZeEE5dzJrLUtR?oc=5"" target=""_blank"">Biocon Stock Soars 4% On USFDA Nod For Cancer Drug Jobevne</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Businessworld</font>",0.8304892182350159,positive,0.8304892182350159,0.0,neutral,0.0,-0.8689,0.0,0.253,0.747,0.0,0.0,0.4745652675628662,0.8496946091175079,other,0.0,[],False,True,6,0.0
2025-03-07,2025-03-07 08:00:00,"Stocks to Watch: Indigo, Infosys, Blue Star, Biocon, Britannia, 63 Moons - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: Indigo, Infosys, Blue Star, Biocon, Britannia, 63 Moons</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Stocks to Watch: Indigo, Infosys, Blue Star, Biocon, Britannia, 63 Moons - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: Indigo, Infosys, Blue Star, Biocon, Britannia, 63 Moons</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.9307594299316406,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.05,0.0,0.9307594299316406,other,0.0,[],False,True,6,0.0
2025-05-12,2025-05-12 07:00:00,"Sun Pharma, Cipla, Biocon Share Price Fall As Nifty Pharma Index Drops 2% On US Drug Price Cut - Samco","<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxPeGRxamdvUDFqOXlNMFltVUNMTTZtWVRHdzdJaXUyR3BhUXVNM05HT2p6OEkxbUM0X0E3T2V3VzRzbHRZQm4wT011XzVYbEtPWFlJemlNU1ZJYkIya0NleUYtZkhVU3V4SFZOc283RWFHY0xwNEhGb09HajdBSDFSM2hMemhBaHFzdXFFYUotcUt5Q3B3dU4yejB0ZUdxOU9yYzBRZ3hSTWl0OTFEVU1QVEtiSkM5MFJiMnFDVw?oc=5"" target=""_blank"">Sun Pharma, Cipla, Biocon Share Price Fall As Nifty Pharma Index Drops 2% On US Drug Price Cut</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxPeGRxamdvUDFqOXlNMFltVUNMTTZtWVRHdzdJaXUyR3BhUXVNM05HT2p6OEkxbUM0X0E3T2V3VzRzbHRZQm4wT011XzVYbEtPWFlJemlNU1ZJYkIya0NleUYtZkhVU3V4SFZOc283RWFHY0xwNEhGb09HajdBSDFSM2hMemhBaHFzdXFFYUotcUt5Q3B3dU4yejB0ZUdxOU9yYzBRZ3hSTWl0OTFEVU1QVEtiSkM5MFJiMnFDVw?oc=5,Google News,Biocon stock price,"Sun Pharma, Cipla, Biocon Share Price Fall As Nifty Pharma Index Drops 2% On US Drug Price Cut - Samco <a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxPeGRxamdvUDFqOXlNMFltVUNMTTZtWVRHdzdJaXUyR3BhUXVNM05HT2p6OEkxbUM0X0E3T2V3VzRzbHRZQm4wT011XzVYbEtPWFlJemlNU1ZJYkIya0NleUYtZkhVU3V4SFZOc283RWFHY0xwNEhGb09HajdBSDFSM2hMemhBaHFzdXFFYUotcUt5Q3B3dU4yejB0ZUdxOU9yYzBRZ3hSTWl0OTFEVU1QVEtiSkM5MFJiMnFDVw?oc=5"" target=""_blank"">Sun Pharma, Cipla, Biocon Share Price Fall As Nifty Pharma Index Drops 2% On US Drug Price Cut</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",-0.9649471640586853,negative,0.9649471640586853,0.0,neutral,0.0,0.7717,0.209,0.045,0.746,0.0,0.0,-0.5513983794621059,0.8683235820293427,other,0.0,[],False,True,6,0.0
2025-01-14,2025-01-14 08:00:00,Biocon shares surge 5% after another upgrade; HSBC expects stock to hit ₹430 - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxPY3dqSE0xUUNidkluT2I1ZnZxRVVrZzQyLXJNLThldWl4V18xaTluLTRTMVdwOThBcGFyOVUtejdVOTdzTUM4V0NYZWZpdG9NWmw3RWtidGJ5aC1PYmk0dmZFLVh2UVc3Wlk3cjRXOFBoalFPMDVPNGIyRlljdmpERTBBZVppMXNUMVdiQno4UE9idVBub2tlU190VzBPc1N4X05iRHZJM3pleHpCM1NKTi1LckJGdy1rSk5sOUl5SDZmaGPSAcgBQVVfeXFMUDN3MkJTUGREeGZibGZBUGRGbkdITTlZdWhuSnl6RXhaYTVtb0VOYVhRUTYwZGloX0NSeElzLVBCT29BNkdhZHZHeTJNcWZ5UGo3RkVFUUJxYmlxWmlFaGZ5Yk8tZHdjUTYtYnpIc3JJdUFGeFM4THBKeFNVYU5rTlRYRnBHVmJSUE9kU0szc3gzRVVrY2ltQm1ST2MtNEM3ZVNmaEs1c3FKMlloZTFzS0l6ZWYwQTBMN3ZvNzdkMHIzR2Y4QVRveUo?oc=5"" target=""_blank"">Biocon shares surge 5% after another upgrade; HSBC expects stock to hit ₹430</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares surge 5% after another upgrade; HSBC expects stock to hit ₹430 - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxPY3dqSE0xUUNidkluT2I1ZnZxRVVrZzQyLXJNLThldWl4V18xaTluLTRTMVdwOThBcGFyOVUtejdVOTdzTUM4V0NYZWZpdG9NWmw3RWtidGJ5aC1PYmk0dmZFLVh2UVc3Wlk3cjRXOFBoalFPMDVPNGIyRlljdmpERTBBZVppMXNUMVdiQno4UE9idVBub2tlU190VzBPc1N4X05iRHZJM3pleHpCM1NKTi1LckJGdy1rSk5sOUl5SDZmaGPSAcgBQVVfeXFMUDN3MkJTUGREeGZibGZBUGRGbkdITTlZdWhuSnl6RXhaYTVtb0VOYVhRUTYwZGloX0NSeElzLVBCT29BNkdhZHZHeTJNcWZ5UGo3RkVFUUJxYmlxWmlFaGZ5Yk8tZHdjUTYtYnpIc3JJdUFGeFM4THBKeFNVYU5rTlRYRnBHVmJSUE9kU0szc3gzRVVrY2ltQm1ST2MtNEM3ZVNmaEs1c3FKMlloZTFzS0l6ZWYwQTBMN3ZvNzdkMHIzR2Y4QVRveUo?oc=5"" target=""_blank"">Biocon shares surge 5% after another upgrade; HSBC expects stock to hit ₹430</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.9269720911979675,positive,0.9269720911979675,0.0,neutral,0.0,0.5267,0.128,0.0,0.872,0.0,0.0,0.52969833782741,0.7268360455989837,other,0.0,[],False,True,6,0.0
2025-01-13,2025-01-13 08:00:00,"Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.9158660769462585,positive,0.9158660769462585,0.0,neutral,0.0,0.6124,0.2,0.0,0.8,0.0,0.0,0.5233520439692906,0.7641330384731293,other,0.0,[],False,True,6,0.0
2024-12-24,2024-12-24 08:00:00,Biocon share price jumps 5% on DCP nod for diabetes drug in European Union - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price jumps 5% on DCP nod for diabetes drug in European Union</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxQYzlzNkRnYVZLM3FHVWpUckhvcXc4blY5b3FDbWxqMDlxNXFBZkF6UEp0cDhfbVRRWThManVDM2lRd0wwOFNxVDBlVEZydkZEeUNxMzZHV2p5VDNQc0hZMWk2WTZ6cnZoemw0R0QyaS1xZkRjTXpsWWNsdndfTGtpOU5ac0FmMk5fbEwwbzBwZ3pnd0duTU15aUQzU2F1aUV2U2xVbXpmMXd1WXcwWmNVdHVwRGR0WERrdmZ4RUF1Ym1GZkNDd2hwLWxsaG1MZEJIa3QxZVdjRdIB3AFBVV95cUxOMGlMcDNlOWlIa1FBSjJqLWcweGFyWkRTSnd1c1RTR1Y1WGYxeFQydk1HdkRhUjR3UVZXclRvaHlqQU9VT003NlZndERBNGoyLXUzWXY3RFlzaDJ0VFdmdm01UGZSb3drR1pfT1RjYTdGZnU1elZRUHpicnpBVTFQcXdCM2hxa2w1T041Z1ZKNnlibTg2RS10WFdsOS1lUXlFbjVXeGQybzB2bklocklEYkNHNlBucS1ScDl6TzVLUnlhY19IVEhfdlBydG9rQ0RFYS1NR1ppdWZQWXFG?oc=5,Google News,Biocon stock price,"Biocon share price jumps 5% on DCP nod for diabetes drug in European Union - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price jumps 5% on DCP nod for diabetes drug in European Union</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8717814683914185,positive,0.8717814683914185,0.0,neutral,0.0,0.5267,0.121,0.0,0.879,0.0,0.0,0.49816083908081055,0.6992407341957092,other,0.0,[],False,True,6,0.0
2024-12-09,2024-12-09 08:00:00,Biocon share falls 4% after USFDA issues VAI tag for Bengaluru's API unit - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share falls 4% after USFDA issues VAI tag for Bengaluru's API unit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon share falls 4% after USFDA issues VAI tag for Bengaluru's API unit - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share falls 4% after USFDA issues VAI tag for Bengaluru's API unit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9498026967048645,negative,0.9498026967048645,0.0,neutral,0.0,0.5267,0.128,0.0,0.872,0.0,0.0,-0.5427443981170654,0.7382513483524322,other,0.0,[],False,True,6,0.0
2024-09-02,2024-09-02 07:00:00,Biocon shares gain after arm gets multiple USFDA approval - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain after arm gets multiple USFDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares gain after arm gets multiple USFDA approval - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain after arm gets multiple USFDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.8280218839645386,positive,0.8280218839645386,0.0,neutral,0.0,0.9231,0.457,0.0,0.543,0.0,0.0,0.47315536226545063,0.8755609419822693,approval_process,0.7050805389881134,['FDA approval'],False,True,16,0.4101610779762268
2025-06-17,2025-06-17 07:00:00,"Stocks to Watch: Biocon, NTPC, Zee Entertainment, Tanla Platforms and more - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: Biocon, NTPC, Zee Entertainment, Tanla Platforms and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Stocks to Watch: Biocon, NTPC, Zee Entertainment, Tanla Platforms and more - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: Biocon, NTPC, Zee Entertainment, Tanla Platforms and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.9409672021865845,0.0,neutral,0.0,0.6808,0.177,0.0,0.823,0.25,0.25,0.0,0.6239224007288615,other,0.0,[],False,True,6,0.0
2025-05-09,2025-05-09 07:00:00,"Stocks to watch: Larsen and Toubro, Swiggy, Dr. Reddy's, Titan, Paytm, Biocon shares in focus - Fortune India","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch: Larsen and Toubro, Swiggy, Dr. Reddy's, Titan, Paytm, Biocon shares in focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Stocks to watch: Larsen and Toubro, Swiggy, Dr. Reddy's, Titan, Paytm, Biocon shares in focus - Fortune India <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch: Larsen and Toubro, Swiggy, Dr. Reddy's, Titan, Paytm, Biocon shares in focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",0.0,neutral,0.9255945682525635,0.0,neutral,0.0,0.5267,0.115,0.0,0.885,0.0,0.0,0.0,0.7261472841262817,other,0.0,[],False,True,6,0.0
2025-01-13,2025-01-13 08:00:00,Biocon shares in focus after Malaysia unit gets clearance from the USFDA - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after Malaysia unit gets clearance from the USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon stock price,"Biocon shares in focus after Malaysia unit gets clearance from the USFDA - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after Malaysia unit gets clearance from the USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.5160942077636719,0.0,neutral,0.0,0.5267,0.136,0.0,0.864,0.0,0.0,0.0,0.5213971038818359,other,0.0,[],False,True,6,0.0
2024-08-15,2024-08-15 07:00:00,Oyo registers 1st-ever profit of ₹229cr in FY24 - Times of India,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Oyo registers 1st-ever profit of ₹229cr in FY24</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"Oyo registers 1st-ever profit of ₹229cr in FY24 - Times of India <a href=""https://news.google.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?oc=5"" target=""_blank"">Oyo registers 1st-ever profit of ₹229cr in FY24</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",0.0,neutral,0.5644046068191528,0.0,neutral,0.0,0.7003,0.209,0.0,0.791,0.0,0.0,0.0,0.6323523034095764,other,0.0,[],False,False,1,0.0
2024-08-08,2024-08-08 07:00:00,"SAIL Q1 Results | Net profit tumbles 62% to ₹82 crore, misses estimates by a mile - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxQTXUtdkF5N091TFhLbDdwT2hrSFBWOU9IZmtUZ0NHMkxvQ1NsYjJkRk15aUhDS2U3SUktdHgyMjZqOHJQUW1PS0lRU3dBblJpcmxKVzlFS2xodmUydVZ6UXNyNzZFTzkxN1lTMEFoYWViaG1pRW5FLV9uZ0RCTlF5ZW5oZFRpOVNpOVowSW1IYjFlcldIbDQ0blNBaFJWQV9uVGtiLUVBcVdhYjdFNnNOY2xsVUM2NWJ6Vk05LXFIc0lKd25FaDRQNE0tS001bG_SAdQBQVVfeXFMTzRyaE1kamhKcEFpdUFBaUF5OWdEMDFkb1I5U2lPT2QtWWw3WkhmZ19GdldNU0FVZ1dOLUtnenFDcnJ0N0VSdEtJUmpkX2tVbVhCRHBtQUJ5VEp2QmlzSlNxNDhoV3c3cmhtaGV0SW1Jdkc1M2VtOHEtRFk4M2lBcWpLOGJQNURsTzI1YWZfMFJ4WWRINldZcG9HdWhzMDA0MjUxNmUtNUtFbVFGLXhScEdDRE9jX3Q0TzZGeTB0ZTZyZkFqWmVUelY2U0k0QUMtQkczemQ?oc=5"" target=""_blank"">SAIL Q1 Results | Net profit tumbles 62% to ₹82 crore, misses estimates by a mile</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxQTXUtdkF5N091TFhLbDdwT2hrSFBWOU9IZmtUZ0NHMkxvQ1NsYjJkRk15aUhDS2U3SUktdHgyMjZqOHJQUW1PS0lRU3dBblJpcmxKVzlFS2xodmUydVZ6UXNyNzZFTzkxN1lTMEFoYWViaG1pRW5FLV9uZ0RCTlF5ZW5oZFRpOVNpOVowSW1IYjFlcldIbDQ0blNBaFJWQV9uVGtiLUVBcVdhYjdFNnNOY2xsVUM2NWJ6Vk05LXFIc0lKd25FaDRQNE0tS001bG_SAdQBQVVfeXFMTzRyaE1kamhKcEFpdUFBaUF5OWdEMDFkb1I5U2lPT2QtWWw3WkhmZ19GdldNU0FVZ1dOLUtnenFDcnJ0N0VSdEtJUmpkX2tVbVhCRHBtQUJ5VEp2QmlzSlNxNDhoV3c3cmhtaGV0SW1Jdkc1M2VtOHEtRFk4M2lBcWpLOGJQNURsTzI1YWZfMFJ4WWRINldZcG9HdWhzMDA0MjUxNmUtNUtFbVFGLXhScEdDRE9jX3Q0TzZGeTB0ZTZyZkFqWmVUelY2U0k0QUMtQkczemQ?oc=5,Google News,Biocon Q1 earnings,"SAIL Q1 Results | Net profit tumbles 62% to ₹82 crore, misses estimates by a mile - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxQTXUtdkF5N091TFhLbDdwT2hrSFBWOU9IZmtUZ0NHMkxvQ1NsYjJkRk15aUhDS2U3SUktdHgyMjZqOHJQUW1PS0lRU3dBblJpcmxKVzlFS2xodmUydVZ6UXNyNzZFTzkxN1lTMEFoYWViaG1pRW5FLV9uZ0RCTlF5ZW5oZFRpOVNpOVowSW1IYjFlcldIbDQ0blNBaFJWQV9uVGtiLUVBcVdhYjdFNnNOY2xsVUM2NWJ6Vk05LXFIc0lKd25FaDRQNE0tS001bG_SAdQBQVVfeXFMTzRyaE1kamhKcEFpdUFBaUF5OWdEMDFkb1I5U2lPT2QtWWw3WkhmZ19GdldNU0FVZ1dOLUtnenFDcnJ0N0VSdEtJUmpkX2tVbVhCRHBtQUJ5VEp2QmlzSlNxNDhoV3c3cmhtaGV0SW1Jdkc1M2VtOHEtRFk4M2lBcWpLOGJQNURsTzI1YWZfMFJ4WWRINldZcG9HdWhzMDA0MjUxNmUtNUtFbVFGLXhScEdDRE9jX3Q0TzZGeTB0ZTZyZkFqWmVUelY2U0k0QUMtQkczemQ?oc=5"" target=""_blank"">SAIL Q1 Results | Net profit tumbles 62% to ₹82 crore, misses estimates by a mile</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",-0.9700334668159485,negative,0.9700334668159485,0.0,neutral,0.0,0.4588,0.146,0.096,0.758,0.0,0.0,-0.554304838180542,0.7144167334079743,other,0.0,[],False,False,1,0.0
2024-08-09,2024-08-09 07:00:00,"Biocon Biologics exploring multiple strategies to reduce debt, says MD Shreehas Tambe - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxONURyczZUOTN4UjkteERFUXIyY3ZiU3dHMTNRNXZOLTZsbXhCQUFydUE1SlpzNlVwSkpNX08yMVNUVTBkTW0wbS1pMGoxbHhxV1VpbzJoanVRTDA2RWlYdEdGNy12T1dRcjMtLTV6cXU4TUNPbFpoS1ZUbzNrbzJYNE1fX2c0RV9hWFZhM2pjcDVCRVdNR1EzN0ZMUjVDdnJVTnhoRkJ3YmxBMVdYUG5pSkYxdGo1dDBH0gG-AUFVX3lxTE03VzVCZExGM3NRMUx5cHl5S0xsczZlelVXQnlmZ3hFUkQxN1NkZU1iYUNLNG1oeWt4bjRsOTJYN1FoMU5ncmFMdW5QM3NGNlJpWlZveFVpTVBCR2NaNTU0b3BYaEJFcXJ0U3RsWk9ROHFXU0VpbmpNWkRFVTBLZzVkcmxFaUt4bk16V2FJOFd2aHN4UEJYR0NHNTNMWXdrWDZUQjRuajh3REE5UnM1NFVSSHllWHppUC10VlpFelE?oc=5"" target=""_blank"">Biocon Biologics exploring multiple strategies to reduce debt, says MD Shreehas Tambe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxONURyczZUOTN4UjkteERFUXIyY3ZiU3dHMTNRNXZOLTZsbXhCQUFydUE1SlpzNlVwSkpNX08yMVNUVTBkTW0wbS1pMGoxbHhxV1VpbzJoanVRTDA2RWlYdEdGNy12T1dRcjMtLTV6cXU4TUNPbFpoS1ZUbzNrbzJYNE1fX2c0RV9hWFZhM2pjcDVCRVdNR1EzN0ZMUjVDdnJVTnhoRkJ3YmxBMVdYUG5pSkYxdGo1dDBH0gG-AUFVX3lxTE03VzVCZExGM3NRMUx5cHl5S0xsczZlelVXQnlmZ3hFUkQxN1NkZU1iYUNLNG1oeWt4bjRsOTJYN1FoMU5ncmFMdW5QM3NGNlJpWlZveFVpTVBCR2NaNTU0b3BYaEJFcXJ0U3RsWk9ROHFXU0VpbmpNWkRFVTBLZzVkcmxFaUt4bk16V2FJOFd2aHN4UEJYR0NHNTNMWXdrWDZUQjRuajh3REE5UnM1NFVSSHllWHppUC10VlpFelE?oc=5,Google News,Biocon Q1 earnings,"Biocon Biologics exploring multiple strategies to reduce debt, says MD Shreehas Tambe - CNBC TV18 <a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxONURyczZUOTN4UjkteERFUXIyY3ZiU3dHMTNRNXZOLTZsbXhCQUFydUE1SlpzNlVwSkpNX08yMVNUVTBkTW0wbS1pMGoxbHhxV1VpbzJoanVRTDA2RWlYdEdGNy12T1dRcjMtLTV6cXU4TUNPbFpoS1ZUbzNrbzJYNE1fX2c0RV9hWFZhM2pjcDVCRVdNR1EzN0ZMUjVDdnJVTnhoRkJ3YmxBMVdYUG5pSkYxdGo1dDBH0gG-AUFVX3lxTE03VzVCZExGM3NRMUx5cHl5S0xsczZlelVXQnlmZ3hFUkQxN1NkZU1iYUNLNG1oeWt4bjRsOTJYN1FoMU5ncmFMdW5QM3NGNlJpWlZveFVpTVBCR2NaNTU0b3BYaEJFcXJ0U3RsWk9ROHFXU0VpbmpNWkRFVTBLZzVkcmxFaUt4bk16V2FJOFd2aHN4UEJYR0NHNTNMWXdrWDZUQjRuajh3REE5UnM1NFVSSHllWHppUC10VlpFelE?oc=5"" target=""_blank"">Biocon Biologics exploring multiple strategies to reduce debt, says MD Shreehas Tambe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.6920936703681946,positive,0.6920936703681946,0.0,neutral,0.0,-0.6124,0.0,0.152,0.848,0.0,0.0,0.395482097353254,0.6522468351840973,other,0.0,[],False,True,6,0.0
2024-08-04,2024-08-04 07:00:00,"Q1 results this week: From Bharti Airtel, RVNL, Apollo Tyres, ONGC, NHPC to MRF, here’s list of earnings to watch out - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi9wFBVV95cUxOUnNZLWs3bXNxYlVXRzhFeExGb2UyRmpSLVZBVU0zU0FZaVRLak9TeDc4a0lHQkhpbTdTYnFKdE41Q3JMa05sUHFIMk1lM1FSd0NLWW9qZVh1N0JiLWFlTXdzNElUbElkTFA3OF9EYUlRdF91MnFLeWI4dG9GWFBPQk5NZlkwVjMyOHRMR0ZtX01DNTJmUGdmUHVzN3NMR3E4XzNDVnh4M09BZm9rckRzSEdwMk1OOFZhcHVLclNuNXlFcm9qY0dsaVBsVmRMS281U0kyeGxiYzB6RVdvQ3JTcXFTYmxuQzg2REpPY2M0VXFXc0xiQV9F?oc=5"" target=""_blank"">Q1 results this week: From Bharti Airtel, RVNL, Apollo Tyres, ONGC, NHPC to MRF, here’s list of earnings to watch out</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi9wFBVV95cUxOUnNZLWs3bXNxYlVXRzhFeExGb2UyRmpSLVZBVU0zU0FZaVRLak9TeDc4a0lHQkhpbTdTYnFKdE41Q3JMa05sUHFIMk1lM1FSd0NLWW9qZVh1N0JiLWFlTXdzNElUbElkTFA3OF9EYUlRdF91MnFLeWI4dG9GWFBPQk5NZlkwVjMyOHRMR0ZtX01DNTJmUGdmUHVzN3NMR3E4XzNDVnh4M09BZm9rckRzSEdwMk1OOFZhcHVLclNuNXlFcm9qY0dsaVBsVmRMS281U0kyeGxiYzB6RVdvQ3JTcXFTYmxuQzg2REpPY2M0VXFXc0xiQV9F?oc=5,Google News,Biocon Q1 earnings,"Q1 results this week: From Bharti Airtel, RVNL, Apollo Tyres, ONGC, NHPC to MRF, here’s list of earnings to watch out - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi9wFBVV95cUxOUnNZLWs3bXNxYlVXRzhFeExGb2UyRmpSLVZBVU0zU0FZaVRLak9TeDc4a0lHQkhpbTdTYnFKdE41Q3JMa05sUHFIMk1lM1FSd0NLWW9qZVh1N0JiLWFlTXdzNElUbElkTFA3OF9EYUlRdF91MnFLeWI4dG9GWFBPQk5NZlkwVjMyOHRMR0ZtX01DNTJmUGdmUHVzN3NMR3E4XzNDVnh4M09BZm9rckRzSEdwMk1OOFZhcHVLclNuNXlFcm9qY0dsaVBsVmRMS281U0kyeGxiYzB6RVdvQ3JTcXFTYmxuQzg2REpPY2M0VXFXc0xiQV9F?oc=5"" target=""_blank"">Q1 results this week: From Bharti Airtel, RVNL, Apollo Tyres, ONGC, NHPC to MRF, here’s list of earnings to watch out</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9307908415794373,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9307908415794373,other,0.0,[],False,False,1,0.0
2024-03-04,2024-03-04 08:00:00,Biocon Biologics secures Canada market entry date for YESAFILI - Industry News - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxPS0FYNXZCX0kxYzNwRDl5Sm53SHhwa20xZXZWbmFxcGJ3akU2OUZxLU9oTng0V0FlOWJtQXN1XzQ4Qnd4aDVyZzNVWG5kR25lXy1GMUVIZzQ3U0ZYZDJ5SkN6MjJvOGZIUWdRbTRORGkyZDVSSl96Rk1LcWU4MlNJaGs4MVlpemEyVGQ3VnBXQUVybHo2UlVocmcyYWNqSmxxZjhlQXBNcktycU1ROE1mVThTRzdOaEllY0RIVnpPaw?oc=5"" target=""_blank"">Biocon Biologics secures Canada market entry date for YESAFILI - Industry News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMivwFBVV95cUxPS0FYNXZCX0kxYzNwRDl5Sm53SHhwa20xZXZWbmFxcGJ3akU2OUZxLU9oTng0V0FlOWJtQXN1XzQ4Qnd4aDVyZzNVWG5kR25lXy1GMUVIZzQ3U0ZYZDJ5SkN6MjJvOGZIUWdRbTRORGkyZDVSSl96Rk1LcWU4MlNJaGs4MVlpemEyVGQ3VnBXQUVybHo2UlVocmcyYWNqSmxxZjhlQXBNcktycU1ROE1mVThTRzdOaEllY0RIVnpPaw?oc=5,Google News,Biocon Q1 earnings,"Biocon Biologics secures Canada market entry date for YESAFILI - Industry News - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxPS0FYNXZCX0kxYzNwRDl5Sm53SHhwa20xZXZWbmFxcGJ3akU2OUZxLU9oTng0V0FlOWJtQXN1XzQ4Qnd4aDVyZzNVWG5kR25lXy1GMUVIZzQ3U0ZYZDJ5SkN6MjJvOGZIUWdRbTRORGkyZDVSSl96Rk1LcWU4MlNJaGs4MVlpemEyVGQ3VnBXQUVybHo2UlVocmcyYWNqSmxxZjhlQXBNcktycU1ROE1mVThTRzdOaEllY0RIVnpPaw?oc=5"" target=""_blank"">Biocon Biologics secures Canada market entry date for YESAFILI - Industry News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.8934070467948914,0.0,neutral,0.0,0.5574,0.161,0.0,0.839,0.0,0.0,0.0,0.7254035233974456,other,0.0,[],False,True,6,0.0
2024-07-26,2024-07-26 07:00:00,"Biocon plans a ₹4,000 crore QIP to pare debt — Exclusive - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon plans a ₹4,000 crore QIP to pare debt — Exclusive</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"Biocon plans a ₹4,000 crore QIP to pare debt — Exclusive - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon plans a ₹4,000 crore QIP to pare debt — Exclusive</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.847090482711792,0.0,neutral,0.0,-0.5423,0.055,0.182,0.764,0.0,0.0,0.0,0.694695241355896,other,0.0,[],False,True,6,0.0
2024-08-06,2024-08-06 07:00:00,"Q1 Results 2024: Vedanta, TVS Motor, Lupin, Fortis Healthcare, Raymond, and around 100 others reporting Q1 earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxQVFVJbkFXY3puaEhBV1VnZHVWT1BINVBRMkFwNGVPeGY0S09oR0doc1MtOXBTaWdGU0hBU3gtRzJVdnJqNkp3bUIxZ05GV0ZrdGRRZFFLOVNuRWxIeHhKQ29PckpGVkRTVl96bXYtSl9JT1FacTIxalA5NXFzSi1uRERwbEtFU2NYUDNDRTZXb0VxRGVkREttcTRGWWZKRmFFMDE3dkpLYXA5SmJOekFmNEI4UVZFekstM3lSVmQ3S1RrZGQzdkFWZFUxWmp2Mzh5YzdhU3hXS1Z6MG9sbFdnQy1iQzlvTnd2NFNSeS05TmZiNUJtdkEwUzZvQk5Fc191RjBvVTdfUkpJWmZfMENVdmYxdm90bk0?oc=5"" target=""_blank"">Q1 Results 2024: Vedanta, TVS Motor, Lupin, Fortis Healthcare, Raymond, and around 100 others reporting Q1 earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilwJBVV95cUxQVFVJbkFXY3puaEhBV1VnZHVWT1BINVBRMkFwNGVPeGY0S09oR0doc1MtOXBTaWdGU0hBU3gtRzJVdnJqNkp3bUIxZ05GV0ZrdGRRZFFLOVNuRWxIeHhKQ29PckpGVkRTVl96bXYtSl9JT1FacTIxalA5NXFzSi1uRERwbEtFU2NYUDNDRTZXb0VxRGVkREttcTRGWWZKRmFFMDE3dkpLYXA5SmJOekFmNEI4UVZFekstM3lSVmQ3S1RrZGQzdkFWZFUxWmp2Mzh5YzdhU3hXS1Z6MG9sbFdnQy1iQzlvTnd2NFNSeS05TmZiNUJtdkEwUzZvQk5Fc191RjBvVTdfUkpJWmZfMENVdmYxdm90bk0?oc=5,Google News,Biocon Q1 earnings,"Q1 Results 2024: Vedanta, TVS Motor, Lupin, Fortis Healthcare, Raymond, and around 100 others reporting Q1 earnings today - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxQVFVJbkFXY3puaEhBV1VnZHVWT1BINVBRMkFwNGVPeGY0S09oR0doc1MtOXBTaWdGU0hBU3gtRzJVdnJqNkp3bUIxZ05GV0ZrdGRRZFFLOVNuRWxIeHhKQ29PckpGVkRTVl96bXYtSl9JT1FacTIxalA5NXFzSi1uRERwbEtFU2NYUDNDRTZXb0VxRGVkREttcTRGWWZKRmFFMDE3dkpLYXA5SmJOekFmNEI4UVZFekstM3lSVmQ3S1RrZGQzdkFWZFUxWmp2Mzh5YzdhU3hXS1Z6MG9sbFdnQy1iQzlvTnd2NFNSeS05TmZiNUJtdkEwUzZvQk5Fc191RjBvVTdfUkpJWmZfMENVdmYxdm90bk0?oc=5"" target=""_blank"">Q1 Results 2024: Vedanta, TVS Motor, Lupin, Fortis Healthcare, Raymond, and around 100 others reporting Q1 earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9069222211837769,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9069222211837769,other,0.0,[],False,False,1,0.0
2025-01-12,2025-01-12 08:00:00,"Top Stocks To Watch For January 13: Avenue Supermarts, PCBL, Biocon, Waaree Energies and more - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxPZFdOVnlhWnA4SHhnMTlHa2JBN0U0RHNqVG5uUmd3NlVGYzBhMTFhTUk4OWc0X1pnelRRVDB6bTRhMnJObmxpblVCLVZZYU45UmFCbGdDd1JaNEd0cy1mQVVXanlYVFpfcXhuaFZleklIVUdYenhXSFUyMHExT0xTN3daMURaanRSQzNjV1RLdU9Tdnh2V2JkSlJQQUFlQ0E3RTNQUzkyR0g5enllRFNnSGxpVjd2dlBHU25jMk5TZVJ5Vk4wLTVIT2JNTk9rQ2PSAdQBQVVfeXFMT19mZnFTeVktckEzOHBKTm5kdFJmaHg1aTZKem92MnJFNng1SWoteFNNOFZoWENOTWtrMUl6bFRISG9xZnFnVllOWkhfWVI1ZXF3NmFPcE1TVDlpV2h6TU5CaFMwa3o0d3k0bWNGWThVQ1JfYURwOEFxYTlIbUJjeFY3WFNmV3UydEpBUnczb055Sm42T0ZiQm02VnNlSWluV1JEUEZuaGlNZTY2aTZLeVNUQldVNGc2NHZNLTZJLWZJQW9weXNvVW1WWmRWcXVkSjNxSDQ?oc=5"" target=""_blank"">Top Stocks To Watch For January 13: Avenue Supermarts, PCBL, Biocon, Waaree Energies and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"Top Stocks To Watch For January 13: Avenue Supermarts, PCBL, Biocon, Waaree Energies and more - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Top Stocks To Watch For January 13: Avenue Supermarts, PCBL, Biocon, Waaree Energies and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.0,neutral,0.9313631057739258,0.0,neutral,0.0,0.5574,0.145,0.0,0.855,0.3333333333333333,0.3333333333333333,0.0,0.6073654797024196,other,0.0,[],False,True,6,0.0
2024-08-08,2024-08-08 07:00:00,"Q1 results today: LIC, RVNL, GRSE, MRF among 225 companies to announce earnings on Thursday - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q1 results today: LIC, RVNL, GRSE, MRF among 225 companies to announce earnings on Thursday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"Q1 results today: LIC, RVNL, GRSE, MRF among 225 companies to announce earnings on Thursday - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Q1 results today: LIC, RVNL, GRSE, MRF among 225 companies to announce earnings on Thursday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.8052952289581299,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.0,0.4693142811457316,other,0.0,[],False,False,1,0.0
2023-07-27,2023-07-27 07:00:00,Syngene's playbook: 50% revenue from contract manufacturing in 2-3 years - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene's playbook: 50% revenue from contract manufacturing in 2-3 years</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"Syngene's playbook: 50% revenue from contract manufacturing in 2-3 years - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene's playbook: 50% revenue from contract manufacturing in 2-3 years</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.8144594430923462,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8144594430923462,other,0.0,[],False,False,1,0.0
2024-08-08,2024-08-08 07:00:00,Alembic Q1 Results: Net profit jumps 12 percent to Rs 135 crore; US business grows by 18 percent - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi7AFBVV95cUxNTHgyZEhXQ0xzUktUam03TFp2WHk3bnlPQlZrZ0dzcktuZk1Uei1Qc1Q4d0lmUmpKNGtCQ2F5NXFSWnpfMXBTQWxfbFFzcFNhdzNtMHA5ZmhlSzBvQUtiZWN5WUR6dkhDTnJ1akxTTDVjMG5LaXVjT05VMDVYVDJxRFUxdkZqQWlCNXNhN1FfcXhwcWFRV20zQXJ2Mi13VXYyRHhpR3JCQzUyazk2d1VKaTdqOUxaUUJ4S09iY0JIdk52NU1XV2luNDVxUVhhT3ZzNXhfTEdGNlVrUk5KX240blBhSnhLNUJWT09EaQ?oc=5"" target=""_blank"">Alembic Q1 Results: Net profit jumps 12 percent to Rs 135 crore; US business grows by 18 percent</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi7AFBVV95cUxNTHgyZEhXQ0xzUktUam03TFp2WHk3bnlPQlZrZ0dzcktuZk1Uei1Qc1Q4d0lmUmpKNGtCQ2F5NXFSWnpfMXBTQWxfbFFzcFNhdzNtMHA5ZmhlSzBvQUtiZWN5WUR6dkhDTnJ1akxTTDVjMG5LaXVjT05VMDVYVDJxRFUxdkZqQWlCNXNhN1FfcXhwcWFRV20zQXJ2Mi13VXYyRHhpR3JCQzUyazk2d1VKaTdqOUxaUUJ4S09iY0JIdk52NU1XV2luNDVxUVhhT3ZzNXhfTEdGNlVrUk5KX240blBhSnhLNUJWT09EaQ?oc=5,Google News,Biocon Q1 earnings,"Alembic Q1 Results: Net profit jumps 12 percent to Rs 135 crore; US business grows by 18 percent - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMi7AFBVV95cUxNTHgyZEhXQ0xzUktUam03TFp2WHk3bnlPQlZrZ0dzcktuZk1Uei1Qc1Q4d0lmUmpKNGtCQ2F5NXFSWnpfMXBTQWxfbFFzcFNhdzNtMHA5ZmhlSzBvQUtiZWN5WUR6dkhDTnJ1akxTTDVjMG5LaXVjT05VMDVYVDJxRFUxdkZqQWlCNXNhN1FfcXhwcWFRV20zQXJ2Mi13VXYyRHhpR3JCQzUyazk2d1VKaTdqOUxaUUJ4S09iY0JIdk52NU1XV2luNDVxUVhhT3ZzNXhfTEdGNlVrUk5KX240blBhSnhLNUJWT09EaQ?oc=5"" target=""_blank"">Alembic Q1 Results: Net profit jumps 12 percent to Rs 135 crore; US business grows by 18 percent</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.9356497526168823,positive,0.9356497526168823,0.0,neutral,0.0,0.7003,0.132,0.0,0.868,0.0,0.0,0.5346570014953613,0.8179748763084411,other,0.0,[],False,False,1,0.0
2024-08-03,2024-08-03 07:00:00,Eris Lifesciences posts Q1 FY25 at Rs. 89 Cr - Indian Pharma Post,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxOTEUyd0lVRTFyT3ZndFQ0Ymh4eFNaMThuMEo0UGZlakU4U1g3T0FfX1pVVHJJUVh3M0lSUk1LYm9HdXZTeEtWUDZmVW1Dc3l5VFdLVEk4alNYdUVYdjNZT29sZnZZZTRqS0xJX2p6VGQ2aGt6ZTB3VkVocnJZaFg3UXJlWUwxR0pBOW9BLS1zNTLSAZcBQVVfeXFMUEJDQkVoal9weXVYbmFSRkVQeUNGU0g4UXRzcnNnel91RDI4THFkNmJWVEFNMkN4SGh4U3VRa2dqRWZYS3pQLUZJZDFRMEhpM21aZzQ1SFBvSDdVWVVGWHB1UWNoLWs0Y2RWcnF2dUh5T3ZZSVJ3cUNxcXRKcnMwWmhWeVNLUTAtbkNYd0FKcFZZMmttbWNQdw?oc=5"" target=""_blank"">Eris Lifesciences posts Q1 FY25 at Rs. 89 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxOTEUyd0lVRTFyT3ZndFQ0Ymh4eFNaMThuMEo0UGZlakU4U1g3T0FfX1pVVHJJUVh3M0lSUk1LYm9HdXZTeEtWUDZmVW1Dc3l5VFdLVEk4alNYdUVYdjNZT29sZnZZZTRqS0xJX2p6VGQ2aGt6ZTB3VkVocnJZaFg3UXJlWUwxR0pBOW9BLS1zNTLSAZcBQVVfeXFMUEJDQkVoal9weXVYbmFSRkVQeUNGU0g4UXRzcnNnel91RDI4THFkNmJWVEFNMkN4SGh4U3VRa2dqRWZYS3pQLUZJZDFRMEhpM21aZzQ1SFBvSDdVWVVGWHB1UWNoLWs0Y2RWcnF2dUh5T3ZZSVJ3cUNxcXRKcnMwWmhWeVNLUTAtbkNYd0FKcFZZMmttbWNQdw?oc=5,Google News,Biocon Q1 earnings,"Eris Lifesciences posts Q1 FY25 at Rs. 89 Cr - Indian Pharma Post <a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxOTEUyd0lVRTFyT3ZndFQ0Ymh4eFNaMThuMEo0UGZlakU4U1g3T0FfX1pVVHJJUVh3M0lSUk1LYm9HdXZTeEtWUDZmVW1Dc3l5VFdLVEk4alNYdUVYdjNZT29sZnZZZTRqS0xJX2p6VGQ2aGt6ZTB3VkVocnJZaFg3UXJlWUwxR0pBOW9BLS1zNTLSAZcBQVVfeXFMUEJDQkVoal9weXVYbmFSRkVQeUNGU0g4UXRzcnNnel91RDI4THFkNmJWVEFNMkN4SGh4U3VRa2dqRWZYS3pQLUZJZDFRMEhpM21aZzQ1SFBvSDdVWVVGWHB1UWNoLWs0Y2RWcnF2dUh5T3ZZSVJ3cUNxcXRKcnMwWmhWeVNLUTAtbkNYd0FKcFZZMmttbWNQdw?oc=5"" target=""_blank"">Eris Lifesciences posts Q1 FY25 at Rs. 89 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",0.0,neutral,0.8666304349899292,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8666304349899292,other,0.0,[],False,False,1,0.0
2024-08-08,2024-08-08 07:00:00,"LIC Q1 Results Highlights: Net profit rises 9.6% YoY to ₹10,461 crore, total premium income surges 15.6% YoY - Upstox","<a href=""https://news.google.com/rss/articles/CBMi4wFBVV95cUxQUzM5Rmdmek1BV3BocFpRZkJLYzBDME55Vm03cHY3bnJpY212MDA0WTd0R2dsTkRURmdra0Fmd3J0VWR4bl9GN3BYRmJucFBUeDJEYVAxZVRjdk43RWpZZ21LWXJwWHRXa2E2N3hYNUU5MFIteWxtbFI3eUZBMVU3dG4zNGFTTHNMV195Tm0tNUhVVjZpY25lSFNXaVphZVo0bkwzRFltNmlFanBzOGh5Y3g5QjAydWFnNUphdUpaQ1F6T1RzbkdZbWxYanF5OFpfdE1EVTB2dzRNY3hFbDdxQ2FpTQ?oc=5"" target=""_blank"">LIC Q1 Results Highlights: Net profit rises 9.6% YoY to ₹10,461 crore, total premium income surges 15.6% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi4wFBVV95cUxQUzM5Rmdmek1BV3BocFpRZkJLYzBDME55Vm03cHY3bnJpY212MDA0WTd0R2dsTkRURmdra0Fmd3J0VWR4bl9GN3BYRmJucFBUeDJEYVAxZVRjdk43RWpZZ21LWXJwWHRXa2E2N3hYNUU5MFIteWxtbFI3eUZBMVU3dG4zNGFTTHNMV195Tm0tNUhVVjZpY25lSFNXaVphZVo0bkwzRFltNmlFanBzOGh5Y3g5QjAydWFnNUphdUpaQ1F6T1RzbkdZbWxYanF5OFpfdE1EVTB2dzRNY3hFbDdxQ2FpTQ?oc=5,Google News,Biocon Q1 earnings,"LIC Q1 Results Highlights: Net profit rises 9.6% YoY to ₹10,461 crore, total premium income surges 15.6% YoY - Upstox <a href=""https://news.google.com/rss/articles/CBMi4wFBVV95cUxQUzM5Rmdmek1BV3BocFpRZkJLYzBDME55Vm03cHY3bnJpY212MDA0WTd0R2dsTkRURmdra0Fmd3J0VWR4bl9GN3BYRmJucFBUeDJEYVAxZVRjdk43RWpZZ21LWXJwWHRXa2E2N3hYNUU5MFIteWxtbFI3eUZBMVU3dG4zNGFTTHNMV195Tm0tNUhVVjZpY25lSFNXaVphZVo0bkwzRFltNmlFanBzOGh5Y3g5QjAydWFnNUphdUpaQ1F6T1RzbkdZbWxYanF5OFpfdE1EVTB2dzRNY3hFbDdxQ2FpTQ?oc=5"" target=""_blank"">LIC Q1 Results Highlights: Net profit rises 9.6% YoY to ₹10,461 crore, total premium income surges 15.6% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.9354422092437744,positive,0.9354422092437744,0.0,neutral,0.0,0.7003,0.132,0.0,0.868,0.0,0.3,0.5345384052821568,0.8178711046218872,other,0.0,[],False,False,1,0.0
2024-08-07,2024-08-07 07:00:00,"Q1 Results 2024: Pidilite Industries, Apollo Tyres, BSE, Godfrey Phillips, and over 100 others reporting Q1 earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMimgJBVV95cUxNQWx2Y2hmUzdkb2VHSTJhSGg5eE5NcktoQ1dUaUlKZmlKSXlEU3BoVWpOeTdzanNvajhCbHU5b0x4bWpPVWczVF9jTTBvdWVNeUM1UVMzWWV1MzEwSDBEajFHTmZZLWVORWlKRWR0a2stZDZKdUVxWlRpU2YtTm9LaE5DaFh5ZE41NDVJdGw2aTZ4OWRMNlR5eWV1alh3UkpsUWFhdVFEbVpBdEl5WjEyaFJwUF90UDM5S0IzNjE5UE9rZ2loVE82VzkxWVBTSGYtVHU5Q2h3RGhHNmxRaC16V2hYWGlyLU0xd29jVTBhZHpFLXhBdVB6bWIydWxOVW16blJhVWF2QVhoYm92b3VkcER3V1dZeUFfY1E?oc=5"" target=""_blank"">Q1 Results 2024: Pidilite Industries, Apollo Tyres, BSE, Godfrey Phillips, and over 100 others reporting Q1 earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMimgJBVV95cUxNQWx2Y2hmUzdkb2VHSTJhSGg5eE5NcktoQ1dUaUlKZmlKSXlEU3BoVWpOeTdzanNvajhCbHU5b0x4bWpPVWczVF9jTTBvdWVNeUM1UVMzWWV1MzEwSDBEajFHTmZZLWVORWlKRWR0a2stZDZKdUVxWlRpU2YtTm9LaE5DaFh5ZE41NDVJdGw2aTZ4OWRMNlR5eWV1alh3UkpsUWFhdVFEbVpBdEl5WjEyaFJwUF90UDM5S0IzNjE5UE9rZ2loVE82VzkxWVBTSGYtVHU5Q2h3RGhHNmxRaC16V2hYWGlyLU0xd29jVTBhZHpFLXhBdVB6bWIydWxOVW16blJhVWF2QVhoYm92b3VkcER3V1dZeUFfY1E?oc=5,Google News,Biocon Q1 earnings,"Q1 Results 2024: Pidilite Industries, Apollo Tyres, BSE, Godfrey Phillips, and over 100 others reporting Q1 earnings today - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMimgJBVV95cUxNQWx2Y2hmUzdkb2VHSTJhSGg5eE5NcktoQ1dUaUlKZmlKSXlEU3BoVWpOeTdzanNvajhCbHU5b0x4bWpPVWczVF9jTTBvdWVNeUM1UVMzWWV1MzEwSDBEajFHTmZZLWVORWlKRWR0a2stZDZKdUVxWlRpU2YtTm9LaE5DaFh5ZE41NDVJdGw2aTZ4OWRMNlR5eWV1alh3UkpsUWFhdVFEbVpBdEl5WjEyaFJwUF90UDM5S0IzNjE5UE9rZ2loVE82VzkxWVBTSGYtVHU5Q2h3RGhHNmxRaC16V2hYWGlyLU0xd29jVTBhZHpFLXhBdVB6bWIydWxOVW16blJhVWF2QVhoYm92b3VkcER3V1dZeUFfY1E?oc=5"" target=""_blank"">Q1 Results 2024: Pidilite Industries, Apollo Tyres, BSE, Godfrey Phillips, and over 100 others reporting Q1 earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9001234769821167,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9001234769821167,other,0.0,[],False,False,1,0.0
2024-08-13,2024-08-13 07:00:00,"Q1 Results 2024: Hindalco, Hero Motocorp, GMR Airports, Nykaa, Omaxe and over 400 others release Q1 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMikgJBVV95cUxPTkdraDlaNmdyazZVZlVXcTZyTG15Mm1LQVJPeDFjWFdEUXljTmx3V0VCbmNfVWNreUFGTC1ib3M1aC14Rmlqak5zSzZxTElCbHVQLVRzZUpTMzRBcGh0YzlUMERRQnQ3eGNHV2s4MTZkS29peGFoOE0yQ2d6ZU5Wb3FSZzgzTFhUSXlkV3FvQVpRNnVOazRHakZZQlJXajh6cllEM1hzSTBUZG1oMXZpZU9NWW40cnYyMzlocDFqSEN5RVlsdFY0cGkzaFUwcWFrNUdCajRuSkVja0dWQWdxN1UxeVFWTUpRYURkcWp2SEZBajRZU2hMWDJHNjFYTjA3bEs4XzBJTzZlY2t6Yk1YZ05R?oc=5"" target=""_blank"">Q1 Results 2024: Hindalco, Hero Motocorp, GMR Airports, Nykaa, Omaxe and over 400 others release Q1 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMikgJBVV95cUxPTkdraDlaNmdyazZVZlVXcTZyTG15Mm1LQVJPeDFjWFdEUXljTmx3V0VCbmNfVWNreUFGTC1ib3M1aC14Rmlqak5zSzZxTElCbHVQLVRzZUpTMzRBcGh0YzlUMERRQnQ3eGNHV2s4MTZkS29peGFoOE0yQ2d6ZU5Wb3FSZzgzTFhUSXlkV3FvQVpRNnVOazRHakZZQlJXajh6cllEM1hzSTBUZG1oMXZpZU9NWW40cnYyMzlocDFqSEN5RVlsdFY0cGkzaFUwcWFrNUdCajRuSkVja0dWQWdxN1UxeVFWTUpRYURkcWp2SEZBajRZU2hMWDJHNjFYTjA3bEs4XzBJTzZlY2t6Yk1YZ05R?oc=5,Google News,Biocon Q1 earnings,"Q1 Results 2024: Hindalco, Hero Motocorp, GMR Airports, Nykaa, Omaxe and over 400 others release Q1 results today - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMikgJBVV95cUxPTkdraDlaNmdyazZVZlVXcTZyTG15Mm1LQVJPeDFjWFdEUXljTmx3V0VCbmNfVWNreUFGTC1ib3M1aC14Rmlqak5zSzZxTElCbHVQLVRzZUpTMzRBcGh0YzlUMERRQnQ3eGNHV2s4MTZkS29peGFoOE0yQ2d6ZU5Wb3FSZzgzTFhUSXlkV3FvQVpRNnVOazRHakZZQlJXajh6cllEM1hzSTBUZG1oMXZpZU9NWW40cnYyMzlocDFqSEN5RVlsdFY0cGkzaFUwcWFrNUdCajRuSkVja0dWQWdxN1UxeVFWTUpRYURkcWp2SEZBajRZU2hMWDJHNjFYTjA3bEs4XzBJTzZlY2t6Yk1YZ05R?oc=5"" target=""_blank"">Q1 Results 2024: Hindalco, Hero Motocorp, GMR Airports, Nykaa, Omaxe and over 400 others release Q1 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9368178248405457,0.0,neutral,0.0,0.802,0.159,0.0,0.841,0.0,0.0,0.0,0.8694089124202729,other,0.0,[],False,False,1,0.0
2024-08-07,2024-08-07 07:00:00,Mukesh Ambani draws no salary for fourth year in a row - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPZmhBWjNuZXMwcmxDVEp3bnJ1T191NFNlV1p5VjFiOGpFa1BnZmFxbF8tTS1lUnJ3VEV6Q3M5bmtfb0h4dXc3TWVEd2p2VmFNRVdWem45YldHSVdzWEVBUFlxNXVvc3ZoU29ZdUNrVTBCTkRjNXVXZUU1cGZJWURHNC1LNzNyUFdkbDAzcWNLeVhmNzBwZTQySmRBZExhVnhzUS1IbnVJOU9uMmM5Q1JHcmsxWnk?oc=5"" target=""_blank"">Mukesh Ambani draws no salary for fourth year in a row</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxPZmhBWjNuZXMwcmxDVEp3bnJ1T191NFNlV1p5VjFiOGpFa1BnZmFxbF8tTS1lUnJ3VEV6Q3M5bmtfb0h4dXc3TWVEd2p2VmFNRVdWem45YldHSVdzWEVBUFlxNXVvc3ZoU29ZdUNrVTBCTkRjNXVXZUU1cGZJWURHNC1LNzNyUFdkbDAzcWNLeVhmNzBwZTQySmRBZExhVnhzUS1IbnVJOU9uMmM5Q1JHcmsxWnk?oc=5,Google News,Biocon Q1 earnings,"Mukesh Ambani draws no salary for fourth year in a row - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPZmhBWjNuZXMwcmxDVEp3bnJ1T191NFNlV1p5VjFiOGpFa1BnZmFxbF8tTS1lUnJ3VEV6Q3M5bmtfb0h4dXc3TWVEd2p2VmFNRVdWem45YldHSVdzWEVBUFlxNXVvc3ZoU29ZdUNrVTBCTkRjNXVXZUU1cGZJWURHNC1LNzNyUFdkbDAzcWNLeVhmNzBwZTQySmRBZExhVnhzUS1IbnVJOU9uMmM5Q1JHcmsxWnk?oc=5"" target=""_blank"">Mukesh Ambani draws no salary for fourth year in a row</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",-0.6883777976036072,negative,0.6883777976036072,0.0,neutral,0.0,-0.5267,0.0,0.167,0.833,0.0,0.0,-0.3933587414877755,0.6075388988018036,other,0.0,[],False,False,1,0.0
2024-08-08,2024-08-08 07:00:00,FMCG sector growth at 4% in Apr-June on relaxed consumption: NielsenIQ data - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">FMCG sector growth at 4% in Apr-June on relaxed consumption: NielsenIQ data</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q1 earnings,"FMCG sector growth at 4% in Apr-June on relaxed consumption: NielsenIQ data - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">FMCG sector growth at 4% in Apr-June on relaxed consumption: NielsenIQ data</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.7658940553665161,0.0,neutral,0.0,0.891,0.309,0.0,0.691,0.0,0.0,0.0,0.8284470276832581,other,0.0,[],False,False,1,0.0
2024-08-08,2024-08-08 07:00:00,Domestic steel prices plunge to 45-month low as supplies outpace demand - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMiywFBVV95cUxPZ2R6UFlZaExMWE5OS19MYnFkNEwzUk02MjZXMXpqX2dtUjY2aXVxWEh0OS11WS04YXBtXy1ZVm1aeDF6TVBDNUh4ZTlQc19ZYmZyN3FmdWE2VFczNFJMSy16TGFlZHNpeUxxYmw4WV95QU5FMDdrOERQcFVCZldET2Z5LXhSempqVVRuVXF2WFVQWHlJaU51X1VxSnk0MGZqeWgwRk5TUmVPM2VrdmwwTHA1emlJZ21jZVhJemdkd2UzWk56Znp6b0Jpcw?oc=5"" target=""_blank"">Domestic steel prices plunge to 45-month low as supplies outpace demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiywFBVV95cUxPZ2R6UFlZaExMWE5OS19MYnFkNEwzUk02MjZXMXpqX2dtUjY2aXVxWEh0OS11WS04YXBtXy1ZVm1aeDF6TVBDNUh4ZTlQc19ZYmZyN3FmdWE2VFczNFJMSy16TGFlZHNpeUxxYmw4WV95QU5FMDdrOERQcFVCZldET2Z5LXhSempqVVRuVXF2WFVQWHlJaU51X1VxSnk0MGZqeWgwRk5TUmVPM2VrdmwwTHA1emlJZ21jZVhJemdkd2UzWk56Znp6b0Jpcw?oc=5,Google News,Biocon Q1 earnings,"Domestic steel prices plunge to 45-month low as supplies outpace demand - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMiywFBVV95cUxPZ2R6UFlZaExMWE5OS19MYnFkNEwzUk02MjZXMXpqX2dtUjY2aXVxWEh0OS11WS04YXBtXy1ZVm1aeDF6TVBDNUh4ZTlQc19ZYmZyN3FmdWE2VFczNFJMSy16TGFlZHNpeUxxYmw4WV95QU5FMDdrOERQcFVCZldET2Z5LXhSempqVVRuVXF2WFVQWHlJaU51X1VxSnk0MGZqeWgwRk5TUmVPM2VrdmwwTHA1emlJZ21jZVhJemdkd2UzWk56Znp6b0Jpcw?oc=5"" target=""_blank"">Domestic steel prices plunge to 45-month low as supplies outpace demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",-0.9690359830856323,negative,0.9690359830856323,0.0,neutral,0.0,-0.5719,0.0,0.199,0.801,0.0,0.175,-0.5537348474775041,0.7704679915428161,other,0.0,[],False,False,1,0.0
2022-04-25,2022-04-25 07:00:00,Duopharma and Biocon to Supply Insugen to MOH - BusinessToday Malaysia,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQVnZKQzNqazNJR1RjV2YtbkFhS3JGaWNVUXN2b3lIQ1RVU0pweDRqQ25jZ2YwdVRXMGxYNmplaUV5M1loaVlZWFVHdEtUTHZ1UmZ5ZW9uUHk4SEZjVkpPVE84RHhCWjVMVXhtTVlmTWl5TXVTTk9pRlJUdUxsbFFRWlRESUozeXRqTFpOMkxrYjBfNlIx?oc=5"" target=""_blank"">Duopharma and Biocon to Supply Insugen to MOH</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessToday Malaysia</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQVnZKQzNqazNJR1RjV2YtbkFhS3JGaWNVUXN2b3lIQ1RVU0pweDRqQ25jZ2YwdVRXMGxYNmplaUV5M1loaVlZWFVHdEtUTHZ1UmZ5ZW9uUHk4SEZjVkpPVE84RHhCWjVMVXhtTVlmTWl5TXVTTk9pRlJUdUxsbFFRWlRESUozeXRqTFpOMkxrYjBfNlIx?oc=5,Google News,Biocon Q1 earnings,"Duopharma and Biocon to Supply Insugen to MOH - BusinessToday Malaysia <a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQVnZKQzNqazNJR1RjV2YtbkFhS3JGaWNVUXN2b3lIQ1RVU0pweDRqQ25jZ2YwdVRXMGxYNmplaUV5M1loaVlZWFVHdEtUTHZ1UmZ5ZW9uUHk4SEZjVkpPVE84RHhCWjVMVXhtTVlmTWl5TXVTTk9pRlJUdUxsbFFRWlRESUozeXRqTFpOMkxrYjBfNlIx?oc=5"" target=""_blank"">Duopharma and Biocon to Supply Insugen to MOH</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessToday Malaysia</font>",0.0,neutral,0.6078588962554932,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.6078588962554932,other,0.0,[],False,True,6,0.0
2024-10-31,2024-10-31 07:00:00,"Stock Radar: Larsen & Toubro, Biocon, Tata Power, DCM Shriram, Godavari Biorefineries, Yatharth... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Radar: Larsen & Toubro, Biocon, Tata Power, DCM Shriram, Godavari Biorefineries, Yatharth...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon Q2 earnings,"Stock Radar: Larsen & Toubro, Biocon, Tata Power, DCM Shriram, Godavari Biorefineries, Yatharth... - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Radar: Larsen & Toubro, Biocon, Tata Power, DCM Shriram, Godavari Biorefineries, Yatharth...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.9403284192085266,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9403284192085266,other,0.0,[],False,True,6,0.0
2024-10-31,2024-10-31 07:00:00,"Stocks to Watch, Oct 31: Biocon, L&T, Tata Power, RVNL, Zydus Wellness - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch, Oct 31: Biocon, L&amp;T, Tata Power, RVNL, Zydus Wellness</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q2 earnings,"Stocks to Watch, Oct 31: Biocon, L&T, Tata Power, RVNL, Zydus Wellness - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch, Oct 31: Biocon, L&amp;T, Tata Power, RVNL, Zydus Wellness</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.9301761984825134,0.0,neutral,0.0,0.4404,0.091,0.0,0.909,0.0,0.0,0.0,0.6852880992412567,other,0.0,[],False,True,6,0.0
2024-10-30,2024-10-30 07:00:00,Tata Power Q2FY25 results: Net profit rises 6% to Rs 926.53 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Tata Power Q2FY25 results: Net profit rises 6% to Rs 926.53 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q2 earnings,"Tata Power Q2FY25 results: Net profit rises 6% to Rs 926.53 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Tata Power Q2FY25 results: Net profit rises 6% to Rs 926.53 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9339812994003296,positive,0.9339812994003296,0.0,neutral,0.0,0.7003,0.172,0.0,0.828,0.0,0.0,0.5337035996573312,0.8171406497001648,other,0.0,[],False,False,1,0.0
2024-10-30,2024-10-30 07:00:00,"The bottom line: Private lenders stumble sequentially in Q2, PSBs shine - Business Standard","<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxQRXJvRFh0WVk0TnA0dzVxNXRMZmx0UDBfRmY2NTVIdW01MGRoYk9SRWlHWjBudkFncjRtV1l0QlFoZl9LZEJFb2xaTTF2RXNNUmthaHQ0amJPVkVUUzFudVA5NUQ2cm9YVG9femVtTnExUVBiX2lHb21mbXRIQTBfdFVXenc2OFctV3l6V2d5WlRpWFgxaVdiZjUtRGJYVjFzcjdVS3VzS2ZySTdhdzhLbG9tWnN6bl9qSEpBWENaMm5jb1M5aktUV1YwVHhPeF9HaVZ5Q9IB2gFBVV95cUxNcWxwZThwYU5FNm4tOW5Ddmw2OVItRl9nRFItX3VXb2hoWnJQbnltZS1tTlhDVHJtdGEzRU9Zd3VrZmNOT2dzUzN3XzJtVkJzYkFPMmwza05BRWdlRlVwcFBPakk5c2xvUWhPRUFsS1k5UXhNWWdvaWN5OWFVNElqVkkzYjZtbmE0Q3hrZFowVmVNRlV3TkdLZy1WYUpBRVNqbzUtNi1Hb1NlbkZBX1NBdmVaNUtvUDJBQl9LMm5FVU8tNFYwNDltdExXSVk1cUNFSTZhSE1Fa0t6UQ?oc=5"" target=""_blank"">The bottom line: Private lenders stumble sequentially in Q2, PSBs shine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q2 earnings,"The bottom line: Private lenders stumble sequentially in Q2, PSBs shine - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">The bottom line: Private lenders stumble sequentially in Q2, PSBs shine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9604055881500244,negative,0.9604055881500244,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.016666666666666666,0.15833333333333333,-0.5488031932285854,0.48853612740834557,other,0.0,[],False,False,1,0.0
2024-10-30,2024-10-30 07:00:00,"Redington Q2 results: Net profit down at Rs 282.88 cr, total income rises - Business Standard","<a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxQQkRtNjlMUGJIMFlLZjl1cEZFdHJrQ0RmMDJsejktZVhMa2Q1ZHE2bXR1NTc1d0VYUDIzSnhwVVlYRFNUVTdad1BlZnA2ZDAtNmhLVWtoVkFGbUljZjIwZTZLM1IxeTEzRDFxbVVQTm5KdEt1NjJsdm16NUJ3VFI1eTZicmJnS0M4Z2UyN0V1UU1EdHJyZGh6TU1ZaTZ6ZHZqbXhHTWFDbXRZYUQxNXN1a2VVczlHOXQ1QldiMl9HbVF5aGdRNG9JSk5UNk1NbTZlUnhHTHhVVkVNMW_SAeABQVVfeXFMTktWeFlELUVEM1VvSDM1UGNMZmhuVUs0dk5wUHNvMWFyWlR1SGdKMEU3YzY5WEpSWlV4NWhrRE5XY1VGWVp0aGlzemNLUy1RY0V4Q1ZhYnlYRXNOQmJHbERZSkZmcldZRW5KTEdxQVBIYkNRb3J6ZWFucVJ2VkdoSUUtUWJCa2hlRGh4b1FnSWZaZlZXVS11X0pMaS1ma0VyQnlOTG04SGd0ZkQtSnV6bXA2WWZxcjRvOWk1T2FQVGNJaFRlZWNSRi0xQV9Xa1lXbjJWbklmWFR5VDlHenRrZE4?oc=5"" target=""_blank"">Redington Q2 results: Net profit down at Rs 282.88 cr, total income rises</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi2wFBVV95cUxQQkRtNjlMUGJIMFlLZjl1cEZFdHJrQ0RmMDJsejktZVhMa2Q1ZHE2bXR1NTc1d0VYUDIzSnhwVVlYRFNUVTdad1BlZnA2ZDAtNmhLVWtoVkFGbUljZjIwZTZLM1IxeTEzRDFxbVVQTm5KdEt1NjJsdm16NUJ3VFI1eTZicmJnS0M4Z2UyN0V1UU1EdHJyZGh6TU1ZaTZ6ZHZqbXhHTWFDbXRZYUQxNXN1a2VVczlHOXQ1QldiMl9HbVF5aGdRNG9JSk5UNk1NbTZlUnhHTHhVVkVNMW_SAeABQVVfeXFMTktWeFlELUVEM1VvSDM1UGNMZmhuVUs0dk5wUHNvMWFyWlR1SGdKMEU3YzY5WEpSWlV4NWhrRE5XY1VGWVp0aGlzemNLUy1RY0V4Q1ZhYnlYRXNOQmJHbERZSkZmcldZRW5KTEdxQVBIYkNRb3J6ZWFucVJ2VkdoSUUtUWJCa2hlRGh4b1FnSWZaZlZXVS11X0pMaS1ma0VyQnlOTG04SGd0ZkQtSnV6bXA2WWZxcjRvOWk1T2FQVGNJaFRlZWNSRi0xQV9Xa1lXbjJWbklmWFR5VDlHenRrZE4?oc=5,Google News,Biocon Q2 earnings,"Redington Q2 results: Net profit down at Rs 282.88 cr, total income rises - Business Standard <a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxQQkRtNjlMUGJIMFlLZjl1cEZFdHJrQ0RmMDJsejktZVhMa2Q1ZHE2bXR1NTc1d0VYUDIzSnhwVVlYRFNUVTdad1BlZnA2ZDAtNmhLVWtoVkFGbUljZjIwZTZLM1IxeTEzRDFxbVVQTm5KdEt1NjJsdm16NUJ3VFI1eTZicmJnS0M4Z2UyN0V1UU1EdHJyZGh6TU1ZaTZ6ZHZqbXhHTWFDbXRZYUQxNXN1a2VVczlHOXQ1QldiMl9HbVF5aGdRNG9JSk5UNk1NbTZlUnhHTHhVVkVNMW_SAeABQVVfeXFMTktWeFlELUVEM1VvSDM1UGNMZmhuVUs0dk5wUHNvMWFyWlR1SGdKMEU3YzY5WEpSWlV4NWhrRE5XY1VGWVp0aGlzemNLUy1RY0V4Q1ZhYnlYRXNOQmJHbERZSkZmcldZRW5KTEdxQVBIYkNRb3J6ZWFucVJ2VkdoSUUtUWJCa2hlRGh4b1FnSWZaZlZXVS11X0pMaS1ma0VyQnlOTG04SGd0ZkQtSnV6bXA2WWZxcjRvOWk1T2FQVGNJaFRlZWNSRi0xQV9Xa1lXbjJWbklmWFR5VDlHenRrZE4?oc=5"" target=""_blank"">Redington Q2 results: Net profit down at Rs 282.88 cr, total income rises</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9696741104125977,negative,0.9696741104125977,0.0,neutral,0.0,0.7003,0.162,0.0,0.838,-0.03888888888888889,0.25972222222222224,-0.5540994916643416,0.5696209997671622,other,0.0,[],False,False,1,0.0
2024-10-30,2024-10-30 07:00:00,DCM Shriram Q2 results: Net profit jumps 95% to Rs 62.92 cr on strong sales - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">DCM Shriram Q2 results: Net profit jumps 95% to Rs 62.92 cr on strong sales</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q2 earnings,"DCM Shriram Q2 results: Net profit jumps 95% to Rs 62.92 cr on strong sales - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">DCM Shriram Q2 results: Net profit jumps 95% to Rs 62.92 cr on strong sales</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9341588020324707,positive,0.9341588020324707,0.0,neutral,0.0,0.9081,0.279,0.0,0.721,0.14444444444444446,0.24444444444444446,0.5338050297328404,0.6622344154923051,other,0.0,[],False,False,1,0.0
2024-10-30,2024-10-30 07:00:00,Dabur Q2 results: Net profit falls 17% to Rs 425 crore on low urban demand - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Dabur Q2 results: Net profit falls 17% to Rs 425 crore on low urban demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q2 earnings,"Dabur Q2 results: Net profit falls 17% to Rs 425 crore on low urban demand - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Dabur Q2 results: Net profit falls 17% to Rs 425 crore on low urban demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9730197787284851,negative,0.9730197787284851,0.0,neutral,0.0,0.2732,0.136,0.134,0.729,0.0,0.075,-0.5560113021305629,0.6231098893642426,other,0.0,[],False,False,1,0.0
2023-11-15,2023-11-15 08:00:00,"Interview With Shreehas Tambe, MD On Biocon's Strong Q2 Earnings And Acquisition Plans - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Interview With Shreehas Tambe, MD On Biocon's Strong Q2 Earnings And Acquisition Plans</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon Q2 earnings,"Interview With Shreehas Tambe, MD On Biocon's Strong Q2 Earnings And Acquisition Plans - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Interview With Shreehas Tambe, MD On Biocon's Strong Q2 Earnings And Acquisition Plans</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.7479197382926941,0.0,neutral,0.0,0.765,0.18,0.0,0.82,0.2888888888888889,0.48888888888888893,0.0,0.6006028757271944,other,0.0,[],False,True,6,0.0
2024-10-29,2024-10-29 07:00:00,"Q2 Result 2024 Highlights: Maruti Suzuki India, Adani Enterprises, Cipla, Marico, V-Mart, others report Q2 numbers today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMiigJBVV95cUxNZEk2RXdvaTdjMFdlTnl2RkRCaVhxdDNwR1E5Rks1b21sRXA5cFJYTnlqeDJzcVpIbEVBNEl3QXNZZWRZZXk4ZVVHczcwNjRILVBydEsyMVpna0ktbjM1b2c1b0t6Skp0eHRwRDBDbFpHWmRUeEM1OVUxVEtIYlFtVmFyV0dpSjBmVWh4ZFJqTlhjLUNNRjMxVGJlY0lOVHZVR3FONXVyWDhDZl9sM3NJY3BrYlc5eFJDRVZpdFdPMmtuYk9YMFpHcFJ3SU5QN1hKTnZWVm9ETE5WSEQzNXpuQkhaWEhMU0ZhS2JxRGhEOVZMcGowLVNmVVRMN0NwZkNXSDZleU52anNQUQ?oc=5"" target=""_blank"">Q2 Result 2024 Highlights: Maruti Suzuki India, Adani Enterprises, Cipla, Marico, V-Mart, others report Q2 numbers today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiigJBVV95cUxNZEk2RXdvaTdjMFdlTnl2RkRCaVhxdDNwR1E5Rks1b21sRXA5cFJYTnlqeDJzcVpIbEVBNEl3QXNZZWRZZXk4ZVVHczcwNjRILVBydEsyMVpna0ktbjM1b2c1b0t6Skp0eHRwRDBDbFpHWmRUeEM1OVUxVEtIYlFtVmFyV0dpSjBmVWh4ZFJqTlhjLUNNRjMxVGJlY0lOVHZVR3FONXVyWDhDZl9sM3NJY3BrYlc5eFJDRVZpdFdPMmtuYk9YMFpHcFJ3SU5QN1hKTnZWVm9ETE5WSEQzNXpuQkhaWEhMU0ZhS2JxRGhEOVZMcGowLVNmVVRMN0NwZkNXSDZleU52anNQUQ?oc=5,Google News,Biocon Q2 earnings,"Q2 Result 2024 Highlights: Maruti Suzuki India, Adani Enterprises, Cipla, Marico, V-Mart, others report Q2 numbers today - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMiigJBVV95cUxNZEk2RXdvaTdjMFdlTnl2RkRCaVhxdDNwR1E5Rks1b21sRXA5cFJYTnlqeDJzcVpIbEVBNEl3QXNZZWRZZXk4ZVVHczcwNjRILVBydEsyMVpna0ktbjM1b2c1b0t6Skp0eHRwRDBDbFpHWmRUeEM1OVUxVEtIYlFtVmFyV0dpSjBmVWh4ZFJqTlhjLUNNRjMxVGJlY0lOVHZVR3FONXVyWDhDZl9sM3NJY3BrYlc5eFJDRVZpdFdPMmtuYk9YMFpHcFJ3SU5QN1hKTnZWVm9ETE5WSEQzNXpuQkhaWEhMU0ZhS2JxRGhEOVZMcGowLVNmVVRMN0NwZkNXSDZleU52anNQUQ?oc=5"" target=""_blank"">Q2 Result 2024 Highlights: Maruti Suzuki India, Adani Enterprises, Cipla, Marico, V-Mart, others report Q2 numbers today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9202821254730225,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9202821254730225,other,0.0,[],False,False,1,0.0
2024-10-29,2024-10-29 07:00:00,"Q2 Result 2024: Bharti Airtel, Indian Oil, Ambuja Cements, PNB, IGL, Pfizer, Sun Pharma, others releasing Q2 report today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilAJBVV95cUxQc0U2VXNNeUpWczlJQVBrMF83RFQtd3NEeWc0LXhuNjc5eDlyb3k5T1JpQlZ5cE9MNGM2TlF2M2VQZzFSaVY4OHNCbk9SLUF1QVQ1SFpuX1FfbGl3ZGg2VjhWT2JJSEIxc2tXWDNJRVhUNjFNOGZDa0dsVXB0bFhsc3puTTB2aUhxVlFTb3VGbkstb3BoRG1WREFJTTJGU1hOU0pQNWVpeVhyc3lTbDFWZDBSeVp5Wk9RbkFtZTBsbFZQYW1WNm9TVGhnMnRTN05SVC10cGloNk1DUmtaYklfQ2dNcWxsckxsU0VwSWRzQ2ZxMXM1ZkJKNzJQWkh3UXJXM2FWMUg5QjZWbEJITkEydkU4ZEw?oc=5"" target=""_blank"">Q2 Result 2024: Bharti Airtel, Indian Oil, Ambuja Cements, PNB, IGL, Pfizer, Sun Pharma, others releasing Q2 report today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilAJBVV95cUxQc0U2VXNNeUpWczlJQVBrMF83RFQtd3NEeWc0LXhuNjc5eDlyb3k5T1JpQlZ5cE9MNGM2TlF2M2VQZzFSaVY4OHNCbk9SLUF1QVQ1SFpuX1FfbGl3ZGg2VjhWT2JJSEIxc2tXWDNJRVhUNjFNOGZDa0dsVXB0bFhsc3puTTB2aUhxVlFTb3VGbkstb3BoRG1WREFJTTJGU1hOU0pQNWVpeVhyc3lTbDFWZDBSeVp5Wk9RbkFtZTBsbFZQYW1WNm9TVGhnMnRTN05SVC10cGloNk1DUmtaYklfQ2dNcWxsckxsU0VwSWRzQ2ZxMXM1ZkJKNzJQWkh3UXJXM2FWMUg5QjZWbEJITkEydkU4ZEw?oc=5,Google News,Biocon Q2 earnings,"Q2 Result 2024: Bharti Airtel, Indian Oil, Ambuja Cements, PNB, IGL, Pfizer, Sun Pharma, others releasing Q2 report today - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMilAJBVV95cUxQc0U2VXNNeUpWczlJQVBrMF83RFQtd3NEeWc0LXhuNjc5eDlyb3k5T1JpQlZ5cE9MNGM2TlF2M2VQZzFSaVY4OHNCbk9SLUF1QVQ1SFpuX1FfbGl3ZGg2VjhWT2JJSEIxc2tXWDNJRVhUNjFNOGZDa0dsVXB0bFhsc3puTTB2aUhxVlFTb3VGbkstb3BoRG1WREFJTTJGU1hOU0pQNWVpeVhyc3lTbDFWZDBSeVp5Wk9RbkFtZTBsbFZQYW1WNm9TVGhnMnRTN05SVC10cGloNk1DUmtaYklfQ2dNcWxsckxsU0VwSWRzQ2ZxMXM1ZkJKNzJQWkh3UXJXM2FWMUg5QjZWbEJITkEydkU4ZEw?oc=5"" target=""_blank"">Q2 Result 2024: Bharti Airtel, Indian Oil, Ambuja Cements, PNB, IGL, Pfizer, Sun Pharma, others releasing Q2 report today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.0,neutral,0.9421235918998718,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9421235918998718,other,0.0,[],False,False,1,0.0
2023-11-10,2023-11-10 08:00:00,"Eicher Motors Q2 net profit rises 55% to Rs 1,016 cr on robust sales - Business Standard","<a href=""https://news.google.com/rss/articles/CBMi1gFBVV95cUxOUHZJeWpuQzNTWFJPNEk4NThmcVJYY3JsSzJaWkVoOTRSMl9mYmQ2aWptWmNneWdpX2NnQkJwM0VnYzI3aHM5TGtOSXRhRHR0VHVDZGNHZXk0c3JrcmlqVVN2RE5yNjlKOU01WTh6T2JxSjcyNjU3Und2MjRzbnYxbEJMZllSUzlYZGhqUEFxVGFSVDFMZFFyVUY1SmNybzRHLU1LTWpuWmhZZGotSlFzS1MzLTRaVHNRbE0yeTJKT1ltMHpKTTBxbWJtMEpDTDRwOHUxbTZ30gHbAUFVX3lxTE9NZXZvTHpYOEpWZ3pYU1ROM0lDTlh1QTAxaE1PSDN5VHEwelBEazJsUnd4dTZwYUtGcmREbWhsaFVzQ0RLUzV3LUE5dFNTV2NtYk85TnhzSWVlTFF3RHNoWEQ2bnZtTTc2bkdldGZyaHl1ckhMRzFtTDQwOUVFQXhtSHdCTDFzWTJYSkxIUVo5Q3k5ZmtZbU94azAzRDliV045cndURHJseWFYWUF6cGw2bVpobmI0YWpNeDdWRVVINTRTZktWXzdYMmlQaEYzT0RSa0c5eWNabUpoNA?oc=5"" target=""_blank"">Eicher Motors Q2 net profit rises 55% to Rs 1,016 cr on robust sales</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q2 earnings,"Eicher Motors Q2 net profit rises 55% to Rs 1,016 cr on robust sales - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Eicher Motors Q2 net profit rises 55% to Rs 1,016 cr on robust sales</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9354284405708313,positive,0.9354284405708313,0.0,neutral,0.0,0.8625,0.261,0.0,0.739,0.0,0.0,0.5345305374690464,0.8989642202854157,other,0.0,[],False,False,1,0.0
2024-10-31,2024-10-31 07:00:00,"Stocks To Watch Today: L&T, Tata Power, Dabur, Tata Invest, RVNL and other stocks in focus on Oct 31 - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Watch Today: L&amp;T, Tata Power, Dabur, Tata Invest, RVNL and other stocks in focus on Oct 31</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News,Biocon Q2 earnings,"Stocks To Watch Today: L&T, Tata Power, Dabur, Tata Invest, RVNL and other stocks in focus on Oct 31 - ET Now <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Watch Today: L&amp;T, Tata Power, Dabur, Tata Invest, RVNL and other stocks in focus on Oct 31</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",0.0,neutral,0.938981294631958,0.0,neutral,0.0,0.0,0.0,0.0,1.0,-0.08333333333333333,0.25,0.0,0.5111573139826456,other,0.0,[],False,False,1,0.0
2024-10-30,2024-10-30 07:00:00,"Stocks to watch on October 31: Tata Investment Corp, L&T, Cipla, Yatharth Hospital, Biocon and more - Upstox","<a href=""https://news.google.com/rss/articles/CBMi7gFBVV95cUxNTzE1eHVJbmdxQWFXVkVYc2hzQktxLUVKTXplM3FxckpEWVNnemlQN3Y2X3hKZEhnVFdpVjlQazFKcVdYSFIxQXY4RHpIYWszaDcyN09lQnZvQzdGVUZEbTRmZjU2WnFKQ2ktMUlmY1B1cVo3ZlNrZmpya2h6TXh5cnlQZGNxM0RueWJZYUtyYzN4NTZGU0Vmay1aQVpIRXhVWXlSVk1fc1BzMDBnajVxd1p5V3kxSlhtM2VjcWhsM1o4Yl9yT3RYcDRaY0kzeE1fZk84VzF2NzlhdFFlLW9ma0VaVTY5ZFFSV1Y3eEdn?oc=5"" target=""_blank"">Stocks to watch on October 31: Tata Investment Corp, L&amp;T, Cipla, Yatharth Hospital, Biocon and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi7gFBVV95cUxNTzE1eHVJbmdxQWFXVkVYc2hzQktxLUVKTXplM3FxckpEWVNnemlQN3Y2X3hKZEhnVFdpVjlQazFKcVdYSFIxQXY4RHpIYWszaDcyN09lQnZvQzdGVUZEbTRmZjU2WnFKQ2ktMUlmY1B1cVo3ZlNrZmpya2h6TXh5cnlQZGNxM0RueWJZYUtyYzN4NTZGU0Vmay1aQVpIRXhVWXlSVk1fc1BzMDBnajVxd1p5V3kxSlhtM2VjcWhsM1o4Yl9yT3RYcDRaY0kzeE1fZk84VzF2NzlhdFFlLW9ma0VaVTY5ZFFSV1Y3eEdn?oc=5,Google News,Biocon Q2 earnings,"Stocks to watch on October 31: Tata Investment Corp, L&T, Cipla, Yatharth Hospital, Biocon and more - Upstox <a href=""https://news.google.com/rss/articles/CBMi7gFBVV95cUxNTzE1eHVJbmdxQWFXVkVYc2hzQktxLUVKTXplM3FxckpEWVNnemlQN3Y2X3hKZEhnVFdpVjlQazFKcVdYSFIxQXY4RHpIYWszaDcyN09lQnZvQzdGVUZEbTRmZjU2WnFKQ2ktMUlmY1B1cVo3ZlNrZmpya2h6TXh5cnlQZGNxM0RueWJZYUtyYzN4NTZGU0Vmay1aQVpIRXhVWXlSVk1fc1BzMDBnajVxd1p5V3kxSlhtM2VjcWhsM1o4Yl9yT3RYcDRaY0kzeE1fZk84VzF2NzlhdFFlLW9ma0VaVTY5ZFFSV1Y3eEdn?oc=5"" target=""_blank"">Stocks to watch on October 31: Tata Investment Corp, L&amp;T, Cipla, Yatharth Hospital, Biocon and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.0,neutral,0.8132885098457336,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.25,0.25,0.0,0.5316442549228668,other,0.0,[],False,True,6,0.0
2025-01-31,2025-01-31 08:00:00,Biocon Q3 Results: PAT plunges 96% to ₹25 cr; revenue up 7% - BusinessLine,"<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxQYXBMLUU1OTNhUjJ6MVp3TDJHSDEtLXlHQjJzUm9DeG9XZy1LNFlieGl1YWV4aGNWQlVwSHNpQmdfRUx3blZqc1E5RnNBMGJ3NnFNQjRZN216RGJVbGJjek5qaVlGMC1IMHdscGppTm15cUNIZzRqTVBRZ2o4Mk5yWDFlZWZpdFNQVlFOdkgySUp0SWtmOVdlblpYWGhsa2R5MHJOdHFEWXlDT0l4c3RFVUt0bUhLUWxw0gG_AUFVX3lxTE5oa2VVMUVPX2RhQWVsdFYwQml4eUM0R0V1TmkwSW0zLUFSb1BCZHpJNTBkeFNkVGNjSEtyLTVLMzhwejU5N2VKQ09TQ0ttdlNGdFlTZHZwdThpSVI2VDVSVk1Va1V6T0o4cHFGbHA4QjR3b0VDdndLTGVKUWtQLTFHaU1QSFhYS0phOUV2NFAxajluOVNLeTBwMk1RNk9ORGZkOGxLVzE0eWVWODJuWVlNc0dtUW53N0dnNmQ3b3dv?oc=5"" target=""_blank"">Biocon Q3 Results: PAT plunges 96% to ₹25 cr; revenue up 7%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxQYXBMLUU1OTNhUjJ6MVp3TDJHSDEtLXlHQjJzUm9DeG9XZy1LNFlieGl1YWV4aGNWQlVwSHNpQmdfRUx3blZqc1E5RnNBMGJ3NnFNQjRZN216RGJVbGJjek5qaVlGMC1IMHdscGppTm15cUNIZzRqTVBRZ2o4Mk5yWDFlZWZpdFNQVlFOdkgySUp0SWtmOVdlblpYWGhsa2R5MHJOdHFEWXlDT0l4c3RFVUt0bUhLUWxw0gG_AUFVX3lxTE5oa2VVMUVPX2RhQWVsdFYwQml4eUM0R0V1TmkwSW0zLUFSb1BCZHpJNTBkeFNkVGNjSEtyLTVLMzhwejU5N2VKQ09TQ0ttdlNGdFlTZHZwdThpSVI2VDVSVk1Va1V6T0o4cHFGbHA4QjR3b0VDdndLTGVKUWtQLTFHaU1QSFhYS0phOUV2NFAxajluOVNLeTBwMk1RNk9ORGZkOGxLVzE0eWVWODJuWVlNc0dtUW53N0dnNmQ3b3dv?oc=5,Google News,Biocon Q3 earnings,"Biocon Q3 Results: PAT plunges 96% to ₹25 cr; revenue up 7% - BusinessLine <a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxQYXBMLUU1OTNhUjJ6MVp3TDJHSDEtLXlHQjJzUm9DeG9XZy1LNFlieGl1YWV4aGNWQlVwSHNpQmdfRUx3blZqc1E5RnNBMGJ3NnFNQjRZN216RGJVbGJjek5qaVlGMC1IMHdscGppTm15cUNIZzRqTVBRZ2o4Mk5yWDFlZWZpdFNQVlFOdkgySUp0SWtmOVdlblpYWGhsa2R5MHJOdHFEWXlDT0l4c3RFVUt0bUhLUWxw0gG_AUFVX3lxTE5oa2VVMUVPX2RhQWVsdFYwQml4eUM0R0V1TmkwSW0zLUFSb1BCZHpJNTBkeFNkVGNjSEtyLTVLMzhwejU5N2VKQ09TQ0ttdlNGdFlTZHZwdThpSVI2VDVSVk1Va1V6T0o4cHFGbHA4QjR3b0VDdndLTGVKUWtQLTFHaU1QSFhYS0phOUV2NFAxajluOVNLeTBwMk1RNk9ORGZkOGxLVzE0eWVWODJuWVlNc0dtUW53N0dnNmQ3b3dv?oc=5"" target=""_blank"">Biocon Q3 Results: PAT plunges 96% to ₹25 cr; revenue up 7%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",-0.6718848943710327,negative,0.6718848943710327,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,-0.3839342253548758,0.6718848943710327,other,0.0,[],False,True,6,0.0
2025-01-27,2025-01-27 08:00:00,"Q3 results today: Coal India, Tata Steel among 78 companies to announce earnings on Monday - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxNeEV6b29ESGhoNXlJc20wSkZ0OU0zV3d1UlNzRC13TUxUaXgybVBBcEhVMWxSUmJPbzQ5WjRBUk5UUEs2ZjFwakFXODkzT0cyY1lPS1I3d1NOajNGYWd0NmprNEp6c1k2OUVuQnU2Vmd0enhhbjlSV1Z4TDV6eXpCU3N4RzdlMlhWUUFpOTNsNEtKTnI0aGpHaURLeUxBWjJGYzU1WEo2VlFKbEdUeG1hZTBVeVhER2Q0ZTktcUxYakc1cV9GeGlGT3g3X3MxLVhzeWJSSzJfckJwNm9OQW1kQUlqcWsydXBhUVVOeVpZMEppamlOVWFMZV930gH_AUFVX3lxTFBHOW5KSEg0U1F5eUdJYnJoODJKVGZLUEZ6SjJLcHlfRGNWcGt2SzEyM3JfRk1sT3hjR0NhYXY2SWstZmEyS2o2WEVDUHZYUnlwMFpHUXJfbXBSSjFLTFVLdnp1b1lkQmxOT0VWdy1rT3BPRzhuVVhDWXZDMmdXSXNZdmtOOWFhVFBxdV9aandRUm1fek9vRTctM20xRWlCdktPZklabVlsbjFFdzI0VzBucUZuS1J3M2ZoaXV4d08zQXV4NHVOQzhZc19RNS1wZ3lpUmhVMkl5Ymc2NmdFWUZwbF9PLVBMNlZUX3BBZ2ZMdXNOMExaZ0c4cE9YWkRkYw?oc=5"" target=""_blank"">Q3 results today: Coal India, Tata Steel among 78 companies to announce earnings on Monday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxNeEV6b29ESGhoNXlJc20wSkZ0OU0zV3d1UlNzRC13TUxUaXgybVBBcEhVMWxSUmJPbzQ5WjRBUk5UUEs2ZjFwakFXODkzT0cyY1lPS1I3d1NOajNGYWd0NmprNEp6c1k2OUVuQnU2Vmd0enhhbjlSV1Z4TDV6eXpCU3N4RzdlMlhWUUFpOTNsNEtKTnI0aGpHaURLeUxBWjJGYzU1WEo2VlFKbEdUeG1hZTBVeVhER2Q0ZTktcUxYakc1cV9GeGlGT3g3X3MxLVhzeWJSSzJfckJwNm9OQW1kQUlqcWsydXBhUVVOeVpZMEppamlOVWFMZV930gH_AUFVX3lxTFBHOW5KSEg0U1F5eUdJYnJoODJKVGZLUEZ6SjJLcHlfRGNWcGt2SzEyM3JfRk1sT3hjR0NhYXY2SWstZmEyS2o2WEVDUHZYUnlwMFpHUXJfbXBSSjFLTFVLdnp1b1lkQmxOT0VWdy1rT3BPRzhuVVhDWXZDMmdXSXNZdmtOOWFhVFBxdV9aandRUm1fek9vRTctM20xRWlCdktPZklabVlsbjFFdzI0VzBucUZuS1J3M2ZoaXV4d08zQXV4NHVOQzhZc19RNS1wZ3lpUmhVMkl5Ymc2NmdFWUZwbF9PLVBMNlZUX3BBZ2ZMdXNOMExaZ0c4cE9YWkRkYw?oc=5,Google News,Biocon Q3 earnings,"Q3 results today: Coal India, Tata Steel among 78 companies to announce earnings on Monday - The Economic Times <a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxNeEV6b29ESGhoNXlJc20wSkZ0OU0zV3d1UlNzRC13TUxUaXgybVBBcEhVMWxSUmJPbzQ5WjRBUk5UUEs2ZjFwakFXODkzT0cyY1lPS1I3d1NOajNGYWd0NmprNEp6c1k2OUVuQnU2Vmd0enhhbjlSV1Z4TDV6eXpCU3N4RzdlMlhWUUFpOTNsNEtKTnI0aGpHaURLeUxBWjJGYzU1WEo2VlFKbEdUeG1hZTBVeVhER2Q0ZTktcUxYakc1cV9GeGlGT3g3X3MxLVhzeWJSSzJfckJwNm9OQW1kQUlqcWsydXBhUVVOeVpZMEppamlOVWFMZV930gH_AUFVX3lxTFBHOW5KSEg0U1F5eUdJYnJoODJKVGZLUEZ6SjJLcHlfRGNWcGt2SzEyM3JfRk1sT3hjR0NhYXY2SWstZmEyS2o2WEVDUHZYUnlwMFpHUXJfbXBSSjFLTFVLdnp1b1lkQmxOT0VWdy1rT3BPRzhuVVhDWXZDMmdXSXNZdmtOOWFhVFBxdV9aandRUm1fek9vRTctM20xRWlCdktPZklabVlsbjFFdzI0VzBucUZuS1J3M2ZoaXV4d08zQXV4NHVOQzhZc19RNS1wZ3lpUmhVMkl5Ymc2NmdFWUZwbF9PLVBMNlZUX3BBZ2ZMdXNOMExaZ0c4cE9YWkRkYw?oc=5"" target=""_blank"">Q3 results today: Coal India, Tata Steel among 78 companies to announce earnings on Monday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.8054074048995972,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.0,0.46937036911646524,other,0.0,[],False,False,1,0.0
2025-01-30,2025-01-30 08:00:00,"Q3 results today: Adani Enterprises, Adani Ports, L&T among 101 companies to declare earnings on January 30 - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q3 results today: Adani Enterprises, Adani Ports, L&amp;T among 101 companies to declare earnings on January 30</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News,Biocon Q3 earnings,"Q3 results today: Adani Enterprises, Adani Ports, L&T among 101 companies to declare earnings on January 30 - Mint <a href=""https://news.google.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?oc=5"" target=""_blank"">Q3 results today: Adani Enterprises, Adani Ports, L&amp;T among 101 companies to declare earnings on January 30</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",0.0,neutral,0.7995924353599548,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7995924353599548,other,0.0,[],False,False,1,0.0
2025-01-30,2025-01-30 08:00:00,"Brookfield REIT Q3: NOI grows 11% amid rise in occupancy, gross leasing - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Brookfield REIT Q3: NOI grows 11% amid rise in occupancy, gross leasing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q3 earnings,"Brookfield REIT Q3: NOI grows 11% amid rise in occupancy, gross leasing - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Brookfield REIT Q3: NOI grows 11% amid rise in occupancy, gross leasing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9425170421600342,positive,0.9425170421600342,0.0,neutral,0.0,-0.7351,0.0,0.181,0.819,0.0,0.0,0.5385811669485909,0.8388085210800171,other,0.0,[],False,False,1,0.0
2025-01-16,2025-01-16 08:00:00,"Ajit Mishra of Religare Broking picks Biocon, Marico as stocks to buy today - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Ajit Mishra of Religare Broking picks Biocon, Marico as stocks to buy today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q3 earnings,"Ajit Mishra of Religare Broking picks Biocon, Marico as stocks to buy today - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Ajit Mishra of Religare Broking picks Biocon, Marico as stocks to buy today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.0,neutral,0.8492865562438965,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.8492865562438965,other,0.0,[],False,True,6,0.0
2025-01-31,2025-01-31 08:00:00,"Bank of Baroda, L&T, Biocon, IndusInd Bank, Nestle India| Stocks On Radar - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Bank of Baroda, L&amp;T, Biocon, IndusInd Bank, Nestle India| Stocks On Radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News,Biocon Q3 earnings,"Bank of Baroda, L&T, Biocon, IndusInd Bank, Nestle India| Stocks On Radar - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Bank of Baroda, L&amp;T, Biocon, IndusInd Bank, Nestle India| Stocks On Radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.9057552814483643,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9057552814483643,other,0.0,[],False,True,6,0.0
2025-01-31,2025-01-31 08:00:00,"Stocks in news today: L&T, JSW Steel, Wipro, Bank of Baroda, Biocon, Kalyan & PB Fintech - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news today: L&amp;T, JSW Steel, Wipro, Bank of Baroda, Biocon, Kalyan & PB Fintech</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon Q3 earnings,"Stocks in news today: L&T, JSW Steel, Wipro, Bank of Baroda, Biocon, Kalyan & PB Fintech - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news today: L&amp;T, JSW Steel, Wipro, Bank of Baroda, Biocon, Kalyan & PB Fintech</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.9316868185997009,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9316868185997009,other,0.0,[],False,True,6,0.0
2025-02-25,2025-02-25 08:00:00,"Stocks in news: NTPC, LIC, Biocon, ONGC, SBI Life, UPL, SBI Card, IREDA & Welspun Corp - Business Today","<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxOOGRzZ3R0dHVYazRodGNjVWcwakxPcjd1M1dwWUxBX0piVEpDMFQ5ZWw3cm1EZmZHSFRoeENIM2hqdWlwZ2J6bTRHRFlKM0pWQVhKQVIwWlhGZ3NIOGExdDEtTkxSVlc5TmgyTTNFOE5LNDVwdDhMRmpibXh5R2QxcHFiOUxUMGhEc3JKalUwRC1EdEloQ095VkZ0MGlUWkY4SG5IcHF2QTJYTjlpZlhZQXQ3bzdrMWtCczBmUHJuX0o0TTRqaFBTMVdGR3ZVelRQbFdBcGNyVnN5cEdP0gHiAUFVX3lxTFBkN1poVXN3NWRrMG5IdURlcUVtaFlNWGtuMDcxWkRobnZyY0w2ZERLWHZDQ3FNdVJtOWdicEFTdlpuem9td3FMVDhueHZIeTY2am9IdC1KNHRsNXVTN291UnFFSENZWWlDT0x1Z0tLUWNRenlnUjlfRUNBQk5ZX0x5R01LUWYzcmx4UlhnWGRZWlFENEVkNDA3YmRkdUk0OVgwV3QzRTUwalVvbi1yM0ZBaW9XZDNQWUswejRrMjJIZEtweU5SeW9rcTgxbnRNbllhSjlXNXd6M01fVkpHakJwc1E?oc=5"" target=""_blank"">Stocks in news: NTPC, LIC, Biocon, ONGC, SBI Life, UPL, SBI Card, IREDA & Welspun Corp</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon Q3 earnings,"Stocks in news: NTPC, LIC, Biocon, ONGC, SBI Life, UPL, SBI Card, IREDA & Welspun Corp - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: NTPC, LIC, Biocon, ONGC, SBI Life, UPL, SBI Card, IREDA & Welspun Corp</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.9325410723686218,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9325410723686218,other,0.0,[],False,True,6,0.0
2025-01-30,2025-01-30 08:00:00,"Q3 results: Adani Enterprises, L&T, GAIL, Waaree Energies, BEL among companies to post earnings on Jan 30; check list - Upstox","<a href=""https://news.google.com/rss/articles/CBMiggJBVV95cUxPTFUwNTF4dXBNbEt2b0U1VU1nNkRJOFhhZ3hmRnBCQ3VkbDdHbEFKelFKVE5QTlhKSjFSNG1mOGl5ZXBkVUpfZ0xXVURQQ3lMNHRuSjVTc1NDbTVoYWd0SGpoc1NDQzZvOXNvdHIwblhxMDVkWkRNc3laN1V2TjRjWTN0cWhGQkhvYjFOQXdYREZXVDNvSkFyaVRzYzR2YVl0RHVUdTROTmpqLUpPNk5IVV8tanJSbHc3RWRicmdGVE10Wm54ekhWV2FPWTh0emtQSnVFaVFRM2RRSzRfd0ZIV0NKbWlMbU42MWpqRzJKN2gwODhDN0E1dVhWUkdBeEU3REE?oc=5"" target=""_blank"">Q3 results: Adani Enterprises, L&amp;T, GAIL, Waaree Energies, BEL among companies to post earnings on Jan 30; check list</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMiggJBVV95cUxPTFUwNTF4dXBNbEt2b0U1VU1nNkRJOFhhZ3hmRnBCQ3VkbDdHbEFKelFKVE5QTlhKSjFSNG1mOGl5ZXBkVUpfZ0xXVURQQ3lMNHRuSjVTc1NDbTVoYWd0SGpoc1NDQzZvOXNvdHIwblhxMDVkWkRNc3laN1V2TjRjWTN0cWhGQkhvYjFOQXdYREZXVDNvSkFyaVRzYzR2YVl0RHVUdTROTmpqLUpPNk5IVV8tanJSbHc3RWRicmdGVE10Wm54ekhWV2FPWTh0emtQSnVFaVFRM2RRSzRfd0ZIV0NKbWlMbU42MWpqRzJKN2gwODhDN0E1dVhWUkdBeEU3REE?oc=5,Google News,Biocon Q3 earnings,"Q3 results: Adani Enterprises, L&T, GAIL, Waaree Energies, BEL among companies to post earnings on Jan 30; check list - Upstox <a href=""https://news.google.com/rss/articles/CBMiggJBVV95cUxPTFUwNTF4dXBNbEt2b0U1VU1nNkRJOFhhZ3hmRnBCQ3VkbDdHbEFKelFKVE5QTlhKSjFSNG1mOGl5ZXBkVUpfZ0xXVURQQ3lMNHRuSjVTc1NDbTVoYWd0SGpoc1NDQzZvOXNvdHIwblhxMDVkWkRNc3laN1V2TjRjWTN0cWhGQkhvYjFOQXdYREZXVDNvSkFyaVRzYzR2YVl0RHVUdTROTmpqLUpPNk5IVV8tanJSbHc3RWRicmdGVE10Wm54ekhWV2FPWTh0emtQSnVFaVFRM2RRSzRfd0ZIV0NKbWlMbU42MWpqRzJKN2gwODhDN0E1dVhWUkdBeEU3REE?oc=5"" target=""_blank"">Q3 results: Adani Enterprises, L&amp;T, GAIL, Waaree Energies, BEL among companies to post earnings on Jan 30; check list</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.0,neutral,0.8422154188156128,0.0,neutral,0.0,0.4215,0.087,0.0,0.913,0.0,0.0,0.0,0.6318577094078064,other,0.0,[],False,False,1,0.0
2025-02-28,2025-02-28 06:44:35,"Biocon Launches Diabetes, Obesity Management Drug In UK - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxOdC1CX045UHFvUVgzZ2hpYnFfUUg2QWVNVTNpVUtkVjJ3YjJnMHpJdUU2U3FNXzdmd2c4NGJlT25oZEw0WGQyMGM0eXp3cjFCaGxRNmY0LTI0QkFzQTM0ZDJ3VTVkYlBUNWVZbDhHUDllS1JzbXMzdzA1OGRJREg1RFFnakVhNm02dkZlbURqUk5iT0hwbmdjZzJn0gGaAUFVX3lxTE50LUJfTjlQcW9RWDNnaGlicV9RSDZBZU1VM2lVS2RWMndiMmcwekl1RTZTcU1fN2Z3Zzg0YmVPbmhkTDRYZDIwYzR5endyMUJobFE2ZjQtMjRCQXNBMzRkMndVNWRiUFQ1ZVlsOEdQOWVLUnNtczN3MDU4ZElESDVEUWdqRWE2bTZ2RmVtRGpSTmJPSHBuZ2NnMmc?oc=5"" target=""_blank"">Biocon Launches Diabetes, Obesity Management Drug In UK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxOdC1CX045UHFvUVgzZ2hpYnFfUUg2QWVNVTNpVUtkVjJ3YjJnMHpJdUU2U3FNXzdmd2c4NGJlT25oZEw0WGQyMGM0eXp3cjFCaGxRNmY0LTI0QkFzQTM0ZDJ3VTVkYlBUNWVZbDhHUDllS1JzbXMzdzA1OGRJREg1RFFnakVhNm02dkZlbURqUk5iT0hwbmdjZzJn0gGaAUFVX3lxTE50LUJfTjlQcW9RWDNnaGlicV9RSDZBZU1VM2lVS2RWMndiMmcwekl1RTZTcU1fN2Z3Zzg0YmVPbmhkTDRYZDIwYzR5endyMUJobFE2ZjQtMjRCQXNBMzRkMndVNWRiUFQ1ZVlsOEdQOWVLUnNtczN3MDU4ZElESDVEUWdqRWE2bTZ2RmVtRGpSTmJPSHBuZ2NnMmc?oc=5,Google News,Biocon Q3 earnings,"Biocon Launches Diabetes, Obesity Management Drug In UK - NDTV Profit <a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxOdC1CX045UHFvUVgzZ2hpYnFfUUg2QWVNVTNpVUtkVjJ3YjJnMHpJdUU2U3FNXzdmd2c4NGJlT25oZEw0WGQyMGM0eXp3cjFCaGxRNmY0LTI0QkFzQTM0ZDJ3VTVkYlBUNWVZbDhHUDllS1JzbXMzdzA1OGRJREg1RFFnakVhNm02dkZlbURqUk5iT0hwbmdjZzJn0gGaAUFVX3lxTE50LUJfTjlQcW9RWDNnaGlicV9RSDZBZU1VM2lVS2RWMndiMmcwekl1RTZTcU1fN2Z3Zzg0YmVPbmhkTDRYZDIwYzR5endyMUJobFE2ZjQtMjRCQXNBMzRkMndVNWRiUFQ1ZVlsOEdQOWVLUnNtczN3MDU4ZElESDVEUWdqRWE2bTZ2RmVtRGpSTmJPSHBuZ2NnMmc?oc=5"" target=""_blank"">Biocon Launches Diabetes, Obesity Management Drug In UK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",0.0,neutral,0.867076575756073,0.0,neutral,0.0,0.4404,0.121,0.0,0.879,0.0,0.0,0.0,0.6537382878780365,other,0.0,[],False,True,6,0.0
2025-01-31,2025-01-31 08:00:00,"Stocks to Watch Today: Larsen and Toubro, Wipro, PB Fintech, Biocon, IRCON, Kalyan Jewellers, Shree... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch Today: Larsen and Toubro, Wipro, PB Fintech, Biocon, IRCON, Kalyan Jewellers, Shree...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMiqAJBVV95cUxPRWZ0bl9vVTFDUENveXFzMnZLX1pwY2tZOGZQWFp4Smd2TE5OSloxNGRWQjNITHJWTU13a2dUUlNxUlRXUWJZZDBNMGw5WWdWU2M4d2FmTkJzNG1oRVUtbnZINGVYaFhHeW50Z2lKRC1rY2tjaFBPTXVWbHlMUUh0bTYyOEQ3eFpKdEpBVk1MWTFUYlRNWkc1bWFFdzZRMlltM2o2TVYwSGxjZXBabzZQWExUeHZzMXVXRG5kVjhHRlE3cXRJS3l4SkFMSUdaUUlQR3QyOEc4LUNCWmtWQmRmV0JOUDkwTlhzemc5cXM1bV9rY3JnMUY2QTBfbWhJV1Y2ZE5jZU9zWG1wTGpQT3Z3REtPVjRFbmVRVWl5NU5RM3Y3dm9FMXRFWdIBrgJBVV95cUxNVGtxa2JRNVJyQnFCN3c2ei1KOFVEVGJvUzFYOVJqSkdrMmhld2xTZXRtbmJpR092VzlqcEhwenpBLTlKX05lQlFxNUp3MllFcVUzNC1NNXctUGVha1YycXFtWVlxYndMQmdOeFRGNVlLMk1zSnRhcFRNRlkwOHh3QTBHbDUtd3pYbzZiUlhsTlBwWmRTU0p3VnRReG1QRDBMZ19QNFh3NFF5OEVhdlUtbllfZG9PN3JPMV9FWVVqNDUxMWI3a1h1TkFsdERQTWhTYzRCMUIwOFh2UFdjVU85QWxMSGFxM2kzQXZyc1N0SEEzUTRQLVBSaFZqdlBobTh5TV9Ydy1qN0dPSDZrRDc0SzlMUC1UV3pOVkZ4NUREazBkVzFXREUtVElZVVJtdw?oc=5,Google News,Biocon Q3 earnings,"Stocks to Watch Today: Larsen and Toubro, Wipro, PB Fintech, Biocon, IRCON, Kalyan Jewellers, Shree... - Moneycontrol <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch Today: Larsen and Toubro, Wipro, PB Fintech, Biocon, IRCON, Kalyan Jewellers, Shree...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",0.0,neutral,0.9308709502220154,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9308709502220154,other,0.0,[],False,True,6,0.0
2025-01-30,2025-01-30 08:00:00,"Q3 results today: L&T, Adani Enterprises among 133 companies to announce earnings on Thursday - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q3 results today: L&amp;T, Adani Enterprises among 133 companies to announce earnings on Thursday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News,Biocon Q3 earnings,"Q3 results today: L&T, Adani Enterprises among 133 companies to announce earnings on Thursday - The Economic Times <a href=""https://news.google.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?oc=5"" target=""_blank"">Q3 results today: L&amp;T, Adani Enterprises among 133 companies to announce earnings on Thursday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",0.0,neutral,0.8540019392967224,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13333333333333333,0.13333333333333333,0.0,0.49366763631502786,other,0.0,[],False,False,1,0.0
2025-01-31,2025-01-31 08:00:00,"Vishal Mega Mart Q3 Results | Net profit surges 28%, revenue up 20% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Vishal Mega Mart Q3 Results | Net profit surges 28%, revenue up 20%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMiwgFBVV95cUxNQjVGTldLalQ1TXB3MGkyNzE4NkpDdFI1dUxKUF9zNzZNNkdVaWRiRmdmdWFCcUpOaklLc213YWdBZWxNd2ZNdWE1S1NzQ0dOa1lkQTFaamJXNFF4eGFiSzZrWHoxT2VHX1lUR3AwWVJKcXFYb3JJc3E2SFRiTjBJT1dSV2h5UGYyMG1hYlpyaER2YkJYMkFaRUhpekxyUnRyNEVyX2R1c1hGci1ZT2tPSmtKSGZyeHRLQ0x5aE91QTBrUdIBxwFBVV95cUxNR0pEQWxOeTl0ZmhTSThxWGNIU0oyTzlaRFFkQUN1aUlNck9JU2NmSUl3bEZFWWFHeS1YVWNLaGpVRzZlRGVGOHFQdnJCVWhPNGhIVFdpMTU5Z3Z6TjY3ZVFldUhvY2ZRaHNXSjNUVXJfQThBdFhtTDlDMG9RQnFJVXJoVXVudXFmVGpIU2pVZ0I4dzJfSFV5dURSdkdxU2ZpNV9iNmpfelIwVm1oUXZ6QzFraWdjdUo4XzJlMkR4cXpLRDNDRGpz?oc=5,Google News,Biocon Q3 earnings,"Vishal Mega Mart Q3 Results | Net profit surges 28%, revenue up 20% - CNBC TV18 <a href=""https://news.google.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?oc=5"" target=""_blank"">Vishal Mega Mart Q3 Results | Net profit surges 28%, revenue up 20%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",0.9339975118637085,positive,0.9339975118637085,0.0,neutral,0.0,0.7003,0.172,0.0,0.828,0.0,0.0,0.5337128639221191,0.8171487559318542,other,0.0,[],False,False,1,0.0
2024-02-09,2024-02-09 08:00:00,Biocon Biologics partners with Sandoz Australia to sell cancer drugs - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxNOTNKam9GSkN5alFOa0VRZS1qTEhuWk1HUGdwX0VwRFRpR3ZmZVBuaENfTGttX3hTeGRIUGhoMU42MWhzek5DdHYzUzF2enBHeHpvanB4VGhla0hSWHRrYVBwV1Z1RmJ3TUhLZzlnZFNqbW92QXl4RkRtTWxjOE5sM2hTWmVFeFRISFZLQUZMYjVSWXdZYzhMdi1nWmtmY2k1c1dRMHFGbklrQ2QtZWtqdTFLQUdKOG5TbzlMV09LTGJ1VERZUldYMDZBNlh0engwZ1lN?oc=5"" target=""_blank"">Biocon Biologics partners with Sandoz Australia to sell cancer drugs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi0wFBVV95cUxNOTNKam9GSkN5alFOa0VRZS1qTEhuWk1HUGdwX0VwRFRpR3ZmZVBuaENfTGttX3hTeGRIUGhoMU42MWhzek5DdHYzUzF2enBHeHpvanB4VGhla0hSWHRrYVBwV1Z1RmJ3TUhLZzlnZFNqbW92QXl4RkRtTWxjOE5sM2hTWmVFeFRISFZLQUZMYjVSWXdZYzhMdi1nWmtmY2k1c1dRMHFGbklrQ2QtZWtqdTFLQUdKOG5TbzlMV09LTGJ1VERZUldYMDZBNlh0engwZ1lN?oc=5,Google News,Biocon Q3 earnings,"Biocon Biologics partners with Sandoz Australia to sell cancer drugs - Business Standard <a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxNOTNKam9GSkN5alFOa0VRZS1qTEhuWk1HUGdwX0VwRFRpR3ZmZVBuaENfTGttX3hTeGRIUGhoMU42MWhzek5DdHYzUzF2enBHeHpvanB4VGhla0hSWHRrYVBwV1Z1RmJ3TUhLZzlnZFNqbW92QXl4RkRtTWxjOE5sM2hTWmVFeFRISFZLQUZMYjVSWXdZYzhMdi1nWmtmY2k1c1dRMHFGbklrQ2QtZWtqdTFLQUdKOG5TbzlMV09LTGJ1VERZUldYMDZBNlh0engwZ1lN?oc=5"" target=""_blank"">Biocon Biologics partners with Sandoz Australia to sell cancer drugs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.678606390953064,positive,0.678606390953064,0.0,neutral,0.0,-0.8689,0.0,0.268,0.732,0.0,0.0,0.38777508054460796,0.773753195476532,other,0.0,[],False,True,6,0.0
2025-01-27,2025-01-27 08:00:00,"Eicher Motors, Tata Consumer, Biocon & Chambal Fertilisers: 4 stock picks by SMC Global - Business Today","<a href=""https://news.google.com/rss/articles/CBMi7gFBVV95cUxPOG5faWVuakNiOE5LZ0pKLXYyN0FuVFZ3eUVONE41UHFPT0tiYjN0R210cEVpV1FnQktEcGRWMFJIenowQU5vMUxEZ3ZKdlJvX1JjRGstMDhUQVVuME1zcVRTc1RBaUk4NkJHZE4tZ19XU3R0Wkt5aWZUQ29kWVZYc3h6RzJNZTNCYlVETDdpS0VLcDgyRHFXTlo1aXRnT3dubS10d2l2bUlmaU85a1BlaDRjQWY2WWptOUVTdEttTVFuVXc0cTlkdkw1TTRvLTlTRUdLR3RQQnpjZU5CNVRveEJhQXVSZjV3cDAtbEtB0gHzAUFVX3lxTFBIQ3FwWjJnZ1RkQzRzZzVuaUlQRjQyZGRKdEF1Z0did3Fjd242WUlYOUR5QnQtVjY3RUxLQkVIQl9rekdKV0ZBVmtpam5keWw4U2VLWnNLbVpZNGJvaTZRRGtMVFJ5MTl5Znc2UExIbWRObkx1ZjhuaXNlelBTa2U5eUplUEpZN0lBUVRDMnR3NGlBVlNLMUMtdTkxbWx3NWxYM2ZHV0pTajBwYktfd3NUYmhFcHJod1AzaUR4X3UxMjZaelcwNkVkZE9EYVRRN3VvaDA2UDFxUUYyUXF4NGZjSWtjaDYwdmFjb1ZPUk5ESl9Naw?oc=5"" target=""_blank"">Eicher Motors, Tata Consumer, Biocon & Chambal Fertilisers: 4 stock picks by SMC Global</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon Q3 earnings,"Eicher Motors, Tata Consumer, Biocon & Chambal Fertilisers: 4 stock picks by SMC Global - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Eicher Motors, Tata Consumer, Biocon & Chambal Fertilisers: 4 stock picks by SMC Global</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.9019786715507507,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9019786715507507,other,0.0,[],False,True,6,0.0
2025-01-23,2025-01-23 08:00:00,"Markets rebound! Nifty over 23,200, Sensex up 230 points led by tech stocks - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxQQVFTY1VOdmRjZE8zV3ZDUEZPT3RmZ1Q3cXN3MXpZX1JTLVVRb1ItWlFQdFVOWjBnLXZsSzdlVk9sSlZqQXNjN2VFejNEVTV6NlkwMWdNVGFDZ01xaC15cUVmSF91UDNZS1NmeWptdFdjdktXQTBFX1d6NzJQLUw5aUNKck95UVQ4bUdxVmp3TzBJTEFvZ1l3bGNCOEEzSHdRYjRlOVhqbk52LXd2UFJyb2tPRVJRQQ?oc=5"" target=""_blank"">Markets rebound! Nifty over 23,200, Sensex up 230 points led by tech stocks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxQQVFTY1VOdmRjZE8zV3ZDUEZPT3RmZ1Q3cXN3MXpZX1JTLVVRb1ItWlFQdFVOWjBnLXZsSzdlVk9sSlZqQXNjN2VFejNEVTV6NlkwMWdNVGFDZ01xaC15cUVmSF91UDNZS1NmeWptdFdjdktXQTBFX1d6NzJQLUw5aUNKck95UVQ4bUdxVmp3TzBJTEFvZ1l3bGNCOEEzSHdRYjRlOVhqbk52LXd2UFJyb2tPRVJRQQ?oc=5,Google News,Biocon Q3 earnings,"Markets rebound! Nifty over 23,200, Sensex up 230 points led by tech stocks - financialexpress.com <a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxQQVFTY1VOdmRjZE8zV3ZDUEZPT3RmZ1Q3cXN3MXpZX1JTLVVRb1ItWlFQdFVOWjBnLXZsSzdlVk9sSlZqQXNjN2VFejNEVTV6NlkwMWdNVGFDZ01xaC15cUVmSF91UDNZS1NmeWptdFdjdktXQTBFX1d6NzJQLUw5aUNKck95UVQ4bUdxVmp3TzBJTEFvZ1l3bGNCOEEzSHdRYjRlOVhqbk52LXd2UFJyb2tPRVJRQQ?oc=5"" target=""_blank"">Markets rebound! Nifty over 23,200, Sensex up 230 points led by tech stocks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",0.9337311387062073,positive,0.9337311387062073,0.0,neutral,0.0,0.717,0.176,0.0,0.824,0.0,0.0,0.5335606506892613,0.8253655693531037,other,0.0,[],False,False,1,0.0
2025-05-14,2025-05-14 07:00:00,Biocon Q4 FY25 consolidated PAT jumps 153% to Rs. 344 Cr - Indian Pharma Post,"<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxPaTZCaWZvc3BwTkJMWjV3N2ZYeE1YUkVWUjdaY3BmMWc1MEVzRzlQMDZIcDJsdVNQOU9JYzNwSWhIMEYyNlUtRFhlVUFlalp5TklESmZtQWJrbWUxbWprRnNmVzVvMmY2bm8zZlhobU1XMUxGaEN3YXZyQkR3OGJPUzVpNVVVZVdjTXVreWVIYWVnSkMzYW1BcXBBb0oyVUXSAaYBQVVfeXFMUDN2b0lrb3FGeDg1ZVE4WF9NZnlJaDZkdmNwczlVU2RvN3pLZEJlbHJtS29CT1lqY3Y1NmVqdGZmUnFmQ2xMbkoycTZpcmFySmxxZXgzdXVoLTFfU1g2b2Z5VXBVODZjX2wtTEFrNW16UWgzMHVhcDZwVEhSYXdTamdzUnZvXzlpNktwV2tWLXh6RjhjcVlkQWZsTS1QRklJazJtYUJwdw?oc=5"" target=""_blank"">Biocon Q4 FY25 consolidated PAT jumps 153% to Rs. 344 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxPaTZCaWZvc3BwTkJMWjV3N2ZYeE1YUkVWUjdaY3BmMWc1MEVzRzlQMDZIcDJsdVNQOU9JYzNwSWhIMEYyNlUtRFhlVUFlalp5TklESmZtQWJrbWUxbWprRnNmVzVvMmY2bm8zZlhobU1XMUxGaEN3YXZyQkR3OGJPUzVpNVVVZVdjTXVreWVIYWVnSkMzYW1BcXBBb0oyVUXSAaYBQVVfeXFMUDN2b0lrb3FGeDg1ZVE4WF9NZnlJaDZkdmNwczlVU2RvN3pLZEJlbHJtS29CT1lqY3Y1NmVqdGZmUnFmQ2xMbkoycTZpcmFySmxxZXgzdXVoLTFfU1g2b2Z5VXBVODZjX2wtTEFrNW16UWgzMHVhcDZwVEhSYXdTamdzUnZvXzlpNktwV2tWLXh6RjhjcVlkQWZsTS1QRklJazJtYUJwdw?oc=5,Google News,Biocon Q4 earnings,"Biocon Q4 FY25 consolidated PAT jumps 153% to Rs. 344 Cr - Indian Pharma Post <a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxPaTZCaWZvc3BwTkJMWjV3N2ZYeE1YUkVWUjdaY3BmMWc1MEVzRzlQMDZIcDJsdVNQOU9JYzNwSWhIMEYyNlUtRFhlVUFlalp5TklESmZtQWJrbWUxbWprRnNmVzVvMmY2bm8zZlhobU1XMUxGaEN3YXZyQkR3OGJPUzVpNVVVZVdjTXVreWVIYWVnSkMzYW1BcXBBb0oyVUXSAaYBQVVfeXFMUDN2b0lrb3FGeDg1ZVE4WF9NZnlJaDZkdmNwczlVU2RvN3pLZEJlbHJtS29CT1lqY3Y1NmVqdGZmUnFmQ2xMbkoycTZpcmFySmxxZXgzdXVoLTFfU1g2b2Z5VXBVODZjX2wtTEFrNW16UWgzMHVhcDZwVEhSYXdTamdzUnZvXzlpNktwV2tWLXh6RjhjcVlkQWZsTS1QRklJazJtYUJwdw?oc=5"" target=""_blank"">Biocon Q4 FY25 consolidated PAT jumps 153% to Rs. 344 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",0.9040159583091736,positive,0.9040159583091736,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.5165805476052421,0.9040159583091736,other,0.0,[],False,True,6,0.0
2025-05-09,2025-05-09 07:00:00,Biocon Q4 PAT zooms 154% YoY to Rs 344 crore - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxNZHROUnNLQTVOc0ZmN2Z0RllKMjJZeTRfcmNESjdSZm9yRDJnc0J0MlR4eWFpQjhjbG1wUHRERTVDWkJ0TTdUajlTemhvT0pES21JSFloaEg2SFRQQ1VTUDhjY3ZjVnRpYjBwbFh2azNEbktQR1NMSWhrcm55Z3dSOVc2cVlNOUhqSUNUd3dpTld4b25ZbDUwZ2xiQzBUNjQ5Y2xXdXp0REN2bmI2RFowMF9CRnpNTTBNMDJ5UF9paWs3WGPSAcgBQVVfeXFMUC1wUW9TaVJUOFc5aVNkR2lINGpGdTUzdjFDRlBIWlNnQk5xVkd2SHVsczFET25lYVJQdTNYQmR5cWlSTmR5djFZdTdqX2NLNDBRUy1ieHNnblBNc0VPRjN0SnBQOGt0SHk4bFNSSmhINmRaNTR2NUdETkJIMi1xVDZLcHZQYnZ3b3RJR09IZkppRjhEbk0tX19lREZDd2VkdVJvd3ZIVUI3VzlXWnl2bzY0OWJ5MzZzRGN5ZjVsQ1YzMUU3UHdlZnk?oc=5"" target=""_blank"">Biocon Q4 PAT zooms 154% YoY to Rs 344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q4 earnings,"Biocon Q4 PAT zooms 154% YoY to Rs 344 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 PAT zooms 154% YoY to Rs 344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.8337746858596802,positive,0.8337746858596802,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.4764426776341029,0.8337746858596802,other,0.0,[],False,True,6,0.0
2025-05-12,2025-05-12 11:50:51,"Biocon Q4 Result Review: Competition May Mire Down Potential Turnaround, Says ICICI Securities, Retains 'Sell' - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMi4wFBVV95cUxPSkdUam9WbUZOWklzd2JnMURKeU1hbF8tbXowa1hhVmlHeG9oSWZYeHNadndQQkZyYTdRclZiMU9xNkhPMGtpbmU1MUhIZU1BNkFkblhpMF93UE5Wak1fcFdXUThUZTIxRzJ3UHVUdGtqc0pTSWJUUzhWSGh0QjBrYXZwcmYyWUQwdml5S1VhRGJlTlJFenRIWjBJU0FzVVdsenhtQTl5dDVZVjdtMDdIeTB1OHBRMU9QTXFWdFA1TGdBQ0w2NEJraUh3TVRwcjVwbWtMT25KZWk2c1c4ZmVkQlNQbw?oc=5"" target=""_blank"">Biocon Q4 Result Review: Competition May Mire Down Potential Turnaround, Says ICICI Securities, Retains 'Sell'</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMi4wFBVV95cUxPSkdUam9WbUZOWklzd2JnMURKeU1hbF8tbXowa1hhVmlHeG9oSWZYeHNadndQQkZyYTdRclZiMU9xNkhPMGtpbmU1MUhIZU1BNkFkblhpMF93UE5Wak1fcFdXUThUZTIxRzJ3UHVUdGtqc0pTSWJUUzhWSGh0QjBrYXZwcmYyWUQwdml5S1VhRGJlTlJFenRIWjBJU0FzVVdsenhtQTl5dDVZVjdtMDdIeTB1OHBRMU9QTXFWdFA1TGdBQ0w2NEJraUh3TVRwcjVwbWtMT25KZWk2c1c4ZmVkQlNQbw?oc=5,Google News,Biocon Q4 earnings,"Biocon Q4 Result Review: Competition May Mire Down Potential Turnaround, Says ICICI Securities, Retains 'Sell' - NDTV Profit <a href=""https://news.google.com/rss/articles/CBMi4wFBVV95cUxPSkdUam9WbUZOWklzd2JnMURKeU1hbF8tbXowa1hhVmlHeG9oSWZYeHNadndQQkZyYTdRclZiMU9xNkhPMGtpbmU1MUhIZU1BNkFkblhpMF93UE5Wak1fcFdXUThUZTIxRzJ3UHVUdGtqc0pTSWJUUzhWSGh0QjBrYXZwcmYyWUQwdml5S1VhRGJlTlJFenRIWjBJU0FzVVdsenhtQTl5dDVZVjdtMDdIeTB1OHBRMU9QTXFWdFA1TGdBQ0w2NEJraUh3TVRwcjVwbWtMT25KZWk2c1c4ZmVkQlNQbw?oc=5"" target=""_blank"">Biocon Q4 Result Review: Competition May Mire Down Potential Turnaround, Says ICICI Securities, Retains 'Sell'</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",-0.9271616339683533,negative,0.9271616339683533,0.0,neutral,0.0,0.743,0.181,0.0,0.819,-0.06222222222222222,0.5155555555555555,-0.5298066479819161,0.5774612853968585,other,0.0,[],False,True,6,0.0
2025-04-11,2025-04-11 07:00:00,"Stocks to watch today, April 11: TCS, Tata Motors, Infosys, NBCC, SJVN, Vedanta, Gensol Engineering, Biocon - ET Now","<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxNUEZhYkJvdlJVY3UycG1SN0NTaGItdmU5UUZGSzNFdW9sWWVmQnQ0Z2tUeXc2OXBvZmJwZkJoZ3VBQ1RlZHJ6LWRVTHNvSnBvd1hSVkplaXdzSGlTenczNllRTTNkVHg1ajFjRWViWWh2anlGb0RVQXQxMjZHMm9jQlF3VVZuY05sMEpQVkl3Z2Iycm5sSXFTamVpRDltMlY3SUVRX3hjLVFhQWtITDZPdjZoR0p4VmVscFFzTkdrUy1xX3BRUUx3ZWl6Wm9RdW56TUMyOUhrVmoyLWRWN1RfTk1XVTTSAeoBQVVfeXFMUHh3NHo3cVlxdHBJQno1SmFub1ZoQ1N6RFd0TS1CZ0pxUnFQeGpUQ2NySVpENm9WWmRoNVJDZzNKWlczOV96QVJzN0hNMDltcC1WM1MxX21SMk9NMTBfYVVsdi02YVliRzZhZDllQkoxZE42Z3VLbENzckZOOEhZOFgzbHBCbmc1TmlOaGJKWDFNZ2tWWFNWalNDdjlxLVVjNnRpTEd1TW5FeEhwTUR0SDNmT0FjYmhuYzNWbGxqekZOZVlsdU1OYVltNXE4ejBCMS05aFA1eWlrMms2bjR6ejBBaW9jMng1aG9n?oc=5"" target=""_blank"">Stocks to watch today, April 11: TCS, Tata Motors, Infosys, NBCC, SJVN, Vedanta, Gensol Engineering, Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News,Biocon Q4 earnings,"Stocks to watch today, April 11: TCS, Tata Motors, Infosys, NBCC, SJVN, Vedanta, Gensol Engineering, Biocon - ET Now <a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch today, April 11: TCS, Tata Motors, Infosys, NBCC, SJVN, Vedanta, Gensol Engineering, Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",0.0,neutral,0.9428972601890564,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.9428972601890564,other,0.0,[],False,True,6,0.0
2025-05-09,2025-05-09 07:00:00,"Top stocks to watch: Titan, L&T, BPCL, Suzlon, Paytm, Lupin, Britannia, MCX India, Biocon - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top stocks to watch: Titan, L&amp;T, BPCL, Suzlon, Paytm, Lupin, Britannia, MCX India, Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon Q4 earnings,"Top stocks to watch: Titan, L&T, BPCL, Suzlon, Paytm, Lupin, Britannia, MCX India, Biocon - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Top stocks to watch: Titan, L&amp;T, BPCL, Suzlon, Paytm, Lupin, Britannia, MCX India, Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.9190394282341003,0.0,neutral,0.0,0.2023,0.052,0.0,0.948,0.25,0.25,0.0,0.4571131427447001,other,0.0,[],False,True,6,0.0
2025-04-28,2025-04-28 07:00:00,"Top stocks to watch: RIL, UltraTech, JSW Steel, GAIL, Zydus Life, IDFC First, RBL Bank, IRFC & Biocon - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top stocks to watch: RIL, UltraTech, JSW Steel, GAIL, Zydus Life, IDFC First, RBL Bank, IRFC & Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News,Biocon Q4 earnings,"Top stocks to watch: RIL, UltraTech, JSW Steel, GAIL, Zydus Life, IDFC First, RBL Bank, IRFC & Biocon - Business Today <a href=""https://news.google.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?oc=5"" target=""_blank"">Top stocks to watch: RIL, UltraTech, JSW Steel, GAIL, Zydus Life, IDFC First, RBL Bank, IRFC & Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",0.0,neutral,0.92965167760849,0.0,neutral,0.0,0.2023,0.044,0.0,0.956,0.25,0.29166666666666663,0.0,0.46065055920283,other,0.0,[],False,True,6,0.0
2025-05-07,2025-05-07 07:00:00,"Stocks to Watch, May 8: Pidilite Industries, Asian Paints, L&T, Titan, MCX, Britannia, Canara Bank, Bharat Forge, Biocon, and more - Upstox","<a href=""https://news.google.com/rss/articles/CBMijwJBVV95cUxQR3MxT3p0TVdES0FqMnNYZlQ1N3FlTy1KTmYyanVHczVuS1FBM21VcWNOQUpfODFBVTlmaFB0aW5CZmRCQnVVNnBOcW40dVNGTXJ5WEpVNGpuZk1wdl9LQ2Z4dVNoX1VfbUFZZjdEUnhoT1dUdDlPMUVxVFdETC1BSUEzUGxZZmZFQWdyWE5oWFBBeGhFNDd2bDF1cE9kU0ZRU1Jnc2cwOUZCOWpnZ291ZTdGLWFHRDZuSEQ1RTN1dmtUbGNhXy1tMXFObVViMlBDaEtQVFV6V1I2cDlpMm93dWRKejZra0U1dG9yOFgyZGlYUGNxdEZiTEl3YTBpc3RQVHotc3p4VHZKVzI4amNv?oc=5"" target=""_blank"">Stocks to Watch, May 8: Pidilite Industries, Asian Paints, L&amp;T, Titan, MCX, Britannia, Canara Bank, Bharat Forge, Biocon, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMijwJBVV95cUxQR3MxT3p0TVdES0FqMnNYZlQ1N3FlTy1KTmYyanVHczVuS1FBM21VcWNOQUpfODFBVTlmaFB0aW5CZmRCQnVVNnBOcW40dVNGTXJ5WEpVNGpuZk1wdl9LQ2Z4dVNoX1VfbUFZZjdEUnhoT1dUdDlPMUVxVFdETC1BSUEzUGxZZmZFQWdyWE5oWFBBeGhFNDd2bDF1cE9kU0ZRU1Jnc2cwOUZCOWpnZ291ZTdGLWFHRDZuSEQ1RTN1dmtUbGNhXy1tMXFObVViMlBDaEtQVFV6V1I2cDlpMm93dWRKejZra0U1dG9yOFgyZGlYUGNxdEZiTEl3YTBpc3RQVHotc3p4VHZKVzI4amNv?oc=5,Google News,Biocon Q4 earnings,"Stocks to Watch, May 8: Pidilite Industries, Asian Paints, L&T, Titan, MCX, Britannia, Canara Bank, Bharat Forge, Biocon, and more - Upstox <a href=""https://news.google.com/rss/articles/CBMijwJBVV95cUxQR3MxT3p0TVdES0FqMnNYZlQ1N3FlTy1KTmYyanVHczVuS1FBM21VcWNOQUpfODFBVTlmaFB0aW5CZmRCQnVVNnBOcW40dVNGTXJ5WEpVNGpuZk1wdl9LQ2Z4dVNoX1VfbUFZZjdEUnhoT1dUdDlPMUVxVFdETC1BSUEzUGxZZmZFQWdyWE5oWFBBeGhFNDd2bDF1cE9kU0ZRU1Jnc2cwOUZCOWpnZ291ZTdGLWFHRDZuSEQ1RTN1dmtUbGNhXy1tMXFObVViMlBDaEtQVFV6V1I2cDlpMm93dWRKejZra0U1dG9yOFgyZGlYUGNxdEZiTEl3YTBpc3RQVHotc3p4VHZKVzI4amNv?oc=5"" target=""_blank"">Stocks to Watch, May 8: Pidilite Industries, Asian Paints, L&amp;T, Titan, MCX, Britannia, Canara Bank, Bharat Forge, Biocon, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.0,neutral,0.9404342770576477,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.125,0.125,0.0,0.5327171385288239,other,0.0,[],False,True,6,0.0
2024-05-17,2024-05-17 07:00:00,LT Foods Q4 results: Net profit rises 14% to Rs 150 cr on strong sales - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxPVWhqaks3cDl5WDQ1bU9GVHRaTm9lMlVCX19ybElJbGVMTTR0ZkNBWFFfNXUxdC02WEtEdjJ3OXA3eUVoU0EwZ3FIQzZTS0ZFUUxnOVUxVDFLN2wtTS1ILUxiVXFIcmZvdGh1MmE1SFFwdHQ0dG1ZZ0xtV29MMUg2U0R5b0xPbFl3VWdqVHFJNTRrMkNUenpBelZlS2p3WGE1b2FwZ2xCbEdScFZXWUNkRzdDWEUxWkNIc2cxaDhNck41aFR6cWF4UUY5QmRxX3hjbjFxb0Jic9IB3AFBVV95cUxPTzc2d3VPcU80N3lUOGZtNDhKT19CbEhCaDhWZHlqanRuVzJvSmczbmVKYnRaT25yeFlqazVKTXpOck8zaHlVZHI3ZXB6N09WbE1xZTAwcjVzNE1lUzFkWjV4bFJoQ2p6S1BzMFYtRERHeFc5bGpZTmdVS3FlUU9tQjN5X25HWkc2M3ZTRWdXVFZ3U01fS2pFdVhKb0t1c2FiRVpDWjhSQk5JclNIQWJtMW4wbkJCTnNtZ1EzZkp1SDAyODhwcmtwRElrd1hvSE5MVUVxNnRHUTE5TTBh?oc=5"" target=""_blank"">LT Foods Q4 results: Net profit rises 14% to Rs 150 cr on strong sales</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q4 earnings,"LT Foods Q4 results: Net profit rises 14% to Rs 150 cr on strong sales - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">LT Foods Q4 results: Net profit rises 14% to Rs 150 cr on strong sales</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.941914975643158,positive,0.941914975643158,0.0,neutral,0.0,0.9081,0.279,0.0,0.721,0.14444444444444446,0.24444444444444446,0.5382371289389474,0.6648198066958675,other,0.0,[],False,False,1,0.0
2024-05-17,2024-05-17 07:00:00,"JSW Steel Q4 results: Net profit declines nearly 65% to Rs 1,299 crore - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">JSW Steel Q4 results: Net profit declines nearly 65% to Rs 1,299 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q4 earnings,"JSW Steel Q4 results: Net profit declines nearly 65% to Rs 1,299 crore - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">JSW Steel Q4 results: Net profit declines nearly 65% to Rs 1,299 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",-0.9738329648971558,negative,0.9738329648971558,0.0,neutral,0.0,0.7003,0.162,0.0,0.838,0.03333333333333333,0.13333333333333333,-0.5564759799412319,0.5691554327434963,other,0.0,[],False,False,1,0.0
2024-05-16,2024-05-16 07:00:00,"Info Edge Q4 results: Net profit at Rs 88 crore, revenue rises 7.9% - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Info Edge Q4 results: Net profit at Rs 88 crore, revenue rises 7.9%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q4 earnings,"Info Edge Q4 results: Net profit at Rs 88 crore, revenue rises 7.9% - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">Info Edge Q4 results: Net profit at Rs 88 crore, revenue rises 7.9%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9186903238296509,positive,0.9186903238296509,0.0,neutral,0.0,0.7003,0.162,0.0,0.838,0.0,0.0,0.5249658993312291,0.8094951619148254,other,0.0,[],False,False,1,0.0
2024-05-16,2024-05-16 07:00:00,"M&M Q4 results: PAT rises 4% to Rs 2,754 crore on strong auto biz - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">M&amp;M Q4 results: PAT rises 4% to Rs 2,754 crore on strong auto biz</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q4 earnings,"M&M Q4 results: PAT rises 4% to Rs 2,754 crore on strong auto biz - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">M&amp;M Q4 results: PAT rises 4% to Rs 2,754 crore on strong auto biz</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9409510493278503,positive,0.9409510493278503,0.0,neutral,0.0,0.765,0.171,0.0,0.829,0.21666666666666667,0.3666666666666667,0.5376863139016288,0.6408725719981724,other,0.0,[],False,False,1,0.0
2024-05-17,2024-05-17 07:00:00,GSK Pharma Q4 results: Net profit up 46% at Rs 194.48 cr on higher sales - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">GSK Pharma Q4 results: Net profit up 46% at Rs 194.48 cr on higher sales</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q4 earnings,"GSK Pharma Q4 results: Net profit up 46% at Rs 194.48 cr on higher sales - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">GSK Pharma Q4 results: Net profit up 46% at Rs 194.48 cr on higher sales</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9481936097145081,positive,0.9481936097145081,0.0,neutral,0.0,0.7003,0.146,0.0,0.854,0.08333333333333333,0.16666666666666666,0.5418249198368618,0.5772756476826137,other,0.0,[],False,False,1,0.0
2024-05-17,2024-05-17 07:00:00,IIFL Securities Q4 result: Net profit more than doubles to Rs 180 cr - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi1gFBVV95cUxNLWlZNDhCTDc2bkg4R1lycXRRY1ZoMGduYVh5Uk1nWi1qby1ZOWdUdnBrTkRoYjBNWklTaDVlRTRNN1dLQVFTbDNsY21WUy0zV2lBN01yNWxCWVdrTklqR3FuTmtESHlfVmFUdDlDV3JTdExnYU1pbG5EY2haUG1jY3E5dVFRN3dRaHNhSjJyX3Z3alphOG5OUEtHTVlUS19hTkhsaS1pdzBKbUh4bnZDcjJCWV90SmRNcFNxREROWnVEYTlLOGpxbTB6ZHB4bnVGV3RRWTVB0gHbAUFVX3lxTFBXc2liaGRSVUh1YjFJaXB0YUpLOC1DQmlRYi1MMFp4ajdnMWhrUHpjcENWTGxGM294RUxFck5ocE1JTUhLQnFyZW5la3pWakluYldDQ2hmcG9TNDVTY1MtYk1YWXlmVHk0c0hEcmhpbHV1ZXJ3QmUzTEFMZjFnX0dJSFVVVGNtOVZia2lTcUdjcFB0a0tGUkdoV2NlVUN4THB5aGFhVUdrMmYtSVBDdG0zbjlBMGY5WkE5VlMyNTJGVUx4MFVqVGxDTmNmSHhwOEdXQ1o0ZWQzVmhoMA?oc=5"" target=""_blank"">IIFL Securities Q4 result: Net profit more than doubles to Rs 180 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News,Biocon Q4 earnings,"IIFL Securities Q4 result: Net profit more than doubles to Rs 180 cr - Business Standard <a href=""https://news.google.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?oc=5"" target=""_blank"">IIFL Securities Q4 result: Net profit more than doubles to Rs 180 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",0.9259461164474487,positive,0.9259461164474487,0.0,neutral,0.0,0.8481,0.267,0.0,0.733,0.16666666666666666,0.16666666666666666,0.5291120665413992,0.6469042610380386,other,0.0,[],False,False,1,0.0
2025-05-08,2025-05-08 07:00:00,"Q4 results: L&T, Titan, Asian Paints, REC, Britannia, Pidilite among 76 firms to announce earnings on May 8; check full list - Upstox","<a href=""https://news.google.com/rss/articles/CBMijwJBVV95cUxQTlhnU0ZsQU9IdG1POXFta0RVcnlDbHQ0M2ZMQ1ZTbUpTWEF6VC1DSlNYVjdFYzFwdFF0alRsLTVsY09kdy16aVBIZW1ZSXM0c1p0TEoyQWtFWWtGdlNoWmUzMjQwUVRReXZCYVZGaW5tcUJuTlk3NzhPcUpsYU9jcjVVYnZlM1VGcVJfTzYxOG0tOGQ4dlpoUXM4MlN3VUh3T2syUjVsY0dQQ3Z5X0FBUUttRFN0RDllbllLRW1wNkNSTTVQck41UUpfMlozeEhDYXJackcyUFNZQnZIQXBXMG9SYTliV1FtS3lwOUU3YmhiTTkwU3drOGVNQXBkNE1kck0zeVplbHczY1MyRi1n?oc=5"" target=""_blank"">Q4 results: L&amp;T, Titan, Asian Paints, REC, Britannia, Pidilite among 76 firms to announce earnings on May 8; check full list</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMijwJBVV95cUxQTlhnU0ZsQU9IdG1POXFta0RVcnlDbHQ0M2ZMQ1ZTbUpTWEF6VC1DSlNYVjdFYzFwdFF0alRsLTVsY09kdy16aVBIZW1ZSXM0c1p0TEoyQWtFWWtGdlNoWmUzMjQwUVRReXZCYVZGaW5tcUJuTlk3NzhPcUpsYU9jcjVVYnZlM1VGcVJfTzYxOG0tOGQ4dlpoUXM4MlN3VUh3T2syUjVsY0dQQ3Z5X0FBUUttRFN0RDllbllLRW1wNkNSTTVQck41UUpfMlozeEhDYXJackcyUFNZQnZIQXBXMG9SYTliV1FtS3lwOUU3YmhiTTkwU3drOGVNQXBkNE1kck0zeVplbHczY1MyRi1n?oc=5,Google News,Biocon Q4 earnings,"Q4 results: L&T, Titan, Asian Paints, REC, Britannia, Pidilite among 76 firms to announce earnings on May 8; check full list - Upstox <a href=""https://news.google.com/rss/articles/CBMijwJBVV95cUxQTlhnU0ZsQU9IdG1POXFta0RVcnlDbHQ0M2ZMQ1ZTbUpTWEF6VC1DSlNYVjdFYzFwdFF0alRsLTVsY09kdy16aVBIZW1ZSXM0c1p0TEoyQWtFWWtGdlNoWmUzMjQwUVRReXZCYVZGaW5tcUJuTlk3NzhPcUpsYU9jcjVVYnZlM1VGcVJfTzYxOG0tOGQ4dlpoUXM4MlN3VUh3T2syUjVsY0dQQ3Z5X0FBUUttRFN0RDllbllLRW1wNkNSTTVQck41UUpfMlozeEhDYXJackcyUFNZQnZIQXBXMG9SYTliV1FtS3lwOUU3YmhiTTkwU3drOGVNQXBkNE1kck0zeVplbHczY1MyRi1n?oc=5"" target=""_blank"">Q4 results: L&amp;T, Titan, Asian Paints, REC, Britannia, Pidilite among 76 firms to announce earnings on May 8; check full list</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",0.0,neutral,0.9077354073524475,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.13999999999999999,0.22000000000000003,0.0,0.5238677036762237,other,0.0,[],False,False,1,0.0
2023-05-24,2023-05-24 07:00:00,Biocon surges 7% post-Q4 nos; should you buy now or wait for correction? - Zee Business,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon surges 7% post-Q4 nos; should you buy now or wait for correction?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News,Biocon Q4 earnings,"Biocon surges 7% post-Q4 nos; should you buy now or wait for correction? - Zee Business <a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon surges 7% post-Q4 nos; should you buy now or wait for correction?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",0.0,neutral,0.7845162749290466,0.0,neutral,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.7845162749290466,other,0.0,[],False,True,6,0.0
